data_2m6s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m6s _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -132.62 133.82 44.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.068 1.747 . . . . 0.0 108.461 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 mm -125.95 117.36 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.537 0.735 . . . . 0.0 111.804 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.09 126.81 7.57 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 168.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -118.32 91.21 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.673 1.189 . . . . 0.0 107.857 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -90.5 137.62 32.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.356 1.063 . . . . 0.0 110.478 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -121.26 144.77 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.523 0.678 . . . . 0.0 112.242 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.16 104.56 0.49 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.247 0.927 . . . . 0.0 111.207 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 t -151.13 163.77 38.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.462 1.105 . . . . 0.0 113.076 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.1 mtp -129.82 2.0 4.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 112.204 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -140.18 -11.87 1.08 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.8 -0.8 67.67 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 171.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -74.42 -42.94 58.34 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.739 1.769 . . . . 0.0 111.732 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -33.45 74.77 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.564 -0.71 . . . . 0.0 112.156 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.08 -40.97 97.63 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.997 -1.065 . . . . 0.0 112.562 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 tt -56.15 -44.97 79.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.142 0.883 . . . . 0.0 111.623 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.22 -38.84 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.836 0.454 . . . . 0.0 111.795 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.5 90.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.22 -42.55 99.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.868 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -61.68 -42.44 98.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.501 -0.749 . . . . 0.0 112.385 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.85 95.03 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.771 0.714 . . . . 0.0 112.457 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.08 -48.75 79.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.325 0.65 . . . . 0.0 111.539 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.22 91.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.785 0.834 . . . . 0.0 112.746 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.13 -47.75 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.411 1.085 . . . . 0.0 112.363 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.29 -39.71 78.15 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.734 -0.604 . . . . 0.0 109.892 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -58.32 -44.72 88.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.927 1.291 . . . . 0.0 112.072 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -38.24 86.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.26 1.024 . . . . 0.0 112.561 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.44 -25.01 64.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.938 0.895 . . . . 0.0 112.892 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.16 -7.03 8.7 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.922 1.725 . . . . 0.0 114.759 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -76.34 139.25 40.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.828 1.251 . . . . 0.0 110.93 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -76.93 76.94 3.5 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.784 0.834 . . . . 0.0 110.909 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.34 157.8 32.08 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 111.624 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.3 m -151.99 117.73 5.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.103 -0.998 . . . . 0.0 109.784 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.13 144.97 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.708 0.803 . . . . 0.0 112.262 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.34 97.95 4.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.409 1.484 . . . . 0.0 110.822 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.99 -18.02 60.92 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -141.67 66.04 21.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.893 1.677 . . . . 0.0 109.764 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.67 168.75 24.1 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.14 3.227 . . . . 0.0 115.237 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -149.34 159.96 43.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.973 2.109 . . . . 0.0 109.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.02 -38.05 48.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.954 -1.091 . . . . 0.0 111.468 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -56.03 -24.8 41.66 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.41 1.484 . . . . 0.0 114.826 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -99.6 -23.72 14.97 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.567 1.547 . . . . 0.0 112.908 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -71.59 -39.6 70.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.803 0.841 . . . . 0.0 112.727 170.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.98 -47.66 86.47 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.778 2.031 . . . . 0.0 115.594 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.88 -5.14 1.76 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.101 3.2 . . . . 0.0 117.731 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -119.56 2.84 11.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -28.26 69.52 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.227 -1.546 . . . . 0.0 113.187 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.91 4.91 23.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.705 1.202 . . . . 0.0 113.094 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -135.71 -132.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.867 2.067 . . . . 0.0 110.1 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -139.09 159.47 42.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.943 1.697 . . . . 0.0 111.005 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.37 168.51 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.034 1.733 . . . . 0.0 110.391 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 151.15 23.36 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.849 -1.157 . . . . 0.0 110.433 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.81 136.64 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.829 1.252 . . . . 0.0 110.405 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -135.1 95.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.937 1.295 . . . . 0.0 107.719 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 m -133.56 169.12 17.45 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -167.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -137.71 -158.95 0.91 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.122 1.369 . . . . 0.0 112.578 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.1 m -135.82 151.75 50.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.757 1.623 . . . . 0.0 110.872 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.127 1.371 . . . . 0.0 111.696 -179.797 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.498 0.666 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.47 143.96 93.78 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.219 -0.926 . . . . 0.0 111.054 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.93 137.37 43.82 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.088 3.859 . . . . 0.0 112.349 170.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.85 -24.35 66.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -61.45 -17.95 56.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.718 1.607 . . . . 0.0 114.802 171.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -124.54 -10.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.543 1.137 . . . . 0.0 113.845 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.8 t -46.98 -48.98 51.93 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.965 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.44 -17.21 43.94 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.379 1.885 . . . . 0.0 114.385 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.2 -43.71 17.31 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.962 0.801 . . . . 0.0 109.572 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.57 -49.65 72.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.096 1.359 . . . . 0.0 111.386 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -62.12 -41.7 98.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.846 -1.159 . . . . 0.0 112.262 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.99 -50.23 67.55 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.647 0.641 . . . . 0.0 112.828 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.3 -39.41 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 O-C-N 121.382 -1.069 . . . . 0.0 110.897 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -65.88 -36.7 84.14 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -112.71 -20.36 11.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.2 m -125.61 10.86 7.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.876 1.271 . . . . 0.0 113.782 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.13 -51.59 1.11 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.615 1.566 . . . . 0.0 110.302 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.31 -28.98 0.33 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 119.552 2.581 . . . . 0.0 119.552 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -153.3 136.45 15.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.499 2.15 . . . . 0.0 111.99 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -150.64 56.11 2.0 Allowed Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.219 1.408 . . . . 0.0 113.296 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.43 -18.67 65.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.036 3.158 . . . . 0.0 115.323 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.97 0.17 14.98 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.596 1.959 . . . . 0.0 113.504 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.71 124.07 22.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 109.186 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -121.31 138.89 54.04 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.201 1.4 . . . . 0.0 109.263 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -160.92 -167.48 1.84 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -168.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 160.86 31.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.625 2.536 . . . . 0.0 109.714 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.82 135.46 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 117.897 0.849 . . . . 0.0 112.212 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.2 mt -119.57 130.61 73.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.04 146.85 48.29 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.044 0.938 . . . . 0.0 110.171 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tt -141.53 133.87 28.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.553 0.741 . . . . 0.0 110.852 -169.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.58 -166.15 33.8 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 121.951 0.751 . . . . 0.0 113.733 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -98.07 118.4 34.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.877 1.271 . . . . 0.0 110.962 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.4 p -64.26 -9.94 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.974 1.71 . . . . 0.0 115.207 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -70.56 -8.26 50.1 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -138.13 159.55 41.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.67 1.188 . . . . 0.0 113.387 -169.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.16 -34.5 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.127 1.371 . . . . 0.0 113.176 -171.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -76.2 34.85 0.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.592 1.157 . . . . 0.0 113.215 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.62 113.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.915 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.3 m 52.85 25.36 3.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.329 2.251 . . . . 0.0 116.287 -171.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -60.28 -30.22 69.32 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.661 -1.275 . . . . 0.0 113.692 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.55 -38.8 61.62 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.897 -1.127 . . . . 0.0 112.695 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.67 -40.33 66.06 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.524 -0.986 . . . . 0.0 112.791 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -58.79 -40.74 84.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.881 0.872 . . . . 0.0 112.911 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.86 -38.21 84.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.27 -31.3 68.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.39 0.995 . . . . 0.0 113.413 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.57 -43.73 79.92 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 119.763 -1.835 . . . . 0.0 110.826 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.39 71.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.57 -29.64 11.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.586 1.554 . . . . 0.0 112.936 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.32 -39.1 6.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.517 1.127 . . . . 0.0 111.362 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -67.36 -34.13 76.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.306 -0.871 . . . . 0.0 113.338 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.79 -14.09 49.81 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.427 -0.796 . . . . 0.0 112.414 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -111.57 10.15 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.851 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 72.31 18.93 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.596 1.558 . . . . 0.0 114.516 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.8 165.35 1.76 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.506 0.722 . . . . 0.0 111.92 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -135.6 88.4 2.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 120.76 -1.213 . . . . 0.0 110.344 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -62.42 142.83 57.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.354 0.662 . . . . 0.0 111.346 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.56 34.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.579 1.552 . . . . 0.0 110.757 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.92 -167.89 40.91 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.841 -1.162 . . . . 0.0 113.562 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -120.17 143.14 48.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.515 1.526 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.1 ttp -67.53 124.82 24.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.265 1.026 . . . . 0.0 112.018 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -83.86 133.66 34.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.218 1.007 . . . . 0.0 109.968 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -122.41 98.13 5.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 111.575 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.1 mt -89.47 134.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.617 1.567 . . . . 0.0 111.772 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -113.38 66.97 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.624 3.17 . . . . 0.0 111.35 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -46.1 -38.94 8.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.455 1.902 . . . . 0.0 116.132 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.1 m -62.38 -16.12 52.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -134.46 12.49 3.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.065 1.746 . . . . 0.0 111.964 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -144.5 68.46 15.0 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.242 1.817 . . . . 0.0 110.704 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.85 6.92 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.841 3.694 . . . . 0.0 114.701 -171.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.5 58.91 41.66 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.275 1.83 . . . . 0.0 110.987 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -61.47 -22.06 73.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.608 3.539 . . . . 0.0 114.24 -169.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.56 -44.26 56.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.999 1.32 . . . . 0.0 111.051 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.6 p -68.57 -18.32 64.31 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -95.11 -11.93 27.38 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.283 1.433 . . . . 0.0 112.428 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 26.0 p -128.3 -31.63 2.29 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.71 -53.1 69.13 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.923 1.238 . . . . 0.0 113.877 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.61 -29.42 52.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.418 1.542 . . . . 0.0 112.678 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -61.63 -48.94 78.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.709 0.803 . . . . 0.0 111.715 171.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.31 -40.75 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.694 0.679 . . . . 0.0 110.535 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.57 -44.1 89.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.701 0.682 . . . . 0.0 111.249 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.77 -55.86 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 112.606 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.29 -37.51 67.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.881 0.873 . . . . 0.0 112.195 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.36 -20.45 65.44 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.407 1.003 . . . . 0.0 115.158 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.4 p -74.58 -17.94 60.65 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.654 1.727 . . . . 0.0 113.165 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.62 -5.8 53.29 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.856 1.262 . . . . 0.0 112.73 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.76 -173.6 0.79 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.085 1.754 . . . . 0.0 111.361 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.371 1.869 . . . . 0.0 114.505 178.389 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.969 0 CA-C-O 120.793 0.33 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.44 134.66 47.95 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.174 1.389 . . . . 0.0 109.699 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.03 124.76 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.26 130.63 10.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 168.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -117.65 90.86 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.01 1.324 . . . . 0.0 108.331 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.71 146.58 24.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.852 0.861 . . . . 0.0 112.978 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.44 129.41 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.255 1.026 . . . . 0.0 111.833 -169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.93 71.71 0.46 Allowed Glycine 0 N--CA 1.468 0.798 0 C-N-CA 126.615 2.055 . . . . 0.0 109.568 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 t -129.76 177.73 7.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.631 1.172 . . . . 0.0 113.787 -169.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.3 tpt -135.58 -36.88 0.77 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.153 0.981 . . . . 0.0 113.417 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -129.28 -22.68 3.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.568 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.65 -2.55 7.0 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.7 1.143 . . . . 0.0 115.16 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -36.8 85.08 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.447 1.624 . . . . 0.0 113.084 -169.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 -31.69 37.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.593 1.157 . . . . 0.0 113.505 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.4 tp -59.06 -35.34 73.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.953 -1.092 . . . . 0.0 113.218 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 tp -48.32 -42.04 30.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.555 0.742 . . . . 0.0 111.707 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.26 -36.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.976 -0.535 . . . . 0.0 112.137 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.04 94.37 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.703 1.138 . . . . 0.0 112.415 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.38 -42.57 99.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.032 0.533 . . . . 0.0 112.102 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -60.83 -46.95 88.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.412 0.685 . . . . 0.0 112.38 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.64 84.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.179 0.592 . . . . 0.0 111.907 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.8 -45.82 70.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.136 0.575 . . . . 0.0 111.89 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.75 74.44 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.464 0.706 . . . . 0.0 112.812 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.25 -45.88 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.831 1.252 . . . . 0.0 111.973 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.2 mt -73.52 -40.1 64.29 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.037 0.935 . . . . 0.0 109.846 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.4 m -56.92 -46.6 81.89 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.35 1.06 . . . . 0.0 111.573 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.88 82.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.042 0.937 . . . . 0.0 113.325 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -73.44 -9.25 58.49 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 171.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.95 -6.01 34.74 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.574 1.559 . . . . 0.0 114.982 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -76.84 153.73 34.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.54 1.17 . . . . 0.0 112.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -80.76 130.84 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.66 150.78 46.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.336 0.654 . . . . 0.0 111.457 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -155.75 121.48 4.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.966 0.906 . . . . 0.0 109.925 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.87 150.3 7.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.194 0.521 . . . . 0.0 111.383 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -133.53 102.55 5.55 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.708 1.203 . . . . 0.0 107.985 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.88 -27.12 60.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.57 1.148 . . . . 0.0 113.855 -170.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.65 58.89 4.76 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 126.297 1.839 . . . . 0.0 110.508 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.05 163.94 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.212 3.275 . . . . 0.0 116.114 -169.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.69 170.18 15.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.449 2.3 . . . . 0.0 109.178 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -53.28 -38.85 63.44 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.809 -1.182 . . . . 0.0 113.312 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.84 -13.93 28.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -89.69 -29.41 18.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.719 1.145 . . . . 0.0 112.52 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -81.82 -42.85 19.1 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 0.0 112.665 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.4 tp -47.59 -44.65 55.92 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 126.803 2.041 . . . . 0.0 114.54 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.01 -9.28 0.66 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.271 3.981 . . . . 0.0 118.129 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.22 5.21 7.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 113.173 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -57.02 -36.45 70.46 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.227 -0.921 . . . . 0.0 112.605 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.03 13.06 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.561 1.944 . . . . 0.0 114.479 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -134.43 -130.43 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.591 1.556 . . . . 0.0 111.482 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.33 158.61 44.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.895 2.078 . . . . 0.0 109.691 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.36 172.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 110.467 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -154.86 149.58 26.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.683 1.593 . . . . 0.0 108.86 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.6 139.76 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.402 -0.811 . . . . 0.0 111.143 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 m -124.53 125.95 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.073 1.349 . . . . 0.0 108.257 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.7 m -150.87 158.28 43.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.041 -1.662 . . . . 0.0 113.38 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -136.14 178.61 6.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.505 1.522 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 m -121.51 135.37 55.03 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.01 1.324 . . . . 0.0 110.803 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 126.613 1.965 . . . . 0.0 109.28 -173.297 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.6 t0 . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.07 152.59 96.69 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.279 -0.888 . . . . 0.0 111.339 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -85.21 164.69 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.684 2.923 . . . . 0.0 112.566 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.0 -19.16 64.08 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -61.48 -19.76 62.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 tt -127.01 -8.33 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -48.42 -51.56 50.27 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-O 117.418 -1.277 . . . . 0.0 112.449 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.92 -5.18 16.56 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.362 2.041 . . . . 0.0 114.326 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -92.39 -43.43 9.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.227 0.921 . . . . 0.0 109.399 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.46 -50.03 74.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.806 1.243 . . . . 0.0 111.387 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -62.22 -40.0 94.68 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.981 -1.074 . . . . 0.0 112.485 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.89 -44.65 55.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.169 0.89 . . . . 0.0 113.505 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.43 -47.45 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.098 1.449 . . . . 0.0 110.047 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -59.92 -48.61 81.0 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.581 1.153 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.85 -41.82 22.57 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -88.52 -28.34 20.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -97.13 -42.65 7.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.85 -38.12 0.5 Allowed Glycine 0 CA--C 1.542 1.777 0 C-N-CA 125.84 1.686 . . . . 0.0 115.757 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -145.01 151.58 38.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.26 2.224 . . . . 0.0 110.82 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.24 43.12 0.23 Allowed Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -57.6 -29.48 85.3 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.141 2.561 . . . . 0.0 114.649 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -68.32 -15.26 63.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.924 2.09 . . . . 0.0 115.145 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.27 122.63 28.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.54 136.83 54.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 108.766 169.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -156.43 -172.29 4.02 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.2 161.37 27.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.127 1.346 . . . . 0.0 109.86 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.95 142.18 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.666 0.746 . . . . 0.0 111.749 -169.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mt -127.71 129.48 70.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.51 151.63 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.697 0.76 . . . . 0.0 110.853 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 tt -143.68 131.56 21.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.249 1.02 . . . . 0.0 109.976 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.78 -147.85 5.17 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 174.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -143.78 125.04 14.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.786 1.234 . . . . 0.0 110.385 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -60.16 -7.16 1.72 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -63.9 -7.87 9.49 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 171.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -126.49 136.08 52.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.42 1.488 . . . . 0.0 111.154 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.75 -36.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.513 1.125 . . . . 0.0 113.488 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.92 -17.11 59.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 23.1 t80 34.69 -118.23 0.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.443 1.897 . . . . 0.0 112.867 -169.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.19 24.69 0.52 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -46.36 -43.28 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.095 1.316 . . . . 0.0 113.883 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.55 -36.84 86.92 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 118.49 0.586 . . . . 0.0 113.142 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.53 -45.06 48.23 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.928 0.775 . . . . 0.0 113.463 170.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -58.24 -38.1 76.2 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.357 1.078 . . . . 0.0 113.374 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -55.89 -41.22 74.14 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.351 0.661 . . . . 0.0 112.29 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -71.4 -26.03 62.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.63 -41.45 45.88 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.697 -1.252 . . . . 0.0 111.462 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.93 -40.12 72.67 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.1 tp -50.68 -34.3 26.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.289 1.835 . . . . 0.0 112.92 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -103.71 -36.59 7.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -67.84 -32.39 72.89 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.9 -1.125 . . . . 0.0 113.022 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.03 -16.8 62.48 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 119.17 0.895 . . . . 0.0 111.87 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -107.04 10.14 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.06 1.744 . . . . 0.0 112.672 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m 65.71 23.95 11.55 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 114.713 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.3 177.96 0.23 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 0.0 112.618 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -136.72 163.57 30.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.498 -1.377 . . . . 0.0 109.673 -173.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -133.21 147.09 52.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.11 22.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.926 1.691 . . . . 0.0 112.14 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.2 176.56 41.1 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.405 1.479 . . . . 0.0 114.556 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.84 162.13 16.34 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.801 1.24 . . . . 0.0 112.398 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttp -71.32 123.17 21.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.615 -0.678 . . . . 0.0 111.352 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.25 138.81 47.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.035 0.934 . . . . 0.0 110.206 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.7 mt -124.73 91.3 3.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.84 1.256 . . . . 0.0 112.129 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.78 137.65 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.403 1.481 . . . . 0.0 110.34 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -133.07 102.81 5.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.278 1.037 . . . . 0.0 112.553 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.03 14.31 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 83.1 p -72.25 -14.68 61.84 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.57 1.077 . . . . 0.0 113.825 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.54 -7.54 1.3 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -136.91 112.14 9.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.538 1.135 . . . . 0.0 112.017 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.42 -3.62 12.63 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.68 2.92 . . . . 0.0 114.171 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -134.74 84.02 39.97 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.265 1.426 . . . . 0.0 111.78 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -46.24 -33.76 12.59 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 126.103 4.535 . . . . 0.0 116.229 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.08 -40.79 59.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.139 1.376 . . . . 0.0 112.605 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.5 p -67.26 -9.95 45.73 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -115.25 -3.45 12.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.587 1.155 . . . . 0.0 112.445 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.0 p -133.12 -27.45 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.66 -53.39 60.88 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 120.011 1.278 . . . . 0.0 112.752 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.18 -29.77 32.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.592 1.528 . . . . 0.0 112.694 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -60.76 -50.1 74.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.354 0.662 . . . . 0.0 111.463 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.41 -39.38 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 118.287 0.494 . . . . 0.0 110.571 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.48 -34.88 73.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.022 0.828 . . . . 0.0 112.403 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.51 -63.06 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.319 0.963 . . . . 0.0 111.945 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -57.38 -35.8 70.43 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.788 1.235 . . . . 0.0 113.045 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.58 -33.87 68.08 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.864 0.745 . . . . 0.0 113.905 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.8 p -69.99 -17.62 63.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.426 1.613 . . . . 0.0 113.884 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.99 -18.08 44.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.35 -32.72 73.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.255 1.386 0 C-N-CA 124.844 1.258 . . . . 0.0 112.364 -175.207 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 121.224 0.535 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.03 110.54 7.03 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 108.647 -173.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mm -110.89 137.41 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -169.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.01 126.61 8.85 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mt -119.62 101.12 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.493 1.117 . . . . 0.0 108.149 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.16 120.41 39.47 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.696 0.799 . . . . 0.0 112.481 -168.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.28 143.31 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.904 1.282 . . . . 0.0 110.768 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.84 76.43 0.31 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.064 1.316 . . . . 0.0 110.278 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 t -121.47 154.51 36.5 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.854 0.827 . . . . 0.0 112.447 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 tpt -90.45 -28.72 18.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.527 0.731 . . . . 0.0 112.548 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -146.3 -16.14 0.44 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.57 -14.56 4.74 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -62.96 -42.98 99.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.399 2.1 . . . . 0.0 113.093 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -77.84 -26.01 49.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.48 -44.31 89.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.886 -1.133 . . . . 0.0 112.177 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.8 -45.33 70.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.687 0.676 . . . . 0.0 111.589 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.48 -38.69 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.005 0.522 . . . . 0.0 111.892 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.66 92.44 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.964 0.802 . . . . 0.0 112.885 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.82 -43.7 98.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.696 -0.628 . . . . 0.0 112.081 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.32 -42.34 99.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.543 -0.723 . . . . 0.0 112.311 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.12 90.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.61 -0.681 . . . . 0.0 112.034 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -55.11 -47.8 74.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.425 0.69 . . . . 0.0 111.445 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.42 84.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.736 0.814 . . . . 0.0 112.849 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.13 -45.25 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.481 1.112 . . . . 0.0 112.305 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.34 -41.8 72.74 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.547 -0.721 . . . . 0.0 109.787 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -56.64 -42.92 79.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.919 1.288 . . . . 0.0 112.467 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 -42.33 65.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.31 1.044 . . . . 0.0 113.442 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -71.07 -37.04 72.48 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.4 21.86 0.03 OUTLIER Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -133.66 -175.68 3.91 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.458 1.503 . . . . 0.0 111.155 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.47 144.37 48.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.389 1.476 . . . . 0.0 108.379 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.74 153.1 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.825 -0.547 . . . . 0.0 112.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.5 m -137.6 113.46 9.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 109.442 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.02 147.34 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.336 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -134.79 105.07 6.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.97 -30.0 58.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.982 1.313 . . . . 0.0 114.041 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -148.68 65.1 8.2 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.489 1.916 . . . . 0.0 109.601 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.45 171.71 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.685 2.923 . . . . 0.0 114.188 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.85 169.18 16.1 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.77 2.028 . . . . 0.0 108.913 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.35 -35.31 65.07 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.671 -1.268 . . . . 0.0 112.344 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -57.53 -22.71 46.09 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -83.75 -36.74 23.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.121 0.873 . . . . 0.0 112.478 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -70.57 -39.94 73.61 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.727 0.694 . . . . 0.0 112.034 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -43.25 -58.07 4.61 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 127.241 2.217 . . . . 0.0 115.273 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.17 -26.62 10.48 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.702 2.268 . . . . 0.0 114.731 -171.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -74.18 -7.12 51.52 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -62.11 -30.57 71.11 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.667 -1.27 . . . . 0.0 112.694 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.71 2.64 7.79 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.309 1.444 . . . . 0.0 113.99 171.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -133.14 -120.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.082 2.153 . . . . 0.0 109.566 -169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -143.55 158.1 43.92 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 109.373 171.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.9 163.16 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.315 1.446 . . . . 0.0 110.718 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.19 141.87 20.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.225 1.012 . . . . 0.0 111.48 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.81 133.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.563 1.545 . . . . 0.0 109.606 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.97 106.49 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.4 m -149.16 155.16 40.24 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.297 -1.502 . . . . 0.0 114.913 -168.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -113.29 -174.22 2.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.37 1.468 . . . . 0.0 112.852 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.2 m -129.23 139.86 51.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.673 1.189 . . . . 0.0 110.666 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 108.352 -174.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -65.76 146.03 99.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.659 1.584 . . . . 0.0 112.987 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.01 155.27 19.8 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.706 2.937 . . . . 0.0 111.602 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.7 -23.86 63.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.8 m -56.85 -16.99 7.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.692 1.597 . . . . 0.0 115.153 174.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.0 tt -132.96 -4.98 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.3 t -48.88 -43.13 64.71 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.364 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 -13.95 41.02 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 CA-C-N 122.433 1.905 . . . . 0.0 114.928 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.83 -48.92 6.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.073 0.949 . . . . 0.0 109.017 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -59.85 -46.85 87.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.536 1.534 . . . . 0.0 113.612 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.6 -24.22 58.84 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.042 -1.037 . . . . 0.0 113.098 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.09 -52.21 4.14 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.218 0.913 . . . . 0.0 112.996 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.54 -38.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.591 1.195 . . . . 0.0 111.515 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -62.24 -35.43 78.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 113.297 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -115.7 -32.48 5.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -82.05 -19.14 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.3 mt -127.67 -48.87 1.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.689 1.196 . . . . 0.0 112.068 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.64 -22.84 0.23 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.932 1.933 . . . . 0.0 117.932 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.68 130.44 10.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.51 1.655 . . . . 0.0 111.704 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -163.29 66.97 1.64 Allowed Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.881 1.272 . . . . 0.0 112.895 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.3 -23.18 66.04 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.937 2.425 . . . . 0.0 114.649 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -72.53 -5.48 37.29 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -76.52 133.79 39.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.199 1.0 . . . . 0.0 111.778 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.56 145.01 51.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.732 1.613 . . . . 0.0 110.617 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -162.35 -170.9 2.6 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 165.02 33.61 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.869 2.176 . . . . 0.0 110.727 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 t -142.07 136.94 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.125 0.963 . . . . 0.0 112.259 -170.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -123.15 116.66 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.05 149.32 32.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.339 1.056 . . . . 0.0 110.571 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -138.36 149.77 45.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.267 1.027 . . . . 0.0 111.672 -170.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.03 -143.57 7.75 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.083 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -141.3 126.08 18.05 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.209 1.404 . . . . 0.0 110.262 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -66.02 -12.88 58.29 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -68.61 0.01 4.66 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -125.25 12.73 8.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.46 1.504 . . . . 0.0 114.479 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.37 -44.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 127.9 2.48 . . . . 0.0 115.205 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -76.24 48.33 0.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.027 1.285 . . . . 0.0 111.764 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.18 116.84 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.302 -1.499 . . . . 0.0 112.303 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.1 m 51.05 24.35 1.86 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.851 2.06 . . . . 0.0 116.498 -172.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.33 -15.49 48.53 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.693 -1.254 . . . . 0.0 113.559 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.18 -67.93 1.81 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.7 -36.09 77.22 Favored Glycine 0 CA--C 1.536 1.401 0 O-C-N 121.557 -0.966 . . . . 0.0 114.258 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.27 -38.32 76.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.295 1.047 . . . . 0.0 113.652 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.92 -34.68 78.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.63 0.65 . . . . 0.0 112.189 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.67 -29.88 62.58 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.124 0.874 . . . . 0.0 112.78 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.3 -46.02 74.8 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.098 -1.626 . . . . 0.0 110.395 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -35.8 72.42 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -49.15 -44.16 42.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.936 1.294 . . . . 0.0 111.445 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 mt -80.52 -31.92 36.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.254 0.622 . . . . 0.0 111.69 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -65.77 -32.75 74.47 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.854 -1.154 . . . . 0.0 112.01 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -61.75 -26.18 67.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.885 0.766 . . . . 0.0 112.175 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -82.17 -27.1 32.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.598 -0.689 . . . . 0.0 112.471 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.9 m 101.61 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 130.161 3.384 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 156.97 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.54 1.136 . . . . 0.0 113.625 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -123.93 88.07 2.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.902 1.681 . . . . 0.0 110.318 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -63.04 140.3 58.86 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.32 -0.863 . . . . 0.0 111.401 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.43 33.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.303 1.441 . . . . 0.0 111.702 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.96 -160.64 34.16 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.895 -1.128 . . . . 0.0 113.607 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -125.06 148.27 48.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.617 1.567 . . . . 0.0 111.179 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.3 ttp -69.67 124.56 24.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 112.189 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.45 140.72 39.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.072 0.949 . . . . 0.0 110.188 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.41 89.74 3.01 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.091 1.356 . . . . 0.0 111.534 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -76.87 133.96 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.611 1.564 . . . . 0.0 110.857 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -127.12 98.64 5.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.219 1.009 . . . . 0.0 113.219 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -15.31 9.79 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.0 p -73.45 -13.91 61.15 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.904 1.229 . . . . 0.0 113.822 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.02 -8.26 1.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -135.34 110.58 10.62 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.225 1.01 . . . . 0.0 112.185 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.92 -2.45 12.43 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.017 3.144 . . . . 0.0 114.481 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -129.9 80.59 70.98 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.671 1.588 . . . . 0.0 111.877 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.83 -36.49 7.92 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.654 4.236 . . . . 0.0 116.057 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.36 -45.87 36.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.426 1.89 . . . . 0.0 112.954 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.0 p -68.76 -18.09 64.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.14 -9.31 20.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.944 0.897 . . . . 0.0 112.506 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 m -116.02 -33.02 5.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -58.15 -51.53 81.08 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.396 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.99 -28.7 57.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.625 1.55 . . . . 0.0 112.723 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -61.74 -49.8 74.96 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.616 0.644 . . . . 0.0 111.68 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 t -68.27 -40.78 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.868 0.758 . . . . 0.0 110.367 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.6 -30.09 70.46 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -76.44 -57.94 3.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.274 1.03 . . . . 0.0 112.222 170.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -51.82 -47.44 64.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.831 1.252 . . . . 0.0 111.427 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.48 11.66 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.659 1.6 . . . . 0.0 115.905 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.0 p -70.52 -15.58 62.8 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.888 1.844 . . . . 0.0 113.961 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.94 -15.85 18.98 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.395 1.478 . . . . 0.0 113.192 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.7 157.63 14.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.269 2.227 . . . . 0.0 111.757 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.885 1.274 . . . . 0.0 113.536 174.076 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 121.281 0.562 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -118.36 122.65 43.37 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.509 1.524 . . . . 0.0 108.732 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 mm -120.41 122.91 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.144 0.978 . . . . 0.0 112.367 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.59 128.77 9.17 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 168.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.46 91.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.276 1.038 . . . . 0.0 108.937 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -93.02 148.21 22.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.549 1.139 . . . . 0.0 112.448 -169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.11 143.87 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.55 0.74 . . . . 0.0 111.006 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.47 108.37 0.64 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 172.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -150.51 165.92 31.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.256 1.022 . . . . 0.0 112.08 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -110.15 -19.58 12.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.512 1.125 . . . . 0.0 113.174 171.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -143.78 -13.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.69 11.02 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.02 -44.71 97.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.35 2.075 . . . . 0.0 112.986 -174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 p -75.95 -30.25 58.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.644 0.778 . . . . 0.0 112.803 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.14 -39.25 85.67 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.907 -1.121 . . . . 0.0 113.408 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.89 -45.43 71.09 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.659 0.663 . . . . 0.0 110.899 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.66 -34.46 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 112.104 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.37 94.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.351 0.978 . . . . 0.0 112.831 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.0 -41.69 98.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.584 0.754 . . . . 0.0 111.611 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.0 -48.07 83.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.294 0.638 . . . . 0.0 111.799 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.91 91.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 112.844 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -57.67 -46.86 83.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.748 0.419 . . . . 0.0 111.512 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.98 81.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.369 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -58.1 -45.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.745 1.218 . . . . 0.0 112.201 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 mt -73.08 -40.1 65.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.556 0.616 . . . . 0.0 110.25 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.5 m -56.71 -46.78 81.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.662 1.185 . . . . 0.0 111.808 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.63 80.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.135 0.974 . . . . 0.0 113.009 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.74 -34.38 77.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.121 0.968 . . . . 0.0 111.756 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.86 5.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.213 1.387 . . . . 0.0 114.652 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.36 150.62 38.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.636 1.174 . . . . 0.0 111.73 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -76.49 130.25 37.68 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.62 142.48 31.06 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.428 0.558 . . . . 0.0 111.913 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.0 m -141.0 115.63 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.971 0.908 . . . . 0.0 109.809 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.53 146.76 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.75 0.82 . . . . 0.0 111.895 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -135.18 96.13 3.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.781 . . . . 0.0 108.485 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -72.43 -27.48 62.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.309 1.444 . . . . 0.0 114.61 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -144.74 64.62 11.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.849 2.059 . . . . 0.0 108.524 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.44 162.02 43.65 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.363 3.376 . . . . 0.0 116.248 -168.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.93 163.7 29.67 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.058 2.543 . . . . 0.0 108.274 169.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.89 -45.01 15.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.955 -1.091 . . . . 0.0 112.568 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m -56.68 -20.1 19.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.18 -34.62 32.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.378 0.99 . . . . 0.0 112.313 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -79.41 -32.29 42.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.596 1.558 . . . . 0.0 112.771 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 tp -39.87 -45.85 4.59 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 128.793 2.837 . . . . 0.0 116.167 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -77.58 -18.41 13.68 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.583 2.188 . . . . 0.0 115.354 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.88 -6.09 57.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -57.32 -23.8 51.0 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -102.47 13.81 33.59 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.132 1.373 . . . . 0.0 112.938 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -138.51 -131.55 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.652 1.981 . . . . 0.0 109.651 -169.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -135.31 151.51 50.61 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.237 1.015 . . . . 0.0 111.166 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.85 165.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.723 1.209 . . . . 0.0 111.012 -174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.65 149.72 24.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 109.563 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.14 143.23 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.205 0.602 . . . . 0.0 110.842 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.29 109.45 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.585 0.707 . . . . 0.0 110.298 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.4 m -138.17 144.53 40.77 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 m -95.96 -168.82 1.82 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.677 1.591 . . . . 0.0 112.587 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -128.5 149.71 50.48 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.88 1.272 . . . . 0.0 110.62 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 127.798 2.439 . . . . 0.0 108.561 179.006 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.3 t0 . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.724 0.773 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.47 139.86 55.57 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 127.185 2.194 . . . . 0.0 111.808 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.72 141.38 49.52 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.135 2.556 . . . . 0.0 110.014 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.17 -30.18 64.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -169.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -61.49 -13.35 20.17 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -121.75 -7.65 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.145 1.338 . . . . 0.0 113.896 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -50.7 -48.47 82.85 Favored Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.62 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.5 5.27 2.46 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.11 2.54 . . . . 0.0 114.749 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.4 tp -107.55 -47.34 3.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.663 1.185 . . . . 0.0 109.795 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.43 -53.71 55.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.352 1.061 . . . . 0.0 112.016 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -63.91 -37.06 86.02 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.682 -0.636 . . . . 0.0 111.844 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.81 -46.23 76.66 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.712 0.672 . . . . 0.0 113.281 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.57 -42.01 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.666 1.233 . . . . 0.0 110.57 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.81 -51.28 65.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.683 0.793 . . . . 0.0 112.987 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.93 -25.17 24.52 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.5 m -125.15 -0.37 7.78 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -119.09 -52.52 2.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.521 1.055 . . . . 0.0 110.256 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.23 -23.8 0.2 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 118.135 2.014 . . . . 0.0 118.135 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -151.98 139.76 19.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.041 1.736 . . . . 0.0 110.064 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 50.79 0.54 Allowed Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -66.03 -18.9 57.62 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.249 2.633 . . . . 0.0 114.592 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.53 -17.21 58.15 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -76.8 138.16 39.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.42 1.088 . . . . 0.0 112.663 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -129.15 145.9 51.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.932 1.693 . . . . 0.0 110.792 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -159.3 -174.9 4.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -169.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.77 154.97 25.87 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 127.357 2.408 . . . . 0.0 110.299 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.77 128.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.771 1.286 . . . . 0.0 111.169 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -105.6 143.56 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.93 48.72 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.036 -1.04 . . . . 0.0 110.343 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.3 tt -139.57 153.37 47.4 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.19 0.995 . . . . 0.0 111.339 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.69 -140.82 6.04 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.206 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -143.38 129.28 19.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.257 1.023 . . . . 0.0 111.196 -173.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.8 m -62.59 -7.0 3.96 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 m -67.2 0.34 2.82 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.05 156.09 48.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.535 1.534 . . . . 0.0 112.421 -170.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.46 -39.52 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.032 0.933 . . . . 0.0 111.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -78.08 44.85 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.209 1.404 . . . . 0.0 112.785 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -52.36 116.56 2.31 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.313 -1.492 . . . . 0.0 112.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.1 m 51.18 24.67 2.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.72 2.408 . . . . 0.0 117.219 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.45 -28.5 69.32 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.536 -1.353 . . . . 0.0 113.794 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.55 -35.81 91.66 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 118.912 0.778 . . . . 0.0 113.39 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.08 -34.17 27.45 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.276 -1.132 . . . . 0.0 113.297 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.64 -37.74 82.51 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.581 1.191 . . . . 0.0 112.636 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -57.36 -45.6 84.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.319 0.648 . . . . 0.0 111.407 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.0 -34.74 77.1 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.265 0.939 . . . . 0.0 112.952 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.94 -44.21 97.25 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 111.778 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.91 69.39 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.5 tp -53.92 -20.71 6.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.374 1.469 . . . . 0.0 113.233 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 mt -107.08 -37.7 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.788 1.235 . . . . 0.0 111.22 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -30.5 71.16 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.189 0.904 . . . . 0.0 111.26 169.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -51.83 -30.79 24.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.617 1.567 . . . . 0.0 112.131 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -116.97 17.72 14.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.395 1.478 . . . . 0.0 113.014 -169.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.3 t 65.58 16.0 10.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.602 1.961 . . . . 0.0 115.292 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.06 49.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.239 -0.913 . . . . 0.0 111.982 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -109.96 110.39 21.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.008 0.923 . . . . 0.0 111.23 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -73.1 126.23 29.53 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.054 -1.029 . . . . 0.0 110.853 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -84.44 34.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.176 1.39 . . . . 0.0 111.906 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.3 -171.47 43.1 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.682 1.611 . . . . 0.0 112.468 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -114.66 158.93 21.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.636 1.575 . . . . 0.0 111.375 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.3 mtp -61.85 159.12 14.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -127.85 127.47 43.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.413 1.085 . . . . 0.0 108.632 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.12 94.44 4.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.247 1.019 . . . . 0.0 111.669 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.5 mt -81.01 141.24 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.058 1.743 . . . . 0.0 112.154 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -124.92 103.9 8.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.877 1.271 . . . . 0.0 113.062 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -18.96 47.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.195 1.398 . . . . 0.0 114.403 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.3 p -80.6 -5.63 57.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.581 1.082 . . . . 0.0 113.56 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.13 -24.89 2.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.131 1.372 . . . . 0.0 112.848 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.48 110.44 7.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.876 0.871 . . . . 0.0 113.27 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.65 -1.92 10.76 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.061 3.174 . . . . 0.0 114.159 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -131.41 70.1 81.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.204 1.802 . . . . 0.0 109.291 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.06 -16.5 39.76 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.841 3.694 . . . . 0.0 117.262 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -57.55 -32.34 67.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.988 -1.07 . . . . 0.0 113.217 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -66.18 -6.28 13.0 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -118.91 -0.52 11.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.52 -26.05 1.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.29 -54.31 46.39 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.485 1.039 . . . . 0.0 113.067 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.26 -31.77 34.8 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 121.256 1.484 . . . . 0.0 112.852 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -60.52 -49.51 77.28 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.397 0.679 . . . . 0.0 111.669 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.19 -36.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.715 -0.616 . . . . 0.0 110.451 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.71 -44.31 96.73 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.236 0.926 . . . . 0.0 112.753 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.46 -36.09 58.08 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.995 1.27 . . . . 0.0 113.361 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -57.35 -43.79 83.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.74 1.155 . . . . 0.0 110.437 170.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.76 -13.53 25.55 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.864 -1.52 . . . . 0.0 116.131 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.7 p -107.05 -11.98 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.612 2.206 . . . . 0.0 113.183 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.12 -30.75 31.0 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.22 1.008 . . . . 0.0 111.378 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.23 152.57 20.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.362 1.465 . . . . 0.0 112.566 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.167 2.187 . . . . 0.0 114.006 -179.552 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.802 0 CA-C-O 121.29 0.566 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -135.28 119.05 17.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.976 1.311 . . . . 0.0 109.754 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mm -118.34 124.96 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.744 0.818 . . . . 0.0 112.825 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.18 126.4 7.82 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 168.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.7 mt -117.54 90.97 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.438 1.095 . . . . 0.0 108.411 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -91.3 144.19 25.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.004 -169.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.4 141.54 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.054 0.942 . . . . 0.0 110.54 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.94 91.22 0.21 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -142.88 164.16 30.85 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.559 1.144 . . . . 0.0 113.155 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.6 mmm -125.77 0.83 7.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.531 1.532 . . . . 0.0 112.888 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -140.25 -37.3 0.47 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.32 -5.52 10.16 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.975 1.15 . . . . 0.0 115.975 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -63.15 -42.83 99.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.528 1.164 . . . . 0.0 111.481 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -39.53 86.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.061 . . . . 0.0 112.515 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 tp -59.72 -39.23 83.97 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.8 tp -49.34 -41.69 39.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.991 0.917 . . . . 0.0 112.177 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.6 -39.93 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 123.249 0.619 . . . . 0.0 112.045 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -41.07 96.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.075 0.852 . . . . 0.0 112.434 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.92 -42.06 97.37 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.35 0.66 . . . . 0.0 112.273 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.49 -43.25 85.89 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.467 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.24 92.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.702 0.801 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.64 -47.84 78.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.368 0.667 . . . . 0.0 111.529 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.77 92.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.71 0.804 . . . . 0.0 112.62 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.58 -47.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.28 . . . . 0.0 112.187 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 mt -70.32 -41.34 73.39 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.242 0.617 . . . . 0.0 109.884 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -56.73 -46.02 81.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.1 1.36 . . . . 0.0 112.24 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.79 90.14 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.169 0.987 . . . . 0.0 112.87 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.59 -32.24 71.99 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.48 4.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.26 1.41 . . . . 0.0 114.983 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.95 146.72 35.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.149 1.379 . . . . 0.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -72.94 138.58 46.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.6 35.25 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.74 -0.6 . . . . 0.0 112.455 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.7 m -144.51 116.25 8.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.238 1.015 . . . . 0.0 110.656 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.47 140.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.106 0.562 . . . . 0.0 110.173 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.76 96.91 4.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.384 1.474 . . . . 0.0 107.899 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.4 -29.81 65.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.768 1.627 . . . . 0.0 114.265 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -146.31 64.53 9.79 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 126.862 2.065 . . . . 0.0 108.734 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.91 163.75 37.84 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.007 3.138 . . . . 0.0 115.727 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 160.67 36.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.339 2.256 . . . . 0.0 108.798 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -32.73 -54.04 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.765 2.026 . . . . 0.0 113.691 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -63.04 -21.63 66.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.493 1.517 . . . . 0.0 114.411 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.68 -36.14 62.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.222 0.919 . . . . 0.0 111.625 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 20.1 t-105 -79.46 -38.52 34.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 112.904 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.1 tp -38.39 -45.84 2.66 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 128.112 2.565 . . . . 0.0 116.784 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.64 -26.04 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 CA-C-N 122.543 1.944 . . . . 0.0 115.133 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -71.91 -8.8 56.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -56.49 -26.29 53.89 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.959 -1.088 . . . . 0.0 113.791 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.73 -8.05 57.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.324 1.449 . . . . 0.0 113.749 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -133.25 -128.61 0.17 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.958 2.103 . . . . 0.0 110.02 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -136.88 160.55 38.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.983 1.713 . . . . 0.0 111.277 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -144.08 170.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.878 1.271 . . . . 0.0 111.052 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -159.16 148.35 18.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.446 1.898 . . . . 0.0 108.174 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.34 142.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.684 -0.635 . . . . 0.0 112.048 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.6 116.2 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.097 0.959 . . . . 0.0 111.529 169.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.9 m -141.88 153.39 44.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 0.0 111.929 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 p -138.7 145.8 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -70.64 146.11 50.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.477 1.911 . . . . 0.0 114.654 -174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 127.469 2.308 . . . . 0.0 111.375 -173.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t0 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.59 139.74 96.15 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.734 2.013 . . . . 0.0 110.255 169.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.64 144.59 35.8 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.689 2.926 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.92 -22.39 64.31 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.5 p -63.3 -16.58 60.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.1 tt -124.89 -8.94 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.69 -48.12 77.44 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.8 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.12 5.89 1.65 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.24 2.626 . . . . 0.0 114.817 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.48 -44.98 3.44 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 110.324 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.73 -51.36 70.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.143 0.977 . . . . 0.0 111.679 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -62.87 -41.14 99.28 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 111.859 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -42.89 93.71 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.756 0.693 . . . . 0.0 113.772 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.31 -46.08 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -62.75 -40.77 98.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.54 -25.25 16.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -125.56 -31.47 2.98 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.84 -43.77 62.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.255 1.389 . . . . 0.0 109.391 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.49 -42.18 0.67 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 126.641 2.067 . . . . 0.0 116.679 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -155.14 143.26 20.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.116 1.767 . . . . 0.0 109.703 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -146.22 47.62 0.64 Allowed Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -60.86 -29.88 89.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.139 2.559 . . . . 0.0 113.799 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -65.87 -22.76 66.55 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.407 1.883 . . . . 0.0 114.615 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.8 tp -73.43 138.68 45.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.933 0.788 . . . . 0.0 111.574 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -134.8 132.74 39.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.493 1.917 . . . . 0.0 108.682 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -154.59 -171.56 3.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.59 164.18 30.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.974 1.75 . . . . 0.0 109.513 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 146.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.497 1.142 . . . . 0.0 113.533 -169.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.4 mt -129.83 141.66 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.82 1.648 . . . . 0.0 106.56 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.44 156.36 48.7 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -144.38 149.18 35.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 110.858 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.69 -151.0 9.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 123.654 0.645 . . . . 0.0 111.644 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -137.99 117.35 12.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.999 1.32 . . . . 0.0 109.876 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -59.62 -7.8 1.68 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.995 1.318 . . . . 0.0 114.505 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.0 m -61.32 -10.27 6.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.151 1.38 . . . . 0.0 114.157 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -127.21 137.02 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 111.426 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.57 -26.17 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -81.4 -18.49 45.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.316 0.962 . . . . 0.0 113.285 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.9 t80 38.93 -131.78 0.19 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.748 1.619 . . . . 0.0 112.451 -169.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.4 m -73.58 23.56 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -53.61 -30.42 42.5 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.142 -1.598 . . . . 0.0 114.495 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.1 -35.89 92.56 Favored Glycine 0 CA--C 1.533 1.156 0 O-C-N 121.125 -0.984 . . . . 0.0 113.111 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.32 -40.54 11.13 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.825 -0.809 . . . . 0.0 113.316 173.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.67 -31.9 69.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.67 1.235 . . . . 0.0 113.781 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -58.47 -39.53 80.21 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.16 -27.35 63.48 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.303 0.956 . . . . 0.0 113.33 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.64 -49.66 65.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.766 -1.209 . . . . 0.0 110.053 169.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.31 -40.45 71.15 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -49.89 -27.7 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.82 1.648 . . . . 0.0 113.644 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.6 mt -112.1 -36.67 5.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.609 1.163 . . . . 0.0 111.808 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.76 -31.24 71.75 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.169 -0.957 . . . . 0.0 113.209 170.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -66.25 -14.64 62.27 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 119.419 1.009 . . . . 0.0 112.528 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -111.81 16.84 20.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.641 1.976 . . . . 0.0 111.849 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t 61.97 20.41 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.332 1.853 . . . . 0.0 115.263 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.48 161.07 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.842 0.746 . . . . 0.0 112.972 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -112.09 162.71 15.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.769 1.628 . . . . 0.0 108.645 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mtm105 -133.88 149.05 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.85 21.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.986 172.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.85 -172.35 45.2 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.529 1.538 . . . . 0.0 113.598 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.68 156.26 44.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.282 1.433 . . . . 0.0 111.411 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.85 120.91 14.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.85 0.86 . . . . 0.0 112.098 -170.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.07 135.94 35.88 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.527 1.131 . . . . 0.0 110.074 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.58 96.03 4.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.704 1.202 . . . . 0.0 111.915 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.01 141.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.236 1.415 . . . . 0.0 111.137 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -129.49 116.73 19.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.907 1.283 . . . . 0.0 111.751 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.78 -26.87 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.618 1.167 . . . . 0.0 113.87 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.9 m -81.62 4.78 20.35 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.51 -30.18 2.36 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.371 1.468 . . . . 0.0 112.449 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -143.1 118.48 6.45 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 124.619 1.168 . . . . 0.0 112.278 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.32 -6.2 13.72 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.86 3.04 . . . . 0.0 114.498 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.98 80.58 64.58 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.529 1.532 . . . . 0.0 111.198 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.97 -35.04 9.65 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.712 4.275 . . . . 0.0 116.711 -175.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.67 -38.47 64.2 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.6 p -69.46 -6.14 28.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -116.38 -3.55 11.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.001 1.321 . . . . 0.0 112.554 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 p -132.95 -27.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -170.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -55.44 -54.09 54.92 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.254 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.5 -29.37 53.13 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.598 1.532 . . . . 0.0 112.756 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -62.49 -49.15 76.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.387 0.675 . . . . 0.0 111.442 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.89 -41.04 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.816 0.735 . . . . 0.0 110.506 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -59.03 -45.21 91.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.462 0.573 . . . . 0.0 111.541 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -61.96 -56.05 23.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.087 0.955 . . . . 0.0 112.138 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.38 -49.04 65.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.76 1.224 . . . . 0.0 111.172 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.96 -21.83 32.39 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.582 1.563 . . . . 0.0 116.165 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -70.53 -17.42 62.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.491 2.146 . . . . 0.0 113.737 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.47 -14.43 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.251 1.42 . . . . 0.0 113.578 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.2 157.67 18.79 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.412 1.885 . . . . 0.0 112.367 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.899 1.28 . . . . 0.0 113.651 177.437 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -135.14 119.37 17.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.618 1.567 . . . . 0.0 109.13 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.08 125.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.871 0.868 . . . . 0.0 113.267 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.6 128.6 8.97 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 mt -118.31 91.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.541 1.136 . . . . 0.0 108.519 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -90.93 139.1 31.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.274 1.029 . . . . 0.0 111.698 -169.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -125.47 144.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.713 0.768 . . . . 0.0 111.502 -169.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 105.88 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 t -155.9 161.45 40.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.385 1.474 . . . . 0.0 113.153 -173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.5 mmm -122.96 -9.28 8.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.438 1.495 . . . . 0.0 112.397 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -138.99 0.18 1.93 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.5 -4.39 83.95 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.117 1.607 . . . . 0.0 117.117 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -64.62 -42.87 95.21 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.475 1.637 . . . . 0.0 113.097 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 p -75.46 -33.9 60.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.085 0.954 . . . . 0.0 112.385 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 tp -58.43 -38.76 78.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.995 -1.065 . . . . 0.0 112.771 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -53.88 -45.68 71.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.759 0.709 . . . . 0.0 111.71 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.21 -36.9 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 111.545 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.41 92.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.261 0.937 . . . . 0.0 112.968 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.45 -41.76 97.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.356 0.662 . . . . 0.0 112.184 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.06 -41.72 97.25 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.648 -0.657 . . . . 0.0 112.562 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.528 -0.732 . . . . 0.0 112.061 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.81 -46.83 77.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.677 0.791 . . . . 0.0 111.825 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.48 95.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.742 0.817 . . . . 0.0 112.77 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.95 -43.19 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.547 1.139 . . . . 0.0 112.262 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.27 -38.71 75.15 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.21 -0.932 . . . . 0.0 109.614 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -57.64 -45.47 85.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.251 1.021 . . . . 0.0 111.516 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.14 83.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.991 0.916 . . . . 0.0 113.296 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -69.8 -10.48 58.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.29 41.43 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.574 1.559 . . . . 0.0 114.729 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -73.03 175.36 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.289 1.435 . . . . 0.0 111.894 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -111.62 145.51 39.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.812 1.245 . . . . 0.0 109.622 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 162.67 38.81 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.2 m -153.31 120.36 5.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.111 0.964 . . . . 0.0 110.948 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.3 141.16 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.906 0.882 . . . . 0.0 110.924 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -126.67 111.12 13.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.221 1.408 . . . . 0.0 109.789 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 -16.46 23.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.461 1.504 . . . . 0.0 114.945 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -142.43 55.9 4.82 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.22 1.408 . . . . 0.0 111.068 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.37 163.15 39.81 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.977 3.118 . . . . 0.0 113.517 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -143.34 -44.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.84 -44.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.273 1.029 . . . . 0.0 113.105 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 m -58.76 -28.79 66.24 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.923 0.868 . . . . 0.0 112.257 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -54.83 40.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.948 2.899 . . . . 0.0 112.461 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -68.62 -40.89 80.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.572 1.549 . . . . 0.0 113.748 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -37.97 -56.45 1.94 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.672 2.389 . . . . 0.0 115.28 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.54 -18.72 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.594 2.196 . . . . 0.0 114.867 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.58 -5.95 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -54.88 -30.58 58.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.343 0.974 . . . . 0.0 113.158 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -86.23 4.21 39.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.378 1.471 . . . . 0.0 113.492 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -136.33 -136.27 0.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.438 1.895 . . . . 0.0 110.997 -169.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -130.1 160.47 33.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 110.642 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.89 169.55 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.303 1.441 . . . . 0.0 110.367 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.55 147.46 18.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 109.932 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.38 131.14 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.197 1.399 . . . . 0.0 109.561 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.07 86.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.5 m -126.52 164.17 21.77 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -167.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -129.34 -172.33 2.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.748 1.219 . . . . 0.0 113.216 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 m -136.61 132.08 34.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.652 1.181 . . . . 0.0 110.519 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 125.396 1.478 . . . . 0.0 110.33 -169.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.5 mt -53.46 125.71 44.93 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 126.783 2.033 . . . . 0.0 112.681 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.51 142.72 98.3 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.681 3.587 . . . . 0.0 112.136 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.12 -20.14 65.76 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 p -66.07 -11.55 49.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.76 1.624 . . . . 0.0 114.959 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.3 tt -131.58 -13.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -44.81 -49.33 28.05 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.449 -1.263 . . . . 0.0 112.995 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.37 -24.96 42.54 Favored 'Trans proline' 0 C--N 1.353 0.769 0 CA-C-N 122.155 1.805 . . . . 0.0 113.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.3 tp -75.86 -43.03 47.68 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.835 0.743 . . . . 0.0 110.062 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.86 -46.48 90.42 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.294 1.038 . . . . 0.0 111.091 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -63.7 -43.27 97.12 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.712 -1.243 . . . . 0.0 112.543 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.48 -50.18 66.95 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.688 1.137 . . . . 0.0 112.74 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.02 -46.42 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.567 1.183 . . . . 0.0 110.265 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.07 -46.72 84.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.636 1.174 . . . . 0.0 112.751 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.09 -33.51 20.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -98.59 -30.97 12.18 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.94 -32.96 11.4 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.232 0.924 . . . . 0.0 113.279 -170.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.14 -51.77 1.0 Allowed Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.39 1.947 . . . . 0.0 117.007 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -159.86 140.96 12.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -156.19 104.94 2.06 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.5 1.52 . . . . 0.0 110.298 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.1 -15.45 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.307 2.671 . . . . 0.0 116.074 -169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -124.35 1.8 8.41 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.8 tp -69.49 137.56 52.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.562 0.745 . . . . 0.0 109.811 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -128.93 143.71 50.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.592 1.557 . . . . 0.0 110.748 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.33 -170.6 2.87 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -168.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.31 162.55 31.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 127.41 2.433 . . . . 0.0 109.914 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.7 t -139.87 136.82 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.061 0.934 . . . . 0.0 112.238 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.8 mt -123.18 125.08 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.2 148.98 42.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.717 1.207 . . . . 0.0 109.598 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.07 146.42 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 111.687 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.44 -137.45 3.95 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.018 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 131.99 28.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.726 0.811 . . . . 0.0 112.091 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.4 t -64.44 -10.86 27.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.921 1.689 . . . . 0.0 114.869 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -69.41 5.4 1.35 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -131.69 154.77 48.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.664 1.585 . . . . 0.0 112.833 -171.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.65 -6.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.789 1.636 . . . . 0.0 114.835 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -125.86 44.8 2.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.731 2.012 . . . . 0.0 110.945 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -49.48 115.29 1.28 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.095 -1.628 . . . . 0.0 112.17 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.9 m 53.33 23.39 3.25 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -58.23 -27.24 63.77 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.82 63.59 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.62 -1.3 . . . . 0.0 111.912 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.66 70.7 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.43 -1.041 . . . . 0.0 113.127 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.38 -41.96 90.56 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 117.821 0.81 . . . . 0.0 112.858 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.04 -41.39 92.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.184 0.447 . . . . 0.0 112.147 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -69.5 -28.49 66.1 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.67 -46.06 66.95 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 119.807 -1.808 . . . . 0.0 110.807 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.88 68.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.7 tp -49.66 -31.07 10.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.019 1.728 . . . . 0.0 113.124 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.1 -36.97 8.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.561 1.144 . . . . 0.0 111.399 -171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -66.27 -31.16 71.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.53 -0.731 . . . . 0.0 112.826 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.65 -15.97 63.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.374 1.07 . . . . 0.0 112.942 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -113.26 -9.67 13.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.9 t 98.75 15.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.229 2.611 . . . . 0.0 113.922 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.83 161.17 8.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.222 0.465 . . . . 0.0 110.716 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.61 100.14 5.42 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.838 -1.164 . . . . 0.0 110.566 -171.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttm105 -66.93 135.7 54.23 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.407 -0.808 . . . . 0.0 110.83 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.08 34.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 111.318 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.51 -166.61 39.83 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.776 -1.202 . . . . 0.0 113.75 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.19 145.61 42.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.448 1.499 . . . . 0.0 111.974 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.16 118.08 10.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.149 0.979 . . . . 0.0 111.705 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.79 136.06 38.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.939 0.896 . . . . 0.0 109.881 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.6 mt -120.65 95.85 4.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.774 1.229 . . . . 0.0 111.775 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mt -81.4 134.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.242 1.417 . . . . 0.0 111.226 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -123.94 112.29 17.05 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.389 1.475 . . . . 0.0 111.477 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.94 -23.7 54.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.0 m -82.83 2.11 35.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.446 1.098 . . . . 0.0 113.893 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.11 -27.29 3.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.417 1.487 . . . . 0.0 112.664 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.94 115.28 6.59 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.582 1.153 . . . . 0.0 112.097 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.81 -5.29 14.59 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.682 2.921 . . . . 0.0 114.413 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -131.51 80.64 66.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.611 1.564 . . . . 0.0 111.283 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -43.68 -37.58 8.5 Favored 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 125.668 4.246 . . . . 0.0 116.056 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -45.97 -44.22 14.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.441 1.896 . . . . 0.0 113.214 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.6 p -71.25 -10.01 59.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -116.45 4.34 13.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.001 1.32 . . . . 0.0 112.423 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 p -132.31 -27.51 1.77 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -61.37 -53.68 60.08 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 119.766 1.166 . . . . 0.0 112.9 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.1 -35.6 95.15 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.565 2.177 . . . . 0.0 114.032 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -60.72 -48.03 83.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.647 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.37 -40.08 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.959 0.8 . . . . 0.0 110.774 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.36 -43.56 88.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.662 0.665 . . . . 0.0 111.311 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.24 -55.73 16.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.773 1.229 . . . . 0.0 112.393 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -53.31 -46.9 69.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.034 0.934 . . . . 0.0 111.348 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.81 -27.18 6.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.406 1.955 . . . . 0.0 116.361 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -71.94 -19.32 61.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.995 1.897 . . . . 0.0 113.824 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 -14.7 26.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.436 1.494 . . . . 0.0 113.255 -171.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.05 160.85 17.18 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.897 2.079 . . . . 0.0 112.354 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.251 1.02 . . . . 0.0 112.895 169.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -135.31 117.46 15.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.005 1.722 . . . . 0.0 108.527 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mm -118.9 121.4 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.007 0.821 . . . . 0.0 113.143 -172.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.87 127.41 8.27 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.18 91.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.471 1.135 . . . . 0.0 108.512 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -93.81 136.03 34.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.084 0.954 . . . . 0.0 110.948 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.73 145.26 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.611 0.764 . . . . 0.0 111.52 -169.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.6 90.24 0.22 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 125.034 1.302 . . . . 0.0 110.645 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -140.96 178.37 7.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -169.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -147.98 -21.71 0.35 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.812 2.045 . . . . 0.0 112.754 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.52 -2.49 7.94 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.91 1.21 73.55 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -64.07 -44.95 90.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.849 1.324 . . . . 0.0 112.376 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -73.64 -33.23 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.241 1.416 . . . . 0.0 112.561 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.92 -38.91 80.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.879 -1.138 . . . . 0.0 112.977 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.6 -45.08 73.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.83 0.741 . . . . 0.0 111.734 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -63.82 -36.91 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 111.594 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.73 -43.11 97.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.121 0.873 . . . . 0.0 112.623 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.26 -42.89 99.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.495 0.718 . . . . 0.0 112.578 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -62.72 -40.88 98.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.554 -0.716 . . . . 0.0 112.672 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.19 82.49 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.735 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.57 -46.02 73.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.405 0.682 . . . . 0.0 111.483 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.83 83.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.552 0.741 . . . . 0.0 112.785 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -59.33 -45.14 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.702 1.201 . . . . 0.0 112.068 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.0 mt -70.7 -41.57 71.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.636 -0.665 . . . . 0.0 109.664 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -56.93 -44.19 82.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.25 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -37.67 82.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.011 0.924 . . . . 0.0 113.016 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.522 0.729 . . . . 0.0 112.501 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.16 -9.72 7.86 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.013 1.768 . . . . 0.0 114.445 169.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -72.7 147.54 45.57 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.371 1.069 . . . . 0.0 111.734 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -72.13 140.44 48.85 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.75 159.71 42.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.282 0.633 . . . . 0.0 112.16 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.3 m -153.49 118.43 5.07 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.249 -0.907 . . . . 0.0 111.425 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -74.12 141.31 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.923 0.889 . . . . 0.0 111.014 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -128.88 109.21 11.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.835 1.254 . . . . 0.0 109.635 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.26 -19.36 34.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.614 1.565 . . . . 0.0 114.823 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.2 58.99 5.58 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.922 1.689 . . . . 0.0 109.835 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.1 159.54 53.47 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.115 3.21 . . . . 0.0 115.474 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -138.1 167.33 22.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.193 2.197 . . . . 0.0 109.411 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.41 -45.54 18.05 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.714 1.206 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -59.27 -18.51 38.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -80.27 -34.4 37.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.608 1.095 . . . . 0.0 112.334 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 33.9 t-105 -77.22 -35.98 55.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 112.781 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -41.45 -45.85 7.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 128.609 2.764 . . . . 0.0 115.944 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.68 -26.44 5.71 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.668 2.246 . . . . 0.0 114.527 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -82.76 -13.79 55.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -59.17 -26.35 64.71 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.41 7.2 26.72 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -134.08 -117.31 0.19 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.213 1.805 . . . . 0.0 110.682 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.89 154.7 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.41 1.084 . . . . 0.0 111.151 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.2 m -149.23 169.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 110.988 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.33 146.95 17.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.097 0.959 . . . . 0.0 110.358 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.11 133.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.17 1.388 . . . . 0.0 110.139 -169.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.38 89.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 107.717 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.2 m -131.48 164.83 24.89 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -167.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -136.68 -173.09 3.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.616 1.566 . . . . 0.0 112.793 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.5 m -129.71 146.44 51.48 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.136 0.974 . . . . 0.0 111.201 -171.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 128.183 2.593 . . . . 0.0 108.765 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.95 150.63 87.6 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.275 -0.891 . . . . 0.0 112.935 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 162.61 19.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.87 3.047 . . . . 0.0 112.592 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.16 -17.85 64.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -171.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.5 p -60.3 -18.72 51.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.0 -9.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -45.65 -48.35 37.89 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.489 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.11 -23.3 33.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 122.199 1.821 . . . . 0.0 113.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 tp -76.03 -48.67 20.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 110.097 173.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.35 -49.58 76.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.825 1.65 . . . . 0.0 111.942 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -64.56 -45.13 88.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.235 -0.916 . . . . 0.0 111.851 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.89 -43.53 97.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.254 0.931 . . . . 0.0 114.278 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.72 -46.96 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.413 1.107 . . . . 0.0 110.402 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.69 -48.02 82.68 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.856 -0.527 . . . . 0.0 111.807 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.13 -41.26 61.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.084 1.353 . . . . 0.0 114.378 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -122.29 5.06 9.71 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -168.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -122.34 -49.65 2.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.54 1.064 . . . . 0.0 110.137 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -31.35 0.29 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.696 2.093 . . . . 0.0 117.984 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -154.71 138.77 16.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.197 1.499 . . . . 0.0 112.36 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -158.18 118.24 1.88 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.225 1.41 . . . . 0.0 110.926 169.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -87.45 -30.74 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.181 2.587 . . . . 0.0 115.806 -171.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -100.39 1.58 41.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.01 135.9 41.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.387 1.075 . . . . 0.0 111.388 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -123.64 143.38 50.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.009 1.723 . . . . 0.0 111.04 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.17 -173.84 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 162.48 32.04 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.151 2.31 . . . . 0.0 110.676 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.87 130.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.916 0.865 . . . . 0.0 111.701 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 mt -119.07 125.58 74.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 169.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.29 149.95 40.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.79 0.836 . . . . 0.0 109.728 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -140.36 138.81 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.645 0.778 . . . . 0.0 110.933 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.31 -131.12 1.63 Allowed Glycine 0 CA--C 1.521 0.463 0 O-C-N 122.253 -0.279 . . . . 0.0 113.533 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -141.07 119.48 12.25 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 111.149 -172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -64.16 -6.08 6.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.0 m -65.31 0.08 1.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -134.93 154.58 51.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.722 1.609 . . . . 0.0 112.33 -173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.803 0.841 . . . . 0.0 111.948 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.75 40.7 0.53 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.773 1.229 . . . . 0.0 112.557 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -51.16 115.06 1.38 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.393 -1.442 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m 50.85 26.07 2.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.02 -30.3 69.07 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.497 -1.377 . . . . 0.0 113.117 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -37.62 94.34 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.678 0.672 . . . . 0.0 113.527 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.82 56.29 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.136 -1.214 . . . . 0.0 112.642 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.83 -36.79 82.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.051 0.94 . . . . 0.0 113.032 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.67 -38.16 74.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.141 0.976 . . . . 0.0 112.373 170.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -78.37 -35.54 47.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.677 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.19 -41.06 96.14 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 119.676 -1.89 . . . . 0.0 111.822 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.45 79.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.07 -46.46 68.59 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.454 1.024 . . . . 0.0 111.34 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.4 mt -76.31 -37.23 57.73 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.124 0.969 . . . . 0.0 112.331 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.7 -32.48 74.06 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.471 -0.768 . . . . 0.0 112.333 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.84 -25.48 65.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.701 0.682 . . . . 0.0 111.8 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -76.49 -32.26 58.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.458 1.026 . . . . 0.0 111.477 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m 99.64 15.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.305 3.042 . . . . 0.0 112.198 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.71 162.54 6.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.229 0.612 . . . . 0.0 111.267 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -131.61 104.8 7.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.175 0.99 . . . . 0.0 110.602 -169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -69.63 134.67 49.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.279 -0.888 . . . . 0.0 111.439 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.48 31.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.615 1.566 . . . . 0.0 112.104 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.25 -165.32 38.7 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.954 -1.091 . . . . 0.0 114.37 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.63 151.6 38.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.785 1.634 . . . . 0.0 110.991 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 29.8 ttm -69.3 132.5 46.54 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.64 0.776 . . . . 0.0 112.01 -170.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.97 134.11 33.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.356 0.662 . . . . 0.0 109.474 171.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.1 mt -121.36 93.47 4.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.921 1.288 . . . . 0.0 111.675 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 51.0 mt -75.55 136.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.383 1.473 . . . . 0.0 110.524 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -129.18 110.23 11.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.32 1.048 . . . . 0.0 112.458 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.2 -25.16 58.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.6 m -82.95 4.95 23.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 113.689 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -133.39 -29.98 1.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.132 1.373 . . . . 0.0 113.014 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -142.94 116.84 6.24 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.537 1.135 . . . . 0.0 112.393 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.68 -3.71 11.94 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.103 3.202 . . . . 0.0 114.75 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.34 86.1 58.8 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.528 1.531 . . . . 0.0 110.49 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.28 -26.85 71.78 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.952 2.434 . . . . 0.0 114.383 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.2 -39.14 93.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -12.42 56.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.265 -0.897 . . . . 0.0 112.718 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.06 -0.68 14.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.267 1.827 . . . . 0.0 111.751 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 p -135.2 -24.24 1.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.52 1.128 . . . . 0.0 113.955 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -62.66 -52.82 62.05 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -57.85 -34.58 98.48 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.652 2.234 . . . . 0.0 113.932 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -59.94 -48.6 81.06 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.157 0.583 . . . . 0.0 111.261 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.08 -39.33 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.096 0.862 . . . . 0.0 110.891 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.64 -46.37 90.58 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.661 1.119 . . . . 0.0 111.923 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -63.28 -51.06 67.66 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.024 0.93 . . . . 0.0 112.352 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -58.23 -54.79 42.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.869 0.867 . . . . 0.0 110.623 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.26 -29.66 53.22 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.254 1.883 . . . . 0.0 114.767 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 94.2 m -59.2 -23.18 62.06 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.292 1.037 . . . . 0.0 113.238 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.92 -15.67 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.346 1.458 . . . . 0.0 114.689 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -30.78 70.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.545 1.138 . . . . 0.0 114.044 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.773 2.029 . . . . 0.0 111.685 175.8 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.356 0.598 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.13 121.0 33.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.402 1.481 . . . . 0.0 109.383 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mm -113.05 121.51 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.106 0.962 . . . . 0.0 112.036 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 126.38 7.48 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.4 mt -118.56 108.72 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 108.876 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.07 109.71 21.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.751 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -87.48 147.34 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.774 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.93 114.55 1.21 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -160.9 175.76 12.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.596 1.558 . . . . 0.0 111.309 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ptp -132.61 4.17 3.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -146.71 -54.13 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.656 1.182 . . . . 0.0 112.887 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.35 7.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 118.097 1.999 . . . . 0.0 118.097 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -63.85 -40.02 95.6 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.515 2.158 . . . . 0.0 112.743 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 91.7 p -79.69 -33.97 40.6 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.881 0.872 . . . . 0.0 112.502 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 tp -56.49 -38.49 71.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.054 -1.029 . . . . 0.0 112.719 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.61 -42.91 75.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.698 0.799 . . . . 0.0 111.682 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.41 -37.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 111.651 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.86 -44.25 86.46 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.935 0.789 . . . . 0.0 112.493 173.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.74 -43.36 99.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.073 0.949 . . . . 0.0 112.168 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.41 -48.2 81.46 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.598 -0.688 . . . . 0.0 112.395 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.48 89.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.627 0.771 . . . . 0.0 112.334 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.6 -44.97 85.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.525 0.73 . . . . 0.0 111.792 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -44.99 88.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.716 0.806 . . . . 0.0 112.674 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.5 mt -61.07 -45.61 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.841 1.256 . . . . 0.0 112.216 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.28 -43.23 82.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.374 0.67 . . . . 0.0 109.377 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.7 m -55.24 -47.52 75.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.631 1.173 . . . . 0.0 112.055 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.67 85.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.086 0.955 . . . . 0.0 113.451 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -72.92 -11.14 60.47 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -4.41 42.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.343 1.449 . . . . 0.0 114.524 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -72.86 178.35 4.29 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.16 1.384 . . . . 0.0 111.862 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -118.19 145.26 45.09 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.957 1.703 . . . . 0.0 109.519 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.55 155.03 41.45 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.444 -0.785 . . . . 0.0 112.623 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.3 m -143.42 100.65 3.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.019 0.927 . . . . 0.0 111.042 -172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.48 137.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.154 0.982 . . . . 0.0 111.21 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -126.0 111.1 14.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.853 1.661 . . . . 0.0 109.271 170.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.28 -20.91 43.34 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -146.45 60.07 5.81 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 126.249 1.82 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.48 160.34 49.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.274 2.649 . . . . 0.0 114.651 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -135.89 164.07 28.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.341 2.256 . . . . 0.0 108.899 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -39.08 -48.01 1.61 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.497 1.519 . . . . 0.0 113.572 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 p -58.82 -18.12 29.63 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.07 -31.8 25.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.331 1.052 . . . . 0.0 112.541 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.403 ' CH2' HG22 ' A' ' 52' ' ' VAL . 23.6 t-105 -81.51 -36.87 28.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.349 1.06 . . . . 0.0 112.641 174.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -36.63 -52.28 1.89 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.456 2.302 . . . . 0.0 114.638 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.98 6.07 5.53 Favored 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 123.09 2.527 . . . . 0.0 116.029 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -107.31 2.81 24.8 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.246 1.384 . . . . 0.0 114.64 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -58.59 -25.88 63.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -99.19 9.42 43.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.681 1.592 . . . . 0.0 113.621 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -135.33 -160.68 1.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.694 2.398 . . . . 0.0 110.326 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -111.54 159.01 18.52 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.21 1.005 . . . . 0.0 111.85 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG22 ' CH2' ' A' ' 44' ' ' TRP . 28.4 m -148.51 173.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.409 1.484 . . . . 0.0 111.537 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.51 142.44 15.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.591 1.156 . . . . 0.0 111.379 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.42 130.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.191 1.797 . . . . 0.0 109.609 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 p -140.34 89.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 122.091 0.948 . . . . 0.0 109.504 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.7 m -133.83 133.71 41.94 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -167.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 m -78.84 -166.97 0.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.935 1.694 . . . . 0.0 112.722 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -131.39 152.91 50.21 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.688 -1.257 . . . . 0.0 111.286 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 p . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 127.593 2.357 . . . . 0.0 109.198 -177.457 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 mt -60.72 126.29 84.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.707 2.403 . . . . 0.0 112.008 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.16 142.65 97.27 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.502 2.801 . . . . 0.0 111.335 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.62 -29.26 69.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 m -67.21 -9.55 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -118.18 -7.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.768 1.167 . . . . 0.0 113.243 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.9 t -54.63 -45.82 99.43 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.144 -1.407 . . . . 0.0 112.342 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -55.88 -11.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.216 3.277 . . . . 0.0 116.549 169.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 tp -105.3 -44.22 4.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.405 1.082 . . . . 0.0 110.403 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -58.3 -49.22 77.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 111.47 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -62.4 -42.69 99.62 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.539 -0.726 . . . . 0.0 112.332 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.27 -40.27 70.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.248 0.928 . . . . 0.0 113.585 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.63 -45.61 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.463 1.131 . . . . 0.0 110.063 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.27 -47.21 86.23 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.487 0.715 . . . . 0.0 112.376 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -79.02 -38.2 37.2 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 m -126.06 -10.06 6.53 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -168.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 -33.28 16.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.15 1.795 . . . . 0.0 112.279 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 -55.32 1.53 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.288 1.899 . . . . 0.0 116.802 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -151.76 149.55 29.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.03 1.732 . . . . 0.0 111.383 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -148.76 38.53 0.19 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.82 -33.52 14.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.815 2.344 . . . . 0.0 115.656 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -68.67 -0.37 5.16 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.545 2.338 . . . . 0.0 116.284 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.19 142.75 49.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.961 1.304 . . . . 0.0 112.251 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.7 145.26 51.54 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.054 2.142 . . . . 0.0 110.451 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.48 -169.09 2.33 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.75 167.36 31.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.015 2.245 . . . . 0.0 110.116 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.19 126.69 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 118.391 1.095 . . . . 0.0 112.978 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -114.0 109.86 30.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 168.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.39 142.51 32.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.416 0.686 . . . . 0.0 109.27 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.1 154.6 47.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.112 0.958 . . . . 0.0 110.716 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.7 -129.12 1.86 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.922 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.44 128.13 14.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.547 1.139 . . . . 0.0 111.165 -173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.5 p -72.5 -1.6 16.49 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 m -67.74 4.13 1.22 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.42 156.26 47.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.147 1.779 . . . . 0.0 111.557 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.49 -37.33 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.732 0.813 . . . . 0.0 111.843 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.63 44.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 112.966 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -53.1 113.63 1.18 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.673 -1.267 . . . . 0.0 111.846 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.7 m 50.21 27.7 2.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.122 2.569 . . . . 0.0 116.312 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -58.85 -28.62 66.25 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.896 -1.128 . . . . 0.0 113.498 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.16 -33.49 64.91 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.771 0.7 . . . . 0.0 113.803 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.1 -36.78 9.67 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 117.908 0.854 . . . . 0.0 113.47 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -59.21 -36.79 76.03 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.828 1.314 . . . . 0.0 113.113 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -54.84 -45.74 74.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.927 0.891 . . . . 0.0 111.424 170.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.63 -27.56 62.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.461 -0.775 . . . . 0.0 112.949 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.5 -44.0 75.65 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.674 -1.891 . . . . 0.0 110.781 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.94 77.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.728 0.811 . . . . 0.0 112.979 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.3 tp -51.12 -32.43 22.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 112.847 171.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -97.95 -39.08 9.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.898 1.279 . . . . 0.0 111.857 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -69.17 -33.47 73.44 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.2 -0.938 . . . . 0.0 113.162 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.95 -12.99 56.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.769 0.828 . . . . 0.0 112.296 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.48 10.86 18.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.015 1.726 . . . . 0.0 112.459 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m 69.51 17.86 7.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 171.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.99 165.82 3.08 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.441 -0.787 . . . . 0.0 110.853 169.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -128.03 94.51 3.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.665 -1.272 . . . . 0.0 112.419 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -66.52 132.75 48.92 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.926 -1.109 . . . . 0.0 111.133 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.93 36.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.749 1.62 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.67 40.79 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.676 -1.265 . . . . 0.0 114.331 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.89 153.12 27.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.792 1.637 . . . . 0.0 111.366 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 30.3 ttm -71.07 138.08 49.47 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -94.95 135.44 36.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.92 0.888 . . . . 0.0 109.027 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.8 mt -120.75 93.85 4.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.522 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.14 136.58 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.933 0.893 . . . . 0.0 111.199 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -125.3 100.32 6.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 112.488 -171.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.56 -17.32 13.43 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 114.451 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 p -72.17 -15.0 61.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.542 1.064 . . . . 0.0 113.769 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.61 -10.15 1.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -134.7 103.29 11.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.483 1.038 . . . . 0.0 112.418 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.38 1.47 9.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.046 3.164 . . . . 0.0 114.474 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -131.19 74.86 78.81 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.801 1.64 . . . . 0.0 111.022 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.56 -29.01 13.1 Favored 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 125.442 4.094 . . . . 0.0 117.148 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.4 -39.36 67.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.8 p -68.42 -5.88 21.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.698 1.199 . . . . 0.0 113.443 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -113.94 -7.73 13.14 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.691 1.597 . . . . 0.0 112.077 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.5 p -134.66 -25.43 1.46 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.14 -53.44 58.71 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 119.708 1.14 . . . . 0.0 113.723 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.09 -27.96 29.04 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.538 1.492 . . . . 0.0 112.865 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -63.13 -48.8 76.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.493 0.717 . . . . 0.0 111.608 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.49 -39.52 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.43 0.559 . . . . 0.0 110.198 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -59.21 -44.49 92.27 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.603 0.638 . . . . 0.0 111.644 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.61 -57.01 12.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -53.51 -46.38 70.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.054 0.942 . . . . 0.0 111.238 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.84 -24.81 14.39 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.361 1.934 . . . . 0.0 116.447 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.0 p -70.87 -19.72 62.6 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.118 1.959 . . . . 0.0 113.938 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.4 mt -93.08 -15.27 26.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.482 1.513 . . . . 0.0 113.066 -171.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 162.85 14.83 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.526 1.93 . . . . 0.0 112.458 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.665 1.186 . . . . 0.0 113.387 173.252 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -136.52 116.18 12.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.513 1.525 . . . . 0.0 109.26 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.21 128.75 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.526 1.131 . . . . 0.0 113.11 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.15 130.21 10.22 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -120.8 101.57 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.541 1.17 . . . . 0.0 108.323 -170.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -100.77 118.01 36.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.946 0.899 . . . . 0.0 112.667 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.1 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.864 1.266 . . . . 0.0 110.985 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.35 98.95 0.27 Allowed Glycine 0 N--CA 1.47 0.927 0 C-N-CA 124.355 0.978 . . . . 0.0 110.929 171.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -154.31 166.89 31.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.18 0.992 . . . . 0.0 113.551 -171.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.0 mmm -123.81 -3.28 8.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 113.043 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.29 -58.99 0.54 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.36 -4.79 0.23 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -61.72 -44.44 96.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.285 1.542 . . . . 0.0 113.251 -173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.9 p -77.62 -31.9 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.652 0.781 . . . . 0.0 112.369 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -57.58 -41.87 82.02 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.903 -1.123 . . . . 0.0 112.414 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.91 -43.56 77.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.722 0.692 . . . . 0.0 111.679 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -39.08 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.116 0.566 . . . . 0.0 111.823 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.36 -45.13 95.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.831 0.852 . . . . 0.0 111.963 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.38 -44.2 95.87 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.627 0.771 . . . . 0.0 112.58 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.36 89.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.527 0.731 . . . . 0.0 112.11 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -56.35 -46.78 79.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.938 0.495 . . . . 0.0 111.199 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.09 85.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.839 0.856 . . . . 0.0 113.029 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.73 -46.16 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.418 1.087 . . . . 0.0 111.789 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 mt -70.07 -41.01 74.69 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.82 -0.55 . . . . 0.0 109.996 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.8 m -56.2 -46.12 79.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 112.21 169.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.38 83.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.203 1.001 . . . . 0.0 112.929 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.4 -9.75 58.92 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.307 1.043 . . . . 0.0 113.311 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -11.06 48.87 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.792 1.663 . . . . 0.0 114.587 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -70.26 140.29 52.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.015 0.926 . . . . 0.0 110.655 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -67.94 134.35 50.63 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.01 141.61 30.23 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.208 0.458 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -139.42 115.88 10.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.035 0.934 . . . . 0.0 110.026 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.59 147.27 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.699 0.8 . . . . 0.0 111.921 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.07 103.53 5.83 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.359 1.863 . . . . 0.0 107.651 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.58 -27.9 60.69 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -144.95 64.21 10.97 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.379 1.872 . . . . 0.0 109.009 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.8 160.72 40.36 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.67 2.913 . . . . 0.0 115.188 -168.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 173.51 11.6 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.302 1.841 . . . . 0.0 109.76 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -40.82 -50.74 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.098 1.359 . . . . 0.0 113.182 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 m -62.01 -18.01 59.12 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -81.64 -35.51 29.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.377 0.99 . . . . 0.0 112.122 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -77.73 -35.42 51.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 173.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -40.95 -44.76 5.58 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 127.64 2.376 . . . . 0.0 115.938 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.95 -31.87 23.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.177 2.585 . . . . 0.0 115.471 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -82.08 -4.92 57.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.96 -23.51 46.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -97.27 8.48 44.47 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.646 1.578 . . . . 0.0 112.84 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -132.15 -135.09 0.19 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.741 2.416 . . . . 0.0 109.123 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -133.93 161.35 35.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.605 1.562 . . . . 0.0 109.775 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -148.36 167.31 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.574 1.15 . . . . 0.0 111.204 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.29 139.19 14.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.318 1.056 . . . . 0.0 110.991 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -105.27 132.22 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.0 1.72 . . . . 0.0 109.685 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.83 88.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 122.753 1.264 . . . . 0.0 108.062 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.6 m -129.95 163.88 25.44 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.712 1.205 . . . . 0.0 113.027 -167.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.2 p -128.07 -173.23 2.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.335 1.454 . . . . 0.0 112.782 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -134.77 132.55 38.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.674 1.189 . . . . 0.0 110.081 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 125.183 1.393 . . . . 0.0 110.098 -169.523 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t0 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.71 130.89 78.06 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.301 1.84 . . . . 0.0 113.012 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -60.8 140.41 90.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.249 3.299 . . . . 0.0 111.118 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.21 -26.88 66.72 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.406 -0.809 . . . . 0.0 113.144 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -64.41 -8.95 15.17 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 tt -125.99 -9.26 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.22 -46.9 83.23 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 117.146 -1.407 . . . . 0.0 112.751 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.83 3.91 2.98 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.148 2.566 . . . . 0.0 114.557 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -109.03 -43.08 4.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.863 1.265 . . . . 0.0 110.656 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -59.92 -48.66 80.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.782 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -63.52 -38.16 90.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.287 -0.883 . . . . 0.0 112.622 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.45 -43.32 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.462 1.03 . . . . 0.0 113.093 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.0 mt -62.28 -46.42 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 118.543 1.171 . . . . 0.0 110.106 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -50.2 74.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.699 1.2 . . . . 0.0 112.6 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -77.76 -40.26 41.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -87.62 -45.8 10.1 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.58 -44.53 18.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.074 0.852 . . . . 0.0 113.149 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.18 -43.68 0.54 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 126.172 1.844 . . . . 0.0 116.632 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -156.88 133.12 9.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.902 1.681 . . . . 0.0 110.275 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -153.23 54.55 1.2 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.26 -24.1 78.27 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.589 2.859 . . . . 0.0 114.819 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -81.68 -13.49 57.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.744 . . . . 0.0 114.943 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.76 142.63 32.45 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.165 0.893 . . . . 0.0 111.428 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -131.1 144.35 51.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.145 1.778 . . . . 0.0 111.83 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -158.44 -172.14 3.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.86 162.43 31.67 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.18 2.324 . . . . 0.0 110.55 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.57 131.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 117.927 0.864 . . . . 0.0 112.625 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.2 126.35 74.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.29 147.75 45.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.256 1.022 . . . . 0.0 110.035 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.2 147.43 36.54 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.597 0.759 . . . . 0.0 111.54 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.75 -139.33 4.8 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.257 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -138.55 130.07 27.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 111.655 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.8 p -66.7 -5.3 11.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -69.22 2.2 3.08 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.54 153.21 48.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.423 1.489 . . . . 0.0 112.83 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.47 -7.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.778 1.631 . . . . 0.0 114.831 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -120.66 44.16 2.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.578 1.951 . . . . 0.0 110.761 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -50.38 115.38 1.43 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.211 -1.556 . . . . 0.0 112.344 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.46 25.0 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -55.9 -36.75 68.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.682 -1.261 . . . . 0.0 113.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.78 -41.26 99.88 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.794 0.724 . . . . 0.0 112.583 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.16 -40.49 82.34 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.277 -1.131 . . . . 0.0 112.936 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.76 -37.78 85.54 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.918 0.859 . . . . 0.0 113.311 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -59.77 -46.35 89.46 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.769 0.713 . . . . 0.0 111.01 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.26 -25.36 64.23 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.92 -48.93 56.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.017 -1.677 . . . . 0.0 110.077 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.8 -38.19 72.2 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.2 tp -49.21 -31.94 9.52 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.949 1.7 . . . . 0.0 112.966 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.01 -37.78 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.054 1.342 . . . . 0.0 110.975 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -35.95 82.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -22.24 66.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 112.644 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.79 9.97 41.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.2 m 66.56 15.11 10.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.685 1.994 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.56 141.57 54.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.973 0.806 . . . . 0.0 109.752 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -102.62 107.51 18.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.554 1.141 . . . . 0.0 111.449 -169.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.5 ttm105 -74.02 123.45 24.37 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.838 -1.164 . . . . 0.0 110.465 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.16 35.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.846 1.658 . . . . 0.0 111.925 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -162.12 35.81 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.526 -1.359 . . . . 0.0 114.34 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -125.57 154.38 42.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.254 1.821 . . . . 0.0 111.118 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.0 ttm -69.77 131.6 44.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.896 0.879 . . . . 0.0 112.059 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -85.91 135.37 33.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.41 0.684 . . . . 0.0 109.661 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.38 93.7 3.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.775 1.23 . . . . 0.0 111.599 -171.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mt -86.59 134.34 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.202 1.401 . . . . 0.0 110.773 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -127.17 111.89 14.51 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.085 1.354 . . . . 0.0 111.436 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.07 -23.16 53.54 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -85.48 4.61 34.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.725 1.21 . . . . 0.0 113.695 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -129.91 -30.25 2.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.861 1.264 . . . . 0.0 112.734 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -146.28 118.46 4.98 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.089 0.956 . . . . 0.0 111.789 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.94 -0.76 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.741 2.96 . . . . 0.0 114.708 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.64 77.44 77.44 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.57 1.548 . . . . 0.0 112.331 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.18 -31.33 5.9 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 125.831 4.354 . . . . 0.0 116.351 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -48.08 -44.42 31.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.133 1.773 . . . . 0.0 113.269 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.8 p -71.77 -29.0 64.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.594 1.158 . . . . 0.0 113.314 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.5 -26.46 38.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.317 0.647 . . . . 0.0 112.217 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.5 p -105.33 -28.37 10.94 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.43 -59.8 6.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.2 -28.57 33.85 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.909 1.739 . . . . 0.0 112.226 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -63.05 -50.31 71.14 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.701 0.682 . . . . 0.0 111.691 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.04 -41.12 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.739 0.7 . . . . 0.0 110.318 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.61 -44.44 93.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.349 0.522 . . . . 0.0 111.624 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.92 -55.47 25.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.196 0.998 . . . . 0.0 112.554 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.59 -49.67 64.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.36 1.064 . . . . 0.0 110.907 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.36 -19.57 26.11 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.579 1.562 . . . . 0.0 116.44 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.8 p -69.78 -20.24 63.48 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.884 2.342 . . . . 0.0 113.62 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -97.49 -15.48 20.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.178 1.391 . . . . 0.0 113.151 -171.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 149.9 49.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.303 1.441 . . . . 0.0 112.183 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.023 1.729 . . . . 0.0 114.234 -172.222 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -126.64 123.66 38.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.714 1.606 . . . . 0.0 109.434 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 mm -118.03 123.75 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.496 1.118 . . . . 0.0 112.259 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.42 126.58 7.69 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 168.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -116.97 111.4 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.719 1.259 . . . . 0.0 109.075 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.32 133.09 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.613 0.765 . . . . 0.0 110.79 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.94 144.26 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.903 -169.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.72 115.17 1.64 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -157.58 162.46 38.76 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.508 -0.996 . . . . 0.0 111.424 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -120.7 -19.39 7.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.598 1.159 . . . . 0.0 112.336 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.29 -7.12 2.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.15 -2.34 47.4 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.1 -47.75 78.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.314 1.557 . . . . 0.0 112.515 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -67.83 -30.11 69.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 112.751 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 tp -64.14 -44.36 92.41 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.7 -1.25 . . . . 0.0 113.039 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.09 -42.87 77.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.021 0.828 . . . . 0.0 111.262 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.31 -38.0 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.54 0.736 . . . . 0.0 112.236 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.31 94.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.85 -39.19 93.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.51 -44.63 96.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.483 -0.761 . . . . 0.0 112.216 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.34 88.67 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.922 0.783 . . . . 0.0 112.598 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.44 -46.4 80.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.775 0.83 . . . . 0.0 111.991 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.7 84.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 112.493 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.37 -42.64 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.407 1.083 . . . . 0.0 112.563 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.55 -44.21 78.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.807 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -56.93 -46.23 82.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 112.045 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -39.59 89.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.187 0.995 . . . . 0.0 113.242 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -67.75 -28.87 68.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.657 0.783 . . . . 0.0 112.67 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.76 -5.98 6.16 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.282 1.42 . . . . 0.0 114.502 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -73.58 178.84 4.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.355 1.462 . . . . 0.0 111.482 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -117.64 144.11 45.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.354 1.462 . . . . 0.0 109.392 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.89 163.3 37.23 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.638 -0.664 . . . . 0.0 112.576 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -153.12 116.55 4.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.097 0.959 . . . . 0.0 110.999 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.87 140.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.872 1.269 . . . . 0.0 111.201 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -125.42 107.74 10.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.252 1.821 . . . . 0.0 108.959 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.48 -20.68 46.74 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -171.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.45 61.02 7.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.857 1.663 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.77 161.6 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.077 3.185 . . . . 0.0 115.023 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.2 171.34 14.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.115 2.166 . . . . 0.0 109.405 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -46.54 -48.57 19.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.354 1.062 . . . . 0.0 112.948 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 m -59.4 -19.22 45.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -79.02 -35.64 42.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.503 1.047 . . . . 0.0 111.85 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 23.0 t-105 -78.97 -37.36 39.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.239 1.415 . . . . 0.0 112.56 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.6 tp -38.68 -50.17 3.8 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 128.466 2.706 . . . . 0.0 116.318 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -15.67 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.714 2.276 . . . . 0.0 115.258 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -84.84 -1.8 56.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.12 -33.41 69.1 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.221 -0.925 . . . . 0.0 113.295 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.52 -5.7 50.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.266 1.026 . . . . 0.0 113.519 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -133.08 -134.51 0.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.927 2.491 . . . . 0.0 109.478 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.08 158.8 43.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.115 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.57 170.53 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.058 1.343 . . . . 0.0 111.896 -173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.91 148.64 20.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.334 1.453 . . . . 0.0 110.413 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.09 135.59 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.57 1.548 . . . . 0.0 109.829 -170.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.44 96.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.313 1.045 . . . . 0.0 109.681 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.0 m -138.82 152.99 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.3 p -108.33 -159.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.869 1.267 . . . . 0.0 113.514 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.1 m -122.92 151.19 42.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.082 1.753 . . . . 0.0 109.115 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 125.441 1.496 . . . . 0.0 108.73 -169.824 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pp -119.87 163.0 30.21 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.747 1.619 . . . . 0.0 113.603 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.71 142.9 78.78 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.59 3.527 . . . . 0.0 113.305 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.03 -28.15 67.51 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.617 -0.677 . . . . 0.0 112.816 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -62.02 -10.21 9.32 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.3 tt -128.1 -6.81 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.463 1.029 . . . . 0.0 113.243 175.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -47.9 -50.65 52.18 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 117.392 -1.289 . . . . 0.0 112.647 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 -2.03 10.75 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.239 1.959 . . . . 0.0 114.238 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.0 tp -98.06 -43.98 6.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.99 0.916 . . . . 0.0 110.122 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -61.57 -47.05 87.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -63.91 -44.53 92.66 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.34 -0.85 . . . . 0.0 111.876 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.61 -45.84 93.65 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.981 0.8 . . . . 0.0 113.373 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.02 -43.49 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.31 1.055 . . . . 0.0 110.596 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -62.65 -45.04 94.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.355 1.062 . . . . 0.0 112.617 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -83.67 -39.41 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.115 1.366 . . . . 0.0 114.512 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -121.8 4.92 9.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.65 -48.51 2.93 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.754 1.161 . . . . 0.0 110.823 168.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.49 -26.68 0.22 Allowed Glycine 0 CA--C 1.542 1.725 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -155.22 136.67 14.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 110.211 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -148.68 58.58 3.7 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.195 1.398 . . . . 0.0 112.471 -169.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.45 -2.53 8.45 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.603 3.535 . . . . 0.0 115.21 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -118.67 -6.12 10.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.664 2.385 . . . . 0.0 113.305 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.25 121.18 20.87 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.155 0.982 . . . . 0.0 110.155 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -123.4 140.77 52.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.87 1.668 . . . . 0.0 109.897 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -163.48 -167.57 1.46 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -168.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.54 170.46 34.05 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 127.596 2.522 . . . . 0.0 110.116 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.2 t -142.0 132.65 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.631 1.216 . . . . 0.0 112.247 -174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.72 130.4 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.59 152.5 43.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.017 0.927 . . . . 0.0 110.482 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -142.92 138.5 30.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.368 0.667 . . . . 0.0 111.803 -169.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.03 -138.86 3.36 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -144.09 122.51 12.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.501 1.12 . . . . 0.0 110.782 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -60.63 -9.42 3.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.823 1.249 . . . . 0.0 114.094 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.8 m -59.29 -13.42 7.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.419 1.488 . . . . 0.0 114.809 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -127.56 138.35 52.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.759 1.223 . . . . 0.0 111.834 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.69 -27.47 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -168.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -90.46 -14.08 33.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.761 1.164 . . . . 0.0 113.327 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 36.0 -125.33 0.14 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.409 1.484 . . . . 0.0 112.573 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.3 m -77.32 20.42 0.29 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -54.16 -33.98 59.34 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.095 -1.628 . . . . 0.0 114.71 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.27 85.38 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.481 1.037 . . . . 0.0 113.393 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.22 -41.75 52.42 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.256 -1.144 . . . . 0.0 112.429 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.88 -36.4 79.11 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -56.55 -48.48 77.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.69 0.677 . . . . 0.0 111.418 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -70.01 -29.53 66.62 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.49 -46.33 76.65 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.226 -1.546 . . . . 0.0 111.291 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.09 70.68 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -48.96 -28.55 3.95 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.924 1.689 . . . . 0.0 113.36 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -101.77 -35.26 9.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.645 1.178 . . . . 0.0 111.432 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.59 -32.84 74.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.72 1.145 . . . . 0.0 111.682 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.2 -15.31 14.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.809 1.243 . . . . 0.0 113.002 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -124.16 16.65 9.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.845 1.658 . . . . 0.0 113.201 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m 64.02 25.11 13.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.002 1.721 . . . . 0.0 115.425 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 159.79 12.27 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.243 -0.911 . . . . 0.0 112.332 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -129.13 86.33 2.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.111 1.364 . . . . 0.0 110.394 -170.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -62.51 138.96 58.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.03 31.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.552 1.541 . . . . 0.0 111.544 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.18 -165.46 38.92 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 121.015 -1.053 . . . . 0.0 113.999 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.26 158.48 28.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.066 1.747 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.0 ttm -72.32 133.96 45.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.68 -0.637 . . . . 0.0 112.149 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.27 134.13 33.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.825 0.85 . . . . 0.0 109.469 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.25 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.241 1.016 . . . . 0.0 111.196 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.58 135.07 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.074 1.35 . . . . 0.0 110.609 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -131.63 113.24 13.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.004 1.322 . . . . 0.0 111.09 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.8 30.44 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 m -77.26 -2.78 36.44 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -139.43 -18.5 0.98 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.631 1.573 . . . . 0.0 113.437 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.84 80.64 70.57 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.993 2.117 . . . . 0.0 110.772 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -16.25 42.57 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.947 2.432 . . . . 0.0 113.313 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.92 91.15 48.86 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 107.736 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.35 -27.04 84.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.461 2.774 . . . . 0.0 115.524 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.31 -29.1 60.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 p -68.92 -6.55 28.11 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -111.8 -31.83 6.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.327 1.051 . . . . 0.0 111.335 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.1 p -78.0 -32.88 51.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.88 -60.74 4.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -66.29 -29.78 46.09 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.118 1.879 . . . . 0.0 112.278 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -61.94 -51.15 69.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.532 0.605 . . . . 0.0 111.582 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.02 -40.65 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.525 0.602 . . . . 0.0 110.485 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.71 -38.01 83.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -71.41 -59.08 2.96 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.125 0.97 . . . . 0.0 112.717 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -52.17 -47.54 65.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.926 -174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.03 -34.69 12.26 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.001 1.286 . . . . 0.0 115.268 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.7 p -66.72 -15.88 63.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.023 1.411 . . . . 0.0 114.052 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -96.99 -15.92 20.85 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.249 1.419 . . . . 0.0 113.4 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.17 -36.86 80.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.561 1.544 . . . . 0.0 113.592 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.764 1.626 . . . . 0.0 112.226 -175.416 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.448 0.166 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.18 124.25 24.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.125 1.37 . . . . 0.0 109.181 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mt -136.9 125.05 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.71 132.88 11.39 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -120.02 90.79 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.984 1.314 . . . . 0.0 108.411 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.829 0.852 . . . . 0.0 110.752 -169.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.12 144.9 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.489 0.661 . . . . 0.0 111.567 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.49 101.68 0.48 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -146.92 164.1 33.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.784 1.234 . . . . 0.0 111.022 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 80.2 mmm -111.5 -11.39 14.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.944 0.898 . . . . 0.0 113.359 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -146.51 -19.62 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.89 -10.02 5.44 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 170.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.93 -44.38 91.32 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.176 1.988 . . . . 0.0 113.315 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.6 p -82.59 -28.97 30.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.6 0.76 . . . . 0.0 112.512 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.93 -40.42 84.56 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.729 -1.232 . . . . 0.0 112.912 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 tt -54.57 -41.05 69.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 111.815 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.88 -35.72 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.242 0.617 . . . . 0.0 111.991 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.12 97.87 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.393 0.997 . . . . 0.0 112.506 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.47 -40.86 96.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.534 0.733 . . . . 0.0 112.269 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -60.45 -47.86 84.29 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.772 -0.58 . . . . 0.0 111.552 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.13 87.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.556 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.35 -46.24 80.06 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.727 0.811 . . . . 0.0 112.071 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.88 -47.18 81.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.367 0.667 . . . . 0.0 112.31 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.43 -32.7 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.358 . . . . 0.0 112.964 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 mt -80.14 -38.31 31.73 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.686 -1.259 . . . . 0.0 110.12 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.2 m -57.03 -45.32 83.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.669 0.788 . . . . 0.0 111.17 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.86 78.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.558 1.143 . . . . 0.0 113.487 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.05 -7.06 52.64 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.37 24.32 12.71 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.606 1.098 . . . . 0.0 114.346 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -114.87 147.89 39.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.376 1.088 . . . . 0.0 112.153 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -75.22 134.35 41.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.232 1.013 . . . . 0.0 109.034 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 155.03 45.59 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.168 0.987 . . . . 0.0 111.189 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -154.13 116.49 4.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.08 -1.013 . . . . 0.0 110.665 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.82 138.74 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.121 0.968 . . . . 0.0 110.71 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.68 101.08 6.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.308 . . . . 0.0 109.808 172.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.64 -22.79 56.47 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -144.31 64.12 11.93 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.202 1.801 . . . . 0.0 109.586 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.8 160.7 48.58 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.117 3.211 . . . . 0.0 114.703 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.37 162.04 31.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.164 2.186 . . . . 0.0 109.212 169.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -53.99 -36.62 63.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.713 -1.242 . . . . 0.0 113.346 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -58.07 -18.79 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -83.4 -35.13 25.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.406 1.003 . . . . 0.0 112.344 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -75.2 -37.19 61.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.926 0.89 . . . . 0.0 112.193 172.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.3 tp -41.42 -46.74 8.42 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 128.34 2.656 . . . . 0.0 116.411 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.67 -30.32 4.98 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.211 1.941 . . . . 0.0 114.391 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -81.26 -9.74 59.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -55.44 -28.5 54.72 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.13 -4.98 52.99 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.471 1.508 . . . . 0.0 113.848 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.11 -115.52 0.23 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.761 1.624 . . . . 0.0 111.154 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.02 160.93 39.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.618 1.567 . . . . 0.0 110.694 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.4 m -152.4 172.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.118 1.367 . . . . 0.0 111.314 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 149.31 18.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.938 1.295 . . . . 0.0 109.771 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.07 136.98 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.84 1.256 . . . . 0.0 109.983 -170.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.11 94.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.984 1.314 . . . . 0.0 109.024 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.1 m -135.76 139.82 43.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -168.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -178.1 5.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.868 1.667 . . . . 0.0 112.381 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 m -127.75 139.11 52.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.718 -1.239 . . . . 0.0 110.899 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 120.556 1.526 . . . . 0.0 110.75 -170.644 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 CA--C 1.548 0.869 0 CA-C-O 121.583 0.706 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -53.52 136.97 52.22 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.364 1.866 . . . . 0.0 111.834 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.72 141.99 28.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.354 2.703 . . . . 0.0 110.679 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.46 -25.42 62.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 m -61.67 -17.2 54.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.42 -12.87 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 119.76 1.164 . . . . 0.0 114.138 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.68 -42.88 24.67 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.38 1.472 . . . . 0.0 114.08 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.17 -25.4 10.13 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.97 1.78 . . . . 0.0 114.075 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.49 -45.82 61.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.312 0.96 . . . . 0.0 109.616 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.19 -58.36 6.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.75 1.62 . . . . 0.0 111.381 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -66.96 -33.81 76.4 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.486 -1.384 . . . . 0.0 113.958 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.47 -48.23 87.0 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 119.097 0.862 . . . . 0.0 112.495 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.22 -41.03 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.197 -1.178 . . . . 0.0 110.557 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -61.48 -37.33 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.76 -23.07 10.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -169.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -113.21 0.45 14.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.5 mt -129.32 -49.63 1.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.739 1.216 . . . . 0.0 111.418 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.94 -22.52 0.33 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 118.447 2.139 . . . . 0.0 118.447 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -153.57 139.71 18.38 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.577 1.689 . . . . 0.0 110.677 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.59 45.85 0.28 Allowed Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -59.59 -21.57 62.94 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.555 3.504 . . . . 0.0 116.865 -169.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -106.56 -0.74 23.64 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.308 1.443 . . . . 0.0 113.849 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.52 136.95 40.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.88 0.872 . . . . 0.0 110.258 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -130.7 133.5 46.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.681 1.992 . . . . 0.0 109.525 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -151.93 -170.87 3.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -170.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.46 164.92 30.78 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.823 1.678 . . . . 0.0 110.027 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.78 134.78 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 122.178 0.989 . . . . 0.0 112.253 -169.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.4 mt -121.4 129.9 75.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.78 50.35 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.277 0.631 . . . . 0.0 111.591 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.1 169.69 20.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.494 1.14 . . . . 0.0 113.962 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.02 -126.03 1.28 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.643 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -142.21 128.56 19.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.3 1.04 . . . . 0.0 112.32 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -66.94 -12.13 58.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.714 1.606 . . . . 0.0 114.91 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 -15.77 63.2 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.13 148.84 22.28 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.867 1.267 . . . . 0.0 112.299 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.15 -38.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.71 0.804 . . . . 0.0 111.572 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -76.13 41.32 0.23 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.523 1.529 . . . . 0.0 112.834 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.5 117.15 2.66 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.911 -1.743 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 61.1 m 51.7 24.55 2.45 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -56.32 -33.55 65.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.622 -1.299 . . . . 0.0 113.32 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.9 -34.12 70.7 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.979 0.799 . . . . 0.0 113.522 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.89 -40.43 10.62 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.412 -1.052 . . . . 0.0 112.936 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.27 -35.75 74.28 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.293 1.047 . . . . 0.0 113.257 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -59.9 -41.88 92.6 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.231 1.013 . . . . 0.0 112.223 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -75.86 -29.04 58.41 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.443 -0.786 . . . . 0.0 112.684 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.27 -43.79 80.94 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.076 -1.64 . . . . 0.0 111.289 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.18 84.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.111 0.964 . . . . 0.0 113.199 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.5 tp -49.04 -29.39 4.95 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 112.964 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.0 mt -102.69 -42.91 5.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.567 1.147 . . . . 0.0 111.642 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.18 -31.44 72.63 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.756 1.162 . . . . 0.0 112.76 169.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.88 -18.64 63.25 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.094 -1.004 . . . . 0.0 112.86 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -107.03 15.3 25.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.865 1.666 . . . . 0.0 112.39 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.2 m 62.43 14.92 7.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.944 2.097 . . . . 0.0 115.276 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.02 156.64 17.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.915 0.78 . . . . 0.0 112.008 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -116.53 164.8 14.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 -169.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 -129.61 146.13 51.44 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.46 21.01 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 113.368 -1.742 . . . . 0.0 112.368 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.6 -176.71 46.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.104 1.811 . . . . 0.0 113.464 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.21 159.3 22.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 112.112 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.38 127.08 31.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.433 0.693 . . . . 0.0 112.388 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.81 133.56 35.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.33 94.26 3.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.864 1.266 . . . . 0.0 111.356 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.17 138.57 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.443 0.697 . . . . 0.0 111.817 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.98 114.93 23.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.535 1.534 . . . . 0.0 111.429 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.19 -25.32 58.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m -79.86 1.36 27.34 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -132.47 -27.75 1.72 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.833 1.253 . . . . 0.0 113.453 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -142.47 108.33 5.64 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 112.104 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.87 -0.99 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.112 3.208 . . . . 0.0 114.571 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.18 74.71 79.27 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.465 1.906 . . . . 0.0 109.842 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -57.94 -22.0 52.49 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.445 3.43 . . . . 0.0 116.551 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.04 -37.81 72.32 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.932 -1.105 . . . . 0.0 113.122 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.8 p -68.56 -6.35 24.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.317 1.047 . . . . 0.0 113.476 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -110.47 -12.99 14.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.211 1.404 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -129.17 -24.54 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -51.48 -52.73 57.11 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.251 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.11 -27.58 41.78 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.78 1.654 . . . . 0.0 113.419 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -62.51 -49.91 73.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.66 -33.64 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.558 -0.714 . . . . 0.0 111.113 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.52 -16.65 63.88 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -95.98 -59.26 1.89 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.826 1.251 . . . . 0.0 111.759 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -54.63 -46.04 73.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.775 1.23 . . . . 0.0 112.473 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.91 -19.6 22.83 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.2 p -76.86 -11.99 59.9 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.893 . . . . 0.0 113.715 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.08 -9.32 17.89 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 126.1 45.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.609 1.164 . . . . 0.0 113.698 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.885 2.474 . . . . 0.0 110.563 170.798 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.323 0.583 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -127.99 125.2 38.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 0.0 108.679 174.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 mm -123.07 124.25 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.398 1.079 . . . . 0.0 112.569 -171.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.62 128.52 9.24 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.5 mt -119.25 91.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -91.22 135.41 33.81 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 111.565 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.2 142.56 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.011 -170.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.16 104.72 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -147.7 169.49 19.59 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.911 1.284 . . . . 0.0 110.807 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.7 mtp -116.65 -7.2 11.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.283 1.033 . . . . 0.0 113.029 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -148.37 -32.0 0.26 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.39 -1.58 2.71 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.88 -42.18 97.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.144 1.972 . . . . 0.0 113.199 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -78.37 -31.87 48.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 172.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.3 tp -57.71 -40.09 78.74 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.037 -1.039 . . . . 0.0 113.08 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.87 -45.1 70.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.312 0.645 . . . . 0.0 111.464 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.72 -39.38 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.834 0.454 . . . . 0.0 111.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.42 87.45 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.19 0.905 . . . . 0.0 113.159 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.12 -44.24 96.17 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.564 -0.71 . . . . 0.0 111.886 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.31 -40.74 97.3 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.665 -0.647 . . . . 0.0 112.068 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -46.31 90.65 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.854 0.752 . . . . 0.0 111.799 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.44 -47.0 80.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.013 0.525 . . . . 0.0 111.493 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.67 -47.36 85.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.789 0.836 . . . . 0.0 112.911 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.32 -46.35 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.556 1.142 . . . . 0.0 112.225 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.78 -40.79 75.81 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.942 -0.474 . . . . 0.0 109.751 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -56.24 -46.54 79.55 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.859 1.264 . . . . 0.0 112.215 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.54 89.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 112.955 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -68.71 -30.77 69.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.393 0.677 . . . . 0.0 112.671 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.57 -6.69 4.56 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.875 1.226 . . . . 0.0 115.556 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -79.07 144.1 34.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 111.04 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.82 134.9 49.04 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.76 142.68 31.03 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.8 0.727 . . . . 0.0 112.293 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.6 m -141.45 114.83 8.83 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.086 0.954 . . . . 0.0 110.137 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.6 p -80.53 149.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.919 0.888 . . . . 0.0 111.974 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -137.94 104.9 5.39 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.711 1.605 . . . . 0.0 109.321 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.82 -33.04 70.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.555 1.542 . . . . 0.0 114.522 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -145.81 62.88 8.83 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.418 1.887 . . . . 0.0 109.437 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.67 160.1 49.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.911 3.074 . . . . 0.0 115.658 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.94 170.59 15.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.423 2.289 . . . . 0.0 109.026 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -57.71 -34.99 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.7 -1.25 . . . . 0.0 113.443 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.2 p -61.21 -15.49 34.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.38 -33.38 20.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.568 1.076 . . . . 0.0 112.503 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -75.52 -37.15 60.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.302 1.041 . . . . 0.0 112.501 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.9 tp -43.92 -50.53 19.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 127.789 2.436 . . . . 0.0 115.216 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.61 -1.59 6.93 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.072 2.515 . . . . 0.0 115.708 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.18 0.46 10.68 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.181 1.392 . . . . 0.0 114.02 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -60.84 -14.82 24.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -121.19 18.74 11.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.619 2.368 . . . . 0.0 112.267 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -124.43 -138.05 0.29 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.697 2.399 . . . . 0.0 108.649 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -123.32 157.86 32.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.532 1.533 . . . . 0.0 109.303 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.33 166.79 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.111 1.364 . . . . 0.0 110.08 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.18 144.88 20.19 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.239 -0.913 . . . . 0.0 110.654 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -113.44 132.86 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.382 1.473 . . . . 0.0 110.334 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.78 91.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.52 1.128 . . . . 0.0 108.757 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 m -135.8 138.13 42.28 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -85.15 -167.76 1.96 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.767 2.027 . . . . 0.0 113.034 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -135.81 141.95 44.79 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.537 -1.352 . . . . 0.0 111.157 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.197 1.799 . . . . 0.0 109.539 -179.193 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mt -49.47 127.4 17.58 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 127.511 2.324 . . . . 0.0 113.133 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.27 141.78 94.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.296 3.331 . . . . 0.0 111.351 169.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.37 -25.99 67.54 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -171.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.3 m -63.21 -12.16 26.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.3 tt -125.19 -10.39 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.93 -47.65 63.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.263 -1.351 . . . . 0.0 113.33 170.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.15 -19.2 34.55 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 122.46 1.914 . . . . 0.0 113.987 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -78.02 -42.72 31.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.179 0.9 . . . . 0.0 109.606 171.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -62.04 -45.92 91.42 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.518 1.127 . . . . 0.0 111.386 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -62.77 -40.93 98.81 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.659 -1.276 . . . . 0.0 112.676 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -45.46 69.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.568 1.08 . . . . 0.0 112.967 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.5 mt -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 119.427 1.613 . . . . 0.0 109.98 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.79 -46.12 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.654 1.181 . . . . 0.0 112.265 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.24 -35.17 36.48 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -90.82 -33.95 15.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.22 -53.55 4.19 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.625 1.102 . . . . 0.0 111.689 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -37.59 0.29 Allowed Glycine 0 CA--C 1.544 1.862 0 C-N-CA 126.164 1.84 . . . . 0.0 115.803 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -161.87 124.7 3.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 110.557 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -149.58 53.75 1.4 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 126.035 1.734 . . . . 0.0 113.085 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.78 -27.63 78.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.942 3.095 . . . . 0.0 115.13 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.81 -26.46 67.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.889 1.276 . . . . 0.0 114.247 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.6 tp -77.78 142.1 38.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.678 0.791 . . . . 0.0 112.527 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -138.08 145.61 41.93 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.038 2.135 . . . . 0.0 110.054 -172.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -161.0 -171.15 2.96 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -169.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.91 165.26 33.08 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.933 2.206 . . . . 0.0 110.525 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -139.65 134.78 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.076 0.938 . . . . 0.0 112.618 -169.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.8 mt -118.3 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.16 148.25 40.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.173 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.07 151.41 45.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.175 0.988 . . . . 0.0 112.075 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.78 -133.57 2.76 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.164 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -142.65 133.1 24.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.421 1.088 . . . . 0.0 111.967 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.7 p -68.32 -6.12 22.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 m -68.64 3.18 1.98 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -136.64 154.59 50.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.788 1.635 . . . . 0.0 111.749 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.85 -36.23 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.632 0.773 . . . . 0.0 112.897 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.43 44.78 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.769 0.827 . . . . 0.0 111.944 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -53.77 116.61 2.61 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.553 -1.342 . . . . 0.0 112.003 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 56.7 m 50.83 23.93 1.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.964 2.506 . . . . 0.0 116.957 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.07 -26.28 67.53 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.661 -1.274 . . . . 0.0 114.09 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -30.09 73.46 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.733 0.697 . . . . 0.0 113.404 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.0 -38.71 9.04 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.08 0.94 . . . . 0.0 113.179 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.18 -35.16 74.75 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.509 1.155 . . . . 0.0 113.52 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -59.38 -37.84 78.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.494 0.718 . . . . 0.0 112.423 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.04 -33.2 61.71 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.322 -0.861 . . . . 0.0 112.477 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.95 -1.719 . . . . 0.0 110.911 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.7 89.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.3 tp -46.31 -44.04 16.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.495 1.518 . . . . 0.0 111.998 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.23 -28.63 57.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.114 1.366 . . . . 0.0 112.449 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.16 -29.74 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.106 -0.996 . . . . 0.0 111.587 169.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -66.01 -23.86 66.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.638 1.108 . . . . 0.0 111.607 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -88.05 1.89 53.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.646 1.178 . . . . 0.0 111.967 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m 53.38 22.73 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.995 1.718 . . . . 0.0 114.83 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 156.1 24.34 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 111.433 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -119.48 87.63 2.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.502 1.521 . . . . 0.0 111.539 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.2 ttp85 -59.47 137.86 57.87 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.487 -0.758 . . . . 0.0 112.041 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.67 51.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 126.341 1.856 . . . . 0.0 109.967 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.85 -174.86 44.7 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.326 -0.859 . . . . 0.0 114.083 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.08 147.16 44.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.25 1.42 . . . . 0.0 110.717 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.06 130.66 42.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.452 0.701 . . . . 0.0 111.86 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.34 134.65 35.26 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 92.29 3.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.681 1.192 . . . . 0.0 111.246 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.5 mt -85.1 134.3 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.468 1.507 . . . . 0.0 111.631 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -121.56 109.16 14.46 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.623 1.169 . . . . 0.0 112.809 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.42 -23.39 49.23 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 m -83.5 0.82 44.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.416 1.087 . . . . 0.0 113.867 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -129.21 -26.54 2.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 113.417 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -146.59 119.29 4.97 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.007 0.822 . . . . 0.0 112.835 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.0 -5.11 12.12 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.895 3.063 . . . . 0.0 114.216 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.43 73.94 80.11 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.54 1.536 . . . . 0.0 111.175 -172.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.06 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.311 3.34 . . . . 0.0 115.055 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -48.15 -44.21 32.14 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.146 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.5 p -67.78 -18.41 64.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.51 -17.74 16.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.209 1.004 . . . . 0.0 112.425 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -113.42 -28.43 7.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -59.9 -52.12 75.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.717 -1.135 . . . . 0.0 113.204 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.49 -28.93 61.95 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.349 1.518 . . . . 0.0 112.773 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -60.95 -50.29 73.98 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.609 0.641 . . . . 0.0 111.658 171.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 -41.43 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.684 0.675 . . . . 0.0 110.461 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.91 -39.45 85.45 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.453 0.57 . . . . 0.0 111.966 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -67.19 -56.32 10.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.883 0.873 . . . . 0.0 112.51 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -53.35 -46.23 69.46 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.414 1.086 . . . . 0.0 111.4 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.5 -23.61 6.59 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.393 1.949 . . . . 0.0 116.507 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -72.69 -18.52 61.54 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.068 1.934 . . . . 0.0 114.072 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.65 -15.47 25.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.487 1.515 . . . . 0.0 113.109 -171.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.49 157.67 22.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.521 2.328 . . . . 0.0 113.154 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.256 1.397 0 C-N-CA 128.156 2.582 . . . . 0.0 114.649 -173.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.326 0.584 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -131.88 129.49 40.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.633 1.173 . . . . 0.0 110.094 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 mm -122.0 125.17 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.894 0.878 . . . . 0.0 112.937 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.84 124.87 7.05 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mt -116.41 91.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.448 1.099 . . . . 0.0 108.26 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.68 136.09 35.38 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.021 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.31 145.21 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.215 0.606 . . . . 0.0 111.669 -169.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 80.92 0.3 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.188 1.375 . . . . 0.0 110.741 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.03 168.58 18.54 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.0 tpt -130.58 -4.18 4.2 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.938 2.095 . . . . 0.0 112.203 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -142.82 -54.74 0.41 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.114 . . . . 0.0 113.229 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.08 -2.98 1.04 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 117.097 1.599 . . . . 0.0 117.097 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -62.79 -44.14 96.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.881 1.341 . . . . 0.0 112.289 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -71.59 -35.76 70.63 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.286 1.434 . . . . 0.0 112.309 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.51 -40.78 92.65 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.718 -1.239 . . . . 0.0 112.457 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.49 -41.17 76.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.879 0.763 . . . . 0.0 111.82 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.52 -37.92 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.847 -0.533 . . . . 0.0 112.023 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.1 97.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.35 0.977 . . . . 0.0 112.844 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.48 -40.33 94.16 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.575 0.75 . . . . 0.0 112.413 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.51 -45.64 93.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.386 -0.821 . . . . 0.0 112.102 169.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.19 88.29 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.726 -0.609 . . . . 0.0 112.198 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.19 -47.73 77.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.648 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.84 92.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.564 0.745 . . . . 0.0 112.676 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.1 -47.25 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.749 1.219 . . . . 0.0 112.355 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.09 -39.35 79.08 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.253 0.621 . . . . 0.0 109.805 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -57.01 -48.71 77.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.988 1.315 . . . . 0.0 111.975 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -34.97 79.16 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.025 0.93 . . . . 0.0 113.399 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.26 -8.31 56.29 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.43 36.95 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.974 1.273 . . . . 0.0 115.009 171.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -77.24 172.17 13.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.764 1.226 . . . . 0.0 111.557 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -104.97 145.29 30.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.276 1.03 . . . . 0.0 108.543 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.78 164.17 32.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.47 -0.769 . . . . 0.0 112.788 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.6 m -152.79 120.97 6.22 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 110.565 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.16 138.63 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.053 0.941 . . . . 0.0 110.651 169.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -125.9 107.4 10.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.88 1.272 . . . . 0.0 109.606 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -84.65 -14.43 48.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -143.2 56.67 4.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 126.074 1.75 . . . . 0.0 110.199 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.15 165.4 31.55 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.095 3.197 . . . . 0.0 115.524 -169.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.15 166.38 26.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.181 2.193 . . . . 0.0 109.037 172.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -40.15 25.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.577 1.151 . . . . 0.0 112.404 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.02 -20.12 15.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -97.12 -29.09 13.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.934 1.293 . . . . 0.0 112.181 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -70.66 -42.01 71.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.511 . . . . 0.0 112.771 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.08 -52.79 49.92 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.222 2.209 . . . . 0.0 114.687 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -65.77 -3.65 8.48 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.002 2.468 . . . . 0.0 115.956 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -110.72 1.11 17.67 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.888 1.275 . . . . 0.0 114.07 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -66.24 -30.29 70.7 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.484 -1.385 . . . . 0.0 113.418 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.97 3.93 13.43 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.923 1.289 . . . . 0.0 113.365 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -132.45 -123.77 0.19 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.286 1.835 . . . . 0.0 110.14 -169.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.51 160.0 40.97 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.909 1.684 . . . . 0.0 110.768 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.44 168.47 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 110.65 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.57 146.26 19.47 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.386 -0.821 . . . . 0.0 110.466 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -117.91 137.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.062 1.345 . . . . 0.0 110.595 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.2 94.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.873 1.269 . . . . 0.0 108.091 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.1 m -133.8 167.06 21.24 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.4 p -141.22 173.93 11.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 112.047 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.7 m -99.14 150.97 21.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.748 1.219 . . . . 0.0 112.447 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.476 0.855 0 C-N-CA 128.17 2.588 . . . . 0.0 108.739 170.22 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.962 0.411 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.03 147.15 34.01 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.411 1.885 . . . . 0.0 110.396 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.86 154.38 63.41 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.614 2.876 . . . . 0.0 111.36 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.48 -14.22 56.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.9 p -59.18 -27.51 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.633 1.173 . . . . 0.0 113.538 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.64 -9.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.563 1.145 . . . . 0.0 113.965 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -49.94 -46.03 81.12 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 120.369 -1.457 . . . . 0.0 112.716 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.19 -15.49 23.67 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.02 3.146 . . . . 0.0 116.119 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 tp -98.31 -45.7 6.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.88 1.272 . . . . 0.0 109.806 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -63.42 -45.36 91.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.032 1.333 . . . . 0.0 112.251 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -68.81 -38.5 79.94 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.57 -47.04 64.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.143 0.878 . . . . 0.0 112.936 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.33 -44.33 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.224 1.012 . . . . 0.0 110.652 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.85 -47.45 83.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.997 0.919 . . . . 0.0 112.524 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.22 -26.96 24.78 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -125.9 6.1 7.33 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 -169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.7 mt -123.03 -50.81 1.91 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.517 1.053 . . . . 0.0 111.48 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 -27.06 0.26 Allowed Glycine 0 CA--C 1.543 1.806 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -158.8 131.79 7.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.45 1.625 . . . . 0.0 110.845 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -159.12 52.84 0.52 Allowed Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.14 -32.28 39.26 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.463 2.775 . . . . 0.0 116.582 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -73.14 -13.19 61.13 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 tp -73.94 140.15 45.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.978 0.808 . . . . 0.0 111.845 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -135.45 144.14 46.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.102 1.761 . . . . 0.0 109.505 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -162.8 -169.43 2.06 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.29 163.05 31.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.798 2.142 . . . . 0.0 110.384 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.13 138.05 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 122.233 1.016 . . . . 0.0 112.62 -172.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.3 mt -122.1 131.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.323 1.849 . . . . 0.0 106.052 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.46 147.14 49.85 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.492 0.717 . . . . 0.0 110.36 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.8 tt -139.13 142.82 38.04 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.069 0.947 . . . . 0.0 111.601 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.58 -147.86 7.79 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.362 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -144.15 121.6 11.7 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.273 1.429 . . . . 0.0 110.029 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.5 p -62.41 -5.26 2.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.4 m -60.66 -13.2 13.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.433 1.493 . . . . 0.0 114.453 169.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -123.21 157.45 33.01 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 0.0 113.638 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 m -50.69 -23.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -168.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.99 1.84 4.3 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -173.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 14.5 t80 36.54 -128.83 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.832 1.253 . . . . 0.0 112.784 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.4 m -80.99 21.38 0.7 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.86 -33.27 48.98 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.34 95.52 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.758 1.163 . . . . 0.0 113.327 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.2 -40.25 71.27 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 121.613 -0.934 . . . . 0.0 112.95 171.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.01 -38.45 88.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.383 1.091 . . . . 0.0 113.132 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -59.05 -43.59 91.7 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.506 0.594 . . . . 0.0 111.776 170.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.66 -36.61 78.78 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.45 -43.09 98.38 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.811 -1.806 . . . . 0.0 111.711 170.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.17 69.87 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 tp -49.75 -28.36 6.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 112.956 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 mt -102.35 -37.69 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 -169.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.1 -31.9 73.04 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.938 1.244 . . . . 0.0 111.533 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.02 -17.33 24.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 113.024 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -119.81 16.53 12.68 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.122 1.769 . . . . 0.0 112.463 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m 67.74 18.64 9.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.91 2.084 . . . . 0.0 115.515 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.7 152.75 18.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.425 -0.797 . . . . 0.0 112.386 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -122.43 86.91 2.66 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.906 1.682 . . . . 0.0 110.904 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 ttm105 -61.83 141.58 57.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.675 -0.64 . . . . 0.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.83 33.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.484 1.514 . . . . 0.0 111.204 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.8 -163.29 37.02 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.07 -1.019 . . . . 0.0 113.222 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.25 156.48 43.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.71 1.604 . . . . 0.0 111.293 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.8 ttm -65.19 127.08 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.302 1.041 . . . . 0.0 111.776 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -82.3 134.42 35.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.57 93.76 4.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.01 1.324 . . . . 0.0 111.522 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.9 mt -82.5 132.03 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 0.0 110.479 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -131.75 107.71 8.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 112.352 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -19.06 31.67 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 m -69.28 -14.11 62.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.915 1.234 . . . . 0.0 114.212 171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.38 -12.53 1.59 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -142.91 102.56 5.29 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.29 0.95 . . . . 0.0 112.514 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.72 1.7 9.0 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.87 3.046 . . . . 0.0 114.267 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -121.53 77.0 36.06 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.342 1.857 . . . . 0.0 109.729 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.09 -24.81 78.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.21 3.273 . . . . 0.0 114.861 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.15 -44.58 71.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 111.969 170.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.2 p -66.06 -20.63 66.24 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.98 -15.76 27.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 112.675 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.8 p -123.26 -28.8 3.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -54.2 -52.89 64.71 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 119.503 1.047 . . . . 0.0 113.68 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.35 -29.0 32.46 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.777 1.652 . . . . 0.0 112.673 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.13 -48.73 78.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.787 0.721 . . . . 0.0 111.62 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 t -67.79 -40.37 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 118.425 0.557 . . . . 0.0 110.331 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.39 -40.16 85.7 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.595 0.634 . . . . 0.0 111.911 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -65.03 -58.43 6.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -53.24 -46.78 69.31 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.086 0.954 . . . . 0.0 111.701 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.98 -24.17 13.55 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.123 1.821 . . . . 0.0 116.382 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.7 p -71.43 -19.81 62.19 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.933 1.866 . . . . 0.0 114.072 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.93 -16.25 25.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.243 1.417 . . . . 0.0 112.977 -170.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.37 155.23 21.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.529 2.332 . . . . 0.0 111.599 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 124.772 1.229 . . . . 0.0 113.585 174.112 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -129.23 118.03 21.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.724 2.01 . . . . 0.0 108.032 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.99 126.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.05 131.72 10.68 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mt -120.9 91.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.271 1.428 . . . . 0.0 107.439 -171.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -92.58 141.55 28.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.989 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.8 148.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.569 0.748 . . . . 0.0 112.071 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.31 97.54 0.21 Allowed Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.165 1.364 . . . . 0.0 110.406 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -144.34 168.38 20.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.23 -24.37 6.45 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.312 1.845 . . . . 0.0 112.558 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -134.7 -4.65 2.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 2.09 64.57 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -64.94 -45.41 85.9 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 1.591 . . . . 0.0 112.123 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -69.43 -36.22 76.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.093 1.357 . . . . 0.0 112.408 172.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.4 tp -59.39 -42.13 91.01 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.956 -1.09 . . . . 0.0 112.715 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.9 -41.88 78.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.653 0.661 . . . . 0.0 111.575 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.53 -35.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.662 -0.649 . . . . 0.0 112.271 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.74 97.09 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.179 -0.951 . . . . 0.0 112.504 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.76 -41.04 99.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.668 . . . . 0.0 112.398 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.04 -46.46 88.15 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.504 -0.748 . . . . 0.0 111.652 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.52 85.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.389 0.676 . . . . 0.0 112.217 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.64 -47.65 76.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.777 0.831 . . . . 0.0 111.882 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.19 -47.4 86.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.538 0.735 . . . . 0.0 112.843 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.94 -45.56 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.591 1.156 . . . . 0.0 111.887 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.5 mt -69.59 -41.41 75.81 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.734 -0.604 . . . . 0.0 109.791 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -56.64 -45.65 81.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.872 1.269 . . . . 0.0 111.998 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.8 -38.0 85.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.986 0.914 . . . . 0.0 113.1 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -70.76 -23.07 62.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.3 -8.27 7.94 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.323 1.44 . . . . 0.0 114.981 170.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.13 167.52 20.09 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.654 1.182 . . . . 0.0 112.111 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -100.89 137.87 38.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.323 1.449 . . . . 0.0 109.474 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.28 159.16 43.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.269 0.628 . . . . 0.0 112.432 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -153.77 119.84 5.39 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.974 0.91 . . . . 0.0 111.133 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.7 t -74.26 141.79 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.222 1.009 . . . . 0.0 110.801 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.4 104.28 7.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.856 1.262 . . . . 0.0 110.586 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.65 -17.34 38.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -142.35 60.87 10.91 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.563 1.545 . . . . 0.0 110.582 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.91 166.31 29.98 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.374 3.383 . . . . 0.0 115.694 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.35 162.74 37.53 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.637 2.375 . . . . 0.0 109.181 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.92 -38.49 56.51 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.691 -1.255 . . . . 0.0 113.655 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -62.23 -13.96 33.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -92.06 -25.48 18.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.669 1.122 . . . . 0.0 112.807 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -80.98 -40.76 23.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.557 1.543 . . . . 0.0 112.617 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 tp -50.08 -41.01 61.53 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -55.38 -9.63 2.61 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 125.108 3.872 . . . . 0.0 118.349 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -118.17 4.54 11.97 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -70.06 -9.86 56.79 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -110.65 17.72 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.423 1.489 . . . . 0.0 112.613 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.52 -135.62 0.16 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.572 1.949 . . . . 0.0 110.209 -169.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.63 159.82 38.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.702 1.601 . . . . 0.0 111.145 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.78 178.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.102 1.361 . . . . 0.0 111.581 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.7 149.31 25.07 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.538 1.935 . . . . 0.0 108.232 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.33 133.44 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.577 1.151 . . . . 0.0 108.867 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.27 90.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.032 1.333 . . . . 0.0 109.47 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 m -134.39 157.34 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 t -130.76 -164.66 1.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.487 1.515 . . . . 0.0 112.747 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 m -130.69 150.14 52.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.519 1.928 . . . . 0.0 111.318 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.473 0.688 0 C-N-CA 127.315 2.246 . . . . 0.0 108.908 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.2 t0 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.11 151.59 95.98 Favored Pre-proline 0 CA--C 1.553 1.089 0 O-C-N 121.682 -0.637 . . . . 0.0 111.739 170.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.91 158.33 20.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.391 2.728 . . . . 0.0 112.332 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.2 -21.39 63.79 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -57.27 -17.42 11.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.741 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -132.88 -9.49 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.83 -49.32 38.38 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.599 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.27 -24.72 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.967 1.738 . . . . 0.0 113.7 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.94 -47.49 45.11 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.367 -0.833 . . . . 0.0 110.118 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -58.68 -50.88 72.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.746 1.619 . . . . 0.0 112.151 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -62.88 -41.36 99.37 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.203 -0.935 . . . . 0.0 112.349 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.89 -47.67 80.25 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.451 1.024 . . . . 0.0 113.141 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.59 -39.4 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 118.979 1.39 . . . . 0.0 111.316 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.15 -47.88 75.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.087 0.555 . . . . 0.0 111.751 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.31 -36.29 24.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.9 m -84.15 -30.81 25.57 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.3 mt -100.13 -49.5 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.876 0.762 . . . . 0.0 112.622 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.67 -34.3 0.28 Allowed Glycine 0 CA--C 1.544 1.877 0 C-N-CA 126.21 1.862 . . . . 0.0 116.143 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -158.17 135.75 10.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.833 2.053 . . . . 0.0 110.349 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -156.87 97.77 2.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.939 0.895 . . . . 0.0 112.862 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.85 -20.72 10.18 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.473 2.782 . . . . 0.0 114.418 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -80.66 -17.21 51.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -174.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.9 tp -70.72 138.68 50.75 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 111.779 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -137.49 138.66 39.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 108.966 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -163.5 -173.37 3.29 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.48 162.87 28.49 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.393 1.949 . . . . 0.0 109.038 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.79 132.09 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.015 0.907 . . . . 0.0 112.971 -169.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.19 128.07 74.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.54 155.02 44.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.297 1.046 . . . . 0.0 110.293 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -139.53 151.85 46.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.342 1.057 . . . . 0.0 108.705 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.39 -144.26 7.86 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 112.078 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -137.77 121.27 17.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.916 0.887 . . . . 0.0 110.559 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.1 p -71.99 -2.17 17.22 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -69.92 4.2 2.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -136.87 159.39 41.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.21 1.804 . . . . 0.0 112.425 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.19 -32.42 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.83 1.252 . . . . 0.0 113.412 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -103.94 44.11 1.04 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.812 1.245 . . . . 0.0 112.409 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -49.38 111.37 0.48 Allowed 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.677 -1.264 . . . . 0.0 112.289 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.7 m 52.78 28.15 6.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.22 2.208 . . . . 0.0 116.955 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -53.22 -40.99 64.93 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.445 1.02 . . . . 0.0 112.225 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -36.89 92.84 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 122.132 -0.355 . . . . 0.0 113.134 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.19 46.58 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.557 -0.967 . . . . 0.0 113.052 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.91 -34.49 76.15 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.649 1.179 . . . . 0.0 113.057 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -60.43 -42.76 96.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.47 0.577 . . . . 0.0 111.626 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -71.47 -28.77 64.17 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -64.77 -50.91 64.97 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.624 -1.297 . . . . 0.0 110.241 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 -40.13 72.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.498 0.719 . . . . 0.0 112.901 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.5 tp -49.61 -27.32 4.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 114.111 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.0 -38.42 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 111.782 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -69.71 -16.16 63.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.895 0.878 . . . . 0.0 112.73 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -109.06 -15.3 14.37 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -170.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 m 112.73 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 129.731 3.212 . . . . 0.0 114.013 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.92 147.42 23.76 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 118.886 0.766 . . . . 0.0 111.898 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -121.72 84.02 2.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 109.855 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mtm105 -60.84 152.41 27.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.58 27.89 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.936 1.695 . . . . 0.0 110.869 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.2 175.06 46.93 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.372 1.939 . . . . 0.0 112.184 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -123.27 157.88 32.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.373 1.469 . . . . 0.0 111.88 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.9 ttm -63.92 117.02 6.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.369 1.068 . . . . 0.0 112.171 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.01 141.34 37.55 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.0 81.68 2.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 111.64 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.34 136.74 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 110.139 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.496 ' CG ' ' HG ' ' A' ' 128' ' ' SER . 61.9 t0 -131.26 98.5 4.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.513 1.149 . . . . 0.0 113.679 -169.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.13 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.323 1.449 . . . . 0.0 114.695 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.496 ' HG ' ' CG ' ' A' ' 126' ' ' ASP . 54.4 p -67.6 -19.42 65.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.567 1.076 . . . . 0.0 113.099 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.32 -8.94 1.13 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -134.63 108.64 10.98 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.018 0.927 . . . . 0.0 112.943 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.82 -0.63 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.336 3.358 . . . . 0.0 114.427 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.62 78.49 68.6 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.225 1.81 . . . . 0.0 109.713 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -60.58 -19.77 61.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.086 3.19 . . . . 0.0 115.368 -169.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -66.93 -29.69 69.62 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.962 -1.087 . . . . 0.0 113.893 172.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.7 p -68.24 -5.23 17.24 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -117.0 -8.76 11.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.131 1.372 . . . . 0.0 112.67 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -127.14 -27.1 3.01 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.11 -52.56 67.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.286 169.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.24 -30.24 37.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.643 1.562 . . . . 0.0 113.325 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -58.74 -50.03 75.44 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.891 0.769 . . . . 0.0 111.136 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t -67.85 -41.53 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.676 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -59.63 -39.62 84.91 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.782 0.719 . . . . 0.0 112.117 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -67.93 -58.86 3.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 111.891 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -54.43 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.713 1.205 . . . . 0.0 112.318 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.87 -23.77 16.71 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.914 1.721 . . . . 0.0 115.905 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.4 p -71.82 -17.65 62.14 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.735 1.767 . . . . 0.0 113.954 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.7 mt -93.95 -16.85 23.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.369 1.468 . . . . 0.0 112.996 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.44 150.49 35.34 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.224 2.21 . . . . 0.0 111.747 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.648 1.579 . . . . 0.0 113.624 177.819 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.485 0.659 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -139.96 119.81 13.45 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.07 1.748 . . . . 0.0 108.647 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.93 127.44 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.06 130.88 10.16 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 168.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -116.23 88.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.337 1.455 . . . . 0.0 107.176 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -88.46 126.73 35.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.857 -169.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.66 143.6 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.734 0.813 . . . . 0.0 110.691 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.35 96.64 0.27 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -143.87 170.34 16.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.546 1.138 . . . . 0.0 111.897 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.4 -0.63 5.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.756 1.223 . . . . 0.0 113.553 169.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -146.41 -24.05 0.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.36 -9.47 5.6 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 118.575 2.19 . . . . 0.0 118.575 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.08 -41.64 92.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.645 2.222 . . . . 0.0 113.432 -173.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -78.19 -34.64 49.36 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.763 -0.586 . . . . 0.0 111.993 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.2 tp -55.99 -39.76 72.31 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.066 -1.022 . . . . 0.0 113.069 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.15 -40.7 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 111.713 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -71.02 -41.26 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.907 0.483 . . . . 0.0 111.937 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.08 88.15 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.015 0.825 . . . . 0.0 112.499 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -60.56 -43.38 97.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.108 0.963 . . . . 0.0 112.676 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.48 -41.52 88.85 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.508 -0.745 . . . . 0.0 112.886 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.55 92.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.544 0.738 . . . . 0.0 111.809 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.5 -47.07 80.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.869 0.468 . . . . 0.0 111.869 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.91 88.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 112.694 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.7 -45.66 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.524 1.13 . . . . 0.0 111.892 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.9 mt -72.62 -38.16 67.85 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.4 m -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.454 1.101 . . . . 0.0 111.819 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.8 82.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.097 0.959 . . . . 0.0 113.157 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -73.07 -8.82 57.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 172.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.55 -2.46 32.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.428 1.49 . . . . 0.0 115.067 170.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -80.22 165.56 22.26 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.734 1.214 . . . . 0.0 112.631 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.5 134.18 35.22 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.08 142.32 31.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.193 0.597 . . . . 0.0 112.108 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.3 m -144.72 109.36 4.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.247 1.019 . . . . 0.0 111.025 -172.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -73.98 144.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -131.72 108.94 9.82 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.525 1.53 . . . . 0.0 108.442 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.8 -28.48 40.25 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -144.83 58.03 5.02 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.428 1.891 . . . . 0.0 110.1 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.73 159.65 52.81 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.768 2.979 . . . . 0.0 113.829 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.28 163.85 26.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.0 2.12 . . . . 0.0 108.926 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tt -42.47 -44.62 4.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.347 1.459 . . . . 0.0 112.881 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -54.78 -26.46 34.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.928 1.691 . . . . 0.0 114.849 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -81.16 -35.98 30.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.413 1.085 . . . . 0.0 112.333 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -75.68 -39.01 58.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.883 0.873 . . . . 0.0 112.419 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -36.31 -56.02 1.31 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.098 2.559 . . . . 0.0 115.422 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.42 -18.71 22.75 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.38 2.054 . . . . 0.0 114.748 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -78.54 -0.89 31.4 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -58.72 -25.97 63.46 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.745 -1.222 . . . . 0.0 113.795 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -97.1 12.49 32.48 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.355 1.462 . . . . 0.0 112.632 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -134.25 -145.62 0.24 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.004 2.522 . . . . 0.0 109.3 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.21 162.97 29.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.232 1.813 . . . . 0.0 109.408 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -148.34 171.79 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.356 1.062 . . . . 0.0 111.662 -175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.18 144.43 17.32 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.365 -0.835 . . . . 0.0 110.894 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.77 130.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.937 1.695 . . . . 0.0 110.565 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.46 89.07 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -134.66 136.11 42.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -168.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -87.85 -170.08 2.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.943 2.097 . . . . 0.0 113.069 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 83.0 m -136.67 138.53 41.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.401 1.081 . . . . 0.0 111.32 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 119.813 1.188 . . . . 0.0 111.62 -172.145 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.78 142.25 98.52 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.53 1.132 . . . . 0.0 112.118 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.17 153.17 24.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.644 2.896 . . . . 0.0 111.973 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.32 -26.71 66.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -62.7 -11.15 15.52 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 tt -126.2 -3.42 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -53.53 -43.89 96.6 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 117.148 -1.406 . . . . 0.0 112.356 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.04 -5.37 2.73 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.373 3.382 . . . . 0.0 116.659 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mt -105.88 -48.48 3.62 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.461 1.105 . . . . 0.0 110.308 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.41 -41.34 96.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.666 0.787 . . . . 0.0 112.685 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -67.35 -44.44 79.05 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.451 -0.781 . . . . 0.0 112.214 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.98 -41.91 39.0 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.907 0.765 . . . . 0.0 113.938 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.16 -42.94 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.024 0.912 . . . . 0.0 110.053 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -66.16 -50.19 64.78 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.593 0.757 . . . . 0.0 112.234 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.44 -31.02 42.47 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.1 t -116.01 -43.36 2.99 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -169.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.48 -44.34 58.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.459 1.027 . . . . 0.0 111.709 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.15 -28.95 0.2 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 126.679 2.085 . . . . 0.0 118.142 169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -155.62 138.31 15.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.836 1.654 . . . . 0.0 110.102 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.6 39.59 0.19 Allowed Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -169.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.8 -34.08 15.22 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.476 2.784 . . . . 0.0 118.054 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -72.34 -20.24 61.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.14 118.46 13.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.271 1.428 . . . . 0.0 110.16 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -117.91 139.92 50.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.382 1.473 . . . . 0.0 110.127 174.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.67 -169.05 1.97 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -168.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.3 32.62 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.231 2.348 . . . . 0.0 110.318 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.36 128.81 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.695 0.76 . . . . 0.0 111.644 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -118.13 95.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.15 153.52 24.76 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.05 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -142.64 152.99 43.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.108 0.956 . . . . 0.0 111.502 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.57 -130.1 1.66 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.862 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.77 136.34 21.72 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.252 1.421 . . . . 0.0 111.533 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.5 p -68.83 -4.19 15.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -68.4 3.69 1.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -135.08 151.64 50.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.371 1.468 . . . . 0.0 112.277 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.42 -37.14 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.883 0.873 . . . . 0.0 111.483 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -75.26 39.13 0.14 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.817 1.647 . . . . 0.0 112.907 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -52.21 116.06 2.04 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 119.653 -1.904 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 82.8 m 50.74 23.59 1.44 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.735 2.414 . . . . 0.0 117.174 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.3 -14.1 59.99 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.589 -1.319 . . . . 0.0 114.247 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.45 -28.54 63.43 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.134 -0.979 . . . . 0.0 113.414 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.21 -37.97 6.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.323 1.062 . . . . 0.0 113.313 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -56.66 -39.73 74.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.42 1.11 . . . . 0.0 113.658 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -60.11 -32.79 71.32 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -74.63 -22.2 59.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.56 -44.47 34.58 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.028 -1.67 . . . . 0.0 110.068 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.63 66.92 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 tp -50.67 -28.41 8.89 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.259 1.824 . . . . 0.0 113.322 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.01 -37.13 6.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.953 1.301 . . . . 0.0 111.997 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -68.8 -31.82 71.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.176 -0.952 . . . . 0.0 113.076 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.5 -10.66 36.53 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.123 0.874 . . . . 0.0 111.96 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -115.16 12.08 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.13 1.772 . . . . 0.0 112.816 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m 65.57 20.34 11.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.49 1.516 . . . . 0.0 114.86 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.45 169.5 0.89 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.667 0.787 . . . . 0.0 111.589 169.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -133.57 90.85 2.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.493 -1.379 . . . . 0.0 111.548 -169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -63.89 134.37 55.02 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.439 -0.788 . . . . 0.0 110.924 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.39 29.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.651 1.58 . . . . 0.0 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.61 -168.43 41.49 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.633 1.111 . . . . 0.0 113.852 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.29 152.26 26.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.65 1.58 . . . . 0.0 111.259 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.1 ttm -71.92 138.1 47.88 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.075 0.95 . . . . 0.0 111.957 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.07 137.22 33.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.545 0.738 . . . . 0.0 109.042 169.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.6 mt -119.76 93.45 4.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.686 1.594 . . . . 0.0 110.884 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.4 mt -79.26 135.76 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.537 0.735 . . . . 0.0 111.357 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -124.5 113.05 17.6 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.374 1.47 . . . . 0.0 112.047 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.19 62.95 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.7 m -80.9 1.06 32.53 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.53 1.132 . . . . 0.0 113.553 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -126.52 -27.94 3.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.07 1.348 . . . . 0.0 112.855 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -143.82 117.53 5.93 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.83 0.852 . . . . 0.0 112.85 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.92 -5.72 13.91 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.925 3.084 . . . . 0.0 114.548 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -130.58 76.2 77.79 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.827 1.651 . . . . 0.0 110.662 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -41.69 -34.89 2.44 Favored 'Trans proline' 0 C--N 1.354 0.857 1 C-N-CA 126.001 4.468 . . . . 0.0 118.016 -169.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -51.64 -39.06 57.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.1 p -69.75 -4.89 21.83 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.037 -1.039 . . . . 0.0 113.598 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -121.76 6.03 9.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.43 1.492 . . . . 0.0 112.416 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.1 p -141.26 -26.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -55.05 -51.75 76.87 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.921 1.237 . . . . 0.0 113.433 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.48 -28.62 53.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.673 1.582 . . . . 0.0 113.052 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -60.91 -50.51 73.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.384 0.538 . . . . 0.0 111.297 170.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.51 -42.74 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.007 0.821 . . . . 0.0 110.488 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.59 -34.75 74.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.87 -64.27 0.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.074 0.852 . . . . 0.0 111.313 169.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -51.06 -49.16 61.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.57 1.548 . . . . 0.0 112.144 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.74 -26.3 24.72 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.368 1.461 . . . . 0.0 115.546 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -75.95 -15.5 60.16 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.232 1.516 . . . . 0.0 114.159 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.75 -15.94 33.44 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.181 0.992 . . . . 0.0 113.074 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.6 -18.16 65.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.337 1.455 . . . . 0.0 114.113 -175.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.948 1.699 . . . . 0.0 113.936 -171.177 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -126.99 130.13 49.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 109.503 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.41 126.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -171.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.03 130.72 10.07 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.7 mt -118.26 86.71 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.021 1.329 . . . . 0.0 107.594 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.284 -170.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.38 140.26 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.112 0.482 . . . . 0.0 111.416 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.4 112.46 1.35 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -153.77 152.04 30.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.832 0.853 . . . . 0.0 112.715 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.8 mmm -95.66 -25.18 16.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.166 0.987 . . . . 0.0 112.732 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.93 -12.37 0.65 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.39 -9.06 8.86 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 116.601 1.401 . . . . 0.0 116.601 170.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -61.23 -41.42 96.85 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.691 1.745 . . . . 0.0 113.078 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -76.59 -34.44 58.41 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.188 0.995 . . . . 0.0 112.059 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.39 -39.41 83.28 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.682 -1.261 . . . . 0.0 113.208 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.2 tp -52.96 -47.47 68.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.382 0.992 . . . . 0.0 111.558 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.58 -35.14 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.81 0.444 . . . . 0.0 111.586 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 -37.05 80.3 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.55 -42.5 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.547 -0.72 . . . . 0.0 111.593 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.87 -46.21 85.19 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.264 0.626 . . . . 0.0 111.981 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.89 87.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.359 0.527 . . . . 0.0 112.136 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.86 -48.36 75.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.985 0.514 . . . . 0.0 111.512 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.76 84.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.659 0.784 . . . . 0.0 112.754 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.9 mt -58.61 -46.3 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.653 1.181 . . . . 0.0 111.83 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.48 -40.01 67.25 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.876 -0.515 . . . . 0.0 109.869 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.0 m -56.98 -44.8 83.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.495 1.118 . . . . 0.0 112.159 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.79 83.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.067 0.947 . . . . 0.0 112.961 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.69 -23.9 63.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.38 -13.1 6.63 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.53 1.538 . . . . 0.0 114.832 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -71.44 143.4 50.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.255 1.028 . . . . 0.0 111.535 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -71.95 133.79 45.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 157.78 45.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.51 0.724 . . . . 0.0 111.977 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -151.63 110.53 3.86 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.65 150.71 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.721 0.808 . . . . 0.0 111.269 169.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -127.59 171.76 11.35 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.23 1.412 . . . . 0.0 111.592 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -128.7 -36.16 1.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -142.43 55.57 4.52 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 126.379 1.872 . . . . 0.0 111.511 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.01 155.58 54.64 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.063 3.175 . . . . 0.0 113.945 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.23 174.21 10.46 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.427 1.891 . . . . 0.0 110.165 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.16 -34.73 58.14 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.635 -1.291 . . . . 0.0 112.175 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.5 m -54.76 -21.8 12.16 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -96.34 -25.68 15.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.004 1.721 . . . . 0.0 112.614 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -74.18 -39.6 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.228 1.011 . . . . 0.0 112.809 171.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -49.11 31.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.647 1.979 . . . . 0.0 113.349 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.25 -7.82 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.288 2.658 . . . . 0.0 115.942 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -127.82 0.36 6.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.867 1.667 . . . . 0.0 114.106 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.19 -23.12 63.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.401 1.455 . . . . 0.0 113.953 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -98.59 13.38 32.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.371 2.268 . . . . 0.0 113.302 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -139.45 -172.06 3.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.585 1.954 . . . . 0.0 111.648 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -76.62 154.52 34.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.064 0.935 . . . . 0.0 111.835 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.27 170.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.483 1.913 . . . . 0.0 110.264 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.93 153.24 22.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.57 0.748 . . . . 0.0 110.656 176.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.95 140.29 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.16 0.984 . . . . 0.0 111.764 -169.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 t -136.15 103.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.384 1.074 . . . . 0.0 110.249 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.6 m -140.43 143.09 35.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -93.67 -170.42 2.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.8 1.64 . . . . 0.0 113.497 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.3 m -135.95 137.22 41.08 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 111.626 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 127.819 2.448 . . . . 0.0 107.214 -171.834 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -80.24 155.25 74.6 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.128 -0.983 . . . . 0.0 113.571 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.73 152.01 82.49 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.01 3.14 . . . . 0.0 113.446 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.16 -20.4 65.36 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.8 p -64.71 -13.1 53.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.334 1.454 . . . . 0.0 114.683 171.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.79 -7.4 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.706 1.202 . . . . 0.0 113.919 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -47.19 -50.73 45.9 Favored Pre-proline 0 N--CA 1.481 1.09 0 O-C-N 120.307 -1.496 . . . . 0.0 113.035 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.07 -4.91 16.06 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.135 1.89 . . . . 0.0 114.253 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.36 -47.15 7.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.907 0.883 . . . . 0.0 109.134 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.37 -50.71 68.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.998 1.319 . . . . 0.0 112.107 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -62.75 -39.02 92.83 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.196 -0.94 . . . . 0.0 112.829 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.69 -41.93 48.59 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.445 1.022 . . . . 0.0 112.514 -174.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.98 -45.19 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.426 1.113 . . . . 0.0 109.482 174.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.09 -50.0 74.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.261 1.024 . . . . 0.0 112.301 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.21 -34.68 56.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.098 0.959 . . . . 0.0 113.542 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -96.72 -35.89 10.85 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -169.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 mp -89.44 -44.01 10.46 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.375 0.988 . . . . 0.0 113.365 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.44 -39.87 0.36 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 126.371 1.938 . . . . 0.0 117.118 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -157.71 134.21 9.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.511 1.524 . . . . 0.0 110.954 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -158.54 52.92 0.56 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.02 -21.38 73.1 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.96 2.44 . . . . 0.0 115.052 -173.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -72.0 -21.61 61.54 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.935 1.294 . . . . 0.0 113.876 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.97 138.64 38.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 111.114 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -133.38 143.64 49.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.691 1.996 . . . . 0.0 109.929 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.35 -170.86 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.63 28.82 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 127.676 2.56 . . . . 0.0 109.345 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.43 136.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 117.942 0.871 . . . . 0.0 110.516 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.71 104.81 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.23 25.42 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.571 -0.706 . . . . 0.0 109.871 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -139.26 153.17 47.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.227 1.011 . . . . 0.0 111.106 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.31 -147.66 11.3 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.065 0.84 . . . . 0.0 111.46 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.12 121.32 16.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.57 1.948 . . . . 0.0 109.235 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.6 p -67.12 -2.89 6.23 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -64.01 -25.6 68.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.064 0.946 . . . . 0.0 113.16 170.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -86.49 145.74 26.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.114 0.965 . . . . 0.0 112.14 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.05 -36.33 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.504 1.121 . . . . 0.0 112.422 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -87.14 -1.1 57.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.5 t80 26.72 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.569 2.747 . . . . 0.0 115.699 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 27.9 p -121.94 17.16 10.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.138 1.775 . . . . 0.0 113.853 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.03 -31.04 39.06 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.82 1.248 . . . . 0.0 113.959 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.62 -35.28 80.18 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 123.636 0.636 . . . . 0.0 113.558 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.81 -41.86 14.17 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 120.94 -1.33 . . . . 0.0 113.022 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -57.08 -36.29 70.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.139 0.976 . . . . 0.0 113.248 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -58.12 -40.03 80.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.466 0.706 . . . . 0.0 112.689 172.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.37 -30.72 62.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.45 1.023 . . . . 0.0 112.618 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.36 -45.21 92.21 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.201 -1.562 . . . . 0.0 110.55 169.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.7 -37.56 76.36 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.3 tp -52.79 -33.82 50.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.841 1.257 . . . . 0.0 112.342 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.44 -37.67 10.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.713 1.205 . . . . 0.0 111.771 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.19 -32.82 74.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.091 -1.006 . . . . 0.0 113.429 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.47 -13.26 38.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.444 1.098 . . . . 0.0 112.588 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.32 8.07 14.12 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.556 1.542 . . . . 0.0 112.114 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 m 71.65 17.66 5.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.855 2.062 . . . . 0.0 114.454 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 168.94 1.34 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.94 0.896 . . . . 0.0 111.691 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -131.13 101.67 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.734 -1.229 . . . . 0.0 112.088 -169.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 ttm105 -67.35 134.12 50.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.923 -1.11 . . . . 0.0 111.182 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.53 31.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.726 1.61 . . . . 0.0 111.781 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.05 -178.47 45.02 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.473 -1.392 . . . . 0.0 114.027 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.31 136.56 33.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.449 1.099 . . . . 0.0 110.589 170.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.0 ttp -63.4 127.58 31.93 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.874 0.87 . . . . 0.0 111.216 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.81 139.46 31.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 109.644 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.3 mt -123.95 90.42 3.26 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.858 1.263 . . . . 0.0 111.058 -176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -72.13 136.56 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.182 0.993 . . . . 0.0 110.673 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -129.7 105.65 8.18 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.047 1.339 . . . . 0.0 111.471 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.32 27.44 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -82.92 -6.55 59.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.445 1.02 . . . . 0.0 113.721 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.64 -26.34 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.571 . . . . 0.0 112.52 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -143.01 113.07 5.76 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.811 1.245 . . . . 0.0 111.239 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.69 -1.38 11.55 Favored 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.646 2.897 . . . . 0.0 114.497 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.43 79.12 74.55 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.485 1.514 . . . . 0.0 111.6 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.43 -34.31 7.38 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.782 4.321 . . . . 0.0 116.781 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -52.31 -45.76 65.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 112.233 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -17.0 64.42 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -95.89 -5.65 41.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.211 1.405 . . . . 0.0 112.705 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.31 -30.04 0.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -51.64 -53.83 46.2 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 119.533 1.061 . . . . 0.0 113.451 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.62 -29.52 29.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.556 1.504 . . . . 0.0 113.013 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.2 -48.06 81.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.439 0.695 . . . . 0.0 111.404 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.7 t -67.67 -41.19 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.565 0.62 . . . . 0.0 110.614 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -58.89 -41.74 87.9 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.741 0.701 . . . . 0.0 111.896 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -65.43 -57.78 7.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.874 0.87 . . . . 0.0 112.162 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -53.98 -44.32 70.7 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 111.9 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.34 -19.99 35.0 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.502 1.525 . . . . 0.0 115.995 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p -72.07 -19.0 61.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.982 1.891 . . . . 0.0 113.974 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.9 mt -93.23 -16.41 24.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.107 1.363 . . . . 0.0 113.061 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.22 150.19 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.505 2.322 . . . . 0.0 111.624 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.389 1.475 . . . . 0.0 113.689 179.721 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -140.51 123.96 16.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.555 1.142 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 mm -124.27 136.67 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.93 127.41 9.22 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.3 mt -117.6 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.466 1.106 . . . . 0.0 108.591 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -91.56 138.28 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.037 0.935 . . . . 0.0 111.492 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.63 143.37 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.684 0.754 . . . . 0.0 111.457 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.48 90.39 0.21 Allowed Glycine 0 N--CA 1.463 0.495 0 C-N-CA 125.347 1.451 . . . . 0.0 109.653 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -134.66 165.73 24.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.173 0.989 . . . . 0.0 113.235 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -121.63 -32.14 3.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.179 1.792 . . . . 0.0 110.996 -175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -134.5 -5.3 2.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.611 1.564 . . . . 0.0 113.861 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -0.56 52.92 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.362 1.081 . . . . 0.0 112.776 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -76.19 -32.71 59.15 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.546 1.138 . . . . 0.0 112.872 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.87 -39.03 80.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.641 -1.287 . . . . 0.0 112.796 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.55 -41.17 72.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.572 0.623 . . . . 0.0 111.751 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.9 -35.19 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 121.753 -0.592 . . . . 0.0 112.205 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.59 95.33 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.201 -0.937 . . . . 0.0 112.662 172.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.99 -41.06 97.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.356 0.662 . . . . 0.0 112.337 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.61 -46.79 87.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.535 -0.728 . . . . 0.0 111.902 169.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.5 88.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.224 0.61 . . . . 0.0 112.317 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.15 -47.02 79.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 111.993 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -45.66 92.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.419 0.688 . . . . 0.0 112.643 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.68 -47.38 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.569 1.148 . . . . 0.0 112.094 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -68.39 -39.77 81.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 109.744 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.8 m -55.77 -50.48 70.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.7 1.2 . . . . 0.0 111.855 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.3 77.65 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -77.31 -5.52 49.82 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.84 24.32 10.0 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.918 0.781 . . . . 0.0 114.648 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -115.93 145.69 42.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.742 1.217 . . . . 0.0 111.389 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -74.27 138.25 43.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.13 43.27 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.606 -0.684 . . . . 0.0 111.994 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -154.7 120.13 5.06 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.76 176.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.0 140.26 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.18 0.992 . . . . 0.0 110.958 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.09 110.65 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.002 1.321 . . . . 0.0 109.701 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.99 -17.66 28.97 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -144.93 56.65 3.87 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.635 1.574 . . . . 0.0 110.612 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.34 162.21 40.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.941 3.094 . . . . 0.0 115.185 -169.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.67 175.07 9.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.213 2.205 . . . . 0.0 109.668 169.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -50.73 -40.85 55.56 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.902 -1.124 . . . . 0.0 112.414 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -58.43 -14.77 8.49 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -96.81 -27.33 14.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -82.46 -39.61 22.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.452 1.501 . . . . 0.0 112.221 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -49.16 -45.3 75.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.849 1.66 . . . . 0.0 114.495 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -57.29 -10.6 6.64 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.225 2.617 . . . . 0.0 116.899 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -114.65 4.27 15.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.74 -23.32 67.32 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.263 1.392 . . . . 0.0 114.273 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -92.32 4.2 53.84 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.948 1.299 . . . . 0.0 113.525 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -130.89 -141.06 0.22 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.46 2.304 . . . . 0.0 109.771 -169.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.16 158.7 34.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.672 1.189 . . . . 0.0 111.361 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.96 168.77 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.274 1.429 . . . . 0.0 110.936 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.97 149.63 19.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.98 0.912 . . . . 0.0 110.387 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.87 135.26 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.052 1.341 . . . . 0.0 110.302 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.3 90.73 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.153 1.381 . . . . 0.0 107.581 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.8 m -133.57 168.36 18.79 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -141.51 -174.33 4.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.106 1.363 . . . . 0.0 113.432 -171.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.8 m -131.62 135.61 47.08 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.609 1.164 . . . . 0.0 110.824 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 126.393 1.877 . . . . 0.0 109.929 -173.485 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.37 136.54 60.74 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.146 1.378 . . . . 0.0 113.283 171.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.27 150.19 89.26 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.55 2.833 . . . . 0.0 111.523 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -60.65 -17.4 47.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -57.34 -17.5 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.292 1.837 . . . . 0.0 114.585 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.27 -10.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.3 t -47.1 -45.58 53.1 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 116.867 -1.539 . . . . 0.0 113.664 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.16 -27.65 35.13 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 122.676 1.991 . . . . 0.0 113.82 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.29 -47.17 65.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.023 0.829 . . . . 0.0 110.778 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.25 -47.58 84.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.126 1.37 . . . . 0.0 112.382 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -60.16 -48.95 79.57 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.295 -0.878 . . . . 0.0 112.101 171.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.64 95.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.194 0.902 . . . . 0.0 113.506 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.01 -45.87 97.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.479 1.139 . . . . 0.0 110.486 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.12 -47.04 86.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.978 0.511 . . . . 0.0 112.18 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.95 -37.25 29.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.395 1.478 . . . . 0.0 114.327 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 m -121.39 10.5 10.54 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -168.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.14 -47.18 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.713 1.142 . . . . 0.0 112.474 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.44 -34.86 0.45 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -157.23 137.55 12.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.475 1.637 . . . . 0.0 111.515 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -158.94 63.74 2.46 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.533 1.133 . . . . 0.0 113.34 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.48 -15.02 42.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.416 3.411 . . . . 0.0 116.77 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -120.9 -0.47 10.08 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.555 1.542 . . . . 0.0 114.384 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.02 141.78 47.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.973 0.909 . . . . 0.0 109.578 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -131.07 138.92 49.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 111.338 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -154.67 -171.17 3.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -170.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.71 161.8 31.64 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 127.595 2.521 . . . . 0.0 109.911 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.07 135.46 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.91 0.855 . . . . 0.0 111.879 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.5 mt -119.3 128.8 75.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.4 145.23 48.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.652 1.181 . . . . 0.0 110.231 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.75 139.49 31.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.85 0.86 . . . . 0.0 110.419 -171.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.37 -147.0 6.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -138.74 124.41 19.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.998 0.919 . . . . 0.0 110.649 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.9 p -70.05 -3.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -68.37 -0.92 5.41 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.029 1.331 . . . . 0.0 114.313 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.74 155.88 44.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.071 1.749 . . . . 0.0 112.045 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.1 m -77.21 1.26 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.61 44.74 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.255 1.422 . . . . 0.0 110.315 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -52.05 115.93 1.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.022 -1.674 . . . . 0.0 112.745 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 94.5 m 51.01 26.99 2.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -58.99 -31.79 69.09 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.045 -1.034 . . . . 0.0 113.498 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.43 87.84 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.134 0.879 . . . . 0.0 112.625 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.62 99.54 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.845 -1.385 . . . . 0.0 112.639 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.06 -40.86 97.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.908 0.883 . . . . 0.0 113.001 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -58.95 -42.13 89.08 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.075 0.95 . . . . 0.0 111.637 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.09 -30.54 63.74 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.52 -45.04 76.9 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.007 -1.683 . . . . 0.0 110.963 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.31 74.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.835 0.854 . . . . 0.0 113.212 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -50.53 -31.84 16.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.461 1.504 . . . . 0.0 112.994 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.35 -36.74 8.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.619 1.168 . . . . 0.0 111.766 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -65.49 -31.46 72.54 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.368 -0.833 . . . . 0.0 113.161 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.36 -15.32 57.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.021 . . . . 0.0 112.752 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -113.52 3.53 15.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.081 1.353 . . . . 0.0 112.652 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m 74.68 15.85 3.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.619 1.968 . . . . 0.0 113.955 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.11 164.49 6.72 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -121.93 150.79 41.5 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.869 -1.144 . . . . 0.0 110.585 -170.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -132.01 108.04 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 121.32 -0.863 . . . . 0.0 111.198 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.69 45.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.405 1.482 . . . . 0.0 112.329 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.54 -168.88 42.01 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.402 1.953 . . . . 0.0 111.995 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.42 147.78 50.67 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.223 -1.163 . . . . 0.0 112.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -66.26 123.54 20.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.781 1.232 . . . . 0.0 112.028 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -81.61 138.1 35.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.071 0.948 . . . . 0.0 110.238 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.1 mt -125.49 93.38 3.84 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.722 1.209 . . . . 0.0 111.661 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.8 mt -84.48 138.9 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.586 1.554 . . . . 0.0 111.234 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -125.72 105.17 8.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.001 1.32 . . . . 0.0 112.323 -177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.75 -21.86 43.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.14 1.376 . . . . 0.0 114.267 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -77.86 -7.88 57.29 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -126.36 -26.4 3.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.363 1.465 . . . . 0.0 112.415 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -143.86 114.77 5.52 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.897 0.879 . . . . 0.0 112.313 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.01 -0.68 10.12 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.309 3.339 . . . . 0.0 114.526 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.89 76.51 71.05 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.009 1.724 . . . . 0.0 109.942 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -61.16 -20.13 66.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.236 3.29 . . . . 0.0 115.796 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.45 -35.01 71.47 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.773 -1.204 . . . . 0.0 113.653 169.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 p -66.9 -9.56 39.31 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -109.77 -12.14 14.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.605 1.162 . . . . 0.0 112.103 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 p -126.29 -27.74 3.17 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.23 -52.76 65.99 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 119.64 1.109 . . . . 0.0 113.26 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.77 -30.13 27.83 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.726 1.617 . . . . 0.0 112.826 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -61.32 -48.74 79.98 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.671 -0.643 . . . . 0.0 111.719 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.25 -40.2 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.339 0.518 . . . . 0.0 110.474 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -59.7 -36.34 76.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.893 0.77 . . . . 0.0 112.56 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.41 -59.69 2.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.935 0.789 . . . . 0.0 111.986 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -53.08 -46.24 68.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.462 1.105 . . . . 0.0 112.09 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -24.68 5.52 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.218 1.866 . . . . 0.0 116.172 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.3 p -73.99 -21.38 60.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.723 1.762 . . . . 0.0 114.184 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.21 -23.25 47.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.314 1.046 . . . . 0.0 112.952 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.5 -28.95 69.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.6 1.56 . . . . 0.0 114.823 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.386 1.475 . . . . 0.0 111.935 173.535 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.186 0.517 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.99 121.17 20.08 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.882 1.273 . . . . 0.0 110.399 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.6 125.39 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.911 0.885 . . . . 0.0 113.228 -169.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.98 124.74 7.0 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -117.01 99.07 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.763 1.282 . . . . 0.0 108.995 -170.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -99.66 136.61 39.33 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.06 0.944 . . . . 0.0 110.681 -169.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.83 145.69 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.432 0.634 . . . . 0.0 111.54 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.31 100.51 0.38 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.8 t -151.46 163.97 37.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.285 1.034 . . . . 0.0 113.131 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -122.9 -0.98 8.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.651 1.58 . . . . 0.0 112.54 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -141.08 -58.78 0.5 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.88 0.872 . . . . 0.0 113.053 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.27 -2.5 0.42 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -61.04 -44.99 96.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.6 1.2 . . . . 0.0 112.862 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.1 p -75.96 -32.76 59.66 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.182 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.8 tp -60.03 -40.4 89.2 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.753 -1.217 . . . . 0.0 112.794 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.9 tp -54.97 -42.85 72.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.732 0.697 . . . . 0.0 111.86 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.41 -36.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 121.805 -0.559 . . . . 0.0 111.895 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.27 97.72 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.25 -0.906 . . . . 0.0 112.941 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.88 -41.02 97.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 112.257 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -59.77 -47.54 85.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.581 0.752 . . . . 0.0 111.984 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.02 86.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.372 0.669 . . . . 0.0 112.308 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.79 -46.64 77.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 112.001 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.75 91.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.661 0.784 . . . . 0.0 112.809 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.66 -45.69 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.741 1.216 . . . . 0.0 112.04 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.6 mt -68.09 -42.25 80.61 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.596 -0.69 . . . . 0.0 109.594 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -55.24 -47.97 74.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.757 1.223 . . . . 0.0 112.214 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.35 80.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.117 0.967 . . . . 0.0 113.29 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.14 -8.58 56.67 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.54 -3.61 56.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.198 1.38 . . . . 0.0 114.583 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -73.27 177.05 5.4 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -115.96 147.36 41.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.152 1.381 . . . . 0.0 109.548 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.25 164.32 35.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.463 -0.773 . . . . 0.0 112.642 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 m -152.93 121.01 6.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.811 0.845 . . . . 0.0 110.991 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.2 141.37 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.795 1.238 . . . . 0.0 111.428 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -130.32 109.73 10.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.412 1.485 . . . . 0.0 110.253 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.25 -16.27 40.74 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -147.94 54.77 1.96 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.886 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.17 163.48 34.89 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.6 2.867 . . . . 0.0 113.949 -170.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.0 173.65 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.821 2.048 . . . . 0.0 109.482 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.59 -40.1 62.31 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.435 -1.416 . . . . 0.0 112.499 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.1 m -62.69 -13.84 37.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -92.73 -33.61 14.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.549 1.139 . . . . 0.0 112.187 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -68.21 -48.14 65.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 112.229 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.5 tp -45.95 -49.25 39.83 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.524 2.329 . . . . 0.0 114.522 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.59 -17.4 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.898 3.732 . . . . 0.0 117.92 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.49 -0.4 15.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.21 -20.2 65.66 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.12 -1.93 54.14 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.793 1.237 . . . . 0.0 113.264 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -132.48 -130.87 0.18 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.41 2.284 . . . . 0.0 109.595 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -135.26 157.8 45.99 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.035 1.334 . . . . 0.0 110.093 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.85 168.45 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.008 0.923 . . . . 0.0 111.732 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tp -159.85 145.15 15.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.104 0.962 . . . . 0.0 110.569 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.66 132.43 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.522 1.529 . . . . 0.0 110.921 -169.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.57 87.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.1 m -131.16 159.09 38.72 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -167.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -129.87 -171.62 2.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.621 1.568 . . . . 0.0 113.187 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.0 m -123.86 153.32 41.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.895 1.278 . . . . 0.0 111.734 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 C-N-CA 125.646 1.578 . . . . 0.0 111.836 -168.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.12 145.34 97.58 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 121.563 -0.711 . . . . 0.0 111.134 170.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.39 150.17 32.06 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.679 2.919 . . . . 0.0 111.003 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.84 -25.31 64.9 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -172.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 m -59.81 -13.98 12.87 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 172.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 tt -133.3 -7.15 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.1 t -47.71 -49.96 54.07 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.504 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.83 -9.2 25.52 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.187 1.925 . . . . 0.0 114.209 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.84 -48.8 7.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.04 1.336 . . . . 0.0 108.793 172.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -65.19 -48.79 72.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.96 1.304 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -63.69 -39.2 93.73 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.051 -1.031 . . . . 0.0 111.943 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.82 -48.86 72.62 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 124.071 0.843 . . . . 0.0 112.258 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -64.15 -46.74 92.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 118.068 0.934 . . . . 0.0 110.658 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.12 -35.3 78.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -109.62 -23.5 11.43 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.4 m -113.95 2.11 14.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.9 mt -122.91 -139.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.635 1.574 . . . . 0.0 108.104 169.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.52 -21.0 0.54 Allowed Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.157 -0.964 . . . . 0.0 114.501 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -159.66 126.72 4.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.053 0.926 . . . . 0.0 113.03 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -152.82 61.19 3.66 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 126.262 1.825 . . . . 0.0 112.034 -177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.68 -26.46 80.07 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.003 3.135 . . . . 0.0 115.249 -169.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -82.57 -10.35 59.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.334 1.454 . . . . 0.0 114.678 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.7 140.22 40.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.964 0.802 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -130.94 142.92 50.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.675 1.99 . . . . 0.0 110.847 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -159.47 -171.44 3.31 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -169.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.47 165.98 33.6 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.39 2.424 . . . . 0.0 111.201 172.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.14 137.53 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 118.074 0.937 . . . . 0.0 112.189 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 mt -127.88 98.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.59 153.02 25.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.208 0.527 . . . . 0.0 110.261 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -140.71 138.41 34.2 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.106 0.962 . . . . 0.0 110.58 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.2 4.87 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 122.041 -0.412 . . . . 0.0 112.55 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -150.74 135.57 17.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -5.17 10.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.988 2.115 . . . . 0.0 115.259 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -66.46 1.71 1.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -138.68 156.68 47.21 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.215 1.806 . . . . 0.0 111.627 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.68 -33.8 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -96.18 48.56 1.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.843 0.857 . . . . 0.0 111.718 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -49.92 114.77 1.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.341 -1.475 . . . . 0.0 112.701 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m 51.03 24.84 2.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -59.31 -29.63 67.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.829 -1.17 . . . . 0.0 113.259 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.37 -35.19 91.65 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 113.388 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.92 -40.45 10.56 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.526 -0.985 . . . . 0.0 112.896 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.11 -39.28 78.25 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.197 0.999 . . . . 0.0 113.291 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.7 -35.98 75.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.171 0.588 . . . . 0.0 112.57 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -74.81 -36.01 62.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.338 -0.851 . . . . 0.0 112.502 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.56 -42.87 99.47 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 119.81 -1.806 . . . . 0.0 111.303 169.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.49 88.42 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -52.93 -44.75 67.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.819 1.247 . . . . 0.0 111.142 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.09 -33.55 67.97 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -33.12 74.33 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.033 -1.042 . . . . 0.0 111.875 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.55 -17.96 64.41 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.081 -1.012 . . . . 0.0 112.77 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -99.59 6.09 45.82 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.529 1.532 . . . . 0.0 112.35 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m 58.58 19.99 7.2 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.082 1.753 . . . . 0.0 114.913 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.99 154.02 27.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.394 0.678 . . . . 0.0 111.691 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -117.15 99.9 7.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.087 1.355 . . . . 0.0 111.005 -169.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -67.8 133.89 50.01 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.055 -1.028 . . . . 0.0 111.289 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.81 33.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.92 -163.12 36.2 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.982 1.277 . . . . 0.0 112.432 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -125.86 152.47 45.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.092 1.357 . . . . 0.0 112.382 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.7 ttp -69.03 123.95 22.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.48 1.512 . . . . 0.0 111.963 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.97 140.72 35.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.914 0.885 . . . . 0.0 109.397 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.4 mt -123.24 92.75 3.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.614 1.566 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.98 137.74 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.355 1.062 . . . . 0.0 111.157 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.87 118.48 32.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.94 1.296 . . . . 0.0 111.402 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.7 92.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.9 m -63.41 -41.08 98.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.61 -32.65 68.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.992 0.917 . . . . 0.0 112.43 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -145.4 99.48 4.51 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.163 0.985 . . . . 0.0 112.705 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.9 2.07 7.94 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.898 3.066 . . . . 0.0 114.29 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -122.42 71.84 37.41 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.292 1.837 . . . . 0.0 109.37 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -58.78 -20.62 52.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.646 3.564 . . . . 0.0 116.149 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.84 -39.27 77.27 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.126 -0.984 . . . . 0.0 112.776 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.9 p -68.78 -6.32 25.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.291 1.036 . . . . 0.0 113.526 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.52 -2.33 17.69 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.461 1.505 . . . . 0.0 112.161 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.6 p -139.67 -28.1 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -51.95 -54.0 45.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.8 -28.13 30.53 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.666 1.577 . . . . 0.0 112.951 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -63.22 -47.79 81.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.381 0.672 . . . . 0.0 111.524 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.01 -40.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.587 0.631 . . . . 0.0 110.358 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -58.78 -44.76 90.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.672 0.669 . . . . 0.0 111.719 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -61.72 -56.09 23.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.984 0.914 . . . . 0.0 112.357 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -53.34 -48.62 68.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.599 1.16 . . . . 0.0 111.209 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.03 -21.81 32.82 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.586 1.565 . . . . 0.0 116.144 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -68.88 -19.41 64.23 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.507 2.154 . . . . 0.0 113.517 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -99.31 -14.88 19.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.0 113.109 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.53 147.75 48.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.185 1.394 . . . . 0.0 111.722 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.119 -172.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.395 0.617 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -135.35 116.5 14.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.204 1.402 . . . . 0.0 109.31 -173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -118.72 125.39 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.95 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.53 125.05 7.52 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -114.1 91.17 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.294 1.047 . . . . 0.0 108.256 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -94.02 136.58 34.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.689 0.796 . . . . 0.0 110.872 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.87 142.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.879 0.847 . . . . 0.0 111.086 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.75 79.47 0.32 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -128.04 172.51 10.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.133 0.973 . . . . 0.0 112.974 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.5 tpt -129.67 -34.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.684 1.993 . . . . 0.0 111.627 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -132.17 1.16 3.83 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.35 -1.43 58.84 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -66.19 -42.5 88.77 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.916 1.358 . . . . 0.0 112.164 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -37.32 77.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.337 1.455 . . . . 0.0 112.639 170.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.47 -36.93 76.94 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.725 -1.234 . . . . 0.0 113.513 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -51.85 -45.19 63.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.937 0.79 . . . . 0.0 111.792 172.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.49 -36.54 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.045 -0.41 . . . . 0.0 111.7 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.09 99.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.098 0.863 . . . . 0.0 112.672 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.61 -41.96 98.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.216 0.607 . . . . 0.0 112.347 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.22 -42.19 96.69 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.363 -0.836 . . . . 0.0 112.692 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.9 91.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.494 0.717 . . . . 0.0 112.291 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.55 -47.04 80.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.406 0.682 . . . . 0.0 111.369 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.47 86.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.463 0.705 . . . . 0.0 112.649 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.72 -46.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.046 1.338 . . . . 0.0 112.362 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.46 -39.99 70.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -175.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -57.48 -46.4 83.74 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.552 1.141 . . . . 0.0 111.931 170.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.34 77.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.0 -11.7 60.66 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.33 40.0 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.579 1.561 . . . . 0.0 114.705 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -75.26 153.17 38.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.436 1.118 . . . . 0.0 111.526 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -80.62 135.69 36.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.35 154.55 43.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.13 0.572 . . . . 0.0 111.942 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 m -153.31 122.7 6.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.906 0.883 . . . . 0.0 111.184 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 140.58 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.332 1.053 . . . . 0.0 110.96 171.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -129.0 112.06 13.64 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.82 1.248 . . . . 0.0 110.333 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.49 -11.51 31.86 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.16 53.76 2.14 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.868 1.267 . . . . 0.0 111.794 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.6 162.39 42.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.64 2.893 . . . . 0.0 114.827 -172.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -131.24 169.61 15.71 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.471 2.308 . . . . 0.0 109.295 169.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.34 62.8 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.267 -1.521 . . . . 0.0 112.376 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -61.82 -12.58 18.02 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -92.93 -32.47 14.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.823 1.249 . . . . 0.0 112.216 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -70.75 -42.44 70.49 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.907 0.883 . . . . 0.0 111.926 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.6 tp -47.84 -47.27 63.11 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 127.872 2.469 . . . . 0.0 115.787 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 -9.01 25.17 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.704 2.269 . . . . 0.0 114.881 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -119.53 -15.73 8.98 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -61.77 -27.41 68.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.196 1.362 . . . . 0.0 113.081 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.72 5.97 14.19 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.921 1.288 . . . . 0.0 113.968 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -128.59 -118.95 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.999 2.52 . . . . 0.0 108.245 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -135.56 157.88 45.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.155 1.782 . . . . 0.0 108.833 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 166.39 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.231 1.012 . . . . 0.0 110.613 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.95 144.92 17.97 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.413 -0.804 . . . . 0.0 110.296 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -113.97 133.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.654 1.582 . . . . 0.0 110.467 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 t -134.33 92.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 m -135.4 154.79 51.35 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 p -133.95 -171.56 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.511 1.524 . . . . 0.0 112.469 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -122.06 153.37 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.439 1.096 . . . . 0.0 111.068 -170.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 126.574 1.95 . . . . 0.0 109.31 179.03 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.7 mt -64.76 147.3 98.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.306 1.442 . . . . 0.0 112.967 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -82.1 154.63 16.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.785 2.99 . . . . 0.0 111.87 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -58.78 -23.34 60.05 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.8 m -54.95 -19.1 5.97 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.992 1.717 . . . . 0.0 115.04 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.54 -5.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -45.87 -44.45 33.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 117.183 -1.389 . . . . 0.0 113.442 170.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.04 -27.51 57.66 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 122.375 1.884 . . . . 0.0 114.666 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mt -73.8 -48.54 30.74 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.06 1.3 . . . . 0.0 110.807 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.52 -38.87 82.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.835 1.254 . . . . 0.0 112.909 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -75.08 -48.31 24.52 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.178 -0.952 . . . . 0.0 112.037 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.39 82.34 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 123.795 0.712 . . . . 0.0 113.991 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.89 -44.35 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.262 1.031 . . . . 0.0 110.357 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.28 -48.37 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.196 0.998 . . . . 0.0 112.137 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.01 -41.31 59.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.235 1.414 . . . . 0.0 114.382 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.0 m -123.74 -14.64 7.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -168.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.77 -50.25 7.3 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.662 1.574 . . . . 0.0 109.599 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 -40.45 0.47 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 126.536 2.017 . . . . 0.0 117.598 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -157.68 138.53 13.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.165 1.483 . . . . 0.0 111.492 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -159.49 100.48 1.53 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.886 1.275 . . . . 0.0 111.2 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.58 -16.27 8.07 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.627 2.885 . . . . 0.0 115.067 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -110.5 -9.3 14.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.349 1.46 . . . . 0.0 113.889 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.5 tp -55.62 124.69 18.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.4 1.88 . . . . 0.0 111.113 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -128.21 140.87 51.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.725 1.61 . . . . 0.0 109.856 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -161.56 -169.29 2.22 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.68 160.7 30.48 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 127.205 2.336 . . . . 0.0 109.862 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.2 t -140.46 133.76 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.835 0.818 . . . . 0.0 111.399 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -122.32 100.43 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.78 153.36 25.28 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 0.0 109.736 169.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.16 142.24 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.0 0.92 . . . . 0.0 110.602 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.43 -144.22 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.549 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -146.43 120.2 9.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.43 0.692 . . . . 0.0 111.328 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -59.87 -8.49 2.23 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.687 1.595 . . . . 0.0 113.855 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.5 m -60.73 -7.85 2.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.221 1.409 . . . . 0.0 114.567 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -130.38 159.25 37.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.736 1.614 . . . . 0.0 112.729 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.36 -0.91 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 -169.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.53 48.67 1.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.752 1.221 . . . . 0.0 110.528 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -51.07 114.97 1.33 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.002 -1.686 . . . . 0.0 113.148 -170.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m 52.95 24.89 3.63 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -61.38 -24.05 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.564 -1.335 . . . . 0.0 113.877 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.26 -59.33 8.55 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.562 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.59 96.69 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.317 -1.107 . . . . 0.0 114.008 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -40.46 88.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.171 0.985 . . . . 0.0 113.655 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.52 -36.15 79.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.327 0.512 . . . . 0.0 112.221 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.41 -29.34 63.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.83 -45.42 71.21 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.256 -1.527 . . . . 0.0 110.559 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.35 67.93 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.7 tp -50.39 -30.2 11.84 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.88 1.672 . . . . 0.0 113.151 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.52 -36.64 7.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.568 1.147 . . . . 0.0 111.743 -171.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -65.67 -30.26 70.93 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.343 -0.848 . . . . 0.0 112.777 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.04 -17.24 63.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.048 0.939 . . . . 0.0 112.622 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -113.7 -7.19 13.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 t 100.37 13.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.188 2.595 . . . . 0.0 113.153 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.08 162.68 4.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.365 0.666 . . . . 0.0 111.992 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -133.36 95.66 3.56 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.205 1.002 . . . . 0.0 109.935 -172.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.9 ttm105 -66.18 136.16 55.53 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.482 -0.761 . . . . 0.0 110.659 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -89.59 34.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.294 1.438 . . . . 0.0 111.503 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.64 41.37 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.979 1.276 . . . . 0.0 113.107 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -95.81 144.08 26.48 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.562 1.145 . . . . 0.0 111.02 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -63.82 123.57 19.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.832 0.853 . . . . 0.0 111.056 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.75 140.0 34.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.714 0.806 . . . . 0.0 109.293 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 48.0 mt -122.81 92.84 3.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.272 1.429 . . . . 0.0 110.811 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.9 mt -71.77 136.9 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.797 0.839 . . . . 0.0 110.326 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -130.26 106.8 8.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.158 0.983 . . . . 0.0 113.154 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.31 -17.22 41.29 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -68.53 -14.02 62.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.753 1.161 . . . . 0.0 113.704 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.64 -10.88 1.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -139.93 110.37 7.22 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.905 1.23 . . . . 0.0 112.598 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.48 0.61 9.64 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.442 3.428 . . . . 0.0 114.794 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.01 76.17 77.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.625 1.57 . . . . 0.0 111.592 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -44.35 -34.33 7.17 Favored 'Trans proline' 0 C--N 1.354 0.831 1 C-N-CA 126.077 4.518 . . . . 0.0 117.853 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.49 -37.68 70.7 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 113.39 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -69.64 -5.97 28.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.56 1.144 . . . . 0.0 113.343 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -113.54 -2.18 13.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.595 1.558 . . . . 0.0 111.84 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 p -139.96 -28.43 0.74 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -169.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -55.88 -51.6 79.12 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.0 -28.95 41.21 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.742 1.628 . . . . 0.0 112.619 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -63.37 -48.34 78.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.767 0.827 . . . . 0.0 111.748 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.74 -39.84 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.834 0.743 . . . . 0.0 110.409 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -57.55 -43.98 84.84 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.117 0.417 . . . . 0.0 111.342 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -63.62 -57.49 9.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.701 0.8 . . . . 0.0 112.534 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -51.49 -48.78 62.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.712 1.205 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -28.5 17.19 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.78 1.657 . . . . 0.0 116.122 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.1 p -69.75 -18.9 63.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.566 1.683 . . . . 0.0 114.025 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.96 -14.61 27.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 113.056 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.36 164.21 11.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.458 1.903 . . . . 0.0 112.468 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.767 1.227 . . . . 0.0 113.58 171.528 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.31 115.27 16.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.918 1.687 . . . . 0.0 109.291 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -111.55 126.7 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.821 0.848 . . . . 0.0 112.76 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.93 125.87 7.53 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.1 mt -117.29 91.35 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 108.938 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -90.34 132.74 35.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.94 0.896 . . . . 0.0 110.732 -170.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.55 144.78 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.29 0.636 . . . . 0.0 111.52 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.86 104.46 0.55 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -149.22 161.37 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.028 1.331 . . . . 0.0 111.434 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 79.4 mmm -106.3 -11.79 15.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.073 0.949 . . . . 0.0 113.291 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -146.7 -26.46 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.46 -5.49 4.89 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -44.5 94.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.585 1.693 . . . . 0.0 113.228 -169.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -81.23 -31.04 34.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.372 0.669 . . . . 0.0 112.581 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.57 -38.91 75.61 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.737 -1.227 . . . . 0.0 113.239 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -52.76 -42.06 64.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.075 0.852 . . . . 0.0 111.801 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.9 t -69.47 -34.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.109 0.563 . . . . 0.0 112.008 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.56 92.07 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.44 1.018 . . . . 0.0 112.412 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.91 -41.75 96.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.567 0.747 . . . . 0.0 112.034 173.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -61.3 -46.52 89.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.281 0.632 . . . . 0.0 112.227 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.52 88.64 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 112.793 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.19 -45.89 79.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.724 0.809 . . . . 0.0 112.012 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.92 -45.89 80.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.779 0.832 . . . . 0.0 112.672 176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.56 -31.73 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.058 1.343 . . . . 0.0 112.996 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 mt -75.55 -41.38 55.03 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.807 -1.183 . . . . 0.0 110.175 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.3 m -56.6 -44.65 81.3 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.166 0.986 . . . . 0.0 111.807 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.66 76.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.74 1.216 . . . . 0.0 113.601 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.64 -5.41 47.75 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.405 1.082 . . . . 0.0 113.621 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.83 0.33 55.17 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.294 1.426 . . . . 0.0 114.502 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -81.83 -177.16 6.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.957 1.303 . . . . 0.0 111.919 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -122.51 150.76 42.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.933 1.693 . . . . 0.0 109.145 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.87 167.15 27.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -152.38 119.35 5.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 110.811 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -74.37 145.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.391 1.076 . . . . 0.0 111.02 171.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.0 109.21 9.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.426 1.49 . . . . 0.0 109.193 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.91 -28.59 35.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -144.25 56.43 4.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.878 1.671 . . . . 0.0 110.981 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.04 165.16 32.71 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.684 2.923 . . . . 0.0 115.566 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -133.98 171.68 13.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.728 2.011 . . . . 0.0 109.712 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.91 -39.61 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.989 -1.07 . . . . 0.0 113.038 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 m -58.62 -20.39 47.04 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -85.06 -33.06 22.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.211 0.914 . . . . 0.0 112.498 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -78.34 -40.75 35.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.639 1.175 . . . . 0.0 112.578 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.3 tp -41.44 -46.97 8.67 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.752 2.821 . . . . 0.0 115.577 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.86 -28.89 67.52 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.754 2.969 . . . . 0.0 116.316 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -80.06 2.5 23.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -169.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -60.32 -23.44 64.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.71 -1.244 . . . . 0.0 114.212 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -87.32 3.5 46.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.827 1.251 . . . . 0.0 113.072 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -137.32 -137.63 0.14 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.709 2.003 . . . . 0.0 110.97 -168.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -140.83 164.29 30.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.21 1.804 . . . . 0.0 110.626 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -144.05 174.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.252 1.421 . . . . 0.0 111.741 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tt -152.19 146.44 25.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.669 1.988 . . . . 0.0 108.49 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.28 133.04 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.357 1.063 . . . . 0.0 109.687 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.91 90.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.933 1.293 . . . . 0.0 108.786 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.5 m -135.76 141.62 44.84 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -94.95 -165.21 1.27 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.257 1.823 . . . . 0.0 113.155 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.7 m -132.43 150.35 52.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.337 -1.477 . . . . 0.0 111.715 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 127.28 2.232 . . . . 0.0 109.63 -175.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t0 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.15 145.66 65.45 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.804 1.241 . . . . 0.0 109.759 169.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.69 140.65 57.03 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.316 2.678 . . . . 0.0 110.412 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.37 -28.82 65.49 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -59.29 -12.05 5.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.66 -3.7 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.577 1.08 . . . . 0.0 113.338 173.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.2 t -56.79 -46.2 99.87 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 120.343 -1.473 . . . . 0.0 112.34 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.93 -12.97 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.921 3.081 . . . . 0.0 116.305 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 tp -99.89 -44.49 6.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.545 1.138 . . . . 0.0 110.577 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.32 -42.9 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.644 1.178 . . . . 0.0 112.238 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.88 -26.86 67.09 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.111 -0.993 . . . . 0.0 113.446 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.97 -41.73 4.56 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.078 -171.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.25 -41.06 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.447 1.623 . . . . 0.0 111.054 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.32 -48.01 83.24 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 112.32 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -36.05 19.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.831 0.853 . . . . 0.0 113.226 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -82.49 -37.08 25.81 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.75 -46.41 15.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.18 0.9 . . . . 0.0 112.393 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.97 -39.1 0.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 126.239 1.876 . . . . 0.0 115.415 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -161.94 142.27 10.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.748 2.019 . . . . 0.0 110.187 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -150.9 102.34 3.03 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.705 1.202 . . . . 0.0 111.407 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.68 -16.31 10.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.693 2.262 . . . . 0.0 114.456 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 -5.36 9.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.4 117.39 6.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.663 1.185 . . . . 0.0 109.934 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -127.93 134.55 49.33 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.716 1.606 . . . . 0.0 110.622 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -155.97 -171.13 3.63 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.24 160.39 28.26 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.864 1.697 . . . . 0.0 110.487 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.39 135.62 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.007 0.908 . . . . 0.0 113.328 -169.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.0 119.44 57.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.85 147.32 47.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.468 1.107 . . . . 0.0 109.84 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.0 tt -138.55 148.25 44.01 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.046 0.927 . . . . 0.0 112.158 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.65 -141.17 6.08 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.795 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -141.95 118.6 11.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 111.197 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -74.06 -0.02 15.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 t -73.21 4.49 4.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.56 1.073 . . . . 0.0 113.668 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.02 157.64 46.41 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.306 1.843 . . . . 0.0 111.673 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 m -74.45 -1.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -169.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -122.97 44.51 2.64 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.808 1.243 . . . . 0.0 110.73 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.29 116.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.302 -1.499 . . . . 0.0 113.1 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.17 24.46 2.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.693 2.397 . . . . 0.0 116.685 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -60.61 -27.8 68.04 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.371 -1.455 . . . . 0.0 113.416 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.64 73.02 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.272 -0.892 . . . . 0.0 113.447 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.64 -40.27 6.84 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.079 0.939 . . . . 0.0 113.13 170.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -58.74 -38.76 79.11 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 118.702 1.251 . . . . 0.0 113.659 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -56.34 -32.06 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -75.8 -25.63 56.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.033 0.833 . . . . 0.0 113.182 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.74 -43.16 48.14 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.31 -1.494 . . . . 0.0 110.288 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.12 -42.62 69.66 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 170.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -49.99 -43.86 50.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.88 1.672 . . . . 0.0 112.319 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.17 -37.62 14.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.046 0.939 . . . . 0.0 112.464 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.67 -30.28 71.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.461 -0.774 . . . . 0.0 112.21 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.81 -24.42 67.75 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -91.91 -2.21 56.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.748 0.703 . . . . 0.0 112.456 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m 75.09 23.95 1.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.056 2.143 . . . . 0.0 114.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 177.03 0.14 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.64 1.176 . . . . 0.0 112.681 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -135.59 164.35 28.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 O-C-N 120.565 -1.334 . . . . 0.0 110.305 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 mtm105 -130.58 142.26 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 t -96.16 25.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.004 1.722 . . . . 0.0 111.637 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.01 -171.42 44.43 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.018 1.294 . . . . 0.0 114.461 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.05 155.56 39.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.277 1.431 . . . . 0.0 111.641 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.7 ttm -68.41 121.19 15.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.488 1.115 . . . . 0.0 112.231 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -76.82 136.17 38.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.67 84.94 2.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.743 1.217 . . . . 0.0 110.866 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.2 mt -74.97 132.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.742 1.617 . . . . 0.0 110.634 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -124.35 104.2 8.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -14.86 7.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.5 m -64.58 -23.09 67.15 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.885 1.221 . . . . 0.0 113.598 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.35 -8.31 0.99 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -135.92 107.58 9.74 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.316 0.962 . . . . 0.0 113.064 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.76 -2.06 11.62 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.139 3.226 . . . . 0.0 114.346 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -125.16 78.82 66.53 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.934 1.694 . . . . 0.0 110.514 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.39 -23.24 76.49 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.448 3.432 . . . . 0.0 114.328 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.28 -43.68 67.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.557 1.543 . . . . 0.0 112.417 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -104.25 -7.66 19.9 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.632 1.173 . . . . 0.0 112.877 175.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 m -123.92 -26.16 4.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.32 -50.5 85.55 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 120.575 -1.328 . . . . 0.0 111.754 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.04 -34.46 87.21 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.012 2.475 . . . . 0.0 114.79 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -61.49 -49.32 77.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.985 0.514 . . . . 0.0 111.495 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.2 t -71.19 -33.41 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.351 -0.843 . . . . 0.0 111.223 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -66.12 -14.92 62.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.232 -0.918 . . . . 0.0 113.173 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -95.98 -57.16 2.43 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.745 1.218 . . . . 0.0 111.634 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.85 -49.02 66.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.875 1.27 . . . . 0.0 111.815 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.76 -24.97 27.98 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.835 1.207 . . . . 0.0 115.685 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.4 p -69.2 -16.54 63.64 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 120.117 1.959 . . . . 0.0 113.659 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.3 mt -99.79 -15.13 18.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.482 1.513 . . . . 0.0 112.995 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.59 143.97 53.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 111.671 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.946 1.698 . . . . 0.0 114.128 -174.586 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.94 166.88 8.5 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -132.62 133.82 44.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.068 1.747 . . . . 0.0 108.461 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 mm -125.95 117.36 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.537 0.735 . . . . 0.0 111.804 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.09 126.81 7.57 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 168.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -118.32 91.21 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.673 1.189 . . . . 0.0 107.857 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -90.5 137.62 32.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.356 1.063 . . . . 0.0 110.478 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -121.26 144.77 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.523 0.678 . . . . 0.0 112.242 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.16 104.56 0.49 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.247 0.927 . . . . 0.0 111.207 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 t -151.13 163.77 38.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.462 1.105 . . . . 0.0 113.076 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.1 mtp -129.82 2.0 4.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 112.204 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -140.18 -11.87 1.08 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.8 -0.8 67.67 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 171.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -74.42 -42.94 58.34 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.739 1.769 . . . . 0.0 111.732 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -33.45 74.77 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.564 -0.71 . . . . 0.0 112.156 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.08 -40.97 97.63 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.997 -1.065 . . . . 0.0 112.562 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 tt -56.15 -44.97 79.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.142 0.883 . . . . 0.0 111.623 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.22 -38.84 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.836 0.454 . . . . 0.0 111.795 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.5 90.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.22 -42.55 99.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.868 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -61.68 -42.44 98.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.501 -0.749 . . . . 0.0 112.385 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.85 95.03 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.771 0.714 . . . . 0.0 112.457 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.08 -48.75 79.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.325 0.65 . . . . 0.0 111.539 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.22 91.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.785 0.834 . . . . 0.0 112.746 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.13 -47.75 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.411 1.085 . . . . 0.0 112.363 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.29 -39.71 78.15 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.734 -0.604 . . . . 0.0 109.892 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -58.32 -44.72 88.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.927 1.291 . . . . 0.0 112.072 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -38.24 86.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.26 1.024 . . . . 0.0 112.561 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.44 -25.01 64.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.938 0.895 . . . . 0.0 112.892 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.16 -7.03 8.7 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.922 1.725 . . . . 0.0 114.759 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -76.34 139.25 40.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.828 1.251 . . . . 0.0 110.93 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -76.93 76.94 3.5 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.784 0.834 . . . . 0.0 110.909 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.34 157.8 32.08 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 111.624 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.3 m -151.99 117.73 5.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.103 -0.998 . . . . 0.0 109.784 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.13 144.97 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.708 0.803 . . . . 0.0 112.262 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.34 97.95 4.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.409 1.484 . . . . 0.0 110.822 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.99 -18.02 60.92 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -141.67 66.04 21.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.893 1.677 . . . . 0.0 109.764 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.67 168.75 24.1 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.14 3.227 . . . . 0.0 115.237 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -149.34 159.96 43.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.973 2.109 . . . . 0.0 109.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.02 -38.05 48.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.954 -1.091 . . . . 0.0 111.468 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -56.03 -24.8 41.66 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.41 1.484 . . . . 0.0 114.826 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -99.6 -23.72 14.97 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.567 1.547 . . . . 0.0 112.908 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -71.59 -39.6 70.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.803 0.841 . . . . 0.0 112.727 170.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.98 -47.66 86.47 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.778 2.031 . . . . 0.0 115.594 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.88 -5.14 1.76 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.101 3.2 . . . . 0.0 117.731 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -119.56 2.84 11.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -28.26 69.52 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.227 -1.546 . . . . 0.0 113.187 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.91 4.91 23.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.705 1.202 . . . . 0.0 113.094 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -135.71 -132.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.867 2.067 . . . . 0.0 110.1 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -139.09 159.47 42.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.943 1.697 . . . . 0.0 111.005 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.37 168.51 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.034 1.733 . . . . 0.0 110.391 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 151.15 23.36 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.849 -1.157 . . . . 0.0 110.433 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.81 136.64 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.829 1.252 . . . . 0.0 110.405 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -135.1 95.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.937 1.295 . . . . 0.0 107.719 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 m -133.56 169.12 17.45 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -167.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -137.71 -158.95 0.91 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.122 1.369 . . . . 0.0 112.578 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.1 m -135.82 151.75 50.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.757 1.623 . . . . 0.0 110.872 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 t -150.17 -176.07 5.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.127 1.371 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.46 -132.18 9.07 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.697 1.617 . . . . 0.0 114.377 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -81.74 19.67 1.04 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 113.069 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.65 15.73 10.83 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.763 1.173 . . . . 0.0 114.924 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -80.37 170.07 16.88 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.424 1.89 . . . . 0.0 112.388 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.47 143.96 93.78 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.219 -0.926 . . . . 0.0 111.054 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.93 137.37 43.82 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.088 3.859 . . . . 0.0 112.349 170.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.85 -24.35 66.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -61.45 -17.95 56.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.718 1.607 . . . . 0.0 114.802 171.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -124.54 -10.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.543 1.137 . . . . 0.0 113.845 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.8 t -46.98 -48.98 51.93 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.965 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.44 -17.21 43.94 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.379 1.885 . . . . 0.0 114.385 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.2 -43.71 17.31 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.962 0.801 . . . . 0.0 109.572 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.57 -49.65 72.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.096 1.359 . . . . 0.0 111.386 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -62.12 -41.7 98.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.846 -1.159 . . . . 0.0 112.262 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.99 -50.23 67.55 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.647 0.641 . . . . 0.0 112.828 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.3 -39.41 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 O-C-N 121.382 -1.069 . . . . 0.0 110.897 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -65.88 -36.7 84.14 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -112.71 -20.36 11.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.2 m -125.61 10.86 7.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.876 1.271 . . . . 0.0 113.782 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.13 -51.59 1.11 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.615 1.566 . . . . 0.0 110.302 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.31 -28.98 0.33 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 119.552 2.581 . . . . 0.0 119.552 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -153.3 136.45 15.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.499 2.15 . . . . 0.0 111.99 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -150.64 56.11 2.0 Allowed Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.219 1.408 . . . . 0.0 113.296 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.43 -18.67 65.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.036 3.158 . . . . 0.0 115.323 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.97 0.17 14.98 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.596 1.959 . . . . 0.0 113.504 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.71 124.07 22.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 109.186 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -121.31 138.89 54.04 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.201 1.4 . . . . 0.0 109.263 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -160.92 -167.48 1.84 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -168.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 160.86 31.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.625 2.536 . . . . 0.0 109.714 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.82 135.46 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 117.897 0.849 . . . . 0.0 112.212 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.2 mt -119.57 130.61 73.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.04 146.85 48.29 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.044 0.938 . . . . 0.0 110.171 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tt -141.53 133.87 28.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.553 0.741 . . . . 0.0 110.852 -169.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.58 -166.15 33.8 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 121.951 0.751 . . . . 0.0 113.733 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -98.07 118.4 34.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.877 1.271 . . . . 0.0 110.962 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.4 p -64.26 -9.94 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.974 1.71 . . . . 0.0 115.207 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -70.56 -8.26 50.1 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -138.13 159.55 41.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.67 1.188 . . . . 0.0 113.387 -169.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.16 -34.5 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.127 1.371 . . . . 0.0 113.176 -171.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -76.2 34.85 0.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.592 1.157 . . . . 0.0 113.215 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.62 113.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.915 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.3 m 52.85 25.36 3.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.329 2.251 . . . . 0.0 116.287 -171.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -60.28 -30.22 69.32 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.661 -1.275 . . . . 0.0 113.692 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.55 -38.8 61.62 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.897 -1.127 . . . . 0.0 112.695 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.67 -40.33 66.06 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.524 -0.986 . . . . 0.0 112.791 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -58.79 -40.74 84.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.881 0.872 . . . . 0.0 112.911 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.86 -38.21 84.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.27 -31.3 68.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.39 0.995 . . . . 0.0 113.413 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.57 -43.73 79.92 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 119.763 -1.835 . . . . 0.0 110.826 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.39 71.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.57 -29.64 11.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.586 1.554 . . . . 0.0 112.936 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.32 -39.1 6.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.517 1.127 . . . . 0.0 111.362 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -67.36 -34.13 76.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.306 -0.871 . . . . 0.0 113.338 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.79 -14.09 49.81 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.427 -0.796 . . . . 0.0 112.414 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -111.57 10.15 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.851 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 72.31 18.93 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.596 1.558 . . . . 0.0 114.516 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.8 165.35 1.76 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.506 0.722 . . . . 0.0 111.92 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -135.6 88.4 2.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 120.76 -1.213 . . . . 0.0 110.344 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -62.42 142.83 57.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.354 0.662 . . . . 0.0 111.346 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.56 34.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.579 1.552 . . . . 0.0 110.757 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.92 -167.89 40.91 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.841 -1.162 . . . . 0.0 113.562 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -120.17 143.14 48.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.515 1.526 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.1 ttp -67.53 124.82 24.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.265 1.026 . . . . 0.0 112.018 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -83.86 133.66 34.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.218 1.007 . . . . 0.0 109.968 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -122.41 98.13 5.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 111.575 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.1 mt -89.47 134.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.617 1.567 . . . . 0.0 111.772 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -113.38 66.97 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.624 3.17 . . . . 0.0 111.35 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -46.1 -38.94 8.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.455 1.902 . . . . 0.0 116.132 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.1 m -62.38 -16.12 52.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -134.46 12.49 3.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.065 1.746 . . . . 0.0 111.964 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -144.5 68.46 15.0 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.242 1.817 . . . . 0.0 110.704 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.85 6.92 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.841 3.694 . . . . 0.0 114.701 -171.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.5 58.91 41.66 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.275 1.83 . . . . 0.0 110.987 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -61.47 -22.06 73.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.608 3.539 . . . . 0.0 114.24 -169.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.56 -44.26 56.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.999 1.32 . . . . 0.0 111.051 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.6 p -68.57 -18.32 64.31 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -95.11 -11.93 27.38 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.283 1.433 . . . . 0.0 112.428 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 26.0 p -128.3 -31.63 2.29 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.71 -53.1 69.13 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.923 1.238 . . . . 0.0 113.877 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.61 -29.42 52.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.418 1.542 . . . . 0.0 112.678 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -61.63 -48.94 78.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.709 0.803 . . . . 0.0 111.715 171.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.31 -40.75 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.694 0.679 . . . . 0.0 110.535 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.57 -44.1 89.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.701 0.682 . . . . 0.0 111.249 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.77 -55.86 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 112.606 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.29 -37.51 67.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.881 0.873 . . . . 0.0 112.195 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.36 -20.45 65.44 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.407 1.003 . . . . 0.0 115.158 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.4 p -74.58 -17.94 60.65 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.654 1.727 . . . . 0.0 113.165 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.62 -5.8 53.29 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.856 1.262 . . . . 0.0 112.73 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.76 -173.6 0.79 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.085 1.754 . . . . 0.0 111.361 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.371 1.869 . . . . 0.0 114.505 178.389 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.294 0.092 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.97 179.81 6.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.391 1.876 . . . . 0.0 111.361 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.44 134.66 47.95 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.174 1.389 . . . . 0.0 109.699 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.03 124.76 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.26 130.63 10.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 168.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -117.65 90.86 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.01 1.324 . . . . 0.0 108.331 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.71 146.58 24.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.852 0.861 . . . . 0.0 112.978 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.44 129.41 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.255 1.026 . . . . 0.0 111.833 -169.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.93 71.71 0.46 Allowed Glycine 0 N--CA 1.468 0.798 0 C-N-CA 126.615 2.055 . . . . 0.0 109.568 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 t -129.76 177.73 7.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.631 1.172 . . . . 0.0 113.787 -169.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.3 tpt -135.58 -36.88 0.77 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.153 0.981 . . . . 0.0 113.417 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -129.28 -22.68 3.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.568 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.65 -2.55 7.0 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.7 1.143 . . . . 0.0 115.16 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -36.8 85.08 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.447 1.624 . . . . 0.0 113.084 -169.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 -31.69 37.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.593 1.157 . . . . 0.0 113.505 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.4 tp -59.06 -35.34 73.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.953 -1.092 . . . . 0.0 113.218 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 tp -48.32 -42.04 30.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.555 0.742 . . . . 0.0 111.707 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.26 -36.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.976 -0.535 . . . . 0.0 112.137 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.04 94.37 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.703 1.138 . . . . 0.0 112.415 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.38 -42.57 99.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.032 0.533 . . . . 0.0 112.102 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -60.83 -46.95 88.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.412 0.685 . . . . 0.0 112.38 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.64 84.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.179 0.592 . . . . 0.0 111.907 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.8 -45.82 70.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.136 0.575 . . . . 0.0 111.89 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.75 74.44 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.464 0.706 . . . . 0.0 112.812 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.25 -45.88 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.831 1.252 . . . . 0.0 111.973 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.2 mt -73.52 -40.1 64.29 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.037 0.935 . . . . 0.0 109.846 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.4 m -56.92 -46.6 81.89 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.35 1.06 . . . . 0.0 111.573 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.88 82.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.042 0.937 . . . . 0.0 113.325 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -73.44 -9.25 58.49 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 171.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.95 -6.01 34.74 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.574 1.559 . . . . 0.0 114.982 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -76.84 153.73 34.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.54 1.17 . . . . 0.0 112.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -80.76 130.84 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.66 150.78 46.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.336 0.654 . . . . 0.0 111.457 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -155.75 121.48 4.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.966 0.906 . . . . 0.0 109.925 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.87 150.3 7.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.194 0.521 . . . . 0.0 111.383 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -133.53 102.55 5.55 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.708 1.203 . . . . 0.0 107.985 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.88 -27.12 60.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.57 1.148 . . . . 0.0 113.855 -170.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.65 58.89 4.76 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 126.297 1.839 . . . . 0.0 110.508 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.05 163.94 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.212 3.275 . . . . 0.0 116.114 -169.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.69 170.18 15.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.449 2.3 . . . . 0.0 109.178 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -53.28 -38.85 63.44 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.809 -1.182 . . . . 0.0 113.312 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.84 -13.93 28.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -89.69 -29.41 18.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.719 1.145 . . . . 0.0 112.52 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -81.82 -42.85 19.1 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 0.0 112.665 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.4 tp -47.59 -44.65 55.92 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 126.803 2.041 . . . . 0.0 114.54 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.01 -9.28 0.66 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.271 3.981 . . . . 0.0 118.129 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.22 5.21 7.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 113.173 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -57.02 -36.45 70.46 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.227 -0.921 . . . . 0.0 112.605 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.03 13.06 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.561 1.944 . . . . 0.0 114.479 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -134.43 -130.43 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.591 1.556 . . . . 0.0 111.482 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.33 158.61 44.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.895 2.078 . . . . 0.0 109.691 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.36 172.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 110.467 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -154.86 149.58 26.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.683 1.593 . . . . 0.0 108.86 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.6 139.76 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.402 -0.811 . . . . 0.0 111.143 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 m -124.53 125.95 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.073 1.349 . . . . 0.0 108.257 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.7 m -150.87 158.28 43.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.041 -1.662 . . . . 0.0 113.38 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -136.14 178.61 6.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.505 1.522 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 m -121.51 135.37 55.03 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.01 1.324 . . . . 0.0 110.803 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 t -163.29 -160.08 0.58 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.613 1.965 . . . . 0.0 109.28 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.68 -69.59 0.56 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.822 2.153 . . . . 0.0 115.542 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -154.63 29.64 0.43 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.345 1.858 . . . . 0.0 110.637 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.36 40.88 6.73 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.16 -0.963 . . . . 0.0 111.682 -169.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -137.15 168.21 20.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.051 1.74 . . . . 0.0 112.41 -169.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.07 152.59 96.69 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.279 -0.888 . . . . 0.0 111.339 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -85.21 164.69 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.684 2.923 . . . . 0.0 112.566 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.0 -19.16 64.08 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -61.48 -19.76 62.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 tt -127.01 -8.33 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -48.42 -51.56 50.27 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-O 117.418 -1.277 . . . . 0.0 112.449 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.92 -5.18 16.56 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.362 2.041 . . . . 0.0 114.326 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -92.39 -43.43 9.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.227 0.921 . . . . 0.0 109.399 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.46 -50.03 74.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.806 1.243 . . . . 0.0 111.387 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -62.22 -40.0 94.68 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.981 -1.074 . . . . 0.0 112.485 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.89 -44.65 55.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.169 0.89 . . . . 0.0 113.505 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.43 -47.45 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.098 1.449 . . . . 0.0 110.047 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -59.92 -48.61 81.0 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.581 1.153 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.85 -41.82 22.57 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -88.52 -28.34 20.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -97.13 -42.65 7.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.85 -38.12 0.5 Allowed Glycine 0 CA--C 1.542 1.777 0 C-N-CA 125.84 1.686 . . . . 0.0 115.757 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -145.01 151.58 38.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.26 2.224 . . . . 0.0 110.82 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.24 43.12 0.23 Allowed Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -57.6 -29.48 85.3 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.141 2.561 . . . . 0.0 114.649 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -68.32 -15.26 63.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.924 2.09 . . . . 0.0 115.145 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.27 122.63 28.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.54 136.83 54.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 108.766 169.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -156.43 -172.29 4.02 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.2 161.37 27.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.127 1.346 . . . . 0.0 109.86 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.95 142.18 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.666 0.746 . . . . 0.0 111.749 -169.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mt -127.71 129.48 70.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.51 151.63 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.697 0.76 . . . . 0.0 110.853 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 tt -143.68 131.56 21.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.249 1.02 . . . . 0.0 109.976 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.78 -147.85 5.17 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 174.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -143.78 125.04 14.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.786 1.234 . . . . 0.0 110.385 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -60.16 -7.16 1.72 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -63.9 -7.87 9.49 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 171.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -126.49 136.08 52.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.42 1.488 . . . . 0.0 111.154 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.75 -36.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.513 1.125 . . . . 0.0 113.488 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.92 -17.11 59.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 23.1 t80 34.69 -118.23 0.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.443 1.897 . . . . 0.0 112.867 -169.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.19 24.69 0.52 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -46.36 -43.28 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.095 1.316 . . . . 0.0 113.883 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.55 -36.84 86.92 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 118.49 0.586 . . . . 0.0 113.142 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.53 -45.06 48.23 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.928 0.775 . . . . 0.0 113.463 170.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -58.24 -38.1 76.2 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.357 1.078 . . . . 0.0 113.374 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -55.89 -41.22 74.14 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.351 0.661 . . . . 0.0 112.29 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -71.4 -26.03 62.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.63 -41.45 45.88 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.697 -1.252 . . . . 0.0 111.462 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.93 -40.12 72.67 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.1 tp -50.68 -34.3 26.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.289 1.835 . . . . 0.0 112.92 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -103.71 -36.59 7.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -67.84 -32.39 72.89 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.9 -1.125 . . . . 0.0 113.022 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.03 -16.8 62.48 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 119.17 0.895 . . . . 0.0 111.87 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -107.04 10.14 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.06 1.744 . . . . 0.0 112.672 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m 65.71 23.95 11.55 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 114.713 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.3 177.96 0.23 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 0.0 112.618 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -136.72 163.57 30.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.498 -1.377 . . . . 0.0 109.673 -173.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -133.21 147.09 52.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.11 22.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.926 1.691 . . . . 0.0 112.14 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.2 176.56 41.1 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.405 1.479 . . . . 0.0 114.556 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.84 162.13 16.34 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.801 1.24 . . . . 0.0 112.398 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttp -71.32 123.17 21.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.615 -0.678 . . . . 0.0 111.352 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.25 138.81 47.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.035 0.934 . . . . 0.0 110.206 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.7 mt -124.73 91.3 3.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.84 1.256 . . . . 0.0 112.129 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.78 137.65 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.403 1.481 . . . . 0.0 110.34 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -133.07 102.81 5.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.278 1.037 . . . . 0.0 112.553 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.03 14.31 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 83.1 p -72.25 -14.68 61.84 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.57 1.077 . . . . 0.0 113.825 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.54 -7.54 1.3 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -136.91 112.14 9.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.538 1.135 . . . . 0.0 112.017 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.42 -3.62 12.63 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.68 2.92 . . . . 0.0 114.171 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -134.74 84.02 39.97 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.265 1.426 . . . . 0.0 111.78 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -46.24 -33.76 12.59 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 126.103 4.535 . . . . 0.0 116.229 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.08 -40.79 59.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.139 1.376 . . . . 0.0 112.605 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.5 p -67.26 -9.95 45.73 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -115.25 -3.45 12.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.587 1.155 . . . . 0.0 112.445 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.0 p -133.12 -27.45 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.66 -53.39 60.88 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 120.011 1.278 . . . . 0.0 112.752 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.18 -29.77 32.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.592 1.528 . . . . 0.0 112.694 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -60.76 -50.1 74.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.354 0.662 . . . . 0.0 111.463 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.41 -39.38 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 118.287 0.494 . . . . 0.0 110.571 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.48 -34.88 73.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.022 0.828 . . . . 0.0 112.403 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.51 -63.06 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.319 0.963 . . . . 0.0 111.945 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -57.38 -35.8 70.43 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.788 1.235 . . . . 0.0 113.045 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.58 -33.87 68.08 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.864 0.745 . . . . 0.0 113.905 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.8 p -69.99 -17.62 63.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.426 1.613 . . . . 0.0 113.884 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.99 -18.08 44.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.35 -32.72 73.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.255 1.386 0 C-N-CA 124.844 1.258 . . . . 0.0 112.364 -175.207 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.34 178.07 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.223 1.809 . . . . 0.0 111.862 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.03 110.54 7.03 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 108.647 -173.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mm -110.89 137.41 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -169.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.01 126.61 8.85 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mt -119.62 101.12 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.493 1.117 . . . . 0.0 108.149 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.16 120.41 39.47 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.696 0.799 . . . . 0.0 112.481 -168.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.28 143.31 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.904 1.282 . . . . 0.0 110.768 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.84 76.43 0.31 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.064 1.316 . . . . 0.0 110.278 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 t -121.47 154.51 36.5 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.854 0.827 . . . . 0.0 112.447 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 tpt -90.45 -28.72 18.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.527 0.731 . . . . 0.0 112.548 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -146.3 -16.14 0.44 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.57 -14.56 4.74 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -62.96 -42.98 99.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.399 2.1 . . . . 0.0 113.093 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -77.84 -26.01 49.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.48 -44.31 89.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.886 -1.133 . . . . 0.0 112.177 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.8 -45.33 70.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.687 0.676 . . . . 0.0 111.589 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.48 -38.69 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.005 0.522 . . . . 0.0 111.892 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.66 92.44 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.964 0.802 . . . . 0.0 112.885 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.82 -43.7 98.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.696 -0.628 . . . . 0.0 112.081 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.32 -42.34 99.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.543 -0.723 . . . . 0.0 112.311 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.12 90.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.61 -0.681 . . . . 0.0 112.034 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -55.11 -47.8 74.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.425 0.69 . . . . 0.0 111.445 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.42 84.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.736 0.814 . . . . 0.0 112.849 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.13 -45.25 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.481 1.112 . . . . 0.0 112.305 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.34 -41.8 72.74 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.547 -0.721 . . . . 0.0 109.787 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -56.64 -42.92 79.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.919 1.288 . . . . 0.0 112.467 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 -42.33 65.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.31 1.044 . . . . 0.0 113.442 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -71.07 -37.04 72.48 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.4 21.86 0.03 OUTLIER Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -133.66 -175.68 3.91 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.458 1.503 . . . . 0.0 111.155 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.47 144.37 48.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.389 1.476 . . . . 0.0 108.379 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.74 153.1 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.825 -0.547 . . . . 0.0 112.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.5 m -137.6 113.46 9.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 109.442 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.02 147.34 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.336 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -134.79 105.07 6.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.97 -30.0 58.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.982 1.313 . . . . 0.0 114.041 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -148.68 65.1 8.2 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.489 1.916 . . . . 0.0 109.601 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.45 171.71 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.685 2.923 . . . . 0.0 114.188 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.85 169.18 16.1 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.77 2.028 . . . . 0.0 108.913 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.35 -35.31 65.07 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.671 -1.268 . . . . 0.0 112.344 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -57.53 -22.71 46.09 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -83.75 -36.74 23.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.121 0.873 . . . . 0.0 112.478 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -70.57 -39.94 73.61 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.727 0.694 . . . . 0.0 112.034 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -43.25 -58.07 4.61 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 127.241 2.217 . . . . 0.0 115.273 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.17 -26.62 10.48 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.702 2.268 . . . . 0.0 114.731 -171.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -74.18 -7.12 51.52 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -62.11 -30.57 71.11 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.667 -1.27 . . . . 0.0 112.694 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.71 2.64 7.79 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.309 1.444 . . . . 0.0 113.99 171.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -133.14 -120.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.082 2.153 . . . . 0.0 109.566 -169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -143.55 158.1 43.92 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 109.373 171.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.9 163.16 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.315 1.446 . . . . 0.0 110.718 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.19 141.87 20.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.225 1.012 . . . . 0.0 111.48 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.81 133.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.563 1.545 . . . . 0.0 109.606 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.97 106.49 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.4 m -149.16 155.16 40.24 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.297 -1.502 . . . . 0.0 114.913 -168.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -113.29 -174.22 2.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.37 1.468 . . . . 0.0 112.852 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.2 m -129.23 139.86 51.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.673 1.189 . . . . 0.0 110.666 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -146.23 -166.1 2.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 108.352 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 44.37 44.87 8.12 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 125.876 1.703 . . . . 0.0 116.36 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 65.02 8.23 4.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.359 2.264 . . . . 0.0 115.507 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.47 31.89 0.1 OUTLIER Glycine 0 N--CA 1.475 1.295 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -138.46 172.44 12.88 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.88 1.84 . . . . 0.0 113.194 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -65.76 146.03 99.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.659 1.584 . . . . 0.0 112.987 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.01 155.27 19.8 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.706 2.937 . . . . 0.0 111.602 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.7 -23.86 63.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.8 m -56.85 -16.99 7.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.692 1.597 . . . . 0.0 115.153 174.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.0 tt -132.96 -4.98 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.3 t -48.88 -43.13 64.71 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.364 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 -13.95 41.02 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 CA-C-N 122.433 1.905 . . . . 0.0 114.928 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.83 -48.92 6.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.073 0.949 . . . . 0.0 109.017 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -59.85 -46.85 87.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.536 1.534 . . . . 0.0 113.612 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.6 -24.22 58.84 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.042 -1.037 . . . . 0.0 113.098 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.09 -52.21 4.14 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.218 0.913 . . . . 0.0 112.996 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.54 -38.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.591 1.195 . . . . 0.0 111.515 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -62.24 -35.43 78.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 113.297 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -115.7 -32.48 5.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -82.05 -19.14 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.3 mt -127.67 -48.87 1.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.689 1.196 . . . . 0.0 112.068 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.64 -22.84 0.23 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.932 1.933 . . . . 0.0 117.932 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.68 130.44 10.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.51 1.655 . . . . 0.0 111.704 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -163.29 66.97 1.64 Allowed Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.881 1.272 . . . . 0.0 112.895 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.3 -23.18 66.04 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.937 2.425 . . . . 0.0 114.649 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -72.53 -5.48 37.29 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -76.52 133.79 39.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.199 1.0 . . . . 0.0 111.778 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.56 145.01 51.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.732 1.613 . . . . 0.0 110.617 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -162.35 -170.9 2.6 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 165.02 33.61 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.869 2.176 . . . . 0.0 110.727 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 t -142.07 136.94 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.125 0.963 . . . . 0.0 112.259 -170.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -123.15 116.66 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.05 149.32 32.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.339 1.056 . . . . 0.0 110.571 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -138.36 149.77 45.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.267 1.027 . . . . 0.0 111.672 -170.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.03 -143.57 7.75 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.083 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -141.3 126.08 18.05 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.209 1.404 . . . . 0.0 110.262 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -66.02 -12.88 58.29 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -68.61 0.01 4.66 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -125.25 12.73 8.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.46 1.504 . . . . 0.0 114.479 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.37 -44.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 127.9 2.48 . . . . 0.0 115.205 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -76.24 48.33 0.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.027 1.285 . . . . 0.0 111.764 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.18 116.84 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.302 -1.499 . . . . 0.0 112.303 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.1 m 51.05 24.35 1.86 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.851 2.06 . . . . 0.0 116.498 -172.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.33 -15.49 48.53 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.693 -1.254 . . . . 0.0 113.559 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.18 -67.93 1.81 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.7 -36.09 77.22 Favored Glycine 0 CA--C 1.536 1.401 0 O-C-N 121.557 -0.966 . . . . 0.0 114.258 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.27 -38.32 76.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.295 1.047 . . . . 0.0 113.652 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.92 -34.68 78.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.63 0.65 . . . . 0.0 112.189 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.67 -29.88 62.58 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.124 0.874 . . . . 0.0 112.78 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.3 -46.02 74.8 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.098 -1.626 . . . . 0.0 110.395 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -35.8 72.42 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -49.15 -44.16 42.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.936 1.294 . . . . 0.0 111.445 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 mt -80.52 -31.92 36.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.254 0.622 . . . . 0.0 111.69 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -65.77 -32.75 74.47 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.854 -1.154 . . . . 0.0 112.01 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -61.75 -26.18 67.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.885 0.766 . . . . 0.0 112.175 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -82.17 -27.1 32.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.598 -0.689 . . . . 0.0 112.471 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.9 m 101.61 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 130.161 3.384 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 156.97 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.54 1.136 . . . . 0.0 113.625 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -123.93 88.07 2.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.902 1.681 . . . . 0.0 110.318 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -63.04 140.3 58.86 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.32 -0.863 . . . . 0.0 111.401 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.43 33.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.303 1.441 . . . . 0.0 111.702 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.96 -160.64 34.16 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.895 -1.128 . . . . 0.0 113.607 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -125.06 148.27 48.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.617 1.567 . . . . 0.0 111.179 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.3 ttp -69.67 124.56 24.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 112.189 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.45 140.72 39.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.072 0.949 . . . . 0.0 110.188 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.41 89.74 3.01 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.091 1.356 . . . . 0.0 111.534 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -76.87 133.96 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.611 1.564 . . . . 0.0 110.857 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -127.12 98.64 5.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.219 1.009 . . . . 0.0 113.219 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -15.31 9.79 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.0 p -73.45 -13.91 61.15 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.904 1.229 . . . . 0.0 113.822 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.02 -8.26 1.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -135.34 110.58 10.62 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.225 1.01 . . . . 0.0 112.185 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.92 -2.45 12.43 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.017 3.144 . . . . 0.0 114.481 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -129.9 80.59 70.98 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.671 1.588 . . . . 0.0 111.877 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.83 -36.49 7.92 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.654 4.236 . . . . 0.0 116.057 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.36 -45.87 36.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.426 1.89 . . . . 0.0 112.954 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.0 p -68.76 -18.09 64.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.14 -9.31 20.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.944 0.897 . . . . 0.0 112.506 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 m -116.02 -33.02 5.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -58.15 -51.53 81.08 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.396 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.99 -28.7 57.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.625 1.55 . . . . 0.0 112.723 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -61.74 -49.8 74.96 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.616 0.644 . . . . 0.0 111.68 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 t -68.27 -40.78 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.868 0.758 . . . . 0.0 110.367 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.6 -30.09 70.46 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -76.44 -57.94 3.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.274 1.03 . . . . 0.0 112.222 170.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -51.82 -47.44 64.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.831 1.252 . . . . 0.0 111.427 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.48 11.66 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.659 1.6 . . . . 0.0 115.905 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.0 p -70.52 -15.58 62.8 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.888 1.844 . . . . 0.0 113.961 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.94 -15.85 18.98 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.395 1.478 . . . . 0.0 113.192 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.7 157.63 14.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.269 2.227 . . . . 0.0 111.757 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.885 1.274 . . . . 0.0 113.536 174.076 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.396 0.141 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.24 -177.53 4.56 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.14 1.776 . . . . 0.0 112.416 -170.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -118.36 122.65 43.37 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.509 1.524 . . . . 0.0 108.732 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 mm -120.41 122.91 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.144 0.978 . . . . 0.0 112.367 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.59 128.77 9.17 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 168.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.46 91.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.276 1.038 . . . . 0.0 108.937 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -93.02 148.21 22.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.549 1.139 . . . . 0.0 112.448 -169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.11 143.87 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.55 0.74 . . . . 0.0 111.006 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.47 108.37 0.64 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 172.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -150.51 165.92 31.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.256 1.022 . . . . 0.0 112.08 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -110.15 -19.58 12.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.512 1.125 . . . . 0.0 113.174 171.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -143.78 -13.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.69 11.02 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.02 -44.71 97.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.35 2.075 . . . . 0.0 112.986 -174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 p -75.95 -30.25 58.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.644 0.778 . . . . 0.0 112.803 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.14 -39.25 85.67 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.907 -1.121 . . . . 0.0 113.408 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.89 -45.43 71.09 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.659 0.663 . . . . 0.0 110.899 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.66 -34.46 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 112.104 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.37 94.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.351 0.978 . . . . 0.0 112.831 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.0 -41.69 98.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.584 0.754 . . . . 0.0 111.611 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.0 -48.07 83.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.294 0.638 . . . . 0.0 111.799 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.91 91.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 112.844 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -57.67 -46.86 83.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.748 0.419 . . . . 0.0 111.512 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.98 81.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.369 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -58.1 -45.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.745 1.218 . . . . 0.0 112.201 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 mt -73.08 -40.1 65.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.556 0.616 . . . . 0.0 110.25 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.5 m -56.71 -46.78 81.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.662 1.185 . . . . 0.0 111.808 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.63 80.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.135 0.974 . . . . 0.0 113.009 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.74 -34.38 77.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.121 0.968 . . . . 0.0 111.756 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.86 5.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.213 1.387 . . . . 0.0 114.652 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.36 150.62 38.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.636 1.174 . . . . 0.0 111.73 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -76.49 130.25 37.68 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.62 142.48 31.06 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.428 0.558 . . . . 0.0 111.913 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.0 m -141.0 115.63 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.971 0.908 . . . . 0.0 109.809 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.53 146.76 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.75 0.82 . . . . 0.0 111.895 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -135.18 96.13 3.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.781 . . . . 0.0 108.485 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -72.43 -27.48 62.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.309 1.444 . . . . 0.0 114.61 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -144.74 64.62 11.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.849 2.059 . . . . 0.0 108.524 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.44 162.02 43.65 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.363 3.376 . . . . 0.0 116.248 -168.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.93 163.7 29.67 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.058 2.543 . . . . 0.0 108.274 169.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.89 -45.01 15.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.955 -1.091 . . . . 0.0 112.568 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m -56.68 -20.1 19.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.18 -34.62 32.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.378 0.99 . . . . 0.0 112.313 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -79.41 -32.29 42.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.596 1.558 . . . . 0.0 112.771 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 tp -39.87 -45.85 4.59 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 128.793 2.837 . . . . 0.0 116.167 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -77.58 -18.41 13.68 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.583 2.188 . . . . 0.0 115.354 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.88 -6.09 57.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -57.32 -23.8 51.0 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -102.47 13.81 33.59 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.132 1.373 . . . . 0.0 112.938 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -138.51 -131.55 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.652 1.981 . . . . 0.0 109.651 -169.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -135.31 151.51 50.61 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.237 1.015 . . . . 0.0 111.166 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.85 165.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.723 1.209 . . . . 0.0 111.012 -174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.65 149.72 24.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 109.563 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.14 143.23 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.205 0.602 . . . . 0.0 110.842 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.29 109.45 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.585 0.707 . . . . 0.0 110.298 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.4 m -138.17 144.53 40.77 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 m -95.96 -168.82 1.82 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.677 1.591 . . . . 0.0 112.587 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -128.5 149.71 50.48 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.88 1.272 . . . . 0.0 110.62 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.0 p -141.92 -171.59 3.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.798 2.439 . . . . 0.0 108.561 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.36 25.92 1.38 Allowed Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.229 1.871 . . . . 0.0 117.466 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 55.11 18.06 2.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.772 2.029 . . . . 0.0 114.295 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 158.52 36.2 0.02 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.633 1.111 . . . . 0.0 115.302 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -137.52 169.51 17.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.321 1.448 . . . . 0.0 112.971 -169.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.47 139.86 55.57 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 127.185 2.194 . . . . 0.0 111.808 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.72 141.38 49.52 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.135 2.556 . . . . 0.0 110.014 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.17 -30.18 64.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -169.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -61.49 -13.35 20.17 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -121.75 -7.65 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.145 1.338 . . . . 0.0 113.896 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -50.7 -48.47 82.85 Favored Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.62 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.5 5.27 2.46 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.11 2.54 . . . . 0.0 114.749 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.4 tp -107.55 -47.34 3.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.663 1.185 . . . . 0.0 109.795 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.43 -53.71 55.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.352 1.061 . . . . 0.0 112.016 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -63.91 -37.06 86.02 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.682 -0.636 . . . . 0.0 111.844 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.81 -46.23 76.66 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.712 0.672 . . . . 0.0 113.281 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.57 -42.01 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.666 1.233 . . . . 0.0 110.57 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.81 -51.28 65.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.683 0.793 . . . . 0.0 112.987 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.93 -25.17 24.52 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.5 m -125.15 -0.37 7.78 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -119.09 -52.52 2.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.521 1.055 . . . . 0.0 110.256 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.23 -23.8 0.2 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 118.135 2.014 . . . . 0.0 118.135 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -151.98 139.76 19.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.041 1.736 . . . . 0.0 110.064 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 50.79 0.54 Allowed Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -66.03 -18.9 57.62 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.249 2.633 . . . . 0.0 114.592 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.53 -17.21 58.15 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -76.8 138.16 39.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.42 1.088 . . . . 0.0 112.663 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -129.15 145.9 51.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.932 1.693 . . . . 0.0 110.792 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -159.3 -174.9 4.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -169.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.77 154.97 25.87 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 127.357 2.408 . . . . 0.0 110.299 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.77 128.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.771 1.286 . . . . 0.0 111.169 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -105.6 143.56 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.93 48.72 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.036 -1.04 . . . . 0.0 110.343 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.3 tt -139.57 153.37 47.4 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.19 0.995 . . . . 0.0 111.339 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.69 -140.82 6.04 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.206 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -143.38 129.28 19.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.257 1.023 . . . . 0.0 111.196 -173.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.8 m -62.59 -7.0 3.96 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 m -67.2 0.34 2.82 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.05 156.09 48.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.535 1.534 . . . . 0.0 112.421 -170.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.46 -39.52 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.032 0.933 . . . . 0.0 111.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -78.08 44.85 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.209 1.404 . . . . 0.0 112.785 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -52.36 116.56 2.31 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.313 -1.492 . . . . 0.0 112.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.1 m 51.18 24.67 2.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.72 2.408 . . . . 0.0 117.219 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.45 -28.5 69.32 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.536 -1.353 . . . . 0.0 113.794 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.55 -35.81 91.66 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 118.912 0.778 . . . . 0.0 113.39 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.08 -34.17 27.45 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.276 -1.132 . . . . 0.0 113.297 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.64 -37.74 82.51 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.581 1.191 . . . . 0.0 112.636 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -57.36 -45.6 84.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.319 0.648 . . . . 0.0 111.407 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.0 -34.74 77.1 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.265 0.939 . . . . 0.0 112.952 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.94 -44.21 97.25 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 111.778 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.91 69.39 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.5 tp -53.92 -20.71 6.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.374 1.469 . . . . 0.0 113.233 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 mt -107.08 -37.7 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.788 1.235 . . . . 0.0 111.22 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -30.5 71.16 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.189 0.904 . . . . 0.0 111.26 169.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -51.83 -30.79 24.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.617 1.567 . . . . 0.0 112.131 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -116.97 17.72 14.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.395 1.478 . . . . 0.0 113.014 -169.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.3 t 65.58 16.0 10.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.602 1.961 . . . . 0.0 115.292 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.06 49.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.239 -0.913 . . . . 0.0 111.982 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -109.96 110.39 21.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.008 0.923 . . . . 0.0 111.23 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -73.1 126.23 29.53 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.054 -1.029 . . . . 0.0 110.853 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -84.44 34.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.176 1.39 . . . . 0.0 111.906 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.3 -171.47 43.1 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.682 1.611 . . . . 0.0 112.468 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -114.66 158.93 21.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.636 1.575 . . . . 0.0 111.375 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.3 mtp -61.85 159.12 14.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -127.85 127.47 43.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.413 1.085 . . . . 0.0 108.632 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.12 94.44 4.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.247 1.019 . . . . 0.0 111.669 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.5 mt -81.01 141.24 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.058 1.743 . . . . 0.0 112.154 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -124.92 103.9 8.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.877 1.271 . . . . 0.0 113.062 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -18.96 47.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.195 1.398 . . . . 0.0 114.403 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.3 p -80.6 -5.63 57.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.581 1.082 . . . . 0.0 113.56 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.13 -24.89 2.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.131 1.372 . . . . 0.0 112.848 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.48 110.44 7.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.876 0.871 . . . . 0.0 113.27 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.65 -1.92 10.76 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.061 3.174 . . . . 0.0 114.159 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -131.41 70.1 81.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.204 1.802 . . . . 0.0 109.291 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.06 -16.5 39.76 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.841 3.694 . . . . 0.0 117.262 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -57.55 -32.34 67.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.988 -1.07 . . . . 0.0 113.217 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -66.18 -6.28 13.0 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -118.91 -0.52 11.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.52 -26.05 1.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.29 -54.31 46.39 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.485 1.039 . . . . 0.0 113.067 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.26 -31.77 34.8 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 121.256 1.484 . . . . 0.0 112.852 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -60.52 -49.51 77.28 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.397 0.679 . . . . 0.0 111.669 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.19 -36.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.715 -0.616 . . . . 0.0 110.451 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.71 -44.31 96.73 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.236 0.926 . . . . 0.0 112.753 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.46 -36.09 58.08 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.995 1.27 . . . . 0.0 113.361 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -57.35 -43.79 83.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.74 1.155 . . . . 0.0 110.437 170.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.76 -13.53 25.55 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.864 -1.52 . . . . 0.0 116.131 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.7 p -107.05 -11.98 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.612 2.206 . . . . 0.0 113.183 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.12 -30.75 31.0 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.22 1.008 . . . . 0.0 111.378 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.23 152.57 20.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.362 1.465 . . . . 0.0 112.566 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.167 2.187 . . . . 0.0 114.006 -179.552 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.11 -175.61 3.22 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.948 1.699 . . . . 0.0 112.084 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -135.28 119.05 17.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.976 1.311 . . . . 0.0 109.754 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mm -118.34 124.96 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.744 0.818 . . . . 0.0 112.825 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.18 126.4 7.82 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 168.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.7 mt -117.54 90.97 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.438 1.095 . . . . 0.0 108.411 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -91.3 144.19 25.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.004 -169.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.4 141.54 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.054 0.942 . . . . 0.0 110.54 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.94 91.22 0.21 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -142.88 164.16 30.85 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.559 1.144 . . . . 0.0 113.155 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.6 mmm -125.77 0.83 7.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.531 1.532 . . . . 0.0 112.888 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -140.25 -37.3 0.47 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.32 -5.52 10.16 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.975 1.15 . . . . 0.0 115.975 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -63.15 -42.83 99.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.528 1.164 . . . . 0.0 111.481 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -39.53 86.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.061 . . . . 0.0 112.515 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 tp -59.72 -39.23 83.97 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.8 tp -49.34 -41.69 39.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.991 0.917 . . . . 0.0 112.177 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.6 -39.93 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 123.249 0.619 . . . . 0.0 112.045 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -41.07 96.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.075 0.852 . . . . 0.0 112.434 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.92 -42.06 97.37 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.35 0.66 . . . . 0.0 112.273 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.49 -43.25 85.89 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.467 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.24 92.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.702 0.801 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.64 -47.84 78.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.368 0.667 . . . . 0.0 111.529 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.77 92.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.71 0.804 . . . . 0.0 112.62 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.58 -47.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.28 . . . . 0.0 112.187 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 mt -70.32 -41.34 73.39 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.242 0.617 . . . . 0.0 109.884 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -56.73 -46.02 81.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.1 1.36 . . . . 0.0 112.24 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.79 90.14 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.169 0.987 . . . . 0.0 112.87 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.59 -32.24 71.99 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.48 4.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.26 1.41 . . . . 0.0 114.983 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.95 146.72 35.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.149 1.379 . . . . 0.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -72.94 138.58 46.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.6 35.25 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.74 -0.6 . . . . 0.0 112.455 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.7 m -144.51 116.25 8.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.238 1.015 . . . . 0.0 110.656 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.47 140.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.106 0.562 . . . . 0.0 110.173 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.76 96.91 4.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.384 1.474 . . . . 0.0 107.899 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.4 -29.81 65.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.768 1.627 . . . . 0.0 114.265 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -146.31 64.53 9.79 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 126.862 2.065 . . . . 0.0 108.734 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.91 163.75 37.84 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.007 3.138 . . . . 0.0 115.727 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 160.67 36.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.339 2.256 . . . . 0.0 108.798 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -32.73 -54.04 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.765 2.026 . . . . 0.0 113.691 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -63.04 -21.63 66.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.493 1.517 . . . . 0.0 114.411 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.68 -36.14 62.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.222 0.919 . . . . 0.0 111.625 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 20.1 t-105 -79.46 -38.52 34.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 112.904 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.1 tp -38.39 -45.84 2.66 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 128.112 2.565 . . . . 0.0 116.784 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.64 -26.04 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 CA-C-N 122.543 1.944 . . . . 0.0 115.133 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -71.91 -8.8 56.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -56.49 -26.29 53.89 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.959 -1.088 . . . . 0.0 113.791 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.73 -8.05 57.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.324 1.449 . . . . 0.0 113.749 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -133.25 -128.61 0.17 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.958 2.103 . . . . 0.0 110.02 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -136.88 160.55 38.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.983 1.713 . . . . 0.0 111.277 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -144.08 170.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.878 1.271 . . . . 0.0 111.052 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -159.16 148.35 18.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.446 1.898 . . . . 0.0 108.174 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.34 142.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.684 -0.635 . . . . 0.0 112.048 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.6 116.2 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.097 0.959 . . . . 0.0 111.529 169.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.9 m -141.88 153.39 44.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 0.0 111.929 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 p -138.7 145.8 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -70.64 146.11 50.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.477 1.911 . . . . 0.0 114.654 -174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 p -146.13 -165.27 2.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.469 2.308 . . . . 0.0 111.375 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 42.76 -99.68 0.01 OUTLIER Glycine 0 CA--C 1.541 1.705 0 C-N-CA 127.545 2.498 . . . . 0.0 116.599 176.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -129.46 36.22 4.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.965 1.306 . . . . 0.0 110.111 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.24 20.96 7.94 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.066 0.841 . . . . 0.0 113.712 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.06 164.89 12.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.342 1.857 . . . . 0.0 115.169 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.59 139.74 96.15 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.734 2.013 . . . . 0.0 110.255 169.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.64 144.59 35.8 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.689 2.926 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.92 -22.39 64.31 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.5 p -63.3 -16.58 60.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.1 tt -124.89 -8.94 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.69 -48.12 77.44 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.8 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.12 5.89 1.65 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.24 2.626 . . . . 0.0 114.817 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.48 -44.98 3.44 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 110.324 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.73 -51.36 70.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.143 0.977 . . . . 0.0 111.679 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -62.87 -41.14 99.28 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 111.859 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -42.89 93.71 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.756 0.693 . . . . 0.0 113.772 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.31 -46.08 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -62.75 -40.77 98.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.54 -25.25 16.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -125.56 -31.47 2.98 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.84 -43.77 62.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.255 1.389 . . . . 0.0 109.391 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.49 -42.18 0.67 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 126.641 2.067 . . . . 0.0 116.679 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -155.14 143.26 20.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.116 1.767 . . . . 0.0 109.703 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -146.22 47.62 0.64 Allowed Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -60.86 -29.88 89.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.139 2.559 . . . . 0.0 113.799 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -65.87 -22.76 66.55 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.407 1.883 . . . . 0.0 114.615 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.8 tp -73.43 138.68 45.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.933 0.788 . . . . 0.0 111.574 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -134.8 132.74 39.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.493 1.917 . . . . 0.0 108.682 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -154.59 -171.56 3.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.59 164.18 30.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.974 1.75 . . . . 0.0 109.513 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 146.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.497 1.142 . . . . 0.0 113.533 -169.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.4 mt -129.83 141.66 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.82 1.648 . . . . 0.0 106.56 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.44 156.36 48.7 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -144.38 149.18 35.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 110.858 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.69 -151.0 9.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 123.654 0.645 . . . . 0.0 111.644 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -137.99 117.35 12.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.999 1.32 . . . . 0.0 109.876 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -59.62 -7.8 1.68 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.995 1.318 . . . . 0.0 114.505 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.0 m -61.32 -10.27 6.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.151 1.38 . . . . 0.0 114.157 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -127.21 137.02 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 111.426 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.57 -26.17 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -81.4 -18.49 45.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.316 0.962 . . . . 0.0 113.285 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.9 t80 38.93 -131.78 0.19 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.748 1.619 . . . . 0.0 112.451 -169.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.4 m -73.58 23.56 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -53.61 -30.42 42.5 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.142 -1.598 . . . . 0.0 114.495 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.1 -35.89 92.56 Favored Glycine 0 CA--C 1.533 1.156 0 O-C-N 121.125 -0.984 . . . . 0.0 113.111 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.32 -40.54 11.13 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.825 -0.809 . . . . 0.0 113.316 173.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.67 -31.9 69.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.67 1.235 . . . . 0.0 113.781 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -58.47 -39.53 80.21 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.16 -27.35 63.48 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.303 0.956 . . . . 0.0 113.33 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.64 -49.66 65.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.766 -1.209 . . . . 0.0 110.053 169.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.31 -40.45 71.15 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -49.89 -27.7 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.82 1.648 . . . . 0.0 113.644 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.6 mt -112.1 -36.67 5.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.609 1.163 . . . . 0.0 111.808 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.76 -31.24 71.75 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.169 -0.957 . . . . 0.0 113.209 170.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -66.25 -14.64 62.27 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 119.419 1.009 . . . . 0.0 112.528 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -111.81 16.84 20.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.641 1.976 . . . . 0.0 111.849 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t 61.97 20.41 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.332 1.853 . . . . 0.0 115.263 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.48 161.07 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.842 0.746 . . . . 0.0 112.972 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -112.09 162.71 15.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.769 1.628 . . . . 0.0 108.645 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mtm105 -133.88 149.05 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.85 21.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.986 172.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.85 -172.35 45.2 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.529 1.538 . . . . 0.0 113.598 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.68 156.26 44.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.282 1.433 . . . . 0.0 111.411 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.85 120.91 14.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.85 0.86 . . . . 0.0 112.098 -170.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.07 135.94 35.88 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.527 1.131 . . . . 0.0 110.074 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.58 96.03 4.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.704 1.202 . . . . 0.0 111.915 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.01 141.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.236 1.415 . . . . 0.0 111.137 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -129.49 116.73 19.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.907 1.283 . . . . 0.0 111.751 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.78 -26.87 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.618 1.167 . . . . 0.0 113.87 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.9 m -81.62 4.78 20.35 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.51 -30.18 2.36 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.371 1.468 . . . . 0.0 112.449 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -143.1 118.48 6.45 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 124.619 1.168 . . . . 0.0 112.278 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.32 -6.2 13.72 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.86 3.04 . . . . 0.0 114.498 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.98 80.58 64.58 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.529 1.532 . . . . 0.0 111.198 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.97 -35.04 9.65 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.712 4.275 . . . . 0.0 116.711 -175.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.67 -38.47 64.2 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.6 p -69.46 -6.14 28.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -116.38 -3.55 11.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.001 1.321 . . . . 0.0 112.554 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 p -132.95 -27.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -170.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -55.44 -54.09 54.92 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.254 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.5 -29.37 53.13 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.598 1.532 . . . . 0.0 112.756 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -62.49 -49.15 76.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.387 0.675 . . . . 0.0 111.442 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.89 -41.04 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.816 0.735 . . . . 0.0 110.506 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -59.03 -45.21 91.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.462 0.573 . . . . 0.0 111.541 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -61.96 -56.05 23.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.087 0.955 . . . . 0.0 112.138 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.38 -49.04 65.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.76 1.224 . . . . 0.0 111.172 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.96 -21.83 32.39 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.582 1.563 . . . . 0.0 116.165 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -70.53 -17.42 62.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.491 2.146 . . . . 0.0 113.737 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.47 -14.43 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.251 1.42 . . . . 0.0 113.578 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.2 157.67 18.79 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.412 1.885 . . . . 0.0 112.367 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.899 1.28 . . . . 0.0 113.651 177.437 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.0 -177.83 4.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.843 1.657 . . . . 0.0 112.277 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -135.14 119.37 17.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.618 1.567 . . . . 0.0 109.13 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.08 125.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.871 0.868 . . . . 0.0 113.267 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.6 128.6 8.97 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 mt -118.31 91.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.541 1.136 . . . . 0.0 108.519 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -90.93 139.1 31.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.274 1.029 . . . . 0.0 111.698 -169.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -125.47 144.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.713 0.768 . . . . 0.0 111.502 -169.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 105.88 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 t -155.9 161.45 40.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.385 1.474 . . . . 0.0 113.153 -173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.5 mmm -122.96 -9.28 8.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.438 1.495 . . . . 0.0 112.397 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -138.99 0.18 1.93 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.5 -4.39 83.95 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.117 1.607 . . . . 0.0 117.117 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -64.62 -42.87 95.21 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.475 1.637 . . . . 0.0 113.097 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 p -75.46 -33.9 60.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.085 0.954 . . . . 0.0 112.385 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 tp -58.43 -38.76 78.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.995 -1.065 . . . . 0.0 112.771 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -53.88 -45.68 71.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.759 0.709 . . . . 0.0 111.71 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.21 -36.9 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 111.545 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.41 92.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.261 0.937 . . . . 0.0 112.968 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.45 -41.76 97.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.356 0.662 . . . . 0.0 112.184 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.06 -41.72 97.25 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.648 -0.657 . . . . 0.0 112.562 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.528 -0.732 . . . . 0.0 112.061 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.81 -46.83 77.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.677 0.791 . . . . 0.0 111.825 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.48 95.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.742 0.817 . . . . 0.0 112.77 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.95 -43.19 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.547 1.139 . . . . 0.0 112.262 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.27 -38.71 75.15 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.21 -0.932 . . . . 0.0 109.614 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -57.64 -45.47 85.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.251 1.021 . . . . 0.0 111.516 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.14 83.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.991 0.916 . . . . 0.0 113.296 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -69.8 -10.48 58.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.29 41.43 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.574 1.559 . . . . 0.0 114.729 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -73.03 175.36 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.289 1.435 . . . . 0.0 111.894 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -111.62 145.51 39.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.812 1.245 . . . . 0.0 109.622 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 162.67 38.81 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.2 m -153.31 120.36 5.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.111 0.964 . . . . 0.0 110.948 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.3 141.16 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.906 0.882 . . . . 0.0 110.924 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -126.67 111.12 13.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.221 1.408 . . . . 0.0 109.789 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 -16.46 23.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.461 1.504 . . . . 0.0 114.945 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -142.43 55.9 4.82 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.22 1.408 . . . . 0.0 111.068 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.37 163.15 39.81 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.977 3.118 . . . . 0.0 113.517 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -143.34 -44.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.84 -44.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.273 1.029 . . . . 0.0 113.105 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 m -58.76 -28.79 66.24 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.923 0.868 . . . . 0.0 112.257 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -54.83 40.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.948 2.899 . . . . 0.0 112.461 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -68.62 -40.89 80.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.572 1.549 . . . . 0.0 113.748 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -37.97 -56.45 1.94 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.672 2.389 . . . . 0.0 115.28 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.54 -18.72 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.594 2.196 . . . . 0.0 114.867 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.58 -5.95 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -54.88 -30.58 58.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.343 0.974 . . . . 0.0 113.158 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -86.23 4.21 39.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.378 1.471 . . . . 0.0 113.492 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -136.33 -136.27 0.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.438 1.895 . . . . 0.0 110.997 -169.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -130.1 160.47 33.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 110.642 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.89 169.55 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.303 1.441 . . . . 0.0 110.367 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.55 147.46 18.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 109.932 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.38 131.14 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.197 1.399 . . . . 0.0 109.561 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.07 86.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.5 m -126.52 164.17 21.77 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -167.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -129.34 -172.33 2.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.748 1.219 . . . . 0.0 113.216 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 m -136.61 132.08 34.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.652 1.181 . . . . 0.0 110.519 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.5 t -158.71 -166.58 1.92 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.396 1.478 . . . . 0.0 110.33 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.01 -65.4 0.2 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.825 2.631 . . . . 0.0 116.474 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -147.42 22.22 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.034 2.134 . . . . 0.0 111.523 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.21 44.36 6.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 -169.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -139.53 -179.52 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.283 1.433 . . . . 0.0 114.475 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.5 mt -53.46 125.71 44.93 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 126.783 2.033 . . . . 0.0 112.681 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.51 142.72 98.3 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.681 3.587 . . . . 0.0 112.136 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.12 -20.14 65.76 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 p -66.07 -11.55 49.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.76 1.624 . . . . 0.0 114.959 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.3 tt -131.58 -13.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -44.81 -49.33 28.05 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.449 -1.263 . . . . 0.0 112.995 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.37 -24.96 42.54 Favored 'Trans proline' 0 C--N 1.353 0.769 0 CA-C-N 122.155 1.805 . . . . 0.0 113.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.3 tp -75.86 -43.03 47.68 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.835 0.743 . . . . 0.0 110.062 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.86 -46.48 90.42 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.294 1.038 . . . . 0.0 111.091 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -63.7 -43.27 97.12 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.712 -1.243 . . . . 0.0 112.543 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.48 -50.18 66.95 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.688 1.137 . . . . 0.0 112.74 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.02 -46.42 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.567 1.183 . . . . 0.0 110.265 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.07 -46.72 84.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.636 1.174 . . . . 0.0 112.751 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.09 -33.51 20.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -98.59 -30.97 12.18 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.94 -32.96 11.4 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.232 0.924 . . . . 0.0 113.279 -170.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.14 -51.77 1.0 Allowed Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.39 1.947 . . . . 0.0 117.007 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -159.86 140.96 12.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -156.19 104.94 2.06 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.5 1.52 . . . . 0.0 110.298 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.1 -15.45 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.307 2.671 . . . . 0.0 116.074 -169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -124.35 1.8 8.41 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.8 tp -69.49 137.56 52.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.562 0.745 . . . . 0.0 109.811 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -128.93 143.71 50.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.592 1.557 . . . . 0.0 110.748 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.33 -170.6 2.87 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -168.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.31 162.55 31.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 127.41 2.433 . . . . 0.0 109.914 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.7 t -139.87 136.82 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.061 0.934 . . . . 0.0 112.238 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.8 mt -123.18 125.08 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.2 148.98 42.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.717 1.207 . . . . 0.0 109.598 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.07 146.42 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 111.687 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.44 -137.45 3.95 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.018 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 131.99 28.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.726 0.811 . . . . 0.0 112.091 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.4 t -64.44 -10.86 27.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.921 1.689 . . . . 0.0 114.869 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -69.41 5.4 1.35 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -131.69 154.77 48.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.664 1.585 . . . . 0.0 112.833 -171.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.65 -6.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.789 1.636 . . . . 0.0 114.835 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -125.86 44.8 2.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.731 2.012 . . . . 0.0 110.945 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -49.48 115.29 1.28 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.095 -1.628 . . . . 0.0 112.17 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.9 m 53.33 23.39 3.25 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -58.23 -27.24 63.77 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.82 63.59 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.62 -1.3 . . . . 0.0 111.912 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.66 70.7 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.43 -1.041 . . . . 0.0 113.127 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.38 -41.96 90.56 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 117.821 0.81 . . . . 0.0 112.858 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.04 -41.39 92.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.184 0.447 . . . . 0.0 112.147 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -69.5 -28.49 66.1 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.67 -46.06 66.95 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 119.807 -1.808 . . . . 0.0 110.807 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.88 68.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.7 tp -49.66 -31.07 10.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.019 1.728 . . . . 0.0 113.124 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.1 -36.97 8.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.561 1.144 . . . . 0.0 111.399 -171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -66.27 -31.16 71.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.53 -0.731 . . . . 0.0 112.826 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.65 -15.97 63.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.374 1.07 . . . . 0.0 112.942 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -113.26 -9.67 13.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.9 t 98.75 15.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.229 2.611 . . . . 0.0 113.922 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.83 161.17 8.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.222 0.465 . . . . 0.0 110.716 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.61 100.14 5.42 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.838 -1.164 . . . . 0.0 110.566 -171.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttm105 -66.93 135.7 54.23 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.407 -0.808 . . . . 0.0 110.83 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.08 34.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 111.318 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.51 -166.61 39.83 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.776 -1.202 . . . . 0.0 113.75 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.19 145.61 42.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.448 1.499 . . . . 0.0 111.974 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.16 118.08 10.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.149 0.979 . . . . 0.0 111.705 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.79 136.06 38.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.939 0.896 . . . . 0.0 109.881 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.6 mt -120.65 95.85 4.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.774 1.229 . . . . 0.0 111.775 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mt -81.4 134.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.242 1.417 . . . . 0.0 111.226 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -123.94 112.29 17.05 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.389 1.475 . . . . 0.0 111.477 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.94 -23.7 54.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.0 m -82.83 2.11 35.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.446 1.098 . . . . 0.0 113.893 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.11 -27.29 3.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.417 1.487 . . . . 0.0 112.664 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.94 115.28 6.59 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.582 1.153 . . . . 0.0 112.097 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.81 -5.29 14.59 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.682 2.921 . . . . 0.0 114.413 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -131.51 80.64 66.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.611 1.564 . . . . 0.0 111.283 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -43.68 -37.58 8.5 Favored 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 125.668 4.246 . . . . 0.0 116.056 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -45.97 -44.22 14.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.441 1.896 . . . . 0.0 113.214 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.6 p -71.25 -10.01 59.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -116.45 4.34 13.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.001 1.32 . . . . 0.0 112.423 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 p -132.31 -27.51 1.77 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -61.37 -53.68 60.08 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 119.766 1.166 . . . . 0.0 112.9 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.1 -35.6 95.15 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.565 2.177 . . . . 0.0 114.032 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -60.72 -48.03 83.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.647 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.37 -40.08 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.959 0.8 . . . . 0.0 110.774 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.36 -43.56 88.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.662 0.665 . . . . 0.0 111.311 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.24 -55.73 16.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.773 1.229 . . . . 0.0 112.393 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -53.31 -46.9 69.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.034 0.934 . . . . 0.0 111.348 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.81 -27.18 6.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.406 1.955 . . . . 0.0 116.361 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -71.94 -19.32 61.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.995 1.897 . . . . 0.0 113.824 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 -14.7 26.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.436 1.494 . . . . 0.0 113.255 -171.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.05 160.85 17.18 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.897 2.079 . . . . 0.0 112.354 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.251 1.02 . . . . 0.0 112.895 169.867 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.69 171.32 14.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -135.31 117.46 15.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.005 1.722 . . . . 0.0 108.527 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mm -118.9 121.4 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.007 0.821 . . . . 0.0 113.143 -172.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.87 127.41 8.27 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.18 91.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.471 1.135 . . . . 0.0 108.512 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -93.81 136.03 34.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.084 0.954 . . . . 0.0 110.948 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.73 145.26 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.611 0.764 . . . . 0.0 111.52 -169.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.6 90.24 0.22 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 125.034 1.302 . . . . 0.0 110.645 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -140.96 178.37 7.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -169.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -147.98 -21.71 0.35 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.812 2.045 . . . . 0.0 112.754 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.52 -2.49 7.94 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.91 1.21 73.55 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -64.07 -44.95 90.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.849 1.324 . . . . 0.0 112.376 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -73.64 -33.23 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.241 1.416 . . . . 0.0 112.561 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.92 -38.91 80.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.879 -1.138 . . . . 0.0 112.977 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.6 -45.08 73.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.83 0.741 . . . . 0.0 111.734 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -63.82 -36.91 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 111.594 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.73 -43.11 97.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.121 0.873 . . . . 0.0 112.623 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.26 -42.89 99.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.495 0.718 . . . . 0.0 112.578 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -62.72 -40.88 98.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.554 -0.716 . . . . 0.0 112.672 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.19 82.49 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.735 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.57 -46.02 73.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.405 0.682 . . . . 0.0 111.483 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.83 83.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.552 0.741 . . . . 0.0 112.785 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -59.33 -45.14 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.702 1.201 . . . . 0.0 112.068 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.0 mt -70.7 -41.57 71.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.636 -0.665 . . . . 0.0 109.664 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -56.93 -44.19 82.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.25 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -37.67 82.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.011 0.924 . . . . 0.0 113.016 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.522 0.729 . . . . 0.0 112.501 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.16 -9.72 7.86 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.013 1.768 . . . . 0.0 114.445 169.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -72.7 147.54 45.57 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.371 1.069 . . . . 0.0 111.734 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -72.13 140.44 48.85 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.75 159.71 42.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.282 0.633 . . . . 0.0 112.16 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.3 m -153.49 118.43 5.07 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.249 -0.907 . . . . 0.0 111.425 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -74.12 141.31 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.923 0.889 . . . . 0.0 111.014 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -128.88 109.21 11.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.835 1.254 . . . . 0.0 109.635 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.26 -19.36 34.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.614 1.565 . . . . 0.0 114.823 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.2 58.99 5.58 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.922 1.689 . . . . 0.0 109.835 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.1 159.54 53.47 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.115 3.21 . . . . 0.0 115.474 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -138.1 167.33 22.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.193 2.197 . . . . 0.0 109.411 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.41 -45.54 18.05 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.714 1.206 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -59.27 -18.51 38.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -80.27 -34.4 37.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.608 1.095 . . . . 0.0 112.334 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 33.9 t-105 -77.22 -35.98 55.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 112.781 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -41.45 -45.85 7.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 128.609 2.764 . . . . 0.0 115.944 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.68 -26.44 5.71 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.668 2.246 . . . . 0.0 114.527 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -82.76 -13.79 55.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -59.17 -26.35 64.71 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.41 7.2 26.72 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -134.08 -117.31 0.19 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.213 1.805 . . . . 0.0 110.682 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.89 154.7 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.41 1.084 . . . . 0.0 111.151 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.2 m -149.23 169.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 110.988 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.33 146.95 17.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.097 0.959 . . . . 0.0 110.358 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.11 133.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.17 1.388 . . . . 0.0 110.139 -169.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.38 89.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 107.717 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.2 m -131.48 164.83 24.89 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -167.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -136.68 -173.09 3.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.616 1.566 . . . . 0.0 112.793 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.5 m -129.71 146.44 51.48 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.136 0.974 . . . . 0.0 111.201 -171.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.6 t -149.96 -169.62 3.43 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.183 2.593 . . . . 0.0 108.765 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.02 35.37 13.22 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.784 1.659 . . . . 0.0 116.141 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 67.89 6.77 5.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.072 2.149 . . . . 0.0 114.911 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 158.07 18.21 0.03 OUTLIER Glycine 0 CA--C 1.534 1.235 0 N-CA-C 119.368 2.507 . . . . 0.0 119.368 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 159.31 34.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.579 2.19 . . . . 0.0 112.443 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.95 150.63 87.6 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.275 -0.891 . . . . 0.0 112.935 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 162.61 19.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.87 3.047 . . . . 0.0 112.592 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.16 -17.85 64.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -171.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.5 p -60.3 -18.72 51.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.0 -9.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -45.65 -48.35 37.89 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.489 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.11 -23.3 33.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 122.199 1.821 . . . . 0.0 113.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 tp -76.03 -48.67 20.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 110.097 173.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.35 -49.58 76.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.825 1.65 . . . . 0.0 111.942 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -64.56 -45.13 88.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.235 -0.916 . . . . 0.0 111.851 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.89 -43.53 97.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.254 0.931 . . . . 0.0 114.278 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.72 -46.96 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.413 1.107 . . . . 0.0 110.402 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.69 -48.02 82.68 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.856 -0.527 . . . . 0.0 111.807 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.13 -41.26 61.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.084 1.353 . . . . 0.0 114.378 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -122.29 5.06 9.71 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -168.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -122.34 -49.65 2.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.54 1.064 . . . . 0.0 110.137 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -31.35 0.29 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.696 2.093 . . . . 0.0 117.984 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -154.71 138.77 16.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.197 1.499 . . . . 0.0 112.36 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -158.18 118.24 1.88 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.225 1.41 . . . . 0.0 110.926 169.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -87.45 -30.74 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.181 2.587 . . . . 0.0 115.806 -171.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -100.39 1.58 41.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.01 135.9 41.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.387 1.075 . . . . 0.0 111.388 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -123.64 143.38 50.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.009 1.723 . . . . 0.0 111.04 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.17 -173.84 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 162.48 32.04 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.151 2.31 . . . . 0.0 110.676 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.87 130.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.916 0.865 . . . . 0.0 111.701 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 mt -119.07 125.58 74.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 169.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.29 149.95 40.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.79 0.836 . . . . 0.0 109.728 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -140.36 138.81 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.645 0.778 . . . . 0.0 110.933 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.31 -131.12 1.63 Allowed Glycine 0 CA--C 1.521 0.463 0 O-C-N 122.253 -0.279 . . . . 0.0 113.533 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -141.07 119.48 12.25 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 111.149 -172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -64.16 -6.08 6.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.0 m -65.31 0.08 1.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -134.93 154.58 51.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.722 1.609 . . . . 0.0 112.33 -173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.803 0.841 . . . . 0.0 111.948 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.75 40.7 0.53 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.773 1.229 . . . . 0.0 112.557 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -51.16 115.06 1.38 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.393 -1.442 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m 50.85 26.07 2.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.02 -30.3 69.07 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.497 -1.377 . . . . 0.0 113.117 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -37.62 94.34 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.678 0.672 . . . . 0.0 113.527 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.82 56.29 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.136 -1.214 . . . . 0.0 112.642 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.83 -36.79 82.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.051 0.94 . . . . 0.0 113.032 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.67 -38.16 74.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.141 0.976 . . . . 0.0 112.373 170.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -78.37 -35.54 47.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.677 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.19 -41.06 96.14 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 119.676 -1.89 . . . . 0.0 111.822 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.45 79.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.07 -46.46 68.59 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.454 1.024 . . . . 0.0 111.34 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.4 mt -76.31 -37.23 57.73 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.124 0.969 . . . . 0.0 112.331 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.7 -32.48 74.06 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.471 -0.768 . . . . 0.0 112.333 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.84 -25.48 65.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.701 0.682 . . . . 0.0 111.8 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -76.49 -32.26 58.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.458 1.026 . . . . 0.0 111.477 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m 99.64 15.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.305 3.042 . . . . 0.0 112.198 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.71 162.54 6.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.229 0.612 . . . . 0.0 111.267 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -131.61 104.8 7.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.175 0.99 . . . . 0.0 110.602 -169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -69.63 134.67 49.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.279 -0.888 . . . . 0.0 111.439 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.48 31.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.615 1.566 . . . . 0.0 112.104 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.25 -165.32 38.7 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.954 -1.091 . . . . 0.0 114.37 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.63 151.6 38.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.785 1.634 . . . . 0.0 110.991 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 29.8 ttm -69.3 132.5 46.54 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.64 0.776 . . . . 0.0 112.01 -170.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.97 134.11 33.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.356 0.662 . . . . 0.0 109.474 171.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.1 mt -121.36 93.47 4.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.921 1.288 . . . . 0.0 111.675 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 51.0 mt -75.55 136.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.383 1.473 . . . . 0.0 110.524 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -129.18 110.23 11.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.32 1.048 . . . . 0.0 112.458 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.2 -25.16 58.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.6 m -82.95 4.95 23.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 113.689 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -133.39 -29.98 1.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.132 1.373 . . . . 0.0 113.014 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -142.94 116.84 6.24 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.537 1.135 . . . . 0.0 112.393 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.68 -3.71 11.94 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.103 3.202 . . . . 0.0 114.75 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.34 86.1 58.8 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.528 1.531 . . . . 0.0 110.49 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.28 -26.85 71.78 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.952 2.434 . . . . 0.0 114.383 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.2 -39.14 93.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -12.42 56.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.265 -0.897 . . . . 0.0 112.718 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.06 -0.68 14.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.267 1.827 . . . . 0.0 111.751 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 p -135.2 -24.24 1.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.52 1.128 . . . . 0.0 113.955 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -62.66 -52.82 62.05 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -57.85 -34.58 98.48 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.652 2.234 . . . . 0.0 113.932 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -59.94 -48.6 81.06 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.157 0.583 . . . . 0.0 111.261 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.08 -39.33 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.096 0.862 . . . . 0.0 110.891 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.64 -46.37 90.58 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.661 1.119 . . . . 0.0 111.923 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -63.28 -51.06 67.66 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.024 0.93 . . . . 0.0 112.352 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -58.23 -54.79 42.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.869 0.867 . . . . 0.0 110.623 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.26 -29.66 53.22 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.254 1.883 . . . . 0.0 114.767 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 94.2 m -59.2 -23.18 62.06 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.292 1.037 . . . . 0.0 113.238 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.92 -15.67 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.346 1.458 . . . . 0.0 114.689 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -30.78 70.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.545 1.138 . . . . 0.0 114.044 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.773 2.029 . . . . 0.0 111.685 175.8 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.86 169.37 15.84 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.558 1.543 . . . . 0.0 112.292 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.13 121.0 33.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.402 1.481 . . . . 0.0 109.383 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mm -113.05 121.51 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.106 0.962 . . . . 0.0 112.036 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 126.38 7.48 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.4 mt -118.56 108.72 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 108.876 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.07 109.71 21.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.751 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -87.48 147.34 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.774 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.93 114.55 1.21 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -160.9 175.76 12.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.596 1.558 . . . . 0.0 111.309 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ptp -132.61 4.17 3.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -146.71 -54.13 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.656 1.182 . . . . 0.0 112.887 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.35 7.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 118.097 1.999 . . . . 0.0 118.097 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -63.85 -40.02 95.6 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.515 2.158 . . . . 0.0 112.743 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 91.7 p -79.69 -33.97 40.6 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.881 0.872 . . . . 0.0 112.502 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 tp -56.49 -38.49 71.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.054 -1.029 . . . . 0.0 112.719 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.61 -42.91 75.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.698 0.799 . . . . 0.0 111.682 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.41 -37.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 111.651 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.86 -44.25 86.46 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.935 0.789 . . . . 0.0 112.493 173.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.74 -43.36 99.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.073 0.949 . . . . 0.0 112.168 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.41 -48.2 81.46 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.598 -0.688 . . . . 0.0 112.395 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.48 89.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.627 0.771 . . . . 0.0 112.334 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.6 -44.97 85.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.525 0.73 . . . . 0.0 111.792 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -44.99 88.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.716 0.806 . . . . 0.0 112.674 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.5 mt -61.07 -45.61 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.841 1.256 . . . . 0.0 112.216 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.28 -43.23 82.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.374 0.67 . . . . 0.0 109.377 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.7 m -55.24 -47.52 75.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.631 1.173 . . . . 0.0 112.055 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.67 85.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.086 0.955 . . . . 0.0 113.451 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -72.92 -11.14 60.47 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -4.41 42.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.343 1.449 . . . . 0.0 114.524 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -72.86 178.35 4.29 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.16 1.384 . . . . 0.0 111.862 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -118.19 145.26 45.09 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.957 1.703 . . . . 0.0 109.519 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.55 155.03 41.45 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.444 -0.785 . . . . 0.0 112.623 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.3 m -143.42 100.65 3.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.019 0.927 . . . . 0.0 111.042 -172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.48 137.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.154 0.982 . . . . 0.0 111.21 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -126.0 111.1 14.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.853 1.661 . . . . 0.0 109.271 170.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.28 -20.91 43.34 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -146.45 60.07 5.81 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 126.249 1.82 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.48 160.34 49.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.274 2.649 . . . . 0.0 114.651 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -135.89 164.07 28.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.341 2.256 . . . . 0.0 108.899 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -39.08 -48.01 1.61 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.497 1.519 . . . . 0.0 113.572 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 p -58.82 -18.12 29.63 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.07 -31.8 25.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.331 1.052 . . . . 0.0 112.541 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.403 ' CH2' HG22 ' A' ' 52' ' ' VAL . 23.6 t-105 -81.51 -36.87 28.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.349 1.06 . . . . 0.0 112.641 174.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -36.63 -52.28 1.89 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.456 2.302 . . . . 0.0 114.638 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.98 6.07 5.53 Favored 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 123.09 2.527 . . . . 0.0 116.029 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -107.31 2.81 24.8 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.246 1.384 . . . . 0.0 114.64 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -58.59 -25.88 63.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -99.19 9.42 43.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.681 1.592 . . . . 0.0 113.621 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -135.33 -160.68 1.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.694 2.398 . . . . 0.0 110.326 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -111.54 159.01 18.52 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.21 1.005 . . . . 0.0 111.85 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG22 ' CH2' ' A' ' 44' ' ' TRP . 28.4 m -148.51 173.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.409 1.484 . . . . 0.0 111.537 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.51 142.44 15.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.591 1.156 . . . . 0.0 111.379 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.42 130.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.191 1.797 . . . . 0.0 109.609 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 p -140.34 89.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 122.091 0.948 . . . . 0.0 109.504 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.7 m -133.83 133.71 41.94 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -167.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 m -78.84 -166.97 0.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.935 1.694 . . . . 0.0 112.722 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -131.39 152.91 50.21 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.688 -1.257 . . . . 0.0 111.286 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 p -142.96 -167.07 2.44 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.593 2.357 . . . . 0.0 109.198 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 37.89 40.25 0.75 Allowed Glycine 0 CA--C 1.542 1.746 0 C-N-CA 127.05 2.262 . . . . 0.0 118.466 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 58.16 20.18 6.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 114.519 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.13 36.13 0.09 OUTLIER Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -126.51 169.72 12.76 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.509 1.654 . . . . 0.0 114.691 -169.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 mt -60.72 126.29 84.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.707 2.403 . . . . 0.0 112.008 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.16 142.65 97.27 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.502 2.801 . . . . 0.0 111.335 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.62 -29.26 69.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 m -67.21 -9.55 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -118.18 -7.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.768 1.167 . . . . 0.0 113.243 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.9 t -54.63 -45.82 99.43 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.144 -1.407 . . . . 0.0 112.342 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -55.88 -11.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.216 3.277 . . . . 0.0 116.549 169.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 tp -105.3 -44.22 4.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.405 1.082 . . . . 0.0 110.403 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -58.3 -49.22 77.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 111.47 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -62.4 -42.69 99.62 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.539 -0.726 . . . . 0.0 112.332 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.27 -40.27 70.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.248 0.928 . . . . 0.0 113.585 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.63 -45.61 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.463 1.131 . . . . 0.0 110.063 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.27 -47.21 86.23 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.487 0.715 . . . . 0.0 112.376 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -79.02 -38.2 37.2 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 m -126.06 -10.06 6.53 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -168.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 -33.28 16.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.15 1.795 . . . . 0.0 112.279 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 -55.32 1.53 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.288 1.899 . . . . 0.0 116.802 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -151.76 149.55 29.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.03 1.732 . . . . 0.0 111.383 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -148.76 38.53 0.19 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.82 -33.52 14.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.815 2.344 . . . . 0.0 115.656 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -68.67 -0.37 5.16 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.545 2.338 . . . . 0.0 116.284 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.19 142.75 49.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.961 1.304 . . . . 0.0 112.251 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.7 145.26 51.54 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.054 2.142 . . . . 0.0 110.451 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.48 -169.09 2.33 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.75 167.36 31.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.015 2.245 . . . . 0.0 110.116 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.19 126.69 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 118.391 1.095 . . . . 0.0 112.978 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -114.0 109.86 30.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 168.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.39 142.51 32.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.416 0.686 . . . . 0.0 109.27 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.1 154.6 47.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.112 0.958 . . . . 0.0 110.716 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.7 -129.12 1.86 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.922 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.44 128.13 14.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.547 1.139 . . . . 0.0 111.165 -173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.5 p -72.5 -1.6 16.49 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 m -67.74 4.13 1.22 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.42 156.26 47.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.147 1.779 . . . . 0.0 111.557 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.49 -37.33 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.732 0.813 . . . . 0.0 111.843 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.63 44.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 112.966 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -53.1 113.63 1.18 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.673 -1.267 . . . . 0.0 111.846 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.7 m 50.21 27.7 2.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.122 2.569 . . . . 0.0 116.312 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -58.85 -28.62 66.25 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.896 -1.128 . . . . 0.0 113.498 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.16 -33.49 64.91 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.771 0.7 . . . . 0.0 113.803 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.1 -36.78 9.67 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 117.908 0.854 . . . . 0.0 113.47 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -59.21 -36.79 76.03 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.828 1.314 . . . . 0.0 113.113 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -54.84 -45.74 74.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.927 0.891 . . . . 0.0 111.424 170.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.63 -27.56 62.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.461 -0.775 . . . . 0.0 112.949 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.5 -44.0 75.65 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.674 -1.891 . . . . 0.0 110.781 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.94 77.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.728 0.811 . . . . 0.0 112.979 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.3 tp -51.12 -32.43 22.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 112.847 171.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -97.95 -39.08 9.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.898 1.279 . . . . 0.0 111.857 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -69.17 -33.47 73.44 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.2 -0.938 . . . . 0.0 113.162 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.95 -12.99 56.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.769 0.828 . . . . 0.0 112.296 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.48 10.86 18.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.015 1.726 . . . . 0.0 112.459 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m 69.51 17.86 7.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 171.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.99 165.82 3.08 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.441 -0.787 . . . . 0.0 110.853 169.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -128.03 94.51 3.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.665 -1.272 . . . . 0.0 112.419 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -66.52 132.75 48.92 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.926 -1.109 . . . . 0.0 111.133 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.93 36.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.749 1.62 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.67 40.79 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.676 -1.265 . . . . 0.0 114.331 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.89 153.12 27.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.792 1.637 . . . . 0.0 111.366 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 30.3 ttm -71.07 138.08 49.47 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -94.95 135.44 36.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.92 0.888 . . . . 0.0 109.027 172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.8 mt -120.75 93.85 4.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.522 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.14 136.58 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.933 0.893 . . . . 0.0 111.199 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -125.3 100.32 6.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 112.488 -171.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.56 -17.32 13.43 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 114.451 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 p -72.17 -15.0 61.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.542 1.064 . . . . 0.0 113.769 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.61 -10.15 1.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -134.7 103.29 11.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.483 1.038 . . . . 0.0 112.418 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.38 1.47 9.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.046 3.164 . . . . 0.0 114.474 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -131.19 74.86 78.81 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.801 1.64 . . . . 0.0 111.022 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.56 -29.01 13.1 Favored 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 125.442 4.094 . . . . 0.0 117.148 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.4 -39.36 67.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.8 p -68.42 -5.88 21.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.698 1.199 . . . . 0.0 113.443 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -113.94 -7.73 13.14 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.691 1.597 . . . . 0.0 112.077 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.5 p -134.66 -25.43 1.46 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.14 -53.44 58.71 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 119.708 1.14 . . . . 0.0 113.723 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.09 -27.96 29.04 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.538 1.492 . . . . 0.0 112.865 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -63.13 -48.8 76.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.493 0.717 . . . . 0.0 111.608 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.49 -39.52 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.43 0.559 . . . . 0.0 110.198 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -59.21 -44.49 92.27 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.603 0.638 . . . . 0.0 111.644 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.61 -57.01 12.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -53.51 -46.38 70.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.054 0.942 . . . . 0.0 111.238 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.84 -24.81 14.39 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.361 1.934 . . . . 0.0 116.447 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.0 p -70.87 -19.72 62.6 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.118 1.959 . . . . 0.0 113.938 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.4 mt -93.08 -15.27 26.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.482 1.513 . . . . 0.0 113.066 -171.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 162.85 14.83 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.526 1.93 . . . . 0.0 112.458 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.665 1.186 . . . . 0.0 113.387 173.252 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.27 -176.63 3.41 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.119 1.767 . . . . 0.0 112.906 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -136.52 116.18 12.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.513 1.525 . . . . 0.0 109.26 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.21 128.75 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.526 1.131 . . . . 0.0 113.11 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.15 130.21 10.22 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -120.8 101.57 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.541 1.17 . . . . 0.0 108.323 -170.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -100.77 118.01 36.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.946 0.899 . . . . 0.0 112.667 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.1 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.864 1.266 . . . . 0.0 110.985 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.35 98.95 0.27 Allowed Glycine 0 N--CA 1.47 0.927 0 C-N-CA 124.355 0.978 . . . . 0.0 110.929 171.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -154.31 166.89 31.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.18 0.992 . . . . 0.0 113.551 -171.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.0 mmm -123.81 -3.28 8.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 113.043 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.29 -58.99 0.54 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.36 -4.79 0.23 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -61.72 -44.44 96.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.285 1.542 . . . . 0.0 113.251 -173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.9 p -77.62 -31.9 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.652 0.781 . . . . 0.0 112.369 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -57.58 -41.87 82.02 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.903 -1.123 . . . . 0.0 112.414 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.91 -43.56 77.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.722 0.692 . . . . 0.0 111.679 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -39.08 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.116 0.566 . . . . 0.0 111.823 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.36 -45.13 95.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.831 0.852 . . . . 0.0 111.963 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.38 -44.2 95.87 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.627 0.771 . . . . 0.0 112.58 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.36 89.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.527 0.731 . . . . 0.0 112.11 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -56.35 -46.78 79.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.938 0.495 . . . . 0.0 111.199 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.09 85.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.839 0.856 . . . . 0.0 113.029 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.73 -46.16 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.418 1.087 . . . . 0.0 111.789 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 mt -70.07 -41.01 74.69 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.82 -0.55 . . . . 0.0 109.996 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.8 m -56.2 -46.12 79.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 112.21 169.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.38 83.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.203 1.001 . . . . 0.0 112.929 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.4 -9.75 58.92 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.307 1.043 . . . . 0.0 113.311 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -11.06 48.87 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.792 1.663 . . . . 0.0 114.587 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -70.26 140.29 52.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.015 0.926 . . . . 0.0 110.655 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -67.94 134.35 50.63 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.01 141.61 30.23 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.208 0.458 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -139.42 115.88 10.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.035 0.934 . . . . 0.0 110.026 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.59 147.27 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.699 0.8 . . . . 0.0 111.921 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.07 103.53 5.83 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.359 1.863 . . . . 0.0 107.651 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.58 -27.9 60.69 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -144.95 64.21 10.97 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.379 1.872 . . . . 0.0 109.009 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.8 160.72 40.36 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.67 2.913 . . . . 0.0 115.188 -168.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 173.51 11.6 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.302 1.841 . . . . 0.0 109.76 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -40.82 -50.74 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.098 1.359 . . . . 0.0 113.182 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 m -62.01 -18.01 59.12 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -81.64 -35.51 29.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.377 0.99 . . . . 0.0 112.122 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -77.73 -35.42 51.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 173.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -40.95 -44.76 5.58 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 127.64 2.376 . . . . 0.0 115.938 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.95 -31.87 23.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.177 2.585 . . . . 0.0 115.471 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -82.08 -4.92 57.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.96 -23.51 46.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -97.27 8.48 44.47 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.646 1.578 . . . . 0.0 112.84 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -132.15 -135.09 0.19 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.741 2.416 . . . . 0.0 109.123 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -133.93 161.35 35.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.605 1.562 . . . . 0.0 109.775 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -148.36 167.31 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.574 1.15 . . . . 0.0 111.204 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.29 139.19 14.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.318 1.056 . . . . 0.0 110.991 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -105.27 132.22 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.0 1.72 . . . . 0.0 109.685 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.83 88.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 122.753 1.264 . . . . 0.0 108.062 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.6 m -129.95 163.88 25.44 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.712 1.205 . . . . 0.0 113.027 -167.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.2 p -128.07 -173.23 2.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.335 1.454 . . . . 0.0 112.782 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -134.77 132.55 38.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.674 1.189 . . . . 0.0 110.081 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.4 t -158.86 -166.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.183 1.393 . . . . 0.0 110.098 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.59 -64.77 0.11 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.104 2.764 . . . . 0.0 116.378 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.6 21.67 1.03 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.073 2.149 . . . . 0.0 111.842 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.83 43.91 6.6 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -138.88 -178.79 5.48 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.937 1.695 . . . . 0.0 114.029 -168.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.71 130.89 78.06 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.301 1.84 . . . . 0.0 113.012 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -60.8 140.41 90.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.249 3.299 . . . . 0.0 111.118 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.21 -26.88 66.72 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.406 -0.809 . . . . 0.0 113.144 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -64.41 -8.95 15.17 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 tt -125.99 -9.26 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.22 -46.9 83.23 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 117.146 -1.407 . . . . 0.0 112.751 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.83 3.91 2.98 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.148 2.566 . . . . 0.0 114.557 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -109.03 -43.08 4.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.863 1.265 . . . . 0.0 110.656 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -59.92 -48.66 80.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.782 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -63.52 -38.16 90.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.287 -0.883 . . . . 0.0 112.622 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.45 -43.32 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.462 1.03 . . . . 0.0 113.093 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.0 mt -62.28 -46.42 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 118.543 1.171 . . . . 0.0 110.106 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -50.2 74.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.699 1.2 . . . . 0.0 112.6 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -77.76 -40.26 41.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -87.62 -45.8 10.1 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.58 -44.53 18.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.074 0.852 . . . . 0.0 113.149 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.18 -43.68 0.54 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 126.172 1.844 . . . . 0.0 116.632 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -156.88 133.12 9.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.902 1.681 . . . . 0.0 110.275 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -153.23 54.55 1.2 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.26 -24.1 78.27 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.589 2.859 . . . . 0.0 114.819 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -81.68 -13.49 57.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.744 . . . . 0.0 114.943 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.76 142.63 32.45 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.165 0.893 . . . . 0.0 111.428 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -131.1 144.35 51.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.145 1.778 . . . . 0.0 111.83 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -158.44 -172.14 3.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.86 162.43 31.67 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.18 2.324 . . . . 0.0 110.55 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.57 131.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 117.927 0.864 . . . . 0.0 112.625 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.2 126.35 74.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.29 147.75 45.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.256 1.022 . . . . 0.0 110.035 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.2 147.43 36.54 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.597 0.759 . . . . 0.0 111.54 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.75 -139.33 4.8 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.257 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -138.55 130.07 27.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 111.655 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.8 p -66.7 -5.3 11.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -69.22 2.2 3.08 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.54 153.21 48.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.423 1.489 . . . . 0.0 112.83 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.47 -7.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.778 1.631 . . . . 0.0 114.831 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -120.66 44.16 2.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.578 1.951 . . . . 0.0 110.761 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -50.38 115.38 1.43 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.211 -1.556 . . . . 0.0 112.344 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.46 25.0 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -55.9 -36.75 68.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.682 -1.261 . . . . 0.0 113.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.78 -41.26 99.88 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.794 0.724 . . . . 0.0 112.583 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.16 -40.49 82.34 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.277 -1.131 . . . . 0.0 112.936 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.76 -37.78 85.54 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.918 0.859 . . . . 0.0 113.311 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -59.77 -46.35 89.46 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.769 0.713 . . . . 0.0 111.01 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.26 -25.36 64.23 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.92 -48.93 56.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.017 -1.677 . . . . 0.0 110.077 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.8 -38.19 72.2 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.2 tp -49.21 -31.94 9.52 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.949 1.7 . . . . 0.0 112.966 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.01 -37.78 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.054 1.342 . . . . 0.0 110.975 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -35.95 82.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -22.24 66.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 112.644 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.79 9.97 41.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.2 m 66.56 15.11 10.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.685 1.994 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.56 141.57 54.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.973 0.806 . . . . 0.0 109.752 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -102.62 107.51 18.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.554 1.141 . . . . 0.0 111.449 -169.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.5 ttm105 -74.02 123.45 24.37 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.838 -1.164 . . . . 0.0 110.465 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.16 35.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.846 1.658 . . . . 0.0 111.925 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -162.12 35.81 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.526 -1.359 . . . . 0.0 114.34 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -125.57 154.38 42.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.254 1.821 . . . . 0.0 111.118 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.0 ttm -69.77 131.6 44.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.896 0.879 . . . . 0.0 112.059 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -85.91 135.37 33.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.41 0.684 . . . . 0.0 109.661 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.38 93.7 3.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.775 1.23 . . . . 0.0 111.599 -171.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mt -86.59 134.34 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.202 1.401 . . . . 0.0 110.773 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -127.17 111.89 14.51 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.085 1.354 . . . . 0.0 111.436 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.07 -23.16 53.54 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -85.48 4.61 34.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.725 1.21 . . . . 0.0 113.695 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -129.91 -30.25 2.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.861 1.264 . . . . 0.0 112.734 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -146.28 118.46 4.98 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.089 0.956 . . . . 0.0 111.789 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.94 -0.76 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.741 2.96 . . . . 0.0 114.708 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.64 77.44 77.44 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.57 1.548 . . . . 0.0 112.331 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.18 -31.33 5.9 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 125.831 4.354 . . . . 0.0 116.351 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -48.08 -44.42 31.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.133 1.773 . . . . 0.0 113.269 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.8 p -71.77 -29.0 64.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.594 1.158 . . . . 0.0 113.314 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.5 -26.46 38.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.317 0.647 . . . . 0.0 112.217 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.5 p -105.33 -28.37 10.94 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.43 -59.8 6.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.2 -28.57 33.85 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.909 1.739 . . . . 0.0 112.226 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -63.05 -50.31 71.14 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.701 0.682 . . . . 0.0 111.691 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.04 -41.12 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.739 0.7 . . . . 0.0 110.318 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.61 -44.44 93.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.349 0.522 . . . . 0.0 111.624 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.92 -55.47 25.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.196 0.998 . . . . 0.0 112.554 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.59 -49.67 64.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.36 1.064 . . . . 0.0 110.907 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.36 -19.57 26.11 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.579 1.562 . . . . 0.0 116.44 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.8 p -69.78 -20.24 63.48 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.884 2.342 . . . . 0.0 113.62 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -97.49 -15.48 20.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.178 1.391 . . . . 0.0 113.151 -171.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 149.9 49.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.303 1.441 . . . . 0.0 112.183 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.023 1.729 . . . . 0.0 114.234 -172.222 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 110.885 -0.043 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.36 177.94 7.2 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.324 1.45 . . . . 0.0 113.474 -170.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -126.64 123.66 38.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.714 1.606 . . . . 0.0 109.434 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 mm -118.03 123.75 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.496 1.118 . . . . 0.0 112.259 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.42 126.58 7.69 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 168.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -116.97 111.4 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.719 1.259 . . . . 0.0 109.075 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.32 133.09 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.613 0.765 . . . . 0.0 110.79 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.94 144.26 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.903 -169.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.72 115.17 1.64 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -157.58 162.46 38.76 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.508 -0.996 . . . . 0.0 111.424 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -120.7 -19.39 7.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.598 1.159 . . . . 0.0 112.336 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.29 -7.12 2.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.15 -2.34 47.4 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.1 -47.75 78.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.314 1.557 . . . . 0.0 112.515 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -67.83 -30.11 69.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 112.751 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 tp -64.14 -44.36 92.41 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.7 -1.25 . . . . 0.0 113.039 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.09 -42.87 77.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.021 0.828 . . . . 0.0 111.262 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.31 -38.0 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.54 0.736 . . . . 0.0 112.236 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.31 94.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.85 -39.19 93.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.51 -44.63 96.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.483 -0.761 . . . . 0.0 112.216 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.34 88.67 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.922 0.783 . . . . 0.0 112.598 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.44 -46.4 80.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.775 0.83 . . . . 0.0 111.991 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.7 84.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 112.493 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.37 -42.64 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.407 1.083 . . . . 0.0 112.563 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.55 -44.21 78.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.807 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -56.93 -46.23 82.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 112.045 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -39.59 89.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.187 0.995 . . . . 0.0 113.242 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -67.75 -28.87 68.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.657 0.783 . . . . 0.0 112.67 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.76 -5.98 6.16 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.282 1.42 . . . . 0.0 114.502 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -73.58 178.84 4.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.355 1.462 . . . . 0.0 111.482 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -117.64 144.11 45.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.354 1.462 . . . . 0.0 109.392 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.89 163.3 37.23 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.638 -0.664 . . . . 0.0 112.576 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -153.12 116.55 4.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.097 0.959 . . . . 0.0 110.999 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.87 140.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.872 1.269 . . . . 0.0 111.201 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -125.42 107.74 10.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.252 1.821 . . . . 0.0 108.959 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.48 -20.68 46.74 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -171.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.45 61.02 7.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.857 1.663 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.77 161.6 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.077 3.185 . . . . 0.0 115.023 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.2 171.34 14.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.115 2.166 . . . . 0.0 109.405 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -46.54 -48.57 19.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.354 1.062 . . . . 0.0 112.948 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 m -59.4 -19.22 45.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -79.02 -35.64 42.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.503 1.047 . . . . 0.0 111.85 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 23.0 t-105 -78.97 -37.36 39.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.239 1.415 . . . . 0.0 112.56 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.6 tp -38.68 -50.17 3.8 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 128.466 2.706 . . . . 0.0 116.318 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -15.67 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.714 2.276 . . . . 0.0 115.258 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -84.84 -1.8 56.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.12 -33.41 69.1 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.221 -0.925 . . . . 0.0 113.295 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.52 -5.7 50.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.266 1.026 . . . . 0.0 113.519 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -133.08 -134.51 0.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.927 2.491 . . . . 0.0 109.478 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.08 158.8 43.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.115 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.57 170.53 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.058 1.343 . . . . 0.0 111.896 -173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.91 148.64 20.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.334 1.453 . . . . 0.0 110.413 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.0 t -117.09 135.59 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.57 1.548 . . . . 0.0 109.829 -170.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.44 96.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.313 1.045 . . . . 0.0 109.681 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.0 m -138.82 152.99 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.3 p -108.33 -159.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.869 1.267 . . . . 0.0 113.514 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.1 m -122.92 151.19 42.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.082 1.753 . . . . 0.0 109.115 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -158.27 -177.27 6.43 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.441 1.496 . . . . 0.0 108.73 -169.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 42.57 44.58 5.33 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 60.81 21.54 11.64 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.408 1.883 . . . . 0.0 114.801 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.3 -6.87 2.81 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.316 1.436 . . . . 0.0 115.502 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.07 -158.42 0.2 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 126.245 1.818 . . . . 0.0 113.027 175.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pp -119.87 163.0 30.21 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.747 1.619 . . . . 0.0 113.603 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.71 142.9 78.78 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.59 3.527 . . . . 0.0 113.305 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.03 -28.15 67.51 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.617 -0.677 . . . . 0.0 112.816 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -62.02 -10.21 9.32 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.3 tt -128.1 -6.81 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.463 1.029 . . . . 0.0 113.243 175.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -47.9 -50.65 52.18 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 117.392 -1.289 . . . . 0.0 112.647 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 -2.03 10.75 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.239 1.959 . . . . 0.0 114.238 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.0 tp -98.06 -43.98 6.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.99 0.916 . . . . 0.0 110.122 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -61.57 -47.05 87.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -63.91 -44.53 92.66 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.34 -0.85 . . . . 0.0 111.876 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.61 -45.84 93.65 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.981 0.8 . . . . 0.0 113.373 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.02 -43.49 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.31 1.055 . . . . 0.0 110.596 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -62.65 -45.04 94.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.355 1.062 . . . . 0.0 112.617 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -83.67 -39.41 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.115 1.366 . . . . 0.0 114.512 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -121.8 4.92 9.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.65 -48.51 2.93 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.754 1.161 . . . . 0.0 110.823 168.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.49 -26.68 0.22 Allowed Glycine 0 CA--C 1.542 1.725 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -155.22 136.67 14.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 110.211 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -148.68 58.58 3.7 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.195 1.398 . . . . 0.0 112.471 -169.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.45 -2.53 8.45 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.603 3.535 . . . . 0.0 115.21 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -118.67 -6.12 10.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.664 2.385 . . . . 0.0 113.305 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.25 121.18 20.87 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.155 0.982 . . . . 0.0 110.155 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -123.4 140.77 52.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.87 1.668 . . . . 0.0 109.897 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -163.48 -167.57 1.46 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -168.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.54 170.46 34.05 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 127.596 2.522 . . . . 0.0 110.116 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.2 t -142.0 132.65 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.631 1.216 . . . . 0.0 112.247 -174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.72 130.4 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.59 152.5 43.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.017 0.927 . . . . 0.0 110.482 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -142.92 138.5 30.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.368 0.667 . . . . 0.0 111.803 -169.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.03 -138.86 3.36 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -144.09 122.51 12.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.501 1.12 . . . . 0.0 110.782 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -60.63 -9.42 3.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.823 1.249 . . . . 0.0 114.094 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.8 m -59.29 -13.42 7.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.419 1.488 . . . . 0.0 114.809 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -127.56 138.35 52.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.759 1.223 . . . . 0.0 111.834 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.69 -27.47 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -168.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -90.46 -14.08 33.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.761 1.164 . . . . 0.0 113.327 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 36.0 -125.33 0.14 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.409 1.484 . . . . 0.0 112.573 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.3 m -77.32 20.42 0.29 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -54.16 -33.98 59.34 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.095 -1.628 . . . . 0.0 114.71 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.27 85.38 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.481 1.037 . . . . 0.0 113.393 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.22 -41.75 52.42 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.256 -1.144 . . . . 0.0 112.429 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.88 -36.4 79.11 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -56.55 -48.48 77.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.69 0.677 . . . . 0.0 111.418 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -70.01 -29.53 66.62 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.49 -46.33 76.65 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.226 -1.546 . . . . 0.0 111.291 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.09 70.68 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -48.96 -28.55 3.95 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.924 1.689 . . . . 0.0 113.36 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -101.77 -35.26 9.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.645 1.178 . . . . 0.0 111.432 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.59 -32.84 74.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.72 1.145 . . . . 0.0 111.682 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.2 -15.31 14.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.809 1.243 . . . . 0.0 113.002 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -124.16 16.65 9.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.845 1.658 . . . . 0.0 113.201 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m 64.02 25.11 13.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.002 1.721 . . . . 0.0 115.425 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 159.79 12.27 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.243 -0.911 . . . . 0.0 112.332 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -129.13 86.33 2.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.111 1.364 . . . . 0.0 110.394 -170.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -62.51 138.96 58.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.03 31.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.552 1.541 . . . . 0.0 111.544 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.18 -165.46 38.92 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 121.015 -1.053 . . . . 0.0 113.999 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.26 158.48 28.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.066 1.747 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.0 ttm -72.32 133.96 45.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.68 -0.637 . . . . 0.0 112.149 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.27 134.13 33.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.825 0.85 . . . . 0.0 109.469 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.25 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.241 1.016 . . . . 0.0 111.196 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.58 135.07 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.074 1.35 . . . . 0.0 110.609 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -131.63 113.24 13.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.004 1.322 . . . . 0.0 111.09 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.8 30.44 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 m -77.26 -2.78 36.44 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -139.43 -18.5 0.98 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.631 1.573 . . . . 0.0 113.437 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.84 80.64 70.57 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.993 2.117 . . . . 0.0 110.772 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -16.25 42.57 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.947 2.432 . . . . 0.0 113.313 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.92 91.15 48.86 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 107.736 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.35 -27.04 84.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.461 2.774 . . . . 0.0 115.524 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.31 -29.1 60.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 p -68.92 -6.55 28.11 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -111.8 -31.83 6.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.327 1.051 . . . . 0.0 111.335 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.1 p -78.0 -32.88 51.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.88 -60.74 4.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -66.29 -29.78 46.09 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.118 1.879 . . . . 0.0 112.278 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -61.94 -51.15 69.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.532 0.605 . . . . 0.0 111.582 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.02 -40.65 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.525 0.602 . . . . 0.0 110.485 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.71 -38.01 83.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -71.41 -59.08 2.96 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.125 0.97 . . . . 0.0 112.717 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -52.17 -47.54 65.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.926 -174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.03 -34.69 12.26 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.001 1.286 . . . . 0.0 115.268 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.7 p -66.72 -15.88 63.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.023 1.411 . . . . 0.0 114.052 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -96.99 -15.92 20.85 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.249 1.419 . . . . 0.0 113.4 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.17 -36.86 80.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.561 1.544 . . . . 0.0 113.592 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.764 1.626 . . . . 0.0 112.226 -175.416 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.54 176.13 8.0 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.763 2.025 . . . . 0.0 110.78 170.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.18 124.25 24.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.125 1.37 . . . . 0.0 109.181 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mt -136.9 125.05 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.71 132.88 11.39 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -120.02 90.79 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.984 1.314 . . . . 0.0 108.411 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.829 0.852 . . . . 0.0 110.752 -169.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.12 144.9 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.489 0.661 . . . . 0.0 111.567 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.49 101.68 0.48 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -146.92 164.1 33.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.784 1.234 . . . . 0.0 111.022 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 80.2 mmm -111.5 -11.39 14.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.944 0.898 . . . . 0.0 113.359 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -146.51 -19.62 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.89 -10.02 5.44 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 170.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.93 -44.38 91.32 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.176 1.988 . . . . 0.0 113.315 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.6 p -82.59 -28.97 30.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.6 0.76 . . . . 0.0 112.512 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.93 -40.42 84.56 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.729 -1.232 . . . . 0.0 112.912 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 tt -54.57 -41.05 69.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 111.815 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.88 -35.72 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.242 0.617 . . . . 0.0 111.991 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.12 97.87 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.393 0.997 . . . . 0.0 112.506 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.47 -40.86 96.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.534 0.733 . . . . 0.0 112.269 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -60.45 -47.86 84.29 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.772 -0.58 . . . . 0.0 111.552 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.13 87.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.556 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.35 -46.24 80.06 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.727 0.811 . . . . 0.0 112.071 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.88 -47.18 81.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.367 0.667 . . . . 0.0 112.31 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.43 -32.7 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.358 . . . . 0.0 112.964 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 mt -80.14 -38.31 31.73 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.686 -1.259 . . . . 0.0 110.12 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.2 m -57.03 -45.32 83.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.669 0.788 . . . . 0.0 111.17 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.86 78.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.558 1.143 . . . . 0.0 113.487 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.05 -7.06 52.64 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.37 24.32 12.71 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.606 1.098 . . . . 0.0 114.346 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -114.87 147.89 39.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.376 1.088 . . . . 0.0 112.153 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -75.22 134.35 41.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.232 1.013 . . . . 0.0 109.034 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 155.03 45.59 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.168 0.987 . . . . 0.0 111.189 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -154.13 116.49 4.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.08 -1.013 . . . . 0.0 110.665 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.82 138.74 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.121 0.968 . . . . 0.0 110.71 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.68 101.08 6.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.308 . . . . 0.0 109.808 172.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.64 -22.79 56.47 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -144.31 64.12 11.93 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.202 1.801 . . . . 0.0 109.586 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.8 160.7 48.58 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.117 3.211 . . . . 0.0 114.703 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.37 162.04 31.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.164 2.186 . . . . 0.0 109.212 169.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -53.99 -36.62 63.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.713 -1.242 . . . . 0.0 113.346 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -58.07 -18.79 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -83.4 -35.13 25.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.406 1.003 . . . . 0.0 112.344 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -75.2 -37.19 61.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.926 0.89 . . . . 0.0 112.193 172.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.3 tp -41.42 -46.74 8.42 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 128.34 2.656 . . . . 0.0 116.411 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.67 -30.32 4.98 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.211 1.941 . . . . 0.0 114.391 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -81.26 -9.74 59.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -55.44 -28.5 54.72 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.13 -4.98 52.99 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.471 1.508 . . . . 0.0 113.848 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.11 -115.52 0.23 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.761 1.624 . . . . 0.0 111.154 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.02 160.93 39.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.618 1.567 . . . . 0.0 110.694 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.4 m -152.4 172.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.118 1.367 . . . . 0.0 111.314 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 149.31 18.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.938 1.295 . . . . 0.0 109.771 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.07 136.98 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.84 1.256 . . . . 0.0 109.983 -170.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.11 94.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.984 1.314 . . . . 0.0 109.024 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.1 m -135.76 139.82 43.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -168.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -178.1 5.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.868 1.667 . . . . 0.0 112.381 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 m -127.75 139.11 52.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.718 -1.239 . . . . 0.0 110.899 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -158.4 -168.73 2.53 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.556 1.526 . . . . 0.0 110.75 -170.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.64 -66.88 0.17 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 127.807 2.622 . . . . 0.0 116.045 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -153.45 32.02 0.46 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.599 1.96 . . . . 0.0 110.812 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.31 40.48 13.34 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.238 -0.913 . . . . 0.0 111.623 -169.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -129.35 175.22 8.93 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.635 1.974 . . . . 0.0 112.881 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -53.52 136.97 52.22 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.364 1.866 . . . . 0.0 111.834 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.72 141.99 28.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.354 2.703 . . . . 0.0 110.679 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.46 -25.42 62.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 m -61.67 -17.2 54.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.42 -12.87 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 119.76 1.164 . . . . 0.0 114.138 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.68 -42.88 24.67 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.38 1.472 . . . . 0.0 114.08 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.17 -25.4 10.13 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.97 1.78 . . . . 0.0 114.075 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.49 -45.82 61.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.312 0.96 . . . . 0.0 109.616 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.19 -58.36 6.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.75 1.62 . . . . 0.0 111.381 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -66.96 -33.81 76.4 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.486 -1.384 . . . . 0.0 113.958 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.47 -48.23 87.0 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 119.097 0.862 . . . . 0.0 112.495 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.22 -41.03 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.197 -1.178 . . . . 0.0 110.557 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -61.48 -37.33 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.76 -23.07 10.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -169.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -113.21 0.45 14.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.5 mt -129.32 -49.63 1.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.739 1.216 . . . . 0.0 111.418 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.94 -22.52 0.33 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 118.447 2.139 . . . . 0.0 118.447 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -153.57 139.71 18.38 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.577 1.689 . . . . 0.0 110.677 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.59 45.85 0.28 Allowed Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -59.59 -21.57 62.94 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.555 3.504 . . . . 0.0 116.865 -169.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -106.56 -0.74 23.64 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.308 1.443 . . . . 0.0 113.849 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.52 136.95 40.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.88 0.872 . . . . 0.0 110.258 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -130.7 133.5 46.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.681 1.992 . . . . 0.0 109.525 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -151.93 -170.87 3.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -170.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.46 164.92 30.78 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.823 1.678 . . . . 0.0 110.027 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.78 134.78 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 122.178 0.989 . . . . 0.0 112.253 -169.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.4 mt -121.4 129.9 75.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.78 50.35 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.277 0.631 . . . . 0.0 111.591 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.1 169.69 20.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.494 1.14 . . . . 0.0 113.962 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.02 -126.03 1.28 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.643 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -142.21 128.56 19.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.3 1.04 . . . . 0.0 112.32 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -66.94 -12.13 58.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.714 1.606 . . . . 0.0 114.91 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 -15.77 63.2 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.13 148.84 22.28 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.867 1.267 . . . . 0.0 112.299 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.15 -38.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.71 0.804 . . . . 0.0 111.572 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -76.13 41.32 0.23 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.523 1.529 . . . . 0.0 112.834 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.5 117.15 2.66 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.911 -1.743 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 61.1 m 51.7 24.55 2.45 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -56.32 -33.55 65.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.622 -1.299 . . . . 0.0 113.32 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.9 -34.12 70.7 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.979 0.799 . . . . 0.0 113.522 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.89 -40.43 10.62 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.412 -1.052 . . . . 0.0 112.936 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.27 -35.75 74.28 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.293 1.047 . . . . 0.0 113.257 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -59.9 -41.88 92.6 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.231 1.013 . . . . 0.0 112.223 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -75.86 -29.04 58.41 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.443 -0.786 . . . . 0.0 112.684 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.27 -43.79 80.94 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.076 -1.64 . . . . 0.0 111.289 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.18 84.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.111 0.964 . . . . 0.0 113.199 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.5 tp -49.04 -29.39 4.95 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 112.964 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.0 mt -102.69 -42.91 5.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.567 1.147 . . . . 0.0 111.642 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.18 -31.44 72.63 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.756 1.162 . . . . 0.0 112.76 169.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.88 -18.64 63.25 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.094 -1.004 . . . . 0.0 112.86 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -107.03 15.3 25.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.865 1.666 . . . . 0.0 112.39 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.2 m 62.43 14.92 7.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.944 2.097 . . . . 0.0 115.276 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.02 156.64 17.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.915 0.78 . . . . 0.0 112.008 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -116.53 164.8 14.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 -169.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 -129.61 146.13 51.44 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.46 21.01 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 113.368 -1.742 . . . . 0.0 112.368 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.6 -176.71 46.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.104 1.811 . . . . 0.0 113.464 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.21 159.3 22.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 112.112 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.38 127.08 31.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.433 0.693 . . . . 0.0 112.388 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.81 133.56 35.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.33 94.26 3.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.864 1.266 . . . . 0.0 111.356 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.17 138.57 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.443 0.697 . . . . 0.0 111.817 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.98 114.93 23.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.535 1.534 . . . . 0.0 111.429 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.19 -25.32 58.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m -79.86 1.36 27.34 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -132.47 -27.75 1.72 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.833 1.253 . . . . 0.0 113.453 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -142.47 108.33 5.64 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 112.104 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.87 -0.99 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.112 3.208 . . . . 0.0 114.571 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.18 74.71 79.27 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.465 1.906 . . . . 0.0 109.842 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -57.94 -22.0 52.49 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.445 3.43 . . . . 0.0 116.551 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.04 -37.81 72.32 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.932 -1.105 . . . . 0.0 113.122 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.8 p -68.56 -6.35 24.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.317 1.047 . . . . 0.0 113.476 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -110.47 -12.99 14.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.211 1.404 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -129.17 -24.54 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -51.48 -52.73 57.11 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.251 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.11 -27.58 41.78 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.78 1.654 . . . . 0.0 113.419 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -62.51 -49.91 73.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.66 -33.64 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.558 -0.714 . . . . 0.0 111.113 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.52 -16.65 63.88 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -95.98 -59.26 1.89 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.826 1.251 . . . . 0.0 111.759 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -54.63 -46.04 73.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.775 1.23 . . . . 0.0 112.473 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.91 -19.6 22.83 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.2 p -76.86 -11.99 59.9 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.893 . . . . 0.0 113.715 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.08 -9.32 17.89 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 126.1 45.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.609 1.164 . . . . 0.0 113.698 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.885 2.474 . . . . 0.0 110.563 170.798 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 120.326 0.108 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.02 -177.95 3.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.726 1.61 . . . . 0.0 112.525 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -127.99 125.2 38.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 0.0 108.679 174.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 mm -123.07 124.25 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.398 1.079 . . . . 0.0 112.569 -171.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.62 128.52 9.24 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.5 mt -119.25 91.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -91.22 135.41 33.81 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 111.565 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.2 142.56 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.011 -170.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.16 104.72 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -147.7 169.49 19.59 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.911 1.284 . . . . 0.0 110.807 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.7 mtp -116.65 -7.2 11.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.283 1.033 . . . . 0.0 113.029 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -148.37 -32.0 0.26 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.39 -1.58 2.71 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.88 -42.18 97.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.144 1.972 . . . . 0.0 113.199 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -78.37 -31.87 48.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 172.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.3 tp -57.71 -40.09 78.74 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.037 -1.039 . . . . 0.0 113.08 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.87 -45.1 70.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.312 0.645 . . . . 0.0 111.464 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.72 -39.38 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.834 0.454 . . . . 0.0 111.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.42 87.45 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.19 0.905 . . . . 0.0 113.159 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.12 -44.24 96.17 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.564 -0.71 . . . . 0.0 111.886 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.31 -40.74 97.3 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.665 -0.647 . . . . 0.0 112.068 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -46.31 90.65 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.854 0.752 . . . . 0.0 111.799 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.44 -47.0 80.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.013 0.525 . . . . 0.0 111.493 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.67 -47.36 85.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.789 0.836 . . . . 0.0 112.911 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.32 -46.35 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.556 1.142 . . . . 0.0 112.225 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.78 -40.79 75.81 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.942 -0.474 . . . . 0.0 109.751 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -56.24 -46.54 79.55 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.859 1.264 . . . . 0.0 112.215 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.54 89.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 112.955 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -68.71 -30.77 69.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.393 0.677 . . . . 0.0 112.671 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.57 -6.69 4.56 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.875 1.226 . . . . 0.0 115.556 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -79.07 144.1 34.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 111.04 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.82 134.9 49.04 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.76 142.68 31.03 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.8 0.727 . . . . 0.0 112.293 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.6 m -141.45 114.83 8.83 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.086 0.954 . . . . 0.0 110.137 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.6 p -80.53 149.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.919 0.888 . . . . 0.0 111.974 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -137.94 104.9 5.39 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.711 1.605 . . . . 0.0 109.321 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.82 -33.04 70.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.555 1.542 . . . . 0.0 114.522 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -145.81 62.88 8.83 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.418 1.887 . . . . 0.0 109.437 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.67 160.1 49.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.911 3.074 . . . . 0.0 115.658 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.94 170.59 15.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.423 2.289 . . . . 0.0 109.026 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -57.71 -34.99 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.7 -1.25 . . . . 0.0 113.443 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.2 p -61.21 -15.49 34.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.38 -33.38 20.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.568 1.076 . . . . 0.0 112.503 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -75.52 -37.15 60.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.302 1.041 . . . . 0.0 112.501 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.9 tp -43.92 -50.53 19.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 127.789 2.436 . . . . 0.0 115.216 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.61 -1.59 6.93 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.072 2.515 . . . . 0.0 115.708 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.18 0.46 10.68 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.181 1.392 . . . . 0.0 114.02 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -60.84 -14.82 24.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -121.19 18.74 11.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.619 2.368 . . . . 0.0 112.267 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -124.43 -138.05 0.29 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.697 2.399 . . . . 0.0 108.649 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -123.32 157.86 32.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.532 1.533 . . . . 0.0 109.303 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.33 166.79 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.111 1.364 . . . . 0.0 110.08 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.18 144.88 20.19 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.239 -0.913 . . . . 0.0 110.654 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -113.44 132.86 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.382 1.473 . . . . 0.0 110.334 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.78 91.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.52 1.128 . . . . 0.0 108.757 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 m -135.8 138.13 42.28 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -85.15 -167.76 1.96 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.767 2.027 . . . . 0.0 113.034 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -135.81 141.95 44.79 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.537 -1.352 . . . . 0.0 111.157 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -142.12 -169.26 2.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.197 1.799 . . . . 0.0 109.539 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 46.24 37.32 7.97 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 126.08 1.8 . . . . 0.0 116.881 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 67.96 10.7 7.97 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.734 2.014 . . . . 0.0 114.518 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.61 28.38 0.07 OUTLIER Glycine 0 N--CA 1.474 1.185 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.22 168.21 18.44 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 120.094 1.947 . . . . 0.0 114.269 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mt -49.47 127.4 17.58 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 127.511 2.324 . . . . 0.0 113.133 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.27 141.78 94.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.296 3.331 . . . . 0.0 111.351 169.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.37 -25.99 67.54 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -171.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.3 m -63.21 -12.16 26.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.3 tt -125.19 -10.39 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.93 -47.65 63.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.263 -1.351 . . . . 0.0 113.33 170.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.15 -19.2 34.55 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 122.46 1.914 . . . . 0.0 113.987 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -78.02 -42.72 31.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.179 0.9 . . . . 0.0 109.606 171.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -62.04 -45.92 91.42 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.518 1.127 . . . . 0.0 111.386 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -62.77 -40.93 98.81 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.659 -1.276 . . . . 0.0 112.676 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -45.46 69.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.568 1.08 . . . . 0.0 112.967 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.5 mt -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 119.427 1.613 . . . . 0.0 109.98 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.79 -46.12 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.654 1.181 . . . . 0.0 112.265 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.24 -35.17 36.48 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -90.82 -33.95 15.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.22 -53.55 4.19 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.625 1.102 . . . . 0.0 111.689 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -37.59 0.29 Allowed Glycine 0 CA--C 1.544 1.862 0 C-N-CA 126.164 1.84 . . . . 0.0 115.803 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -161.87 124.7 3.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 110.557 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -149.58 53.75 1.4 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 126.035 1.734 . . . . 0.0 113.085 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.78 -27.63 78.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.942 3.095 . . . . 0.0 115.13 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.81 -26.46 67.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.889 1.276 . . . . 0.0 114.247 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.6 tp -77.78 142.1 38.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.678 0.791 . . . . 0.0 112.527 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -138.08 145.61 41.93 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.038 2.135 . . . . 0.0 110.054 -172.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -161.0 -171.15 2.96 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -169.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.91 165.26 33.08 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.933 2.206 . . . . 0.0 110.525 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -139.65 134.78 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.076 0.938 . . . . 0.0 112.618 -169.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.8 mt -118.3 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.16 148.25 40.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.173 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.07 151.41 45.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.175 0.988 . . . . 0.0 112.075 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.78 -133.57 2.76 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.164 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -142.65 133.1 24.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.421 1.088 . . . . 0.0 111.967 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.7 p -68.32 -6.12 22.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 m -68.64 3.18 1.98 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -136.64 154.59 50.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.788 1.635 . . . . 0.0 111.749 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.85 -36.23 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.632 0.773 . . . . 0.0 112.897 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.43 44.78 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.769 0.827 . . . . 0.0 111.944 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -53.77 116.61 2.61 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.553 -1.342 . . . . 0.0 112.003 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 56.7 m 50.83 23.93 1.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.964 2.506 . . . . 0.0 116.957 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.07 -26.28 67.53 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.661 -1.274 . . . . 0.0 114.09 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -30.09 73.46 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.733 0.697 . . . . 0.0 113.404 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.0 -38.71 9.04 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.08 0.94 . . . . 0.0 113.179 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.18 -35.16 74.75 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.509 1.155 . . . . 0.0 113.52 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -59.38 -37.84 78.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.494 0.718 . . . . 0.0 112.423 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.04 -33.2 61.71 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.322 -0.861 . . . . 0.0 112.477 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.95 -1.719 . . . . 0.0 110.911 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.7 89.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.3 tp -46.31 -44.04 16.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.495 1.518 . . . . 0.0 111.998 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.23 -28.63 57.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.114 1.366 . . . . 0.0 112.449 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.16 -29.74 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.106 -0.996 . . . . 0.0 111.587 169.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -66.01 -23.86 66.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.638 1.108 . . . . 0.0 111.607 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -88.05 1.89 53.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.646 1.178 . . . . 0.0 111.967 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m 53.38 22.73 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.995 1.718 . . . . 0.0 114.83 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 156.1 24.34 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 111.433 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -119.48 87.63 2.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.502 1.521 . . . . 0.0 111.539 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.2 ttp85 -59.47 137.86 57.87 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.487 -0.758 . . . . 0.0 112.041 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.67 51.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 126.341 1.856 . . . . 0.0 109.967 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.85 -174.86 44.7 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.326 -0.859 . . . . 0.0 114.083 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.08 147.16 44.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.25 1.42 . . . . 0.0 110.717 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.06 130.66 42.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.452 0.701 . . . . 0.0 111.86 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.34 134.65 35.26 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 92.29 3.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.681 1.192 . . . . 0.0 111.246 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.5 mt -85.1 134.3 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.468 1.507 . . . . 0.0 111.631 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -121.56 109.16 14.46 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.623 1.169 . . . . 0.0 112.809 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.42 -23.39 49.23 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 m -83.5 0.82 44.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.416 1.087 . . . . 0.0 113.867 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -129.21 -26.54 2.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 113.417 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -146.59 119.29 4.97 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.007 0.822 . . . . 0.0 112.835 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.0 -5.11 12.12 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.895 3.063 . . . . 0.0 114.216 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.43 73.94 80.11 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.54 1.536 . . . . 0.0 111.175 -172.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.06 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.311 3.34 . . . . 0.0 115.055 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -48.15 -44.21 32.14 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.146 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.5 p -67.78 -18.41 64.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.51 -17.74 16.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.209 1.004 . . . . 0.0 112.425 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -113.42 -28.43 7.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -59.9 -52.12 75.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.717 -1.135 . . . . 0.0 113.204 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.49 -28.93 61.95 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.349 1.518 . . . . 0.0 112.773 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -60.95 -50.29 73.98 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.609 0.641 . . . . 0.0 111.658 171.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 -41.43 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.684 0.675 . . . . 0.0 110.461 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.91 -39.45 85.45 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.453 0.57 . . . . 0.0 111.966 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -67.19 -56.32 10.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.883 0.873 . . . . 0.0 112.51 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -53.35 -46.23 69.46 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.414 1.086 . . . . 0.0 111.4 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.5 -23.61 6.59 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.393 1.949 . . . . 0.0 116.507 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -72.69 -18.52 61.54 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.068 1.934 . . . . 0.0 114.072 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.65 -15.47 25.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.487 1.515 . . . . 0.0 113.109 -171.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.49 157.67 22.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.521 2.328 . . . . 0.0 113.154 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.256 1.397 0 C-N-CA 128.156 2.582 . . . . 0.0 114.649 -173.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.94 177.16 7.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.79 1.636 . . . . 0.0 111.999 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -131.88 129.49 40.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.633 1.173 . . . . 0.0 110.094 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 mm -122.0 125.17 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.894 0.878 . . . . 0.0 112.937 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.84 124.87 7.05 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mt -116.41 91.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.448 1.099 . . . . 0.0 108.26 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.68 136.09 35.38 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.021 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.31 145.21 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.215 0.606 . . . . 0.0 111.669 -169.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 80.92 0.3 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.188 1.375 . . . . 0.0 110.741 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.03 168.58 18.54 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.0 tpt -130.58 -4.18 4.2 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.938 2.095 . . . . 0.0 112.203 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -142.82 -54.74 0.41 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.114 . . . . 0.0 113.229 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.08 -2.98 1.04 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 117.097 1.599 . . . . 0.0 117.097 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -62.79 -44.14 96.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.881 1.341 . . . . 0.0 112.289 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -71.59 -35.76 70.63 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.286 1.434 . . . . 0.0 112.309 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.51 -40.78 92.65 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.718 -1.239 . . . . 0.0 112.457 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.49 -41.17 76.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.879 0.763 . . . . 0.0 111.82 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.52 -37.92 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.847 -0.533 . . . . 0.0 112.023 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.1 97.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.35 0.977 . . . . 0.0 112.844 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.48 -40.33 94.16 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.575 0.75 . . . . 0.0 112.413 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.51 -45.64 93.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.386 -0.821 . . . . 0.0 112.102 169.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.19 88.29 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.726 -0.609 . . . . 0.0 112.198 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.19 -47.73 77.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.648 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.84 92.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.564 0.745 . . . . 0.0 112.676 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.1 -47.25 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.749 1.219 . . . . 0.0 112.355 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.09 -39.35 79.08 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.253 0.621 . . . . 0.0 109.805 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -57.01 -48.71 77.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.988 1.315 . . . . 0.0 111.975 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -34.97 79.16 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.025 0.93 . . . . 0.0 113.399 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.26 -8.31 56.29 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.43 36.95 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.974 1.273 . . . . 0.0 115.009 171.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -77.24 172.17 13.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.764 1.226 . . . . 0.0 111.557 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -104.97 145.29 30.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.276 1.03 . . . . 0.0 108.543 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.78 164.17 32.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.47 -0.769 . . . . 0.0 112.788 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.6 m -152.79 120.97 6.22 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 110.565 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.16 138.63 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.053 0.941 . . . . 0.0 110.651 169.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -125.9 107.4 10.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.88 1.272 . . . . 0.0 109.606 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -84.65 -14.43 48.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -143.2 56.67 4.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 126.074 1.75 . . . . 0.0 110.199 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.15 165.4 31.55 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.095 3.197 . . . . 0.0 115.524 -169.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.15 166.38 26.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.181 2.193 . . . . 0.0 109.037 172.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -40.15 25.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.577 1.151 . . . . 0.0 112.404 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.02 -20.12 15.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -97.12 -29.09 13.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.934 1.293 . . . . 0.0 112.181 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -70.66 -42.01 71.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.511 . . . . 0.0 112.771 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.08 -52.79 49.92 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.222 2.209 . . . . 0.0 114.687 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -65.77 -3.65 8.48 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.002 2.468 . . . . 0.0 115.956 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -110.72 1.11 17.67 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.888 1.275 . . . . 0.0 114.07 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -66.24 -30.29 70.7 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.484 -1.385 . . . . 0.0 113.418 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.97 3.93 13.43 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.923 1.289 . . . . 0.0 113.365 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -132.45 -123.77 0.19 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.286 1.835 . . . . 0.0 110.14 -169.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.51 160.0 40.97 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.909 1.684 . . . . 0.0 110.768 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.44 168.47 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 110.65 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.57 146.26 19.47 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.386 -0.821 . . . . 0.0 110.466 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -117.91 137.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.062 1.345 . . . . 0.0 110.595 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.2 94.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.873 1.269 . . . . 0.0 108.091 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.1 m -133.8 167.06 21.24 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.4 p -141.22 173.93 11.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 112.047 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.7 m -99.14 150.97 21.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.748 1.219 . . . . 0.0 112.447 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 p -144.16 -169.89 3.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.17 2.588 . . . . 0.0 108.739 170.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 47.07 26.28 2.96 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 126.233 1.873 . . . . 0.0 117.296 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 56.05 13.27 1.12 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.121 2.168 . . . . 0.0 114.231 -169.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.69 38.0 0.02 OUTLIER Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.385 0.993 . . . . 0.0 114.4 -174.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.71 177.52 8.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.914 1.686 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.03 147.15 34.01 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.411 1.885 . . . . 0.0 110.396 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.86 154.38 63.41 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.614 2.876 . . . . 0.0 111.36 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.48 -14.22 56.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.9 p -59.18 -27.51 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.633 1.173 . . . . 0.0 113.538 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.64 -9.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.563 1.145 . . . . 0.0 113.965 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -49.94 -46.03 81.12 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 120.369 -1.457 . . . . 0.0 112.716 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.19 -15.49 23.67 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.02 3.146 . . . . 0.0 116.119 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 tp -98.31 -45.7 6.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.88 1.272 . . . . 0.0 109.806 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -63.42 -45.36 91.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.032 1.333 . . . . 0.0 112.251 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -68.81 -38.5 79.94 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.57 -47.04 64.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.143 0.878 . . . . 0.0 112.936 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.33 -44.33 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.224 1.012 . . . . 0.0 110.652 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.85 -47.45 83.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.997 0.919 . . . . 0.0 112.524 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.22 -26.96 24.78 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -125.9 6.1 7.33 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 -169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.7 mt -123.03 -50.81 1.91 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.517 1.053 . . . . 0.0 111.48 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 -27.06 0.26 Allowed Glycine 0 CA--C 1.543 1.806 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -158.8 131.79 7.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.45 1.625 . . . . 0.0 110.845 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -159.12 52.84 0.52 Allowed Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.14 -32.28 39.26 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.463 2.775 . . . . 0.0 116.582 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -73.14 -13.19 61.13 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 tp -73.94 140.15 45.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.978 0.808 . . . . 0.0 111.845 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -135.45 144.14 46.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.102 1.761 . . . . 0.0 109.505 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -162.8 -169.43 2.06 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.29 163.05 31.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.798 2.142 . . . . 0.0 110.384 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.13 138.05 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 122.233 1.016 . . . . 0.0 112.62 -172.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.3 mt -122.1 131.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.323 1.849 . . . . 0.0 106.052 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.46 147.14 49.85 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.492 0.717 . . . . 0.0 110.36 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.8 tt -139.13 142.82 38.04 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.069 0.947 . . . . 0.0 111.601 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.58 -147.86 7.79 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.362 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -144.15 121.6 11.7 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.273 1.429 . . . . 0.0 110.029 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.5 p -62.41 -5.26 2.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.4 m -60.66 -13.2 13.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.433 1.493 . . . . 0.0 114.453 169.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -123.21 157.45 33.01 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 0.0 113.638 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 m -50.69 -23.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -168.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.99 1.84 4.3 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -173.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 14.5 t80 36.54 -128.83 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.832 1.253 . . . . 0.0 112.784 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.4 m -80.99 21.38 0.7 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.86 -33.27 48.98 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.34 95.52 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.758 1.163 . . . . 0.0 113.327 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.2 -40.25 71.27 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 121.613 -0.934 . . . . 0.0 112.95 171.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.01 -38.45 88.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.383 1.091 . . . . 0.0 113.132 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -59.05 -43.59 91.7 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.506 0.594 . . . . 0.0 111.776 170.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.66 -36.61 78.78 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.45 -43.09 98.38 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.811 -1.806 . . . . 0.0 111.711 170.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.17 69.87 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 tp -49.75 -28.36 6.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 112.956 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 mt -102.35 -37.69 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 -169.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.1 -31.9 73.04 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.938 1.244 . . . . 0.0 111.533 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.02 -17.33 24.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 113.024 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -119.81 16.53 12.68 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.122 1.769 . . . . 0.0 112.463 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m 67.74 18.64 9.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.91 2.084 . . . . 0.0 115.515 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.7 152.75 18.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.425 -0.797 . . . . 0.0 112.386 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -122.43 86.91 2.66 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.906 1.682 . . . . 0.0 110.904 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 ttm105 -61.83 141.58 57.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.675 -0.64 . . . . 0.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.83 33.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.484 1.514 . . . . 0.0 111.204 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.8 -163.29 37.02 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.07 -1.019 . . . . 0.0 113.222 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.25 156.48 43.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.71 1.604 . . . . 0.0 111.293 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.8 ttm -65.19 127.08 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.302 1.041 . . . . 0.0 111.776 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -82.3 134.42 35.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.57 93.76 4.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.01 1.324 . . . . 0.0 111.522 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.9 mt -82.5 132.03 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 0.0 110.479 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -131.75 107.71 8.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 112.352 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -19.06 31.67 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 m -69.28 -14.11 62.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.915 1.234 . . . . 0.0 114.212 171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.38 -12.53 1.59 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -142.91 102.56 5.29 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.29 0.95 . . . . 0.0 112.514 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.72 1.7 9.0 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.87 3.046 . . . . 0.0 114.267 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -121.53 77.0 36.06 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.342 1.857 . . . . 0.0 109.729 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.09 -24.81 78.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.21 3.273 . . . . 0.0 114.861 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.15 -44.58 71.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 111.969 170.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.2 p -66.06 -20.63 66.24 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.98 -15.76 27.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 112.675 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.8 p -123.26 -28.8 3.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -54.2 -52.89 64.71 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 119.503 1.047 . . . . 0.0 113.68 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.35 -29.0 32.46 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.777 1.652 . . . . 0.0 112.673 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.13 -48.73 78.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.787 0.721 . . . . 0.0 111.62 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 t -67.79 -40.37 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 118.425 0.557 . . . . 0.0 110.331 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.39 -40.16 85.7 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.595 0.634 . . . . 0.0 111.911 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -65.03 -58.43 6.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -53.24 -46.78 69.31 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.086 0.954 . . . . 0.0 111.701 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.98 -24.17 13.55 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.123 1.821 . . . . 0.0 116.382 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.7 p -71.43 -19.81 62.19 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.933 1.866 . . . . 0.0 114.072 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.93 -16.25 25.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.243 1.417 . . . . 0.0 112.977 -170.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.37 155.23 21.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.529 2.332 . . . . 0.0 111.599 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 124.772 1.229 . . . . 0.0 113.585 174.112 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.35 178.97 4.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.727 1.611 . . . . 0.0 112.901 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -129.23 118.03 21.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.724 2.01 . . . . 0.0 108.032 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.99 126.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.05 131.72 10.68 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mt -120.9 91.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.271 1.428 . . . . 0.0 107.439 -171.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -92.58 141.55 28.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.989 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.8 148.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.569 0.748 . . . . 0.0 112.071 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.31 97.54 0.21 Allowed Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.165 1.364 . . . . 0.0 110.406 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -144.34 168.38 20.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.23 -24.37 6.45 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.312 1.845 . . . . 0.0 112.558 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -134.7 -4.65 2.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 2.09 64.57 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -64.94 -45.41 85.9 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 1.591 . . . . 0.0 112.123 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -69.43 -36.22 76.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.093 1.357 . . . . 0.0 112.408 172.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.4 tp -59.39 -42.13 91.01 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.956 -1.09 . . . . 0.0 112.715 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.9 -41.88 78.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.653 0.661 . . . . 0.0 111.575 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.53 -35.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.662 -0.649 . . . . 0.0 112.271 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.74 97.09 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.179 -0.951 . . . . 0.0 112.504 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.76 -41.04 99.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.668 . . . . 0.0 112.398 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.04 -46.46 88.15 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.504 -0.748 . . . . 0.0 111.652 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.52 85.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.389 0.676 . . . . 0.0 112.217 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.64 -47.65 76.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.777 0.831 . . . . 0.0 111.882 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.19 -47.4 86.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.538 0.735 . . . . 0.0 112.843 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.94 -45.56 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.591 1.156 . . . . 0.0 111.887 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.5 mt -69.59 -41.41 75.81 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.734 -0.604 . . . . 0.0 109.791 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -56.64 -45.65 81.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.872 1.269 . . . . 0.0 111.998 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.8 -38.0 85.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.986 0.914 . . . . 0.0 113.1 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -70.76 -23.07 62.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.3 -8.27 7.94 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.323 1.44 . . . . 0.0 114.981 170.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.13 167.52 20.09 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.654 1.182 . . . . 0.0 112.111 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -100.89 137.87 38.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.323 1.449 . . . . 0.0 109.474 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.28 159.16 43.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.269 0.628 . . . . 0.0 112.432 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -153.77 119.84 5.39 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.974 0.91 . . . . 0.0 111.133 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.7 t -74.26 141.79 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.222 1.009 . . . . 0.0 110.801 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.4 104.28 7.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.856 1.262 . . . . 0.0 110.586 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.65 -17.34 38.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -142.35 60.87 10.91 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.563 1.545 . . . . 0.0 110.582 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.91 166.31 29.98 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.374 3.383 . . . . 0.0 115.694 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.35 162.74 37.53 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.637 2.375 . . . . 0.0 109.181 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.92 -38.49 56.51 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.691 -1.255 . . . . 0.0 113.655 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -62.23 -13.96 33.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -92.06 -25.48 18.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.669 1.122 . . . . 0.0 112.807 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -80.98 -40.76 23.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.557 1.543 . . . . 0.0 112.617 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 tp -50.08 -41.01 61.53 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -55.38 -9.63 2.61 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 125.108 3.872 . . . . 0.0 118.349 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -118.17 4.54 11.97 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -70.06 -9.86 56.79 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -110.65 17.72 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.423 1.489 . . . . 0.0 112.613 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.52 -135.62 0.16 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.572 1.949 . . . . 0.0 110.209 -169.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.63 159.82 38.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.702 1.601 . . . . 0.0 111.145 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.78 178.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.102 1.361 . . . . 0.0 111.581 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.7 149.31 25.07 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.538 1.935 . . . . 0.0 108.232 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.33 133.44 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.577 1.151 . . . . 0.0 108.867 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.27 90.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.032 1.333 . . . . 0.0 109.47 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 m -134.39 157.34 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 t -130.76 -164.66 1.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.487 1.515 . . . . 0.0 112.747 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 m -130.69 150.14 52.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.519 1.928 . . . . 0.0 111.318 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 t -148.48 -171.18 3.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.315 2.246 . . . . 0.0 108.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 49.03 35.13 17.88 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.549 1.547 . . . . 0.0 116.122 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 63.57 4.0 1.67 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 127.461 2.304 . . . . 0.0 115.361 -174.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.01 39.79 0.02 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.09 162.2 36.15 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.282 1.541 . . . . 0.0 112.334 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.11 151.59 95.98 Favored Pre-proline 0 CA--C 1.553 1.089 0 O-C-N 121.682 -0.637 . . . . 0.0 111.739 170.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.91 158.33 20.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.391 2.728 . . . . 0.0 112.332 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.2 -21.39 63.79 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -57.27 -17.42 11.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.741 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -132.88 -9.49 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.83 -49.32 38.38 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.599 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.27 -24.72 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.967 1.738 . . . . 0.0 113.7 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.94 -47.49 45.11 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.367 -0.833 . . . . 0.0 110.118 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -58.68 -50.88 72.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.746 1.619 . . . . 0.0 112.151 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -62.88 -41.36 99.37 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.203 -0.935 . . . . 0.0 112.349 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.89 -47.67 80.25 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.451 1.024 . . . . 0.0 113.141 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.59 -39.4 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 118.979 1.39 . . . . 0.0 111.316 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.15 -47.88 75.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.087 0.555 . . . . 0.0 111.751 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.31 -36.29 24.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.9 m -84.15 -30.81 25.57 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.3 mt -100.13 -49.5 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.876 0.762 . . . . 0.0 112.622 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.67 -34.3 0.28 Allowed Glycine 0 CA--C 1.544 1.877 0 C-N-CA 126.21 1.862 . . . . 0.0 116.143 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -158.17 135.75 10.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.833 2.053 . . . . 0.0 110.349 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -156.87 97.77 2.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.939 0.895 . . . . 0.0 112.862 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.85 -20.72 10.18 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.473 2.782 . . . . 0.0 114.418 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -80.66 -17.21 51.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -174.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.9 tp -70.72 138.68 50.75 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 111.779 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -137.49 138.66 39.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 108.966 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -163.5 -173.37 3.29 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.48 162.87 28.49 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.393 1.949 . . . . 0.0 109.038 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.79 132.09 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.015 0.907 . . . . 0.0 112.971 -169.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.19 128.07 74.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.54 155.02 44.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.297 1.046 . . . . 0.0 110.293 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -139.53 151.85 46.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.342 1.057 . . . . 0.0 108.705 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.39 -144.26 7.86 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 112.078 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -137.77 121.27 17.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.916 0.887 . . . . 0.0 110.559 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.1 p -71.99 -2.17 17.22 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -69.92 4.2 2.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -136.87 159.39 41.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.21 1.804 . . . . 0.0 112.425 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.19 -32.42 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.83 1.252 . . . . 0.0 113.412 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -103.94 44.11 1.04 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.812 1.245 . . . . 0.0 112.409 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -49.38 111.37 0.48 Allowed 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.677 -1.264 . . . . 0.0 112.289 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.7 m 52.78 28.15 6.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.22 2.208 . . . . 0.0 116.955 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -53.22 -40.99 64.93 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.445 1.02 . . . . 0.0 112.225 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -36.89 92.84 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 122.132 -0.355 . . . . 0.0 113.134 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.19 46.58 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.557 -0.967 . . . . 0.0 113.052 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.91 -34.49 76.15 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.649 1.179 . . . . 0.0 113.057 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -60.43 -42.76 96.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.47 0.577 . . . . 0.0 111.626 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -71.47 -28.77 64.17 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -64.77 -50.91 64.97 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.624 -1.297 . . . . 0.0 110.241 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 -40.13 72.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.498 0.719 . . . . 0.0 112.901 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.5 tp -49.61 -27.32 4.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 114.111 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.0 -38.42 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 111.782 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -69.71 -16.16 63.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.895 0.878 . . . . 0.0 112.73 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -109.06 -15.3 14.37 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -170.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 m 112.73 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 129.731 3.212 . . . . 0.0 114.013 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.92 147.42 23.76 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 118.886 0.766 . . . . 0.0 111.898 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -121.72 84.02 2.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 109.855 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mtm105 -60.84 152.41 27.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.58 27.89 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.936 1.695 . . . . 0.0 110.869 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.2 175.06 46.93 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.372 1.939 . . . . 0.0 112.184 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -123.27 157.88 32.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.373 1.469 . . . . 0.0 111.88 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.9 ttm -63.92 117.02 6.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.369 1.068 . . . . 0.0 112.171 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.01 141.34 37.55 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.0 81.68 2.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 111.64 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.34 136.74 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 110.139 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.496 ' CG ' ' HG ' ' A' ' 128' ' ' SER . 61.9 t0 -131.26 98.5 4.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.513 1.149 . . . . 0.0 113.679 -169.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.13 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.323 1.449 . . . . 0.0 114.695 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.496 ' HG ' ' CG ' ' A' ' 126' ' ' ASP . 54.4 p -67.6 -19.42 65.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.567 1.076 . . . . 0.0 113.099 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.32 -8.94 1.13 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -134.63 108.64 10.98 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.018 0.927 . . . . 0.0 112.943 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.82 -0.63 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.336 3.358 . . . . 0.0 114.427 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.62 78.49 68.6 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.225 1.81 . . . . 0.0 109.713 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -60.58 -19.77 61.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.086 3.19 . . . . 0.0 115.368 -169.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -66.93 -29.69 69.62 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.962 -1.087 . . . . 0.0 113.893 172.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.7 p -68.24 -5.23 17.24 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -117.0 -8.76 11.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.131 1.372 . . . . 0.0 112.67 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -127.14 -27.1 3.01 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.11 -52.56 67.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.286 169.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.24 -30.24 37.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.643 1.562 . . . . 0.0 113.325 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -58.74 -50.03 75.44 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.891 0.769 . . . . 0.0 111.136 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t -67.85 -41.53 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.676 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -59.63 -39.62 84.91 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.782 0.719 . . . . 0.0 112.117 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -67.93 -58.86 3.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 111.891 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -54.43 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.713 1.205 . . . . 0.0 112.318 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.87 -23.77 16.71 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.914 1.721 . . . . 0.0 115.905 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.4 p -71.82 -17.65 62.14 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.735 1.767 . . . . 0.0 113.954 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.7 mt -93.95 -16.85 23.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.369 1.468 . . . . 0.0 112.996 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.44 150.49 35.34 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.224 2.21 . . . . 0.0 111.747 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.648 1.579 . . . . 0.0 113.624 177.819 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.34 171.01 8.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.114 1.366 . . . . 0.0 112.07 174.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -139.96 119.81 13.45 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.07 1.748 . . . . 0.0 108.647 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.93 127.44 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.06 130.88 10.16 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 168.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -116.23 88.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.337 1.455 . . . . 0.0 107.176 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -88.46 126.73 35.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.857 -169.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.66 143.6 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.734 0.813 . . . . 0.0 110.691 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.35 96.64 0.27 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -143.87 170.34 16.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.546 1.138 . . . . 0.0 111.897 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.4 -0.63 5.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.756 1.223 . . . . 0.0 113.553 169.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -146.41 -24.05 0.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.36 -9.47 5.6 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 118.575 2.19 . . . . 0.0 118.575 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.08 -41.64 92.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.645 2.222 . . . . 0.0 113.432 -173.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -78.19 -34.64 49.36 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.763 -0.586 . . . . 0.0 111.993 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.2 tp -55.99 -39.76 72.31 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.066 -1.022 . . . . 0.0 113.069 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.15 -40.7 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 111.713 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -71.02 -41.26 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.907 0.483 . . . . 0.0 111.937 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.08 88.15 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.015 0.825 . . . . 0.0 112.499 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -60.56 -43.38 97.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.108 0.963 . . . . 0.0 112.676 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.48 -41.52 88.85 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.508 -0.745 . . . . 0.0 112.886 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.55 92.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.544 0.738 . . . . 0.0 111.809 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.5 -47.07 80.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.869 0.468 . . . . 0.0 111.869 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.91 88.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 112.694 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.7 -45.66 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.524 1.13 . . . . 0.0 111.892 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.9 mt -72.62 -38.16 67.85 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.4 m -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.454 1.101 . . . . 0.0 111.819 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.8 82.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.097 0.959 . . . . 0.0 113.157 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -73.07 -8.82 57.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 172.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.55 -2.46 32.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.428 1.49 . . . . 0.0 115.067 170.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -80.22 165.56 22.26 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.734 1.214 . . . . 0.0 112.631 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.5 134.18 35.22 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.08 142.32 31.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.193 0.597 . . . . 0.0 112.108 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.3 m -144.72 109.36 4.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.247 1.019 . . . . 0.0 111.025 -172.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -73.98 144.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -131.72 108.94 9.82 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.525 1.53 . . . . 0.0 108.442 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.8 -28.48 40.25 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -144.83 58.03 5.02 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.428 1.891 . . . . 0.0 110.1 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.73 159.65 52.81 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.768 2.979 . . . . 0.0 113.829 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.28 163.85 26.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.0 2.12 . . . . 0.0 108.926 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tt -42.47 -44.62 4.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.347 1.459 . . . . 0.0 112.881 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -54.78 -26.46 34.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.928 1.691 . . . . 0.0 114.849 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -81.16 -35.98 30.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.413 1.085 . . . . 0.0 112.333 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -75.68 -39.01 58.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.883 0.873 . . . . 0.0 112.419 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -36.31 -56.02 1.31 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.098 2.559 . . . . 0.0 115.422 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.42 -18.71 22.75 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.38 2.054 . . . . 0.0 114.748 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -78.54 -0.89 31.4 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -58.72 -25.97 63.46 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.745 -1.222 . . . . 0.0 113.795 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -97.1 12.49 32.48 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.355 1.462 . . . . 0.0 112.632 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -134.25 -145.62 0.24 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.004 2.522 . . . . 0.0 109.3 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.21 162.97 29.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.232 1.813 . . . . 0.0 109.408 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -148.34 171.79 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.356 1.062 . . . . 0.0 111.662 -175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.18 144.43 17.32 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.365 -0.835 . . . . 0.0 110.894 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.77 130.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.937 1.695 . . . . 0.0 110.565 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.46 89.07 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -134.66 136.11 42.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -168.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -87.85 -170.08 2.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.943 2.097 . . . . 0.0 113.069 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 83.0 m -136.67 138.53 41.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.401 1.081 . . . . 0.0 111.32 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -155.49 -171.01 3.63 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.813 1.188 . . . . 0.0 111.62 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.8 -74.13 0.05 OUTLIER Glycine 0 CA--C 1.54 1.625 0 C-N-CA 128.207 2.813 . . . . 0.0 115.784 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -140.69 11.62 2.27 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.03 2.132 . . . . 0.0 111.835 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.25 38.48 1.65 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.269 0.938 . . . . 0.0 112.902 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -135.65 179.51 6.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.945 1.698 . . . . 0.0 112.658 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.78 142.25 98.52 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.53 1.132 . . . . 0.0 112.118 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.17 153.17 24.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.644 2.896 . . . . 0.0 111.973 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.32 -26.71 66.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -62.7 -11.15 15.52 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 tt -126.2 -3.42 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -53.53 -43.89 96.6 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 117.148 -1.406 . . . . 0.0 112.356 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.04 -5.37 2.73 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.373 3.382 . . . . 0.0 116.659 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mt -105.88 -48.48 3.62 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.461 1.105 . . . . 0.0 110.308 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.41 -41.34 96.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.666 0.787 . . . . 0.0 112.685 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -67.35 -44.44 79.05 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.451 -0.781 . . . . 0.0 112.214 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.98 -41.91 39.0 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.907 0.765 . . . . 0.0 113.938 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.16 -42.94 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.024 0.912 . . . . 0.0 110.053 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -66.16 -50.19 64.78 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.593 0.757 . . . . 0.0 112.234 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.44 -31.02 42.47 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.1 t -116.01 -43.36 2.99 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -169.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.48 -44.34 58.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.459 1.027 . . . . 0.0 111.709 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.15 -28.95 0.2 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 126.679 2.085 . . . . 0.0 118.142 169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -155.62 138.31 15.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.836 1.654 . . . . 0.0 110.102 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.6 39.59 0.19 Allowed Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -169.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.8 -34.08 15.22 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.476 2.784 . . . . 0.0 118.054 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -72.34 -20.24 61.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.14 118.46 13.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.271 1.428 . . . . 0.0 110.16 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -117.91 139.92 50.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.382 1.473 . . . . 0.0 110.127 174.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.67 -169.05 1.97 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -168.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.3 32.62 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.231 2.348 . . . . 0.0 110.318 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.36 128.81 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.695 0.76 . . . . 0.0 111.644 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -118.13 95.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.15 153.52 24.76 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.05 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -142.64 152.99 43.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.108 0.956 . . . . 0.0 111.502 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.57 -130.1 1.66 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.862 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.77 136.34 21.72 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.252 1.421 . . . . 0.0 111.533 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.5 p -68.83 -4.19 15.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -68.4 3.69 1.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -135.08 151.64 50.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.371 1.468 . . . . 0.0 112.277 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.42 -37.14 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.883 0.873 . . . . 0.0 111.483 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -75.26 39.13 0.14 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.817 1.647 . . . . 0.0 112.907 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -52.21 116.06 2.04 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 119.653 -1.904 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 82.8 m 50.74 23.59 1.44 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.735 2.414 . . . . 0.0 117.174 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.3 -14.1 59.99 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.589 -1.319 . . . . 0.0 114.247 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.45 -28.54 63.43 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.134 -0.979 . . . . 0.0 113.414 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.21 -37.97 6.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.323 1.062 . . . . 0.0 113.313 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -56.66 -39.73 74.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.42 1.11 . . . . 0.0 113.658 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -60.11 -32.79 71.32 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -74.63 -22.2 59.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.56 -44.47 34.58 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.028 -1.67 . . . . 0.0 110.068 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.63 66.92 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 tp -50.67 -28.41 8.89 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.259 1.824 . . . . 0.0 113.322 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.01 -37.13 6.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.953 1.301 . . . . 0.0 111.997 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -68.8 -31.82 71.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.176 -0.952 . . . . 0.0 113.076 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.5 -10.66 36.53 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.123 0.874 . . . . 0.0 111.96 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -115.16 12.08 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.13 1.772 . . . . 0.0 112.816 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m 65.57 20.34 11.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.49 1.516 . . . . 0.0 114.86 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.45 169.5 0.89 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.667 0.787 . . . . 0.0 111.589 169.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -133.57 90.85 2.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.493 -1.379 . . . . 0.0 111.548 -169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -63.89 134.37 55.02 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.439 -0.788 . . . . 0.0 110.924 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.39 29.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.651 1.58 . . . . 0.0 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.61 -168.43 41.49 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.633 1.111 . . . . 0.0 113.852 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.29 152.26 26.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.65 1.58 . . . . 0.0 111.259 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.1 ttm -71.92 138.1 47.88 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.075 0.95 . . . . 0.0 111.957 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.07 137.22 33.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.545 0.738 . . . . 0.0 109.042 169.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.6 mt -119.76 93.45 4.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.686 1.594 . . . . 0.0 110.884 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.4 mt -79.26 135.76 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.537 0.735 . . . . 0.0 111.357 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -124.5 113.05 17.6 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.374 1.47 . . . . 0.0 112.047 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.19 62.95 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.7 m -80.9 1.06 32.53 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.53 1.132 . . . . 0.0 113.553 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -126.52 -27.94 3.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.07 1.348 . . . . 0.0 112.855 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -143.82 117.53 5.93 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.83 0.852 . . . . 0.0 112.85 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.92 -5.72 13.91 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.925 3.084 . . . . 0.0 114.548 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -130.58 76.2 77.79 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.827 1.651 . . . . 0.0 110.662 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -41.69 -34.89 2.44 Favored 'Trans proline' 0 C--N 1.354 0.857 1 C-N-CA 126.001 4.468 . . . . 0.0 118.016 -169.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -51.64 -39.06 57.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.1 p -69.75 -4.89 21.83 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.037 -1.039 . . . . 0.0 113.598 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -121.76 6.03 9.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.43 1.492 . . . . 0.0 112.416 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.1 p -141.26 -26.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -55.05 -51.75 76.87 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.921 1.237 . . . . 0.0 113.433 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.48 -28.62 53.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.673 1.582 . . . . 0.0 113.052 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -60.91 -50.51 73.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.384 0.538 . . . . 0.0 111.297 170.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.51 -42.74 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.007 0.821 . . . . 0.0 110.488 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.59 -34.75 74.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.87 -64.27 0.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.074 0.852 . . . . 0.0 111.313 169.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -51.06 -49.16 61.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.57 1.548 . . . . 0.0 112.144 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.74 -26.3 24.72 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.368 1.461 . . . . 0.0 115.546 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -75.95 -15.5 60.16 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.232 1.516 . . . . 0.0 114.159 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.75 -15.94 33.44 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.181 0.992 . . . . 0.0 113.074 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.6 -18.16 65.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.337 1.455 . . . . 0.0 114.113 -175.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.948 1.699 . . . . 0.0 113.936 -171.177 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.5 -178.24 3.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.397 1.479 . . . . 0.0 112.826 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -126.99 130.13 49.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 109.503 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.41 126.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -171.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.03 130.72 10.07 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.7 mt -118.26 86.71 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.021 1.329 . . . . 0.0 107.594 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.284 -170.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.38 140.26 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.112 0.482 . . . . 0.0 111.416 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.4 112.46 1.35 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -153.77 152.04 30.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.832 0.853 . . . . 0.0 112.715 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.8 mmm -95.66 -25.18 16.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.166 0.987 . . . . 0.0 112.732 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.93 -12.37 0.65 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.39 -9.06 8.86 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 116.601 1.401 . . . . 0.0 116.601 170.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -61.23 -41.42 96.85 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.691 1.745 . . . . 0.0 113.078 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -76.59 -34.44 58.41 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.188 0.995 . . . . 0.0 112.059 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.39 -39.41 83.28 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.682 -1.261 . . . . 0.0 113.208 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.2 tp -52.96 -47.47 68.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.382 0.992 . . . . 0.0 111.558 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.58 -35.14 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.81 0.444 . . . . 0.0 111.586 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 -37.05 80.3 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.55 -42.5 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.547 -0.72 . . . . 0.0 111.593 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.87 -46.21 85.19 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.264 0.626 . . . . 0.0 111.981 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.89 87.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.359 0.527 . . . . 0.0 112.136 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.86 -48.36 75.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.985 0.514 . . . . 0.0 111.512 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.76 84.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.659 0.784 . . . . 0.0 112.754 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.9 mt -58.61 -46.3 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.653 1.181 . . . . 0.0 111.83 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.48 -40.01 67.25 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.876 -0.515 . . . . 0.0 109.869 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.0 m -56.98 -44.8 83.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.495 1.118 . . . . 0.0 112.159 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.79 83.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.067 0.947 . . . . 0.0 112.961 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.69 -23.9 63.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.38 -13.1 6.63 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.53 1.538 . . . . 0.0 114.832 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -71.44 143.4 50.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.255 1.028 . . . . 0.0 111.535 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -71.95 133.79 45.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 157.78 45.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.51 0.724 . . . . 0.0 111.977 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -151.63 110.53 3.86 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.65 150.71 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.721 0.808 . . . . 0.0 111.269 169.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -127.59 171.76 11.35 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.23 1.412 . . . . 0.0 111.592 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -128.7 -36.16 1.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -142.43 55.57 4.52 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 126.379 1.872 . . . . 0.0 111.511 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.01 155.58 54.64 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.063 3.175 . . . . 0.0 113.945 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.23 174.21 10.46 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.427 1.891 . . . . 0.0 110.165 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.16 -34.73 58.14 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.635 -1.291 . . . . 0.0 112.175 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.5 m -54.76 -21.8 12.16 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -96.34 -25.68 15.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.004 1.721 . . . . 0.0 112.614 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -74.18 -39.6 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.228 1.011 . . . . 0.0 112.809 171.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -49.11 31.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.647 1.979 . . . . 0.0 113.349 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.25 -7.82 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.288 2.658 . . . . 0.0 115.942 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -127.82 0.36 6.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.867 1.667 . . . . 0.0 114.106 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.19 -23.12 63.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.401 1.455 . . . . 0.0 113.953 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -98.59 13.38 32.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.371 2.268 . . . . 0.0 113.302 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -139.45 -172.06 3.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.585 1.954 . . . . 0.0 111.648 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -76.62 154.52 34.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.064 0.935 . . . . 0.0 111.835 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.27 170.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.483 1.913 . . . . 0.0 110.264 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.93 153.24 22.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.57 0.748 . . . . 0.0 110.656 176.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.95 140.29 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.16 0.984 . . . . 0.0 111.764 -169.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 t -136.15 103.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.384 1.074 . . . . 0.0 110.249 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.6 m -140.43 143.09 35.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -93.67 -170.42 2.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.8 1.64 . . . . 0.0 113.497 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.3 m -135.95 137.22 41.08 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 111.626 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -161.43 -148.27 0.15 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.819 2.448 . . . . 0.0 107.214 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 41.94 44.87 4.73 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 126.227 1.87 . . . . 0.0 117.171 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 63.92 26.04 14.11 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 113.997 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.11 26.43 3.51 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.198 1.38 . . . . 0.0 114.302 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -132.26 178.24 6.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 111.628 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -80.24 155.25 74.6 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.128 -0.983 . . . . 0.0 113.571 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.73 152.01 82.49 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.01 3.14 . . . . 0.0 113.446 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.16 -20.4 65.36 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.8 p -64.71 -13.1 53.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.334 1.454 . . . . 0.0 114.683 171.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.79 -7.4 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.706 1.202 . . . . 0.0 113.919 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -47.19 -50.73 45.9 Favored Pre-proline 0 N--CA 1.481 1.09 0 O-C-N 120.307 -1.496 . . . . 0.0 113.035 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.07 -4.91 16.06 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.135 1.89 . . . . 0.0 114.253 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.36 -47.15 7.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.907 0.883 . . . . 0.0 109.134 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.37 -50.71 68.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.998 1.319 . . . . 0.0 112.107 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -62.75 -39.02 92.83 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.196 -0.94 . . . . 0.0 112.829 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.69 -41.93 48.59 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.445 1.022 . . . . 0.0 112.514 -174.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.98 -45.19 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.426 1.113 . . . . 0.0 109.482 174.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.09 -50.0 74.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.261 1.024 . . . . 0.0 112.301 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.21 -34.68 56.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.098 0.959 . . . . 0.0 113.542 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -96.72 -35.89 10.85 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -169.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 mp -89.44 -44.01 10.46 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.375 0.988 . . . . 0.0 113.365 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.44 -39.87 0.36 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 126.371 1.938 . . . . 0.0 117.118 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -157.71 134.21 9.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.511 1.524 . . . . 0.0 110.954 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -158.54 52.92 0.56 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.02 -21.38 73.1 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.96 2.44 . . . . 0.0 115.052 -173.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -72.0 -21.61 61.54 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.935 1.294 . . . . 0.0 113.876 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.97 138.64 38.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 111.114 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -133.38 143.64 49.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.691 1.996 . . . . 0.0 109.929 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.35 -170.86 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.63 28.82 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 127.676 2.56 . . . . 0.0 109.345 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.43 136.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 117.942 0.871 . . . . 0.0 110.516 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.71 104.81 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.23 25.42 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.571 -0.706 . . . . 0.0 109.871 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -139.26 153.17 47.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.227 1.011 . . . . 0.0 111.106 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.31 -147.66 11.3 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.065 0.84 . . . . 0.0 111.46 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.12 121.32 16.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.57 1.948 . . . . 0.0 109.235 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.6 p -67.12 -2.89 6.23 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -64.01 -25.6 68.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.064 0.946 . . . . 0.0 113.16 170.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -86.49 145.74 26.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.114 0.965 . . . . 0.0 112.14 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.05 -36.33 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.504 1.121 . . . . 0.0 112.422 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -87.14 -1.1 57.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.5 t80 26.72 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.569 2.747 . . . . 0.0 115.699 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 27.9 p -121.94 17.16 10.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.138 1.775 . . . . 0.0 113.853 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.03 -31.04 39.06 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.82 1.248 . . . . 0.0 113.959 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.62 -35.28 80.18 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 123.636 0.636 . . . . 0.0 113.558 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.81 -41.86 14.17 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 120.94 -1.33 . . . . 0.0 113.022 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -57.08 -36.29 70.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.139 0.976 . . . . 0.0 113.248 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -58.12 -40.03 80.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.466 0.706 . . . . 0.0 112.689 172.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.37 -30.72 62.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.45 1.023 . . . . 0.0 112.618 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.36 -45.21 92.21 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.201 -1.562 . . . . 0.0 110.55 169.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.7 -37.56 76.36 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.3 tp -52.79 -33.82 50.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.841 1.257 . . . . 0.0 112.342 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.44 -37.67 10.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.713 1.205 . . . . 0.0 111.771 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.19 -32.82 74.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.091 -1.006 . . . . 0.0 113.429 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.47 -13.26 38.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.444 1.098 . . . . 0.0 112.588 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.32 8.07 14.12 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.556 1.542 . . . . 0.0 112.114 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 m 71.65 17.66 5.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.855 2.062 . . . . 0.0 114.454 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 168.94 1.34 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.94 0.896 . . . . 0.0 111.691 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -131.13 101.67 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.734 -1.229 . . . . 0.0 112.088 -169.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 ttm105 -67.35 134.12 50.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.923 -1.11 . . . . 0.0 111.182 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.53 31.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.726 1.61 . . . . 0.0 111.781 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.05 -178.47 45.02 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.473 -1.392 . . . . 0.0 114.027 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.31 136.56 33.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.449 1.099 . . . . 0.0 110.589 170.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.0 ttp -63.4 127.58 31.93 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.874 0.87 . . . . 0.0 111.216 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.81 139.46 31.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 109.644 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.3 mt -123.95 90.42 3.26 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.858 1.263 . . . . 0.0 111.058 -176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -72.13 136.56 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.182 0.993 . . . . 0.0 110.673 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -129.7 105.65 8.18 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.047 1.339 . . . . 0.0 111.471 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.32 27.44 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -82.92 -6.55 59.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.445 1.02 . . . . 0.0 113.721 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.64 -26.34 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.571 . . . . 0.0 112.52 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -143.01 113.07 5.76 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.811 1.245 . . . . 0.0 111.239 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.69 -1.38 11.55 Favored 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.646 2.897 . . . . 0.0 114.497 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.43 79.12 74.55 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.485 1.514 . . . . 0.0 111.6 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.43 -34.31 7.38 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.782 4.321 . . . . 0.0 116.781 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -52.31 -45.76 65.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 112.233 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -17.0 64.42 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -95.89 -5.65 41.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.211 1.405 . . . . 0.0 112.705 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.31 -30.04 0.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -51.64 -53.83 46.2 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 119.533 1.061 . . . . 0.0 113.451 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.62 -29.52 29.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.556 1.504 . . . . 0.0 113.013 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.2 -48.06 81.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.439 0.695 . . . . 0.0 111.404 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.7 t -67.67 -41.19 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.565 0.62 . . . . 0.0 110.614 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -58.89 -41.74 87.9 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.741 0.701 . . . . 0.0 111.896 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -65.43 -57.78 7.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.874 0.87 . . . . 0.0 112.162 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -53.98 -44.32 70.7 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 111.9 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.34 -19.99 35.0 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.502 1.525 . . . . 0.0 115.995 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p -72.07 -19.0 61.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.982 1.891 . . . . 0.0 113.974 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.9 mt -93.23 -16.41 24.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.107 1.363 . . . . 0.0 113.061 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.22 150.19 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.505 2.322 . . . . 0.0 111.624 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.389 1.475 . . . . 0.0 113.689 179.721 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.487 0.184 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.14 -176.88 4.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.591 1.956 . . . . 0.0 110.914 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -140.51 123.96 16.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.555 1.142 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 mm -124.27 136.67 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.93 127.41 9.22 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.3 mt -117.6 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.466 1.106 . . . . 0.0 108.591 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -91.56 138.28 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.037 0.935 . . . . 0.0 111.492 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.63 143.37 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.684 0.754 . . . . 0.0 111.457 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.48 90.39 0.21 Allowed Glycine 0 N--CA 1.463 0.495 0 C-N-CA 125.347 1.451 . . . . 0.0 109.653 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -134.66 165.73 24.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.173 0.989 . . . . 0.0 113.235 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -121.63 -32.14 3.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.179 1.792 . . . . 0.0 110.996 -175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -134.5 -5.3 2.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.611 1.564 . . . . 0.0 113.861 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -0.56 52.92 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.362 1.081 . . . . 0.0 112.776 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -76.19 -32.71 59.15 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.546 1.138 . . . . 0.0 112.872 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.87 -39.03 80.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.641 -1.287 . . . . 0.0 112.796 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.55 -41.17 72.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.572 0.623 . . . . 0.0 111.751 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.9 -35.19 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 121.753 -0.592 . . . . 0.0 112.205 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.59 95.33 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.201 -0.937 . . . . 0.0 112.662 172.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.99 -41.06 97.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.356 0.662 . . . . 0.0 112.337 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.61 -46.79 87.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.535 -0.728 . . . . 0.0 111.902 169.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.5 88.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.224 0.61 . . . . 0.0 112.317 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.15 -47.02 79.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 111.993 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -45.66 92.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.419 0.688 . . . . 0.0 112.643 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.68 -47.38 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.569 1.148 . . . . 0.0 112.094 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -68.39 -39.77 81.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 109.744 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.8 m -55.77 -50.48 70.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.7 1.2 . . . . 0.0 111.855 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.3 77.65 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -77.31 -5.52 49.82 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.84 24.32 10.0 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.918 0.781 . . . . 0.0 114.648 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -115.93 145.69 42.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.742 1.217 . . . . 0.0 111.389 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -74.27 138.25 43.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.13 43.27 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.606 -0.684 . . . . 0.0 111.994 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -154.7 120.13 5.06 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.76 176.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.0 140.26 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.18 0.992 . . . . 0.0 110.958 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.09 110.65 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.002 1.321 . . . . 0.0 109.701 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.99 -17.66 28.97 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -144.93 56.65 3.87 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.635 1.574 . . . . 0.0 110.612 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.34 162.21 40.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.941 3.094 . . . . 0.0 115.185 -169.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.67 175.07 9.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.213 2.205 . . . . 0.0 109.668 169.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -50.73 -40.85 55.56 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.902 -1.124 . . . . 0.0 112.414 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -58.43 -14.77 8.49 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -96.81 -27.33 14.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -82.46 -39.61 22.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.452 1.501 . . . . 0.0 112.221 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -49.16 -45.3 75.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.849 1.66 . . . . 0.0 114.495 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -57.29 -10.6 6.64 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.225 2.617 . . . . 0.0 116.899 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -114.65 4.27 15.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.74 -23.32 67.32 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.263 1.392 . . . . 0.0 114.273 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -92.32 4.2 53.84 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.948 1.299 . . . . 0.0 113.525 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -130.89 -141.06 0.22 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.46 2.304 . . . . 0.0 109.771 -169.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.16 158.7 34.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.672 1.189 . . . . 0.0 111.361 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.96 168.77 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.274 1.429 . . . . 0.0 110.936 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.97 149.63 19.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.98 0.912 . . . . 0.0 110.387 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.87 135.26 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.052 1.341 . . . . 0.0 110.302 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.3 90.73 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.153 1.381 . . . . 0.0 107.581 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.8 m -133.57 168.36 18.79 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -141.51 -174.33 4.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.106 1.363 . . . . 0.0 113.432 -171.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.8 m -131.62 135.61 47.08 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.609 1.164 . . . . 0.0 110.824 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 t -153.71 -167.37 2.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.393 1.877 . . . . 0.0 109.929 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.52 -129.87 9.16 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 126.039 1.781 . . . . 0.0 114.078 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -65.79 -4.23 6.29 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.51 39.52 1.0 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.985 1.279 . . . . 0.0 112.574 -170.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -135.13 176.41 8.69 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.602 1.961 . . . . 0.0 113.85 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.37 136.54 60.74 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.146 1.378 . . . . 0.0 113.283 171.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.27 150.19 89.26 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.55 2.833 . . . . 0.0 111.523 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -60.65 -17.4 47.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -57.34 -17.5 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.292 1.837 . . . . 0.0 114.585 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.27 -10.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.3 t -47.1 -45.58 53.1 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 116.867 -1.539 . . . . 0.0 113.664 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.16 -27.65 35.13 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 122.676 1.991 . . . . 0.0 113.82 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.29 -47.17 65.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.023 0.829 . . . . 0.0 110.778 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.25 -47.58 84.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.126 1.37 . . . . 0.0 112.382 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -60.16 -48.95 79.57 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.295 -0.878 . . . . 0.0 112.101 171.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.64 95.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.194 0.902 . . . . 0.0 113.506 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.01 -45.87 97.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.479 1.139 . . . . 0.0 110.486 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.12 -47.04 86.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.978 0.511 . . . . 0.0 112.18 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.95 -37.25 29.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.395 1.478 . . . . 0.0 114.327 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 m -121.39 10.5 10.54 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -168.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.14 -47.18 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.713 1.142 . . . . 0.0 112.474 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.44 -34.86 0.45 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -157.23 137.55 12.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.475 1.637 . . . . 0.0 111.515 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -158.94 63.74 2.46 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.533 1.133 . . . . 0.0 113.34 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.48 -15.02 42.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.416 3.411 . . . . 0.0 116.77 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -120.9 -0.47 10.08 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.555 1.542 . . . . 0.0 114.384 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.02 141.78 47.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.973 0.909 . . . . 0.0 109.578 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -131.07 138.92 49.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 111.338 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -154.67 -171.17 3.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -170.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.71 161.8 31.64 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 127.595 2.521 . . . . 0.0 109.911 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.07 135.46 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.91 0.855 . . . . 0.0 111.879 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.5 mt -119.3 128.8 75.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.4 145.23 48.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.652 1.181 . . . . 0.0 110.231 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.75 139.49 31.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.85 0.86 . . . . 0.0 110.419 -171.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.37 -147.0 6.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -138.74 124.41 19.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.998 0.919 . . . . 0.0 110.649 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.9 p -70.05 -3.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -68.37 -0.92 5.41 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.029 1.331 . . . . 0.0 114.313 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.74 155.88 44.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.071 1.749 . . . . 0.0 112.045 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.1 m -77.21 1.26 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.61 44.74 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.255 1.422 . . . . 0.0 110.315 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -52.05 115.93 1.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.022 -1.674 . . . . 0.0 112.745 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 94.5 m 51.01 26.99 2.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -58.99 -31.79 69.09 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.045 -1.034 . . . . 0.0 113.498 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.43 87.84 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.134 0.879 . . . . 0.0 112.625 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.62 99.54 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.845 -1.385 . . . . 0.0 112.639 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.06 -40.86 97.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.908 0.883 . . . . 0.0 113.001 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -58.95 -42.13 89.08 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.075 0.95 . . . . 0.0 111.637 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.09 -30.54 63.74 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.52 -45.04 76.9 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.007 -1.683 . . . . 0.0 110.963 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.31 74.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.835 0.854 . . . . 0.0 113.212 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -50.53 -31.84 16.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.461 1.504 . . . . 0.0 112.994 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.35 -36.74 8.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.619 1.168 . . . . 0.0 111.766 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -65.49 -31.46 72.54 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.368 -0.833 . . . . 0.0 113.161 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.36 -15.32 57.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.021 . . . . 0.0 112.752 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -113.52 3.53 15.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.081 1.353 . . . . 0.0 112.652 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m 74.68 15.85 3.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.619 1.968 . . . . 0.0 113.955 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.11 164.49 6.72 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -121.93 150.79 41.5 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.869 -1.144 . . . . 0.0 110.585 -170.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -132.01 108.04 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 121.32 -0.863 . . . . 0.0 111.198 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.69 45.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.405 1.482 . . . . 0.0 112.329 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.54 -168.88 42.01 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.402 1.953 . . . . 0.0 111.995 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.42 147.78 50.67 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.223 -1.163 . . . . 0.0 112.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -66.26 123.54 20.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.781 1.232 . . . . 0.0 112.028 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -81.61 138.1 35.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.071 0.948 . . . . 0.0 110.238 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.1 mt -125.49 93.38 3.84 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.722 1.209 . . . . 0.0 111.661 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.8 mt -84.48 138.9 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.586 1.554 . . . . 0.0 111.234 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -125.72 105.17 8.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.001 1.32 . . . . 0.0 112.323 -177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.75 -21.86 43.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.14 1.376 . . . . 0.0 114.267 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -77.86 -7.88 57.29 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -126.36 -26.4 3.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.363 1.465 . . . . 0.0 112.415 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -143.86 114.77 5.52 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.897 0.879 . . . . 0.0 112.313 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.01 -0.68 10.12 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.309 3.339 . . . . 0.0 114.526 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.89 76.51 71.05 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.009 1.724 . . . . 0.0 109.942 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -61.16 -20.13 66.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.236 3.29 . . . . 0.0 115.796 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.45 -35.01 71.47 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.773 -1.204 . . . . 0.0 113.653 169.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 p -66.9 -9.56 39.31 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -109.77 -12.14 14.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.605 1.162 . . . . 0.0 112.103 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 p -126.29 -27.74 3.17 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.23 -52.76 65.99 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 119.64 1.109 . . . . 0.0 113.26 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.77 -30.13 27.83 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.726 1.617 . . . . 0.0 112.826 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -61.32 -48.74 79.98 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.671 -0.643 . . . . 0.0 111.719 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.25 -40.2 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.339 0.518 . . . . 0.0 110.474 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -59.7 -36.34 76.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.893 0.77 . . . . 0.0 112.56 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.41 -59.69 2.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.935 0.789 . . . . 0.0 111.986 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -53.08 -46.24 68.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.462 1.105 . . . . 0.0 112.09 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -24.68 5.52 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.218 1.866 . . . . 0.0 116.172 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.3 p -73.99 -21.38 60.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.723 1.762 . . . . 0.0 114.184 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.21 -23.25 47.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.314 1.046 . . . . 0.0 112.952 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.5 -28.95 69.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.6 1.56 . . . . 0.0 114.823 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.386 1.475 . . . . 0.0 111.935 173.535 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.53 175.57 8.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.944 1.698 . . . . 0.0 112.119 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.99 121.17 20.08 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.882 1.273 . . . . 0.0 110.399 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.6 125.39 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.911 0.885 . . . . 0.0 113.228 -169.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.98 124.74 7.0 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -117.01 99.07 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.763 1.282 . . . . 0.0 108.995 -170.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -99.66 136.61 39.33 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.06 0.944 . . . . 0.0 110.681 -169.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.83 145.69 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.432 0.634 . . . . 0.0 111.54 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.31 100.51 0.38 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.8 t -151.46 163.97 37.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.285 1.034 . . . . 0.0 113.131 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -122.9 -0.98 8.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.651 1.58 . . . . 0.0 112.54 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -141.08 -58.78 0.5 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.88 0.872 . . . . 0.0 113.053 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.27 -2.5 0.42 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -61.04 -44.99 96.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.6 1.2 . . . . 0.0 112.862 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.1 p -75.96 -32.76 59.66 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.182 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.8 tp -60.03 -40.4 89.2 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.753 -1.217 . . . . 0.0 112.794 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.9 tp -54.97 -42.85 72.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.732 0.697 . . . . 0.0 111.86 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.41 -36.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 121.805 -0.559 . . . . 0.0 111.895 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.27 97.72 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.25 -0.906 . . . . 0.0 112.941 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.88 -41.02 97.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 112.257 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -59.77 -47.54 85.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.581 0.752 . . . . 0.0 111.984 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.02 86.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.372 0.669 . . . . 0.0 112.308 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.79 -46.64 77.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 112.001 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.75 91.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.661 0.784 . . . . 0.0 112.809 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.66 -45.69 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.741 1.216 . . . . 0.0 112.04 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.6 mt -68.09 -42.25 80.61 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.596 -0.69 . . . . 0.0 109.594 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -55.24 -47.97 74.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.757 1.223 . . . . 0.0 112.214 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.35 80.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.117 0.967 . . . . 0.0 113.29 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.14 -8.58 56.67 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.54 -3.61 56.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.198 1.38 . . . . 0.0 114.583 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -73.27 177.05 5.4 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -115.96 147.36 41.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.152 1.381 . . . . 0.0 109.548 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.25 164.32 35.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.463 -0.773 . . . . 0.0 112.642 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 m -152.93 121.01 6.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.811 0.845 . . . . 0.0 110.991 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.2 141.37 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.795 1.238 . . . . 0.0 111.428 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -130.32 109.73 10.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.412 1.485 . . . . 0.0 110.253 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.25 -16.27 40.74 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -147.94 54.77 1.96 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.886 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.17 163.48 34.89 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.6 2.867 . . . . 0.0 113.949 -170.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.0 173.65 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.821 2.048 . . . . 0.0 109.482 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.59 -40.1 62.31 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.435 -1.416 . . . . 0.0 112.499 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.1 m -62.69 -13.84 37.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -92.73 -33.61 14.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.549 1.139 . . . . 0.0 112.187 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -68.21 -48.14 65.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 112.229 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.5 tp -45.95 -49.25 39.83 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.524 2.329 . . . . 0.0 114.522 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.59 -17.4 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.898 3.732 . . . . 0.0 117.92 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.49 -0.4 15.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.21 -20.2 65.66 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.12 -1.93 54.14 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.793 1.237 . . . . 0.0 113.264 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -132.48 -130.87 0.18 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.41 2.284 . . . . 0.0 109.595 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -135.26 157.8 45.99 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.035 1.334 . . . . 0.0 110.093 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.85 168.45 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.008 0.923 . . . . 0.0 111.732 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tp -159.85 145.15 15.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.104 0.962 . . . . 0.0 110.569 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.66 132.43 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.522 1.529 . . . . 0.0 110.921 -169.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.57 87.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.1 m -131.16 159.09 38.72 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -167.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -129.87 -171.62 2.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.621 1.568 . . . . 0.0 113.187 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.0 m -123.86 153.32 41.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.895 1.278 . . . . 0.0 111.734 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.34 -177.68 6.35 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.646 1.578 . . . . 0.0 111.836 -168.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.28 -84.21 0.01 OUTLIER Glycine 0 CA--C 1.545 1.935 0 C-N-CA 127.358 2.409 . . . . 0.0 117.108 173.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -142.43 18.26 2.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.636 1.574 . . . . 0.0 111.014 170.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.01 14.46 1.83 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 114.657 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.81 160.37 14.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.116 2.167 . . . . 0.0 113.446 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.12 145.34 97.58 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 121.563 -0.711 . . . . 0.0 111.134 170.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.39 150.17 32.06 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.679 2.919 . . . . 0.0 111.003 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.84 -25.31 64.9 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -172.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 m -59.81 -13.98 12.87 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 172.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 tt -133.3 -7.15 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.1 t -47.71 -49.96 54.07 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.504 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.83 -9.2 25.52 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.187 1.925 . . . . 0.0 114.209 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.84 -48.8 7.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.04 1.336 . . . . 0.0 108.793 172.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -65.19 -48.79 72.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.96 1.304 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -63.69 -39.2 93.73 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.051 -1.031 . . . . 0.0 111.943 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.82 -48.86 72.62 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 124.071 0.843 . . . . 0.0 112.258 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -64.15 -46.74 92.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 118.068 0.934 . . . . 0.0 110.658 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.12 -35.3 78.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -109.62 -23.5 11.43 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.4 m -113.95 2.11 14.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.9 mt -122.91 -139.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.635 1.574 . . . . 0.0 108.104 169.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.52 -21.0 0.54 Allowed Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.157 -0.964 . . . . 0.0 114.501 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -159.66 126.72 4.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.053 0.926 . . . . 0.0 113.03 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -152.82 61.19 3.66 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 126.262 1.825 . . . . 0.0 112.034 -177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.68 -26.46 80.07 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.003 3.135 . . . . 0.0 115.249 -169.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -82.57 -10.35 59.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.334 1.454 . . . . 0.0 114.678 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.7 140.22 40.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.964 0.802 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -130.94 142.92 50.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.675 1.99 . . . . 0.0 110.847 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -159.47 -171.44 3.31 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -169.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.47 165.98 33.6 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.39 2.424 . . . . 0.0 111.201 172.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.14 137.53 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 118.074 0.937 . . . . 0.0 112.189 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 mt -127.88 98.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.59 153.02 25.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.208 0.527 . . . . 0.0 110.261 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -140.71 138.41 34.2 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.106 0.962 . . . . 0.0 110.58 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.2 4.87 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 122.041 -0.412 . . . . 0.0 112.55 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -150.74 135.57 17.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -5.17 10.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.988 2.115 . . . . 0.0 115.259 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -66.46 1.71 1.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -138.68 156.68 47.21 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.215 1.806 . . . . 0.0 111.627 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.68 -33.8 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -96.18 48.56 1.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.843 0.857 . . . . 0.0 111.718 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -49.92 114.77 1.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.341 -1.475 . . . . 0.0 112.701 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m 51.03 24.84 2.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -59.31 -29.63 67.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.829 -1.17 . . . . 0.0 113.259 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.37 -35.19 91.65 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 113.388 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.92 -40.45 10.56 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.526 -0.985 . . . . 0.0 112.896 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.11 -39.28 78.25 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.197 0.999 . . . . 0.0 113.291 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.7 -35.98 75.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.171 0.588 . . . . 0.0 112.57 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -74.81 -36.01 62.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.338 -0.851 . . . . 0.0 112.502 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.56 -42.87 99.47 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 119.81 -1.806 . . . . 0.0 111.303 169.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.49 88.42 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -52.93 -44.75 67.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.819 1.247 . . . . 0.0 111.142 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.09 -33.55 67.97 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -33.12 74.33 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.033 -1.042 . . . . 0.0 111.875 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.55 -17.96 64.41 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.081 -1.012 . . . . 0.0 112.77 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -99.59 6.09 45.82 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.529 1.532 . . . . 0.0 112.35 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m 58.58 19.99 7.2 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.082 1.753 . . . . 0.0 114.913 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.99 154.02 27.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.394 0.678 . . . . 0.0 111.691 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -117.15 99.9 7.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.087 1.355 . . . . 0.0 111.005 -169.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -67.8 133.89 50.01 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.055 -1.028 . . . . 0.0 111.289 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.81 33.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.92 -163.12 36.2 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.982 1.277 . . . . 0.0 112.432 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -125.86 152.47 45.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.092 1.357 . . . . 0.0 112.382 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.7 ttp -69.03 123.95 22.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.48 1.512 . . . . 0.0 111.963 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.97 140.72 35.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.914 0.885 . . . . 0.0 109.397 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.4 mt -123.24 92.75 3.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.614 1.566 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.98 137.74 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.355 1.062 . . . . 0.0 111.157 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.87 118.48 32.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.94 1.296 . . . . 0.0 111.402 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.7 92.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.9 m -63.41 -41.08 98.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.61 -32.65 68.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.992 0.917 . . . . 0.0 112.43 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -145.4 99.48 4.51 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.163 0.985 . . . . 0.0 112.705 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.9 2.07 7.94 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.898 3.066 . . . . 0.0 114.29 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -122.42 71.84 37.41 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.292 1.837 . . . . 0.0 109.37 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -58.78 -20.62 52.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.646 3.564 . . . . 0.0 116.149 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.84 -39.27 77.27 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.126 -0.984 . . . . 0.0 112.776 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.9 p -68.78 -6.32 25.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.291 1.036 . . . . 0.0 113.526 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.52 -2.33 17.69 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.461 1.505 . . . . 0.0 112.161 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.6 p -139.67 -28.1 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -51.95 -54.0 45.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.8 -28.13 30.53 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.666 1.577 . . . . 0.0 112.951 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -63.22 -47.79 81.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.381 0.672 . . . . 0.0 111.524 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.01 -40.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.587 0.631 . . . . 0.0 110.358 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -58.78 -44.76 90.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.672 0.669 . . . . 0.0 111.719 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -61.72 -56.09 23.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.984 0.914 . . . . 0.0 112.357 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -53.34 -48.62 68.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.599 1.16 . . . . 0.0 111.209 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.03 -21.81 32.82 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.586 1.565 . . . . 0.0 116.144 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -68.88 -19.41 64.23 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.507 2.154 . . . . 0.0 113.517 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -99.31 -14.88 19.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.0 113.109 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.53 147.75 48.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.185 1.394 . . . . 0.0 111.722 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.119 -172.586 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.22 178.41 6.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.974 1.71 . . . . 0.0 112.098 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -135.35 116.5 14.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.204 1.402 . . . . 0.0 109.31 -173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -118.72 125.39 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.95 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.53 125.05 7.52 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -114.1 91.17 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.294 1.047 . . . . 0.0 108.256 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -94.02 136.58 34.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.689 0.796 . . . . 0.0 110.872 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.87 142.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.879 0.847 . . . . 0.0 111.086 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.75 79.47 0.32 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -128.04 172.51 10.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.133 0.973 . . . . 0.0 112.974 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.5 tpt -129.67 -34.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.684 1.993 . . . . 0.0 111.627 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -132.17 1.16 3.83 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.35 -1.43 58.84 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -66.19 -42.5 88.77 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.916 1.358 . . . . 0.0 112.164 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -37.32 77.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.337 1.455 . . . . 0.0 112.639 170.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.47 -36.93 76.94 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.725 -1.234 . . . . 0.0 113.513 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -51.85 -45.19 63.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.937 0.79 . . . . 0.0 111.792 172.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.49 -36.54 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.045 -0.41 . . . . 0.0 111.7 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.09 99.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.098 0.863 . . . . 0.0 112.672 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.61 -41.96 98.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.216 0.607 . . . . 0.0 112.347 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.22 -42.19 96.69 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.363 -0.836 . . . . 0.0 112.692 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.9 91.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.494 0.717 . . . . 0.0 112.291 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.55 -47.04 80.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.406 0.682 . . . . 0.0 111.369 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.47 86.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.463 0.705 . . . . 0.0 112.649 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.72 -46.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.046 1.338 . . . . 0.0 112.362 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.46 -39.99 70.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -175.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -57.48 -46.4 83.74 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.552 1.141 . . . . 0.0 111.931 170.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.34 77.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.0 -11.7 60.66 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.33 40.0 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.579 1.561 . . . . 0.0 114.705 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -75.26 153.17 38.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.436 1.118 . . . . 0.0 111.526 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -80.62 135.69 36.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.35 154.55 43.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.13 0.572 . . . . 0.0 111.942 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 m -153.31 122.7 6.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.906 0.883 . . . . 0.0 111.184 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 140.58 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.332 1.053 . . . . 0.0 110.96 171.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -129.0 112.06 13.64 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.82 1.248 . . . . 0.0 110.333 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.49 -11.51 31.86 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.16 53.76 2.14 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.868 1.267 . . . . 0.0 111.794 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.6 162.39 42.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.64 2.893 . . . . 0.0 114.827 -172.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -131.24 169.61 15.71 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.471 2.308 . . . . 0.0 109.295 169.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.34 62.8 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.267 -1.521 . . . . 0.0 112.376 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -61.82 -12.58 18.02 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -92.93 -32.47 14.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.823 1.249 . . . . 0.0 112.216 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -70.75 -42.44 70.49 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.907 0.883 . . . . 0.0 111.926 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.6 tp -47.84 -47.27 63.11 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 127.872 2.469 . . . . 0.0 115.787 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 -9.01 25.17 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.704 2.269 . . . . 0.0 114.881 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -119.53 -15.73 8.98 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -61.77 -27.41 68.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.196 1.362 . . . . 0.0 113.081 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.72 5.97 14.19 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.921 1.288 . . . . 0.0 113.968 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -128.59 -118.95 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.999 2.52 . . . . 0.0 108.245 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -135.56 157.88 45.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.155 1.782 . . . . 0.0 108.833 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 166.39 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.231 1.012 . . . . 0.0 110.613 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.95 144.92 17.97 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.413 -0.804 . . . . 0.0 110.296 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -113.97 133.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.654 1.582 . . . . 0.0 110.467 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 t -134.33 92.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 m -135.4 154.79 51.35 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 p -133.95 -171.56 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.511 1.524 . . . . 0.0 112.469 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -122.06 153.37 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.439 1.096 . . . . 0.0 111.068 -170.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -155.14 -167.69 2.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.574 1.95 . . . . 0.0 109.31 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.23 44.98 10.37 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.715 1.626 . . . . 0.0 116.582 169.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 64.13 14.93 8.95 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.653 1.981 . . . . 0.0 115.11 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.38 21.07 0.23 Allowed Glycine 0 CA--C 1.537 1.43 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -129.76 173.32 10.76 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.618 1.709 . . . . 0.0 113.803 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.7 mt -64.76 147.3 98.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.306 1.442 . . . . 0.0 112.967 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -82.1 154.63 16.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.785 2.99 . . . . 0.0 111.87 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -58.78 -23.34 60.05 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.8 m -54.95 -19.1 5.97 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.992 1.717 . . . . 0.0 115.04 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.54 -5.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -45.87 -44.45 33.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 117.183 -1.389 . . . . 0.0 113.442 170.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.04 -27.51 57.66 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 122.375 1.884 . . . . 0.0 114.666 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mt -73.8 -48.54 30.74 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.06 1.3 . . . . 0.0 110.807 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.52 -38.87 82.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.835 1.254 . . . . 0.0 112.909 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -75.08 -48.31 24.52 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.178 -0.952 . . . . 0.0 112.037 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.39 82.34 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 123.795 0.712 . . . . 0.0 113.991 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.89 -44.35 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.262 1.031 . . . . 0.0 110.357 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.28 -48.37 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.196 0.998 . . . . 0.0 112.137 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.01 -41.31 59.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.235 1.414 . . . . 0.0 114.382 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.0 m -123.74 -14.64 7.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -168.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.77 -50.25 7.3 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.662 1.574 . . . . 0.0 109.599 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 -40.45 0.47 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 126.536 2.017 . . . . 0.0 117.598 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -157.68 138.53 13.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.165 1.483 . . . . 0.0 111.492 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -159.49 100.48 1.53 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.886 1.275 . . . . 0.0 111.2 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.58 -16.27 8.07 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.627 2.885 . . . . 0.0 115.067 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -110.5 -9.3 14.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.349 1.46 . . . . 0.0 113.889 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.5 tp -55.62 124.69 18.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.4 1.88 . . . . 0.0 111.113 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -128.21 140.87 51.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.725 1.61 . . . . 0.0 109.856 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -161.56 -169.29 2.22 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.68 160.7 30.48 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 127.205 2.336 . . . . 0.0 109.862 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.2 t -140.46 133.76 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.835 0.818 . . . . 0.0 111.399 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -122.32 100.43 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.78 153.36 25.28 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 0.0 109.736 169.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.16 142.24 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.0 0.92 . . . . 0.0 110.602 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.43 -144.22 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.549 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -146.43 120.2 9.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.43 0.692 . . . . 0.0 111.328 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -59.87 -8.49 2.23 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.687 1.595 . . . . 0.0 113.855 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.5 m -60.73 -7.85 2.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.221 1.409 . . . . 0.0 114.567 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -130.38 159.25 37.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.736 1.614 . . . . 0.0 112.729 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.36 -0.91 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 -169.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.53 48.67 1.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.752 1.221 . . . . 0.0 110.528 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -51.07 114.97 1.33 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.002 -1.686 . . . . 0.0 113.148 -170.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m 52.95 24.89 3.63 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -61.38 -24.05 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.564 -1.335 . . . . 0.0 113.877 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.26 -59.33 8.55 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.562 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.59 96.69 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.317 -1.107 . . . . 0.0 114.008 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -40.46 88.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.171 0.985 . . . . 0.0 113.655 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.52 -36.15 79.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.327 0.512 . . . . 0.0 112.221 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.41 -29.34 63.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.83 -45.42 71.21 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.256 -1.527 . . . . 0.0 110.559 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.35 67.93 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.7 tp -50.39 -30.2 11.84 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.88 1.672 . . . . 0.0 113.151 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.52 -36.64 7.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.568 1.147 . . . . 0.0 111.743 -171.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -65.67 -30.26 70.93 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.343 -0.848 . . . . 0.0 112.777 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.04 -17.24 63.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.048 0.939 . . . . 0.0 112.622 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -113.7 -7.19 13.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 t 100.37 13.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.188 2.595 . . . . 0.0 113.153 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.08 162.68 4.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.365 0.666 . . . . 0.0 111.992 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -133.36 95.66 3.56 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.205 1.002 . . . . 0.0 109.935 -172.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.9 ttm105 -66.18 136.16 55.53 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.482 -0.761 . . . . 0.0 110.659 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -89.59 34.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.294 1.438 . . . . 0.0 111.503 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.64 41.37 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.979 1.276 . . . . 0.0 113.107 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -95.81 144.08 26.48 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.562 1.145 . . . . 0.0 111.02 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -63.82 123.57 19.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.832 0.853 . . . . 0.0 111.056 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.75 140.0 34.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.714 0.806 . . . . 0.0 109.293 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 48.0 mt -122.81 92.84 3.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.272 1.429 . . . . 0.0 110.811 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.9 mt -71.77 136.9 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.797 0.839 . . . . 0.0 110.326 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -130.26 106.8 8.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.158 0.983 . . . . 0.0 113.154 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.31 -17.22 41.29 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -68.53 -14.02 62.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.753 1.161 . . . . 0.0 113.704 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.64 -10.88 1.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -139.93 110.37 7.22 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.905 1.23 . . . . 0.0 112.598 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.48 0.61 9.64 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.442 3.428 . . . . 0.0 114.794 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.01 76.17 77.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.625 1.57 . . . . 0.0 111.592 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -44.35 -34.33 7.17 Favored 'Trans proline' 0 C--N 1.354 0.831 1 C-N-CA 126.077 4.518 . . . . 0.0 117.853 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.49 -37.68 70.7 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 113.39 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -69.64 -5.97 28.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.56 1.144 . . . . 0.0 113.343 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -113.54 -2.18 13.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.595 1.558 . . . . 0.0 111.84 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 p -139.96 -28.43 0.74 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -169.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -55.88 -51.6 79.12 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.0 -28.95 41.21 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.742 1.628 . . . . 0.0 112.619 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -63.37 -48.34 78.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.767 0.827 . . . . 0.0 111.748 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.74 -39.84 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.834 0.743 . . . . 0.0 110.409 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -57.55 -43.98 84.84 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.117 0.417 . . . . 0.0 111.342 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -63.62 -57.49 9.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.701 0.8 . . . . 0.0 112.534 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -51.49 -48.78 62.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.712 1.205 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -28.5 17.19 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.78 1.657 . . . . 0.0 116.122 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.1 p -69.75 -18.9 63.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.566 1.683 . . . . 0.0 114.025 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.96 -14.61 27.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 113.056 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.36 164.21 11.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.458 1.903 . . . . 0.0 112.468 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.767 1.227 . . . . 0.0 113.58 171.528 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.72 177.25 7.77 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.793 1.637 . . . . 0.0 112.599 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.31 115.27 16.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.918 1.687 . . . . 0.0 109.291 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -111.55 126.7 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.821 0.848 . . . . 0.0 112.76 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.93 125.87 7.53 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.1 mt -117.29 91.35 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 108.938 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -90.34 132.74 35.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.94 0.896 . . . . 0.0 110.732 -170.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.55 144.78 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.29 0.636 . . . . 0.0 111.52 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.86 104.46 0.55 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -149.22 161.37 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.028 1.331 . . . . 0.0 111.434 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 79.4 mmm -106.3 -11.79 15.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.073 0.949 . . . . 0.0 113.291 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -146.7 -26.46 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.46 -5.49 4.89 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -44.5 94.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.585 1.693 . . . . 0.0 113.228 -169.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -81.23 -31.04 34.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.372 0.669 . . . . 0.0 112.581 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.57 -38.91 75.61 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.737 -1.227 . . . . 0.0 113.239 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -52.76 -42.06 64.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.075 0.852 . . . . 0.0 111.801 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.9 t -69.47 -34.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.109 0.563 . . . . 0.0 112.008 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.56 92.07 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.44 1.018 . . . . 0.0 112.412 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.91 -41.75 96.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.567 0.747 . . . . 0.0 112.034 173.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -61.3 -46.52 89.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.281 0.632 . . . . 0.0 112.227 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.52 88.64 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 112.793 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.19 -45.89 79.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.724 0.809 . . . . 0.0 112.012 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.92 -45.89 80.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.779 0.832 . . . . 0.0 112.672 176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.56 -31.73 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.058 1.343 . . . . 0.0 112.996 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 mt -75.55 -41.38 55.03 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.807 -1.183 . . . . 0.0 110.175 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.3 m -56.6 -44.65 81.3 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.166 0.986 . . . . 0.0 111.807 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.66 76.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.74 1.216 . . . . 0.0 113.601 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.64 -5.41 47.75 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.405 1.082 . . . . 0.0 113.621 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.83 0.33 55.17 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.294 1.426 . . . . 0.0 114.502 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -81.83 -177.16 6.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.957 1.303 . . . . 0.0 111.919 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -122.51 150.76 42.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.933 1.693 . . . . 0.0 109.145 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.87 167.15 27.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -152.38 119.35 5.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 110.811 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -74.37 145.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.391 1.076 . . . . 0.0 111.02 171.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.0 109.21 9.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.426 1.49 . . . . 0.0 109.193 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.91 -28.59 35.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -144.25 56.43 4.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.878 1.671 . . . . 0.0 110.981 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.04 165.16 32.71 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.684 2.923 . . . . 0.0 115.566 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -133.98 171.68 13.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.728 2.011 . . . . 0.0 109.712 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.91 -39.61 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.989 -1.07 . . . . 0.0 113.038 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 m -58.62 -20.39 47.04 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -85.06 -33.06 22.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.211 0.914 . . . . 0.0 112.498 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -78.34 -40.75 35.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.639 1.175 . . . . 0.0 112.578 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.3 tp -41.44 -46.97 8.67 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.752 2.821 . . . . 0.0 115.577 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.86 -28.89 67.52 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.754 2.969 . . . . 0.0 116.316 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -80.06 2.5 23.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -169.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -60.32 -23.44 64.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.71 -1.244 . . . . 0.0 114.212 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -87.32 3.5 46.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.827 1.251 . . . . 0.0 113.072 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -137.32 -137.63 0.14 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.709 2.003 . . . . 0.0 110.97 -168.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -140.83 164.29 30.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.21 1.804 . . . . 0.0 110.626 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.7 m -144.05 174.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.252 1.421 . . . . 0.0 111.741 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tt -152.19 146.44 25.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.669 1.988 . . . . 0.0 108.49 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.28 133.04 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.357 1.063 . . . . 0.0 109.687 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.91 90.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.933 1.293 . . . . 0.0 108.786 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.5 m -135.76 141.62 44.84 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -94.95 -165.21 1.27 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.257 1.823 . . . . 0.0 113.155 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.7 m -132.43 150.35 52.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.337 -1.477 . . . . 0.0 111.715 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -148.08 -164.91 2.13 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.28 2.232 . . . . 0.0 109.63 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 30.82 50.09 0.2 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.886 2.66 . . . . 0.0 118.642 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 54.19 35.05 21.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.611 1.564 . . . . 0.0 113.84 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.32 0.58 9.47 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.884 1.707 . . . . 0.0 115.071 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.26 168.41 20.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.349 1.86 . . . . 0.0 113.601 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.15 145.66 65.45 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.804 1.241 . . . . 0.0 109.759 169.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.69 140.65 57.03 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.316 2.678 . . . . 0.0 110.412 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.37 -28.82 65.49 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -59.29 -12.05 5.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.66 -3.7 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.577 1.08 . . . . 0.0 113.338 173.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.2 t -56.79 -46.2 99.87 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 120.343 -1.473 . . . . 0.0 112.34 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.93 -12.97 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.921 3.081 . . . . 0.0 116.305 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 tp -99.89 -44.49 6.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.545 1.138 . . . . 0.0 110.577 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.32 -42.9 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.644 1.178 . . . . 0.0 112.238 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.88 -26.86 67.09 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.111 -0.993 . . . . 0.0 113.446 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.97 -41.73 4.56 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.078 -171.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.25 -41.06 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.447 1.623 . . . . 0.0 111.054 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.32 -48.01 83.24 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 112.32 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -36.05 19.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.831 0.853 . . . . 0.0 113.226 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -82.49 -37.08 25.81 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.75 -46.41 15.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.18 0.9 . . . . 0.0 112.393 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.97 -39.1 0.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 126.239 1.876 . . . . 0.0 115.415 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -161.94 142.27 10.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.748 2.019 . . . . 0.0 110.187 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -150.9 102.34 3.03 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.705 1.202 . . . . 0.0 111.407 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.68 -16.31 10.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.693 2.262 . . . . 0.0 114.456 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 -5.36 9.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.4 117.39 6.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.663 1.185 . . . . 0.0 109.934 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -127.93 134.55 49.33 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.716 1.606 . . . . 0.0 110.622 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -155.97 -171.13 3.63 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.24 160.39 28.26 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.864 1.697 . . . . 0.0 110.487 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.39 135.62 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.007 0.908 . . . . 0.0 113.328 -169.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.0 119.44 57.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.85 147.32 47.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.468 1.107 . . . . 0.0 109.84 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.0 tt -138.55 148.25 44.01 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.046 0.927 . . . . 0.0 112.158 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.65 -141.17 6.08 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.795 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -141.95 118.6 11.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 111.197 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -74.06 -0.02 15.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 t -73.21 4.49 4.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.56 1.073 . . . . 0.0 113.668 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.02 157.64 46.41 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.306 1.843 . . . . 0.0 111.673 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 m -74.45 -1.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -169.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -122.97 44.51 2.64 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.808 1.243 . . . . 0.0 110.73 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.29 116.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.302 -1.499 . . . . 0.0 113.1 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.17 24.46 2.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.693 2.397 . . . . 0.0 116.685 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -60.61 -27.8 68.04 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.371 -1.455 . . . . 0.0 113.416 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.64 73.02 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.272 -0.892 . . . . 0.0 113.447 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.64 -40.27 6.84 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.079 0.939 . . . . 0.0 113.13 170.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -58.74 -38.76 79.11 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 118.702 1.251 . . . . 0.0 113.659 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -56.34 -32.06 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -75.8 -25.63 56.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.033 0.833 . . . . 0.0 113.182 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.74 -43.16 48.14 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.31 -1.494 . . . . 0.0 110.288 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.12 -42.62 69.66 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 170.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -49.99 -43.86 50.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.88 1.672 . . . . 0.0 112.319 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.17 -37.62 14.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.046 0.939 . . . . 0.0 112.464 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.67 -30.28 71.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.461 -0.774 . . . . 0.0 112.21 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.81 -24.42 67.75 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -91.91 -2.21 56.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.748 0.703 . . . . 0.0 112.456 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m 75.09 23.95 1.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.056 2.143 . . . . 0.0 114.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 177.03 0.14 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.64 1.176 . . . . 0.0 112.681 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -135.59 164.35 28.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 O-C-N 120.565 -1.334 . . . . 0.0 110.305 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 mtm105 -130.58 142.26 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 t -96.16 25.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.004 1.722 . . . . 0.0 111.637 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.01 -171.42 44.43 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.018 1.294 . . . . 0.0 114.461 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.05 155.56 39.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.277 1.431 . . . . 0.0 111.641 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.7 ttm -68.41 121.19 15.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.488 1.115 . . . . 0.0 112.231 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -76.82 136.17 38.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.67 84.94 2.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.743 1.217 . . . . 0.0 110.866 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.2 mt -74.97 132.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.742 1.617 . . . . 0.0 110.634 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -124.35 104.2 8.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -14.86 7.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.5 m -64.58 -23.09 67.15 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.885 1.221 . . . . 0.0 113.598 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.35 -8.31 0.99 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -135.92 107.58 9.74 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.316 0.962 . . . . 0.0 113.064 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.76 -2.06 11.62 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.139 3.226 . . . . 0.0 114.346 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -125.16 78.82 66.53 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.934 1.694 . . . . 0.0 110.514 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.39 -23.24 76.49 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.448 3.432 . . . . 0.0 114.328 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.28 -43.68 67.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.557 1.543 . . . . 0.0 112.417 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -104.25 -7.66 19.9 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.632 1.173 . . . . 0.0 112.877 175.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 m -123.92 -26.16 4.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.32 -50.5 85.55 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 120.575 -1.328 . . . . 0.0 111.754 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.04 -34.46 87.21 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.012 2.475 . . . . 0.0 114.79 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -61.49 -49.32 77.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.985 0.514 . . . . 0.0 111.495 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.2 t -71.19 -33.41 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.351 -0.843 . . . . 0.0 111.223 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -66.12 -14.92 62.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.232 -0.918 . . . . 0.0 113.173 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -95.98 -57.16 2.43 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.745 1.218 . . . . 0.0 111.634 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.85 -49.02 66.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.875 1.27 . . . . 0.0 111.815 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.76 -24.97 27.98 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.835 1.207 . . . . 0.0 115.685 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.4 p -69.2 -16.54 63.64 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 120.117 1.959 . . . . 0.0 113.659 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.3 mt -99.79 -15.13 18.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.482 1.513 . . . . 0.0 112.995 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.59 143.97 53.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 111.671 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.946 1.698 . . . . 0.0 114.128 -174.586 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.567 ' N ' ' HG ' ' A' ' 149' ' ' SER . . . . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -132.62 133.82 44.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.068 1.747 . . . . 0.0 108.461 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.457 HD11 ' CD1' ' A' ' 148' ' ' LEU . 4.5 mm -125.95 117.36 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.537 0.735 . . . . 0.0 111.804 -169.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.09 126.81 7.57 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 168.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -118.32 91.21 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.673 1.189 . . . . 0.0 107.857 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -90.5 137.62 32.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.356 1.063 . . . . 0.0 110.478 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -121.26 144.77 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.523 0.678 . . . . 0.0 112.242 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.16 104.56 0.49 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.247 0.927 . . . . 0.0 111.207 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 t -151.13 163.77 38.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.462 1.105 . . . . 0.0 113.076 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.1 mtp -129.82 2.0 4.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 112.204 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -140.18 -11.87 1.08 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.8 -0.8 67.67 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 171.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -74.42 -42.94 58.34 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.739 1.769 . . . . 0.0 111.732 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -33.45 74.77 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.564 -0.71 . . . . 0.0 112.156 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.08 -40.97 97.63 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.997 -1.065 . . . . 0.0 112.562 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 tt -56.15 -44.97 79.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.142 0.883 . . . . 0.0 111.623 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.22 -38.84 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.836 0.454 . . . . 0.0 111.795 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.5 90.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.22 -42.55 99.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.868 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -61.68 -42.44 98.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.501 -0.749 . . . . 0.0 112.385 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.85 95.03 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.771 0.714 . . . . 0.0 112.457 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.08 -48.75 79.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.325 0.65 . . . . 0.0 111.539 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.22 91.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.785 0.834 . . . . 0.0 112.746 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.13 -47.75 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.411 1.085 . . . . 0.0 112.363 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.29 -39.71 78.15 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.734 -0.604 . . . . 0.0 109.892 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -58.32 -44.72 88.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.927 1.291 . . . . 0.0 112.072 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -38.24 86.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.26 1.024 . . . . 0.0 112.561 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.44 -25.01 64.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.938 0.895 . . . . 0.0 112.892 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.16 -7.03 8.7 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.922 1.725 . . . . 0.0 114.759 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -76.34 139.25 40.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.828 1.251 . . . . 0.0 110.93 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -76.93 76.94 3.5 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.784 0.834 . . . . 0.0 110.909 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.34 157.8 32.08 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 111.624 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.3 m -151.99 117.73 5.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.103 -0.998 . . . . 0.0 109.784 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.13 144.97 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.708 0.803 . . . . 0.0 112.262 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.34 97.95 4.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.409 1.484 . . . . 0.0 110.822 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.99 -18.02 60.92 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -141.67 66.04 21.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.893 1.677 . . . . 0.0 109.764 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.67 168.75 24.1 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.14 3.227 . . . . 0.0 115.237 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -149.34 159.96 43.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.973 2.109 . . . . 0.0 109.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.02 -38.05 48.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.954 -1.091 . . . . 0.0 111.468 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -56.03 -24.8 41.66 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.41 1.484 . . . . 0.0 114.826 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -99.6 -23.72 14.97 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.567 1.547 . . . . 0.0 112.908 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -71.59 -39.6 70.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.803 0.841 . . . . 0.0 112.727 170.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.98 -47.66 86.47 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.778 2.031 . . . . 0.0 115.594 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.88 -5.14 1.76 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.101 3.2 . . . . 0.0 117.731 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -119.56 2.84 11.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -28.26 69.52 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.227 -1.546 . . . . 0.0 113.187 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.91 4.91 23.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.705 1.202 . . . . 0.0 113.094 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -135.71 -132.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.867 2.067 . . . . 0.0 110.1 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -139.09 159.47 42.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.943 1.697 . . . . 0.0 111.005 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.37 168.51 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.034 1.733 . . . . 0.0 110.391 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 151.15 23.36 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.849 -1.157 . . . . 0.0 110.433 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.81 136.64 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.829 1.252 . . . . 0.0 110.405 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -135.1 95.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.937 1.295 . . . . 0.0 107.719 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 m -133.56 169.12 17.45 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -167.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -137.71 -158.95 0.91 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.122 1.369 . . . . 0.0 112.578 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.1 m -135.82 151.75 50.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.757 1.623 . . . . 0.0 110.872 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.127 1.371 . . . . 0.0 111.696 -179.797 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.498 0.666 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.47 143.96 93.78 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.219 -0.926 . . . . 0.0 111.054 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.93 137.37 43.82 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.088 3.859 . . . . 0.0 112.349 170.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.85 -24.35 66.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -61.45 -17.95 56.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.718 1.607 . . . . 0.0 114.802 171.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -124.54 -10.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.543 1.137 . . . . 0.0 113.845 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.8 t -46.98 -48.98 51.93 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.965 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.44 -17.21 43.94 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.379 1.885 . . . . 0.0 114.385 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.2 -43.71 17.31 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.962 0.801 . . . . 0.0 109.572 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.57 -49.65 72.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.096 1.359 . . . . 0.0 111.386 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -62.12 -41.7 98.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.846 -1.159 . . . . 0.0 112.262 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.99 -50.23 67.55 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.647 0.641 . . . . 0.0 112.828 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.3 -39.41 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 O-C-N 121.382 -1.069 . . . . 0.0 110.897 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -65.88 -36.7 84.14 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -112.71 -20.36 11.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.2 m -125.61 10.86 7.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.876 1.271 . . . . 0.0 113.782 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.13 -51.59 1.11 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.615 1.566 . . . . 0.0 110.302 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.31 -28.98 0.33 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 119.552 2.581 . . . . 0.0 119.552 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -153.3 136.45 15.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.499 2.15 . . . . 0.0 111.99 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -150.64 56.11 2.0 Allowed Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.219 1.408 . . . . 0.0 113.296 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.43 -18.67 65.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.036 3.158 . . . . 0.0 115.323 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.97 0.17 14.98 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.596 1.959 . . . . 0.0 113.504 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.71 124.07 22.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 109.186 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -121.31 138.89 54.04 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.201 1.4 . . . . 0.0 109.263 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -160.92 -167.48 1.84 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -168.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 160.86 31.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.625 2.536 . . . . 0.0 109.714 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.82 135.46 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 117.897 0.849 . . . . 0.0 112.212 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.2 mt -119.57 130.61 73.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.04 146.85 48.29 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.044 0.938 . . . . 0.0 110.171 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tt -141.53 133.87 28.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.553 0.741 . . . . 0.0 110.852 -169.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.58 -166.15 33.8 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 121.951 0.751 . . . . 0.0 113.733 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -98.07 118.4 34.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.877 1.271 . . . . 0.0 110.962 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.4 p -64.26 -9.94 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.974 1.71 . . . . 0.0 115.207 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -70.56 -8.26 50.1 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -138.13 159.55 41.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.67 1.188 . . . . 0.0 113.387 -169.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.16 -34.5 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.127 1.371 . . . . 0.0 113.176 -171.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -76.2 34.85 0.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.592 1.157 . . . . 0.0 113.215 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.62 113.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.915 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.3 m 52.85 25.36 3.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.329 2.251 . . . . 0.0 116.287 -171.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -60.28 -30.22 69.32 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.661 -1.275 . . . . 0.0 113.692 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.55 -38.8 61.62 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.897 -1.127 . . . . 0.0 112.695 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.67 -40.33 66.06 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.524 -0.986 . . . . 0.0 112.791 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -58.79 -40.74 84.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.881 0.872 . . . . 0.0 112.911 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.86 -38.21 84.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.27 -31.3 68.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.39 0.995 . . . . 0.0 113.413 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.57 -43.73 79.92 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 119.763 -1.835 . . . . 0.0 110.826 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.39 71.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.57 -29.64 11.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.586 1.554 . . . . 0.0 112.936 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.32 -39.1 6.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.517 1.127 . . . . 0.0 111.362 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -67.36 -34.13 76.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.306 -0.871 . . . . 0.0 113.338 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.79 -14.09 49.81 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.427 -0.796 . . . . 0.0 112.414 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -111.57 10.15 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.851 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 72.31 18.93 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.596 1.558 . . . . 0.0 114.516 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.8 165.35 1.76 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.506 0.722 . . . . 0.0 111.92 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -135.6 88.4 2.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 120.76 -1.213 . . . . 0.0 110.344 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -62.42 142.83 57.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.354 0.662 . . . . 0.0 111.346 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.56 34.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.579 1.552 . . . . 0.0 110.757 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.92 -167.89 40.91 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.841 -1.162 . . . . 0.0 113.562 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -120.17 143.14 48.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.515 1.526 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.1 ttp -67.53 124.82 24.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.265 1.026 . . . . 0.0 112.018 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -83.86 133.66 34.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.218 1.007 . . . . 0.0 109.968 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -122.41 98.13 5.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 111.575 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.1 mt -89.47 134.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.617 1.567 . . . . 0.0 111.772 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -113.38 66.97 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.624 3.17 . . . . 0.0 111.35 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -46.1 -38.94 8.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.455 1.902 . . . . 0.0 116.132 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.1 m -62.38 -16.12 52.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -134.46 12.49 3.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.065 1.746 . . . . 0.0 111.964 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -144.5 68.46 15.0 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.242 1.817 . . . . 0.0 110.704 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.85 6.92 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.841 3.694 . . . . 0.0 114.701 -171.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.5 58.91 41.66 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.275 1.83 . . . . 0.0 110.987 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -61.47 -22.06 73.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.608 3.539 . . . . 0.0 114.24 -169.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.56 -44.26 56.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.999 1.32 . . . . 0.0 111.051 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.6 p -68.57 -18.32 64.31 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -95.11 -11.93 27.38 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.283 1.433 . . . . 0.0 112.428 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 26.0 p -128.3 -31.63 2.29 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.71 -53.1 69.13 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.923 1.238 . . . . 0.0 113.877 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.61 -29.42 52.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.418 1.542 . . . . 0.0 112.678 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -61.63 -48.94 78.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.709 0.803 . . . . 0.0 111.715 171.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.31 -40.75 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.694 0.679 . . . . 0.0 110.535 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.57 -44.1 89.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.701 0.682 . . . . 0.0 111.249 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.77 -55.86 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 112.606 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.29 -37.51 67.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.881 0.873 . . . . 0.0 112.195 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.36 -20.45 65.44 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.407 1.003 . . . . 0.0 115.158 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.4 p -74.58 -17.94 60.65 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.654 1.727 . . . . 0.0 113.165 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.62 -5.8 53.29 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.856 1.262 . . . . 0.0 112.73 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 4' ' ' ILE . 80.8 mt -70.76 -173.6 0.79 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.085 1.754 . . . . 0.0 111.361 169.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 2' ' ' ALA . 92.1 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.371 1.869 . . . . 0.0 114.505 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.432 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.55 0.969 0 CA-C-O 120.793 0.33 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.44 134.66 47.95 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.174 1.389 . . . . 0.0 109.699 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.489 HD12 HD13 ' A' ' 26' ' ' LEU . 1.4 mt -137.03 124.76 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.26 130.63 10.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 168.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -117.65 90.86 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.01 1.324 . . . . 0.0 108.331 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.71 146.58 24.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.852 0.861 . . . . 0.0 112.978 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.44 129.41 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.255 1.026 . . . . 0.0 111.833 -169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.93 71.71 0.46 Allowed Glycine 0 N--CA 1.468 0.798 0 C-N-CA 126.615 2.055 . . . . 0.0 109.568 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 t -129.76 177.73 7.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.631 1.172 . . . . 0.0 113.787 -169.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.3 tpt -135.58 -36.88 0.77 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.153 0.981 . . . . 0.0 113.417 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -129.28 -22.68 3.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.568 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.65 -2.55 7.0 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.7 1.143 . . . . 0.0 115.16 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -36.8 85.08 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.447 1.624 . . . . 0.0 113.084 -169.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 -31.69 37.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.593 1.157 . . . . 0.0 113.505 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.4 tp -59.06 -35.34 73.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.953 -1.092 . . . . 0.0 113.218 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 tp -48.32 -42.04 30.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.555 0.742 . . . . 0.0 111.707 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.26 -36.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.976 -0.535 . . . . 0.0 112.137 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.04 94.37 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.703 1.138 . . . . 0.0 112.415 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.38 -42.57 99.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.032 0.533 . . . . 0.0 112.102 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -60.83 -46.95 88.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.412 0.685 . . . . 0.0 112.38 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.64 84.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.179 0.592 . . . . 0.0 111.907 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.8 -45.82 70.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.136 0.575 . . . . 0.0 111.89 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.75 74.44 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.464 0.706 . . . . 0.0 112.812 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.25 -45.88 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.831 1.252 . . . . 0.0 111.973 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.489 HD13 HD12 ' A' ' 4' ' ' ILE . 52.2 mt -73.52 -40.1 64.29 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.037 0.935 . . . . 0.0 109.846 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.4 m -56.92 -46.6 81.89 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.35 1.06 . . . . 0.0 111.573 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.88 82.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.042 0.937 . . . . 0.0 113.325 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -73.44 -9.25 58.49 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 171.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.95 -6.01 34.74 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.574 1.559 . . . . 0.0 114.982 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.432 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 52.6 m-70 -76.84 153.73 34.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.54 1.17 . . . . 0.0 112.184 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -80.76 130.84 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.66 150.78 46.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.336 0.654 . . . . 0.0 111.457 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -155.75 121.48 4.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.966 0.906 . . . . 0.0 109.925 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.87 150.3 7.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.194 0.521 . . . . 0.0 111.383 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -133.53 102.55 5.55 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.708 1.203 . . . . 0.0 107.985 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.88 -27.12 60.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.57 1.148 . . . . 0.0 113.855 -170.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.65 58.89 4.76 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 126.297 1.839 . . . . 0.0 110.508 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.05 163.94 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.212 3.275 . . . . 0.0 116.114 -169.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.69 170.18 15.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.449 2.3 . . . . 0.0 109.178 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -53.28 -38.85 63.44 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.809 -1.182 . . . . 0.0 113.312 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.84 -13.93 28.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -89.69 -29.41 18.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.719 1.145 . . . . 0.0 112.52 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.512 ' CH2' HG21 ' A' ' 52' ' ' VAL . 38.1 t-105 -81.82 -42.85 19.1 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 0.0 112.665 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.4 tp -47.59 -44.65 55.92 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 126.803 2.041 . . . . 0.0 114.54 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.01 -9.28 0.66 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.271 3.981 . . . . 0.0 118.129 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.22 5.21 7.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 113.173 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -57.02 -36.45 70.46 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.227 -0.921 . . . . 0.0 112.605 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.03 13.06 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.561 1.944 . . . . 0.0 114.479 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -134.43 -130.43 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.591 1.556 . . . . 0.0 111.482 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.33 158.61 44.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.895 2.078 . . . . 0.0 109.691 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.512 HG21 ' CH2' ' A' ' 44' ' ' TRP . 30.3 m -147.36 172.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 110.467 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -154.86 149.58 26.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.683 1.593 . . . . 0.0 108.86 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.6 139.76 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.402 -0.811 . . . . 0.0 111.143 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 m -124.53 125.95 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.073 1.349 . . . . 0.0 108.257 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.7 m -150.87 158.28 43.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.041 -1.662 . . . . 0.0 113.38 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -136.14 178.61 6.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.505 1.522 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 m -121.51 135.37 55.03 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.01 1.324 . . . . 0.0 110.803 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 126.613 1.965 . . . . 0.0 109.28 -173.297 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.6 t0 . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.07 152.59 96.69 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.279 -0.888 . . . . 0.0 111.339 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -85.21 164.69 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.684 2.923 . . . . 0.0 112.566 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.0 -19.16 64.08 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -61.48 -19.76 62.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 tt -127.01 -8.33 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -48.42 -51.56 50.27 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-O 117.418 -1.277 . . . . 0.0 112.449 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.92 -5.18 16.56 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.362 2.041 . . . . 0.0 114.326 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -92.39 -43.43 9.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.227 0.921 . . . . 0.0 109.399 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.46 -50.03 74.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.806 1.243 . . . . 0.0 111.387 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -62.22 -40.0 94.68 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.981 -1.074 . . . . 0.0 112.485 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.89 -44.65 55.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.169 0.89 . . . . 0.0 113.505 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.43 -47.45 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.098 1.449 . . . . 0.0 110.047 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -59.92 -48.61 81.0 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.581 1.153 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.85 -41.82 22.57 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -88.52 -28.34 20.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -97.13 -42.65 7.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.85 -38.12 0.5 Allowed Glycine 0 CA--C 1.542 1.777 0 C-N-CA 125.84 1.686 . . . . 0.0 115.757 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -145.01 151.58 38.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.26 2.224 . . . . 0.0 110.82 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.24 43.12 0.23 Allowed Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -57.6 -29.48 85.3 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.141 2.561 . . . . 0.0 114.649 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -68.32 -15.26 63.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.924 2.09 . . . . 0.0 115.145 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.27 122.63 28.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.54 136.83 54.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 108.766 169.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -156.43 -172.29 4.02 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.2 161.37 27.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.127 1.346 . . . . 0.0 109.86 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.95 142.18 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.666 0.746 . . . . 0.0 111.749 -169.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mt -127.71 129.48 70.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.51 151.63 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.697 0.76 . . . . 0.0 110.853 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 tt -143.68 131.56 21.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.249 1.02 . . . . 0.0 109.976 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.78 -147.85 5.17 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 174.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -143.78 125.04 14.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.786 1.234 . . . . 0.0 110.385 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -60.16 -7.16 1.72 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -63.9 -7.87 9.49 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 171.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -126.49 136.08 52.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.42 1.488 . . . . 0.0 111.154 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.75 -36.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.513 1.125 . . . . 0.0 113.488 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.92 -17.11 59.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 23.1 t80 34.69 -118.23 0.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.443 1.897 . . . . 0.0 112.867 -169.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.19 24.69 0.52 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -46.36 -43.28 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.095 1.316 . . . . 0.0 113.883 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.55 -36.84 86.92 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 118.49 0.586 . . . . 0.0 113.142 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.53 -45.06 48.23 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.928 0.775 . . . . 0.0 113.463 170.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -58.24 -38.1 76.2 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.357 1.078 . . . . 0.0 113.374 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -55.89 -41.22 74.14 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.351 0.661 . . . . 0.0 112.29 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -71.4 -26.03 62.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.63 -41.45 45.88 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.697 -1.252 . . . . 0.0 111.462 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.93 -40.12 72.67 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.1 tp -50.68 -34.3 26.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.289 1.835 . . . . 0.0 112.92 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -103.71 -36.59 7.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -67.84 -32.39 72.89 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.9 -1.125 . . . . 0.0 113.022 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.03 -16.8 62.48 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 119.17 0.895 . . . . 0.0 111.87 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -107.04 10.14 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.06 1.744 . . . . 0.0 112.672 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m 65.71 23.95 11.55 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 114.713 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.3 177.96 0.23 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 0.0 112.618 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -136.72 163.57 30.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.498 -1.377 . . . . 0.0 109.673 -173.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -133.21 147.09 52.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.11 22.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.926 1.691 . . . . 0.0 112.14 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.2 176.56 41.1 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.405 1.479 . . . . 0.0 114.556 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.84 162.13 16.34 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.801 1.24 . . . . 0.0 112.398 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttp -71.32 123.17 21.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.615 -0.678 . . . . 0.0 111.352 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.25 138.81 47.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.035 0.934 . . . . 0.0 110.206 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.7 mt -124.73 91.3 3.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.84 1.256 . . . . 0.0 112.129 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.78 137.65 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.403 1.481 . . . . 0.0 110.34 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -133.07 102.81 5.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.278 1.037 . . . . 0.0 112.553 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.03 14.31 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 83.1 p -72.25 -14.68 61.84 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.57 1.077 . . . . 0.0 113.825 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.54 -7.54 1.3 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -136.91 112.14 9.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.538 1.135 . . . . 0.0 112.017 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.42 -3.62 12.63 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.68 2.92 . . . . 0.0 114.171 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -134.74 84.02 39.97 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.265 1.426 . . . . 0.0 111.78 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -46.24 -33.76 12.59 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 126.103 4.535 . . . . 0.0 116.229 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.08 -40.79 59.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.139 1.376 . . . . 0.0 112.605 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.5 p -67.26 -9.95 45.73 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -115.25 -3.45 12.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.587 1.155 . . . . 0.0 112.445 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.0 p -133.12 -27.45 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.66 -53.39 60.88 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 120.011 1.278 . . . . 0.0 112.752 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.18 -29.77 32.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.592 1.528 . . . . 0.0 112.694 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -60.76 -50.1 74.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.354 0.662 . . . . 0.0 111.463 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.41 -39.38 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 118.287 0.494 . . . . 0.0 110.571 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.48 -34.88 73.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.022 0.828 . . . . 0.0 112.403 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.51 -63.06 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.319 0.963 . . . . 0.0 111.945 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -57.38 -35.8 70.43 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.788 1.235 . . . . 0.0 113.045 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.58 -33.87 68.08 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.864 0.745 . . . . 0.0 113.905 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.8 p -69.99 -17.62 63.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.426 1.613 . . . . 0.0 113.884 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.99 -18.08 44.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.35 -32.72 73.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.255 1.386 0 C-N-CA 124.844 1.258 . . . . 0.0 112.364 -175.207 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.551 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 121.224 0.535 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.03 110.54 7.03 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 108.647 -173.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mm -110.89 137.41 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -169.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.01 126.61 8.85 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mt -119.62 101.12 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.493 1.117 . . . . 0.0 108.149 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.16 120.41 39.47 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.696 0.799 . . . . 0.0 112.481 -168.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.28 143.31 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.904 1.282 . . . . 0.0 110.768 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.84 76.43 0.31 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.064 1.316 . . . . 0.0 110.278 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 t -121.47 154.51 36.5 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.854 0.827 . . . . 0.0 112.447 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 tpt -90.45 -28.72 18.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.527 0.731 . . . . 0.0 112.548 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -146.3 -16.14 0.44 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.57 -14.56 4.74 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -62.96 -42.98 99.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.399 2.1 . . . . 0.0 113.093 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -77.84 -26.01 49.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.48 -44.31 89.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.886 -1.133 . . . . 0.0 112.177 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.8 -45.33 70.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.687 0.676 . . . . 0.0 111.589 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.48 -38.69 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.005 0.522 . . . . 0.0 111.892 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.66 92.44 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.964 0.802 . . . . 0.0 112.885 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.82 -43.7 98.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.696 -0.628 . . . . 0.0 112.081 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.32 -42.34 99.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.543 -0.723 . . . . 0.0 112.311 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.12 90.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.61 -0.681 . . . . 0.0 112.034 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -55.11 -47.8 74.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.425 0.69 . . . . 0.0 111.445 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.42 84.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.736 0.814 . . . . 0.0 112.849 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.13 -45.25 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.481 1.112 . . . . 0.0 112.305 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.34 -41.8 72.74 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.547 -0.721 . . . . 0.0 109.787 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -56.64 -42.92 79.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.919 1.288 . . . . 0.0 112.467 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 -42.33 65.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.31 1.044 . . . . 0.0 113.442 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -71.07 -37.04 72.48 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.4 21.86 0.03 OUTLIER Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.551 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 85.3 m-70 -133.66 -175.68 3.91 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.458 1.503 . . . . 0.0 111.155 -171.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.47 144.37 48.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.389 1.476 . . . . 0.0 108.379 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.74 153.1 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.825 -0.547 . . . . 0.0 112.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.5 m -137.6 113.46 9.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 109.442 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.02 147.34 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.336 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -134.79 105.07 6.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.97 -30.0 58.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.982 1.313 . . . . 0.0 114.041 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -148.68 65.1 8.2 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.489 1.916 . . . . 0.0 109.601 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.45 171.71 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.685 2.923 . . . . 0.0 114.188 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.85 169.18 16.1 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.77 2.028 . . . . 0.0 108.913 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.35 -35.31 65.07 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.671 -1.268 . . . . 0.0 112.344 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -57.53 -22.71 46.09 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -83.75 -36.74 23.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.121 0.873 . . . . 0.0 112.478 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 47.5 t-105 -70.57 -39.94 73.61 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.727 0.694 . . . . 0.0 112.034 174.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -43.25 -58.07 4.61 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 127.241 2.217 . . . . 0.0 115.273 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.17 -26.62 10.48 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.702 2.268 . . . . 0.0 114.731 -171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -74.18 -7.12 51.52 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -62.11 -30.57 71.11 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.667 -1.27 . . . . 0.0 112.694 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.71 2.64 7.79 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.309 1.444 . . . . 0.0 113.99 171.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -133.14 -120.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.082 2.153 . . . . 0.0 109.566 -169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -143.55 158.1 43.92 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 109.373 171.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 20.9 m -140.9 163.16 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.315 1.446 . . . . 0.0 110.718 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.19 141.87 20.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.225 1.012 . . . . 0.0 111.48 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.81 133.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.563 1.545 . . . . 0.0 109.606 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.97 106.49 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.4 m -149.16 155.16 40.24 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.297 -1.502 . . . . 0.0 114.913 -168.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -113.29 -174.22 2.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.37 1.468 . . . . 0.0 112.852 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.2 m -129.23 139.86 51.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.673 1.189 . . . . 0.0 110.666 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 108.352 -174.891 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -65.76 146.03 99.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.659 1.584 . . . . 0.0 112.987 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.01 155.27 19.8 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.706 2.937 . . . . 0.0 111.602 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.7 -23.86 63.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.8 m -56.85 -16.99 7.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.692 1.597 . . . . 0.0 115.153 174.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.0 tt -132.96 -4.98 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.3 t -48.88 -43.13 64.71 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.364 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 -13.95 41.02 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 CA-C-N 122.433 1.905 . . . . 0.0 114.928 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.83 -48.92 6.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.073 0.949 . . . . 0.0 109.017 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -59.85 -46.85 87.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.536 1.534 . . . . 0.0 113.612 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.6 -24.22 58.84 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.042 -1.037 . . . . 0.0 113.098 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.09 -52.21 4.14 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.218 0.913 . . . . 0.0 112.996 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.54 -38.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.591 1.195 . . . . 0.0 111.515 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -62.24 -35.43 78.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 113.297 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -115.7 -32.48 5.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -82.05 -19.14 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.3 mt -127.67 -48.87 1.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.689 1.196 . . . . 0.0 112.068 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.64 -22.84 0.23 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.932 1.933 . . . . 0.0 117.932 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.68 130.44 10.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.51 1.655 . . . . 0.0 111.704 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -163.29 66.97 1.64 Allowed Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.881 1.272 . . . . 0.0 112.895 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.3 -23.18 66.04 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.937 2.425 . . . . 0.0 114.649 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -72.53 -5.48 37.29 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -76.52 133.79 39.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.199 1.0 . . . . 0.0 111.778 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.56 145.01 51.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.732 1.613 . . . . 0.0 110.617 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -162.35 -170.9 2.6 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 165.02 33.61 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.869 2.176 . . . . 0.0 110.727 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 t -142.07 136.94 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.125 0.963 . . . . 0.0 112.259 -170.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -123.15 116.66 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.05 149.32 32.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.339 1.056 . . . . 0.0 110.571 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -138.36 149.77 45.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.267 1.027 . . . . 0.0 111.672 -170.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.03 -143.57 7.75 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.083 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -141.3 126.08 18.05 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.209 1.404 . . . . 0.0 110.262 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -66.02 -12.88 58.29 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -68.61 0.01 4.66 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -125.25 12.73 8.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.46 1.504 . . . . 0.0 114.479 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.37 -44.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 127.9 2.48 . . . . 0.0 115.205 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -76.24 48.33 0.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.027 1.285 . . . . 0.0 111.764 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.18 116.84 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.302 -1.499 . . . . 0.0 112.303 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.1 m 51.05 24.35 1.86 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.851 2.06 . . . . 0.0 116.498 -172.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.33 -15.49 48.53 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.693 -1.254 . . . . 0.0 113.559 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.18 -67.93 1.81 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.7 -36.09 77.22 Favored Glycine 0 CA--C 1.536 1.401 0 O-C-N 121.557 -0.966 . . . . 0.0 114.258 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.27 -38.32 76.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.295 1.047 . . . . 0.0 113.652 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.92 -34.68 78.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.63 0.65 . . . . 0.0 112.189 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.67 -29.88 62.58 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.124 0.874 . . . . 0.0 112.78 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.3 -46.02 74.8 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.098 -1.626 . . . . 0.0 110.395 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -35.8 72.42 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -49.15 -44.16 42.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.936 1.294 . . . . 0.0 111.445 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 mt -80.52 -31.92 36.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.254 0.622 . . . . 0.0 111.69 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -65.77 -32.75 74.47 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.854 -1.154 . . . . 0.0 112.01 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -61.75 -26.18 67.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.885 0.766 . . . . 0.0 112.175 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -82.17 -27.1 32.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.598 -0.689 . . . . 0.0 112.471 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.9 m 101.61 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 130.161 3.384 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 156.97 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.54 1.136 . . . . 0.0 113.625 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -123.93 88.07 2.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.902 1.681 . . . . 0.0 110.318 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -63.04 140.3 58.86 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.32 -0.863 . . . . 0.0 111.401 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.43 33.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.303 1.441 . . . . 0.0 111.702 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.96 -160.64 34.16 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.895 -1.128 . . . . 0.0 113.607 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -125.06 148.27 48.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.617 1.567 . . . . 0.0 111.179 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.3 ttp -69.67 124.56 24.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 112.189 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.45 140.72 39.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.072 0.949 . . . . 0.0 110.188 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.41 89.74 3.01 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.091 1.356 . . . . 0.0 111.534 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -76.87 133.96 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.611 1.564 . . . . 0.0 110.857 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -127.12 98.64 5.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.219 1.009 . . . . 0.0 113.219 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -15.31 9.79 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.0 p -73.45 -13.91 61.15 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.904 1.229 . . . . 0.0 113.822 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.02 -8.26 1.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -135.34 110.58 10.62 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.225 1.01 . . . . 0.0 112.185 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.92 -2.45 12.43 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.017 3.144 . . . . 0.0 114.481 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -129.9 80.59 70.98 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.671 1.588 . . . . 0.0 111.877 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.83 -36.49 7.92 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.654 4.236 . . . . 0.0 116.057 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.36 -45.87 36.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.426 1.89 . . . . 0.0 112.954 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.0 p -68.76 -18.09 64.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.14 -9.31 20.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.944 0.897 . . . . 0.0 112.506 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 m -116.02 -33.02 5.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -58.15 -51.53 81.08 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.396 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.99 -28.7 57.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.625 1.55 . . . . 0.0 112.723 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -61.74 -49.8 74.96 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.616 0.644 . . . . 0.0 111.68 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 t -68.27 -40.78 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.868 0.758 . . . . 0.0 110.367 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.6 -30.09 70.46 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -76.44 -57.94 3.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.274 1.03 . . . . 0.0 112.222 170.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -51.82 -47.44 64.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.831 1.252 . . . . 0.0 111.427 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.48 11.66 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.659 1.6 . . . . 0.0 115.905 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.0 p -70.52 -15.58 62.8 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.888 1.844 . . . . 0.0 113.961 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.94 -15.85 18.98 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.395 1.478 . . . . 0.0 113.192 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.7 157.63 14.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.269 2.227 . . . . 0.0 111.757 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.885 1.274 . . . . 0.0 113.536 174.076 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.593 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 121.281 0.562 . . . . 0.0 112.416 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -118.36 122.65 43.37 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.509 1.524 . . . . 0.0 108.732 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 mm -120.41 122.91 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.144 0.978 . . . . 0.0 112.367 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.59 128.77 9.17 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 168.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.46 91.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.276 1.038 . . . . 0.0 108.937 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -93.02 148.21 22.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.549 1.139 . . . . 0.0 112.448 -169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.11 143.87 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.55 0.74 . . . . 0.0 111.006 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.47 108.37 0.64 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 172.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -150.51 165.92 31.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.256 1.022 . . . . 0.0 112.08 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -110.15 -19.58 12.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.512 1.125 . . . . 0.0 113.174 171.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -143.78 -13.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.69 11.02 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.02 -44.71 97.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.35 2.075 . . . . 0.0 112.986 -174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 p -75.95 -30.25 58.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.644 0.778 . . . . 0.0 112.803 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.14 -39.25 85.67 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.907 -1.121 . . . . 0.0 113.408 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.89 -45.43 71.09 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.659 0.663 . . . . 0.0 110.899 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.66 -34.46 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 112.104 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.37 94.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.351 0.978 . . . . 0.0 112.831 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.0 -41.69 98.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.584 0.754 . . . . 0.0 111.611 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.0 -48.07 83.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.294 0.638 . . . . 0.0 111.799 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.91 91.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 112.844 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -57.67 -46.86 83.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.748 0.419 . . . . 0.0 111.512 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.98 81.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.369 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -58.1 -45.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.745 1.218 . . . . 0.0 112.201 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 mt -73.08 -40.1 65.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.556 0.616 . . . . 0.0 110.25 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.5 m -56.71 -46.78 81.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.662 1.185 . . . . 0.0 111.808 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.63 80.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.135 0.974 . . . . 0.0 113.009 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.74 -34.38 77.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.121 0.968 . . . . 0.0 111.756 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.86 5.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.213 1.387 . . . . 0.0 114.652 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.593 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 92.9 m-70 -75.36 150.62 38.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.636 1.174 . . . . 0.0 111.73 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -76.49 130.25 37.68 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.62 142.48 31.06 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.428 0.558 . . . . 0.0 111.913 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.0 m -141.0 115.63 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.971 0.908 . . . . 0.0 109.809 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.53 146.76 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.75 0.82 . . . . 0.0 111.895 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -135.18 96.13 3.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.781 . . . . 0.0 108.485 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -72.43 -27.48 62.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.309 1.444 . . . . 0.0 114.61 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -144.74 64.62 11.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.849 2.059 . . . . 0.0 108.524 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.44 162.02 43.65 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.363 3.376 . . . . 0.0 116.248 -168.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.93 163.7 29.67 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.058 2.543 . . . . 0.0 108.274 169.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.89 -45.01 15.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.955 -1.091 . . . . 0.0 112.568 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m -56.68 -20.1 19.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.18 -34.62 32.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.378 0.99 . . . . 0.0 112.313 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.5 ' CH2' HG21 ' A' ' 52' ' ' VAL . 14.3 t-105 -79.41 -32.29 42.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.596 1.558 . . . . 0.0 112.771 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 tp -39.87 -45.85 4.59 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 128.793 2.837 . . . . 0.0 116.167 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -77.58 -18.41 13.68 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.583 2.188 . . . . 0.0 115.354 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.88 -6.09 57.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -57.32 -23.8 51.0 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -102.47 13.81 33.59 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.132 1.373 . . . . 0.0 112.938 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -138.51 -131.55 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.652 1.981 . . . . 0.0 109.651 -169.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -135.31 151.51 50.61 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.237 1.015 . . . . 0.0 111.166 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.5 HG21 ' CH2' ' A' ' 44' ' ' TRP . 27.6 m -147.85 165.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.723 1.209 . . . . 0.0 111.012 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.65 149.72 24.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 109.563 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.14 143.23 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.205 0.602 . . . . 0.0 110.842 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.29 109.45 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.585 0.707 . . . . 0.0 110.298 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.4 m -138.17 144.53 40.77 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 m -95.96 -168.82 1.82 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.677 1.591 . . . . 0.0 112.587 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -128.5 149.71 50.48 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.88 1.272 . . . . 0.0 110.62 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 127.798 2.439 . . . . 0.0 108.561 179.006 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.3 t0 . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.724 0.773 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.47 139.86 55.57 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 127.185 2.194 . . . . 0.0 111.808 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.72 141.38 49.52 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.135 2.556 . . . . 0.0 110.014 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.17 -30.18 64.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -169.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -61.49 -13.35 20.17 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -121.75 -7.65 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.145 1.338 . . . . 0.0 113.896 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -50.7 -48.47 82.85 Favored Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.62 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.5 5.27 2.46 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.11 2.54 . . . . 0.0 114.749 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.4 tp -107.55 -47.34 3.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.663 1.185 . . . . 0.0 109.795 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.43 -53.71 55.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.352 1.061 . . . . 0.0 112.016 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -63.91 -37.06 86.02 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.682 -0.636 . . . . 0.0 111.844 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.81 -46.23 76.66 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.712 0.672 . . . . 0.0 113.281 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.57 -42.01 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.666 1.233 . . . . 0.0 110.57 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.81 -51.28 65.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.683 0.793 . . . . 0.0 112.987 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.93 -25.17 24.52 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.5 m -125.15 -0.37 7.78 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -119.09 -52.52 2.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.521 1.055 . . . . 0.0 110.256 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.23 -23.8 0.2 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 118.135 2.014 . . . . 0.0 118.135 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -151.98 139.76 19.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.041 1.736 . . . . 0.0 110.064 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 50.79 0.54 Allowed Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -66.03 -18.9 57.62 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.249 2.633 . . . . 0.0 114.592 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.53 -17.21 58.15 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -76.8 138.16 39.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.42 1.088 . . . . 0.0 112.663 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -129.15 145.9 51.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.932 1.693 . . . . 0.0 110.792 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -159.3 -174.9 4.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -169.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.77 154.97 25.87 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 127.357 2.408 . . . . 0.0 110.299 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.77 128.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.771 1.286 . . . . 0.0 111.169 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -105.6 143.56 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.93 48.72 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.036 -1.04 . . . . 0.0 110.343 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.3 tt -139.57 153.37 47.4 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.19 0.995 . . . . 0.0 111.339 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.69 -140.82 6.04 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.206 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -143.38 129.28 19.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.257 1.023 . . . . 0.0 111.196 -173.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.8 m -62.59 -7.0 3.96 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 m -67.2 0.34 2.82 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.05 156.09 48.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.535 1.534 . . . . 0.0 112.421 -170.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.46 -39.52 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.032 0.933 . . . . 0.0 111.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -78.08 44.85 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.209 1.404 . . . . 0.0 112.785 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -52.36 116.56 2.31 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.313 -1.492 . . . . 0.0 112.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.1 m 51.18 24.67 2.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.72 2.408 . . . . 0.0 117.219 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.45 -28.5 69.32 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.536 -1.353 . . . . 0.0 113.794 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.55 -35.81 91.66 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 118.912 0.778 . . . . 0.0 113.39 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.08 -34.17 27.45 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.276 -1.132 . . . . 0.0 113.297 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.64 -37.74 82.51 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.581 1.191 . . . . 0.0 112.636 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -57.36 -45.6 84.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.319 0.648 . . . . 0.0 111.407 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.0 -34.74 77.1 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.265 0.939 . . . . 0.0 112.952 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.94 -44.21 97.25 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 111.778 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.91 69.39 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.5 tp -53.92 -20.71 6.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.374 1.469 . . . . 0.0 113.233 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 mt -107.08 -37.7 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.788 1.235 . . . . 0.0 111.22 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -30.5 71.16 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.189 0.904 . . . . 0.0 111.26 169.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -51.83 -30.79 24.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.617 1.567 . . . . 0.0 112.131 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -116.97 17.72 14.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.395 1.478 . . . . 0.0 113.014 -169.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.3 t 65.58 16.0 10.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.602 1.961 . . . . 0.0 115.292 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.06 49.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.239 -0.913 . . . . 0.0 111.982 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -109.96 110.39 21.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.008 0.923 . . . . 0.0 111.23 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -73.1 126.23 29.53 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.054 -1.029 . . . . 0.0 110.853 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -84.44 34.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.176 1.39 . . . . 0.0 111.906 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.3 -171.47 43.1 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.682 1.611 . . . . 0.0 112.468 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -114.66 158.93 21.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.636 1.575 . . . . 0.0 111.375 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.3 mtp -61.85 159.12 14.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -127.85 127.47 43.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.413 1.085 . . . . 0.0 108.632 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.12 94.44 4.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.247 1.019 . . . . 0.0 111.669 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.5 mt -81.01 141.24 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.058 1.743 . . . . 0.0 112.154 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -124.92 103.9 8.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.877 1.271 . . . . 0.0 113.062 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -18.96 47.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.195 1.398 . . . . 0.0 114.403 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.3 p -80.6 -5.63 57.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.581 1.082 . . . . 0.0 113.56 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.13 -24.89 2.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.131 1.372 . . . . 0.0 112.848 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.48 110.44 7.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.876 0.871 . . . . 0.0 113.27 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.65 -1.92 10.76 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.061 3.174 . . . . 0.0 114.159 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -131.41 70.1 81.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.204 1.802 . . . . 0.0 109.291 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.06 -16.5 39.76 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.841 3.694 . . . . 0.0 117.262 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -57.55 -32.34 67.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.988 -1.07 . . . . 0.0 113.217 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -66.18 -6.28 13.0 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -118.91 -0.52 11.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.52 -26.05 1.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.29 -54.31 46.39 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.485 1.039 . . . . 0.0 113.067 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.26 -31.77 34.8 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 121.256 1.484 . . . . 0.0 112.852 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -60.52 -49.51 77.28 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.397 0.679 . . . . 0.0 111.669 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.19 -36.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.715 -0.616 . . . . 0.0 110.451 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.71 -44.31 96.73 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.236 0.926 . . . . 0.0 112.753 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.46 -36.09 58.08 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.995 1.27 . . . . 0.0 113.361 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -57.35 -43.79 83.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.74 1.155 . . . . 0.0 110.437 170.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.76 -13.53 25.55 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.864 -1.52 . . . . 0.0 116.131 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.7 p -107.05 -11.98 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.612 2.206 . . . . 0.0 113.183 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.12 -30.75 31.0 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.22 1.008 . . . . 0.0 111.378 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.23 152.57 20.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.362 1.465 . . . . 0.0 112.566 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.167 2.187 . . . . 0.0 114.006 -179.552 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.571 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.546 0.802 0 CA-C-O 121.29 0.566 . . . . 0.0 112.084 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -135.28 119.05 17.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.976 1.311 . . . . 0.0 109.754 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mm -118.34 124.96 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.744 0.818 . . . . 0.0 112.825 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.18 126.4 7.82 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 168.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.7 mt -117.54 90.97 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.438 1.095 . . . . 0.0 108.411 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -91.3 144.19 25.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.004 -169.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.4 141.54 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.054 0.942 . . . . 0.0 110.54 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.94 91.22 0.21 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -142.88 164.16 30.85 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.559 1.144 . . . . 0.0 113.155 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.6 mmm -125.77 0.83 7.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.531 1.532 . . . . 0.0 112.888 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -140.25 -37.3 0.47 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.32 -5.52 10.16 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.975 1.15 . . . . 0.0 115.975 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -63.15 -42.83 99.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.528 1.164 . . . . 0.0 111.481 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -39.53 86.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.061 . . . . 0.0 112.515 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 tp -59.72 -39.23 83.97 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.8 tp -49.34 -41.69 39.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.991 0.917 . . . . 0.0 112.177 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.6 -39.93 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 123.249 0.619 . . . . 0.0 112.045 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -41.07 96.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.075 0.852 . . . . 0.0 112.434 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.92 -42.06 97.37 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.35 0.66 . . . . 0.0 112.273 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.49 -43.25 85.89 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.467 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.24 92.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.702 0.801 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.64 -47.84 78.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.368 0.667 . . . . 0.0 111.529 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.77 92.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.71 0.804 . . . . 0.0 112.62 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.58 -47.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.28 . . . . 0.0 112.187 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 mt -70.32 -41.34 73.39 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.242 0.617 . . . . 0.0 109.884 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -56.73 -46.02 81.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.1 1.36 . . . . 0.0 112.24 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.79 90.14 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.169 0.987 . . . . 0.0 112.87 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.59 -32.24 71.99 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.48 4.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.26 1.41 . . . . 0.0 114.983 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.571 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 84.3 m-70 -77.95 146.72 35.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.149 1.379 . . . . 0.0 111.899 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -72.94 138.58 46.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.6 35.25 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.74 -0.6 . . . . 0.0 112.455 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.7 m -144.51 116.25 8.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.238 1.015 . . . . 0.0 110.656 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.47 140.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.106 0.562 . . . . 0.0 110.173 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.76 96.91 4.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.384 1.474 . . . . 0.0 107.899 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.4 -29.81 65.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.768 1.627 . . . . 0.0 114.265 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -146.31 64.53 9.79 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 126.862 2.065 . . . . 0.0 108.734 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.91 163.75 37.84 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.007 3.138 . . . . 0.0 115.727 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 160.67 36.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.339 2.256 . . . . 0.0 108.798 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -32.73 -54.04 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.765 2.026 . . . . 0.0 113.691 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -63.04 -21.63 66.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.493 1.517 . . . . 0.0 114.411 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.68 -36.14 62.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.222 0.919 . . . . 0.0 111.625 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.443 ' CH2' HG21 ' A' ' 52' ' ' VAL . 20.1 t-105 -79.46 -38.52 34.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 112.904 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.1 tp -38.39 -45.84 2.66 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 128.112 2.565 . . . . 0.0 116.784 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.64 -26.04 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 CA-C-N 122.543 1.944 . . . . 0.0 115.133 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -71.91 -8.8 56.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -56.49 -26.29 53.89 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.959 -1.088 . . . . 0.0 113.791 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.73 -8.05 57.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.324 1.449 . . . . 0.0 113.749 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -133.25 -128.61 0.17 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.958 2.103 . . . . 0.0 110.02 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -136.88 160.55 38.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.983 1.713 . . . . 0.0 111.277 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' CH2' ' A' ' 44' ' ' TRP . 33.6 m -144.08 170.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.878 1.271 . . . . 0.0 111.052 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -159.16 148.35 18.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.446 1.898 . . . . 0.0 108.174 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.34 142.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.684 -0.635 . . . . 0.0 112.048 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.6 116.2 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.097 0.959 . . . . 0.0 111.529 169.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.9 m -141.88 153.39 44.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 0.0 111.929 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 p -138.7 145.8 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -70.64 146.11 50.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.477 1.911 . . . . 0.0 114.654 -174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 127.469 2.308 . . . . 0.0 111.375 -173.898 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t0 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.59 139.74 96.15 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.734 2.013 . . . . 0.0 110.255 169.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.64 144.59 35.8 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.689 2.926 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.92 -22.39 64.31 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.5 p -63.3 -16.58 60.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.1 tt -124.89 -8.94 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.69 -48.12 77.44 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.8 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.12 5.89 1.65 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.24 2.626 . . . . 0.0 114.817 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.48 -44.98 3.44 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 110.324 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.73 -51.36 70.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.143 0.977 . . . . 0.0 111.679 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -62.87 -41.14 99.28 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 111.859 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -42.89 93.71 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.756 0.693 . . . . 0.0 113.772 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.31 -46.08 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -62.75 -40.77 98.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.54 -25.25 16.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -125.56 -31.47 2.98 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.84 -43.77 62.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.255 1.389 . . . . 0.0 109.391 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.49 -42.18 0.67 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 126.641 2.067 . . . . 0.0 116.679 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -155.14 143.26 20.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.116 1.767 . . . . 0.0 109.703 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -146.22 47.62 0.64 Allowed Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -60.86 -29.88 89.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.139 2.559 . . . . 0.0 113.799 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -65.87 -22.76 66.55 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.407 1.883 . . . . 0.0 114.615 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.8 tp -73.43 138.68 45.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.933 0.788 . . . . 0.0 111.574 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -134.8 132.74 39.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.493 1.917 . . . . 0.0 108.682 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -154.59 -171.56 3.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.59 164.18 30.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.974 1.75 . . . . 0.0 109.513 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 146.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.497 1.142 . . . . 0.0 113.533 -169.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.4 mt -129.83 141.66 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.82 1.648 . . . . 0.0 106.56 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.44 156.36 48.7 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -144.38 149.18 35.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 110.858 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.69 -151.0 9.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 123.654 0.645 . . . . 0.0 111.644 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -137.99 117.35 12.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.999 1.32 . . . . 0.0 109.876 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -59.62 -7.8 1.68 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.995 1.318 . . . . 0.0 114.505 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.0 m -61.32 -10.27 6.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.151 1.38 . . . . 0.0 114.157 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -127.21 137.02 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 111.426 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.57 -26.17 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -81.4 -18.49 45.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.316 0.962 . . . . 0.0 113.285 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.9 t80 38.93 -131.78 0.19 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.748 1.619 . . . . 0.0 112.451 -169.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.4 m -73.58 23.56 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -53.61 -30.42 42.5 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.142 -1.598 . . . . 0.0 114.495 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.1 -35.89 92.56 Favored Glycine 0 CA--C 1.533 1.156 0 O-C-N 121.125 -0.984 . . . . 0.0 113.111 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.32 -40.54 11.13 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.825 -0.809 . . . . 0.0 113.316 173.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.67 -31.9 69.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.67 1.235 . . . . 0.0 113.781 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -58.47 -39.53 80.21 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.16 -27.35 63.48 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.303 0.956 . . . . 0.0 113.33 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.64 -49.66 65.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.766 -1.209 . . . . 0.0 110.053 169.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.31 -40.45 71.15 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -49.89 -27.7 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.82 1.648 . . . . 0.0 113.644 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.6 mt -112.1 -36.67 5.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.609 1.163 . . . . 0.0 111.808 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.76 -31.24 71.75 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.169 -0.957 . . . . 0.0 113.209 170.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -66.25 -14.64 62.27 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 119.419 1.009 . . . . 0.0 112.528 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -111.81 16.84 20.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.641 1.976 . . . . 0.0 111.849 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t 61.97 20.41 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.332 1.853 . . . . 0.0 115.263 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.48 161.07 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.842 0.746 . . . . 0.0 112.972 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -112.09 162.71 15.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.769 1.628 . . . . 0.0 108.645 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mtm105 -133.88 149.05 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.85 21.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.986 172.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.85 -172.35 45.2 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.529 1.538 . . . . 0.0 113.598 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.68 156.26 44.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.282 1.433 . . . . 0.0 111.411 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.85 120.91 14.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.85 0.86 . . . . 0.0 112.098 -170.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.07 135.94 35.88 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.527 1.131 . . . . 0.0 110.074 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.58 96.03 4.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.704 1.202 . . . . 0.0 111.915 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.01 141.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.236 1.415 . . . . 0.0 111.137 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -129.49 116.73 19.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.907 1.283 . . . . 0.0 111.751 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.78 -26.87 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.618 1.167 . . . . 0.0 113.87 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.9 m -81.62 4.78 20.35 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.51 -30.18 2.36 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.371 1.468 . . . . 0.0 112.449 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -143.1 118.48 6.45 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 124.619 1.168 . . . . 0.0 112.278 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.32 -6.2 13.72 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.86 3.04 . . . . 0.0 114.498 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.98 80.58 64.58 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.529 1.532 . . . . 0.0 111.198 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.97 -35.04 9.65 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.712 4.275 . . . . 0.0 116.711 -175.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.67 -38.47 64.2 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.6 p -69.46 -6.14 28.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -116.38 -3.55 11.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.001 1.321 . . . . 0.0 112.554 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 p -132.95 -27.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -170.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -55.44 -54.09 54.92 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.254 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.5 -29.37 53.13 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.598 1.532 . . . . 0.0 112.756 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -62.49 -49.15 76.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.387 0.675 . . . . 0.0 111.442 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.89 -41.04 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.816 0.735 . . . . 0.0 110.506 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -59.03 -45.21 91.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.462 0.573 . . . . 0.0 111.541 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -61.96 -56.05 23.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.087 0.955 . . . . 0.0 112.138 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.38 -49.04 65.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.76 1.224 . . . . 0.0 111.172 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.96 -21.83 32.39 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.582 1.563 . . . . 0.0 116.165 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -70.53 -17.42 62.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.491 2.146 . . . . 0.0 113.737 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.47 -14.43 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.251 1.42 . . . . 0.0 113.578 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.2 157.67 18.79 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.412 1.885 . . . . 0.0 112.367 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.899 1.28 . . . . 0.0 113.651 177.437 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.465 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -135.14 119.37 17.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.618 1.567 . . . . 0.0 109.13 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.08 125.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.871 0.868 . . . . 0.0 113.267 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.6 128.6 8.97 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 mt -118.31 91.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.541 1.136 . . . . 0.0 108.519 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -90.93 139.1 31.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.274 1.029 . . . . 0.0 111.698 -169.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -125.47 144.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.713 0.768 . . . . 0.0 111.502 -169.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 105.88 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 t -155.9 161.45 40.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.385 1.474 . . . . 0.0 113.153 -173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.5 mmm -122.96 -9.28 8.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.438 1.495 . . . . 0.0 112.397 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -138.99 0.18 1.93 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.5 -4.39 83.95 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.117 1.607 . . . . 0.0 117.117 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -64.62 -42.87 95.21 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.475 1.637 . . . . 0.0 113.097 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 p -75.46 -33.9 60.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.085 0.954 . . . . 0.0 112.385 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 tp -58.43 -38.76 78.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.995 -1.065 . . . . 0.0 112.771 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -53.88 -45.68 71.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.759 0.709 . . . . 0.0 111.71 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.21 -36.9 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 111.545 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.41 92.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.261 0.937 . . . . 0.0 112.968 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.45 -41.76 97.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.356 0.662 . . . . 0.0 112.184 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.06 -41.72 97.25 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.648 -0.657 . . . . 0.0 112.562 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.528 -0.732 . . . . 0.0 112.061 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.81 -46.83 77.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.677 0.791 . . . . 0.0 111.825 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.48 95.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.742 0.817 . . . . 0.0 112.77 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.95 -43.19 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.547 1.139 . . . . 0.0 112.262 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.27 -38.71 75.15 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.21 -0.932 . . . . 0.0 109.614 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -57.64 -45.47 85.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.251 1.021 . . . . 0.0 111.516 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.14 83.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.991 0.916 . . . . 0.0 113.296 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -69.8 -10.48 58.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.29 41.43 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.574 1.559 . . . . 0.0 114.729 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.465 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 70.8 m-70 -73.03 175.36 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.289 1.435 . . . . 0.0 111.894 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -111.62 145.51 39.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.812 1.245 . . . . 0.0 109.622 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 162.67 38.81 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.2 m -153.31 120.36 5.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.111 0.964 . . . . 0.0 110.948 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.3 141.16 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.906 0.882 . . . . 0.0 110.924 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -126.67 111.12 13.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.221 1.408 . . . . 0.0 109.789 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 -16.46 23.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.461 1.504 . . . . 0.0 114.945 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -142.43 55.9 4.82 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.22 1.408 . . . . 0.0 111.068 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.37 163.15 39.81 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.977 3.118 . . . . 0.0 113.517 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -143.34 -44.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.84 -44.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.273 1.029 . . . . 0.0 113.105 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 m -58.76 -28.79 66.24 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.923 0.868 . . . . 0.0 112.257 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -54.83 40.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.948 2.899 . . . . 0.0 112.461 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -68.62 -40.89 80.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.572 1.549 . . . . 0.0 113.748 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -37.97 -56.45 1.94 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.672 2.389 . . . . 0.0 115.28 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.54 -18.72 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.594 2.196 . . . . 0.0 114.867 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.58 -5.95 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -54.88 -30.58 58.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.343 0.974 . . . . 0.0 113.158 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -86.23 4.21 39.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.378 1.471 . . . . 0.0 113.492 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -136.33 -136.27 0.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.438 1.895 . . . . 0.0 110.997 -169.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -130.1 160.47 33.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 110.642 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.89 169.55 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.303 1.441 . . . . 0.0 110.367 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.55 147.46 18.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 109.932 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.38 131.14 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.197 1.399 . . . . 0.0 109.561 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.07 86.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.5 m -126.52 164.17 21.77 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -167.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -129.34 -172.33 2.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.748 1.219 . . . . 0.0 113.216 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 m -136.61 132.08 34.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.652 1.181 . . . . 0.0 110.519 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 125.396 1.478 . . . . 0.0 110.33 -169.854 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.5 mt -53.46 125.71 44.93 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 126.783 2.033 . . . . 0.0 112.681 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.51 142.72 98.3 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.681 3.587 . . . . 0.0 112.136 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.12 -20.14 65.76 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 p -66.07 -11.55 49.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.76 1.624 . . . . 0.0 114.959 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.3 tt -131.58 -13.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -44.81 -49.33 28.05 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.449 -1.263 . . . . 0.0 112.995 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.37 -24.96 42.54 Favored 'Trans proline' 0 C--N 1.353 0.769 0 CA-C-N 122.155 1.805 . . . . 0.0 113.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.3 tp -75.86 -43.03 47.68 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.835 0.743 . . . . 0.0 110.062 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.86 -46.48 90.42 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.294 1.038 . . . . 0.0 111.091 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -63.7 -43.27 97.12 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.712 -1.243 . . . . 0.0 112.543 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.48 -50.18 66.95 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.688 1.137 . . . . 0.0 112.74 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.02 -46.42 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.567 1.183 . . . . 0.0 110.265 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.07 -46.72 84.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.636 1.174 . . . . 0.0 112.751 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.09 -33.51 20.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -98.59 -30.97 12.18 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.94 -32.96 11.4 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.232 0.924 . . . . 0.0 113.279 -170.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.14 -51.77 1.0 Allowed Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.39 1.947 . . . . 0.0 117.007 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -159.86 140.96 12.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -156.19 104.94 2.06 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.5 1.52 . . . . 0.0 110.298 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.1 -15.45 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.307 2.671 . . . . 0.0 116.074 -169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -124.35 1.8 8.41 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.8 tp -69.49 137.56 52.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.562 0.745 . . . . 0.0 109.811 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -128.93 143.71 50.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.592 1.557 . . . . 0.0 110.748 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.33 -170.6 2.87 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -168.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.31 162.55 31.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 127.41 2.433 . . . . 0.0 109.914 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.7 t -139.87 136.82 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.061 0.934 . . . . 0.0 112.238 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.8 mt -123.18 125.08 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.2 148.98 42.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.717 1.207 . . . . 0.0 109.598 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.07 146.42 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 111.687 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.44 -137.45 3.95 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.018 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 131.99 28.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.726 0.811 . . . . 0.0 112.091 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.4 t -64.44 -10.86 27.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.921 1.689 . . . . 0.0 114.869 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -69.41 5.4 1.35 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -131.69 154.77 48.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.664 1.585 . . . . 0.0 112.833 -171.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.65 -6.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.789 1.636 . . . . 0.0 114.835 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -125.86 44.8 2.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.731 2.012 . . . . 0.0 110.945 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -49.48 115.29 1.28 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.095 -1.628 . . . . 0.0 112.17 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.9 m 53.33 23.39 3.25 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -58.23 -27.24 63.77 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.82 63.59 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.62 -1.3 . . . . 0.0 111.912 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.66 70.7 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.43 -1.041 . . . . 0.0 113.127 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.38 -41.96 90.56 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 117.821 0.81 . . . . 0.0 112.858 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.04 -41.39 92.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.184 0.447 . . . . 0.0 112.147 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -69.5 -28.49 66.1 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.67 -46.06 66.95 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 119.807 -1.808 . . . . 0.0 110.807 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.88 68.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.7 tp -49.66 -31.07 10.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.019 1.728 . . . . 0.0 113.124 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.1 -36.97 8.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.561 1.144 . . . . 0.0 111.399 -171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -66.27 -31.16 71.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.53 -0.731 . . . . 0.0 112.826 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.65 -15.97 63.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.374 1.07 . . . . 0.0 112.942 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -113.26 -9.67 13.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.9 t 98.75 15.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.229 2.611 . . . . 0.0 113.922 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.83 161.17 8.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.222 0.465 . . . . 0.0 110.716 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.61 100.14 5.42 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.838 -1.164 . . . . 0.0 110.566 -171.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttm105 -66.93 135.7 54.23 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.407 -0.808 . . . . 0.0 110.83 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.08 34.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 111.318 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.51 -166.61 39.83 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.776 -1.202 . . . . 0.0 113.75 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.19 145.61 42.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.448 1.499 . . . . 0.0 111.974 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.16 118.08 10.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.149 0.979 . . . . 0.0 111.705 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.79 136.06 38.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.939 0.896 . . . . 0.0 109.881 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.6 mt -120.65 95.85 4.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.774 1.229 . . . . 0.0 111.775 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mt -81.4 134.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.242 1.417 . . . . 0.0 111.226 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -123.94 112.29 17.05 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.389 1.475 . . . . 0.0 111.477 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.94 -23.7 54.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.0 m -82.83 2.11 35.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.446 1.098 . . . . 0.0 113.893 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.11 -27.29 3.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.417 1.487 . . . . 0.0 112.664 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.94 115.28 6.59 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.582 1.153 . . . . 0.0 112.097 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.81 -5.29 14.59 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.682 2.921 . . . . 0.0 114.413 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -131.51 80.64 66.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.611 1.564 . . . . 0.0 111.283 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -43.68 -37.58 8.5 Favored 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 125.668 4.246 . . . . 0.0 116.056 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -45.97 -44.22 14.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.441 1.896 . . . . 0.0 113.214 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.6 p -71.25 -10.01 59.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -116.45 4.34 13.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.001 1.32 . . . . 0.0 112.423 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 p -132.31 -27.51 1.77 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -61.37 -53.68 60.08 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 119.766 1.166 . . . . 0.0 112.9 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.1 -35.6 95.15 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.565 2.177 . . . . 0.0 114.032 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -60.72 -48.03 83.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.647 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.37 -40.08 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.959 0.8 . . . . 0.0 110.774 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.36 -43.56 88.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.662 0.665 . . . . 0.0 111.311 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.24 -55.73 16.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.773 1.229 . . . . 0.0 112.393 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -53.31 -46.9 69.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.034 0.934 . . . . 0.0 111.348 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.81 -27.18 6.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.406 1.955 . . . . 0.0 116.361 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -71.94 -19.32 61.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.995 1.897 . . . . 0.0 113.824 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 -14.7 26.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.436 1.494 . . . . 0.0 113.255 -171.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.05 160.85 17.18 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.897 2.079 . . . . 0.0 112.354 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.251 1.02 . . . . 0.0 112.895 169.867 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -135.31 117.46 15.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.005 1.722 . . . . 0.0 108.527 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mm -118.9 121.4 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.007 0.821 . . . . 0.0 113.143 -172.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.87 127.41 8.27 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.18 91.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.471 1.135 . . . . 0.0 108.512 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -93.81 136.03 34.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.084 0.954 . . . . 0.0 110.948 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.73 145.26 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.611 0.764 . . . . 0.0 111.52 -169.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.6 90.24 0.22 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 125.034 1.302 . . . . 0.0 110.645 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -140.96 178.37 7.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -169.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -147.98 -21.71 0.35 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.812 2.045 . . . . 0.0 112.754 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.52 -2.49 7.94 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.91 1.21 73.55 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -64.07 -44.95 90.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.849 1.324 . . . . 0.0 112.376 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -73.64 -33.23 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.241 1.416 . . . . 0.0 112.561 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.92 -38.91 80.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.879 -1.138 . . . . 0.0 112.977 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.6 -45.08 73.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.83 0.741 . . . . 0.0 111.734 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -63.82 -36.91 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 111.594 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.73 -43.11 97.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.121 0.873 . . . . 0.0 112.623 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.26 -42.89 99.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.495 0.718 . . . . 0.0 112.578 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -62.72 -40.88 98.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.554 -0.716 . . . . 0.0 112.672 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.19 82.49 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.735 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.57 -46.02 73.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.405 0.682 . . . . 0.0 111.483 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.83 83.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.552 0.741 . . . . 0.0 112.785 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -59.33 -45.14 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.702 1.201 . . . . 0.0 112.068 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.0 mt -70.7 -41.57 71.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.636 -0.665 . . . . 0.0 109.664 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -56.93 -44.19 82.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.25 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -37.67 82.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.011 0.924 . . . . 0.0 113.016 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.522 0.729 . . . . 0.0 112.501 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.16 -9.72 7.86 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.013 1.768 . . . . 0.0 114.445 169.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -72.7 147.54 45.57 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.371 1.069 . . . . 0.0 111.734 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -72.13 140.44 48.85 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.75 159.71 42.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.282 0.633 . . . . 0.0 112.16 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.3 m -153.49 118.43 5.07 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.249 -0.907 . . . . 0.0 111.425 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -74.12 141.31 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.923 0.889 . . . . 0.0 111.014 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -128.88 109.21 11.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.835 1.254 . . . . 0.0 109.635 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.26 -19.36 34.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.614 1.565 . . . . 0.0 114.823 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.2 58.99 5.58 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.922 1.689 . . . . 0.0 109.835 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.1 159.54 53.47 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.115 3.21 . . . . 0.0 115.474 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -138.1 167.33 22.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.193 2.197 . . . . 0.0 109.411 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.41 -45.54 18.05 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.714 1.206 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -59.27 -18.51 38.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -80.27 -34.4 37.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.608 1.095 . . . . 0.0 112.334 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CH2' HG21 ' A' ' 52' ' ' VAL . 33.9 t-105 -77.22 -35.98 55.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 112.781 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -41.45 -45.85 7.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 128.609 2.764 . . . . 0.0 115.944 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.68 -26.44 5.71 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.668 2.246 . . . . 0.0 114.527 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -82.76 -13.79 55.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -59.17 -26.35 64.71 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.41 7.2 26.72 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -134.08 -117.31 0.19 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.213 1.805 . . . . 0.0 110.682 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.89 154.7 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.41 1.084 . . . . 0.0 111.151 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 44' ' ' TRP . 23.2 m -149.23 169.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 110.988 -173.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.33 146.95 17.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.097 0.959 . . . . 0.0 110.358 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.11 133.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.17 1.388 . . . . 0.0 110.139 -169.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.38 89.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 107.717 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.2 m -131.48 164.83 24.89 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -167.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -136.68 -173.09 3.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.616 1.566 . . . . 0.0 112.793 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.5 m -129.71 146.44 51.48 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.136 0.974 . . . . 0.0 111.201 -171.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 128.183 2.593 . . . . 0.0 108.765 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.95 150.63 87.6 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.275 -0.891 . . . . 0.0 112.935 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 162.61 19.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.87 3.047 . . . . 0.0 112.592 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.16 -17.85 64.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -171.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.5 p -60.3 -18.72 51.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.0 -9.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -45.65 -48.35 37.89 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.489 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.11 -23.3 33.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 122.199 1.821 . . . . 0.0 113.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 tp -76.03 -48.67 20.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 110.097 173.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.35 -49.58 76.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.825 1.65 . . . . 0.0 111.942 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -64.56 -45.13 88.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.235 -0.916 . . . . 0.0 111.851 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.89 -43.53 97.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.254 0.931 . . . . 0.0 114.278 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.72 -46.96 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.413 1.107 . . . . 0.0 110.402 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.69 -48.02 82.68 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.856 -0.527 . . . . 0.0 111.807 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.13 -41.26 61.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.084 1.353 . . . . 0.0 114.378 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -122.29 5.06 9.71 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -168.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -122.34 -49.65 2.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.54 1.064 . . . . 0.0 110.137 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -31.35 0.29 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.696 2.093 . . . . 0.0 117.984 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -154.71 138.77 16.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.197 1.499 . . . . 0.0 112.36 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -158.18 118.24 1.88 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.225 1.41 . . . . 0.0 110.926 169.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -87.45 -30.74 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.181 2.587 . . . . 0.0 115.806 -171.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -100.39 1.58 41.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.01 135.9 41.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.387 1.075 . . . . 0.0 111.388 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -123.64 143.38 50.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.009 1.723 . . . . 0.0 111.04 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.17 -173.84 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 162.48 32.04 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.151 2.31 . . . . 0.0 110.676 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.87 130.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.916 0.865 . . . . 0.0 111.701 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 mt -119.07 125.58 74.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 169.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.29 149.95 40.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.79 0.836 . . . . 0.0 109.728 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -140.36 138.81 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.645 0.778 . . . . 0.0 110.933 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.31 -131.12 1.63 Allowed Glycine 0 CA--C 1.521 0.463 0 O-C-N 122.253 -0.279 . . . . 0.0 113.533 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -141.07 119.48 12.25 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 111.149 -172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -64.16 -6.08 6.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.0 m -65.31 0.08 1.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -134.93 154.58 51.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.722 1.609 . . . . 0.0 112.33 -173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.803 0.841 . . . . 0.0 111.948 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.75 40.7 0.53 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.773 1.229 . . . . 0.0 112.557 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -51.16 115.06 1.38 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.393 -1.442 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m 50.85 26.07 2.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.02 -30.3 69.07 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.497 -1.377 . . . . 0.0 113.117 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -37.62 94.34 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.678 0.672 . . . . 0.0 113.527 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.82 56.29 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.136 -1.214 . . . . 0.0 112.642 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.83 -36.79 82.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.051 0.94 . . . . 0.0 113.032 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.67 -38.16 74.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.141 0.976 . . . . 0.0 112.373 170.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -78.37 -35.54 47.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.677 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.19 -41.06 96.14 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 119.676 -1.89 . . . . 0.0 111.822 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.45 79.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.07 -46.46 68.59 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.454 1.024 . . . . 0.0 111.34 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.4 mt -76.31 -37.23 57.73 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.124 0.969 . . . . 0.0 112.331 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.7 -32.48 74.06 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.471 -0.768 . . . . 0.0 112.333 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.84 -25.48 65.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.701 0.682 . . . . 0.0 111.8 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -76.49 -32.26 58.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.458 1.026 . . . . 0.0 111.477 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m 99.64 15.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.305 3.042 . . . . 0.0 112.198 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.71 162.54 6.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.229 0.612 . . . . 0.0 111.267 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -131.61 104.8 7.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.175 0.99 . . . . 0.0 110.602 -169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -69.63 134.67 49.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.279 -0.888 . . . . 0.0 111.439 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.48 31.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.615 1.566 . . . . 0.0 112.104 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.25 -165.32 38.7 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.954 -1.091 . . . . 0.0 114.37 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.63 151.6 38.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.785 1.634 . . . . 0.0 110.991 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 29.8 ttm -69.3 132.5 46.54 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.64 0.776 . . . . 0.0 112.01 -170.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.9 tm? -87.97 134.11 33.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.356 0.662 . . . . 0.0 109.474 171.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.463 ' N ' HD13 ' A' ' 123' ' ' LEU . 70.1 mt -121.36 93.47 4.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.921 1.288 . . . . 0.0 111.675 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 51.0 mt -75.55 136.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.383 1.473 . . . . 0.0 110.524 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -129.18 110.23 11.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.32 1.048 . . . . 0.0 112.458 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.2 -25.16 58.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.6 m -82.95 4.95 23.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 113.689 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -133.39 -29.98 1.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.132 1.373 . . . . 0.0 113.014 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -142.94 116.84 6.24 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.537 1.135 . . . . 0.0 112.393 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.68 -3.71 11.94 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.103 3.202 . . . . 0.0 114.75 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.34 86.1 58.8 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.528 1.531 . . . . 0.0 110.49 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.28 -26.85 71.78 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.952 2.434 . . . . 0.0 114.383 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.2 -39.14 93.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -12.42 56.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.265 -0.897 . . . . 0.0 112.718 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.06 -0.68 14.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.267 1.827 . . . . 0.0 111.751 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 p -135.2 -24.24 1.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.52 1.128 . . . . 0.0 113.955 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -62.66 -52.82 62.05 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -57.85 -34.58 98.48 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.652 2.234 . . . . 0.0 113.932 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -59.94 -48.6 81.06 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.157 0.583 . . . . 0.0 111.261 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.08 -39.33 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.096 0.862 . . . . 0.0 110.891 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.64 -46.37 90.58 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.661 1.119 . . . . 0.0 111.923 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -63.28 -51.06 67.66 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.024 0.93 . . . . 0.0 112.352 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -58.23 -54.79 42.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.869 0.867 . . . . 0.0 110.623 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.26 -29.66 53.22 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.254 1.883 . . . . 0.0 114.767 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 94.2 m -59.2 -23.18 62.06 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.292 1.037 . . . . 0.0 113.238 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.92 -15.67 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.346 1.458 . . . . 0.0 114.689 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -30.78 70.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.545 1.138 . . . . 0.0 114.044 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.773 2.029 . . . . 0.0 111.685 175.8 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.421 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.356 0.598 . . . . 0.0 112.292 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.13 121.0 33.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.402 1.481 . . . . 0.0 109.383 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mm -113.05 121.51 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.106 0.962 . . . . 0.0 112.036 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 126.38 7.48 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.4 mt -118.56 108.72 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 108.876 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.07 109.71 21.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.751 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -87.48 147.34 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.774 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.93 114.55 1.21 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -160.9 175.76 12.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.596 1.558 . . . . 0.0 111.309 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ptp -132.61 4.17 3.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -146.71 -54.13 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.656 1.182 . . . . 0.0 112.887 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.35 7.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 118.097 1.999 . . . . 0.0 118.097 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -63.85 -40.02 95.6 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.515 2.158 . . . . 0.0 112.743 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 91.7 p -79.69 -33.97 40.6 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.881 0.872 . . . . 0.0 112.502 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 tp -56.49 -38.49 71.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.054 -1.029 . . . . 0.0 112.719 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.61 -42.91 75.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.698 0.799 . . . . 0.0 111.682 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.41 -37.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 111.651 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -57.86 -44.25 86.46 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.935 0.789 . . . . 0.0 112.493 173.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.74 -43.36 99.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.073 0.949 . . . . 0.0 112.168 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.41 -48.2 81.46 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.598 -0.688 . . . . 0.0 112.395 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.48 89.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.627 0.771 . . . . 0.0 112.334 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.6 -44.97 85.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.525 0.73 . . . . 0.0 111.792 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -44.99 88.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.716 0.806 . . . . 0.0 112.674 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.5 mt -61.07 -45.61 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.841 1.256 . . . . 0.0 112.216 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.28 -43.23 82.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.374 0.67 . . . . 0.0 109.377 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.7 m -55.24 -47.52 75.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.631 1.173 . . . . 0.0 112.055 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.67 85.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.086 0.955 . . . . 0.0 113.451 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -72.92 -11.14 60.47 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -4.41 42.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.343 1.449 . . . . 0.0 114.524 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.421 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 83.9 m-70 -72.86 178.35 4.29 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.16 1.384 . . . . 0.0 111.862 172.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -118.19 145.26 45.09 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.957 1.703 . . . . 0.0 109.519 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.55 155.03 41.45 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.444 -0.785 . . . . 0.0 112.623 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.3 m -143.42 100.65 3.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.019 0.927 . . . . 0.0 111.042 -172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.48 137.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.154 0.982 . . . . 0.0 111.21 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -126.0 111.1 14.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.853 1.661 . . . . 0.0 109.271 170.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.28 -20.91 43.34 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -146.45 60.07 5.81 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 126.249 1.82 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.48 160.34 49.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.274 2.649 . . . . 0.0 114.651 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -135.89 164.07 28.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.341 2.256 . . . . 0.0 108.899 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -39.08 -48.01 1.61 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.497 1.519 . . . . 0.0 113.572 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 p -58.82 -18.12 29.63 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.07 -31.8 25.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.331 1.052 . . . . 0.0 112.541 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.518 ' CH2' HG21 ' A' ' 52' ' ' VAL . 23.6 t-105 -81.51 -36.87 28.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.349 1.06 . . . . 0.0 112.641 174.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -36.63 -52.28 1.89 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.456 2.302 . . . . 0.0 114.638 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.98 6.07 5.53 Favored 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 123.09 2.527 . . . . 0.0 116.029 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -107.31 2.81 24.8 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.246 1.384 . . . . 0.0 114.64 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -58.59 -25.88 63.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -99.19 9.42 43.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.681 1.592 . . . . 0.0 113.621 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -135.33 -160.68 1.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.694 2.398 . . . . 0.0 110.326 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -111.54 159.01 18.52 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.21 1.005 . . . . 0.0 111.85 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.518 HG21 ' CH2' ' A' ' 44' ' ' TRP . 28.4 m -148.51 173.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.409 1.484 . . . . 0.0 111.537 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.51 142.44 15.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.591 1.156 . . . . 0.0 111.379 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.42 130.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.191 1.797 . . . . 0.0 109.609 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 19' ' ' ALA . 11.4 p -140.34 89.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 122.091 0.948 . . . . 0.0 109.504 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.7 m -133.83 133.71 41.94 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -167.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 m -78.84 -166.97 0.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.935 1.694 . . . . 0.0 112.722 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -131.39 152.91 50.21 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.688 -1.257 . . . . 0.0 111.286 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 p . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 127.593 2.357 . . . . 0.0 109.198 -177.457 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 mt -60.72 126.29 84.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.707 2.403 . . . . 0.0 112.008 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.16 142.65 97.27 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.502 2.801 . . . . 0.0 111.335 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.62 -29.26 69.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 m -67.21 -9.55 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -118.18 -7.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.768 1.167 . . . . 0.0 113.243 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.9 t -54.63 -45.82 99.43 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.144 -1.407 . . . . 0.0 112.342 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -55.88 -11.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.216 3.277 . . . . 0.0 116.549 169.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 tp -105.3 -44.22 4.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.405 1.082 . . . . 0.0 110.403 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -58.3 -49.22 77.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 111.47 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -62.4 -42.69 99.62 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.539 -0.726 . . . . 0.0 112.332 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.27 -40.27 70.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.248 0.928 . . . . 0.0 113.585 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.63 -45.61 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.463 1.131 . . . . 0.0 110.063 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.27 -47.21 86.23 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.487 0.715 . . . . 0.0 112.376 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -79.02 -38.2 37.2 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 m -126.06 -10.06 6.53 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -168.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 -33.28 16.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.15 1.795 . . . . 0.0 112.279 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 -55.32 1.53 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.288 1.899 . . . . 0.0 116.802 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -151.76 149.55 29.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.03 1.732 . . . . 0.0 111.383 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -148.76 38.53 0.19 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.82 -33.52 14.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.815 2.344 . . . . 0.0 115.656 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -68.67 -0.37 5.16 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.545 2.338 . . . . 0.0 116.284 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.19 142.75 49.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.961 1.304 . . . . 0.0 112.251 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.7 145.26 51.54 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.054 2.142 . . . . 0.0 110.451 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.48 -169.09 2.33 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.75 167.36 31.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.015 2.245 . . . . 0.0 110.116 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.19 126.69 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 118.391 1.095 . . . . 0.0 112.978 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -114.0 109.86 30.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 168.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.39 142.51 32.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.416 0.686 . . . . 0.0 109.27 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.1 154.6 47.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.112 0.958 . . . . 0.0 110.716 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.7 -129.12 1.86 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.922 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.44 128.13 14.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.547 1.139 . . . . 0.0 111.165 -173.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.5 p -72.5 -1.6 16.49 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 m -67.74 4.13 1.22 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.42 156.26 47.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.147 1.779 . . . . 0.0 111.557 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.49 -37.33 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.732 0.813 . . . . 0.0 111.843 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.63 44.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 112.966 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -53.1 113.63 1.18 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.673 -1.267 . . . . 0.0 111.846 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.7 m 50.21 27.7 2.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.122 2.569 . . . . 0.0 116.312 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -58.85 -28.62 66.25 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.896 -1.128 . . . . 0.0 113.498 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.16 -33.49 64.91 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.771 0.7 . . . . 0.0 113.803 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.1 -36.78 9.67 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 117.908 0.854 . . . . 0.0 113.47 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -59.21 -36.79 76.03 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.828 1.314 . . . . 0.0 113.113 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -54.84 -45.74 74.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.927 0.891 . . . . 0.0 111.424 170.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.63 -27.56 62.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.461 -0.775 . . . . 0.0 112.949 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.5 -44.0 75.65 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.674 -1.891 . . . . 0.0 110.781 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.94 77.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.728 0.811 . . . . 0.0 112.979 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.3 tp -51.12 -32.43 22.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 112.847 171.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -97.95 -39.08 9.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.898 1.279 . . . . 0.0 111.857 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -69.17 -33.47 73.44 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.2 -0.938 . . . . 0.0 113.162 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.95 -12.99 56.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.769 0.828 . . . . 0.0 112.296 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.48 10.86 18.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.015 1.726 . . . . 0.0 112.459 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m 69.51 17.86 7.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 171.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.99 165.82 3.08 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.441 -0.787 . . . . 0.0 110.853 169.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -128.03 94.51 3.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.665 -1.272 . . . . 0.0 112.419 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -66.52 132.75 48.92 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.926 -1.109 . . . . 0.0 111.133 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.93 36.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.749 1.62 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.67 40.79 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.676 -1.265 . . . . 0.0 114.331 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.89 153.12 27.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.792 1.637 . . . . 0.0 111.366 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 30.3 ttm -71.07 138.08 49.47 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -94.95 135.44 36.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.92 0.888 . . . . 0.0 109.027 172.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.453 ' N ' HD13 ' A' ' 123' ' ' LEU . 55.8 mt -120.75 93.85 4.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.522 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.14 136.58 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.933 0.893 . . . . 0.0 111.199 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -125.3 100.32 6.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 112.488 -171.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.56 -17.32 13.43 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 114.451 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 p -72.17 -15.0 61.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.542 1.064 . . . . 0.0 113.769 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.61 -10.15 1.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -134.7 103.29 11.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.483 1.038 . . . . 0.0 112.418 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.38 1.47 9.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.046 3.164 . . . . 0.0 114.474 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -131.19 74.86 78.81 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.801 1.64 . . . . 0.0 111.022 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.56 -29.01 13.1 Favored 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 125.442 4.094 . . . . 0.0 117.148 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.4 -39.36 67.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.8 p -68.42 -5.88 21.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.698 1.199 . . . . 0.0 113.443 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -113.94 -7.73 13.14 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.691 1.597 . . . . 0.0 112.077 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.5 p -134.66 -25.43 1.46 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.14 -53.44 58.71 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 119.708 1.14 . . . . 0.0 113.723 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.09 -27.96 29.04 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.538 1.492 . . . . 0.0 112.865 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -63.13 -48.8 76.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.493 0.717 . . . . 0.0 111.608 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.49 -39.52 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.43 0.559 . . . . 0.0 110.198 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -59.21 -44.49 92.27 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.603 0.638 . . . . 0.0 111.644 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.61 -57.01 12.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -53.51 -46.38 70.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.054 0.942 . . . . 0.0 111.238 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.84 -24.81 14.39 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.361 1.934 . . . . 0.0 116.447 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.0 p -70.87 -19.72 62.6 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.118 1.959 . . . . 0.0 113.938 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.4 mt -93.08 -15.27 26.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.482 1.513 . . . . 0.0 113.066 -171.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 162.85 14.83 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.526 1.93 . . . . 0.0 112.458 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.665 1.186 . . . . 0.0 113.387 173.252 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.582 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -136.52 116.18 12.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.513 1.525 . . . . 0.0 109.26 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.21 128.75 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.526 1.131 . . . . 0.0 113.11 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.15 130.21 10.22 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -120.8 101.57 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.541 1.17 . . . . 0.0 108.323 -170.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -100.77 118.01 36.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.946 0.899 . . . . 0.0 112.667 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.1 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.864 1.266 . . . . 0.0 110.985 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.35 98.95 0.27 Allowed Glycine 0 N--CA 1.47 0.927 0 C-N-CA 124.355 0.978 . . . . 0.0 110.929 171.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -154.31 166.89 31.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.18 0.992 . . . . 0.0 113.551 -171.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.0 mmm -123.81 -3.28 8.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 113.043 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.29 -58.99 0.54 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.36 -4.79 0.23 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -61.72 -44.44 96.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.285 1.542 . . . . 0.0 113.251 -173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.9 p -77.62 -31.9 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.652 0.781 . . . . 0.0 112.369 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -57.58 -41.87 82.02 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.903 -1.123 . . . . 0.0 112.414 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.91 -43.56 77.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.722 0.692 . . . . 0.0 111.679 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -39.08 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.116 0.566 . . . . 0.0 111.823 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.36 -45.13 95.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.831 0.852 . . . . 0.0 111.963 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.38 -44.2 95.87 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.627 0.771 . . . . 0.0 112.58 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.36 89.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.527 0.731 . . . . 0.0 112.11 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -56.35 -46.78 79.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.938 0.495 . . . . 0.0 111.199 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.09 85.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.839 0.856 . . . . 0.0 113.029 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.73 -46.16 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.418 1.087 . . . . 0.0 111.789 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 mt -70.07 -41.01 74.69 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.82 -0.55 . . . . 0.0 109.996 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.8 m -56.2 -46.12 79.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 112.21 169.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.38 83.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.203 1.001 . . . . 0.0 112.929 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.4 -9.75 58.92 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.307 1.043 . . . . 0.0 113.311 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -11.06 48.87 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.792 1.663 . . . . 0.0 114.587 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.582 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 81.0 m-70 -70.26 140.29 52.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.015 0.926 . . . . 0.0 110.655 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -67.94 134.35 50.63 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.01 141.61 30.23 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.208 0.458 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -139.42 115.88 10.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.035 0.934 . . . . 0.0 110.026 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.59 147.27 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.699 0.8 . . . . 0.0 111.921 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.07 103.53 5.83 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.359 1.863 . . . . 0.0 107.651 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.58 -27.9 60.69 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -144.95 64.21 10.97 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.379 1.872 . . . . 0.0 109.009 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.8 160.72 40.36 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.67 2.913 . . . . 0.0 115.188 -168.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 173.51 11.6 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.302 1.841 . . . . 0.0 109.76 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -40.82 -50.74 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.098 1.359 . . . . 0.0 113.182 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 m -62.01 -18.01 59.12 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -81.64 -35.51 29.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.377 0.99 . . . . 0.0 112.122 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.45 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 17.4 t-105 -77.73 -35.42 51.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -40.95 -44.76 5.58 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 127.64 2.376 . . . . 0.0 115.938 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.95 -31.87 23.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.177 2.585 . . . . 0.0 115.471 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -82.08 -4.92 57.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.96 -23.51 46.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -97.27 8.48 44.47 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.646 1.578 . . . . 0.0 112.84 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -132.15 -135.09 0.19 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.741 2.416 . . . . 0.0 109.123 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -133.93 161.35 35.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.605 1.562 . . . . 0.0 109.775 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 18.8 m -148.36 167.31 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.574 1.15 . . . . 0.0 111.204 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.29 139.19 14.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.318 1.056 . . . . 0.0 110.991 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -105.27 132.22 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.0 1.72 . . . . 0.0 109.685 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 19' ' ' ALA . 3.1 p -139.83 88.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 122.753 1.264 . . . . 0.0 108.062 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.6 m -129.95 163.88 25.44 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.712 1.205 . . . . 0.0 113.027 -167.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.2 p -128.07 -173.23 2.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.335 1.454 . . . . 0.0 112.782 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -134.77 132.55 38.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.674 1.189 . . . . 0.0 110.081 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 125.183 1.393 . . . . 0.0 110.098 -169.523 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t0 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.71 130.89 78.06 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.301 1.84 . . . . 0.0 113.012 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -60.8 140.41 90.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.249 3.299 . . . . 0.0 111.118 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.21 -26.88 66.72 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.406 -0.809 . . . . 0.0 113.144 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -64.41 -8.95 15.17 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 tt -125.99 -9.26 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.22 -46.9 83.23 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 117.146 -1.407 . . . . 0.0 112.751 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.83 3.91 2.98 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.148 2.566 . . . . 0.0 114.557 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -109.03 -43.08 4.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.863 1.265 . . . . 0.0 110.656 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -59.92 -48.66 80.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.782 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -63.52 -38.16 90.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.287 -0.883 . . . . 0.0 112.622 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.45 -43.32 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.462 1.03 . . . . 0.0 113.093 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.0 mt -62.28 -46.42 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 118.543 1.171 . . . . 0.0 110.106 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -50.2 74.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.699 1.2 . . . . 0.0 112.6 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -77.76 -40.26 41.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -87.62 -45.8 10.1 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.58 -44.53 18.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.074 0.852 . . . . 0.0 113.149 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.18 -43.68 0.54 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 126.172 1.844 . . . . 0.0 116.632 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -156.88 133.12 9.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.902 1.681 . . . . 0.0 110.275 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -153.23 54.55 1.2 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.26 -24.1 78.27 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.589 2.859 . . . . 0.0 114.819 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -81.68 -13.49 57.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.744 . . . . 0.0 114.943 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.76 142.63 32.45 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.165 0.893 . . . . 0.0 111.428 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -131.1 144.35 51.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.145 1.778 . . . . 0.0 111.83 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -158.44 -172.14 3.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.86 162.43 31.67 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.18 2.324 . . . . 0.0 110.55 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.57 131.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 117.927 0.864 . . . . 0.0 112.625 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.2 126.35 74.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.29 147.75 45.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.256 1.022 . . . . 0.0 110.035 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.2 147.43 36.54 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.597 0.759 . . . . 0.0 111.54 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.75 -139.33 4.8 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.257 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -138.55 130.07 27.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 111.655 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.8 p -66.7 -5.3 11.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -69.22 2.2 3.08 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.54 153.21 48.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.423 1.489 . . . . 0.0 112.83 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.47 -7.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.778 1.631 . . . . 0.0 114.831 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -120.66 44.16 2.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.578 1.951 . . . . 0.0 110.761 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -50.38 115.38 1.43 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.211 -1.556 . . . . 0.0 112.344 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.46 25.0 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -55.9 -36.75 68.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.682 -1.261 . . . . 0.0 113.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.78 -41.26 99.88 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.794 0.724 . . . . 0.0 112.583 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.16 -40.49 82.34 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.277 -1.131 . . . . 0.0 112.936 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.76 -37.78 85.54 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.918 0.859 . . . . 0.0 113.311 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -59.77 -46.35 89.46 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.769 0.713 . . . . 0.0 111.01 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.26 -25.36 64.23 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.92 -48.93 56.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.017 -1.677 . . . . 0.0 110.077 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.8 -38.19 72.2 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.2 tp -49.21 -31.94 9.52 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.949 1.7 . . . . 0.0 112.966 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.01 -37.78 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.054 1.342 . . . . 0.0 110.975 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -35.95 82.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -22.24 66.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 112.644 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.79 9.97 41.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.2 m 66.56 15.11 10.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.685 1.994 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.56 141.57 54.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.973 0.806 . . . . 0.0 109.752 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -102.62 107.51 18.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.554 1.141 . . . . 0.0 111.449 -169.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.5 ttm105 -74.02 123.45 24.37 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.838 -1.164 . . . . 0.0 110.465 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.16 35.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.846 1.658 . . . . 0.0 111.925 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -162.12 35.81 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.526 -1.359 . . . . 0.0 114.34 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -125.57 154.38 42.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.254 1.821 . . . . 0.0 111.118 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.0 ttm -69.77 131.6 44.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.896 0.879 . . . . 0.0 112.059 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -85.91 135.37 33.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.41 0.684 . . . . 0.0 109.661 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.38 93.7 3.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.775 1.23 . . . . 0.0 111.599 -171.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mt -86.59 134.34 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.202 1.401 . . . . 0.0 110.773 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -127.17 111.89 14.51 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.085 1.354 . . . . 0.0 111.436 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.07 -23.16 53.54 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -85.48 4.61 34.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.725 1.21 . . . . 0.0 113.695 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -129.91 -30.25 2.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.861 1.264 . . . . 0.0 112.734 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -146.28 118.46 4.98 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.089 0.956 . . . . 0.0 111.789 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.94 -0.76 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.741 2.96 . . . . 0.0 114.708 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.64 77.44 77.44 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.57 1.548 . . . . 0.0 112.331 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.18 -31.33 5.9 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 125.831 4.354 . . . . 0.0 116.351 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -48.08 -44.42 31.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.133 1.773 . . . . 0.0 113.269 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.8 p -71.77 -29.0 64.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.594 1.158 . . . . 0.0 113.314 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.5 -26.46 38.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.317 0.647 . . . . 0.0 112.217 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.5 p -105.33 -28.37 10.94 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.43 -59.8 6.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.2 -28.57 33.85 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.909 1.739 . . . . 0.0 112.226 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -63.05 -50.31 71.14 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.701 0.682 . . . . 0.0 111.691 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.04 -41.12 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.739 0.7 . . . . 0.0 110.318 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.61 -44.44 93.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.349 0.522 . . . . 0.0 111.624 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.92 -55.47 25.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.196 0.998 . . . . 0.0 112.554 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.59 -49.67 64.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.36 1.064 . . . . 0.0 110.907 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.36 -19.57 26.11 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.579 1.562 . . . . 0.0 116.44 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.8 p -69.78 -20.24 63.48 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.884 2.342 . . . . 0.0 113.62 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -97.49 -15.48 20.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.178 1.391 . . . . 0.0 113.151 -171.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 149.9 49.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.303 1.441 . . . . 0.0 112.183 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.023 1.729 . . . . 0.0 114.234 -172.222 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.519 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -126.64 123.66 38.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.714 1.606 . . . . 0.0 109.434 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 mm -118.03 123.75 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.496 1.118 . . . . 0.0 112.259 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.42 126.58 7.69 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 168.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -116.97 111.4 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.719 1.259 . . . . 0.0 109.075 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.32 133.09 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.613 0.765 . . . . 0.0 110.79 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.94 144.26 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.903 -169.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.72 115.17 1.64 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -157.58 162.46 38.76 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.508 -0.996 . . . . 0.0 111.424 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -120.7 -19.39 7.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.598 1.159 . . . . 0.0 112.336 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.29 -7.12 2.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.15 -2.34 47.4 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.1 -47.75 78.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.314 1.557 . . . . 0.0 112.515 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -67.83 -30.11 69.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 112.751 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 tp -64.14 -44.36 92.41 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.7 -1.25 . . . . 0.0 113.039 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.09 -42.87 77.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.021 0.828 . . . . 0.0 111.262 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.31 -38.0 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.54 0.736 . . . . 0.0 112.236 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.31 94.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.85 -39.19 93.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.51 -44.63 96.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.483 -0.761 . . . . 0.0 112.216 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.34 88.67 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.922 0.783 . . . . 0.0 112.598 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.44 -46.4 80.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.775 0.83 . . . . 0.0 111.991 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.7 84.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 112.493 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.37 -42.64 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.407 1.083 . . . . 0.0 112.563 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.55 -44.21 78.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.807 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -56.93 -46.23 82.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 112.045 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -39.59 89.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.187 0.995 . . . . 0.0 113.242 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -67.75 -28.87 68.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.657 0.783 . . . . 0.0 112.67 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.76 -5.98 6.16 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.282 1.42 . . . . 0.0 114.502 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.519 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 85.8 m-70 -73.58 178.84 4.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.355 1.462 . . . . 0.0 111.482 175.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -117.64 144.11 45.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.354 1.462 . . . . 0.0 109.392 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.89 163.3 37.23 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.638 -0.664 . . . . 0.0 112.576 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -153.12 116.55 4.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.097 0.959 . . . . 0.0 110.999 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.87 140.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.872 1.269 . . . . 0.0 111.201 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -125.42 107.74 10.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.252 1.821 . . . . 0.0 108.959 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.48 -20.68 46.74 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -171.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.45 61.02 7.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.857 1.663 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.77 161.6 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.077 3.185 . . . . 0.0 115.023 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.2 171.34 14.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.115 2.166 . . . . 0.0 109.405 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -46.54 -48.57 19.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.354 1.062 . . . . 0.0 112.948 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 m -59.4 -19.22 45.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -79.02 -35.64 42.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.503 1.047 . . . . 0.0 111.85 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.441 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 23.0 t-105 -78.97 -37.36 39.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.239 1.415 . . . . 0.0 112.56 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.6 tp -38.68 -50.17 3.8 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 128.466 2.706 . . . . 0.0 116.318 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -15.67 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.714 2.276 . . . . 0.0 115.258 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -84.84 -1.8 56.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.12 -33.41 69.1 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.221 -0.925 . . . . 0.0 113.295 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.52 -5.7 50.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.266 1.026 . . . . 0.0 113.519 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -133.08 -134.51 0.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.927 2.491 . . . . 0.0 109.478 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.08 158.8 43.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.115 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.441 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 34.3 m -145.57 170.53 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.058 1.343 . . . . 0.0 111.896 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -157.91 148.64 20.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.334 1.453 . . . . 0.0 110.413 174.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' H ' HD22 ' A' ' 53' ' ' LEU . 39.0 t -117.09 135.59 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.57 1.548 . . . . 0.0 109.829 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.44 96.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.313 1.045 . . . . 0.0 109.681 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.0 m -138.82 152.99 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.3 p -108.33 -159.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.869 1.267 . . . . 0.0 113.514 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.1 m -122.92 151.19 42.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.082 1.753 . . . . 0.0 109.115 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 125.441 1.496 . . . . 0.0 108.73 -169.824 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pp -119.87 163.0 30.21 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.747 1.619 . . . . 0.0 113.603 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.71 142.9 78.78 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.59 3.527 . . . . 0.0 113.305 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.03 -28.15 67.51 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.617 -0.677 . . . . 0.0 112.816 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -62.02 -10.21 9.32 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.3 tt -128.1 -6.81 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.463 1.029 . . . . 0.0 113.243 175.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -47.9 -50.65 52.18 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 117.392 -1.289 . . . . 0.0 112.647 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 -2.03 10.75 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.239 1.959 . . . . 0.0 114.238 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.0 tp -98.06 -43.98 6.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.99 0.916 . . . . 0.0 110.122 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -61.57 -47.05 87.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -63.91 -44.53 92.66 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.34 -0.85 . . . . 0.0 111.876 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.61 -45.84 93.65 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.981 0.8 . . . . 0.0 113.373 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.02 -43.49 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.31 1.055 . . . . 0.0 110.596 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -62.65 -45.04 94.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.355 1.062 . . . . 0.0 112.617 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -83.67 -39.41 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.115 1.366 . . . . 0.0 114.512 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -121.8 4.92 9.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.65 -48.51 2.93 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.754 1.161 . . . . 0.0 110.823 168.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.49 -26.68 0.22 Allowed Glycine 0 CA--C 1.542 1.725 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -155.22 136.67 14.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 110.211 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -148.68 58.58 3.7 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.195 1.398 . . . . 0.0 112.471 -169.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.45 -2.53 8.45 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.603 3.535 . . . . 0.0 115.21 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -118.67 -6.12 10.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.664 2.385 . . . . 0.0 113.305 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.25 121.18 20.87 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.155 0.982 . . . . 0.0 110.155 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -123.4 140.77 52.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.87 1.668 . . . . 0.0 109.897 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -163.48 -167.57 1.46 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -168.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.54 170.46 34.05 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 127.596 2.522 . . . . 0.0 110.116 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.2 t -142.0 132.65 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.631 1.216 . . . . 0.0 112.247 -174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.72 130.4 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.59 152.5 43.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.017 0.927 . . . . 0.0 110.482 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -142.92 138.5 30.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.368 0.667 . . . . 0.0 111.803 -169.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.03 -138.86 3.36 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -144.09 122.51 12.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.501 1.12 . . . . 0.0 110.782 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -60.63 -9.42 3.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.823 1.249 . . . . 0.0 114.094 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.8 m -59.29 -13.42 7.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.419 1.488 . . . . 0.0 114.809 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -127.56 138.35 52.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.759 1.223 . . . . 0.0 111.834 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.69 -27.47 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -168.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -90.46 -14.08 33.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.761 1.164 . . . . 0.0 113.327 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 36.0 -125.33 0.14 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.409 1.484 . . . . 0.0 112.573 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.3 m -77.32 20.42 0.29 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -54.16 -33.98 59.34 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.095 -1.628 . . . . 0.0 114.71 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.27 85.38 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.481 1.037 . . . . 0.0 113.393 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.22 -41.75 52.42 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.256 -1.144 . . . . 0.0 112.429 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.88 -36.4 79.11 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -56.55 -48.48 77.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.69 0.677 . . . . 0.0 111.418 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -70.01 -29.53 66.62 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.49 -46.33 76.65 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.226 -1.546 . . . . 0.0 111.291 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.09 70.68 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -48.96 -28.55 3.95 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.924 1.689 . . . . 0.0 113.36 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -101.77 -35.26 9.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.645 1.178 . . . . 0.0 111.432 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.59 -32.84 74.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.72 1.145 . . . . 0.0 111.682 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.2 -15.31 14.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.809 1.243 . . . . 0.0 113.002 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -124.16 16.65 9.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.845 1.658 . . . . 0.0 113.201 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m 64.02 25.11 13.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.002 1.721 . . . . 0.0 115.425 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 159.79 12.27 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.243 -0.911 . . . . 0.0 112.332 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -129.13 86.33 2.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.111 1.364 . . . . 0.0 110.394 -170.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -62.51 138.96 58.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.03 31.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.552 1.541 . . . . 0.0 111.544 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.18 -165.46 38.92 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 121.015 -1.053 . . . . 0.0 113.999 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.26 158.48 28.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.066 1.747 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.0 ttm -72.32 133.96 45.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.68 -0.637 . . . . 0.0 112.149 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.27 134.13 33.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.825 0.85 . . . . 0.0 109.469 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.25 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.241 1.016 . . . . 0.0 111.196 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.58 135.07 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.074 1.35 . . . . 0.0 110.609 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -131.63 113.24 13.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.004 1.322 . . . . 0.0 111.09 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.8 30.44 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 m -77.26 -2.78 36.44 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -139.43 -18.5 0.98 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.631 1.573 . . . . 0.0 113.437 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.84 80.64 70.57 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.993 2.117 . . . . 0.0 110.772 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -16.25 42.57 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.947 2.432 . . . . 0.0 113.313 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.92 91.15 48.86 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 107.736 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.35 -27.04 84.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.461 2.774 . . . . 0.0 115.524 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.31 -29.1 60.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 p -68.92 -6.55 28.11 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -111.8 -31.83 6.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.327 1.051 . . . . 0.0 111.335 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.1 p -78.0 -32.88 51.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.88 -60.74 4.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -66.29 -29.78 46.09 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.118 1.879 . . . . 0.0 112.278 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -61.94 -51.15 69.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.532 0.605 . . . . 0.0 111.582 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.02 -40.65 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.525 0.602 . . . . 0.0 110.485 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.71 -38.01 83.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -71.41 -59.08 2.96 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.125 0.97 . . . . 0.0 112.717 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -52.17 -47.54 65.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.926 -174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.03 -34.69 12.26 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.001 1.286 . . . . 0.0 115.268 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.7 p -66.72 -15.88 63.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.023 1.411 . . . . 0.0 114.052 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -96.99 -15.92 20.85 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.249 1.419 . . . . 0.0 113.4 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.17 -36.86 80.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.561 1.544 . . . . 0.0 113.592 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.764 1.626 . . . . 0.0 112.226 -175.416 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.448 0.166 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.18 124.25 24.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.125 1.37 . . . . 0.0 109.181 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mt -136.9 125.05 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.71 132.88 11.39 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -120.02 90.79 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.984 1.314 . . . . 0.0 108.411 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.829 0.852 . . . . 0.0 110.752 -169.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.12 144.9 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.489 0.661 . . . . 0.0 111.567 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.49 101.68 0.48 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -146.92 164.1 33.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.784 1.234 . . . . 0.0 111.022 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 80.2 mmm -111.5 -11.39 14.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.944 0.898 . . . . 0.0 113.359 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -146.51 -19.62 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.89 -10.02 5.44 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 170.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.93 -44.38 91.32 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.176 1.988 . . . . 0.0 113.315 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.6 p -82.59 -28.97 30.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.6 0.76 . . . . 0.0 112.512 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.93 -40.42 84.56 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.729 -1.232 . . . . 0.0 112.912 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 tt -54.57 -41.05 69.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 111.815 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 90' ' ' ILE . 98.8 t -69.88 -35.72 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.242 0.617 . . . . 0.0 111.991 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.12 97.87 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.393 0.997 . . . . 0.0 112.506 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.47 -40.86 96.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.534 0.733 . . . . 0.0 112.269 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -60.45 -47.86 84.29 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.772 -0.58 . . . . 0.0 111.552 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.13 87.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.556 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.35 -46.24 80.06 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.727 0.811 . . . . 0.0 112.071 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.88 -47.18 81.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.367 0.667 . . . . 0.0 112.31 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.43 -32.7 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.358 . . . . 0.0 112.964 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 mt -80.14 -38.31 31.73 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.686 -1.259 . . . . 0.0 110.12 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.2 m -57.03 -45.32 83.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.669 0.788 . . . . 0.0 111.17 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.86 78.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.558 1.143 . . . . 0.0 113.487 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.05 -7.06 52.64 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.37 24.32 12.71 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.606 1.098 . . . . 0.0 114.346 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -114.87 147.89 39.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.376 1.088 . . . . 0.0 112.153 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -75.22 134.35 41.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.232 1.013 . . . . 0.0 109.034 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 155.03 45.59 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.168 0.987 . . . . 0.0 111.189 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -154.13 116.49 4.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.08 -1.013 . . . . 0.0 110.665 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.82 138.74 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.121 0.968 . . . . 0.0 110.71 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.68 101.08 6.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.308 . . . . 0.0 109.808 172.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.64 -22.79 56.47 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -144.31 64.12 11.93 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.202 1.801 . . . . 0.0 109.586 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.8 160.7 48.58 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.117 3.211 . . . . 0.0 114.703 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.37 162.04 31.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.164 2.186 . . . . 0.0 109.212 169.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -53.99 -36.62 63.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.713 -1.242 . . . . 0.0 113.346 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -58.07 -18.79 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -83.4 -35.13 25.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.406 1.003 . . . . 0.0 112.344 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.604 ' CH2' HG21 ' A' ' 52' ' ' VAL . 27.5 t-105 -75.2 -37.19 61.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.926 0.89 . . . . 0.0 112.193 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.3 tp -41.42 -46.74 8.42 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 128.34 2.656 . . . . 0.0 116.411 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.67 -30.32 4.98 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.211 1.941 . . . . 0.0 114.391 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -81.26 -9.74 59.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -55.44 -28.5 54.72 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.13 -4.98 52.99 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.471 1.508 . . . . 0.0 113.848 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.11 -115.52 0.23 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.761 1.624 . . . . 0.0 111.154 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.02 160.93 39.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.618 1.567 . . . . 0.0 110.694 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG21 ' CH2' ' A' ' 44' ' ' TRP . 31.4 m -152.4 172.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.118 1.367 . . . . 0.0 111.314 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 149.31 18.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.938 1.295 . . . . 0.0 109.771 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.07 136.98 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.84 1.256 . . . . 0.0 109.983 -170.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.11 94.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.984 1.314 . . . . 0.0 109.024 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.1 m -135.76 139.82 43.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -168.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -178.1 5.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.868 1.667 . . . . 0.0 112.381 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 m -127.75 139.11 52.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.718 -1.239 . . . . 0.0 110.899 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 120.556 1.526 . . . . 0.0 110.75 -170.644 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 CA--C 1.548 0.869 0 CA-C-O 121.583 0.706 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -53.52 136.97 52.22 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.364 1.866 . . . . 0.0 111.834 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.72 141.99 28.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.354 2.703 . . . . 0.0 110.679 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.46 -25.42 62.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 m -61.67 -17.2 54.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.42 -12.87 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 119.76 1.164 . . . . 0.0 114.138 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.68 -42.88 24.67 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.38 1.472 . . . . 0.0 114.08 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.17 -25.4 10.13 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.97 1.78 . . . . 0.0 114.075 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.49 -45.82 61.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.312 0.96 . . . . 0.0 109.616 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.19 -58.36 6.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.75 1.62 . . . . 0.0 111.381 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -66.96 -33.81 76.4 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.486 -1.384 . . . . 0.0 113.958 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.47 -48.23 87.0 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 119.097 0.862 . . . . 0.0 112.495 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.22 -41.03 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.197 -1.178 . . . . 0.0 110.557 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -61.48 -37.33 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.76 -23.07 10.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -169.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -113.21 0.45 14.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.5 mt -129.32 -49.63 1.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.739 1.216 . . . . 0.0 111.418 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.94 -22.52 0.33 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 118.447 2.139 . . . . 0.0 118.447 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -153.57 139.71 18.38 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.577 1.689 . . . . 0.0 110.677 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.59 45.85 0.28 Allowed Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -59.59 -21.57 62.94 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.555 3.504 . . . . 0.0 116.865 -169.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -106.56 -0.74 23.64 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.308 1.443 . . . . 0.0 113.849 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 52' ' ' VAL . 2.9 tm? -75.52 136.95 40.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.88 0.872 . . . . 0.0 110.258 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -130.7 133.5 46.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.681 1.992 . . . . 0.0 109.525 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -151.93 -170.87 3.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -170.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.46 164.92 30.78 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.823 1.678 . . . . 0.0 110.027 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.78 134.78 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 122.178 0.989 . . . . 0.0 112.253 -169.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 18' ' ' VAL . 87.4 mt -121.4 129.9 75.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.78 50.35 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.277 0.631 . . . . 0.0 111.591 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.1 169.69 20.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.494 1.14 . . . . 0.0 113.962 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.02 -126.03 1.28 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.643 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -142.21 128.56 19.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.3 1.04 . . . . 0.0 112.32 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -66.94 -12.13 58.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.714 1.606 . . . . 0.0 114.91 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 -15.77 63.2 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.13 148.84 22.28 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.867 1.267 . . . . 0.0 112.299 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.15 -38.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.71 0.804 . . . . 0.0 111.572 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -76.13 41.32 0.23 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.523 1.529 . . . . 0.0 112.834 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.5 117.15 2.66 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.911 -1.743 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 61.1 m 51.7 24.55 2.45 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -56.32 -33.55 65.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.622 -1.299 . . . . 0.0 113.32 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.9 -34.12 70.7 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.979 0.799 . . . . 0.0 113.522 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.89 -40.43 10.62 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.412 -1.052 . . . . 0.0 112.936 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.27 -35.75 74.28 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.293 1.047 . . . . 0.0 113.257 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -59.9 -41.88 92.6 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.231 1.013 . . . . 0.0 112.223 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -75.86 -29.04 58.41 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.443 -0.786 . . . . 0.0 112.684 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.27 -43.79 80.94 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.076 -1.64 . . . . 0.0 111.289 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.18 84.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.111 0.964 . . . . 0.0 113.199 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.5 tp -49.04 -29.39 4.95 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 112.964 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.0 mt -102.69 -42.91 5.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.567 1.147 . . . . 0.0 111.642 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.18 -31.44 72.63 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.756 1.162 . . . . 0.0 112.76 169.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.88 -18.64 63.25 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.094 -1.004 . . . . 0.0 112.86 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -107.03 15.3 25.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.865 1.666 . . . . 0.0 112.39 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.2 m 62.43 14.92 7.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.944 2.097 . . . . 0.0 115.276 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.02 156.64 17.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.915 0.78 . . . . 0.0 112.008 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -116.53 164.8 14.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 -169.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 -129.61 146.13 51.44 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.46 21.01 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 113.368 -1.742 . . . . 0.0 112.368 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.6 -176.71 46.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.104 1.811 . . . . 0.0 113.464 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.21 159.3 22.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 112.112 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.38 127.08 31.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.433 0.693 . . . . 0.0 112.388 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.81 133.56 35.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.33 94.26 3.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.864 1.266 . . . . 0.0 111.356 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.17 138.57 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.443 0.697 . . . . 0.0 111.817 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.98 114.93 23.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.535 1.534 . . . . 0.0 111.429 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.19 -25.32 58.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m -79.86 1.36 27.34 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -132.47 -27.75 1.72 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.833 1.253 . . . . 0.0 113.453 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -142.47 108.33 5.64 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 112.104 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.87 -0.99 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.112 3.208 . . . . 0.0 114.571 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.18 74.71 79.27 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.465 1.906 . . . . 0.0 109.842 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -57.94 -22.0 52.49 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.445 3.43 . . . . 0.0 116.551 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.04 -37.81 72.32 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.932 -1.105 . . . . 0.0 113.122 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.8 p -68.56 -6.35 24.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.317 1.047 . . . . 0.0 113.476 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -110.47 -12.99 14.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.211 1.404 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -129.17 -24.54 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -51.48 -52.73 57.11 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.251 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.11 -27.58 41.78 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.78 1.654 . . . . 0.0 113.419 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -62.51 -49.91 73.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.66 -33.64 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.558 -0.714 . . . . 0.0 111.113 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.52 -16.65 63.88 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -95.98 -59.26 1.89 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.826 1.251 . . . . 0.0 111.759 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -54.63 -46.04 73.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.775 1.23 . . . . 0.0 112.473 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.91 -19.6 22.83 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.2 p -76.86 -11.99 59.9 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.893 . . . . 0.0 113.715 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.08 -9.32 17.89 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 126.1 45.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.609 1.164 . . . . 0.0 113.698 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.885 2.474 . . . . 0.0 110.563 170.798 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.572 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.323 0.583 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -127.99 125.2 38.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 0.0 108.679 174.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 mm -123.07 124.25 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.398 1.079 . . . . 0.0 112.569 -171.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.62 128.52 9.24 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.5 mt -119.25 91.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -91.22 135.41 33.81 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 111.565 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.2 142.56 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.011 -170.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.16 104.72 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -147.7 169.49 19.59 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.911 1.284 . . . . 0.0 110.807 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.7 mtp -116.65 -7.2 11.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.283 1.033 . . . . 0.0 113.029 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -148.37 -32.0 0.26 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.39 -1.58 2.71 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.88 -42.18 97.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.144 1.972 . . . . 0.0 113.199 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -78.37 -31.87 48.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 172.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.3 tp -57.71 -40.09 78.74 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.037 -1.039 . . . . 0.0 113.08 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.87 -45.1 70.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.312 0.645 . . . . 0.0 111.464 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.72 -39.38 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.834 0.454 . . . . 0.0 111.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.42 87.45 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.19 0.905 . . . . 0.0 113.159 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.12 -44.24 96.17 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.564 -0.71 . . . . 0.0 111.886 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.31 -40.74 97.3 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.665 -0.647 . . . . 0.0 112.068 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -46.31 90.65 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.854 0.752 . . . . 0.0 111.799 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.44 -47.0 80.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.013 0.525 . . . . 0.0 111.493 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.67 -47.36 85.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.789 0.836 . . . . 0.0 112.911 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.32 -46.35 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.556 1.142 . . . . 0.0 112.225 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.78 -40.79 75.81 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.942 -0.474 . . . . 0.0 109.751 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -56.24 -46.54 79.55 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.859 1.264 . . . . 0.0 112.215 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.54 89.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 112.955 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -68.71 -30.77 69.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.393 0.677 . . . . 0.0 112.671 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.57 -6.69 4.56 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.875 1.226 . . . . 0.0 115.556 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.572 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 80.6 m-70 -79.07 144.1 34.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 111.04 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.82 134.9 49.04 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.76 142.68 31.03 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.8 0.727 . . . . 0.0 112.293 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.6 m -141.45 114.83 8.83 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.086 0.954 . . . . 0.0 110.137 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.6 p -80.53 149.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.919 0.888 . . . . 0.0 111.974 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -137.94 104.9 5.39 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.711 1.605 . . . . 0.0 109.321 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.82 -33.04 70.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.555 1.542 . . . . 0.0 114.522 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -145.81 62.88 8.83 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.418 1.887 . . . . 0.0 109.437 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.67 160.1 49.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.911 3.074 . . . . 0.0 115.658 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.94 170.59 15.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.423 2.289 . . . . 0.0 109.026 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -57.71 -34.99 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.7 -1.25 . . . . 0.0 113.443 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.2 p -61.21 -15.49 34.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.38 -33.38 20.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.568 1.076 . . . . 0.0 112.503 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CH2' HG21 ' A' ' 52' ' ' VAL . 39.6 t-105 -75.52 -37.15 60.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.302 1.041 . . . . 0.0 112.501 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.9 tp -43.92 -50.53 19.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 127.789 2.436 . . . . 0.0 115.216 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.61 -1.59 6.93 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.072 2.515 . . . . 0.0 115.708 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.18 0.46 10.68 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.181 1.392 . . . . 0.0 114.02 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -60.84 -14.82 24.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -121.19 18.74 11.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.619 2.368 . . . . 0.0 112.267 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -124.43 -138.05 0.29 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.697 2.399 . . . . 0.0 108.649 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -123.32 157.86 32.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.532 1.533 . . . . 0.0 109.303 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG21 ' CH2' ' A' ' 44' ' ' TRP . 18.9 m -146.33 166.79 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.111 1.364 . . . . 0.0 110.08 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.18 144.88 20.19 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.239 -0.913 . . . . 0.0 110.654 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -113.44 132.86 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.382 1.473 . . . . 0.0 110.334 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.78 91.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.52 1.128 . . . . 0.0 108.757 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 m -135.8 138.13 42.28 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -85.15 -167.76 1.96 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.767 2.027 . . . . 0.0 113.034 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -135.81 141.95 44.79 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.537 -1.352 . . . . 0.0 111.157 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.197 1.799 . . . . 0.0 109.539 -179.193 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mt -49.47 127.4 17.58 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 127.511 2.324 . . . . 0.0 113.133 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.27 141.78 94.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.296 3.331 . . . . 0.0 111.351 169.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.37 -25.99 67.54 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -171.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.3 m -63.21 -12.16 26.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.3 tt -125.19 -10.39 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.93 -47.65 63.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.263 -1.351 . . . . 0.0 113.33 170.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.15 -19.2 34.55 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 122.46 1.914 . . . . 0.0 113.987 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -78.02 -42.72 31.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.179 0.9 . . . . 0.0 109.606 171.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -62.04 -45.92 91.42 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.518 1.127 . . . . 0.0 111.386 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -62.77 -40.93 98.81 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.659 -1.276 . . . . 0.0 112.676 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -45.46 69.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.568 1.08 . . . . 0.0 112.967 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.5 mt -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 119.427 1.613 . . . . 0.0 109.98 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.79 -46.12 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.654 1.181 . . . . 0.0 112.265 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.24 -35.17 36.48 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -90.82 -33.95 15.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.22 -53.55 4.19 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.625 1.102 . . . . 0.0 111.689 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -37.59 0.29 Allowed Glycine 0 CA--C 1.544 1.862 0 C-N-CA 126.164 1.84 . . . . 0.0 115.803 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -161.87 124.7 3.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 110.557 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -149.58 53.75 1.4 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 126.035 1.734 . . . . 0.0 113.085 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.78 -27.63 78.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.942 3.095 . . . . 0.0 115.13 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.81 -26.46 67.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.889 1.276 . . . . 0.0 114.247 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.6 tp -77.78 142.1 38.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.678 0.791 . . . . 0.0 112.527 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -138.08 145.61 41.93 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.038 2.135 . . . . 0.0 110.054 -172.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 118' ' ' ARG . 29.2 p90 -161.0 -171.15 2.96 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -169.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.91 165.26 33.08 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.933 2.206 . . . . 0.0 110.525 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -139.65 134.78 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.076 0.938 . . . . 0.0 112.618 -169.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.8 mt -118.3 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.16 148.25 40.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.173 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.07 151.41 45.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.175 0.988 . . . . 0.0 112.075 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.78 -133.57 2.76 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.164 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -142.65 133.1 24.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.421 1.088 . . . . 0.0 111.967 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.7 p -68.32 -6.12 22.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 m -68.64 3.18 1.98 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -136.64 154.59 50.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.788 1.635 . . . . 0.0 111.749 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.85 -36.23 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.632 0.773 . . . . 0.0 112.897 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.43 44.78 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.769 0.827 . . . . 0.0 111.944 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -53.77 116.61 2.61 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.553 -1.342 . . . . 0.0 112.003 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 56.7 m 50.83 23.93 1.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.964 2.506 . . . . 0.0 116.957 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.07 -26.28 67.53 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.661 -1.274 . . . . 0.0 114.09 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -30.09 73.46 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.733 0.697 . . . . 0.0 113.404 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.0 -38.71 9.04 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.08 0.94 . . . . 0.0 113.179 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.18 -35.16 74.75 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.509 1.155 . . . . 0.0 113.52 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -59.38 -37.84 78.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.494 0.718 . . . . 0.0 112.423 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.04 -33.2 61.71 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.322 -0.861 . . . . 0.0 112.477 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.95 -1.719 . . . . 0.0 110.911 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.7 89.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.3 tp -46.31 -44.04 16.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.495 1.518 . . . . 0.0 111.998 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.23 -28.63 57.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.114 1.366 . . . . 0.0 112.449 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.16 -29.74 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.106 -0.996 . . . . 0.0 111.587 169.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -66.01 -23.86 66.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.638 1.108 . . . . 0.0 111.607 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -88.05 1.89 53.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.646 1.178 . . . . 0.0 111.967 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m 53.38 22.73 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.995 1.718 . . . . 0.0 114.83 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 156.1 24.34 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 111.433 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -119.48 87.63 2.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.502 1.521 . . . . 0.0 111.539 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 30.2 ttp85 -59.47 137.86 57.87 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.487 -0.758 . . . . 0.0 112.041 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.67 51.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 126.341 1.856 . . . . 0.0 109.967 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.85 -174.86 44.7 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.326 -0.859 . . . . 0.0 114.083 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.08 147.16 44.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.25 1.42 . . . . 0.0 110.717 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.06 130.66 42.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.452 0.701 . . . . 0.0 111.86 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.34 134.65 35.26 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 92.29 3.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.681 1.192 . . . . 0.0 111.246 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.5 mt -85.1 134.3 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.468 1.507 . . . . 0.0 111.631 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -121.56 109.16 14.46 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.623 1.169 . . . . 0.0 112.809 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.42 -23.39 49.23 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 m -83.5 0.82 44.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.416 1.087 . . . . 0.0 113.867 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -129.21 -26.54 2.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 113.417 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -146.59 119.29 4.97 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.007 0.822 . . . . 0.0 112.835 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.0 -5.11 12.12 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.895 3.063 . . . . 0.0 114.216 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.43 73.94 80.11 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.54 1.536 . . . . 0.0 111.175 -172.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.06 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.311 3.34 . . . . 0.0 115.055 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -48.15 -44.21 32.14 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.146 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.5 p -67.78 -18.41 64.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.51 -17.74 16.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.209 1.004 . . . . 0.0 112.425 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -113.42 -28.43 7.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -59.9 -52.12 75.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.717 -1.135 . . . . 0.0 113.204 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.49 -28.93 61.95 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.349 1.518 . . . . 0.0 112.773 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -60.95 -50.29 73.98 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.609 0.641 . . . . 0.0 111.658 171.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 -41.43 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.684 0.675 . . . . 0.0 110.461 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.91 -39.45 85.45 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.453 0.57 . . . . 0.0 111.966 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -67.19 -56.32 10.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.883 0.873 . . . . 0.0 112.51 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -53.35 -46.23 69.46 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.414 1.086 . . . . 0.0 111.4 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.5 -23.61 6.59 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.393 1.949 . . . . 0.0 116.507 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -72.69 -18.52 61.54 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.068 1.934 . . . . 0.0 114.072 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.65 -15.47 25.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.487 1.515 . . . . 0.0 113.109 -171.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.49 157.67 22.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.521 2.328 . . . . 0.0 113.154 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.256 1.397 0 C-N-CA 128.156 2.582 . . . . 0.0 114.649 -173.968 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.454 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.326 0.584 . . . . 0.0 111.999 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -131.88 129.49 40.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.633 1.173 . . . . 0.0 110.094 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 mm -122.0 125.17 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.894 0.878 . . . . 0.0 112.937 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.84 124.87 7.05 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mt -116.41 91.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.448 1.099 . . . . 0.0 108.26 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.68 136.09 35.38 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.021 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.31 145.21 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.215 0.606 . . . . 0.0 111.669 -169.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 80.92 0.3 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.188 1.375 . . . . 0.0 110.741 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.03 168.58 18.54 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.0 tpt -130.58 -4.18 4.2 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.938 2.095 . . . . 0.0 112.203 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -142.82 -54.74 0.41 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.114 . . . . 0.0 113.229 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.08 -2.98 1.04 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 117.097 1.599 . . . . 0.0 117.097 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -62.79 -44.14 96.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.881 1.341 . . . . 0.0 112.289 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -71.59 -35.76 70.63 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.286 1.434 . . . . 0.0 112.309 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.51 -40.78 92.65 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.718 -1.239 . . . . 0.0 112.457 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.49 -41.17 76.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.879 0.763 . . . . 0.0 111.82 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.52 -37.92 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.847 -0.533 . . . . 0.0 112.023 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.1 97.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.35 0.977 . . . . 0.0 112.844 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.48 -40.33 94.16 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.575 0.75 . . . . 0.0 112.413 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.51 -45.64 93.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.386 -0.821 . . . . 0.0 112.102 169.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.19 88.29 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.726 -0.609 . . . . 0.0 112.198 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.19 -47.73 77.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.648 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.84 92.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.564 0.745 . . . . 0.0 112.676 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.1 -47.25 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.749 1.219 . . . . 0.0 112.355 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.09 -39.35 79.08 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.253 0.621 . . . . 0.0 109.805 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -57.01 -48.71 77.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.988 1.315 . . . . 0.0 111.975 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -34.97 79.16 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.025 0.93 . . . . 0.0 113.399 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.26 -8.31 56.29 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.43 36.95 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.974 1.273 . . . . 0.0 115.009 171.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.454 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 81.5 m-70 -77.24 172.17 13.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.764 1.226 . . . . 0.0 111.557 173.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -104.97 145.29 30.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.276 1.03 . . . . 0.0 108.543 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.78 164.17 32.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.47 -0.769 . . . . 0.0 112.788 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.6 m -152.79 120.97 6.22 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 110.565 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.16 138.63 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.053 0.941 . . . . 0.0 110.651 169.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -125.9 107.4 10.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.88 1.272 . . . . 0.0 109.606 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -84.65 -14.43 48.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -143.2 56.67 4.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 126.074 1.75 . . . . 0.0 110.199 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.15 165.4 31.55 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.095 3.197 . . . . 0.0 115.524 -169.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.15 166.38 26.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.181 2.193 . . . . 0.0 109.037 172.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -40.15 25.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.577 1.151 . . . . 0.0 112.404 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.02 -20.12 15.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -97.12 -29.09 13.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.934 1.293 . . . . 0.0 112.181 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -70.66 -42.01 71.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.511 . . . . 0.0 112.771 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.08 -52.79 49.92 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.222 2.209 . . . . 0.0 114.687 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -65.77 -3.65 8.48 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.002 2.468 . . . . 0.0 115.956 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -110.72 1.11 17.67 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.888 1.275 . . . . 0.0 114.07 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -66.24 -30.29 70.7 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.484 -1.385 . . . . 0.0 113.418 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.97 3.93 13.43 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.923 1.289 . . . . 0.0 113.365 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -132.45 -123.77 0.19 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.286 1.835 . . . . 0.0 110.14 -169.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.51 160.0 40.97 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.909 1.684 . . . . 0.0 110.768 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.44 168.47 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 110.65 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.57 146.26 19.47 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.386 -0.821 . . . . 0.0 110.466 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -117.91 137.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.062 1.345 . . . . 0.0 110.595 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.2 94.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.873 1.269 . . . . 0.0 108.091 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.1 m -133.8 167.06 21.24 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.4 p -141.22 173.93 11.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 112.047 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.7 m -99.14 150.97 21.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.748 1.219 . . . . 0.0 112.447 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.476 0.855 0 C-N-CA 128.17 2.588 . . . . 0.0 108.739 170.22 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.962 0.411 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.03 147.15 34.01 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.411 1.885 . . . . 0.0 110.396 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.86 154.38 63.41 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.614 2.876 . . . . 0.0 111.36 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.48 -14.22 56.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.9 p -59.18 -27.51 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.633 1.173 . . . . 0.0 113.538 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.64 -9.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.563 1.145 . . . . 0.0 113.965 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -49.94 -46.03 81.12 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 120.369 -1.457 . . . . 0.0 112.716 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.19 -15.49 23.67 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.02 3.146 . . . . 0.0 116.119 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 tp -98.31 -45.7 6.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.88 1.272 . . . . 0.0 109.806 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -63.42 -45.36 91.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.032 1.333 . . . . 0.0 112.251 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -68.81 -38.5 79.94 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.57 -47.04 64.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.143 0.878 . . . . 0.0 112.936 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.33 -44.33 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.224 1.012 . . . . 0.0 110.652 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.85 -47.45 83.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.997 0.919 . . . . 0.0 112.524 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.22 -26.96 24.78 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -125.9 6.1 7.33 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 -169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.7 mt -123.03 -50.81 1.91 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.517 1.053 . . . . 0.0 111.48 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 -27.06 0.26 Allowed Glycine 0 CA--C 1.543 1.806 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -158.8 131.79 7.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.45 1.625 . . . . 0.0 110.845 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -159.12 52.84 0.52 Allowed Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.14 -32.28 39.26 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.463 2.775 . . . . 0.0 116.582 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -73.14 -13.19 61.13 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 tp -73.94 140.15 45.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.978 0.808 . . . . 0.0 111.845 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -135.45 144.14 46.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.102 1.761 . . . . 0.0 109.505 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -162.8 -169.43 2.06 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.29 163.05 31.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.798 2.142 . . . . 0.0 110.384 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.13 138.05 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 122.233 1.016 . . . . 0.0 112.62 -172.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.3 mt -122.1 131.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.323 1.849 . . . . 0.0 106.052 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.46 147.14 49.85 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.492 0.717 . . . . 0.0 110.36 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.8 tt -139.13 142.82 38.04 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.069 0.947 . . . . 0.0 111.601 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.58 -147.86 7.79 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.362 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -144.15 121.6 11.7 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.273 1.429 . . . . 0.0 110.029 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.5 p -62.41 -5.26 2.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.4 m -60.66 -13.2 13.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.433 1.493 . . . . 0.0 114.453 169.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -123.21 157.45 33.01 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 0.0 113.638 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 m -50.69 -23.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -168.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.99 1.84 4.3 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -173.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 14.5 t80 36.54 -128.83 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.832 1.253 . . . . 0.0 112.784 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.4 m -80.99 21.38 0.7 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.86 -33.27 48.98 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.34 95.52 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.758 1.163 . . . . 0.0 113.327 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.2 -40.25 71.27 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 121.613 -0.934 . . . . 0.0 112.95 171.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.01 -38.45 88.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.383 1.091 . . . . 0.0 113.132 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -59.05 -43.59 91.7 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.506 0.594 . . . . 0.0 111.776 170.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.66 -36.61 78.78 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.45 -43.09 98.38 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.811 -1.806 . . . . 0.0 111.711 170.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.17 69.87 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 tp -49.75 -28.36 6.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 112.956 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 mt -102.35 -37.69 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 -169.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.1 -31.9 73.04 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.938 1.244 . . . . 0.0 111.533 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.02 -17.33 24.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 113.024 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -119.81 16.53 12.68 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.122 1.769 . . . . 0.0 112.463 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m 67.74 18.64 9.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.91 2.084 . . . . 0.0 115.515 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.7 152.75 18.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.425 -0.797 . . . . 0.0 112.386 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -122.43 86.91 2.66 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.906 1.682 . . . . 0.0 110.904 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 ttm105 -61.83 141.58 57.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.675 -0.64 . . . . 0.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.83 33.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.484 1.514 . . . . 0.0 111.204 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.8 -163.29 37.02 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.07 -1.019 . . . . 0.0 113.222 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.25 156.48 43.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.71 1.604 . . . . 0.0 111.293 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.8 ttm -65.19 127.08 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.302 1.041 . . . . 0.0 111.776 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -82.3 134.42 35.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.57 93.76 4.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.01 1.324 . . . . 0.0 111.522 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.9 mt -82.5 132.03 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 0.0 110.479 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -131.75 107.71 8.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 112.352 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -19.06 31.67 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 m -69.28 -14.11 62.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.915 1.234 . . . . 0.0 114.212 171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.38 -12.53 1.59 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -142.91 102.56 5.29 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.29 0.95 . . . . 0.0 112.514 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.72 1.7 9.0 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.87 3.046 . . . . 0.0 114.267 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -121.53 77.0 36.06 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.342 1.857 . . . . 0.0 109.729 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.09 -24.81 78.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.21 3.273 . . . . 0.0 114.861 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.15 -44.58 71.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 111.969 170.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.2 p -66.06 -20.63 66.24 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.98 -15.76 27.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 112.675 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.8 p -123.26 -28.8 3.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -54.2 -52.89 64.71 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 119.503 1.047 . . . . 0.0 113.68 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.35 -29.0 32.46 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.777 1.652 . . . . 0.0 112.673 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.13 -48.73 78.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.787 0.721 . . . . 0.0 111.62 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 t -67.79 -40.37 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 118.425 0.557 . . . . 0.0 110.331 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.39 -40.16 85.7 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.595 0.634 . . . . 0.0 111.911 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -65.03 -58.43 6.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -53.24 -46.78 69.31 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.086 0.954 . . . . 0.0 111.701 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.98 -24.17 13.55 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.123 1.821 . . . . 0.0 116.382 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.7 p -71.43 -19.81 62.19 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.933 1.866 . . . . 0.0 114.072 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.93 -16.25 25.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.243 1.417 . . . . 0.0 112.977 -170.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.37 155.23 21.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.529 2.332 . . . . 0.0 111.599 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 124.772 1.229 . . . . 0.0 113.585 174.112 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.468 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -129.23 118.03 21.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.724 2.01 . . . . 0.0 108.032 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.99 126.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.05 131.72 10.68 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mt -120.9 91.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.271 1.428 . . . . 0.0 107.439 -171.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -92.58 141.55 28.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.989 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.8 148.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.569 0.748 . . . . 0.0 112.071 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.31 97.54 0.21 Allowed Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.165 1.364 . . . . 0.0 110.406 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -144.34 168.38 20.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.23 -24.37 6.45 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.312 1.845 . . . . 0.0 112.558 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -134.7 -4.65 2.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 2.09 64.57 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -64.94 -45.41 85.9 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 1.591 . . . . 0.0 112.123 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -69.43 -36.22 76.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.093 1.357 . . . . 0.0 112.408 172.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.4 tp -59.39 -42.13 91.01 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.956 -1.09 . . . . 0.0 112.715 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.9 -41.88 78.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.653 0.661 . . . . 0.0 111.575 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.53 -35.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.662 -0.649 . . . . 0.0 112.271 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.74 97.09 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.179 -0.951 . . . . 0.0 112.504 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.76 -41.04 99.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.668 . . . . 0.0 112.398 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.04 -46.46 88.15 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.504 -0.748 . . . . 0.0 111.652 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.52 85.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.389 0.676 . . . . 0.0 112.217 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.64 -47.65 76.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.777 0.831 . . . . 0.0 111.882 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.19 -47.4 86.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.538 0.735 . . . . 0.0 112.843 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.94 -45.56 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.591 1.156 . . . . 0.0 111.887 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.5 mt -69.59 -41.41 75.81 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.734 -0.604 . . . . 0.0 109.791 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -56.64 -45.65 81.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.872 1.269 . . . . 0.0 111.998 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.8 -38.0 85.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.986 0.914 . . . . 0.0 113.1 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -70.76 -23.07 62.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.3 -8.27 7.94 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.323 1.44 . . . . 0.0 114.981 170.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.468 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 86.7 m-70 -72.13 167.52 20.09 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.654 1.182 . . . . 0.0 112.111 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -100.89 137.87 38.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.323 1.449 . . . . 0.0 109.474 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.28 159.16 43.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.269 0.628 . . . . 0.0 112.432 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -153.77 119.84 5.39 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.974 0.91 . . . . 0.0 111.133 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.7 t -74.26 141.79 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.222 1.009 . . . . 0.0 110.801 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.4 104.28 7.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.856 1.262 . . . . 0.0 110.586 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.65 -17.34 38.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -142.35 60.87 10.91 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.563 1.545 . . . . 0.0 110.582 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.91 166.31 29.98 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.374 3.383 . . . . 0.0 115.694 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.35 162.74 37.53 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.637 2.375 . . . . 0.0 109.181 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.92 -38.49 56.51 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.691 -1.255 . . . . 0.0 113.655 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -62.23 -13.96 33.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -92.06 -25.48 18.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.669 1.122 . . . . 0.0 112.807 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -80.98 -40.76 23.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.557 1.543 . . . . 0.0 112.617 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 tp -50.08 -41.01 61.53 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -55.38 -9.63 2.61 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 125.108 3.872 . . . . 0.0 118.349 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -118.17 4.54 11.97 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -70.06 -9.86 56.79 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -110.65 17.72 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.423 1.489 . . . . 0.0 112.613 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.52 -135.62 0.16 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.572 1.949 . . . . 0.0 110.209 -169.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.63 159.82 38.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.702 1.601 . . . . 0.0 111.145 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.78 178.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.102 1.361 . . . . 0.0 111.581 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -155.7 149.31 25.07 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.538 1.935 . . . . 0.0 108.232 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.429 ' H ' HD23 ' A' ' 53' ' ' LEU . 89.4 t -130.33 133.44 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.577 1.151 . . . . 0.0 108.867 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.27 90.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.032 1.333 . . . . 0.0 109.47 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 m -134.39 157.34 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 t -130.76 -164.66 1.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.487 1.515 . . . . 0.0 112.747 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 m -130.69 150.14 52.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.519 1.928 . . . . 0.0 111.318 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.473 0.688 0 C-N-CA 127.315 2.246 . . . . 0.0 108.908 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.2 t0 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.11 151.59 95.98 Favored Pre-proline 0 CA--C 1.553 1.089 0 O-C-N 121.682 -0.637 . . . . 0.0 111.739 170.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.91 158.33 20.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.391 2.728 . . . . 0.0 112.332 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.2 -21.39 63.79 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -57.27 -17.42 11.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.741 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -132.88 -9.49 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.83 -49.32 38.38 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.599 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.27 -24.72 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.967 1.738 . . . . 0.0 113.7 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.94 -47.49 45.11 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.367 -0.833 . . . . 0.0 110.118 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -58.68 -50.88 72.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.746 1.619 . . . . 0.0 112.151 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -62.88 -41.36 99.37 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.203 -0.935 . . . . 0.0 112.349 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.89 -47.67 80.25 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.451 1.024 . . . . 0.0 113.141 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.59 -39.4 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 118.979 1.39 . . . . 0.0 111.316 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.15 -47.88 75.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.087 0.555 . . . . 0.0 111.751 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.31 -36.29 24.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.9 m -84.15 -30.81 25.57 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -173.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.3 mt -100.13 -49.5 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.876 0.762 . . . . 0.0 112.622 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.67 -34.3 0.28 Allowed Glycine 0 CA--C 1.544 1.877 0 C-N-CA 126.21 1.862 . . . . 0.0 116.143 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -158.17 135.75 10.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.833 2.053 . . . . 0.0 110.349 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -156.87 97.77 2.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.939 0.895 . . . . 0.0 112.862 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.85 -20.72 10.18 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.473 2.782 . . . . 0.0 114.418 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -80.66 -17.21 51.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -174.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.9 tp -70.72 138.68 50.75 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 111.779 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -137.49 138.66 39.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 108.966 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -163.5 -173.37 3.29 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.48 162.87 28.49 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.393 1.949 . . . . 0.0 109.038 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.79 132.09 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.015 0.907 . . . . 0.0 112.971 -169.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.19 128.07 74.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.54 155.02 44.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.297 1.046 . . . . 0.0 110.293 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -139.53 151.85 46.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.342 1.057 . . . . 0.0 108.705 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.39 -144.26 7.86 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 112.078 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -137.77 121.27 17.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.916 0.887 . . . . 0.0 110.559 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.1 p -71.99 -2.17 17.22 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -69.92 4.2 2.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -136.87 159.39 41.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.21 1.804 . . . . 0.0 112.425 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.19 -32.42 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.83 1.252 . . . . 0.0 113.412 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -103.94 44.11 1.04 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.812 1.245 . . . . 0.0 112.409 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -49.38 111.37 0.48 Allowed 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.677 -1.264 . . . . 0.0 112.289 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.7 m 52.78 28.15 6.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.22 2.208 . . . . 0.0 116.955 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -53.22 -40.99 64.93 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.445 1.02 . . . . 0.0 112.225 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -36.89 92.84 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 122.132 -0.355 . . . . 0.0 113.134 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.19 46.58 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.557 -0.967 . . . . 0.0 113.052 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.91 -34.49 76.15 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.649 1.179 . . . . 0.0 113.057 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -60.43 -42.76 96.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.47 0.577 . . . . 0.0 111.626 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -71.47 -28.77 64.17 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -64.77 -50.91 64.97 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.624 -1.297 . . . . 0.0 110.241 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 -40.13 72.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.498 0.719 . . . . 0.0 112.901 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.5 tp -49.61 -27.32 4.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 114.111 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.0 -38.42 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 111.782 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -69.71 -16.16 63.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.895 0.878 . . . . 0.0 112.73 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -109.06 -15.3 14.37 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -170.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 m 112.73 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 129.731 3.212 . . . . 0.0 114.013 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.92 147.42 23.76 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 118.886 0.766 . . . . 0.0 111.898 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -121.72 84.02 2.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 109.855 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mtm105 -60.84 152.41 27.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.58 27.89 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.936 1.695 . . . . 0.0 110.869 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.2 175.06 46.93 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.372 1.939 . . . . 0.0 112.184 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -123.27 157.88 32.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.373 1.469 . . . . 0.0 111.88 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.9 ttm -63.92 117.02 6.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.369 1.068 . . . . 0.0 112.171 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.01 141.34 37.55 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.0 81.68 2.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 111.64 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.34 136.74 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 110.139 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -131.26 98.5 4.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.513 1.149 . . . . 0.0 113.679 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.13 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.323 1.449 . . . . 0.0 114.695 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.4 p -67.6 -19.42 65.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.567 1.076 . . . . 0.0 113.099 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.32 -8.94 1.13 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -134.63 108.64 10.98 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.018 0.927 . . . . 0.0 112.943 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.82 -0.63 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.336 3.358 . . . . 0.0 114.427 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.62 78.49 68.6 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.225 1.81 . . . . 0.0 109.713 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -60.58 -19.77 61.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.086 3.19 . . . . 0.0 115.368 -169.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -66.93 -29.69 69.62 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.962 -1.087 . . . . 0.0 113.893 172.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.7 p -68.24 -5.23 17.24 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -117.0 -8.76 11.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.131 1.372 . . . . 0.0 112.67 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -127.14 -27.1 3.01 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.11 -52.56 67.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.286 169.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.24 -30.24 37.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.643 1.562 . . . . 0.0 113.325 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -58.74 -50.03 75.44 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.891 0.769 . . . . 0.0 111.136 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t -67.85 -41.53 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.676 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -59.63 -39.62 84.91 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.782 0.719 . . . . 0.0 112.117 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -67.93 -58.86 3.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 111.891 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -54.43 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.713 1.205 . . . . 0.0 112.318 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.87 -23.77 16.71 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.914 1.721 . . . . 0.0 115.905 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.4 p -71.82 -17.65 62.14 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.735 1.767 . . . . 0.0 113.954 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.7 mt -93.95 -16.85 23.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.369 1.468 . . . . 0.0 112.996 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.44 150.49 35.34 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.224 2.21 . . . . 0.0 111.747 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.648 1.579 . . . . 0.0 113.624 177.819 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.485 0.659 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -139.96 119.81 13.45 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.07 1.748 . . . . 0.0 108.647 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.93 127.44 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.06 130.88 10.16 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 168.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -116.23 88.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.337 1.455 . . . . 0.0 107.176 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -88.46 126.73 35.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.857 -169.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.66 143.6 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.734 0.813 . . . . 0.0 110.691 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.35 96.64 0.27 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -143.87 170.34 16.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.546 1.138 . . . . 0.0 111.897 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.4 -0.63 5.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.756 1.223 . . . . 0.0 113.553 169.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -146.41 -24.05 0.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.36 -9.47 5.6 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 118.575 2.19 . . . . 0.0 118.575 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.08 -41.64 92.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.645 2.222 . . . . 0.0 113.432 -173.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -78.19 -34.64 49.36 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.763 -0.586 . . . . 0.0 111.993 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.2 tp -55.99 -39.76 72.31 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.066 -1.022 . . . . 0.0 113.069 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.15 -40.7 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 111.713 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -71.02 -41.26 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.907 0.483 . . . . 0.0 111.937 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.08 88.15 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.015 0.825 . . . . 0.0 112.499 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -60.56 -43.38 97.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.108 0.963 . . . . 0.0 112.676 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.48 -41.52 88.85 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.508 -0.745 . . . . 0.0 112.886 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.55 92.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.544 0.738 . . . . 0.0 111.809 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.5 -47.07 80.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.869 0.468 . . . . 0.0 111.869 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.91 88.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 112.694 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.7 -45.66 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.524 1.13 . . . . 0.0 111.892 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.9 mt -72.62 -38.16 67.85 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.4 m -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.454 1.101 . . . . 0.0 111.819 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.8 82.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.097 0.959 . . . . 0.0 113.157 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -73.07 -8.82 57.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 172.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.55 -2.46 32.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.428 1.49 . . . . 0.0 115.067 170.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -80.22 165.56 22.26 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.734 1.214 . . . . 0.0 112.631 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.5 134.18 35.22 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.08 142.32 31.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.193 0.597 . . . . 0.0 112.108 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.3 m -144.72 109.36 4.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.247 1.019 . . . . 0.0 111.025 -172.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -73.98 144.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -131.72 108.94 9.82 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.525 1.53 . . . . 0.0 108.442 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.8 -28.48 40.25 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -144.83 58.03 5.02 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.428 1.891 . . . . 0.0 110.1 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.73 159.65 52.81 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.768 2.979 . . . . 0.0 113.829 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.28 163.85 26.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.0 2.12 . . . . 0.0 108.926 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tt -42.47 -44.62 4.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.347 1.459 . . . . 0.0 112.881 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -54.78 -26.46 34.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.928 1.691 . . . . 0.0 114.849 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -81.16 -35.98 30.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.413 1.085 . . . . 0.0 112.333 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.436 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 26.2 t-105 -75.68 -39.01 58.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.883 0.873 . . . . 0.0 112.419 175.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -36.31 -56.02 1.31 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.098 2.559 . . . . 0.0 115.422 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.42 -18.71 22.75 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.38 2.054 . . . . 0.0 114.748 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -78.54 -0.89 31.4 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -58.72 -25.97 63.46 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.745 -1.222 . . . . 0.0 113.795 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -97.1 12.49 32.48 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.355 1.462 . . . . 0.0 112.632 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -134.25 -145.62 0.24 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.004 2.522 . . . . 0.0 109.3 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.21 162.97 29.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.232 1.813 . . . . 0.0 109.408 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 34.5 m -148.34 171.79 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.356 1.062 . . . . 0.0 111.662 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.18 144.43 17.32 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.365 -0.835 . . . . 0.0 110.894 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.77 130.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.937 1.695 . . . . 0.0 110.565 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.46 89.07 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -134.66 136.11 42.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -168.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -87.85 -170.08 2.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.943 2.097 . . . . 0.0 113.069 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 83.0 m -136.67 138.53 41.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.401 1.081 . . . . 0.0 111.32 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 119.813 1.188 . . . . 0.0 111.62 -172.145 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.78 142.25 98.52 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.53 1.132 . . . . 0.0 112.118 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.17 153.17 24.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.644 2.896 . . . . 0.0 111.973 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.32 -26.71 66.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -62.7 -11.15 15.52 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 tt -126.2 -3.42 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -53.53 -43.89 96.6 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 117.148 -1.406 . . . . 0.0 112.356 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.04 -5.37 2.73 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.373 3.382 . . . . 0.0 116.659 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mt -105.88 -48.48 3.62 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.461 1.105 . . . . 0.0 110.308 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.41 -41.34 96.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.666 0.787 . . . . 0.0 112.685 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -67.35 -44.44 79.05 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.451 -0.781 . . . . 0.0 112.214 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.98 -41.91 39.0 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.907 0.765 . . . . 0.0 113.938 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.16 -42.94 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.024 0.912 . . . . 0.0 110.053 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -66.16 -50.19 64.78 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.593 0.757 . . . . 0.0 112.234 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.44 -31.02 42.47 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.1 t -116.01 -43.36 2.99 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -169.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.48 -44.34 58.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.459 1.027 . . . . 0.0 111.709 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.15 -28.95 0.2 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 126.679 2.085 . . . . 0.0 118.142 169.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -155.62 138.31 15.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.836 1.654 . . . . 0.0 110.102 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.6 39.59 0.19 Allowed Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -169.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.8 -34.08 15.22 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.476 2.784 . . . . 0.0 118.054 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -72.34 -20.24 61.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.14 118.46 13.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.271 1.428 . . . . 0.0 110.16 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -117.91 139.92 50.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.382 1.473 . . . . 0.0 110.127 174.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.67 -169.05 1.97 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -168.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.3 32.62 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.231 2.348 . . . . 0.0 110.318 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.36 128.81 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.695 0.76 . . . . 0.0 111.644 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -118.13 95.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.15 153.52 24.76 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.05 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -142.64 152.99 43.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.108 0.956 . . . . 0.0 111.502 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.57 -130.1 1.66 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.862 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.77 136.34 21.72 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.252 1.421 . . . . 0.0 111.533 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.5 p -68.83 -4.19 15.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -68.4 3.69 1.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -135.08 151.64 50.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.371 1.468 . . . . 0.0 112.277 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.42 -37.14 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.883 0.873 . . . . 0.0 111.483 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -75.26 39.13 0.14 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.817 1.647 . . . . 0.0 112.907 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -52.21 116.06 2.04 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 119.653 -1.904 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 82.8 m 50.74 23.59 1.44 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.735 2.414 . . . . 0.0 117.174 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.3 -14.1 59.99 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.589 -1.319 . . . . 0.0 114.247 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.45 -28.54 63.43 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.134 -0.979 . . . . 0.0 113.414 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.21 -37.97 6.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.323 1.062 . . . . 0.0 113.313 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -56.66 -39.73 74.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.42 1.11 . . . . 0.0 113.658 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -60.11 -32.79 71.32 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -74.63 -22.2 59.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.56 -44.47 34.58 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.028 -1.67 . . . . 0.0 110.068 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.63 66.92 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 tp -50.67 -28.41 8.89 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.259 1.824 . . . . 0.0 113.322 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.01 -37.13 6.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.953 1.301 . . . . 0.0 111.997 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -68.8 -31.82 71.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.176 -0.952 . . . . 0.0 113.076 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.5 -10.66 36.53 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.123 0.874 . . . . 0.0 111.96 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -115.16 12.08 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.13 1.772 . . . . 0.0 112.816 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m 65.57 20.34 11.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.49 1.516 . . . . 0.0 114.86 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.45 169.5 0.89 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.667 0.787 . . . . 0.0 111.589 169.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -133.57 90.85 2.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.493 -1.379 . . . . 0.0 111.548 -169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -63.89 134.37 55.02 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.439 -0.788 . . . . 0.0 110.924 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.39 29.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.651 1.58 . . . . 0.0 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.61 -168.43 41.49 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.633 1.111 . . . . 0.0 113.852 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.29 152.26 26.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.65 1.58 . . . . 0.0 111.259 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.1 ttm -71.92 138.1 47.88 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.075 0.95 . . . . 0.0 111.957 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -94.07 137.22 33.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.545 0.738 . . . . 0.0 109.042 169.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 123' ' ' LEU . 47.6 mt -119.76 93.45 4.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.686 1.594 . . . . 0.0 110.884 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.4 mt -79.26 135.76 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.537 0.735 . . . . 0.0 111.357 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -124.5 113.05 17.6 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.374 1.47 . . . . 0.0 112.047 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.19 62.95 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.7 m -80.9 1.06 32.53 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.53 1.132 . . . . 0.0 113.553 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -126.52 -27.94 3.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.07 1.348 . . . . 0.0 112.855 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -143.82 117.53 5.93 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.83 0.852 . . . . 0.0 112.85 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.92 -5.72 13.91 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.925 3.084 . . . . 0.0 114.548 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -130.58 76.2 77.79 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.827 1.651 . . . . 0.0 110.662 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -41.69 -34.89 2.44 Favored 'Trans proline' 0 C--N 1.354 0.857 1 C-N-CA 126.001 4.468 . . . . 0.0 118.016 -169.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -51.64 -39.06 57.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.1 p -69.75 -4.89 21.83 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.037 -1.039 . . . . 0.0 113.598 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -121.76 6.03 9.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.43 1.492 . . . . 0.0 112.416 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.1 p -141.26 -26.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -55.05 -51.75 76.87 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.921 1.237 . . . . 0.0 113.433 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.48 -28.62 53.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.673 1.582 . . . . 0.0 113.052 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -60.91 -50.51 73.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.384 0.538 . . . . 0.0 111.297 170.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.51 -42.74 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.007 0.821 . . . . 0.0 110.488 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.59 -34.75 74.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.87 -64.27 0.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.074 0.852 . . . . 0.0 111.313 169.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -51.06 -49.16 61.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.57 1.548 . . . . 0.0 112.144 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.74 -26.3 24.72 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.368 1.461 . . . . 0.0 115.546 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -75.95 -15.5 60.16 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.232 1.516 . . . . 0.0 114.159 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.75 -15.94 33.44 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.181 0.992 . . . . 0.0 113.074 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.6 -18.16 65.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.337 1.455 . . . . 0.0 114.113 -175.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.948 1.699 . . . . 0.0 113.936 -171.177 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.507 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -126.99 130.13 49.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 109.503 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.41 126.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -171.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.03 130.72 10.07 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.7 mt -118.26 86.71 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.021 1.329 . . . . 0.0 107.594 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.284 -170.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.38 140.26 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.112 0.482 . . . . 0.0 111.416 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.4 112.46 1.35 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -153.77 152.04 30.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.832 0.853 . . . . 0.0 112.715 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.8 mmm -95.66 -25.18 16.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.166 0.987 . . . . 0.0 112.732 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.93 -12.37 0.65 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.39 -9.06 8.86 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 116.601 1.401 . . . . 0.0 116.601 170.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -61.23 -41.42 96.85 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.691 1.745 . . . . 0.0 113.078 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -76.59 -34.44 58.41 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.188 0.995 . . . . 0.0 112.059 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.39 -39.41 83.28 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.682 -1.261 . . . . 0.0 113.208 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.2 tp -52.96 -47.47 68.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.382 0.992 . . . . 0.0 111.558 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.58 -35.14 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.81 0.444 . . . . 0.0 111.586 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -68.28 -37.05 80.3 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.55 -42.5 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.547 -0.72 . . . . 0.0 111.593 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.87 -46.21 85.19 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.264 0.626 . . . . 0.0 111.981 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.89 87.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.359 0.527 . . . . 0.0 112.136 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.86 -48.36 75.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.985 0.514 . . . . 0.0 111.512 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.76 84.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.659 0.784 . . . . 0.0 112.754 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.9 mt -58.61 -46.3 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.653 1.181 . . . . 0.0 111.83 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.48 -40.01 67.25 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.876 -0.515 . . . . 0.0 109.869 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.0 m -56.98 -44.8 83.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.495 1.118 . . . . 0.0 112.159 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.79 83.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.067 0.947 . . . . 0.0 112.961 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.69 -23.9 63.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.38 -13.1 6.63 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.53 1.538 . . . . 0.0 114.832 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.507 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 70.5 m-70 -71.44 143.4 50.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.255 1.028 . . . . 0.0 111.535 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -71.95 133.79 45.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 157.78 45.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.51 0.724 . . . . 0.0 111.977 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -151.63 110.53 3.86 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' HB1' ' A' ' 19' ' ' ALA . 7.5 p -79.65 150.71 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.721 0.808 . . . . 0.0 111.269 169.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -127.59 171.76 11.35 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.23 1.412 . . . . 0.0 111.592 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -128.7 -36.16 1.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -142.43 55.57 4.52 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 126.379 1.872 . . . . 0.0 111.511 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.01 155.58 54.64 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.063 3.175 . . . . 0.0 113.945 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.23 174.21 10.46 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.427 1.891 . . . . 0.0 110.165 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.16 -34.73 58.14 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.635 -1.291 . . . . 0.0 112.175 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.5 m -54.76 -21.8 12.16 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -96.34 -25.68 15.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.004 1.721 . . . . 0.0 112.614 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.455 ' CH2' HG21 ' A' ' 52' ' ' VAL . 60.7 t-105 -74.18 -39.6 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.228 1.011 . . . . 0.0 112.809 171.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -49.11 31.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.647 1.979 . . . . 0.0 113.349 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.25 -7.82 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.288 2.658 . . . . 0.0 115.942 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -127.82 0.36 6.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.867 1.667 . . . . 0.0 114.106 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.19 -23.12 63.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.401 1.455 . . . . 0.0 113.953 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -98.59 13.38 32.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.371 2.268 . . . . 0.0 113.302 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -139.45 -172.06 3.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.585 1.954 . . . . 0.0 111.648 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -76.62 154.52 34.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.064 0.935 . . . . 0.0 111.835 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.455 HG21 ' CH2' ' A' ' 44' ' ' TRP . 27.7 m -149.27 170.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.483 1.913 . . . . 0.0 110.264 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.93 153.24 22.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.57 0.748 . . . . 0.0 110.656 176.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.95 140.29 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.16 0.984 . . . . 0.0 111.764 -169.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 t -136.15 103.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.384 1.074 . . . . 0.0 110.249 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.6 m -140.43 143.09 35.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -93.67 -170.42 2.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.8 1.64 . . . . 0.0 113.497 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.3 m -135.95 137.22 41.08 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 111.626 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 127.819 2.448 . . . . 0.0 107.214 -171.834 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -80.24 155.25 74.6 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.128 -0.983 . . . . 0.0 113.571 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.73 152.01 82.49 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.01 3.14 . . . . 0.0 113.446 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.16 -20.4 65.36 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.8 p -64.71 -13.1 53.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.334 1.454 . . . . 0.0 114.683 171.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.79 -7.4 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.706 1.202 . . . . 0.0 113.919 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -47.19 -50.73 45.9 Favored Pre-proline 0 N--CA 1.481 1.09 0 O-C-N 120.307 -1.496 . . . . 0.0 113.035 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.07 -4.91 16.06 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.135 1.89 . . . . 0.0 114.253 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.36 -47.15 7.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.907 0.883 . . . . 0.0 109.134 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.37 -50.71 68.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.998 1.319 . . . . 0.0 112.107 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -62.75 -39.02 92.83 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.196 -0.94 . . . . 0.0 112.829 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.69 -41.93 48.59 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.445 1.022 . . . . 0.0 112.514 -174.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.98 -45.19 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.426 1.113 . . . . 0.0 109.482 174.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.09 -50.0 74.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.261 1.024 . . . . 0.0 112.301 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.21 -34.68 56.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.098 0.959 . . . . 0.0 113.542 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -96.72 -35.89 10.85 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -169.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 mp -89.44 -44.01 10.46 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.375 0.988 . . . . 0.0 113.365 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.44 -39.87 0.36 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 126.371 1.938 . . . . 0.0 117.118 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -157.71 134.21 9.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.511 1.524 . . . . 0.0 110.954 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -158.54 52.92 0.56 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.02 -21.38 73.1 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.96 2.44 . . . . 0.0 115.052 -173.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -72.0 -21.61 61.54 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.935 1.294 . . . . 0.0 113.876 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.97 138.64 38.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 111.114 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -133.38 143.64 49.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.691 1.996 . . . . 0.0 109.929 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.35 -170.86 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.63 28.82 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 127.676 2.56 . . . . 0.0 109.345 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.43 136.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 117.942 0.871 . . . . 0.0 110.516 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.71 104.81 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.23 25.42 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.571 -0.706 . . . . 0.0 109.871 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -139.26 153.17 47.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.227 1.011 . . . . 0.0 111.106 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.31 -147.66 11.3 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.065 0.84 . . . . 0.0 111.46 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.12 121.32 16.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.57 1.948 . . . . 0.0 109.235 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.6 p -67.12 -2.89 6.23 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -64.01 -25.6 68.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.064 0.946 . . . . 0.0 113.16 170.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -86.49 145.74 26.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.114 0.965 . . . . 0.0 112.14 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.05 -36.33 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.504 1.121 . . . . 0.0 112.422 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -87.14 -1.1 57.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.5 t80 26.72 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.569 2.747 . . . . 0.0 115.699 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 27.9 p -121.94 17.16 10.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.138 1.775 . . . . 0.0 113.853 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.03 -31.04 39.06 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.82 1.248 . . . . 0.0 113.959 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.62 -35.28 80.18 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 123.636 0.636 . . . . 0.0 113.558 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.81 -41.86 14.17 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 120.94 -1.33 . . . . 0.0 113.022 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -57.08 -36.29 70.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.139 0.976 . . . . 0.0 113.248 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -58.12 -40.03 80.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.466 0.706 . . . . 0.0 112.689 172.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.37 -30.72 62.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.45 1.023 . . . . 0.0 112.618 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.36 -45.21 92.21 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.201 -1.562 . . . . 0.0 110.55 169.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.7 -37.56 76.36 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.3 tp -52.79 -33.82 50.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.841 1.257 . . . . 0.0 112.342 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.44 -37.67 10.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.713 1.205 . . . . 0.0 111.771 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.19 -32.82 74.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.091 -1.006 . . . . 0.0 113.429 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.47 -13.26 38.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.444 1.098 . . . . 0.0 112.588 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.32 8.07 14.12 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.556 1.542 . . . . 0.0 112.114 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 m 71.65 17.66 5.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.855 2.062 . . . . 0.0 114.454 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 168.94 1.34 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.94 0.896 . . . . 0.0 111.691 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -131.13 101.67 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.734 -1.229 . . . . 0.0 112.088 -169.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 ttm105 -67.35 134.12 50.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.923 -1.11 . . . . 0.0 111.182 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.53 31.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.726 1.61 . . . . 0.0 111.781 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.05 -178.47 45.02 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.473 -1.392 . . . . 0.0 114.027 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.31 136.56 33.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.449 1.099 . . . . 0.0 110.589 170.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.0 ttp -63.4 127.58 31.93 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.874 0.87 . . . . 0.0 111.216 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.471 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -84.81 139.46 31.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 109.644 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.471 ' N ' HD13 ' A' ' 123' ' ' LEU . 37.3 mt -123.95 90.42 3.26 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.858 1.263 . . . . 0.0 111.058 -176.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -72.13 136.56 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.182 0.993 . . . . 0.0 110.673 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -129.7 105.65 8.18 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.047 1.339 . . . . 0.0 111.471 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.32 27.44 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -82.92 -6.55 59.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.445 1.02 . . . . 0.0 113.721 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.64 -26.34 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.571 . . . . 0.0 112.52 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -143.01 113.07 5.76 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.811 1.245 . . . . 0.0 111.239 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.69 -1.38 11.55 Favored 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.646 2.897 . . . . 0.0 114.497 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.43 79.12 74.55 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.485 1.514 . . . . 0.0 111.6 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.43 -34.31 7.38 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.782 4.321 . . . . 0.0 116.781 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -52.31 -45.76 65.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 112.233 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -17.0 64.42 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -95.89 -5.65 41.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.211 1.405 . . . . 0.0 112.705 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.31 -30.04 0.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -51.64 -53.83 46.2 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 119.533 1.061 . . . . 0.0 113.451 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.62 -29.52 29.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.556 1.504 . . . . 0.0 113.013 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.2 -48.06 81.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.439 0.695 . . . . 0.0 111.404 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.7 t -67.67 -41.19 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.565 0.62 . . . . 0.0 110.614 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -58.89 -41.74 87.9 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.741 0.701 . . . . 0.0 111.896 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -65.43 -57.78 7.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.874 0.87 . . . . 0.0 112.162 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -53.98 -44.32 70.7 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 111.9 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.34 -19.99 35.0 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.502 1.525 . . . . 0.0 115.995 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p -72.07 -19.0 61.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.982 1.891 . . . . 0.0 113.974 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.9 mt -93.23 -16.41 24.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.107 1.363 . . . . 0.0 113.061 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.22 150.19 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.505 2.322 . . . . 0.0 111.624 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.389 1.475 . . . . 0.0 113.689 179.721 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.478 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -140.51 123.96 16.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.555 1.142 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 mm -124.27 136.67 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.93 127.41 9.22 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.3 mt -117.6 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.466 1.106 . . . . 0.0 108.591 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -91.56 138.28 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.037 0.935 . . . . 0.0 111.492 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.63 143.37 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.684 0.754 . . . . 0.0 111.457 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.48 90.39 0.21 Allowed Glycine 0 N--CA 1.463 0.495 0 C-N-CA 125.347 1.451 . . . . 0.0 109.653 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -134.66 165.73 24.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.173 0.989 . . . . 0.0 113.235 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -121.63 -32.14 3.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.179 1.792 . . . . 0.0 110.996 -175.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -134.5 -5.3 2.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.611 1.564 . . . . 0.0 113.861 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -0.56 52.92 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.362 1.081 . . . . 0.0 112.776 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -76.19 -32.71 59.15 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.546 1.138 . . . . 0.0 112.872 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.87 -39.03 80.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.641 -1.287 . . . . 0.0 112.796 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.55 -41.17 72.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.572 0.623 . . . . 0.0 111.751 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.9 -35.19 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 121.753 -0.592 . . . . 0.0 112.205 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.59 95.33 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.201 -0.937 . . . . 0.0 112.662 172.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.99 -41.06 97.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.356 0.662 . . . . 0.0 112.337 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.61 -46.79 87.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.535 -0.728 . . . . 0.0 111.902 169.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.5 88.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.224 0.61 . . . . 0.0 112.317 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.15 -47.02 79.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 111.993 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -45.66 92.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.419 0.688 . . . . 0.0 112.643 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.68 -47.38 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.569 1.148 . . . . 0.0 112.094 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -68.39 -39.77 81.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 109.744 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.8 m -55.77 -50.48 70.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.7 1.2 . . . . 0.0 111.855 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.3 77.65 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -77.31 -5.52 49.82 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.84 24.32 10.0 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.918 0.781 . . . . 0.0 114.648 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 61.5 m-70 -115.93 145.69 42.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.742 1.217 . . . . 0.0 111.389 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -74.27 138.25 43.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.13 43.27 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.606 -0.684 . . . . 0.0 111.994 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -154.7 120.13 5.06 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.76 176.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.0 140.26 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.18 0.992 . . . . 0.0 110.958 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.09 110.65 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.002 1.321 . . . . 0.0 109.701 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.99 -17.66 28.97 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -144.93 56.65 3.87 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.635 1.574 . . . . 0.0 110.612 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.34 162.21 40.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.941 3.094 . . . . 0.0 115.185 -169.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.67 175.07 9.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.213 2.205 . . . . 0.0 109.668 169.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -50.73 -40.85 55.56 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.902 -1.124 . . . . 0.0 112.414 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -58.43 -14.77 8.49 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -96.81 -27.33 14.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -82.46 -39.61 22.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.452 1.501 . . . . 0.0 112.221 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -49.16 -45.3 75.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.849 1.66 . . . . 0.0 114.495 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -57.29 -10.6 6.64 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.225 2.617 . . . . 0.0 116.899 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -114.65 4.27 15.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.74 -23.32 67.32 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.263 1.392 . . . . 0.0 114.273 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -92.32 4.2 53.84 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.948 1.299 . . . . 0.0 113.525 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -130.89 -141.06 0.22 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.46 2.304 . . . . 0.0 109.771 -169.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.16 158.7 34.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.672 1.189 . . . . 0.0 111.361 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.96 168.77 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.274 1.429 . . . . 0.0 110.936 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.97 149.63 19.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.98 0.912 . . . . 0.0 110.387 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.87 135.26 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.052 1.341 . . . . 0.0 110.302 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.3 90.73 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.153 1.381 . . . . 0.0 107.581 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.8 m -133.57 168.36 18.79 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -141.51 -174.33 4.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.106 1.363 . . . . 0.0 113.432 -171.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.8 m -131.62 135.61 47.08 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.609 1.164 . . . . 0.0 110.824 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 126.393 1.877 . . . . 0.0 109.929 -173.485 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.37 136.54 60.74 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.146 1.378 . . . . 0.0 113.283 171.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.27 150.19 89.26 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.55 2.833 . . . . 0.0 111.523 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -60.65 -17.4 47.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -57.34 -17.5 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.292 1.837 . . . . 0.0 114.585 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.27 -10.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.3 t -47.1 -45.58 53.1 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 116.867 -1.539 . . . . 0.0 113.664 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.16 -27.65 35.13 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 122.676 1.991 . . . . 0.0 113.82 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.29 -47.17 65.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.023 0.829 . . . . 0.0 110.778 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.25 -47.58 84.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.126 1.37 . . . . 0.0 112.382 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -60.16 -48.95 79.57 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.295 -0.878 . . . . 0.0 112.101 171.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.64 95.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.194 0.902 . . . . 0.0 113.506 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.01 -45.87 97.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.479 1.139 . . . . 0.0 110.486 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.12 -47.04 86.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.978 0.511 . . . . 0.0 112.18 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.95 -37.25 29.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.395 1.478 . . . . 0.0 114.327 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 m -121.39 10.5 10.54 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -168.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.14 -47.18 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.713 1.142 . . . . 0.0 112.474 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.44 -34.86 0.45 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -157.23 137.55 12.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.475 1.637 . . . . 0.0 111.515 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -158.94 63.74 2.46 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.533 1.133 . . . . 0.0 113.34 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.48 -15.02 42.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.416 3.411 . . . . 0.0 116.77 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -120.9 -0.47 10.08 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.555 1.542 . . . . 0.0 114.384 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.02 141.78 47.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.973 0.909 . . . . 0.0 109.578 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -131.07 138.92 49.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 111.338 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -154.67 -171.17 3.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -170.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.71 161.8 31.64 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 127.595 2.521 . . . . 0.0 109.911 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.07 135.46 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.91 0.855 . . . . 0.0 111.879 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.5 mt -119.3 128.8 75.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.4 145.23 48.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.652 1.181 . . . . 0.0 110.231 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.75 139.49 31.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.85 0.86 . . . . 0.0 110.419 -171.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.37 -147.0 6.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -138.74 124.41 19.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.998 0.919 . . . . 0.0 110.649 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.9 p -70.05 -3.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -68.37 -0.92 5.41 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.029 1.331 . . . . 0.0 114.313 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.74 155.88 44.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.071 1.749 . . . . 0.0 112.045 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.1 m -77.21 1.26 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.61 44.74 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.255 1.422 . . . . 0.0 110.315 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -52.05 115.93 1.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.022 -1.674 . . . . 0.0 112.745 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 94.5 m 51.01 26.99 2.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -58.99 -31.79 69.09 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.045 -1.034 . . . . 0.0 113.498 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.43 87.84 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.134 0.879 . . . . 0.0 112.625 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.62 99.54 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.845 -1.385 . . . . 0.0 112.639 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.06 -40.86 97.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.908 0.883 . . . . 0.0 113.001 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -58.95 -42.13 89.08 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.075 0.95 . . . . 0.0 111.637 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.09 -30.54 63.74 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.52 -45.04 76.9 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.007 -1.683 . . . . 0.0 110.963 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.31 74.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.835 0.854 . . . . 0.0 113.212 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -50.53 -31.84 16.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.461 1.504 . . . . 0.0 112.994 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.35 -36.74 8.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.619 1.168 . . . . 0.0 111.766 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -65.49 -31.46 72.54 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.368 -0.833 . . . . 0.0 113.161 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.36 -15.32 57.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.021 . . . . 0.0 112.752 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -113.52 3.53 15.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.081 1.353 . . . . 0.0 112.652 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m 74.68 15.85 3.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.619 1.968 . . . . 0.0 113.955 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.11 164.49 6.72 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -121.93 150.79 41.5 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.869 -1.144 . . . . 0.0 110.585 -170.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -132.01 108.04 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 121.32 -0.863 . . . . 0.0 111.198 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.69 45.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.405 1.482 . . . . 0.0 112.329 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.54 -168.88 42.01 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.402 1.953 . . . . 0.0 111.995 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.42 147.78 50.67 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.223 -1.163 . . . . 0.0 112.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -66.26 123.54 20.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.781 1.232 . . . . 0.0 112.028 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -81.61 138.1 35.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.071 0.948 . . . . 0.0 110.238 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.1 mt -125.49 93.38 3.84 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.722 1.209 . . . . 0.0 111.661 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.8 mt -84.48 138.9 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.586 1.554 . . . . 0.0 111.234 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -125.72 105.17 8.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.001 1.32 . . . . 0.0 112.323 -177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.75 -21.86 43.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.14 1.376 . . . . 0.0 114.267 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -77.86 -7.88 57.29 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -126.36 -26.4 3.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.363 1.465 . . . . 0.0 112.415 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -143.86 114.77 5.52 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.897 0.879 . . . . 0.0 112.313 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.01 -0.68 10.12 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.309 3.339 . . . . 0.0 114.526 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.89 76.51 71.05 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.009 1.724 . . . . 0.0 109.942 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -61.16 -20.13 66.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.236 3.29 . . . . 0.0 115.796 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.45 -35.01 71.47 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.773 -1.204 . . . . 0.0 113.653 169.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 p -66.9 -9.56 39.31 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -109.77 -12.14 14.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.605 1.162 . . . . 0.0 112.103 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 p -126.29 -27.74 3.17 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.23 -52.76 65.99 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 119.64 1.109 . . . . 0.0 113.26 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.77 -30.13 27.83 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.726 1.617 . . . . 0.0 112.826 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -61.32 -48.74 79.98 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.671 -0.643 . . . . 0.0 111.719 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.25 -40.2 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.339 0.518 . . . . 0.0 110.474 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -59.7 -36.34 76.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.893 0.77 . . . . 0.0 112.56 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.41 -59.69 2.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.935 0.789 . . . . 0.0 111.986 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -53.08 -46.24 68.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.462 1.105 . . . . 0.0 112.09 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -24.68 5.52 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.218 1.866 . . . . 0.0 116.172 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.3 p -73.99 -21.38 60.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.723 1.762 . . . . 0.0 114.184 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.21 -23.25 47.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.314 1.046 . . . . 0.0 112.952 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.5 -28.95 69.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.6 1.56 . . . . 0.0 114.823 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.386 1.475 . . . . 0.0 111.935 173.535 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.512 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.186 0.517 . . . . 0.0 112.119 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.99 121.17 20.08 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.882 1.273 . . . . 0.0 110.399 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.6 125.39 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.911 0.885 . . . . 0.0 113.228 -169.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.98 124.74 7.0 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -117.01 99.07 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.763 1.282 . . . . 0.0 108.995 -170.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -99.66 136.61 39.33 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.06 0.944 . . . . 0.0 110.681 -169.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.83 145.69 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.432 0.634 . . . . 0.0 111.54 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.31 100.51 0.38 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.8 t -151.46 163.97 37.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.285 1.034 . . . . 0.0 113.131 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -122.9 -0.98 8.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.651 1.58 . . . . 0.0 112.54 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -141.08 -58.78 0.5 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.88 0.872 . . . . 0.0 113.053 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.27 -2.5 0.42 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -61.04 -44.99 96.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.6 1.2 . . . . 0.0 112.862 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.1 p -75.96 -32.76 59.66 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.182 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.8 tp -60.03 -40.4 89.2 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.753 -1.217 . . . . 0.0 112.794 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.9 tp -54.97 -42.85 72.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.732 0.697 . . . . 0.0 111.86 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.41 -36.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 121.805 -0.559 . . . . 0.0 111.895 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.27 97.72 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.25 -0.906 . . . . 0.0 112.941 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.88 -41.02 97.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 112.257 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -59.77 -47.54 85.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.581 0.752 . . . . 0.0 111.984 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.02 86.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.372 0.669 . . . . 0.0 112.308 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.79 -46.64 77.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 112.001 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.75 91.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.661 0.784 . . . . 0.0 112.809 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.66 -45.69 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.741 1.216 . . . . 0.0 112.04 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.6 mt -68.09 -42.25 80.61 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.596 -0.69 . . . . 0.0 109.594 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -55.24 -47.97 74.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.757 1.223 . . . . 0.0 112.214 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.35 80.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.117 0.967 . . . . 0.0 113.29 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.14 -8.58 56.67 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.54 -3.61 56.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.198 1.38 . . . . 0.0 114.583 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.512 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 86.5 m-70 -73.27 177.05 5.4 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -115.96 147.36 41.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.152 1.381 . . . . 0.0 109.548 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.25 164.32 35.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.463 -0.773 . . . . 0.0 112.642 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 m -152.93 121.01 6.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.811 0.845 . . . . 0.0 110.991 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.2 141.37 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.795 1.238 . . . . 0.0 111.428 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -130.32 109.73 10.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.412 1.485 . . . . 0.0 110.253 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.25 -16.27 40.74 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -147.94 54.77 1.96 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.886 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.17 163.48 34.89 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.6 2.867 . . . . 0.0 113.949 -170.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.0 173.65 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.821 2.048 . . . . 0.0 109.482 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.59 -40.1 62.31 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.435 -1.416 . . . . 0.0 112.499 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.1 m -62.69 -13.84 37.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -92.73 -33.61 14.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.549 1.139 . . . . 0.0 112.187 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -68.21 -48.14 65.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 112.229 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.5 tp -45.95 -49.25 39.83 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.524 2.329 . . . . 0.0 114.522 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.59 -17.4 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.898 3.732 . . . . 0.0 117.92 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.49 -0.4 15.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.21 -20.2 65.66 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.12 -1.93 54.14 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.793 1.237 . . . . 0.0 113.264 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -132.48 -130.87 0.18 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.41 2.284 . . . . 0.0 109.595 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -135.26 157.8 45.99 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.035 1.334 . . . . 0.0 110.093 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.85 168.45 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.008 0.923 . . . . 0.0 111.732 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tp -159.85 145.15 15.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.104 0.962 . . . . 0.0 110.569 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.66 132.43 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.522 1.529 . . . . 0.0 110.921 -169.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.57 87.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.1 m -131.16 159.09 38.72 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -167.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -129.87 -171.62 2.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.621 1.568 . . . . 0.0 113.187 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.0 m -123.86 153.32 41.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.895 1.278 . . . . 0.0 111.734 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 C-N-CA 125.646 1.578 . . . . 0.0 111.836 -168.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.12 145.34 97.58 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 121.563 -0.711 . . . . 0.0 111.134 170.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.39 150.17 32.06 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.679 2.919 . . . . 0.0 111.003 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.84 -25.31 64.9 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -172.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 m -59.81 -13.98 12.87 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 172.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 tt -133.3 -7.15 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.1 t -47.71 -49.96 54.07 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.504 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.83 -9.2 25.52 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.187 1.925 . . . . 0.0 114.209 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.84 -48.8 7.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.04 1.336 . . . . 0.0 108.793 172.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -65.19 -48.79 72.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.96 1.304 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -63.69 -39.2 93.73 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.051 -1.031 . . . . 0.0 111.943 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.82 -48.86 72.62 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 124.071 0.843 . . . . 0.0 112.258 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -64.15 -46.74 92.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 118.068 0.934 . . . . 0.0 110.658 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.12 -35.3 78.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -109.62 -23.5 11.43 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.4 m -113.95 2.11 14.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.9 mt -122.91 -139.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.635 1.574 . . . . 0.0 108.104 169.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.52 -21.0 0.54 Allowed Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.157 -0.964 . . . . 0.0 114.501 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -159.66 126.72 4.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.053 0.926 . . . . 0.0 113.03 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -152.82 61.19 3.66 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 126.262 1.825 . . . . 0.0 112.034 -177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.68 -26.46 80.07 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.003 3.135 . . . . 0.0 115.249 -169.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -82.57 -10.35 59.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.334 1.454 . . . . 0.0 114.678 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.7 140.22 40.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.964 0.802 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -130.94 142.92 50.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.675 1.99 . . . . 0.0 110.847 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -159.47 -171.44 3.31 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -169.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.47 165.98 33.6 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.39 2.424 . . . . 0.0 111.201 172.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.14 137.53 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 118.074 0.937 . . . . 0.0 112.189 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.441 HD11 ' CE3' ' A' ' 140' ' ' TRP . 41.4 mt -127.88 98.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.59 153.02 25.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.208 0.527 . . . . 0.0 110.261 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -140.71 138.41 34.2 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.106 0.962 . . . . 0.0 110.58 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.2 4.87 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 122.041 -0.412 . . . . 0.0 112.55 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -150.74 135.57 17.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -5.17 10.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.988 2.115 . . . . 0.0 115.259 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -66.46 1.71 1.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -138.68 156.68 47.21 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.215 1.806 . . . . 0.0 111.627 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.68 -33.8 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -96.18 48.56 1.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.843 0.857 . . . . 0.0 111.718 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -49.92 114.77 1.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.341 -1.475 . . . . 0.0 112.701 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m 51.03 24.84 2.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -59.31 -29.63 67.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.829 -1.17 . . . . 0.0 113.259 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.37 -35.19 91.65 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 113.388 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.92 -40.45 10.56 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.526 -0.985 . . . . 0.0 112.896 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.11 -39.28 78.25 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.197 0.999 . . . . 0.0 113.291 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.7 -35.98 75.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.171 0.588 . . . . 0.0 112.57 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -74.81 -36.01 62.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.338 -0.851 . . . . 0.0 112.502 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.56 -42.87 99.47 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 119.81 -1.806 . . . . 0.0 111.303 169.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.49 88.42 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -52.93 -44.75 67.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.819 1.247 . . . . 0.0 111.142 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.09 -33.55 67.97 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -33.12 74.33 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.033 -1.042 . . . . 0.0 111.875 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.55 -17.96 64.41 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.081 -1.012 . . . . 0.0 112.77 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -99.59 6.09 45.82 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.529 1.532 . . . . 0.0 112.35 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m 58.58 19.99 7.2 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.082 1.753 . . . . 0.0 114.913 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.99 154.02 27.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.394 0.678 . . . . 0.0 111.691 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -117.15 99.9 7.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.087 1.355 . . . . 0.0 111.005 -169.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -67.8 133.89 50.01 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.055 -1.028 . . . . 0.0 111.289 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.81 33.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.92 -163.12 36.2 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.982 1.277 . . . . 0.0 112.432 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -125.86 152.47 45.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.092 1.357 . . . . 0.0 112.382 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.7 ttp -69.03 123.95 22.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.48 1.512 . . . . 0.0 111.963 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.3 tm? -80.97 140.72 35.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.914 0.885 . . . . 0.0 109.397 172.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' N ' HD13 ' A' ' 123' ' ' LEU . 59.4 mt -123.24 92.75 3.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.614 1.566 . . . . 0.0 111.167 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.98 137.74 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.355 1.062 . . . . 0.0 111.157 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.87 118.48 32.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.94 1.296 . . . . 0.0 111.402 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.7 92.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.9 m -63.41 -41.08 98.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.61 -32.65 68.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.992 0.917 . . . . 0.0 112.43 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -145.4 99.48 4.51 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.163 0.985 . . . . 0.0 112.705 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.9 2.07 7.94 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.898 3.066 . . . . 0.0 114.29 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -122.42 71.84 37.41 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.292 1.837 . . . . 0.0 109.37 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -58.78 -20.62 52.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.646 3.564 . . . . 0.0 116.149 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.84 -39.27 77.27 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.126 -0.984 . . . . 0.0 112.776 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.9 p -68.78 -6.32 25.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.291 1.036 . . . . 0.0 113.526 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.52 -2.33 17.69 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.461 1.505 . . . . 0.0 112.161 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.6 p -139.67 -28.1 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -51.95 -54.0 45.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.8 -28.13 30.53 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.666 1.577 . . . . 0.0 112.951 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.441 ' CE3' HD11 ' A' ' 90' ' ' ILE . 75.5 t90 -63.22 -47.79 81.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.381 0.672 . . . . 0.0 111.524 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.01 -40.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.587 0.631 . . . . 0.0 110.358 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -58.78 -44.76 90.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.672 0.669 . . . . 0.0 111.719 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -61.72 -56.09 23.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.984 0.914 . . . . 0.0 112.357 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -53.34 -48.62 68.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.599 1.16 . . . . 0.0 111.209 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.03 -21.81 32.82 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.586 1.565 . . . . 0.0 116.144 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -68.88 -19.41 64.23 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.507 2.154 . . . . 0.0 113.517 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -99.31 -14.88 19.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.0 113.109 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.53 147.75 48.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.185 1.394 . . . . 0.0 111.722 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.119 -172.586 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.484 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.395 0.617 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -135.35 116.5 14.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.204 1.402 . . . . 0.0 109.31 -173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -118.72 125.39 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.95 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.53 125.05 7.52 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -114.1 91.17 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.294 1.047 . . . . 0.0 108.256 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -94.02 136.58 34.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.689 0.796 . . . . 0.0 110.872 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.87 142.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.879 0.847 . . . . 0.0 111.086 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.75 79.47 0.32 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -128.04 172.51 10.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.133 0.973 . . . . 0.0 112.974 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.5 tpt -129.67 -34.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.684 1.993 . . . . 0.0 111.627 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -132.17 1.16 3.83 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.35 -1.43 58.84 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -66.19 -42.5 88.77 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.916 1.358 . . . . 0.0 112.164 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -37.32 77.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.337 1.455 . . . . 0.0 112.639 170.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.47 -36.93 76.94 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.725 -1.234 . . . . 0.0 113.513 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -51.85 -45.19 63.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.937 0.79 . . . . 0.0 111.792 172.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.49 -36.54 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.045 -0.41 . . . . 0.0 111.7 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.09 99.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.098 0.863 . . . . 0.0 112.672 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.61 -41.96 98.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.216 0.607 . . . . 0.0 112.347 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.22 -42.19 96.69 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.363 -0.836 . . . . 0.0 112.692 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.9 91.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.494 0.717 . . . . 0.0 112.291 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.55 -47.04 80.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.406 0.682 . . . . 0.0 111.369 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.47 86.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.463 0.705 . . . . 0.0 112.649 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.72 -46.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.046 1.338 . . . . 0.0 112.362 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.46 -39.99 70.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -175.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -57.48 -46.4 83.74 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.552 1.141 . . . . 0.0 111.931 170.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.34 77.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.0 -11.7 60.66 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.33 40.0 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.579 1.561 . . . . 0.0 114.705 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.484 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 74.8 m-70 -75.26 153.17 38.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.436 1.118 . . . . 0.0 111.526 176.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -80.62 135.69 36.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.35 154.55 43.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.13 0.572 . . . . 0.0 111.942 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 m -153.31 122.7 6.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.906 0.883 . . . . 0.0 111.184 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 140.58 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.332 1.053 . . . . 0.0 110.96 171.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -129.0 112.06 13.64 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.82 1.248 . . . . 0.0 110.333 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.49 -11.51 31.86 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.16 53.76 2.14 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.868 1.267 . . . . 0.0 111.794 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.6 162.39 42.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.64 2.893 . . . . 0.0 114.827 -172.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -131.24 169.61 15.71 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.471 2.308 . . . . 0.0 109.295 169.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.34 62.8 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.267 -1.521 . . . . 0.0 112.376 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -61.82 -12.58 18.02 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -92.93 -32.47 14.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.823 1.249 . . . . 0.0 112.216 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -70.75 -42.44 70.49 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.907 0.883 . . . . 0.0 111.926 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.6 tp -47.84 -47.27 63.11 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 127.872 2.469 . . . . 0.0 115.787 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 -9.01 25.17 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.704 2.269 . . . . 0.0 114.881 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -119.53 -15.73 8.98 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -61.77 -27.41 68.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.196 1.362 . . . . 0.0 113.081 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.72 5.97 14.19 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.921 1.288 . . . . 0.0 113.968 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -128.59 -118.95 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.999 2.52 . . . . 0.0 108.245 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -135.56 157.88 45.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.155 1.782 . . . . 0.0 108.833 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 166.39 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.231 1.012 . . . . 0.0 110.613 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.95 144.92 17.97 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.413 -0.804 . . . . 0.0 110.296 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -113.97 133.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.654 1.582 . . . . 0.0 110.467 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 t -134.33 92.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 m -135.4 154.79 51.35 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 p -133.95 -171.56 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.511 1.524 . . . . 0.0 112.469 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -122.06 153.37 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.439 1.096 . . . . 0.0 111.068 -170.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 126.574 1.95 . . . . 0.0 109.31 179.03 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.7 mt -64.76 147.3 98.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.306 1.442 . . . . 0.0 112.967 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -82.1 154.63 16.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.785 2.99 . . . . 0.0 111.87 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -58.78 -23.34 60.05 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.8 m -54.95 -19.1 5.97 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.992 1.717 . . . . 0.0 115.04 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.54 -5.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -45.87 -44.45 33.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 117.183 -1.389 . . . . 0.0 113.442 170.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.04 -27.51 57.66 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 122.375 1.884 . . . . 0.0 114.666 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mt -73.8 -48.54 30.74 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.06 1.3 . . . . 0.0 110.807 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.52 -38.87 82.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.835 1.254 . . . . 0.0 112.909 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -75.08 -48.31 24.52 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.178 -0.952 . . . . 0.0 112.037 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.39 82.34 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 123.795 0.712 . . . . 0.0 113.991 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.89 -44.35 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.262 1.031 . . . . 0.0 110.357 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.28 -48.37 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.196 0.998 . . . . 0.0 112.137 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.01 -41.31 59.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.235 1.414 . . . . 0.0 114.382 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.0 m -123.74 -14.64 7.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -168.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.77 -50.25 7.3 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.662 1.574 . . . . 0.0 109.599 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 -40.45 0.47 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 126.536 2.017 . . . . 0.0 117.598 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -157.68 138.53 13.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.165 1.483 . . . . 0.0 111.492 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -159.49 100.48 1.53 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.886 1.275 . . . . 0.0 111.2 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.58 -16.27 8.07 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.627 2.885 . . . . 0.0 115.067 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -110.5 -9.3 14.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.349 1.46 . . . . 0.0 113.889 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.5 tp -55.62 124.69 18.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.4 1.88 . . . . 0.0 111.113 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -128.21 140.87 51.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.725 1.61 . . . . 0.0 109.856 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -161.56 -169.29 2.22 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.68 160.7 30.48 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 127.205 2.336 . . . . 0.0 109.862 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.2 t -140.46 133.76 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.835 0.818 . . . . 0.0 111.399 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.417 HD11 ' CE3' ' A' ' 140' ' ' TRP . 42.1 mt -122.32 100.43 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.78 153.36 25.28 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 0.0 109.736 169.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.16 142.24 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.0 0.92 . . . . 0.0 110.602 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.43 -144.22 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.549 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -146.43 120.2 9.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.43 0.692 . . . . 0.0 111.328 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -59.87 -8.49 2.23 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.687 1.595 . . . . 0.0 113.855 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.5 m -60.73 -7.85 2.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.221 1.409 . . . . 0.0 114.567 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -130.38 159.25 37.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.736 1.614 . . . . 0.0 112.729 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.36 -0.91 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 -169.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.53 48.67 1.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.752 1.221 . . . . 0.0 110.528 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -51.07 114.97 1.33 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.002 -1.686 . . . . 0.0 113.148 -170.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m 52.95 24.89 3.63 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -61.38 -24.05 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.564 -1.335 . . . . 0.0 113.877 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.26 -59.33 8.55 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.562 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.59 96.69 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.317 -1.107 . . . . 0.0 114.008 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -40.46 88.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.171 0.985 . . . . 0.0 113.655 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.52 -36.15 79.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.327 0.512 . . . . 0.0 112.221 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.41 -29.34 63.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.83 -45.42 71.21 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.256 -1.527 . . . . 0.0 110.559 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.35 67.93 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.7 tp -50.39 -30.2 11.84 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.88 1.672 . . . . 0.0 113.151 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.52 -36.64 7.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.568 1.147 . . . . 0.0 111.743 -171.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -65.67 -30.26 70.93 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.343 -0.848 . . . . 0.0 112.777 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.04 -17.24 63.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.048 0.939 . . . . 0.0 112.622 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -113.7 -7.19 13.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 t 100.37 13.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.188 2.595 . . . . 0.0 113.153 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.08 162.68 4.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.365 0.666 . . . . 0.0 111.992 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -133.36 95.66 3.56 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.205 1.002 . . . . 0.0 109.935 -172.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.9 ttm105 -66.18 136.16 55.53 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.482 -0.761 . . . . 0.0 110.659 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -89.59 34.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.294 1.438 . . . . 0.0 111.503 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.64 41.37 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.979 1.276 . . . . 0.0 113.107 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -95.81 144.08 26.48 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.562 1.145 . . . . 0.0 111.02 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -63.82 123.57 19.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.832 0.853 . . . . 0.0 111.056 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.5 tm? -81.75 140.0 34.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.714 0.806 . . . . 0.0 109.293 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.505 ' N ' HD13 ' A' ' 123' ' ' LEU . 48.0 mt -122.81 92.84 3.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.272 1.429 . . . . 0.0 110.811 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.9 mt -71.77 136.9 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.797 0.839 . . . . 0.0 110.326 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -130.26 106.8 8.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.158 0.983 . . . . 0.0 113.154 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.31 -17.22 41.29 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -68.53 -14.02 62.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.753 1.161 . . . . 0.0 113.704 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.64 -10.88 1.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -139.93 110.37 7.22 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.905 1.23 . . . . 0.0 112.598 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.48 0.61 9.64 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.442 3.428 . . . . 0.0 114.794 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.01 76.17 77.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.625 1.57 . . . . 0.0 111.592 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -44.35 -34.33 7.17 Favored 'Trans proline' 0 C--N 1.354 0.831 1 C-N-CA 126.077 4.518 . . . . 0.0 117.853 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.49 -37.68 70.7 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 113.39 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -69.64 -5.97 28.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.56 1.144 . . . . 0.0 113.343 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -113.54 -2.18 13.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.595 1.558 . . . . 0.0 111.84 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 p -139.96 -28.43 0.74 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -169.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -55.88 -51.6 79.12 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.0 -28.95 41.21 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.742 1.628 . . . . 0.0 112.619 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CE3' HD11 ' A' ' 90' ' ' ILE . 70.9 t90 -63.37 -48.34 78.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.767 0.827 . . . . 0.0 111.748 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.74 -39.84 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.834 0.743 . . . . 0.0 110.409 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -57.55 -43.98 84.84 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.117 0.417 . . . . 0.0 111.342 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -63.62 -57.49 9.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.701 0.8 . . . . 0.0 112.534 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -51.49 -48.78 62.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.712 1.205 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -28.5 17.19 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.78 1.657 . . . . 0.0 116.122 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.1 p -69.75 -18.9 63.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.566 1.683 . . . . 0.0 114.025 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.96 -14.61 27.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 113.056 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.36 164.21 11.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.458 1.903 . . . . 0.0 112.468 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.767 1.227 . . . . 0.0 113.58 171.528 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.536 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.31 115.27 16.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.918 1.687 . . . . 0.0 109.291 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -111.55 126.7 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.821 0.848 . . . . 0.0 112.76 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.93 125.87 7.53 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.1 mt -117.29 91.35 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 108.938 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -90.34 132.74 35.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.94 0.896 . . . . 0.0 110.732 -170.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.55 144.78 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.29 0.636 . . . . 0.0 111.52 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.86 104.46 0.55 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -149.22 161.37 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.028 1.331 . . . . 0.0 111.434 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 79.4 mmm -106.3 -11.79 15.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.073 0.949 . . . . 0.0 113.291 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -146.7 -26.46 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.46 -5.49 4.89 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -44.5 94.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.585 1.693 . . . . 0.0 113.228 -169.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -81.23 -31.04 34.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.372 0.669 . . . . 0.0 112.581 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.57 -38.91 75.61 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.737 -1.227 . . . . 0.0 113.239 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -52.76 -42.06 64.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.075 0.852 . . . . 0.0 111.801 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.9 t -69.47 -34.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.109 0.563 . . . . 0.0 112.008 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.56 92.07 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.44 1.018 . . . . 0.0 112.412 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.91 -41.75 96.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.567 0.747 . . . . 0.0 112.034 173.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -61.3 -46.52 89.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.281 0.632 . . . . 0.0 112.227 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.52 88.64 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 112.793 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.19 -45.89 79.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.724 0.809 . . . . 0.0 112.012 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.92 -45.89 80.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.779 0.832 . . . . 0.0 112.672 176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.56 -31.73 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.058 1.343 . . . . 0.0 112.996 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 mt -75.55 -41.38 55.03 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.807 -1.183 . . . . 0.0 110.175 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.3 m -56.6 -44.65 81.3 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.166 0.986 . . . . 0.0 111.807 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.66 76.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.74 1.216 . . . . 0.0 113.601 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.64 -5.41 47.75 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.405 1.082 . . . . 0.0 113.621 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.83 0.33 55.17 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.294 1.426 . . . . 0.0 114.502 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 87.0 m-70 -81.83 -177.16 6.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.957 1.303 . . . . 0.0 111.919 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -122.51 150.76 42.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.933 1.693 . . . . 0.0 109.145 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.87 167.15 27.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -152.38 119.35 5.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 110.811 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -74.37 145.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.391 1.076 . . . . 0.0 111.02 171.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.0 109.21 9.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.426 1.49 . . . . 0.0 109.193 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.91 -28.59 35.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -144.25 56.43 4.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.878 1.671 . . . . 0.0 110.981 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.04 165.16 32.71 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.684 2.923 . . . . 0.0 115.566 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -133.98 171.68 13.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.728 2.011 . . . . 0.0 109.712 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.91 -39.61 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.989 -1.07 . . . . 0.0 113.038 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 m -58.62 -20.39 47.04 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -85.06 -33.06 22.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.211 0.914 . . . . 0.0 112.498 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.538 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 28.4 t-105 -78.34 -40.75 35.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.639 1.175 . . . . 0.0 112.578 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.3 tp -41.44 -46.97 8.67 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.752 2.821 . . . . 0.0 115.577 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.86 -28.89 67.52 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.754 2.969 . . . . 0.0 116.316 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -80.06 2.5 23.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -169.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -60.32 -23.44 64.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.71 -1.244 . . . . 0.0 114.212 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -87.32 3.5 46.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.827 1.251 . . . . 0.0 113.072 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -137.32 -137.63 0.14 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.709 2.003 . . . . 0.0 110.97 -168.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -140.83 164.29 30.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.21 1.804 . . . . 0.0 110.626 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.538 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 28.7 m -144.05 174.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.252 1.421 . . . . 0.0 111.741 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tt -152.19 146.44 25.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.669 1.988 . . . . 0.0 108.49 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.28 133.04 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.357 1.063 . . . . 0.0 109.687 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.91 90.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.933 1.293 . . . . 0.0 108.786 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.5 m -135.76 141.62 44.84 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -94.95 -165.21 1.27 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.257 1.823 . . . . 0.0 113.155 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.7 m -132.43 150.35 52.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.337 -1.477 . . . . 0.0 111.715 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 127.28 2.232 . . . . 0.0 109.63 -175.84 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t0 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.15 145.66 65.45 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.804 1.241 . . . . 0.0 109.759 169.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.69 140.65 57.03 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.316 2.678 . . . . 0.0 110.412 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.37 -28.82 65.49 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -59.29 -12.05 5.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.66 -3.7 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.577 1.08 . . . . 0.0 113.338 173.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.2 t -56.79 -46.2 99.87 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 120.343 -1.473 . . . . 0.0 112.34 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.93 -12.97 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.921 3.081 . . . . 0.0 116.305 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 tp -99.89 -44.49 6.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.545 1.138 . . . . 0.0 110.577 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.32 -42.9 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.644 1.178 . . . . 0.0 112.238 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.88 -26.86 67.09 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.111 -0.993 . . . . 0.0 113.446 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.97 -41.73 4.56 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.078 -171.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.25 -41.06 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.447 1.623 . . . . 0.0 111.054 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.32 -48.01 83.24 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 112.32 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -36.05 19.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.831 0.853 . . . . 0.0 113.226 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -82.49 -37.08 25.81 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.75 -46.41 15.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.18 0.9 . . . . 0.0 112.393 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.97 -39.1 0.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 126.239 1.876 . . . . 0.0 115.415 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -161.94 142.27 10.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.748 2.019 . . . . 0.0 110.187 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -150.9 102.34 3.03 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.705 1.202 . . . . 0.0 111.407 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.68 -16.31 10.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.693 2.262 . . . . 0.0 114.456 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 -5.36 9.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.4 117.39 6.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.663 1.185 . . . . 0.0 109.934 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -127.93 134.55 49.33 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.716 1.606 . . . . 0.0 110.622 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CB ' HG23 ' A' ' 52' ' ' VAL . 1.3 p90 -155.97 -171.13 3.63 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -171.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.24 160.39 28.26 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.864 1.697 . . . . 0.0 110.487 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.39 135.62 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.007 0.908 . . . . 0.0 113.328 -169.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.0 119.44 57.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.85 147.32 47.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.468 1.107 . . . . 0.0 109.84 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.0 tt -138.55 148.25 44.01 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.046 0.927 . . . . 0.0 112.158 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.65 -141.17 6.08 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.795 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -141.95 118.6 11.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 111.197 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -74.06 -0.02 15.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 t -73.21 4.49 4.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.56 1.073 . . . . 0.0 113.668 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.02 157.64 46.41 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.306 1.843 . . . . 0.0 111.673 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 m -74.45 -1.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -169.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -122.97 44.51 2.64 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.808 1.243 . . . . 0.0 110.73 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.29 116.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.302 -1.499 . . . . 0.0 113.1 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.17 24.46 2.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.693 2.397 . . . . 0.0 116.685 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -60.61 -27.8 68.04 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.371 -1.455 . . . . 0.0 113.416 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.64 73.02 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.272 -0.892 . . . . 0.0 113.447 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.64 -40.27 6.84 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.079 0.939 . . . . 0.0 113.13 170.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -58.74 -38.76 79.11 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 118.702 1.251 . . . . 0.0 113.659 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -56.34 -32.06 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -75.8 -25.63 56.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.033 0.833 . . . . 0.0 113.182 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.74 -43.16 48.14 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.31 -1.494 . . . . 0.0 110.288 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.12 -42.62 69.66 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 170.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -49.99 -43.86 50.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.88 1.672 . . . . 0.0 112.319 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.17 -37.62 14.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.046 0.939 . . . . 0.0 112.464 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.67 -30.28 71.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.461 -0.774 . . . . 0.0 112.21 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.81 -24.42 67.75 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -91.91 -2.21 56.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.748 0.703 . . . . 0.0 112.456 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m 75.09 23.95 1.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.056 2.143 . . . . 0.0 114.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 177.03 0.14 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.64 1.176 . . . . 0.0 112.681 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -135.59 164.35 28.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 O-C-N 120.565 -1.334 . . . . 0.0 110.305 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 mtm105 -130.58 142.26 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 t -96.16 25.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.004 1.722 . . . . 0.0 111.637 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.01 -171.42 44.43 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.018 1.294 . . . . 0.0 114.461 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.05 155.56 39.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.277 1.431 . . . . 0.0 111.641 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.7 ttm -68.41 121.19 15.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.488 1.115 . . . . 0.0 112.231 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -76.82 136.17 38.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.67 84.94 2.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.743 1.217 . . . . 0.0 110.866 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.2 mt -74.97 132.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.742 1.617 . . . . 0.0 110.634 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -124.35 104.2 8.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -14.86 7.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.5 m -64.58 -23.09 67.15 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.885 1.221 . . . . 0.0 113.598 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.35 -8.31 0.99 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -135.92 107.58 9.74 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.316 0.962 . . . . 0.0 113.064 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.76 -2.06 11.62 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.139 3.226 . . . . 0.0 114.346 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -125.16 78.82 66.53 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.934 1.694 . . . . 0.0 110.514 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.39 -23.24 76.49 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.448 3.432 . . . . 0.0 114.328 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.28 -43.68 67.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.557 1.543 . . . . 0.0 112.417 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -104.25 -7.66 19.9 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.632 1.173 . . . . 0.0 112.877 175.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 m -123.92 -26.16 4.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.32 -50.5 85.55 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 120.575 -1.328 . . . . 0.0 111.754 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.04 -34.46 87.21 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.012 2.475 . . . . 0.0 114.79 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -61.49 -49.32 77.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.985 0.514 . . . . 0.0 111.495 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.2 t -71.19 -33.41 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.351 -0.843 . . . . 0.0 111.223 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -66.12 -14.92 62.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.232 -0.918 . . . . 0.0 113.173 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -95.98 -57.16 2.43 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.745 1.218 . . . . 0.0 111.634 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.85 -49.02 66.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.875 1.27 . . . . 0.0 111.815 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.76 -24.97 27.98 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.835 1.207 . . . . 0.0 115.685 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.4 p -69.2 -16.54 63.64 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 120.117 1.959 . . . . 0.0 113.659 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.3 mt -99.79 -15.13 18.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.482 1.513 . . . . 0.0 112.995 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.59 143.97 53.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 111.671 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.946 1.698 . . . . 0.0 114.128 -174.586 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.94 166.88 8.5 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -132.62 133.82 44.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.068 1.747 . . . . 0.0 108.461 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.457 HD11 ' CD1' ' A' ' 148' ' ' LEU . 4.5 mm -125.95 117.36 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.537 0.735 . . . . 0.0 111.804 -169.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.09 126.81 7.57 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 168.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -118.32 91.21 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.673 1.189 . . . . 0.0 107.857 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -90.5 137.62 32.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.356 1.063 . . . . 0.0 110.478 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -121.26 144.77 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.523 0.678 . . . . 0.0 112.242 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.16 104.56 0.49 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.247 0.927 . . . . 0.0 111.207 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 t -151.13 163.77 38.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.462 1.105 . . . . 0.0 113.076 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.1 mtp -129.82 2.0 4.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 112.204 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -140.18 -11.87 1.08 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.8 -0.8 67.67 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 171.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -74.42 -42.94 58.34 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.739 1.769 . . . . 0.0 111.732 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -33.45 74.77 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.564 -0.71 . . . . 0.0 112.156 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.08 -40.97 97.63 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.997 -1.065 . . . . 0.0 112.562 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 tt -56.15 -44.97 79.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.142 0.883 . . . . 0.0 111.623 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.22 -38.84 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.836 0.454 . . . . 0.0 111.795 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.5 90.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.22 -42.55 99.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.868 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -61.68 -42.44 98.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.501 -0.749 . . . . 0.0 112.385 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.85 95.03 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.771 0.714 . . . . 0.0 112.457 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.08 -48.75 79.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.325 0.65 . . . . 0.0 111.539 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.22 91.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.785 0.834 . . . . 0.0 112.746 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.13 -47.75 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.411 1.085 . . . . 0.0 112.363 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.29 -39.71 78.15 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.734 -0.604 . . . . 0.0 109.892 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -58.32 -44.72 88.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.927 1.291 . . . . 0.0 112.072 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -38.24 86.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.26 1.024 . . . . 0.0 112.561 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.44 -25.01 64.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.938 0.895 . . . . 0.0 112.892 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.16 -7.03 8.7 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.922 1.725 . . . . 0.0 114.759 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -76.34 139.25 40.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.828 1.251 . . . . 0.0 110.93 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -76.93 76.94 3.5 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.784 0.834 . . . . 0.0 110.909 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.34 157.8 32.08 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 111.624 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.3 m -151.99 117.73 5.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.103 -0.998 . . . . 0.0 109.784 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.13 144.97 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.708 0.803 . . . . 0.0 112.262 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.34 97.95 4.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.409 1.484 . . . . 0.0 110.822 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.99 -18.02 60.92 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -141.67 66.04 21.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.893 1.677 . . . . 0.0 109.764 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.67 168.75 24.1 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.14 3.227 . . . . 0.0 115.237 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -149.34 159.96 43.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.973 2.109 . . . . 0.0 109.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.02 -38.05 48.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.954 -1.091 . . . . 0.0 111.468 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -56.03 -24.8 41.66 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.41 1.484 . . . . 0.0 114.826 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -99.6 -23.72 14.97 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.567 1.547 . . . . 0.0 112.908 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -71.59 -39.6 70.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.803 0.841 . . . . 0.0 112.727 170.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.98 -47.66 86.47 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.778 2.031 . . . . 0.0 115.594 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.88 -5.14 1.76 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.101 3.2 . . . . 0.0 117.731 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -119.56 2.84 11.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -28.26 69.52 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.227 -1.546 . . . . 0.0 113.187 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.91 4.91 23.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.705 1.202 . . . . 0.0 113.094 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -135.71 -132.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.867 2.067 . . . . 0.0 110.1 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -139.09 159.47 42.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.943 1.697 . . . . 0.0 111.005 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.37 168.51 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.034 1.733 . . . . 0.0 110.391 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 151.15 23.36 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.849 -1.157 . . . . 0.0 110.433 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.81 136.64 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.829 1.252 . . . . 0.0 110.405 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -135.1 95.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.937 1.295 . . . . 0.0 107.719 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 m -133.56 169.12 17.45 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -167.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -137.71 -158.95 0.91 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.122 1.369 . . . . 0.0 112.578 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.1 m -135.82 151.75 50.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.757 1.623 . . . . 0.0 110.872 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 t -150.17 -176.07 5.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.127 1.371 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.46 -132.18 9.07 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.697 1.617 . . . . 0.0 114.377 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -81.74 19.67 1.04 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 113.069 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.65 15.73 10.83 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.763 1.173 . . . . 0.0 114.924 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -80.37 170.07 16.88 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.424 1.89 . . . . 0.0 112.388 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.47 143.96 93.78 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.219 -0.926 . . . . 0.0 111.054 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.93 137.37 43.82 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.088 3.859 . . . . 0.0 112.349 170.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.85 -24.35 66.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -61.45 -17.95 56.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.718 1.607 . . . . 0.0 114.802 171.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -124.54 -10.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.543 1.137 . . . . 0.0 113.845 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.8 t -46.98 -48.98 51.93 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.965 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.44 -17.21 43.94 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.379 1.885 . . . . 0.0 114.385 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.2 -43.71 17.31 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.962 0.801 . . . . 0.0 109.572 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.57 -49.65 72.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.096 1.359 . . . . 0.0 111.386 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -62.12 -41.7 98.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.846 -1.159 . . . . 0.0 112.262 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.99 -50.23 67.55 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.647 0.641 . . . . 0.0 112.828 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.3 -39.41 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 O-C-N 121.382 -1.069 . . . . 0.0 110.897 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -65.88 -36.7 84.14 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -112.71 -20.36 11.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.2 m -125.61 10.86 7.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.876 1.271 . . . . 0.0 113.782 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.13 -51.59 1.11 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.615 1.566 . . . . 0.0 110.302 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.31 -28.98 0.33 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 119.552 2.581 . . . . 0.0 119.552 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -153.3 136.45 15.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.499 2.15 . . . . 0.0 111.99 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -150.64 56.11 2.0 Allowed Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.219 1.408 . . . . 0.0 113.296 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.43 -18.67 65.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.036 3.158 . . . . 0.0 115.323 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.97 0.17 14.98 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.596 1.959 . . . . 0.0 113.504 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.71 124.07 22.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 109.186 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -121.31 138.89 54.04 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.201 1.4 . . . . 0.0 109.263 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -160.92 -167.48 1.84 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -168.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 160.86 31.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.625 2.536 . . . . 0.0 109.714 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.82 135.46 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 117.897 0.849 . . . . 0.0 112.212 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.2 mt -119.57 130.61 73.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.04 146.85 48.29 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.044 0.938 . . . . 0.0 110.171 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tt -141.53 133.87 28.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.553 0.741 . . . . 0.0 110.852 -169.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.58 -166.15 33.8 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 121.951 0.751 . . . . 0.0 113.733 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -98.07 118.4 34.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.877 1.271 . . . . 0.0 110.962 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.4 p -64.26 -9.94 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.974 1.71 . . . . 0.0 115.207 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -70.56 -8.26 50.1 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -138.13 159.55 41.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.67 1.188 . . . . 0.0 113.387 -169.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.16 -34.5 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.127 1.371 . . . . 0.0 113.176 -171.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -76.2 34.85 0.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.592 1.157 . . . . 0.0 113.215 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.62 113.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.915 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.3 m 52.85 25.36 3.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.329 2.251 . . . . 0.0 116.287 -171.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -60.28 -30.22 69.32 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.661 -1.275 . . . . 0.0 113.692 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.55 -38.8 61.62 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.897 -1.127 . . . . 0.0 112.695 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.67 -40.33 66.06 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.524 -0.986 . . . . 0.0 112.791 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -58.79 -40.74 84.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.881 0.872 . . . . 0.0 112.911 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.86 -38.21 84.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.27 -31.3 68.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.39 0.995 . . . . 0.0 113.413 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.57 -43.73 79.92 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 119.763 -1.835 . . . . 0.0 110.826 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.39 71.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.57 -29.64 11.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.586 1.554 . . . . 0.0 112.936 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.32 -39.1 6.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.517 1.127 . . . . 0.0 111.362 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -67.36 -34.13 76.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.306 -0.871 . . . . 0.0 113.338 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.79 -14.09 49.81 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.427 -0.796 . . . . 0.0 112.414 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -111.57 10.15 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.851 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 72.31 18.93 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.596 1.558 . . . . 0.0 114.516 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.8 165.35 1.76 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.506 0.722 . . . . 0.0 111.92 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -135.6 88.4 2.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 120.76 -1.213 . . . . 0.0 110.344 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -62.42 142.83 57.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.354 0.662 . . . . 0.0 111.346 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.56 34.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.579 1.552 . . . . 0.0 110.757 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.92 -167.89 40.91 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.841 -1.162 . . . . 0.0 113.562 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -120.17 143.14 48.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.515 1.526 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.1 ttp -67.53 124.82 24.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.265 1.026 . . . . 0.0 112.018 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -83.86 133.66 34.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.218 1.007 . . . . 0.0 109.968 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -122.41 98.13 5.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 111.575 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.1 mt -89.47 134.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.617 1.567 . . . . 0.0 111.772 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -113.38 66.97 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.624 3.17 . . . . 0.0 111.35 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -46.1 -38.94 8.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.455 1.902 . . . . 0.0 116.132 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.1 m -62.38 -16.12 52.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -134.46 12.49 3.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.065 1.746 . . . . 0.0 111.964 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -144.5 68.46 15.0 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.242 1.817 . . . . 0.0 110.704 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.85 6.92 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.841 3.694 . . . . 0.0 114.701 -171.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.5 58.91 41.66 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.275 1.83 . . . . 0.0 110.987 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -61.47 -22.06 73.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.608 3.539 . . . . 0.0 114.24 -169.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.56 -44.26 56.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.999 1.32 . . . . 0.0 111.051 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.6 p -68.57 -18.32 64.31 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -95.11 -11.93 27.38 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.283 1.433 . . . . 0.0 112.428 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 26.0 p -128.3 -31.63 2.29 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.71 -53.1 69.13 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.923 1.238 . . . . 0.0 113.877 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.61 -29.42 52.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.418 1.542 . . . . 0.0 112.678 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -61.63 -48.94 78.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.709 0.803 . . . . 0.0 111.715 171.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.31 -40.75 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.694 0.679 . . . . 0.0 110.535 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.57 -44.1 89.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.701 0.682 . . . . 0.0 111.249 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.77 -55.86 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 112.606 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.29 -37.51 67.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.881 0.873 . . . . 0.0 112.195 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.36 -20.45 65.44 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.407 1.003 . . . . 0.0 115.158 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.4 p -74.58 -17.94 60.65 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.654 1.727 . . . . 0.0 113.165 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.62 -5.8 53.29 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.856 1.262 . . . . 0.0 112.73 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 4' ' ' ILE . 80.8 mt -70.76 -173.6 0.79 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.085 1.754 . . . . 0.0 111.361 169.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.371 1.869 . . . . 0.0 114.505 178.389 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.294 0.092 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.97 179.81 6.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.391 1.876 . . . . 0.0 111.361 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.44 134.66 47.95 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.174 1.389 . . . . 0.0 109.699 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.489 HD12 HD13 ' A' ' 26' ' ' LEU . 1.4 mt -137.03 124.76 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.26 130.63 10.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 168.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -117.65 90.86 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.01 1.324 . . . . 0.0 108.331 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.71 146.58 24.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.852 0.861 . . . . 0.0 112.978 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.44 129.41 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.255 1.026 . . . . 0.0 111.833 -169.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.93 71.71 0.46 Allowed Glycine 0 N--CA 1.468 0.798 0 C-N-CA 126.615 2.055 . . . . 0.0 109.568 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 t -129.76 177.73 7.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.631 1.172 . . . . 0.0 113.787 -169.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.3 tpt -135.58 -36.88 0.77 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.153 0.981 . . . . 0.0 113.417 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -129.28 -22.68 3.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.568 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.65 -2.55 7.0 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.7 1.143 . . . . 0.0 115.16 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -36.8 85.08 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.447 1.624 . . . . 0.0 113.084 -169.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 -31.69 37.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.593 1.157 . . . . 0.0 113.505 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.4 tp -59.06 -35.34 73.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.953 -1.092 . . . . 0.0 113.218 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 tp -48.32 -42.04 30.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.555 0.742 . . . . 0.0 111.707 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.26 -36.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.976 -0.535 . . . . 0.0 112.137 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.04 94.37 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.703 1.138 . . . . 0.0 112.415 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.38 -42.57 99.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.032 0.533 . . . . 0.0 112.102 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -60.83 -46.95 88.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.412 0.685 . . . . 0.0 112.38 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.64 84.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.179 0.592 . . . . 0.0 111.907 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.8 -45.82 70.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.136 0.575 . . . . 0.0 111.89 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.75 74.44 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.464 0.706 . . . . 0.0 112.812 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.25 -45.88 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.831 1.252 . . . . 0.0 111.973 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.489 HD13 HD12 ' A' ' 4' ' ' ILE . 52.2 mt -73.52 -40.1 64.29 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.037 0.935 . . . . 0.0 109.846 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.4 m -56.92 -46.6 81.89 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.35 1.06 . . . . 0.0 111.573 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.88 82.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.042 0.937 . . . . 0.0 113.325 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -73.44 -9.25 58.49 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 171.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.95 -6.01 34.74 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.574 1.559 . . . . 0.0 114.982 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -76.84 153.73 34.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.54 1.17 . . . . 0.0 112.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -80.76 130.84 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.66 150.78 46.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.336 0.654 . . . . 0.0 111.457 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -155.75 121.48 4.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.966 0.906 . . . . 0.0 109.925 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.87 150.3 7.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.194 0.521 . . . . 0.0 111.383 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -133.53 102.55 5.55 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.708 1.203 . . . . 0.0 107.985 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.88 -27.12 60.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.57 1.148 . . . . 0.0 113.855 -170.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.65 58.89 4.76 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 126.297 1.839 . . . . 0.0 110.508 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.05 163.94 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.212 3.275 . . . . 0.0 116.114 -169.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.69 170.18 15.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.449 2.3 . . . . 0.0 109.178 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -53.28 -38.85 63.44 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.809 -1.182 . . . . 0.0 113.312 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.84 -13.93 28.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -89.69 -29.41 18.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.719 1.145 . . . . 0.0 112.52 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.512 ' CH2' HG21 ' A' ' 52' ' ' VAL . 38.1 t-105 -81.82 -42.85 19.1 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 0.0 112.665 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.4 tp -47.59 -44.65 55.92 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 126.803 2.041 . . . . 0.0 114.54 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.01 -9.28 0.66 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.271 3.981 . . . . 0.0 118.129 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.22 5.21 7.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 113.173 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -57.02 -36.45 70.46 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.227 -0.921 . . . . 0.0 112.605 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.03 13.06 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.561 1.944 . . . . 0.0 114.479 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -134.43 -130.43 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.591 1.556 . . . . 0.0 111.482 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.33 158.61 44.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.895 2.078 . . . . 0.0 109.691 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.512 HG21 ' CH2' ' A' ' 44' ' ' TRP . 30.3 m -147.36 172.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 110.467 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -154.86 149.58 26.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.683 1.593 . . . . 0.0 108.86 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.6 139.76 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.402 -0.811 . . . . 0.0 111.143 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 m -124.53 125.95 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.073 1.349 . . . . 0.0 108.257 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.7 m -150.87 158.28 43.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.041 -1.662 . . . . 0.0 113.38 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -136.14 178.61 6.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.505 1.522 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 m -121.51 135.37 55.03 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.01 1.324 . . . . 0.0 110.803 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 t -163.29 -160.08 0.58 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.613 1.965 . . . . 0.0 109.28 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.68 -69.59 0.56 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.822 2.153 . . . . 0.0 115.542 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -154.63 29.64 0.43 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.345 1.858 . . . . 0.0 110.637 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.36 40.88 6.73 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.16 -0.963 . . . . 0.0 111.682 -169.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -137.15 168.21 20.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.051 1.74 . . . . 0.0 112.41 -169.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.07 152.59 96.69 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.279 -0.888 . . . . 0.0 111.339 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -85.21 164.69 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.684 2.923 . . . . 0.0 112.566 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.0 -19.16 64.08 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -61.48 -19.76 62.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 tt -127.01 -8.33 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -48.42 -51.56 50.27 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-O 117.418 -1.277 . . . . 0.0 112.449 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.92 -5.18 16.56 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.362 2.041 . . . . 0.0 114.326 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -92.39 -43.43 9.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.227 0.921 . . . . 0.0 109.399 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.46 -50.03 74.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.806 1.243 . . . . 0.0 111.387 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -62.22 -40.0 94.68 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.981 -1.074 . . . . 0.0 112.485 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.89 -44.65 55.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.169 0.89 . . . . 0.0 113.505 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.43 -47.45 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.098 1.449 . . . . 0.0 110.047 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -59.92 -48.61 81.0 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.581 1.153 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.85 -41.82 22.57 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -88.52 -28.34 20.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -97.13 -42.65 7.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.85 -38.12 0.5 Allowed Glycine 0 CA--C 1.542 1.777 0 C-N-CA 125.84 1.686 . . . . 0.0 115.757 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -145.01 151.58 38.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.26 2.224 . . . . 0.0 110.82 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.24 43.12 0.23 Allowed Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -57.6 -29.48 85.3 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.141 2.561 . . . . 0.0 114.649 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -68.32 -15.26 63.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.924 2.09 . . . . 0.0 115.145 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.27 122.63 28.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.54 136.83 54.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 108.766 169.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -156.43 -172.29 4.02 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.2 161.37 27.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.127 1.346 . . . . 0.0 109.86 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.95 142.18 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.666 0.746 . . . . 0.0 111.749 -169.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mt -127.71 129.48 70.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.51 151.63 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.697 0.76 . . . . 0.0 110.853 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 tt -143.68 131.56 21.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.249 1.02 . . . . 0.0 109.976 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.78 -147.85 5.17 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 174.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -143.78 125.04 14.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.786 1.234 . . . . 0.0 110.385 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -60.16 -7.16 1.72 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -63.9 -7.87 9.49 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 171.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -126.49 136.08 52.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.42 1.488 . . . . 0.0 111.154 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.75 -36.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.513 1.125 . . . . 0.0 113.488 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.92 -17.11 59.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 23.1 t80 34.69 -118.23 0.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.443 1.897 . . . . 0.0 112.867 -169.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.19 24.69 0.52 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -46.36 -43.28 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.095 1.316 . . . . 0.0 113.883 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.55 -36.84 86.92 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 118.49 0.586 . . . . 0.0 113.142 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.53 -45.06 48.23 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.928 0.775 . . . . 0.0 113.463 170.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -58.24 -38.1 76.2 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.357 1.078 . . . . 0.0 113.374 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -55.89 -41.22 74.14 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.351 0.661 . . . . 0.0 112.29 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -71.4 -26.03 62.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.63 -41.45 45.88 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.697 -1.252 . . . . 0.0 111.462 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.93 -40.12 72.67 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.1 tp -50.68 -34.3 26.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.289 1.835 . . . . 0.0 112.92 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -103.71 -36.59 7.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -67.84 -32.39 72.89 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.9 -1.125 . . . . 0.0 113.022 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.03 -16.8 62.48 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 119.17 0.895 . . . . 0.0 111.87 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -107.04 10.14 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.06 1.744 . . . . 0.0 112.672 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m 65.71 23.95 11.55 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 114.713 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.3 177.96 0.23 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 0.0 112.618 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -136.72 163.57 30.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.498 -1.377 . . . . 0.0 109.673 -173.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -133.21 147.09 52.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.11 22.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.926 1.691 . . . . 0.0 112.14 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.2 176.56 41.1 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.405 1.479 . . . . 0.0 114.556 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.84 162.13 16.34 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.801 1.24 . . . . 0.0 112.398 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttp -71.32 123.17 21.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.615 -0.678 . . . . 0.0 111.352 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.25 138.81 47.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.035 0.934 . . . . 0.0 110.206 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.7 mt -124.73 91.3 3.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.84 1.256 . . . . 0.0 112.129 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.78 137.65 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.403 1.481 . . . . 0.0 110.34 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -133.07 102.81 5.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.278 1.037 . . . . 0.0 112.553 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.03 14.31 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 83.1 p -72.25 -14.68 61.84 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.57 1.077 . . . . 0.0 113.825 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.54 -7.54 1.3 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -136.91 112.14 9.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.538 1.135 . . . . 0.0 112.017 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.42 -3.62 12.63 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.68 2.92 . . . . 0.0 114.171 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -134.74 84.02 39.97 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.265 1.426 . . . . 0.0 111.78 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -46.24 -33.76 12.59 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 126.103 4.535 . . . . 0.0 116.229 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.08 -40.79 59.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.139 1.376 . . . . 0.0 112.605 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.5 p -67.26 -9.95 45.73 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -115.25 -3.45 12.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.587 1.155 . . . . 0.0 112.445 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.0 p -133.12 -27.45 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.66 -53.39 60.88 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 120.011 1.278 . . . . 0.0 112.752 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.18 -29.77 32.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.592 1.528 . . . . 0.0 112.694 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -60.76 -50.1 74.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.354 0.662 . . . . 0.0 111.463 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.41 -39.38 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 118.287 0.494 . . . . 0.0 110.571 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.48 -34.88 73.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.022 0.828 . . . . 0.0 112.403 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.51 -63.06 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.319 0.963 . . . . 0.0 111.945 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -57.38 -35.8 70.43 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.788 1.235 . . . . 0.0 113.045 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.58 -33.87 68.08 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.864 0.745 . . . . 0.0 113.905 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.8 p -69.99 -17.62 63.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.426 1.613 . . . . 0.0 113.884 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.99 -18.08 44.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.35 -32.72 73.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.255 1.386 0 C-N-CA 124.844 1.258 . . . . 0.0 112.364 -175.207 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.34 178.07 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.223 1.809 . . . . 0.0 111.862 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.03 110.54 7.03 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 108.647 -173.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mm -110.89 137.41 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -169.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.01 126.61 8.85 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mt -119.62 101.12 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.493 1.117 . . . . 0.0 108.149 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.16 120.41 39.47 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.696 0.799 . . . . 0.0 112.481 -168.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.28 143.31 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.904 1.282 . . . . 0.0 110.768 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.84 76.43 0.31 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.064 1.316 . . . . 0.0 110.278 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 t -121.47 154.51 36.5 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.854 0.827 . . . . 0.0 112.447 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 tpt -90.45 -28.72 18.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.527 0.731 . . . . 0.0 112.548 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -146.3 -16.14 0.44 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.57 -14.56 4.74 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -62.96 -42.98 99.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.399 2.1 . . . . 0.0 113.093 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -77.84 -26.01 49.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.48 -44.31 89.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.886 -1.133 . . . . 0.0 112.177 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.8 -45.33 70.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.687 0.676 . . . . 0.0 111.589 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.48 -38.69 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.005 0.522 . . . . 0.0 111.892 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.66 92.44 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.964 0.802 . . . . 0.0 112.885 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.82 -43.7 98.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.696 -0.628 . . . . 0.0 112.081 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.32 -42.34 99.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.543 -0.723 . . . . 0.0 112.311 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.12 90.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.61 -0.681 . . . . 0.0 112.034 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -55.11 -47.8 74.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.425 0.69 . . . . 0.0 111.445 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.42 84.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.736 0.814 . . . . 0.0 112.849 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.13 -45.25 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.481 1.112 . . . . 0.0 112.305 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.34 -41.8 72.74 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.547 -0.721 . . . . 0.0 109.787 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -56.64 -42.92 79.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.919 1.288 . . . . 0.0 112.467 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 -42.33 65.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.31 1.044 . . . . 0.0 113.442 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -71.07 -37.04 72.48 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.4 21.86 0.03 OUTLIER Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -133.66 -175.68 3.91 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.458 1.503 . . . . 0.0 111.155 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.47 144.37 48.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.389 1.476 . . . . 0.0 108.379 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.74 153.1 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.825 -0.547 . . . . 0.0 112.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.5 m -137.6 113.46 9.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 109.442 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.02 147.34 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.336 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -134.79 105.07 6.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.97 -30.0 58.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.982 1.313 . . . . 0.0 114.041 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -148.68 65.1 8.2 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.489 1.916 . . . . 0.0 109.601 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.45 171.71 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.685 2.923 . . . . 0.0 114.188 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.85 169.18 16.1 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.77 2.028 . . . . 0.0 108.913 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.35 -35.31 65.07 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.671 -1.268 . . . . 0.0 112.344 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -57.53 -22.71 46.09 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -83.75 -36.74 23.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.121 0.873 . . . . 0.0 112.478 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 47.5 t-105 -70.57 -39.94 73.61 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.727 0.694 . . . . 0.0 112.034 174.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -43.25 -58.07 4.61 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 127.241 2.217 . . . . 0.0 115.273 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.17 -26.62 10.48 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.702 2.268 . . . . 0.0 114.731 -171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -74.18 -7.12 51.52 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -62.11 -30.57 71.11 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.667 -1.27 . . . . 0.0 112.694 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.71 2.64 7.79 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.309 1.444 . . . . 0.0 113.99 171.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -133.14 -120.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.082 2.153 . . . . 0.0 109.566 -169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -143.55 158.1 43.92 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 109.373 171.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 20.9 m -140.9 163.16 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.315 1.446 . . . . 0.0 110.718 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.19 141.87 20.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.225 1.012 . . . . 0.0 111.48 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.81 133.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.563 1.545 . . . . 0.0 109.606 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.97 106.49 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.4 m -149.16 155.16 40.24 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.297 -1.502 . . . . 0.0 114.913 -168.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -113.29 -174.22 2.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.37 1.468 . . . . 0.0 112.852 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.2 m -129.23 139.86 51.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.673 1.189 . . . . 0.0 110.666 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -146.23 -166.1 2.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 108.352 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 44.37 44.87 8.12 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 125.876 1.703 . . . . 0.0 116.36 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.438 ' H ' HM73 ' A' ' 201' ' ' FMN . 82.8 mt-30 65.02 8.23 4.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.359 2.264 . . . . 0.0 115.507 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.47 31.89 0.1 OUTLIER Glycine 0 N--CA 1.475 1.295 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -138.46 172.44 12.88 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.88 1.84 . . . . 0.0 113.194 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -65.76 146.03 99.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.659 1.584 . . . . 0.0 112.987 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.01 155.27 19.8 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.706 2.937 . . . . 0.0 111.602 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.7 -23.86 63.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.8 m -56.85 -16.99 7.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.692 1.597 . . . . 0.0 115.153 174.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.0 tt -132.96 -4.98 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.3 t -48.88 -43.13 64.71 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.364 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 -13.95 41.02 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 CA-C-N 122.433 1.905 . . . . 0.0 114.928 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.83 -48.92 6.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.073 0.949 . . . . 0.0 109.017 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -59.85 -46.85 87.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.536 1.534 . . . . 0.0 113.612 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.6 -24.22 58.84 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.042 -1.037 . . . . 0.0 113.098 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.09 -52.21 4.14 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.218 0.913 . . . . 0.0 112.996 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.54 -38.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.591 1.195 . . . . 0.0 111.515 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -62.24 -35.43 78.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 113.297 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -115.7 -32.48 5.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -82.05 -19.14 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.3 mt -127.67 -48.87 1.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.689 1.196 . . . . 0.0 112.068 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.64 -22.84 0.23 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.932 1.933 . . . . 0.0 117.932 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.68 130.44 10.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.51 1.655 . . . . 0.0 111.704 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -163.29 66.97 1.64 Allowed Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.881 1.272 . . . . 0.0 112.895 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.3 -23.18 66.04 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.937 2.425 . . . . 0.0 114.649 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -72.53 -5.48 37.29 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -76.52 133.79 39.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.199 1.0 . . . . 0.0 111.778 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.56 145.01 51.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.732 1.613 . . . . 0.0 110.617 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -162.35 -170.9 2.6 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 165.02 33.61 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.869 2.176 . . . . 0.0 110.727 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 t -142.07 136.94 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.125 0.963 . . . . 0.0 112.259 -170.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -123.15 116.66 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.05 149.32 32.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.339 1.056 . . . . 0.0 110.571 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -138.36 149.77 45.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.267 1.027 . . . . 0.0 111.672 -170.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.03 -143.57 7.75 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.083 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -141.3 126.08 18.05 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.209 1.404 . . . . 0.0 110.262 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -66.02 -12.88 58.29 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -68.61 0.01 4.66 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -125.25 12.73 8.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.46 1.504 . . . . 0.0 114.479 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.37 -44.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 127.9 2.48 . . . . 0.0 115.205 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -76.24 48.33 0.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.027 1.285 . . . . 0.0 111.764 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.18 116.84 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.302 -1.499 . . . . 0.0 112.303 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.1 m 51.05 24.35 1.86 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.851 2.06 . . . . 0.0 116.498 -172.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.33 -15.49 48.53 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.693 -1.254 . . . . 0.0 113.559 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.18 -67.93 1.81 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.7 -36.09 77.22 Favored Glycine 0 CA--C 1.536 1.401 0 O-C-N 121.557 -0.966 . . . . 0.0 114.258 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.27 -38.32 76.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.295 1.047 . . . . 0.0 113.652 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.92 -34.68 78.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.63 0.65 . . . . 0.0 112.189 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.67 -29.88 62.58 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.124 0.874 . . . . 0.0 112.78 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.3 -46.02 74.8 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.098 -1.626 . . . . 0.0 110.395 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -35.8 72.42 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -49.15 -44.16 42.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.936 1.294 . . . . 0.0 111.445 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 mt -80.52 -31.92 36.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.254 0.622 . . . . 0.0 111.69 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -65.77 -32.75 74.47 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.854 -1.154 . . . . 0.0 112.01 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -61.75 -26.18 67.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.885 0.766 . . . . 0.0 112.175 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -82.17 -27.1 32.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.598 -0.689 . . . . 0.0 112.471 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.9 m 101.61 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 130.161 3.384 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 156.97 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.54 1.136 . . . . 0.0 113.625 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -123.93 88.07 2.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.902 1.681 . . . . 0.0 110.318 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -63.04 140.3 58.86 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.32 -0.863 . . . . 0.0 111.401 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.43 33.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.303 1.441 . . . . 0.0 111.702 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.96 -160.64 34.16 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.895 -1.128 . . . . 0.0 113.607 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -125.06 148.27 48.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.617 1.567 . . . . 0.0 111.179 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.3 ttp -69.67 124.56 24.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 112.189 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.45 140.72 39.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.072 0.949 . . . . 0.0 110.188 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.41 89.74 3.01 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.091 1.356 . . . . 0.0 111.534 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -76.87 133.96 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.611 1.564 . . . . 0.0 110.857 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -127.12 98.64 5.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.219 1.009 . . . . 0.0 113.219 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -15.31 9.79 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.0 p -73.45 -13.91 61.15 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.904 1.229 . . . . 0.0 113.822 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.02 -8.26 1.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -135.34 110.58 10.62 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.225 1.01 . . . . 0.0 112.185 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.92 -2.45 12.43 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.017 3.144 . . . . 0.0 114.481 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -129.9 80.59 70.98 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.671 1.588 . . . . 0.0 111.877 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.83 -36.49 7.92 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.654 4.236 . . . . 0.0 116.057 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.36 -45.87 36.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.426 1.89 . . . . 0.0 112.954 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.0 p -68.76 -18.09 64.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.14 -9.31 20.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.944 0.897 . . . . 0.0 112.506 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 m -116.02 -33.02 5.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -58.15 -51.53 81.08 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.396 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.99 -28.7 57.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.625 1.55 . . . . 0.0 112.723 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -61.74 -49.8 74.96 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.616 0.644 . . . . 0.0 111.68 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 t -68.27 -40.78 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.868 0.758 . . . . 0.0 110.367 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.6 -30.09 70.46 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -76.44 -57.94 3.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.274 1.03 . . . . 0.0 112.222 170.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -51.82 -47.44 64.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.831 1.252 . . . . 0.0 111.427 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.48 11.66 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.659 1.6 . . . . 0.0 115.905 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.0 p -70.52 -15.58 62.8 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.888 1.844 . . . . 0.0 113.961 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.94 -15.85 18.98 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.395 1.478 . . . . 0.0 113.192 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.7 157.63 14.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.269 2.227 . . . . 0.0 111.757 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.885 1.274 . . . . 0.0 113.536 174.076 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.438 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.396 0.141 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.24 -177.53 4.56 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.14 1.776 . . . . 0.0 112.416 -170.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -118.36 122.65 43.37 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.509 1.524 . . . . 0.0 108.732 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 mm -120.41 122.91 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.144 0.978 . . . . 0.0 112.367 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.59 128.77 9.17 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 168.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.46 91.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.276 1.038 . . . . 0.0 108.937 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -93.02 148.21 22.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.549 1.139 . . . . 0.0 112.448 -169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.11 143.87 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.55 0.74 . . . . 0.0 111.006 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.47 108.37 0.64 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 172.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -150.51 165.92 31.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.256 1.022 . . . . 0.0 112.08 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -110.15 -19.58 12.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.512 1.125 . . . . 0.0 113.174 171.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -143.78 -13.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.69 11.02 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.02 -44.71 97.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.35 2.075 . . . . 0.0 112.986 -174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 p -75.95 -30.25 58.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.644 0.778 . . . . 0.0 112.803 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.14 -39.25 85.67 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.907 -1.121 . . . . 0.0 113.408 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.89 -45.43 71.09 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.659 0.663 . . . . 0.0 110.899 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.66 -34.46 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 112.104 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.37 94.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.351 0.978 . . . . 0.0 112.831 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.0 -41.69 98.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.584 0.754 . . . . 0.0 111.611 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.0 -48.07 83.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.294 0.638 . . . . 0.0 111.799 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.91 91.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 112.844 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -57.67 -46.86 83.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.748 0.419 . . . . 0.0 111.512 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.98 81.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.369 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -58.1 -45.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.745 1.218 . . . . 0.0 112.201 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 mt -73.08 -40.1 65.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.556 0.616 . . . . 0.0 110.25 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.5 m -56.71 -46.78 81.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.662 1.185 . . . . 0.0 111.808 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.63 80.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.135 0.974 . . . . 0.0 113.009 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.74 -34.38 77.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.121 0.968 . . . . 0.0 111.756 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.86 5.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.213 1.387 . . . . 0.0 114.652 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.36 150.62 38.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.636 1.174 . . . . 0.0 111.73 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -76.49 130.25 37.68 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.62 142.48 31.06 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.428 0.558 . . . . 0.0 111.913 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.0 m -141.0 115.63 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.971 0.908 . . . . 0.0 109.809 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.53 146.76 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.75 0.82 . . . . 0.0 111.895 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -135.18 96.13 3.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.781 . . . . 0.0 108.485 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -72.43 -27.48 62.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.309 1.444 . . . . 0.0 114.61 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -144.74 64.62 11.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.849 2.059 . . . . 0.0 108.524 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.44 162.02 43.65 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.363 3.376 . . . . 0.0 116.248 -168.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.93 163.7 29.67 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.058 2.543 . . . . 0.0 108.274 169.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.89 -45.01 15.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.955 -1.091 . . . . 0.0 112.568 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m -56.68 -20.1 19.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.18 -34.62 32.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.378 0.99 . . . . 0.0 112.313 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.5 ' CH2' HG21 ' A' ' 52' ' ' VAL . 14.3 t-105 -79.41 -32.29 42.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.596 1.558 . . . . 0.0 112.771 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 tp -39.87 -45.85 4.59 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 128.793 2.837 . . . . 0.0 116.167 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -77.58 -18.41 13.68 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.583 2.188 . . . . 0.0 115.354 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.88 -6.09 57.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -57.32 -23.8 51.0 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -102.47 13.81 33.59 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.132 1.373 . . . . 0.0 112.938 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -138.51 -131.55 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.652 1.981 . . . . 0.0 109.651 -169.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -135.31 151.51 50.61 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.237 1.015 . . . . 0.0 111.166 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.5 HG21 ' CH2' ' A' ' 44' ' ' TRP . 27.6 m -147.85 165.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.723 1.209 . . . . 0.0 111.012 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.65 149.72 24.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 109.563 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.14 143.23 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.205 0.602 . . . . 0.0 110.842 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.29 109.45 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.585 0.707 . . . . 0.0 110.298 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.4 m -138.17 144.53 40.77 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 m -95.96 -168.82 1.82 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.677 1.591 . . . . 0.0 112.587 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -128.5 149.71 50.48 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.88 1.272 . . . . 0.0 110.62 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.0 p -141.92 -171.59 3.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.798 2.439 . . . . 0.0 108.561 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.36 25.92 1.38 Allowed Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.229 1.871 . . . . 0.0 117.466 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 55.11 18.06 2.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.772 2.029 . . . . 0.0 114.295 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 158.52 36.2 0.02 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.633 1.111 . . . . 0.0 115.302 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -137.52 169.51 17.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.321 1.448 . . . . 0.0 112.971 -169.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.47 139.86 55.57 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 127.185 2.194 . . . . 0.0 111.808 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.72 141.38 49.52 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.135 2.556 . . . . 0.0 110.014 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.17 -30.18 64.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -169.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -61.49 -13.35 20.17 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -121.75 -7.65 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.145 1.338 . . . . 0.0 113.896 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -50.7 -48.47 82.85 Favored Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.62 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.5 5.27 2.46 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.11 2.54 . . . . 0.0 114.749 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.4 tp -107.55 -47.34 3.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.663 1.185 . . . . 0.0 109.795 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.43 -53.71 55.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.352 1.061 . . . . 0.0 112.016 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -63.91 -37.06 86.02 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.682 -0.636 . . . . 0.0 111.844 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.81 -46.23 76.66 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.712 0.672 . . . . 0.0 113.281 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.57 -42.01 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.666 1.233 . . . . 0.0 110.57 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.81 -51.28 65.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.683 0.793 . . . . 0.0 112.987 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.93 -25.17 24.52 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.5 m -125.15 -0.37 7.78 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -119.09 -52.52 2.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.521 1.055 . . . . 0.0 110.256 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.23 -23.8 0.2 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 118.135 2.014 . . . . 0.0 118.135 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -151.98 139.76 19.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.041 1.736 . . . . 0.0 110.064 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 50.79 0.54 Allowed Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -66.03 -18.9 57.62 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.249 2.633 . . . . 0.0 114.592 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.53 -17.21 58.15 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -76.8 138.16 39.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.42 1.088 . . . . 0.0 112.663 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -129.15 145.9 51.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.932 1.693 . . . . 0.0 110.792 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -159.3 -174.9 4.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -169.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.77 154.97 25.87 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 127.357 2.408 . . . . 0.0 110.299 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.77 128.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.771 1.286 . . . . 0.0 111.169 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -105.6 143.56 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.93 48.72 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.036 -1.04 . . . . 0.0 110.343 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.3 tt -139.57 153.37 47.4 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.19 0.995 . . . . 0.0 111.339 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.69 -140.82 6.04 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.206 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -143.38 129.28 19.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.257 1.023 . . . . 0.0 111.196 -173.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.8 m -62.59 -7.0 3.96 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 m -67.2 0.34 2.82 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.05 156.09 48.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.535 1.534 . . . . 0.0 112.421 -170.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.46 -39.52 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.032 0.933 . . . . 0.0 111.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -78.08 44.85 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.209 1.404 . . . . 0.0 112.785 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -52.36 116.56 2.31 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.313 -1.492 . . . . 0.0 112.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.1 m 51.18 24.67 2.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.72 2.408 . . . . 0.0 117.219 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.45 -28.5 69.32 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.536 -1.353 . . . . 0.0 113.794 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.55 -35.81 91.66 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 118.912 0.778 . . . . 0.0 113.39 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.08 -34.17 27.45 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.276 -1.132 . . . . 0.0 113.297 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.64 -37.74 82.51 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.581 1.191 . . . . 0.0 112.636 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -57.36 -45.6 84.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.319 0.648 . . . . 0.0 111.407 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.0 -34.74 77.1 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.265 0.939 . . . . 0.0 112.952 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.94 -44.21 97.25 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 111.778 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.91 69.39 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.5 tp -53.92 -20.71 6.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.374 1.469 . . . . 0.0 113.233 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 mt -107.08 -37.7 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.788 1.235 . . . . 0.0 111.22 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -30.5 71.16 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.189 0.904 . . . . 0.0 111.26 169.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -51.83 -30.79 24.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.617 1.567 . . . . 0.0 112.131 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -116.97 17.72 14.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.395 1.478 . . . . 0.0 113.014 -169.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.3 t 65.58 16.0 10.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.602 1.961 . . . . 0.0 115.292 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.06 49.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.239 -0.913 . . . . 0.0 111.982 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -109.96 110.39 21.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.008 0.923 . . . . 0.0 111.23 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -73.1 126.23 29.53 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.054 -1.029 . . . . 0.0 110.853 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -84.44 34.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.176 1.39 . . . . 0.0 111.906 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.3 -171.47 43.1 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.682 1.611 . . . . 0.0 112.468 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -114.66 158.93 21.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.636 1.575 . . . . 0.0 111.375 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.3 mtp -61.85 159.12 14.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -127.85 127.47 43.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.413 1.085 . . . . 0.0 108.632 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.12 94.44 4.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.247 1.019 . . . . 0.0 111.669 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.5 mt -81.01 141.24 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.058 1.743 . . . . 0.0 112.154 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -124.92 103.9 8.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.877 1.271 . . . . 0.0 113.062 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -18.96 47.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.195 1.398 . . . . 0.0 114.403 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.3 p -80.6 -5.63 57.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.581 1.082 . . . . 0.0 113.56 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.13 -24.89 2.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.131 1.372 . . . . 0.0 112.848 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.48 110.44 7.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.876 0.871 . . . . 0.0 113.27 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.65 -1.92 10.76 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.061 3.174 . . . . 0.0 114.159 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -131.41 70.1 81.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.204 1.802 . . . . 0.0 109.291 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.06 -16.5 39.76 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.841 3.694 . . . . 0.0 117.262 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -57.55 -32.34 67.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.988 -1.07 . . . . 0.0 113.217 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -66.18 -6.28 13.0 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -118.91 -0.52 11.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.52 -26.05 1.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.29 -54.31 46.39 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.485 1.039 . . . . 0.0 113.067 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.26 -31.77 34.8 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 121.256 1.484 . . . . 0.0 112.852 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -60.52 -49.51 77.28 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.397 0.679 . . . . 0.0 111.669 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.19 -36.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.715 -0.616 . . . . 0.0 110.451 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.71 -44.31 96.73 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.236 0.926 . . . . 0.0 112.753 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.46 -36.09 58.08 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.995 1.27 . . . . 0.0 113.361 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -57.35 -43.79 83.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.74 1.155 . . . . 0.0 110.437 170.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.76 -13.53 25.55 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.864 -1.52 . . . . 0.0 116.131 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.7 p -107.05 -11.98 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.612 2.206 . . . . 0.0 113.183 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.12 -30.75 31.0 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.22 1.008 . . . . 0.0 111.378 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.23 152.57 20.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.362 1.465 . . . . 0.0 112.566 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.167 2.187 . . . . 0.0 114.006 -179.552 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.11 -175.61 3.22 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.948 1.699 . . . . 0.0 112.084 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -135.28 119.05 17.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.976 1.311 . . . . 0.0 109.754 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mm -118.34 124.96 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.744 0.818 . . . . 0.0 112.825 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.18 126.4 7.82 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 168.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.7 mt -117.54 90.97 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.438 1.095 . . . . 0.0 108.411 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -91.3 144.19 25.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.004 -169.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.4 141.54 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.054 0.942 . . . . 0.0 110.54 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.94 91.22 0.21 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -142.88 164.16 30.85 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.559 1.144 . . . . 0.0 113.155 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.6 mmm -125.77 0.83 7.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.531 1.532 . . . . 0.0 112.888 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -140.25 -37.3 0.47 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.32 -5.52 10.16 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.975 1.15 . . . . 0.0 115.975 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -63.15 -42.83 99.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.528 1.164 . . . . 0.0 111.481 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -39.53 86.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.061 . . . . 0.0 112.515 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 tp -59.72 -39.23 83.97 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.8 tp -49.34 -41.69 39.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.991 0.917 . . . . 0.0 112.177 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.6 -39.93 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 123.249 0.619 . . . . 0.0 112.045 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -41.07 96.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.075 0.852 . . . . 0.0 112.434 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.92 -42.06 97.37 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.35 0.66 . . . . 0.0 112.273 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.49 -43.25 85.89 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.467 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.24 92.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.702 0.801 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.64 -47.84 78.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.368 0.667 . . . . 0.0 111.529 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.77 92.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.71 0.804 . . . . 0.0 112.62 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.58 -47.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.28 . . . . 0.0 112.187 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 mt -70.32 -41.34 73.39 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.242 0.617 . . . . 0.0 109.884 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -56.73 -46.02 81.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.1 1.36 . . . . 0.0 112.24 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.79 90.14 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.169 0.987 . . . . 0.0 112.87 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.59 -32.24 71.99 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.48 4.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.26 1.41 . . . . 0.0 114.983 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.95 146.72 35.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.149 1.379 . . . . 0.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -72.94 138.58 46.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.6 35.25 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.74 -0.6 . . . . 0.0 112.455 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.7 m -144.51 116.25 8.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.238 1.015 . . . . 0.0 110.656 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.47 140.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.106 0.562 . . . . 0.0 110.173 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.76 96.91 4.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.384 1.474 . . . . 0.0 107.899 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.4 -29.81 65.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.768 1.627 . . . . 0.0 114.265 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -146.31 64.53 9.79 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 126.862 2.065 . . . . 0.0 108.734 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.91 163.75 37.84 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.007 3.138 . . . . 0.0 115.727 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 160.67 36.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.339 2.256 . . . . 0.0 108.798 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -32.73 -54.04 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.765 2.026 . . . . 0.0 113.691 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -63.04 -21.63 66.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.493 1.517 . . . . 0.0 114.411 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.68 -36.14 62.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.222 0.919 . . . . 0.0 111.625 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.443 ' CH2' HG21 ' A' ' 52' ' ' VAL . 20.1 t-105 -79.46 -38.52 34.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 112.904 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.1 tp -38.39 -45.84 2.66 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 128.112 2.565 . . . . 0.0 116.784 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.64 -26.04 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 CA-C-N 122.543 1.944 . . . . 0.0 115.133 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -71.91 -8.8 56.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -56.49 -26.29 53.89 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.959 -1.088 . . . . 0.0 113.791 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.73 -8.05 57.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.324 1.449 . . . . 0.0 113.749 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -133.25 -128.61 0.17 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.958 2.103 . . . . 0.0 110.02 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -136.88 160.55 38.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.983 1.713 . . . . 0.0 111.277 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' CH2' ' A' ' 44' ' ' TRP . 33.6 m -144.08 170.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.878 1.271 . . . . 0.0 111.052 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -159.16 148.35 18.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.446 1.898 . . . . 0.0 108.174 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.34 142.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.684 -0.635 . . . . 0.0 112.048 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.6 116.2 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.097 0.959 . . . . 0.0 111.529 169.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.9 m -141.88 153.39 44.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 0.0 111.929 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 p -138.7 145.8 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -70.64 146.11 50.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.477 1.911 . . . . 0.0 114.654 -174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 p -146.13 -165.27 2.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.469 2.308 . . . . 0.0 111.375 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 42.76 -99.68 0.01 OUTLIER Glycine 0 CA--C 1.541 1.705 0 C-N-CA 127.545 2.498 . . . . 0.0 116.599 176.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -129.46 36.22 4.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.965 1.306 . . . . 0.0 110.111 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.24 20.96 7.94 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.066 0.841 . . . . 0.0 113.712 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.06 164.89 12.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.342 1.857 . . . . 0.0 115.169 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.59 139.74 96.15 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.734 2.013 . . . . 0.0 110.255 169.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.64 144.59 35.8 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.689 2.926 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.92 -22.39 64.31 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.5 p -63.3 -16.58 60.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.1 tt -124.89 -8.94 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.69 -48.12 77.44 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.8 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.12 5.89 1.65 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.24 2.626 . . . . 0.0 114.817 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.48 -44.98 3.44 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 110.324 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.73 -51.36 70.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.143 0.977 . . . . 0.0 111.679 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -62.87 -41.14 99.28 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 111.859 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -42.89 93.71 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.756 0.693 . . . . 0.0 113.772 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.31 -46.08 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -62.75 -40.77 98.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.54 -25.25 16.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -125.56 -31.47 2.98 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.84 -43.77 62.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.255 1.389 . . . . 0.0 109.391 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.49 -42.18 0.67 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 126.641 2.067 . . . . 0.0 116.679 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -155.14 143.26 20.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.116 1.767 . . . . 0.0 109.703 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -146.22 47.62 0.64 Allowed Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -60.86 -29.88 89.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.139 2.559 . . . . 0.0 113.799 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -65.87 -22.76 66.55 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.407 1.883 . . . . 0.0 114.615 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.8 tp -73.43 138.68 45.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.933 0.788 . . . . 0.0 111.574 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -134.8 132.74 39.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.493 1.917 . . . . 0.0 108.682 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -154.59 -171.56 3.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.59 164.18 30.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.974 1.75 . . . . 0.0 109.513 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 146.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.497 1.142 . . . . 0.0 113.533 -169.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.4 mt -129.83 141.66 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.82 1.648 . . . . 0.0 106.56 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.44 156.36 48.7 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -144.38 149.18 35.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 110.858 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.69 -151.0 9.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 123.654 0.645 . . . . 0.0 111.644 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -137.99 117.35 12.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.999 1.32 . . . . 0.0 109.876 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -59.62 -7.8 1.68 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.995 1.318 . . . . 0.0 114.505 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.0 m -61.32 -10.27 6.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.151 1.38 . . . . 0.0 114.157 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -127.21 137.02 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 111.426 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.57 -26.17 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -81.4 -18.49 45.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.316 0.962 . . . . 0.0 113.285 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.9 t80 38.93 -131.78 0.19 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.748 1.619 . . . . 0.0 112.451 -169.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.4 m -73.58 23.56 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -53.61 -30.42 42.5 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.142 -1.598 . . . . 0.0 114.495 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.1 -35.89 92.56 Favored Glycine 0 CA--C 1.533 1.156 0 O-C-N 121.125 -0.984 . . . . 0.0 113.111 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.32 -40.54 11.13 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.825 -0.809 . . . . 0.0 113.316 173.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.67 -31.9 69.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.67 1.235 . . . . 0.0 113.781 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -58.47 -39.53 80.21 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.16 -27.35 63.48 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.303 0.956 . . . . 0.0 113.33 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.64 -49.66 65.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.766 -1.209 . . . . 0.0 110.053 169.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.31 -40.45 71.15 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -49.89 -27.7 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.82 1.648 . . . . 0.0 113.644 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.6 mt -112.1 -36.67 5.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.609 1.163 . . . . 0.0 111.808 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.76 -31.24 71.75 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.169 -0.957 . . . . 0.0 113.209 170.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -66.25 -14.64 62.27 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 119.419 1.009 . . . . 0.0 112.528 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -111.81 16.84 20.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.641 1.976 . . . . 0.0 111.849 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t 61.97 20.41 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.332 1.853 . . . . 0.0 115.263 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.48 161.07 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.842 0.746 . . . . 0.0 112.972 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -112.09 162.71 15.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.769 1.628 . . . . 0.0 108.645 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mtm105 -133.88 149.05 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.85 21.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.986 172.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.85 -172.35 45.2 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.529 1.538 . . . . 0.0 113.598 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.68 156.26 44.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.282 1.433 . . . . 0.0 111.411 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.85 120.91 14.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.85 0.86 . . . . 0.0 112.098 -170.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.07 135.94 35.88 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.527 1.131 . . . . 0.0 110.074 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.58 96.03 4.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.704 1.202 . . . . 0.0 111.915 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.01 141.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.236 1.415 . . . . 0.0 111.137 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -129.49 116.73 19.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.907 1.283 . . . . 0.0 111.751 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.78 -26.87 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.618 1.167 . . . . 0.0 113.87 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.9 m -81.62 4.78 20.35 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.51 -30.18 2.36 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.371 1.468 . . . . 0.0 112.449 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -143.1 118.48 6.45 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 124.619 1.168 . . . . 0.0 112.278 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.32 -6.2 13.72 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.86 3.04 . . . . 0.0 114.498 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.98 80.58 64.58 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.529 1.532 . . . . 0.0 111.198 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.97 -35.04 9.65 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.712 4.275 . . . . 0.0 116.711 -175.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.67 -38.47 64.2 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.6 p -69.46 -6.14 28.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -116.38 -3.55 11.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.001 1.321 . . . . 0.0 112.554 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 p -132.95 -27.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -170.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -55.44 -54.09 54.92 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.254 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.5 -29.37 53.13 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.598 1.532 . . . . 0.0 112.756 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -62.49 -49.15 76.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.387 0.675 . . . . 0.0 111.442 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.89 -41.04 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.816 0.735 . . . . 0.0 110.506 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -59.03 -45.21 91.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.462 0.573 . . . . 0.0 111.541 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -61.96 -56.05 23.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.087 0.955 . . . . 0.0 112.138 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.38 -49.04 65.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.76 1.224 . . . . 0.0 111.172 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.96 -21.83 32.39 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.582 1.563 . . . . 0.0 116.165 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -70.53 -17.42 62.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.491 2.146 . . . . 0.0 113.737 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.47 -14.43 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.251 1.42 . . . . 0.0 113.578 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.2 157.67 18.79 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.412 1.885 . . . . 0.0 112.367 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.899 1.28 . . . . 0.0 113.651 177.437 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.0 -177.83 4.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.843 1.657 . . . . 0.0 112.277 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -135.14 119.37 17.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.618 1.567 . . . . 0.0 109.13 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.08 125.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.871 0.868 . . . . 0.0 113.267 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.6 128.6 8.97 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 mt -118.31 91.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.541 1.136 . . . . 0.0 108.519 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -90.93 139.1 31.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.274 1.029 . . . . 0.0 111.698 -169.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -125.47 144.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.713 0.768 . . . . 0.0 111.502 -169.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 105.88 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 t -155.9 161.45 40.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.385 1.474 . . . . 0.0 113.153 -173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.5 mmm -122.96 -9.28 8.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.438 1.495 . . . . 0.0 112.397 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -138.99 0.18 1.93 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.5 -4.39 83.95 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.117 1.607 . . . . 0.0 117.117 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -64.62 -42.87 95.21 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.475 1.637 . . . . 0.0 113.097 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 p -75.46 -33.9 60.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.085 0.954 . . . . 0.0 112.385 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 tp -58.43 -38.76 78.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.995 -1.065 . . . . 0.0 112.771 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -53.88 -45.68 71.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.759 0.709 . . . . 0.0 111.71 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.21 -36.9 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 111.545 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.41 92.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.261 0.937 . . . . 0.0 112.968 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.45 -41.76 97.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.356 0.662 . . . . 0.0 112.184 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.06 -41.72 97.25 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.648 -0.657 . . . . 0.0 112.562 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.528 -0.732 . . . . 0.0 112.061 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.81 -46.83 77.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.677 0.791 . . . . 0.0 111.825 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.48 95.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.742 0.817 . . . . 0.0 112.77 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.95 -43.19 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.547 1.139 . . . . 0.0 112.262 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.27 -38.71 75.15 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.21 -0.932 . . . . 0.0 109.614 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -57.64 -45.47 85.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.251 1.021 . . . . 0.0 111.516 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.14 83.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.991 0.916 . . . . 0.0 113.296 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -69.8 -10.48 58.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.29 41.43 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.574 1.559 . . . . 0.0 114.729 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -73.03 175.36 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.289 1.435 . . . . 0.0 111.894 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -111.62 145.51 39.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.812 1.245 . . . . 0.0 109.622 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 162.67 38.81 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.2 m -153.31 120.36 5.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.111 0.964 . . . . 0.0 110.948 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.3 141.16 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.906 0.882 . . . . 0.0 110.924 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -126.67 111.12 13.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.221 1.408 . . . . 0.0 109.789 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 -16.46 23.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.461 1.504 . . . . 0.0 114.945 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -142.43 55.9 4.82 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.22 1.408 . . . . 0.0 111.068 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.37 163.15 39.81 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.977 3.118 . . . . 0.0 113.517 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -143.34 -44.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.84 -44.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.273 1.029 . . . . 0.0 113.105 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 m -58.76 -28.79 66.24 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.923 0.868 . . . . 0.0 112.257 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -54.83 40.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.948 2.899 . . . . 0.0 112.461 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -68.62 -40.89 80.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.572 1.549 . . . . 0.0 113.748 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -37.97 -56.45 1.94 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.672 2.389 . . . . 0.0 115.28 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.54 -18.72 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.594 2.196 . . . . 0.0 114.867 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.58 -5.95 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -54.88 -30.58 58.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.343 0.974 . . . . 0.0 113.158 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -86.23 4.21 39.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.378 1.471 . . . . 0.0 113.492 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -136.33 -136.27 0.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.438 1.895 . . . . 0.0 110.997 -169.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -130.1 160.47 33.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 110.642 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.89 169.55 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.303 1.441 . . . . 0.0 110.367 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.55 147.46 18.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 109.932 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.38 131.14 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.197 1.399 . . . . 0.0 109.561 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.07 86.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.5 m -126.52 164.17 21.77 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -167.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -129.34 -172.33 2.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.748 1.219 . . . . 0.0 113.216 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 m -136.61 132.08 34.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.652 1.181 . . . . 0.0 110.519 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.5 t -158.71 -166.58 1.92 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.396 1.478 . . . . 0.0 110.33 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.01 -65.4 0.2 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.825 2.631 . . . . 0.0 116.474 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -147.42 22.22 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.034 2.134 . . . . 0.0 111.523 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.21 44.36 6.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 -169.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -139.53 -179.52 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.283 1.433 . . . . 0.0 114.475 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.5 mt -53.46 125.71 44.93 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 126.783 2.033 . . . . 0.0 112.681 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.51 142.72 98.3 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.681 3.587 . . . . 0.0 112.136 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.12 -20.14 65.76 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 p -66.07 -11.55 49.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.76 1.624 . . . . 0.0 114.959 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.3 tt -131.58 -13.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -44.81 -49.33 28.05 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.449 -1.263 . . . . 0.0 112.995 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.37 -24.96 42.54 Favored 'Trans proline' 0 C--N 1.353 0.769 0 CA-C-N 122.155 1.805 . . . . 0.0 113.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.3 tp -75.86 -43.03 47.68 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.835 0.743 . . . . 0.0 110.062 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.86 -46.48 90.42 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.294 1.038 . . . . 0.0 111.091 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -63.7 -43.27 97.12 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.712 -1.243 . . . . 0.0 112.543 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.48 -50.18 66.95 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.688 1.137 . . . . 0.0 112.74 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.02 -46.42 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.567 1.183 . . . . 0.0 110.265 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.07 -46.72 84.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.636 1.174 . . . . 0.0 112.751 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.09 -33.51 20.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -98.59 -30.97 12.18 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.94 -32.96 11.4 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.232 0.924 . . . . 0.0 113.279 -170.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.14 -51.77 1.0 Allowed Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.39 1.947 . . . . 0.0 117.007 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -159.86 140.96 12.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -156.19 104.94 2.06 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.5 1.52 . . . . 0.0 110.298 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.1 -15.45 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.307 2.671 . . . . 0.0 116.074 -169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -124.35 1.8 8.41 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.8 tp -69.49 137.56 52.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.562 0.745 . . . . 0.0 109.811 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -128.93 143.71 50.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.592 1.557 . . . . 0.0 110.748 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.33 -170.6 2.87 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -168.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.31 162.55 31.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 127.41 2.433 . . . . 0.0 109.914 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.7 t -139.87 136.82 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.061 0.934 . . . . 0.0 112.238 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.8 mt -123.18 125.08 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.2 148.98 42.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.717 1.207 . . . . 0.0 109.598 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.07 146.42 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 111.687 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.44 -137.45 3.95 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.018 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 131.99 28.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.726 0.811 . . . . 0.0 112.091 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.4 t -64.44 -10.86 27.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.921 1.689 . . . . 0.0 114.869 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -69.41 5.4 1.35 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -131.69 154.77 48.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.664 1.585 . . . . 0.0 112.833 -171.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.65 -6.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.789 1.636 . . . . 0.0 114.835 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -125.86 44.8 2.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.731 2.012 . . . . 0.0 110.945 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -49.48 115.29 1.28 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.095 -1.628 . . . . 0.0 112.17 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.9 m 53.33 23.39 3.25 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -58.23 -27.24 63.77 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.82 63.59 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.62 -1.3 . . . . 0.0 111.912 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.66 70.7 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.43 -1.041 . . . . 0.0 113.127 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.38 -41.96 90.56 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 117.821 0.81 . . . . 0.0 112.858 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.04 -41.39 92.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.184 0.447 . . . . 0.0 112.147 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -69.5 -28.49 66.1 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.67 -46.06 66.95 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 119.807 -1.808 . . . . 0.0 110.807 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.88 68.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.7 tp -49.66 -31.07 10.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.019 1.728 . . . . 0.0 113.124 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.1 -36.97 8.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.561 1.144 . . . . 0.0 111.399 -171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -66.27 -31.16 71.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.53 -0.731 . . . . 0.0 112.826 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.65 -15.97 63.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.374 1.07 . . . . 0.0 112.942 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -113.26 -9.67 13.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.9 t 98.75 15.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.229 2.611 . . . . 0.0 113.922 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.83 161.17 8.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.222 0.465 . . . . 0.0 110.716 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.61 100.14 5.42 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.838 -1.164 . . . . 0.0 110.566 -171.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttm105 -66.93 135.7 54.23 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.407 -0.808 . . . . 0.0 110.83 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.08 34.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 111.318 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.51 -166.61 39.83 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.776 -1.202 . . . . 0.0 113.75 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.19 145.61 42.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.448 1.499 . . . . 0.0 111.974 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.16 118.08 10.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.149 0.979 . . . . 0.0 111.705 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.79 136.06 38.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.939 0.896 . . . . 0.0 109.881 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.6 mt -120.65 95.85 4.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.774 1.229 . . . . 0.0 111.775 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mt -81.4 134.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.242 1.417 . . . . 0.0 111.226 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -123.94 112.29 17.05 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.389 1.475 . . . . 0.0 111.477 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.94 -23.7 54.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.0 m -82.83 2.11 35.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.446 1.098 . . . . 0.0 113.893 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.11 -27.29 3.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.417 1.487 . . . . 0.0 112.664 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.94 115.28 6.59 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.582 1.153 . . . . 0.0 112.097 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.81 -5.29 14.59 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.682 2.921 . . . . 0.0 114.413 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -131.51 80.64 66.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.611 1.564 . . . . 0.0 111.283 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -43.68 -37.58 8.5 Favored 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 125.668 4.246 . . . . 0.0 116.056 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -45.97 -44.22 14.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.441 1.896 . . . . 0.0 113.214 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.6 p -71.25 -10.01 59.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -116.45 4.34 13.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.001 1.32 . . . . 0.0 112.423 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 p -132.31 -27.51 1.77 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -61.37 -53.68 60.08 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 119.766 1.166 . . . . 0.0 112.9 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.1 -35.6 95.15 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.565 2.177 . . . . 0.0 114.032 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -60.72 -48.03 83.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.647 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.37 -40.08 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.959 0.8 . . . . 0.0 110.774 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.36 -43.56 88.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.662 0.665 . . . . 0.0 111.311 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.24 -55.73 16.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.773 1.229 . . . . 0.0 112.393 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -53.31 -46.9 69.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.034 0.934 . . . . 0.0 111.348 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.81 -27.18 6.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.406 1.955 . . . . 0.0 116.361 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -71.94 -19.32 61.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.995 1.897 . . . . 0.0 113.824 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 -14.7 26.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.436 1.494 . . . . 0.0 113.255 -171.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.05 160.85 17.18 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.897 2.079 . . . . 0.0 112.354 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.251 1.02 . . . . 0.0 112.895 169.867 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.69 171.32 14.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -135.31 117.46 15.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.005 1.722 . . . . 0.0 108.527 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mm -118.9 121.4 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.007 0.821 . . . . 0.0 113.143 -172.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.87 127.41 8.27 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.18 91.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.471 1.135 . . . . 0.0 108.512 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -93.81 136.03 34.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.084 0.954 . . . . 0.0 110.948 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.73 145.26 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.611 0.764 . . . . 0.0 111.52 -169.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.6 90.24 0.22 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 125.034 1.302 . . . . 0.0 110.645 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -140.96 178.37 7.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -169.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -147.98 -21.71 0.35 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.812 2.045 . . . . 0.0 112.754 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.52 -2.49 7.94 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.91 1.21 73.55 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -64.07 -44.95 90.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.849 1.324 . . . . 0.0 112.376 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -73.64 -33.23 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.241 1.416 . . . . 0.0 112.561 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.92 -38.91 80.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.879 -1.138 . . . . 0.0 112.977 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.6 -45.08 73.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.83 0.741 . . . . 0.0 111.734 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -63.82 -36.91 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 111.594 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.73 -43.11 97.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.121 0.873 . . . . 0.0 112.623 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.26 -42.89 99.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.495 0.718 . . . . 0.0 112.578 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -62.72 -40.88 98.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.554 -0.716 . . . . 0.0 112.672 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.19 82.49 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.735 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.57 -46.02 73.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.405 0.682 . . . . 0.0 111.483 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.83 83.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.552 0.741 . . . . 0.0 112.785 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -59.33 -45.14 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.702 1.201 . . . . 0.0 112.068 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.0 mt -70.7 -41.57 71.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.636 -0.665 . . . . 0.0 109.664 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -56.93 -44.19 82.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.25 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -37.67 82.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.011 0.924 . . . . 0.0 113.016 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.522 0.729 . . . . 0.0 112.501 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.16 -9.72 7.86 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.013 1.768 . . . . 0.0 114.445 169.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -72.7 147.54 45.57 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.371 1.069 . . . . 0.0 111.734 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -72.13 140.44 48.85 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.75 159.71 42.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.282 0.633 . . . . 0.0 112.16 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.3 m -153.49 118.43 5.07 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.249 -0.907 . . . . 0.0 111.425 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -74.12 141.31 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.923 0.889 . . . . 0.0 111.014 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -128.88 109.21 11.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.835 1.254 . . . . 0.0 109.635 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.26 -19.36 34.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.614 1.565 . . . . 0.0 114.823 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.2 58.99 5.58 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.922 1.689 . . . . 0.0 109.835 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.1 159.54 53.47 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.115 3.21 . . . . 0.0 115.474 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -138.1 167.33 22.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.193 2.197 . . . . 0.0 109.411 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.41 -45.54 18.05 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.714 1.206 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -59.27 -18.51 38.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -80.27 -34.4 37.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.608 1.095 . . . . 0.0 112.334 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CH2' HG21 ' A' ' 52' ' ' VAL . 33.9 t-105 -77.22 -35.98 55.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 112.781 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -41.45 -45.85 7.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 128.609 2.764 . . . . 0.0 115.944 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.68 -26.44 5.71 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.668 2.246 . . . . 0.0 114.527 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -82.76 -13.79 55.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -59.17 -26.35 64.71 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.41 7.2 26.72 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -134.08 -117.31 0.19 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.213 1.805 . . . . 0.0 110.682 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.89 154.7 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.41 1.084 . . . . 0.0 111.151 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 44' ' ' TRP . 23.2 m -149.23 169.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 110.988 -173.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.33 146.95 17.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.097 0.959 . . . . 0.0 110.358 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.11 133.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.17 1.388 . . . . 0.0 110.139 -169.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.38 89.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 107.717 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.2 m -131.48 164.83 24.89 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -167.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -136.68 -173.09 3.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.616 1.566 . . . . 0.0 112.793 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.5 m -129.71 146.44 51.48 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.136 0.974 . . . . 0.0 111.201 -171.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.6 t -149.96 -169.62 3.43 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.183 2.593 . . . . 0.0 108.765 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.02 35.37 13.22 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.784 1.659 . . . . 0.0 116.141 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.442 ' H ' HM73 ' A' ' 201' ' ' FMN . 18.2 tp60 67.89 6.77 5.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.072 2.149 . . . . 0.0 114.911 -176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 158.07 18.21 0.03 OUTLIER Glycine 0 CA--C 1.534 1.235 0 N-CA-C 119.368 2.507 . . . . 0.0 119.368 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 159.31 34.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.579 2.19 . . . . 0.0 112.443 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.95 150.63 87.6 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.275 -0.891 . . . . 0.0 112.935 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 162.61 19.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.87 3.047 . . . . 0.0 112.592 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.16 -17.85 64.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -171.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.5 p -60.3 -18.72 51.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.0 -9.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -45.65 -48.35 37.89 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.489 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.11 -23.3 33.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 122.199 1.821 . . . . 0.0 113.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 tp -76.03 -48.67 20.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 110.097 173.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.35 -49.58 76.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.825 1.65 . . . . 0.0 111.942 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -64.56 -45.13 88.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.235 -0.916 . . . . 0.0 111.851 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.89 -43.53 97.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.254 0.931 . . . . 0.0 114.278 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.72 -46.96 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.413 1.107 . . . . 0.0 110.402 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.69 -48.02 82.68 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.856 -0.527 . . . . 0.0 111.807 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.13 -41.26 61.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.084 1.353 . . . . 0.0 114.378 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -122.29 5.06 9.71 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -168.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -122.34 -49.65 2.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.54 1.064 . . . . 0.0 110.137 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -31.35 0.29 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.696 2.093 . . . . 0.0 117.984 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -154.71 138.77 16.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.197 1.499 . . . . 0.0 112.36 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -158.18 118.24 1.88 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.225 1.41 . . . . 0.0 110.926 169.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -87.45 -30.74 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.181 2.587 . . . . 0.0 115.806 -171.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -100.39 1.58 41.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.01 135.9 41.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.387 1.075 . . . . 0.0 111.388 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -123.64 143.38 50.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.009 1.723 . . . . 0.0 111.04 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.17 -173.84 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 162.48 32.04 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.151 2.31 . . . . 0.0 110.676 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.87 130.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.916 0.865 . . . . 0.0 111.701 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 mt -119.07 125.58 74.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 169.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.29 149.95 40.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.79 0.836 . . . . 0.0 109.728 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -140.36 138.81 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.645 0.778 . . . . 0.0 110.933 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.31 -131.12 1.63 Allowed Glycine 0 CA--C 1.521 0.463 0 O-C-N 122.253 -0.279 . . . . 0.0 113.533 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -141.07 119.48 12.25 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 111.149 -172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -64.16 -6.08 6.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.0 m -65.31 0.08 1.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -134.93 154.58 51.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.722 1.609 . . . . 0.0 112.33 -173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.803 0.841 . . . . 0.0 111.948 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.75 40.7 0.53 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.773 1.229 . . . . 0.0 112.557 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -51.16 115.06 1.38 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.393 -1.442 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m 50.85 26.07 2.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.02 -30.3 69.07 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.497 -1.377 . . . . 0.0 113.117 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -37.62 94.34 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.678 0.672 . . . . 0.0 113.527 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.82 56.29 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.136 -1.214 . . . . 0.0 112.642 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.83 -36.79 82.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.051 0.94 . . . . 0.0 113.032 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.67 -38.16 74.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.141 0.976 . . . . 0.0 112.373 170.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -78.37 -35.54 47.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.677 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.19 -41.06 96.14 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 119.676 -1.89 . . . . 0.0 111.822 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.45 79.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.07 -46.46 68.59 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.454 1.024 . . . . 0.0 111.34 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.4 mt -76.31 -37.23 57.73 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.124 0.969 . . . . 0.0 112.331 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.7 -32.48 74.06 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.471 -0.768 . . . . 0.0 112.333 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.84 -25.48 65.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.701 0.682 . . . . 0.0 111.8 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -76.49 -32.26 58.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.458 1.026 . . . . 0.0 111.477 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m 99.64 15.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.305 3.042 . . . . 0.0 112.198 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.71 162.54 6.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.229 0.612 . . . . 0.0 111.267 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -131.61 104.8 7.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.175 0.99 . . . . 0.0 110.602 -169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -69.63 134.67 49.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.279 -0.888 . . . . 0.0 111.439 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.48 31.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.615 1.566 . . . . 0.0 112.104 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.25 -165.32 38.7 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.954 -1.091 . . . . 0.0 114.37 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.63 151.6 38.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.785 1.634 . . . . 0.0 110.991 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 29.8 ttm -69.3 132.5 46.54 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.64 0.776 . . . . 0.0 112.01 -170.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.9 tm? -87.97 134.11 33.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.356 0.662 . . . . 0.0 109.474 171.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' N ' HD13 ' A' ' 123' ' ' LEU . 70.1 mt -121.36 93.47 4.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.921 1.288 . . . . 0.0 111.675 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 51.0 mt -75.55 136.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.383 1.473 . . . . 0.0 110.524 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -129.18 110.23 11.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.32 1.048 . . . . 0.0 112.458 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.2 -25.16 58.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.6 m -82.95 4.95 23.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 113.689 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -133.39 -29.98 1.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.132 1.373 . . . . 0.0 113.014 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -142.94 116.84 6.24 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.537 1.135 . . . . 0.0 112.393 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.68 -3.71 11.94 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.103 3.202 . . . . 0.0 114.75 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.34 86.1 58.8 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.528 1.531 . . . . 0.0 110.49 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.28 -26.85 71.78 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.952 2.434 . . . . 0.0 114.383 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.2 -39.14 93.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -12.42 56.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.265 -0.897 . . . . 0.0 112.718 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.06 -0.68 14.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.267 1.827 . . . . 0.0 111.751 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 p -135.2 -24.24 1.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.52 1.128 . . . . 0.0 113.955 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -62.66 -52.82 62.05 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -57.85 -34.58 98.48 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.652 2.234 . . . . 0.0 113.932 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -59.94 -48.6 81.06 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.157 0.583 . . . . 0.0 111.261 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.08 -39.33 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.096 0.862 . . . . 0.0 110.891 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.64 -46.37 90.58 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.661 1.119 . . . . 0.0 111.923 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -63.28 -51.06 67.66 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.024 0.93 . . . . 0.0 112.352 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -58.23 -54.79 42.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.869 0.867 . . . . 0.0 110.623 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.26 -29.66 53.22 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.254 1.883 . . . . 0.0 114.767 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 94.2 m -59.2 -23.18 62.06 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.292 1.037 . . . . 0.0 113.238 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.92 -15.67 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.346 1.458 . . . . 0.0 114.689 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -30.78 70.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.545 1.138 . . . . 0.0 114.044 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.773 2.029 . . . . 0.0 111.685 175.8 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.442 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.86 169.37 15.84 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.558 1.543 . . . . 0.0 112.292 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.13 121.0 33.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.402 1.481 . . . . 0.0 109.383 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mm -113.05 121.51 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.106 0.962 . . . . 0.0 112.036 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 126.38 7.48 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.4 mt -118.56 108.72 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 108.876 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.07 109.71 21.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.751 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -87.48 147.34 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.774 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.93 114.55 1.21 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -160.9 175.76 12.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.596 1.558 . . . . 0.0 111.309 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ptp -132.61 4.17 3.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -146.71 -54.13 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.656 1.182 . . . . 0.0 112.887 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.35 7.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 118.097 1.999 . . . . 0.0 118.097 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -63.85 -40.02 95.6 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.515 2.158 . . . . 0.0 112.743 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 91.7 p -79.69 -33.97 40.6 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.881 0.872 . . . . 0.0 112.502 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 tp -56.49 -38.49 71.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.054 -1.029 . . . . 0.0 112.719 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.61 -42.91 75.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.698 0.799 . . . . 0.0 111.682 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.41 -37.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 111.651 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -57.86 -44.25 86.46 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.935 0.789 . . . . 0.0 112.493 173.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.74 -43.36 99.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.073 0.949 . . . . 0.0 112.168 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.41 -48.2 81.46 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.598 -0.688 . . . . 0.0 112.395 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.48 89.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.627 0.771 . . . . 0.0 112.334 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.6 -44.97 85.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.525 0.73 . . . . 0.0 111.792 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -44.99 88.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.716 0.806 . . . . 0.0 112.674 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.5 mt -61.07 -45.61 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.841 1.256 . . . . 0.0 112.216 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.28 -43.23 82.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.374 0.67 . . . . 0.0 109.377 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.7 m -55.24 -47.52 75.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.631 1.173 . . . . 0.0 112.055 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.67 85.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.086 0.955 . . . . 0.0 113.451 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -72.92 -11.14 60.47 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -4.41 42.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.343 1.449 . . . . 0.0 114.524 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -72.86 178.35 4.29 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.16 1.384 . . . . 0.0 111.862 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -118.19 145.26 45.09 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.957 1.703 . . . . 0.0 109.519 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.55 155.03 41.45 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.444 -0.785 . . . . 0.0 112.623 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.3 m -143.42 100.65 3.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.019 0.927 . . . . 0.0 111.042 -172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.48 137.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.154 0.982 . . . . 0.0 111.21 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -126.0 111.1 14.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.853 1.661 . . . . 0.0 109.271 170.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.28 -20.91 43.34 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -146.45 60.07 5.81 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 126.249 1.82 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.48 160.34 49.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.274 2.649 . . . . 0.0 114.651 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -135.89 164.07 28.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.341 2.256 . . . . 0.0 108.899 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -39.08 -48.01 1.61 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.497 1.519 . . . . 0.0 113.572 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 p -58.82 -18.12 29.63 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.07 -31.8 25.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.331 1.052 . . . . 0.0 112.541 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.518 ' CH2' HG21 ' A' ' 52' ' ' VAL . 23.6 t-105 -81.51 -36.87 28.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.349 1.06 . . . . 0.0 112.641 174.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -36.63 -52.28 1.89 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.456 2.302 . . . . 0.0 114.638 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.98 6.07 5.53 Favored 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 123.09 2.527 . . . . 0.0 116.029 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -107.31 2.81 24.8 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.246 1.384 . . . . 0.0 114.64 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -58.59 -25.88 63.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -99.19 9.42 43.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.681 1.592 . . . . 0.0 113.621 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -135.33 -160.68 1.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.694 2.398 . . . . 0.0 110.326 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -111.54 159.01 18.52 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.21 1.005 . . . . 0.0 111.85 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.518 HG21 ' CH2' ' A' ' 44' ' ' TRP . 28.4 m -148.51 173.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.409 1.484 . . . . 0.0 111.537 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.51 142.44 15.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.591 1.156 . . . . 0.0 111.379 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.42 130.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.191 1.797 . . . . 0.0 109.609 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 19' ' ' ALA . 11.4 p -140.34 89.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 122.091 0.948 . . . . 0.0 109.504 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.7 m -133.83 133.71 41.94 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -167.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 m -78.84 -166.97 0.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.935 1.694 . . . . 0.0 112.722 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -131.39 152.91 50.21 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.688 -1.257 . . . . 0.0 111.286 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 p -142.96 -167.07 2.44 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.593 2.357 . . . . 0.0 109.198 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 37.89 40.25 0.75 Allowed Glycine 0 CA--C 1.542 1.746 0 C-N-CA 127.05 2.262 . . . . 0.0 118.466 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 58.16 20.18 6.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 114.519 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.13 36.13 0.09 OUTLIER Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -126.51 169.72 12.76 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.509 1.654 . . . . 0.0 114.691 -169.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 mt -60.72 126.29 84.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.707 2.403 . . . . 0.0 112.008 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.16 142.65 97.27 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.502 2.801 . . . . 0.0 111.335 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.62 -29.26 69.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 m -67.21 -9.55 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -118.18 -7.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.768 1.167 . . . . 0.0 113.243 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.9 t -54.63 -45.82 99.43 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.144 -1.407 . . . . 0.0 112.342 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -55.88 -11.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.216 3.277 . . . . 0.0 116.549 169.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 tp -105.3 -44.22 4.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.405 1.082 . . . . 0.0 110.403 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -58.3 -49.22 77.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 111.47 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -62.4 -42.69 99.62 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.539 -0.726 . . . . 0.0 112.332 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.27 -40.27 70.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.248 0.928 . . . . 0.0 113.585 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.63 -45.61 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.463 1.131 . . . . 0.0 110.063 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.27 -47.21 86.23 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.487 0.715 . . . . 0.0 112.376 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -79.02 -38.2 37.2 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 m -126.06 -10.06 6.53 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -168.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 -33.28 16.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.15 1.795 . . . . 0.0 112.279 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 -55.32 1.53 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.288 1.899 . . . . 0.0 116.802 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -151.76 149.55 29.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.03 1.732 . . . . 0.0 111.383 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -148.76 38.53 0.19 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.82 -33.52 14.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.815 2.344 . . . . 0.0 115.656 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -68.67 -0.37 5.16 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.545 2.338 . . . . 0.0 116.284 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.19 142.75 49.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.961 1.304 . . . . 0.0 112.251 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.7 145.26 51.54 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.054 2.142 . . . . 0.0 110.451 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.48 -169.09 2.33 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.75 167.36 31.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.015 2.245 . . . . 0.0 110.116 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.19 126.69 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 118.391 1.095 . . . . 0.0 112.978 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -114.0 109.86 30.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 168.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.39 142.51 32.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.416 0.686 . . . . 0.0 109.27 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.1 154.6 47.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.112 0.958 . . . . 0.0 110.716 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.7 -129.12 1.86 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.922 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.44 128.13 14.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.547 1.139 . . . . 0.0 111.165 -173.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.5 p -72.5 -1.6 16.49 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 m -67.74 4.13 1.22 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.42 156.26 47.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.147 1.779 . . . . 0.0 111.557 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.49 -37.33 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.732 0.813 . . . . 0.0 111.843 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.63 44.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 112.966 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -53.1 113.63 1.18 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.673 -1.267 . . . . 0.0 111.846 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.7 m 50.21 27.7 2.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.122 2.569 . . . . 0.0 116.312 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -58.85 -28.62 66.25 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.896 -1.128 . . . . 0.0 113.498 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.16 -33.49 64.91 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.771 0.7 . . . . 0.0 113.803 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.1 -36.78 9.67 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 117.908 0.854 . . . . 0.0 113.47 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -59.21 -36.79 76.03 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.828 1.314 . . . . 0.0 113.113 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -54.84 -45.74 74.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.927 0.891 . . . . 0.0 111.424 170.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.63 -27.56 62.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.461 -0.775 . . . . 0.0 112.949 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.5 -44.0 75.65 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.674 -1.891 . . . . 0.0 110.781 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.94 77.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.728 0.811 . . . . 0.0 112.979 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.3 tp -51.12 -32.43 22.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 112.847 171.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -97.95 -39.08 9.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.898 1.279 . . . . 0.0 111.857 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -69.17 -33.47 73.44 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.2 -0.938 . . . . 0.0 113.162 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.95 -12.99 56.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.769 0.828 . . . . 0.0 112.296 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.48 10.86 18.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.015 1.726 . . . . 0.0 112.459 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m 69.51 17.86 7.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 171.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.99 165.82 3.08 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.441 -0.787 . . . . 0.0 110.853 169.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -128.03 94.51 3.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.665 -1.272 . . . . 0.0 112.419 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -66.52 132.75 48.92 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.926 -1.109 . . . . 0.0 111.133 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.93 36.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.749 1.62 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.67 40.79 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.676 -1.265 . . . . 0.0 114.331 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.89 153.12 27.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.792 1.637 . . . . 0.0 111.366 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 30.3 ttm -71.07 138.08 49.47 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -94.95 135.44 36.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.92 0.888 . . . . 0.0 109.027 172.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.453 ' N ' HD13 ' A' ' 123' ' ' LEU . 55.8 mt -120.75 93.85 4.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.522 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.14 136.58 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.933 0.893 . . . . 0.0 111.199 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -125.3 100.32 6.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 112.488 -171.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.56 -17.32 13.43 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 114.451 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 p -72.17 -15.0 61.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.542 1.064 . . . . 0.0 113.769 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.61 -10.15 1.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -134.7 103.29 11.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.483 1.038 . . . . 0.0 112.418 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.38 1.47 9.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.046 3.164 . . . . 0.0 114.474 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -131.19 74.86 78.81 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.801 1.64 . . . . 0.0 111.022 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.56 -29.01 13.1 Favored 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 125.442 4.094 . . . . 0.0 117.148 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.4 -39.36 67.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.8 p -68.42 -5.88 21.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.698 1.199 . . . . 0.0 113.443 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -113.94 -7.73 13.14 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.691 1.597 . . . . 0.0 112.077 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.5 p -134.66 -25.43 1.46 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.14 -53.44 58.71 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 119.708 1.14 . . . . 0.0 113.723 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.09 -27.96 29.04 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.538 1.492 . . . . 0.0 112.865 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -63.13 -48.8 76.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.493 0.717 . . . . 0.0 111.608 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.49 -39.52 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.43 0.559 . . . . 0.0 110.198 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -59.21 -44.49 92.27 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.603 0.638 . . . . 0.0 111.644 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.61 -57.01 12.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -53.51 -46.38 70.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.054 0.942 . . . . 0.0 111.238 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.84 -24.81 14.39 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.361 1.934 . . . . 0.0 116.447 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.0 p -70.87 -19.72 62.6 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.118 1.959 . . . . 0.0 113.938 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.4 mt -93.08 -15.27 26.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.482 1.513 . . . . 0.0 113.066 -171.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 162.85 14.83 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.526 1.93 . . . . 0.0 112.458 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.665 1.186 . . . . 0.0 113.387 173.252 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.27 -176.63 3.41 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.119 1.767 . . . . 0.0 112.906 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -136.52 116.18 12.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.513 1.525 . . . . 0.0 109.26 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.21 128.75 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.526 1.131 . . . . 0.0 113.11 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.15 130.21 10.22 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -120.8 101.57 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.541 1.17 . . . . 0.0 108.323 -170.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -100.77 118.01 36.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.946 0.899 . . . . 0.0 112.667 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.1 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.864 1.266 . . . . 0.0 110.985 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.35 98.95 0.27 Allowed Glycine 0 N--CA 1.47 0.927 0 C-N-CA 124.355 0.978 . . . . 0.0 110.929 171.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -154.31 166.89 31.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.18 0.992 . . . . 0.0 113.551 -171.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.0 mmm -123.81 -3.28 8.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 113.043 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.29 -58.99 0.54 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.36 -4.79 0.23 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -61.72 -44.44 96.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.285 1.542 . . . . 0.0 113.251 -173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.9 p -77.62 -31.9 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.652 0.781 . . . . 0.0 112.369 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -57.58 -41.87 82.02 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.903 -1.123 . . . . 0.0 112.414 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.91 -43.56 77.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.722 0.692 . . . . 0.0 111.679 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -39.08 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.116 0.566 . . . . 0.0 111.823 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.36 -45.13 95.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.831 0.852 . . . . 0.0 111.963 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.38 -44.2 95.87 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.627 0.771 . . . . 0.0 112.58 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.36 89.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.527 0.731 . . . . 0.0 112.11 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -56.35 -46.78 79.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.938 0.495 . . . . 0.0 111.199 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.09 85.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.839 0.856 . . . . 0.0 113.029 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.73 -46.16 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.418 1.087 . . . . 0.0 111.789 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 mt -70.07 -41.01 74.69 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.82 -0.55 . . . . 0.0 109.996 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.8 m -56.2 -46.12 79.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 112.21 169.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.38 83.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.203 1.001 . . . . 0.0 112.929 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.4 -9.75 58.92 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.307 1.043 . . . . 0.0 113.311 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -11.06 48.87 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.792 1.663 . . . . 0.0 114.587 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -70.26 140.29 52.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.015 0.926 . . . . 0.0 110.655 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -67.94 134.35 50.63 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.01 141.61 30.23 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.208 0.458 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -139.42 115.88 10.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.035 0.934 . . . . 0.0 110.026 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.59 147.27 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.699 0.8 . . . . 0.0 111.921 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.07 103.53 5.83 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.359 1.863 . . . . 0.0 107.651 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.58 -27.9 60.69 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -144.95 64.21 10.97 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.379 1.872 . . . . 0.0 109.009 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.8 160.72 40.36 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.67 2.913 . . . . 0.0 115.188 -168.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 173.51 11.6 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.302 1.841 . . . . 0.0 109.76 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -40.82 -50.74 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.098 1.359 . . . . 0.0 113.182 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 m -62.01 -18.01 59.12 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -81.64 -35.51 29.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.377 0.99 . . . . 0.0 112.122 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.45 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 17.4 t-105 -77.73 -35.42 51.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -40.95 -44.76 5.58 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 127.64 2.376 . . . . 0.0 115.938 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.95 -31.87 23.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.177 2.585 . . . . 0.0 115.471 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -82.08 -4.92 57.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.96 -23.51 46.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -97.27 8.48 44.47 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.646 1.578 . . . . 0.0 112.84 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -132.15 -135.09 0.19 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.741 2.416 . . . . 0.0 109.123 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -133.93 161.35 35.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.605 1.562 . . . . 0.0 109.775 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 18.8 m -148.36 167.31 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.574 1.15 . . . . 0.0 111.204 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.29 139.19 14.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.318 1.056 . . . . 0.0 110.991 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -105.27 132.22 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.0 1.72 . . . . 0.0 109.685 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 19' ' ' ALA . 3.1 p -139.83 88.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 122.753 1.264 . . . . 0.0 108.062 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.6 m -129.95 163.88 25.44 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.712 1.205 . . . . 0.0 113.027 -167.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.2 p -128.07 -173.23 2.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.335 1.454 . . . . 0.0 112.782 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -134.77 132.55 38.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.674 1.189 . . . . 0.0 110.081 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.4 t -158.86 -166.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.183 1.393 . . . . 0.0 110.098 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.59 -64.77 0.11 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.104 2.764 . . . . 0.0 116.378 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.6 21.67 1.03 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.073 2.149 . . . . 0.0 111.842 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.83 43.91 6.6 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -138.88 -178.79 5.48 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.937 1.695 . . . . 0.0 114.029 -168.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.71 130.89 78.06 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.301 1.84 . . . . 0.0 113.012 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -60.8 140.41 90.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.249 3.299 . . . . 0.0 111.118 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.21 -26.88 66.72 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.406 -0.809 . . . . 0.0 113.144 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -64.41 -8.95 15.17 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 tt -125.99 -9.26 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.22 -46.9 83.23 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 117.146 -1.407 . . . . 0.0 112.751 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.83 3.91 2.98 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.148 2.566 . . . . 0.0 114.557 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -109.03 -43.08 4.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.863 1.265 . . . . 0.0 110.656 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -59.92 -48.66 80.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.782 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -63.52 -38.16 90.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.287 -0.883 . . . . 0.0 112.622 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.45 -43.32 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.462 1.03 . . . . 0.0 113.093 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.0 mt -62.28 -46.42 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 118.543 1.171 . . . . 0.0 110.106 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -50.2 74.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.699 1.2 . . . . 0.0 112.6 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -77.76 -40.26 41.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -87.62 -45.8 10.1 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.58 -44.53 18.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.074 0.852 . . . . 0.0 113.149 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.18 -43.68 0.54 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 126.172 1.844 . . . . 0.0 116.632 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -156.88 133.12 9.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.902 1.681 . . . . 0.0 110.275 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -153.23 54.55 1.2 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.26 -24.1 78.27 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.589 2.859 . . . . 0.0 114.819 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -81.68 -13.49 57.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.744 . . . . 0.0 114.943 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.76 142.63 32.45 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.165 0.893 . . . . 0.0 111.428 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -131.1 144.35 51.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.145 1.778 . . . . 0.0 111.83 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -158.44 -172.14 3.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.86 162.43 31.67 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.18 2.324 . . . . 0.0 110.55 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.57 131.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 117.927 0.864 . . . . 0.0 112.625 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.2 126.35 74.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.29 147.75 45.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.256 1.022 . . . . 0.0 110.035 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.2 147.43 36.54 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.597 0.759 . . . . 0.0 111.54 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.75 -139.33 4.8 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.257 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -138.55 130.07 27.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 111.655 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.8 p -66.7 -5.3 11.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -69.22 2.2 3.08 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.54 153.21 48.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.423 1.489 . . . . 0.0 112.83 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.47 -7.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.778 1.631 . . . . 0.0 114.831 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -120.66 44.16 2.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.578 1.951 . . . . 0.0 110.761 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -50.38 115.38 1.43 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.211 -1.556 . . . . 0.0 112.344 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.46 25.0 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -55.9 -36.75 68.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.682 -1.261 . . . . 0.0 113.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.78 -41.26 99.88 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.794 0.724 . . . . 0.0 112.583 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.16 -40.49 82.34 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.277 -1.131 . . . . 0.0 112.936 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.76 -37.78 85.54 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.918 0.859 . . . . 0.0 113.311 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -59.77 -46.35 89.46 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.769 0.713 . . . . 0.0 111.01 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.26 -25.36 64.23 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.92 -48.93 56.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.017 -1.677 . . . . 0.0 110.077 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.8 -38.19 72.2 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.2 tp -49.21 -31.94 9.52 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.949 1.7 . . . . 0.0 112.966 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.01 -37.78 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.054 1.342 . . . . 0.0 110.975 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -35.95 82.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -22.24 66.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 112.644 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.79 9.97 41.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.2 m 66.56 15.11 10.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.685 1.994 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.56 141.57 54.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.973 0.806 . . . . 0.0 109.752 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -102.62 107.51 18.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.554 1.141 . . . . 0.0 111.449 -169.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.5 ttm105 -74.02 123.45 24.37 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.838 -1.164 . . . . 0.0 110.465 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.16 35.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.846 1.658 . . . . 0.0 111.925 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -162.12 35.81 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.526 -1.359 . . . . 0.0 114.34 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -125.57 154.38 42.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.254 1.821 . . . . 0.0 111.118 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.0 ttm -69.77 131.6 44.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.896 0.879 . . . . 0.0 112.059 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -85.91 135.37 33.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.41 0.684 . . . . 0.0 109.661 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.38 93.7 3.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.775 1.23 . . . . 0.0 111.599 -171.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mt -86.59 134.34 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.202 1.401 . . . . 0.0 110.773 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -127.17 111.89 14.51 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.085 1.354 . . . . 0.0 111.436 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.07 -23.16 53.54 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -85.48 4.61 34.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.725 1.21 . . . . 0.0 113.695 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -129.91 -30.25 2.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.861 1.264 . . . . 0.0 112.734 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -146.28 118.46 4.98 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.089 0.956 . . . . 0.0 111.789 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.94 -0.76 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.741 2.96 . . . . 0.0 114.708 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.64 77.44 77.44 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.57 1.548 . . . . 0.0 112.331 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.18 -31.33 5.9 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 125.831 4.354 . . . . 0.0 116.351 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -48.08 -44.42 31.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.133 1.773 . . . . 0.0 113.269 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.8 p -71.77 -29.0 64.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.594 1.158 . . . . 0.0 113.314 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.5 -26.46 38.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.317 0.647 . . . . 0.0 112.217 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.5 p -105.33 -28.37 10.94 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.43 -59.8 6.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.2 -28.57 33.85 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.909 1.739 . . . . 0.0 112.226 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -63.05 -50.31 71.14 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.701 0.682 . . . . 0.0 111.691 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.04 -41.12 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.739 0.7 . . . . 0.0 110.318 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.61 -44.44 93.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.349 0.522 . . . . 0.0 111.624 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.92 -55.47 25.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.196 0.998 . . . . 0.0 112.554 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.59 -49.67 64.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.36 1.064 . . . . 0.0 110.907 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.36 -19.57 26.11 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.579 1.562 . . . . 0.0 116.44 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.8 p -69.78 -20.24 63.48 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.884 2.342 . . . . 0.0 113.62 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -97.49 -15.48 20.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.178 1.391 . . . . 0.0 113.151 -171.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 149.9 49.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.303 1.441 . . . . 0.0 112.183 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.023 1.729 . . . . 0.0 114.234 -172.222 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 110.885 -0.043 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.36 177.94 7.2 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.324 1.45 . . . . 0.0 113.474 -170.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -126.64 123.66 38.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.714 1.606 . . . . 0.0 109.434 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 mm -118.03 123.75 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.496 1.118 . . . . 0.0 112.259 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.42 126.58 7.69 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 168.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -116.97 111.4 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.719 1.259 . . . . 0.0 109.075 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.32 133.09 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.613 0.765 . . . . 0.0 110.79 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.94 144.26 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.903 -169.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.72 115.17 1.64 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -157.58 162.46 38.76 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.508 -0.996 . . . . 0.0 111.424 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -120.7 -19.39 7.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.598 1.159 . . . . 0.0 112.336 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.29 -7.12 2.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.15 -2.34 47.4 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.1 -47.75 78.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.314 1.557 . . . . 0.0 112.515 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -67.83 -30.11 69.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 112.751 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 tp -64.14 -44.36 92.41 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.7 -1.25 . . . . 0.0 113.039 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.09 -42.87 77.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.021 0.828 . . . . 0.0 111.262 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.31 -38.0 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.54 0.736 . . . . 0.0 112.236 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.31 94.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.85 -39.19 93.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.51 -44.63 96.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.483 -0.761 . . . . 0.0 112.216 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.34 88.67 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.922 0.783 . . . . 0.0 112.598 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.44 -46.4 80.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.775 0.83 . . . . 0.0 111.991 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.7 84.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 112.493 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.37 -42.64 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.407 1.083 . . . . 0.0 112.563 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.55 -44.21 78.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.807 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -56.93 -46.23 82.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 112.045 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -39.59 89.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.187 0.995 . . . . 0.0 113.242 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -67.75 -28.87 68.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.657 0.783 . . . . 0.0 112.67 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.76 -5.98 6.16 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.282 1.42 . . . . 0.0 114.502 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -73.58 178.84 4.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.355 1.462 . . . . 0.0 111.482 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -117.64 144.11 45.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.354 1.462 . . . . 0.0 109.392 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.89 163.3 37.23 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.638 -0.664 . . . . 0.0 112.576 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -153.12 116.55 4.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.097 0.959 . . . . 0.0 110.999 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.87 140.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.872 1.269 . . . . 0.0 111.201 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -125.42 107.74 10.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.252 1.821 . . . . 0.0 108.959 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.48 -20.68 46.74 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -171.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.45 61.02 7.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.857 1.663 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.77 161.6 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.077 3.185 . . . . 0.0 115.023 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.2 171.34 14.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.115 2.166 . . . . 0.0 109.405 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -46.54 -48.57 19.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.354 1.062 . . . . 0.0 112.948 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 m -59.4 -19.22 45.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -79.02 -35.64 42.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.503 1.047 . . . . 0.0 111.85 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.441 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 23.0 t-105 -78.97 -37.36 39.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.239 1.415 . . . . 0.0 112.56 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.6 tp -38.68 -50.17 3.8 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 128.466 2.706 . . . . 0.0 116.318 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -15.67 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.714 2.276 . . . . 0.0 115.258 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -84.84 -1.8 56.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.12 -33.41 69.1 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.221 -0.925 . . . . 0.0 113.295 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.52 -5.7 50.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.266 1.026 . . . . 0.0 113.519 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -133.08 -134.51 0.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.927 2.491 . . . . 0.0 109.478 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.08 158.8 43.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.115 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.441 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 34.3 m -145.57 170.53 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.058 1.343 . . . . 0.0 111.896 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -157.91 148.64 20.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.334 1.453 . . . . 0.0 110.413 174.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' H ' HD22 ' A' ' 53' ' ' LEU . 39.0 t -117.09 135.59 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.57 1.548 . . . . 0.0 109.829 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.44 96.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.313 1.045 . . . . 0.0 109.681 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.0 m -138.82 152.99 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.3 p -108.33 -159.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.869 1.267 . . . . 0.0 113.514 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.1 m -122.92 151.19 42.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.082 1.753 . . . . 0.0 109.115 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -158.27 -177.27 6.43 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.441 1.496 . . . . 0.0 108.73 -169.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 42.57 44.58 5.33 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.61 ' H ' HM73 ' A' ' 201' ' ' FMN . 7.6 tt0 60.81 21.54 11.64 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.408 1.883 . . . . 0.0 114.801 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.3 -6.87 2.81 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.316 1.436 . . . . 0.0 115.502 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.07 -158.42 0.2 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 126.245 1.818 . . . . 0.0 113.027 175.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pp -119.87 163.0 30.21 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.747 1.619 . . . . 0.0 113.603 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.71 142.9 78.78 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.59 3.527 . . . . 0.0 113.305 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.03 -28.15 67.51 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.617 -0.677 . . . . 0.0 112.816 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -62.02 -10.21 9.32 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.3 tt -128.1 -6.81 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.463 1.029 . . . . 0.0 113.243 175.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -47.9 -50.65 52.18 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 117.392 -1.289 . . . . 0.0 112.647 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 -2.03 10.75 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.239 1.959 . . . . 0.0 114.238 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.0 tp -98.06 -43.98 6.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.99 0.916 . . . . 0.0 110.122 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -61.57 -47.05 87.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -63.91 -44.53 92.66 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.34 -0.85 . . . . 0.0 111.876 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.61 -45.84 93.65 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.981 0.8 . . . . 0.0 113.373 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.02 -43.49 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.31 1.055 . . . . 0.0 110.596 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -62.65 -45.04 94.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.355 1.062 . . . . 0.0 112.617 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -83.67 -39.41 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.115 1.366 . . . . 0.0 114.512 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -121.8 4.92 9.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.65 -48.51 2.93 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.754 1.161 . . . . 0.0 110.823 168.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.49 -26.68 0.22 Allowed Glycine 0 CA--C 1.542 1.725 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -155.22 136.67 14.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 110.211 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -148.68 58.58 3.7 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.195 1.398 . . . . 0.0 112.471 -169.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.45 -2.53 8.45 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.603 3.535 . . . . 0.0 115.21 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -118.67 -6.12 10.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.664 2.385 . . . . 0.0 113.305 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.25 121.18 20.87 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.155 0.982 . . . . 0.0 110.155 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -123.4 140.77 52.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.87 1.668 . . . . 0.0 109.897 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -163.48 -167.57 1.46 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -168.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.54 170.46 34.05 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 127.596 2.522 . . . . 0.0 110.116 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.2 t -142.0 132.65 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.631 1.216 . . . . 0.0 112.247 -174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.72 130.4 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.59 152.5 43.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.017 0.927 . . . . 0.0 110.482 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -142.92 138.5 30.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.368 0.667 . . . . 0.0 111.803 -169.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.03 -138.86 3.36 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -144.09 122.51 12.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.501 1.12 . . . . 0.0 110.782 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -60.63 -9.42 3.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.823 1.249 . . . . 0.0 114.094 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.8 m -59.29 -13.42 7.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.419 1.488 . . . . 0.0 114.809 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -127.56 138.35 52.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.759 1.223 . . . . 0.0 111.834 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.69 -27.47 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -168.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -90.46 -14.08 33.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.761 1.164 . . . . 0.0 113.327 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 36.0 -125.33 0.14 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.409 1.484 . . . . 0.0 112.573 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.3 m -77.32 20.42 0.29 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -54.16 -33.98 59.34 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.095 -1.628 . . . . 0.0 114.71 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.27 85.38 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.481 1.037 . . . . 0.0 113.393 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.22 -41.75 52.42 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.256 -1.144 . . . . 0.0 112.429 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.88 -36.4 79.11 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -56.55 -48.48 77.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.69 0.677 . . . . 0.0 111.418 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -70.01 -29.53 66.62 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.49 -46.33 76.65 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.226 -1.546 . . . . 0.0 111.291 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.09 70.68 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -48.96 -28.55 3.95 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.924 1.689 . . . . 0.0 113.36 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -101.77 -35.26 9.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.645 1.178 . . . . 0.0 111.432 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.59 -32.84 74.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.72 1.145 . . . . 0.0 111.682 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.2 -15.31 14.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.809 1.243 . . . . 0.0 113.002 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -124.16 16.65 9.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.845 1.658 . . . . 0.0 113.201 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m 64.02 25.11 13.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.002 1.721 . . . . 0.0 115.425 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 159.79 12.27 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.243 -0.911 . . . . 0.0 112.332 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -129.13 86.33 2.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.111 1.364 . . . . 0.0 110.394 -170.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -62.51 138.96 58.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.03 31.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.552 1.541 . . . . 0.0 111.544 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.18 -165.46 38.92 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 121.015 -1.053 . . . . 0.0 113.999 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.26 158.48 28.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.066 1.747 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.0 ttm -72.32 133.96 45.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.68 -0.637 . . . . 0.0 112.149 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.27 134.13 33.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.825 0.85 . . . . 0.0 109.469 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.25 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.241 1.016 . . . . 0.0 111.196 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.58 135.07 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.074 1.35 . . . . 0.0 110.609 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -131.63 113.24 13.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.004 1.322 . . . . 0.0 111.09 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.8 30.44 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 m -77.26 -2.78 36.44 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -139.43 -18.5 0.98 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.631 1.573 . . . . 0.0 113.437 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.84 80.64 70.57 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.993 2.117 . . . . 0.0 110.772 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -16.25 42.57 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.947 2.432 . . . . 0.0 113.313 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.92 91.15 48.86 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 107.736 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.35 -27.04 84.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.461 2.774 . . . . 0.0 115.524 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.31 -29.1 60.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 p -68.92 -6.55 28.11 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -111.8 -31.83 6.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.327 1.051 . . . . 0.0 111.335 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.1 p -78.0 -32.88 51.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.88 -60.74 4.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -66.29 -29.78 46.09 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.118 1.879 . . . . 0.0 112.278 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -61.94 -51.15 69.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.532 0.605 . . . . 0.0 111.582 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.02 -40.65 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.525 0.602 . . . . 0.0 110.485 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.71 -38.01 83.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -71.41 -59.08 2.96 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.125 0.97 . . . . 0.0 112.717 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -52.17 -47.54 65.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.926 -174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.03 -34.69 12.26 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.001 1.286 . . . . 0.0 115.268 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.7 p -66.72 -15.88 63.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.023 1.411 . . . . 0.0 114.052 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -96.99 -15.92 20.85 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.249 1.419 . . . . 0.0 113.4 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.17 -36.86 80.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.561 1.544 . . . . 0.0 113.592 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.764 1.626 . . . . 0.0 112.226 -175.416 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.61 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.54 176.13 8.0 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.763 2.025 . . . . 0.0 110.78 170.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.18 124.25 24.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.125 1.37 . . . . 0.0 109.181 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mt -136.9 125.05 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.71 132.88 11.39 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -120.02 90.79 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.984 1.314 . . . . 0.0 108.411 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.829 0.852 . . . . 0.0 110.752 -169.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.12 144.9 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.489 0.661 . . . . 0.0 111.567 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.49 101.68 0.48 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -146.92 164.1 33.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.784 1.234 . . . . 0.0 111.022 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 80.2 mmm -111.5 -11.39 14.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.944 0.898 . . . . 0.0 113.359 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -146.51 -19.62 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.89 -10.02 5.44 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 170.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.93 -44.38 91.32 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.176 1.988 . . . . 0.0 113.315 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.6 p -82.59 -28.97 30.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.6 0.76 . . . . 0.0 112.512 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.93 -40.42 84.56 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.729 -1.232 . . . . 0.0 112.912 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 tt -54.57 -41.05 69.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 111.815 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 90' ' ' ILE . 98.8 t -69.88 -35.72 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.242 0.617 . . . . 0.0 111.991 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.12 97.87 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.393 0.997 . . . . 0.0 112.506 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.47 -40.86 96.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.534 0.733 . . . . 0.0 112.269 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -60.45 -47.86 84.29 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.772 -0.58 . . . . 0.0 111.552 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.13 87.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.556 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.35 -46.24 80.06 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.727 0.811 . . . . 0.0 112.071 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.88 -47.18 81.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.367 0.667 . . . . 0.0 112.31 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.43 -32.7 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.358 . . . . 0.0 112.964 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 mt -80.14 -38.31 31.73 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.686 -1.259 . . . . 0.0 110.12 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.2 m -57.03 -45.32 83.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.669 0.788 . . . . 0.0 111.17 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.86 78.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.558 1.143 . . . . 0.0 113.487 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.05 -7.06 52.64 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.37 24.32 12.71 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.606 1.098 . . . . 0.0 114.346 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -114.87 147.89 39.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.376 1.088 . . . . 0.0 112.153 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -75.22 134.35 41.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.232 1.013 . . . . 0.0 109.034 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 155.03 45.59 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.168 0.987 . . . . 0.0 111.189 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -154.13 116.49 4.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.08 -1.013 . . . . 0.0 110.665 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.82 138.74 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.121 0.968 . . . . 0.0 110.71 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.68 101.08 6.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.308 . . . . 0.0 109.808 172.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.64 -22.79 56.47 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -144.31 64.12 11.93 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.202 1.801 . . . . 0.0 109.586 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.8 160.7 48.58 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.117 3.211 . . . . 0.0 114.703 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.37 162.04 31.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.164 2.186 . . . . 0.0 109.212 169.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -53.99 -36.62 63.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.713 -1.242 . . . . 0.0 113.346 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -58.07 -18.79 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -83.4 -35.13 25.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.406 1.003 . . . . 0.0 112.344 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.604 ' CH2' HG21 ' A' ' 52' ' ' VAL . 27.5 t-105 -75.2 -37.19 61.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.926 0.89 . . . . 0.0 112.193 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.3 tp -41.42 -46.74 8.42 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 128.34 2.656 . . . . 0.0 116.411 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.67 -30.32 4.98 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.211 1.941 . . . . 0.0 114.391 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -81.26 -9.74 59.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -55.44 -28.5 54.72 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.13 -4.98 52.99 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.471 1.508 . . . . 0.0 113.848 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.11 -115.52 0.23 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.761 1.624 . . . . 0.0 111.154 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.02 160.93 39.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.618 1.567 . . . . 0.0 110.694 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG21 ' CH2' ' A' ' 44' ' ' TRP . 31.4 m -152.4 172.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.118 1.367 . . . . 0.0 111.314 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 149.31 18.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.938 1.295 . . . . 0.0 109.771 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.07 136.98 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.84 1.256 . . . . 0.0 109.983 -170.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.11 94.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.984 1.314 . . . . 0.0 109.024 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.1 m -135.76 139.82 43.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -168.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -178.1 5.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.868 1.667 . . . . 0.0 112.381 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 m -127.75 139.11 52.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.718 -1.239 . . . . 0.0 110.899 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -158.4 -168.73 2.53 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.556 1.526 . . . . 0.0 110.75 -170.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.64 -66.88 0.17 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 127.807 2.622 . . . . 0.0 116.045 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -153.45 32.02 0.46 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.599 1.96 . . . . 0.0 110.812 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.31 40.48 13.34 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.238 -0.913 . . . . 0.0 111.623 -169.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -129.35 175.22 8.93 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.635 1.974 . . . . 0.0 112.881 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -53.52 136.97 52.22 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.364 1.866 . . . . 0.0 111.834 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.72 141.99 28.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.354 2.703 . . . . 0.0 110.679 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.46 -25.42 62.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 m -61.67 -17.2 54.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.42 -12.87 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 119.76 1.164 . . . . 0.0 114.138 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.68 -42.88 24.67 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.38 1.472 . . . . 0.0 114.08 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.17 -25.4 10.13 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.97 1.78 . . . . 0.0 114.075 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.49 -45.82 61.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.312 0.96 . . . . 0.0 109.616 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.19 -58.36 6.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.75 1.62 . . . . 0.0 111.381 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -66.96 -33.81 76.4 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.486 -1.384 . . . . 0.0 113.958 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.47 -48.23 87.0 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 119.097 0.862 . . . . 0.0 112.495 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.22 -41.03 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.197 -1.178 . . . . 0.0 110.557 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -61.48 -37.33 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.76 -23.07 10.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -169.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -113.21 0.45 14.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.5 mt -129.32 -49.63 1.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.739 1.216 . . . . 0.0 111.418 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.94 -22.52 0.33 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 118.447 2.139 . . . . 0.0 118.447 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -153.57 139.71 18.38 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.577 1.689 . . . . 0.0 110.677 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.59 45.85 0.28 Allowed Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -59.59 -21.57 62.94 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.555 3.504 . . . . 0.0 116.865 -169.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -106.56 -0.74 23.64 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.308 1.443 . . . . 0.0 113.849 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 52' ' ' VAL . 2.9 tm? -75.52 136.95 40.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.88 0.872 . . . . 0.0 110.258 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -130.7 133.5 46.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.681 1.992 . . . . 0.0 109.525 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -151.93 -170.87 3.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -170.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.46 164.92 30.78 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.823 1.678 . . . . 0.0 110.027 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.78 134.78 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 122.178 0.989 . . . . 0.0 112.253 -169.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 18' ' ' VAL . 87.4 mt -121.4 129.9 75.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.78 50.35 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.277 0.631 . . . . 0.0 111.591 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.1 169.69 20.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.494 1.14 . . . . 0.0 113.962 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.02 -126.03 1.28 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.643 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -142.21 128.56 19.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.3 1.04 . . . . 0.0 112.32 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -66.94 -12.13 58.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.714 1.606 . . . . 0.0 114.91 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 -15.77 63.2 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.13 148.84 22.28 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.867 1.267 . . . . 0.0 112.299 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.15 -38.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.71 0.804 . . . . 0.0 111.572 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -76.13 41.32 0.23 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.523 1.529 . . . . 0.0 112.834 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.5 117.15 2.66 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.911 -1.743 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 61.1 m 51.7 24.55 2.45 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -56.32 -33.55 65.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.622 -1.299 . . . . 0.0 113.32 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.9 -34.12 70.7 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.979 0.799 . . . . 0.0 113.522 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.89 -40.43 10.62 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.412 -1.052 . . . . 0.0 112.936 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.27 -35.75 74.28 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.293 1.047 . . . . 0.0 113.257 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -59.9 -41.88 92.6 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.231 1.013 . . . . 0.0 112.223 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -75.86 -29.04 58.41 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.443 -0.786 . . . . 0.0 112.684 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.27 -43.79 80.94 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.076 -1.64 . . . . 0.0 111.289 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.18 84.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.111 0.964 . . . . 0.0 113.199 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.5 tp -49.04 -29.39 4.95 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 112.964 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.0 mt -102.69 -42.91 5.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.567 1.147 . . . . 0.0 111.642 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.18 -31.44 72.63 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.756 1.162 . . . . 0.0 112.76 169.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.88 -18.64 63.25 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.094 -1.004 . . . . 0.0 112.86 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -107.03 15.3 25.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.865 1.666 . . . . 0.0 112.39 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.2 m 62.43 14.92 7.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.944 2.097 . . . . 0.0 115.276 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.02 156.64 17.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.915 0.78 . . . . 0.0 112.008 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -116.53 164.8 14.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 -169.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 -129.61 146.13 51.44 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.46 21.01 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 113.368 -1.742 . . . . 0.0 112.368 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.6 -176.71 46.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.104 1.811 . . . . 0.0 113.464 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.21 159.3 22.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 112.112 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.38 127.08 31.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.433 0.693 . . . . 0.0 112.388 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.81 133.56 35.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.33 94.26 3.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.864 1.266 . . . . 0.0 111.356 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.17 138.57 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.443 0.697 . . . . 0.0 111.817 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.98 114.93 23.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.535 1.534 . . . . 0.0 111.429 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.19 -25.32 58.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m -79.86 1.36 27.34 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -132.47 -27.75 1.72 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.833 1.253 . . . . 0.0 113.453 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -142.47 108.33 5.64 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 112.104 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.87 -0.99 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.112 3.208 . . . . 0.0 114.571 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.18 74.71 79.27 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.465 1.906 . . . . 0.0 109.842 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -57.94 -22.0 52.49 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.445 3.43 . . . . 0.0 116.551 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.04 -37.81 72.32 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.932 -1.105 . . . . 0.0 113.122 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.8 p -68.56 -6.35 24.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.317 1.047 . . . . 0.0 113.476 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -110.47 -12.99 14.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.211 1.404 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -129.17 -24.54 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -51.48 -52.73 57.11 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.251 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.11 -27.58 41.78 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.78 1.654 . . . . 0.0 113.419 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -62.51 -49.91 73.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.66 -33.64 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.558 -0.714 . . . . 0.0 111.113 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.52 -16.65 63.88 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -95.98 -59.26 1.89 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.826 1.251 . . . . 0.0 111.759 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -54.63 -46.04 73.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.775 1.23 . . . . 0.0 112.473 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.91 -19.6 22.83 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.2 p -76.86 -11.99 59.9 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.893 . . . . 0.0 113.715 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.08 -9.32 17.89 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 126.1 45.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.609 1.164 . . . . 0.0 113.698 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.885 2.474 . . . . 0.0 110.563 170.798 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 120.326 0.108 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.02 -177.95 3.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.726 1.61 . . . . 0.0 112.525 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -127.99 125.2 38.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 0.0 108.679 174.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 mm -123.07 124.25 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.398 1.079 . . . . 0.0 112.569 -171.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.62 128.52 9.24 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.5 mt -119.25 91.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -91.22 135.41 33.81 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 111.565 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.2 142.56 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.011 -170.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.16 104.72 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -147.7 169.49 19.59 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.911 1.284 . . . . 0.0 110.807 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.7 mtp -116.65 -7.2 11.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.283 1.033 . . . . 0.0 113.029 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -148.37 -32.0 0.26 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.39 -1.58 2.71 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.88 -42.18 97.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.144 1.972 . . . . 0.0 113.199 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -78.37 -31.87 48.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 172.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.3 tp -57.71 -40.09 78.74 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.037 -1.039 . . . . 0.0 113.08 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.87 -45.1 70.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.312 0.645 . . . . 0.0 111.464 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.72 -39.38 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.834 0.454 . . . . 0.0 111.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.42 87.45 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.19 0.905 . . . . 0.0 113.159 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.12 -44.24 96.17 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.564 -0.71 . . . . 0.0 111.886 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.31 -40.74 97.3 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.665 -0.647 . . . . 0.0 112.068 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -46.31 90.65 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.854 0.752 . . . . 0.0 111.799 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.44 -47.0 80.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.013 0.525 . . . . 0.0 111.493 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.67 -47.36 85.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.789 0.836 . . . . 0.0 112.911 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.32 -46.35 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.556 1.142 . . . . 0.0 112.225 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.78 -40.79 75.81 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.942 -0.474 . . . . 0.0 109.751 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -56.24 -46.54 79.55 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.859 1.264 . . . . 0.0 112.215 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.54 89.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 112.955 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -68.71 -30.77 69.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.393 0.677 . . . . 0.0 112.671 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.57 -6.69 4.56 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.875 1.226 . . . . 0.0 115.556 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -79.07 144.1 34.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 111.04 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.82 134.9 49.04 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.76 142.68 31.03 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.8 0.727 . . . . 0.0 112.293 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.6 m -141.45 114.83 8.83 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.086 0.954 . . . . 0.0 110.137 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.6 p -80.53 149.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.919 0.888 . . . . 0.0 111.974 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -137.94 104.9 5.39 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.711 1.605 . . . . 0.0 109.321 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.82 -33.04 70.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.555 1.542 . . . . 0.0 114.522 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -145.81 62.88 8.83 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.418 1.887 . . . . 0.0 109.437 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.67 160.1 49.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.911 3.074 . . . . 0.0 115.658 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.94 170.59 15.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.423 2.289 . . . . 0.0 109.026 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -57.71 -34.99 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.7 -1.25 . . . . 0.0 113.443 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.2 p -61.21 -15.49 34.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.38 -33.38 20.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.568 1.076 . . . . 0.0 112.503 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CH2' HG21 ' A' ' 52' ' ' VAL . 39.6 t-105 -75.52 -37.15 60.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.302 1.041 . . . . 0.0 112.501 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.9 tp -43.92 -50.53 19.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 127.789 2.436 . . . . 0.0 115.216 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.61 -1.59 6.93 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.072 2.515 . . . . 0.0 115.708 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.18 0.46 10.68 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.181 1.392 . . . . 0.0 114.02 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -60.84 -14.82 24.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -121.19 18.74 11.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.619 2.368 . . . . 0.0 112.267 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -124.43 -138.05 0.29 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.697 2.399 . . . . 0.0 108.649 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -123.32 157.86 32.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.532 1.533 . . . . 0.0 109.303 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG21 ' CH2' ' A' ' 44' ' ' TRP . 18.9 m -146.33 166.79 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.111 1.364 . . . . 0.0 110.08 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.18 144.88 20.19 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.239 -0.913 . . . . 0.0 110.654 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -113.44 132.86 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.382 1.473 . . . . 0.0 110.334 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.78 91.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.52 1.128 . . . . 0.0 108.757 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 m -135.8 138.13 42.28 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -85.15 -167.76 1.96 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.767 2.027 . . . . 0.0 113.034 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -135.81 141.95 44.79 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.537 -1.352 . . . . 0.0 111.157 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -142.12 -169.26 2.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.197 1.799 . . . . 0.0 109.539 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 46.24 37.32 7.97 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 126.08 1.8 . . . . 0.0 116.881 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 67.96 10.7 7.97 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.734 2.014 . . . . 0.0 114.518 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.61 28.38 0.07 OUTLIER Glycine 0 N--CA 1.474 1.185 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.22 168.21 18.44 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 120.094 1.947 . . . . 0.0 114.269 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mt -49.47 127.4 17.58 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 127.511 2.324 . . . . 0.0 113.133 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.27 141.78 94.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.296 3.331 . . . . 0.0 111.351 169.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.37 -25.99 67.54 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -171.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.3 m -63.21 -12.16 26.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.3 tt -125.19 -10.39 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.93 -47.65 63.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.263 -1.351 . . . . 0.0 113.33 170.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.15 -19.2 34.55 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 122.46 1.914 . . . . 0.0 113.987 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -78.02 -42.72 31.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.179 0.9 . . . . 0.0 109.606 171.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -62.04 -45.92 91.42 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.518 1.127 . . . . 0.0 111.386 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -62.77 -40.93 98.81 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.659 -1.276 . . . . 0.0 112.676 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -45.46 69.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.568 1.08 . . . . 0.0 112.967 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.5 mt -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 119.427 1.613 . . . . 0.0 109.98 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.79 -46.12 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.654 1.181 . . . . 0.0 112.265 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.24 -35.17 36.48 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -90.82 -33.95 15.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.22 -53.55 4.19 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.625 1.102 . . . . 0.0 111.689 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -37.59 0.29 Allowed Glycine 0 CA--C 1.544 1.862 0 C-N-CA 126.164 1.84 . . . . 0.0 115.803 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -161.87 124.7 3.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 110.557 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -149.58 53.75 1.4 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 126.035 1.734 . . . . 0.0 113.085 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.78 -27.63 78.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.942 3.095 . . . . 0.0 115.13 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.81 -26.46 67.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.889 1.276 . . . . 0.0 114.247 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.6 tp -77.78 142.1 38.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.678 0.791 . . . . 0.0 112.527 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -138.08 145.61 41.93 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.038 2.135 . . . . 0.0 110.054 -172.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 118' ' ' ARG . 29.2 p90 -161.0 -171.15 2.96 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -169.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.91 165.26 33.08 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.933 2.206 . . . . 0.0 110.525 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -139.65 134.78 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.076 0.938 . . . . 0.0 112.618 -169.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.8 mt -118.3 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.16 148.25 40.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.173 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.07 151.41 45.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.175 0.988 . . . . 0.0 112.075 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.78 -133.57 2.76 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.164 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -142.65 133.1 24.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.421 1.088 . . . . 0.0 111.967 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.7 p -68.32 -6.12 22.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 m -68.64 3.18 1.98 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -136.64 154.59 50.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.788 1.635 . . . . 0.0 111.749 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.85 -36.23 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.632 0.773 . . . . 0.0 112.897 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.43 44.78 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.769 0.827 . . . . 0.0 111.944 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -53.77 116.61 2.61 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.553 -1.342 . . . . 0.0 112.003 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 56.7 m 50.83 23.93 1.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.964 2.506 . . . . 0.0 116.957 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.07 -26.28 67.53 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.661 -1.274 . . . . 0.0 114.09 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -30.09 73.46 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.733 0.697 . . . . 0.0 113.404 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.0 -38.71 9.04 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.08 0.94 . . . . 0.0 113.179 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.18 -35.16 74.75 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.509 1.155 . . . . 0.0 113.52 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -59.38 -37.84 78.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.494 0.718 . . . . 0.0 112.423 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.04 -33.2 61.71 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.322 -0.861 . . . . 0.0 112.477 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.95 -1.719 . . . . 0.0 110.911 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.7 89.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.3 tp -46.31 -44.04 16.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.495 1.518 . . . . 0.0 111.998 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.23 -28.63 57.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.114 1.366 . . . . 0.0 112.449 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.16 -29.74 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.106 -0.996 . . . . 0.0 111.587 169.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -66.01 -23.86 66.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.638 1.108 . . . . 0.0 111.607 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -88.05 1.89 53.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.646 1.178 . . . . 0.0 111.967 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m 53.38 22.73 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.995 1.718 . . . . 0.0 114.83 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 156.1 24.34 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 111.433 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -119.48 87.63 2.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.502 1.521 . . . . 0.0 111.539 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 30.2 ttp85 -59.47 137.86 57.87 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.487 -0.758 . . . . 0.0 112.041 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.67 51.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 126.341 1.856 . . . . 0.0 109.967 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.85 -174.86 44.7 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.326 -0.859 . . . . 0.0 114.083 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.08 147.16 44.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.25 1.42 . . . . 0.0 110.717 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.06 130.66 42.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.452 0.701 . . . . 0.0 111.86 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.34 134.65 35.26 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 92.29 3.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.681 1.192 . . . . 0.0 111.246 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.5 mt -85.1 134.3 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.468 1.507 . . . . 0.0 111.631 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -121.56 109.16 14.46 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.623 1.169 . . . . 0.0 112.809 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.42 -23.39 49.23 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 m -83.5 0.82 44.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.416 1.087 . . . . 0.0 113.867 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -129.21 -26.54 2.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 113.417 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -146.59 119.29 4.97 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.007 0.822 . . . . 0.0 112.835 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.0 -5.11 12.12 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.895 3.063 . . . . 0.0 114.216 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.43 73.94 80.11 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.54 1.536 . . . . 0.0 111.175 -172.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.06 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.311 3.34 . . . . 0.0 115.055 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -48.15 -44.21 32.14 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.146 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.5 p -67.78 -18.41 64.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.51 -17.74 16.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.209 1.004 . . . . 0.0 112.425 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -113.42 -28.43 7.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -59.9 -52.12 75.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.717 -1.135 . . . . 0.0 113.204 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.49 -28.93 61.95 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.349 1.518 . . . . 0.0 112.773 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -60.95 -50.29 73.98 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.609 0.641 . . . . 0.0 111.658 171.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 -41.43 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.684 0.675 . . . . 0.0 110.461 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.91 -39.45 85.45 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.453 0.57 . . . . 0.0 111.966 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -67.19 -56.32 10.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.883 0.873 . . . . 0.0 112.51 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -53.35 -46.23 69.46 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.414 1.086 . . . . 0.0 111.4 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.5 -23.61 6.59 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.393 1.949 . . . . 0.0 116.507 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -72.69 -18.52 61.54 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.068 1.934 . . . . 0.0 114.072 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.65 -15.47 25.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.487 1.515 . . . . 0.0 113.109 -171.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.49 157.67 22.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.521 2.328 . . . . 0.0 113.154 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.256 1.397 0 C-N-CA 128.156 2.582 . . . . 0.0 114.649 -173.968 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.94 177.16 7.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.79 1.636 . . . . 0.0 111.999 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -131.88 129.49 40.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.633 1.173 . . . . 0.0 110.094 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 mm -122.0 125.17 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.894 0.878 . . . . 0.0 112.937 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.84 124.87 7.05 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mt -116.41 91.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.448 1.099 . . . . 0.0 108.26 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.68 136.09 35.38 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.021 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.31 145.21 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.215 0.606 . . . . 0.0 111.669 -169.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 80.92 0.3 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.188 1.375 . . . . 0.0 110.741 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.03 168.58 18.54 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.0 tpt -130.58 -4.18 4.2 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.938 2.095 . . . . 0.0 112.203 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -142.82 -54.74 0.41 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.114 . . . . 0.0 113.229 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.08 -2.98 1.04 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 117.097 1.599 . . . . 0.0 117.097 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -62.79 -44.14 96.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.881 1.341 . . . . 0.0 112.289 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -71.59 -35.76 70.63 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.286 1.434 . . . . 0.0 112.309 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.51 -40.78 92.65 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.718 -1.239 . . . . 0.0 112.457 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.49 -41.17 76.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.879 0.763 . . . . 0.0 111.82 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.52 -37.92 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.847 -0.533 . . . . 0.0 112.023 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.1 97.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.35 0.977 . . . . 0.0 112.844 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.48 -40.33 94.16 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.575 0.75 . . . . 0.0 112.413 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.51 -45.64 93.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.386 -0.821 . . . . 0.0 112.102 169.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.19 88.29 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.726 -0.609 . . . . 0.0 112.198 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.19 -47.73 77.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.648 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.84 92.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.564 0.745 . . . . 0.0 112.676 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.1 -47.25 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.749 1.219 . . . . 0.0 112.355 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.09 -39.35 79.08 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.253 0.621 . . . . 0.0 109.805 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -57.01 -48.71 77.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.988 1.315 . . . . 0.0 111.975 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -34.97 79.16 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.025 0.93 . . . . 0.0 113.399 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.26 -8.31 56.29 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.43 36.95 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.974 1.273 . . . . 0.0 115.009 171.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -77.24 172.17 13.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.764 1.226 . . . . 0.0 111.557 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -104.97 145.29 30.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.276 1.03 . . . . 0.0 108.543 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.78 164.17 32.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.47 -0.769 . . . . 0.0 112.788 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.6 m -152.79 120.97 6.22 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 110.565 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.16 138.63 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.053 0.941 . . . . 0.0 110.651 169.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -125.9 107.4 10.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.88 1.272 . . . . 0.0 109.606 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -84.65 -14.43 48.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -143.2 56.67 4.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 126.074 1.75 . . . . 0.0 110.199 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.15 165.4 31.55 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.095 3.197 . . . . 0.0 115.524 -169.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.15 166.38 26.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.181 2.193 . . . . 0.0 109.037 172.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -40.15 25.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.577 1.151 . . . . 0.0 112.404 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.02 -20.12 15.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -97.12 -29.09 13.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.934 1.293 . . . . 0.0 112.181 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -70.66 -42.01 71.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.511 . . . . 0.0 112.771 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.08 -52.79 49.92 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.222 2.209 . . . . 0.0 114.687 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -65.77 -3.65 8.48 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.002 2.468 . . . . 0.0 115.956 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -110.72 1.11 17.67 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.888 1.275 . . . . 0.0 114.07 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -66.24 -30.29 70.7 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.484 -1.385 . . . . 0.0 113.418 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.97 3.93 13.43 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.923 1.289 . . . . 0.0 113.365 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -132.45 -123.77 0.19 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.286 1.835 . . . . 0.0 110.14 -169.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.51 160.0 40.97 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.909 1.684 . . . . 0.0 110.768 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.44 168.47 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 110.65 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.57 146.26 19.47 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.386 -0.821 . . . . 0.0 110.466 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -117.91 137.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.062 1.345 . . . . 0.0 110.595 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.2 94.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.873 1.269 . . . . 0.0 108.091 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.1 m -133.8 167.06 21.24 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.4 p -141.22 173.93 11.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 112.047 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.7 m -99.14 150.97 21.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.748 1.219 . . . . 0.0 112.447 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 p -144.16 -169.89 3.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.17 2.588 . . . . 0.0 108.739 170.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 47.07 26.28 2.96 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 126.233 1.873 . . . . 0.0 117.296 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 56.05 13.27 1.12 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.121 2.168 . . . . 0.0 114.231 -169.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.69 38.0 0.02 OUTLIER Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.385 0.993 . . . . 0.0 114.4 -174.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.71 177.52 8.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.914 1.686 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.03 147.15 34.01 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.411 1.885 . . . . 0.0 110.396 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.86 154.38 63.41 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.614 2.876 . . . . 0.0 111.36 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.48 -14.22 56.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.9 p -59.18 -27.51 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.633 1.173 . . . . 0.0 113.538 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.64 -9.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.563 1.145 . . . . 0.0 113.965 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -49.94 -46.03 81.12 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 120.369 -1.457 . . . . 0.0 112.716 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.19 -15.49 23.67 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.02 3.146 . . . . 0.0 116.119 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 tp -98.31 -45.7 6.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.88 1.272 . . . . 0.0 109.806 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -63.42 -45.36 91.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.032 1.333 . . . . 0.0 112.251 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -68.81 -38.5 79.94 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.57 -47.04 64.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.143 0.878 . . . . 0.0 112.936 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.33 -44.33 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.224 1.012 . . . . 0.0 110.652 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.85 -47.45 83.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.997 0.919 . . . . 0.0 112.524 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.22 -26.96 24.78 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -125.9 6.1 7.33 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 -169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.7 mt -123.03 -50.81 1.91 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.517 1.053 . . . . 0.0 111.48 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 -27.06 0.26 Allowed Glycine 0 CA--C 1.543 1.806 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -158.8 131.79 7.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.45 1.625 . . . . 0.0 110.845 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -159.12 52.84 0.52 Allowed Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.14 -32.28 39.26 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.463 2.775 . . . . 0.0 116.582 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -73.14 -13.19 61.13 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 tp -73.94 140.15 45.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.978 0.808 . . . . 0.0 111.845 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -135.45 144.14 46.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.102 1.761 . . . . 0.0 109.505 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -162.8 -169.43 2.06 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.29 163.05 31.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.798 2.142 . . . . 0.0 110.384 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.13 138.05 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 122.233 1.016 . . . . 0.0 112.62 -172.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.3 mt -122.1 131.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.323 1.849 . . . . 0.0 106.052 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.46 147.14 49.85 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.492 0.717 . . . . 0.0 110.36 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.8 tt -139.13 142.82 38.04 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.069 0.947 . . . . 0.0 111.601 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.58 -147.86 7.79 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.362 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -144.15 121.6 11.7 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.273 1.429 . . . . 0.0 110.029 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.5 p -62.41 -5.26 2.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.4 m -60.66 -13.2 13.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.433 1.493 . . . . 0.0 114.453 169.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -123.21 157.45 33.01 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 0.0 113.638 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 m -50.69 -23.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -168.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.99 1.84 4.3 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -173.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 14.5 t80 36.54 -128.83 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.832 1.253 . . . . 0.0 112.784 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.4 m -80.99 21.38 0.7 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.86 -33.27 48.98 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.34 95.52 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.758 1.163 . . . . 0.0 113.327 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.2 -40.25 71.27 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 121.613 -0.934 . . . . 0.0 112.95 171.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.01 -38.45 88.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.383 1.091 . . . . 0.0 113.132 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -59.05 -43.59 91.7 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.506 0.594 . . . . 0.0 111.776 170.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.66 -36.61 78.78 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.45 -43.09 98.38 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.811 -1.806 . . . . 0.0 111.711 170.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.17 69.87 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 tp -49.75 -28.36 6.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 112.956 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 mt -102.35 -37.69 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 -169.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.1 -31.9 73.04 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.938 1.244 . . . . 0.0 111.533 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.02 -17.33 24.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 113.024 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -119.81 16.53 12.68 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.122 1.769 . . . . 0.0 112.463 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m 67.74 18.64 9.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.91 2.084 . . . . 0.0 115.515 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.7 152.75 18.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.425 -0.797 . . . . 0.0 112.386 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -122.43 86.91 2.66 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.906 1.682 . . . . 0.0 110.904 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 ttm105 -61.83 141.58 57.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.675 -0.64 . . . . 0.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.83 33.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.484 1.514 . . . . 0.0 111.204 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.8 -163.29 37.02 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.07 -1.019 . . . . 0.0 113.222 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.25 156.48 43.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.71 1.604 . . . . 0.0 111.293 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.8 ttm -65.19 127.08 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.302 1.041 . . . . 0.0 111.776 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -82.3 134.42 35.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.57 93.76 4.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.01 1.324 . . . . 0.0 111.522 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.9 mt -82.5 132.03 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 0.0 110.479 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -131.75 107.71 8.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 112.352 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -19.06 31.67 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 m -69.28 -14.11 62.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.915 1.234 . . . . 0.0 114.212 171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.38 -12.53 1.59 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -142.91 102.56 5.29 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.29 0.95 . . . . 0.0 112.514 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.72 1.7 9.0 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.87 3.046 . . . . 0.0 114.267 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -121.53 77.0 36.06 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.342 1.857 . . . . 0.0 109.729 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.09 -24.81 78.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.21 3.273 . . . . 0.0 114.861 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.15 -44.58 71.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 111.969 170.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.2 p -66.06 -20.63 66.24 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.98 -15.76 27.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 112.675 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.8 p -123.26 -28.8 3.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -54.2 -52.89 64.71 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 119.503 1.047 . . . . 0.0 113.68 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.35 -29.0 32.46 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.777 1.652 . . . . 0.0 112.673 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.13 -48.73 78.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.787 0.721 . . . . 0.0 111.62 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 t -67.79 -40.37 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 118.425 0.557 . . . . 0.0 110.331 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.39 -40.16 85.7 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.595 0.634 . . . . 0.0 111.911 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -65.03 -58.43 6.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -53.24 -46.78 69.31 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.086 0.954 . . . . 0.0 111.701 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.98 -24.17 13.55 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.123 1.821 . . . . 0.0 116.382 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.7 p -71.43 -19.81 62.19 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.933 1.866 . . . . 0.0 114.072 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.93 -16.25 25.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.243 1.417 . . . . 0.0 112.977 -170.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.37 155.23 21.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.529 2.332 . . . . 0.0 111.599 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 124.772 1.229 . . . . 0.0 113.585 174.112 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.35 178.97 4.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.727 1.611 . . . . 0.0 112.901 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -129.23 118.03 21.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.724 2.01 . . . . 0.0 108.032 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.99 126.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.05 131.72 10.68 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mt -120.9 91.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.271 1.428 . . . . 0.0 107.439 -171.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -92.58 141.55 28.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.989 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.8 148.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.569 0.748 . . . . 0.0 112.071 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.31 97.54 0.21 Allowed Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.165 1.364 . . . . 0.0 110.406 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -144.34 168.38 20.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.23 -24.37 6.45 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.312 1.845 . . . . 0.0 112.558 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -134.7 -4.65 2.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 2.09 64.57 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -64.94 -45.41 85.9 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 1.591 . . . . 0.0 112.123 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -69.43 -36.22 76.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.093 1.357 . . . . 0.0 112.408 172.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.4 tp -59.39 -42.13 91.01 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.956 -1.09 . . . . 0.0 112.715 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.9 -41.88 78.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.653 0.661 . . . . 0.0 111.575 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.53 -35.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.662 -0.649 . . . . 0.0 112.271 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.74 97.09 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.179 -0.951 . . . . 0.0 112.504 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.76 -41.04 99.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.668 . . . . 0.0 112.398 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.04 -46.46 88.15 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.504 -0.748 . . . . 0.0 111.652 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.52 85.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.389 0.676 . . . . 0.0 112.217 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.64 -47.65 76.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.777 0.831 . . . . 0.0 111.882 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.19 -47.4 86.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.538 0.735 . . . . 0.0 112.843 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.94 -45.56 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.591 1.156 . . . . 0.0 111.887 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.5 mt -69.59 -41.41 75.81 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.734 -0.604 . . . . 0.0 109.791 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -56.64 -45.65 81.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.872 1.269 . . . . 0.0 111.998 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.8 -38.0 85.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.986 0.914 . . . . 0.0 113.1 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -70.76 -23.07 62.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.3 -8.27 7.94 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.323 1.44 . . . . 0.0 114.981 170.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.13 167.52 20.09 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.654 1.182 . . . . 0.0 112.111 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -100.89 137.87 38.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.323 1.449 . . . . 0.0 109.474 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.28 159.16 43.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.269 0.628 . . . . 0.0 112.432 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -153.77 119.84 5.39 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.974 0.91 . . . . 0.0 111.133 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.7 t -74.26 141.79 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.222 1.009 . . . . 0.0 110.801 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.4 104.28 7.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.856 1.262 . . . . 0.0 110.586 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.65 -17.34 38.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -142.35 60.87 10.91 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.563 1.545 . . . . 0.0 110.582 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.91 166.31 29.98 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.374 3.383 . . . . 0.0 115.694 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.35 162.74 37.53 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.637 2.375 . . . . 0.0 109.181 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.92 -38.49 56.51 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.691 -1.255 . . . . 0.0 113.655 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -62.23 -13.96 33.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -92.06 -25.48 18.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.669 1.122 . . . . 0.0 112.807 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -80.98 -40.76 23.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.557 1.543 . . . . 0.0 112.617 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 tp -50.08 -41.01 61.53 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -55.38 -9.63 2.61 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 125.108 3.872 . . . . 0.0 118.349 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -118.17 4.54 11.97 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -70.06 -9.86 56.79 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -110.65 17.72 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.423 1.489 . . . . 0.0 112.613 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.52 -135.62 0.16 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.572 1.949 . . . . 0.0 110.209 -169.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.63 159.82 38.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.702 1.601 . . . . 0.0 111.145 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.78 178.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.102 1.361 . . . . 0.0 111.581 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -155.7 149.31 25.07 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.538 1.935 . . . . 0.0 108.232 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.429 ' H ' HD23 ' A' ' 53' ' ' LEU . 89.4 t -130.33 133.44 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.577 1.151 . . . . 0.0 108.867 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.27 90.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.032 1.333 . . . . 0.0 109.47 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 m -134.39 157.34 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 t -130.76 -164.66 1.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.487 1.515 . . . . 0.0 112.747 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 m -130.69 150.14 52.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.519 1.928 . . . . 0.0 111.318 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 t -148.48 -171.18 3.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.315 2.246 . . . . 0.0 108.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 49.03 35.13 17.88 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.549 1.547 . . . . 0.0 116.122 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.555 ' H ' HM73 ' A' ' 201' ' ' FMN . 86.6 mt-30 63.57 4.0 1.67 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 127.461 2.304 . . . . 0.0 115.361 -174.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.01 39.79 0.02 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.09 162.2 36.15 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.282 1.541 . . . . 0.0 112.334 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.11 151.59 95.98 Favored Pre-proline 0 CA--C 1.553 1.089 0 O-C-N 121.682 -0.637 . . . . 0.0 111.739 170.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.91 158.33 20.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.391 2.728 . . . . 0.0 112.332 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.2 -21.39 63.79 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -57.27 -17.42 11.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.741 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -132.88 -9.49 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.83 -49.32 38.38 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.599 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.27 -24.72 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.967 1.738 . . . . 0.0 113.7 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.94 -47.49 45.11 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.367 -0.833 . . . . 0.0 110.118 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -58.68 -50.88 72.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.746 1.619 . . . . 0.0 112.151 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -62.88 -41.36 99.37 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.203 -0.935 . . . . 0.0 112.349 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.89 -47.67 80.25 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.451 1.024 . . . . 0.0 113.141 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.59 -39.4 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 118.979 1.39 . . . . 0.0 111.316 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.15 -47.88 75.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.087 0.555 . . . . 0.0 111.751 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.31 -36.29 24.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.9 m -84.15 -30.81 25.57 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -173.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.3 mt -100.13 -49.5 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.876 0.762 . . . . 0.0 112.622 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.67 -34.3 0.28 Allowed Glycine 0 CA--C 1.544 1.877 0 C-N-CA 126.21 1.862 . . . . 0.0 116.143 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -158.17 135.75 10.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.833 2.053 . . . . 0.0 110.349 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -156.87 97.77 2.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.939 0.895 . . . . 0.0 112.862 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.85 -20.72 10.18 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.473 2.782 . . . . 0.0 114.418 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -80.66 -17.21 51.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -174.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.9 tp -70.72 138.68 50.75 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 111.779 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -137.49 138.66 39.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 108.966 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -163.5 -173.37 3.29 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.48 162.87 28.49 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.393 1.949 . . . . 0.0 109.038 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.79 132.09 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.015 0.907 . . . . 0.0 112.971 -169.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.19 128.07 74.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.54 155.02 44.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.297 1.046 . . . . 0.0 110.293 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -139.53 151.85 46.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.342 1.057 . . . . 0.0 108.705 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.39 -144.26 7.86 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 112.078 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -137.77 121.27 17.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.916 0.887 . . . . 0.0 110.559 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.1 p -71.99 -2.17 17.22 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -69.92 4.2 2.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -136.87 159.39 41.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.21 1.804 . . . . 0.0 112.425 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.19 -32.42 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.83 1.252 . . . . 0.0 113.412 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -103.94 44.11 1.04 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.812 1.245 . . . . 0.0 112.409 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -49.38 111.37 0.48 Allowed 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.677 -1.264 . . . . 0.0 112.289 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.7 m 52.78 28.15 6.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.22 2.208 . . . . 0.0 116.955 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -53.22 -40.99 64.93 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.445 1.02 . . . . 0.0 112.225 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -36.89 92.84 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 122.132 -0.355 . . . . 0.0 113.134 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.19 46.58 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.557 -0.967 . . . . 0.0 113.052 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.91 -34.49 76.15 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.649 1.179 . . . . 0.0 113.057 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -60.43 -42.76 96.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.47 0.577 . . . . 0.0 111.626 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -71.47 -28.77 64.17 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -64.77 -50.91 64.97 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.624 -1.297 . . . . 0.0 110.241 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 -40.13 72.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.498 0.719 . . . . 0.0 112.901 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.5 tp -49.61 -27.32 4.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 114.111 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.0 -38.42 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 111.782 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -69.71 -16.16 63.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.895 0.878 . . . . 0.0 112.73 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -109.06 -15.3 14.37 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -170.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 m 112.73 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 129.731 3.212 . . . . 0.0 114.013 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.92 147.42 23.76 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 118.886 0.766 . . . . 0.0 111.898 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -121.72 84.02 2.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 109.855 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mtm105 -60.84 152.41 27.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.58 27.89 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.936 1.695 . . . . 0.0 110.869 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.2 175.06 46.93 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.372 1.939 . . . . 0.0 112.184 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -123.27 157.88 32.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.373 1.469 . . . . 0.0 111.88 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.9 ttm -63.92 117.02 6.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.369 1.068 . . . . 0.0 112.171 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.01 141.34 37.55 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.0 81.68 2.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 111.64 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.34 136.74 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 110.139 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -131.26 98.5 4.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.513 1.149 . . . . 0.0 113.679 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.13 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.323 1.449 . . . . 0.0 114.695 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.4 p -67.6 -19.42 65.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.567 1.076 . . . . 0.0 113.099 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.32 -8.94 1.13 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -134.63 108.64 10.98 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.018 0.927 . . . . 0.0 112.943 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.82 -0.63 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.336 3.358 . . . . 0.0 114.427 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.62 78.49 68.6 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.225 1.81 . . . . 0.0 109.713 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -60.58 -19.77 61.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.086 3.19 . . . . 0.0 115.368 -169.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -66.93 -29.69 69.62 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.962 -1.087 . . . . 0.0 113.893 172.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.7 p -68.24 -5.23 17.24 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -117.0 -8.76 11.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.131 1.372 . . . . 0.0 112.67 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -127.14 -27.1 3.01 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.11 -52.56 67.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.286 169.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.24 -30.24 37.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.643 1.562 . . . . 0.0 113.325 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -58.74 -50.03 75.44 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.891 0.769 . . . . 0.0 111.136 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t -67.85 -41.53 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.676 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -59.63 -39.62 84.91 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.782 0.719 . . . . 0.0 112.117 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -67.93 -58.86 3.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 111.891 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -54.43 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.713 1.205 . . . . 0.0 112.318 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.87 -23.77 16.71 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.914 1.721 . . . . 0.0 115.905 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.4 p -71.82 -17.65 62.14 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.735 1.767 . . . . 0.0 113.954 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.7 mt -93.95 -16.85 23.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.369 1.468 . . . . 0.0 112.996 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.44 150.49 35.34 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.224 2.21 . . . . 0.0 111.747 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.648 1.579 . . . . 0.0 113.624 177.819 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.555 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.34 171.01 8.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.114 1.366 . . . . 0.0 112.07 174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -139.96 119.81 13.45 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.07 1.748 . . . . 0.0 108.647 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.93 127.44 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.06 130.88 10.16 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 168.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -116.23 88.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.337 1.455 . . . . 0.0 107.176 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -88.46 126.73 35.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.857 -169.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.66 143.6 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.734 0.813 . . . . 0.0 110.691 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.35 96.64 0.27 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -143.87 170.34 16.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.546 1.138 . . . . 0.0 111.897 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.4 -0.63 5.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.756 1.223 . . . . 0.0 113.553 169.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -146.41 -24.05 0.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.36 -9.47 5.6 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 118.575 2.19 . . . . 0.0 118.575 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.08 -41.64 92.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.645 2.222 . . . . 0.0 113.432 -173.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -78.19 -34.64 49.36 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.763 -0.586 . . . . 0.0 111.993 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.2 tp -55.99 -39.76 72.31 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.066 -1.022 . . . . 0.0 113.069 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.15 -40.7 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 111.713 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -71.02 -41.26 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.907 0.483 . . . . 0.0 111.937 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.08 88.15 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.015 0.825 . . . . 0.0 112.499 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -60.56 -43.38 97.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.108 0.963 . . . . 0.0 112.676 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.48 -41.52 88.85 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.508 -0.745 . . . . 0.0 112.886 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.55 92.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.544 0.738 . . . . 0.0 111.809 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.5 -47.07 80.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.869 0.468 . . . . 0.0 111.869 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.91 88.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 112.694 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.7 -45.66 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.524 1.13 . . . . 0.0 111.892 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.9 mt -72.62 -38.16 67.85 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.4 m -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.454 1.101 . . . . 0.0 111.819 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.8 82.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.097 0.959 . . . . 0.0 113.157 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -73.07 -8.82 57.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 172.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.55 -2.46 32.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.428 1.49 . . . . 0.0 115.067 170.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -80.22 165.56 22.26 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.734 1.214 . . . . 0.0 112.631 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.5 134.18 35.22 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.08 142.32 31.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.193 0.597 . . . . 0.0 112.108 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.3 m -144.72 109.36 4.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.247 1.019 . . . . 0.0 111.025 -172.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -73.98 144.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -131.72 108.94 9.82 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.525 1.53 . . . . 0.0 108.442 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.8 -28.48 40.25 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -144.83 58.03 5.02 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.428 1.891 . . . . 0.0 110.1 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.73 159.65 52.81 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.768 2.979 . . . . 0.0 113.829 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.28 163.85 26.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.0 2.12 . . . . 0.0 108.926 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tt -42.47 -44.62 4.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.347 1.459 . . . . 0.0 112.881 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -54.78 -26.46 34.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.928 1.691 . . . . 0.0 114.849 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -81.16 -35.98 30.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.413 1.085 . . . . 0.0 112.333 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.436 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 26.2 t-105 -75.68 -39.01 58.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.883 0.873 . . . . 0.0 112.419 175.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -36.31 -56.02 1.31 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.098 2.559 . . . . 0.0 115.422 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.42 -18.71 22.75 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.38 2.054 . . . . 0.0 114.748 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -78.54 -0.89 31.4 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -58.72 -25.97 63.46 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.745 -1.222 . . . . 0.0 113.795 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -97.1 12.49 32.48 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.355 1.462 . . . . 0.0 112.632 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -134.25 -145.62 0.24 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.004 2.522 . . . . 0.0 109.3 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.21 162.97 29.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.232 1.813 . . . . 0.0 109.408 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 34.5 m -148.34 171.79 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.356 1.062 . . . . 0.0 111.662 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.18 144.43 17.32 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.365 -0.835 . . . . 0.0 110.894 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.77 130.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.937 1.695 . . . . 0.0 110.565 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.46 89.07 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -134.66 136.11 42.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -168.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -87.85 -170.08 2.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.943 2.097 . . . . 0.0 113.069 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 83.0 m -136.67 138.53 41.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.401 1.081 . . . . 0.0 111.32 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -155.49 -171.01 3.63 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.813 1.188 . . . . 0.0 111.62 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.8 -74.13 0.05 OUTLIER Glycine 0 CA--C 1.54 1.625 0 C-N-CA 128.207 2.813 . . . . 0.0 115.784 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -140.69 11.62 2.27 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.03 2.132 . . . . 0.0 111.835 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.25 38.48 1.65 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.269 0.938 . . . . 0.0 112.902 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -135.65 179.51 6.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.945 1.698 . . . . 0.0 112.658 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.78 142.25 98.52 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.53 1.132 . . . . 0.0 112.118 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.17 153.17 24.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.644 2.896 . . . . 0.0 111.973 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.32 -26.71 66.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -62.7 -11.15 15.52 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 tt -126.2 -3.42 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -53.53 -43.89 96.6 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 117.148 -1.406 . . . . 0.0 112.356 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.04 -5.37 2.73 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.373 3.382 . . . . 0.0 116.659 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mt -105.88 -48.48 3.62 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.461 1.105 . . . . 0.0 110.308 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.41 -41.34 96.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.666 0.787 . . . . 0.0 112.685 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -67.35 -44.44 79.05 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.451 -0.781 . . . . 0.0 112.214 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.98 -41.91 39.0 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.907 0.765 . . . . 0.0 113.938 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.16 -42.94 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.024 0.912 . . . . 0.0 110.053 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -66.16 -50.19 64.78 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.593 0.757 . . . . 0.0 112.234 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.44 -31.02 42.47 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.1 t -116.01 -43.36 2.99 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -169.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.48 -44.34 58.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.459 1.027 . . . . 0.0 111.709 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.15 -28.95 0.2 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 126.679 2.085 . . . . 0.0 118.142 169.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -155.62 138.31 15.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.836 1.654 . . . . 0.0 110.102 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.6 39.59 0.19 Allowed Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -169.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.8 -34.08 15.22 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.476 2.784 . . . . 0.0 118.054 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -72.34 -20.24 61.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.14 118.46 13.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.271 1.428 . . . . 0.0 110.16 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -117.91 139.92 50.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.382 1.473 . . . . 0.0 110.127 174.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.67 -169.05 1.97 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -168.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.3 32.62 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.231 2.348 . . . . 0.0 110.318 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.36 128.81 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.695 0.76 . . . . 0.0 111.644 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -118.13 95.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.15 153.52 24.76 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.05 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -142.64 152.99 43.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.108 0.956 . . . . 0.0 111.502 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.57 -130.1 1.66 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.862 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.77 136.34 21.72 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.252 1.421 . . . . 0.0 111.533 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.5 p -68.83 -4.19 15.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -68.4 3.69 1.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -135.08 151.64 50.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.371 1.468 . . . . 0.0 112.277 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.42 -37.14 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.883 0.873 . . . . 0.0 111.483 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -75.26 39.13 0.14 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.817 1.647 . . . . 0.0 112.907 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -52.21 116.06 2.04 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 119.653 -1.904 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 82.8 m 50.74 23.59 1.44 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.735 2.414 . . . . 0.0 117.174 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.3 -14.1 59.99 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.589 -1.319 . . . . 0.0 114.247 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.45 -28.54 63.43 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.134 -0.979 . . . . 0.0 113.414 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.21 -37.97 6.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.323 1.062 . . . . 0.0 113.313 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -56.66 -39.73 74.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.42 1.11 . . . . 0.0 113.658 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -60.11 -32.79 71.32 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -74.63 -22.2 59.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.56 -44.47 34.58 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.028 -1.67 . . . . 0.0 110.068 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.63 66.92 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 tp -50.67 -28.41 8.89 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.259 1.824 . . . . 0.0 113.322 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.01 -37.13 6.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.953 1.301 . . . . 0.0 111.997 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -68.8 -31.82 71.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.176 -0.952 . . . . 0.0 113.076 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.5 -10.66 36.53 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.123 0.874 . . . . 0.0 111.96 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -115.16 12.08 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.13 1.772 . . . . 0.0 112.816 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m 65.57 20.34 11.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.49 1.516 . . . . 0.0 114.86 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.45 169.5 0.89 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.667 0.787 . . . . 0.0 111.589 169.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -133.57 90.85 2.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.493 -1.379 . . . . 0.0 111.548 -169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -63.89 134.37 55.02 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.439 -0.788 . . . . 0.0 110.924 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.39 29.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.651 1.58 . . . . 0.0 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.61 -168.43 41.49 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.633 1.111 . . . . 0.0 113.852 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.29 152.26 26.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.65 1.58 . . . . 0.0 111.259 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.1 ttm -71.92 138.1 47.88 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.075 0.95 . . . . 0.0 111.957 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -94.07 137.22 33.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.545 0.738 . . . . 0.0 109.042 169.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 123' ' ' LEU . 47.6 mt -119.76 93.45 4.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.686 1.594 . . . . 0.0 110.884 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.4 mt -79.26 135.76 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.537 0.735 . . . . 0.0 111.357 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -124.5 113.05 17.6 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.374 1.47 . . . . 0.0 112.047 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.19 62.95 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.7 m -80.9 1.06 32.53 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.53 1.132 . . . . 0.0 113.553 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -126.52 -27.94 3.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.07 1.348 . . . . 0.0 112.855 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -143.82 117.53 5.93 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.83 0.852 . . . . 0.0 112.85 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.92 -5.72 13.91 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.925 3.084 . . . . 0.0 114.548 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -130.58 76.2 77.79 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.827 1.651 . . . . 0.0 110.662 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -41.69 -34.89 2.44 Favored 'Trans proline' 0 C--N 1.354 0.857 1 C-N-CA 126.001 4.468 . . . . 0.0 118.016 -169.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -51.64 -39.06 57.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.1 p -69.75 -4.89 21.83 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.037 -1.039 . . . . 0.0 113.598 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -121.76 6.03 9.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.43 1.492 . . . . 0.0 112.416 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.1 p -141.26 -26.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -55.05 -51.75 76.87 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.921 1.237 . . . . 0.0 113.433 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.48 -28.62 53.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.673 1.582 . . . . 0.0 113.052 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -60.91 -50.51 73.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.384 0.538 . . . . 0.0 111.297 170.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.51 -42.74 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.007 0.821 . . . . 0.0 110.488 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.59 -34.75 74.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.87 -64.27 0.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.074 0.852 . . . . 0.0 111.313 169.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -51.06 -49.16 61.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.57 1.548 . . . . 0.0 112.144 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.74 -26.3 24.72 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.368 1.461 . . . . 0.0 115.546 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -75.95 -15.5 60.16 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.232 1.516 . . . . 0.0 114.159 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.75 -15.94 33.44 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.181 0.992 . . . . 0.0 113.074 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.6 -18.16 65.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.337 1.455 . . . . 0.0 114.113 -175.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.948 1.699 . . . . 0.0 113.936 -171.177 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.5 -178.24 3.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.397 1.479 . . . . 0.0 112.826 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -126.99 130.13 49.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 109.503 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.41 126.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -171.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.03 130.72 10.07 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.7 mt -118.26 86.71 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.021 1.329 . . . . 0.0 107.594 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.284 -170.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.38 140.26 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.112 0.482 . . . . 0.0 111.416 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.4 112.46 1.35 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -153.77 152.04 30.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.832 0.853 . . . . 0.0 112.715 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.8 mmm -95.66 -25.18 16.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.166 0.987 . . . . 0.0 112.732 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.93 -12.37 0.65 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.39 -9.06 8.86 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 116.601 1.401 . . . . 0.0 116.601 170.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -61.23 -41.42 96.85 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.691 1.745 . . . . 0.0 113.078 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -76.59 -34.44 58.41 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.188 0.995 . . . . 0.0 112.059 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.39 -39.41 83.28 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.682 -1.261 . . . . 0.0 113.208 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.2 tp -52.96 -47.47 68.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.382 0.992 . . . . 0.0 111.558 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.58 -35.14 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.81 0.444 . . . . 0.0 111.586 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -68.28 -37.05 80.3 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.55 -42.5 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.547 -0.72 . . . . 0.0 111.593 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.87 -46.21 85.19 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.264 0.626 . . . . 0.0 111.981 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.89 87.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.359 0.527 . . . . 0.0 112.136 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.86 -48.36 75.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.985 0.514 . . . . 0.0 111.512 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.76 84.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.659 0.784 . . . . 0.0 112.754 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.9 mt -58.61 -46.3 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.653 1.181 . . . . 0.0 111.83 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.48 -40.01 67.25 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.876 -0.515 . . . . 0.0 109.869 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.0 m -56.98 -44.8 83.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.495 1.118 . . . . 0.0 112.159 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.79 83.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.067 0.947 . . . . 0.0 112.961 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.69 -23.9 63.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.38 -13.1 6.63 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.53 1.538 . . . . 0.0 114.832 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -71.44 143.4 50.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.255 1.028 . . . . 0.0 111.535 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -71.95 133.79 45.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 157.78 45.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.51 0.724 . . . . 0.0 111.977 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -151.63 110.53 3.86 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' HB1' ' A' ' 19' ' ' ALA . 7.5 p -79.65 150.71 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.721 0.808 . . . . 0.0 111.269 169.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -127.59 171.76 11.35 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.23 1.412 . . . . 0.0 111.592 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -128.7 -36.16 1.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -142.43 55.57 4.52 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 126.379 1.872 . . . . 0.0 111.511 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.01 155.58 54.64 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.063 3.175 . . . . 0.0 113.945 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.23 174.21 10.46 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.427 1.891 . . . . 0.0 110.165 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.16 -34.73 58.14 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.635 -1.291 . . . . 0.0 112.175 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.5 m -54.76 -21.8 12.16 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -96.34 -25.68 15.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.004 1.721 . . . . 0.0 112.614 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.455 ' CH2' HG21 ' A' ' 52' ' ' VAL . 60.7 t-105 -74.18 -39.6 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.228 1.011 . . . . 0.0 112.809 171.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -49.11 31.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.647 1.979 . . . . 0.0 113.349 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.25 -7.82 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.288 2.658 . . . . 0.0 115.942 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -127.82 0.36 6.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.867 1.667 . . . . 0.0 114.106 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.19 -23.12 63.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.401 1.455 . . . . 0.0 113.953 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -98.59 13.38 32.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.371 2.268 . . . . 0.0 113.302 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -139.45 -172.06 3.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.585 1.954 . . . . 0.0 111.648 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -76.62 154.52 34.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.064 0.935 . . . . 0.0 111.835 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.455 HG21 ' CH2' ' A' ' 44' ' ' TRP . 27.7 m -149.27 170.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.483 1.913 . . . . 0.0 110.264 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.93 153.24 22.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.57 0.748 . . . . 0.0 110.656 176.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.95 140.29 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.16 0.984 . . . . 0.0 111.764 -169.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 t -136.15 103.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.384 1.074 . . . . 0.0 110.249 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.6 m -140.43 143.09 35.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -93.67 -170.42 2.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.8 1.64 . . . . 0.0 113.497 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.3 m -135.95 137.22 41.08 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 111.626 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -161.43 -148.27 0.15 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.819 2.448 . . . . 0.0 107.214 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 41.94 44.87 4.73 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 126.227 1.87 . . . . 0.0 117.171 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.66 ' H ' HM73 ' A' ' 201' ' ' FMN . 8.9 tt0 63.92 26.04 14.11 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 113.997 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.11 26.43 3.51 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.198 1.38 . . . . 0.0 114.302 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -132.26 178.24 6.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 111.628 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -80.24 155.25 74.6 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.128 -0.983 . . . . 0.0 113.571 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.73 152.01 82.49 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.01 3.14 . . . . 0.0 113.446 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.16 -20.4 65.36 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.8 p -64.71 -13.1 53.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.334 1.454 . . . . 0.0 114.683 171.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.79 -7.4 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.706 1.202 . . . . 0.0 113.919 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -47.19 -50.73 45.9 Favored Pre-proline 0 N--CA 1.481 1.09 0 O-C-N 120.307 -1.496 . . . . 0.0 113.035 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.07 -4.91 16.06 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.135 1.89 . . . . 0.0 114.253 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.36 -47.15 7.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.907 0.883 . . . . 0.0 109.134 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.37 -50.71 68.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.998 1.319 . . . . 0.0 112.107 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -62.75 -39.02 92.83 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.196 -0.94 . . . . 0.0 112.829 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.69 -41.93 48.59 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.445 1.022 . . . . 0.0 112.514 -174.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.98 -45.19 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.426 1.113 . . . . 0.0 109.482 174.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.09 -50.0 74.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.261 1.024 . . . . 0.0 112.301 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.21 -34.68 56.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.098 0.959 . . . . 0.0 113.542 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -96.72 -35.89 10.85 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -169.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 mp -89.44 -44.01 10.46 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.375 0.988 . . . . 0.0 113.365 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.44 -39.87 0.36 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 126.371 1.938 . . . . 0.0 117.118 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -157.71 134.21 9.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.511 1.524 . . . . 0.0 110.954 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -158.54 52.92 0.56 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.02 -21.38 73.1 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.96 2.44 . . . . 0.0 115.052 -173.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -72.0 -21.61 61.54 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.935 1.294 . . . . 0.0 113.876 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.97 138.64 38.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 111.114 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -133.38 143.64 49.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.691 1.996 . . . . 0.0 109.929 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.35 -170.86 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.63 28.82 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 127.676 2.56 . . . . 0.0 109.345 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.43 136.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 117.942 0.871 . . . . 0.0 110.516 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.71 104.81 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.23 25.42 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.571 -0.706 . . . . 0.0 109.871 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -139.26 153.17 47.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.227 1.011 . . . . 0.0 111.106 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.31 -147.66 11.3 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.065 0.84 . . . . 0.0 111.46 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.12 121.32 16.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.57 1.948 . . . . 0.0 109.235 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.6 p -67.12 -2.89 6.23 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -64.01 -25.6 68.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.064 0.946 . . . . 0.0 113.16 170.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -86.49 145.74 26.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.114 0.965 . . . . 0.0 112.14 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.05 -36.33 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.504 1.121 . . . . 0.0 112.422 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -87.14 -1.1 57.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.5 t80 26.72 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.569 2.747 . . . . 0.0 115.699 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 27.9 p -121.94 17.16 10.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.138 1.775 . . . . 0.0 113.853 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.03 -31.04 39.06 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.82 1.248 . . . . 0.0 113.959 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.62 -35.28 80.18 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 123.636 0.636 . . . . 0.0 113.558 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.81 -41.86 14.17 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 120.94 -1.33 . . . . 0.0 113.022 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -57.08 -36.29 70.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.139 0.976 . . . . 0.0 113.248 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -58.12 -40.03 80.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.466 0.706 . . . . 0.0 112.689 172.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.37 -30.72 62.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.45 1.023 . . . . 0.0 112.618 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.36 -45.21 92.21 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.201 -1.562 . . . . 0.0 110.55 169.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.7 -37.56 76.36 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.3 tp -52.79 -33.82 50.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.841 1.257 . . . . 0.0 112.342 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.44 -37.67 10.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.713 1.205 . . . . 0.0 111.771 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.19 -32.82 74.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.091 -1.006 . . . . 0.0 113.429 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.47 -13.26 38.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.444 1.098 . . . . 0.0 112.588 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.32 8.07 14.12 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.556 1.542 . . . . 0.0 112.114 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 m 71.65 17.66 5.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.855 2.062 . . . . 0.0 114.454 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 168.94 1.34 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.94 0.896 . . . . 0.0 111.691 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -131.13 101.67 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.734 -1.229 . . . . 0.0 112.088 -169.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 ttm105 -67.35 134.12 50.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.923 -1.11 . . . . 0.0 111.182 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.53 31.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.726 1.61 . . . . 0.0 111.781 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.05 -178.47 45.02 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.473 -1.392 . . . . 0.0 114.027 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.31 136.56 33.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.449 1.099 . . . . 0.0 110.589 170.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.0 ttp -63.4 127.58 31.93 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.874 0.87 . . . . 0.0 111.216 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.471 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -84.81 139.46 31.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 109.644 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.471 ' N ' HD13 ' A' ' 123' ' ' LEU . 37.3 mt -123.95 90.42 3.26 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.858 1.263 . . . . 0.0 111.058 -176.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -72.13 136.56 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.182 0.993 . . . . 0.0 110.673 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -129.7 105.65 8.18 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.047 1.339 . . . . 0.0 111.471 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.32 27.44 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -82.92 -6.55 59.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.445 1.02 . . . . 0.0 113.721 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.64 -26.34 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.571 . . . . 0.0 112.52 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -143.01 113.07 5.76 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.811 1.245 . . . . 0.0 111.239 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.69 -1.38 11.55 Favored 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.646 2.897 . . . . 0.0 114.497 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.43 79.12 74.55 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.485 1.514 . . . . 0.0 111.6 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.43 -34.31 7.38 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.782 4.321 . . . . 0.0 116.781 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -52.31 -45.76 65.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 112.233 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -17.0 64.42 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -95.89 -5.65 41.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.211 1.405 . . . . 0.0 112.705 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.31 -30.04 0.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -51.64 -53.83 46.2 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 119.533 1.061 . . . . 0.0 113.451 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.62 -29.52 29.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.556 1.504 . . . . 0.0 113.013 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.2 -48.06 81.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.439 0.695 . . . . 0.0 111.404 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.7 t -67.67 -41.19 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.565 0.62 . . . . 0.0 110.614 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -58.89 -41.74 87.9 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.741 0.701 . . . . 0.0 111.896 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -65.43 -57.78 7.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.874 0.87 . . . . 0.0 112.162 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -53.98 -44.32 70.7 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 111.9 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.34 -19.99 35.0 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.502 1.525 . . . . 0.0 115.995 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p -72.07 -19.0 61.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.982 1.891 . . . . 0.0 113.974 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.9 mt -93.23 -16.41 24.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.107 1.363 . . . . 0.0 113.061 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.22 150.19 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.505 2.322 . . . . 0.0 111.624 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.389 1.475 . . . . 0.0 113.689 179.721 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.66 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.487 0.184 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.14 -176.88 4.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.591 1.956 . . . . 0.0 110.914 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -140.51 123.96 16.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.555 1.142 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 mm -124.27 136.67 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.93 127.41 9.22 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.3 mt -117.6 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.466 1.106 . . . . 0.0 108.591 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -91.56 138.28 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.037 0.935 . . . . 0.0 111.492 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.63 143.37 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.684 0.754 . . . . 0.0 111.457 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.48 90.39 0.21 Allowed Glycine 0 N--CA 1.463 0.495 0 C-N-CA 125.347 1.451 . . . . 0.0 109.653 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -134.66 165.73 24.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.173 0.989 . . . . 0.0 113.235 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -121.63 -32.14 3.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.179 1.792 . . . . 0.0 110.996 -175.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -134.5 -5.3 2.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.611 1.564 . . . . 0.0 113.861 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -0.56 52.92 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.362 1.081 . . . . 0.0 112.776 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -76.19 -32.71 59.15 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.546 1.138 . . . . 0.0 112.872 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.87 -39.03 80.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.641 -1.287 . . . . 0.0 112.796 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.55 -41.17 72.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.572 0.623 . . . . 0.0 111.751 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.9 -35.19 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 121.753 -0.592 . . . . 0.0 112.205 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.59 95.33 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.201 -0.937 . . . . 0.0 112.662 172.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.99 -41.06 97.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.356 0.662 . . . . 0.0 112.337 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.61 -46.79 87.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.535 -0.728 . . . . 0.0 111.902 169.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.5 88.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.224 0.61 . . . . 0.0 112.317 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.15 -47.02 79.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 111.993 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -45.66 92.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.419 0.688 . . . . 0.0 112.643 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.68 -47.38 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.569 1.148 . . . . 0.0 112.094 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -68.39 -39.77 81.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 109.744 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.8 m -55.77 -50.48 70.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.7 1.2 . . . . 0.0 111.855 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.3 77.65 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -77.31 -5.52 49.82 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.84 24.32 10.0 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.918 0.781 . . . . 0.0 114.648 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -115.93 145.69 42.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.742 1.217 . . . . 0.0 111.389 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -74.27 138.25 43.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.13 43.27 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.606 -0.684 . . . . 0.0 111.994 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -154.7 120.13 5.06 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.76 176.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.0 140.26 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.18 0.992 . . . . 0.0 110.958 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.09 110.65 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.002 1.321 . . . . 0.0 109.701 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.99 -17.66 28.97 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -144.93 56.65 3.87 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.635 1.574 . . . . 0.0 110.612 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.34 162.21 40.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.941 3.094 . . . . 0.0 115.185 -169.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.67 175.07 9.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.213 2.205 . . . . 0.0 109.668 169.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -50.73 -40.85 55.56 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.902 -1.124 . . . . 0.0 112.414 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -58.43 -14.77 8.49 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -96.81 -27.33 14.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -82.46 -39.61 22.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.452 1.501 . . . . 0.0 112.221 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -49.16 -45.3 75.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.849 1.66 . . . . 0.0 114.495 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -57.29 -10.6 6.64 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.225 2.617 . . . . 0.0 116.899 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -114.65 4.27 15.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.74 -23.32 67.32 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.263 1.392 . . . . 0.0 114.273 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -92.32 4.2 53.84 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.948 1.299 . . . . 0.0 113.525 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -130.89 -141.06 0.22 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.46 2.304 . . . . 0.0 109.771 -169.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.16 158.7 34.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.672 1.189 . . . . 0.0 111.361 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.96 168.77 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.274 1.429 . . . . 0.0 110.936 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.97 149.63 19.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.98 0.912 . . . . 0.0 110.387 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.87 135.26 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.052 1.341 . . . . 0.0 110.302 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.3 90.73 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.153 1.381 . . . . 0.0 107.581 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.8 m -133.57 168.36 18.79 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -141.51 -174.33 4.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.106 1.363 . . . . 0.0 113.432 -171.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.8 m -131.62 135.61 47.08 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.609 1.164 . . . . 0.0 110.824 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 t -153.71 -167.37 2.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.393 1.877 . . . . 0.0 109.929 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' HM73 ' A' ' 201' ' ' FMN . . . 45.52 -129.87 9.16 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 126.039 1.781 . . . . 0.0 114.078 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -65.79 -4.23 6.29 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.51 39.52 1.0 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.985 1.279 . . . . 0.0 112.574 -170.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -135.13 176.41 8.69 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.602 1.961 . . . . 0.0 113.85 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.37 136.54 60.74 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.146 1.378 . . . . 0.0 113.283 171.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.27 150.19 89.26 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.55 2.833 . . . . 0.0 111.523 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -60.65 -17.4 47.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -57.34 -17.5 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.292 1.837 . . . . 0.0 114.585 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.27 -10.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.3 t -47.1 -45.58 53.1 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 116.867 -1.539 . . . . 0.0 113.664 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.16 -27.65 35.13 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 122.676 1.991 . . . . 0.0 113.82 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.29 -47.17 65.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.023 0.829 . . . . 0.0 110.778 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.25 -47.58 84.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.126 1.37 . . . . 0.0 112.382 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -60.16 -48.95 79.57 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.295 -0.878 . . . . 0.0 112.101 171.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.64 95.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.194 0.902 . . . . 0.0 113.506 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.01 -45.87 97.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.479 1.139 . . . . 0.0 110.486 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.12 -47.04 86.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.978 0.511 . . . . 0.0 112.18 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.95 -37.25 29.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.395 1.478 . . . . 0.0 114.327 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 m -121.39 10.5 10.54 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -168.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.14 -47.18 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.713 1.142 . . . . 0.0 112.474 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.44 -34.86 0.45 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -157.23 137.55 12.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.475 1.637 . . . . 0.0 111.515 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -158.94 63.74 2.46 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.533 1.133 . . . . 0.0 113.34 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.48 -15.02 42.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.416 3.411 . . . . 0.0 116.77 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -120.9 -0.47 10.08 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.555 1.542 . . . . 0.0 114.384 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.02 141.78 47.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.973 0.909 . . . . 0.0 109.578 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -131.07 138.92 49.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 111.338 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -154.67 -171.17 3.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -170.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.71 161.8 31.64 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 127.595 2.521 . . . . 0.0 109.911 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.07 135.46 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.91 0.855 . . . . 0.0 111.879 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.5 mt -119.3 128.8 75.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.4 145.23 48.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.652 1.181 . . . . 0.0 110.231 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.75 139.49 31.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.85 0.86 . . . . 0.0 110.419 -171.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.37 -147.0 6.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -138.74 124.41 19.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.998 0.919 . . . . 0.0 110.649 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.9 p -70.05 -3.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -68.37 -0.92 5.41 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.029 1.331 . . . . 0.0 114.313 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.74 155.88 44.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.071 1.749 . . . . 0.0 112.045 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.1 m -77.21 1.26 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.61 44.74 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.255 1.422 . . . . 0.0 110.315 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -52.05 115.93 1.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.022 -1.674 . . . . 0.0 112.745 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 94.5 m 51.01 26.99 2.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -58.99 -31.79 69.09 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.045 -1.034 . . . . 0.0 113.498 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.43 87.84 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.134 0.879 . . . . 0.0 112.625 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.62 99.54 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.845 -1.385 . . . . 0.0 112.639 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.06 -40.86 97.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.908 0.883 . . . . 0.0 113.001 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -58.95 -42.13 89.08 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.075 0.95 . . . . 0.0 111.637 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.09 -30.54 63.74 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.52 -45.04 76.9 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.007 -1.683 . . . . 0.0 110.963 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.31 74.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.835 0.854 . . . . 0.0 113.212 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -50.53 -31.84 16.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.461 1.504 . . . . 0.0 112.994 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.35 -36.74 8.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.619 1.168 . . . . 0.0 111.766 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -65.49 -31.46 72.54 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.368 -0.833 . . . . 0.0 113.161 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.36 -15.32 57.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.021 . . . . 0.0 112.752 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -113.52 3.53 15.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.081 1.353 . . . . 0.0 112.652 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m 74.68 15.85 3.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.619 1.968 . . . . 0.0 113.955 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.11 164.49 6.72 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -121.93 150.79 41.5 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.869 -1.144 . . . . 0.0 110.585 -170.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -132.01 108.04 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 121.32 -0.863 . . . . 0.0 111.198 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.69 45.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.405 1.482 . . . . 0.0 112.329 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.54 -168.88 42.01 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.402 1.953 . . . . 0.0 111.995 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.42 147.78 50.67 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.223 -1.163 . . . . 0.0 112.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -66.26 123.54 20.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.781 1.232 . . . . 0.0 112.028 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -81.61 138.1 35.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.071 0.948 . . . . 0.0 110.238 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.1 mt -125.49 93.38 3.84 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.722 1.209 . . . . 0.0 111.661 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.8 mt -84.48 138.9 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.586 1.554 . . . . 0.0 111.234 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -125.72 105.17 8.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.001 1.32 . . . . 0.0 112.323 -177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.75 -21.86 43.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.14 1.376 . . . . 0.0 114.267 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -77.86 -7.88 57.29 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -126.36 -26.4 3.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.363 1.465 . . . . 0.0 112.415 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -143.86 114.77 5.52 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.897 0.879 . . . . 0.0 112.313 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.01 -0.68 10.12 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.309 3.339 . . . . 0.0 114.526 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.89 76.51 71.05 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.009 1.724 . . . . 0.0 109.942 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -61.16 -20.13 66.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.236 3.29 . . . . 0.0 115.796 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.45 -35.01 71.47 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.773 -1.204 . . . . 0.0 113.653 169.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 p -66.9 -9.56 39.31 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -109.77 -12.14 14.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.605 1.162 . . . . 0.0 112.103 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 p -126.29 -27.74 3.17 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.23 -52.76 65.99 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 119.64 1.109 . . . . 0.0 113.26 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.77 -30.13 27.83 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.726 1.617 . . . . 0.0 112.826 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -61.32 -48.74 79.98 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.671 -0.643 . . . . 0.0 111.719 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.25 -40.2 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.339 0.518 . . . . 0.0 110.474 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -59.7 -36.34 76.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.893 0.77 . . . . 0.0 112.56 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.41 -59.69 2.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.935 0.789 . . . . 0.0 111.986 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -53.08 -46.24 68.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.462 1.105 . . . . 0.0 112.09 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -24.68 5.52 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.218 1.866 . . . . 0.0 116.172 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.3 p -73.99 -21.38 60.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.723 1.762 . . . . 0.0 114.184 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.21 -23.25 47.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.314 1.046 . . . . 0.0 112.952 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.5 -28.95 69.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.6 1.56 . . . . 0.0 114.823 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.386 1.475 . . . . 0.0 111.935 173.535 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.405 HM73 ' O ' ' A' ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.53 175.57 8.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.944 1.698 . . . . 0.0 112.119 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.99 121.17 20.08 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.882 1.273 . . . . 0.0 110.399 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.6 125.39 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.911 0.885 . . . . 0.0 113.228 -169.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.98 124.74 7.0 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -117.01 99.07 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.763 1.282 . . . . 0.0 108.995 -170.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -99.66 136.61 39.33 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.06 0.944 . . . . 0.0 110.681 -169.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.83 145.69 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.432 0.634 . . . . 0.0 111.54 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.31 100.51 0.38 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.8 t -151.46 163.97 37.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.285 1.034 . . . . 0.0 113.131 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -122.9 -0.98 8.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.651 1.58 . . . . 0.0 112.54 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -141.08 -58.78 0.5 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.88 0.872 . . . . 0.0 113.053 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.27 -2.5 0.42 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -61.04 -44.99 96.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.6 1.2 . . . . 0.0 112.862 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.1 p -75.96 -32.76 59.66 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.182 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.8 tp -60.03 -40.4 89.2 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.753 -1.217 . . . . 0.0 112.794 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.9 tp -54.97 -42.85 72.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.732 0.697 . . . . 0.0 111.86 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.41 -36.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 121.805 -0.559 . . . . 0.0 111.895 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.27 97.72 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.25 -0.906 . . . . 0.0 112.941 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.88 -41.02 97.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 112.257 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -59.77 -47.54 85.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.581 0.752 . . . . 0.0 111.984 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.02 86.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.372 0.669 . . . . 0.0 112.308 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.79 -46.64 77.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 112.001 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.75 91.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.661 0.784 . . . . 0.0 112.809 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.66 -45.69 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.741 1.216 . . . . 0.0 112.04 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.6 mt -68.09 -42.25 80.61 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.596 -0.69 . . . . 0.0 109.594 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -55.24 -47.97 74.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.757 1.223 . . . . 0.0 112.214 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.35 80.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.117 0.967 . . . . 0.0 113.29 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.14 -8.58 56.67 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.54 -3.61 56.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.198 1.38 . . . . 0.0 114.583 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -73.27 177.05 5.4 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -115.96 147.36 41.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.152 1.381 . . . . 0.0 109.548 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.25 164.32 35.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.463 -0.773 . . . . 0.0 112.642 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 m -152.93 121.01 6.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.811 0.845 . . . . 0.0 110.991 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.2 141.37 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.795 1.238 . . . . 0.0 111.428 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -130.32 109.73 10.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.412 1.485 . . . . 0.0 110.253 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.25 -16.27 40.74 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -147.94 54.77 1.96 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.886 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.17 163.48 34.89 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.6 2.867 . . . . 0.0 113.949 -170.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.0 173.65 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.821 2.048 . . . . 0.0 109.482 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.59 -40.1 62.31 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.435 -1.416 . . . . 0.0 112.499 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.1 m -62.69 -13.84 37.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -92.73 -33.61 14.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.549 1.139 . . . . 0.0 112.187 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -68.21 -48.14 65.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 112.229 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.5 tp -45.95 -49.25 39.83 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.524 2.329 . . . . 0.0 114.522 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.59 -17.4 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.898 3.732 . . . . 0.0 117.92 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.49 -0.4 15.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.21 -20.2 65.66 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.12 -1.93 54.14 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.793 1.237 . . . . 0.0 113.264 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -132.48 -130.87 0.18 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.41 2.284 . . . . 0.0 109.595 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -135.26 157.8 45.99 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.035 1.334 . . . . 0.0 110.093 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.85 168.45 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.008 0.923 . . . . 0.0 111.732 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tp -159.85 145.15 15.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.104 0.962 . . . . 0.0 110.569 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.66 132.43 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.522 1.529 . . . . 0.0 110.921 -169.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.57 87.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.1 m -131.16 159.09 38.72 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -167.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -129.87 -171.62 2.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.621 1.568 . . . . 0.0 113.187 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.0 m -123.86 153.32 41.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.895 1.278 . . . . 0.0 111.734 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.34 -177.68 6.35 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.646 1.578 . . . . 0.0 111.836 -168.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.407 ' O ' HM73 ' A' ' 201' ' ' FMN . . . 53.28 -84.21 0.01 OUTLIER Glycine 0 CA--C 1.545 1.935 0 C-N-CA 127.358 2.409 . . . . 0.0 117.108 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -142.43 18.26 2.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.636 1.574 . . . . 0.0 111.014 170.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.01 14.46 1.83 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 114.657 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.81 160.37 14.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.116 2.167 . . . . 0.0 113.446 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.12 145.34 97.58 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 121.563 -0.711 . . . . 0.0 111.134 170.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.39 150.17 32.06 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.679 2.919 . . . . 0.0 111.003 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.84 -25.31 64.9 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -172.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 m -59.81 -13.98 12.87 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 172.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 tt -133.3 -7.15 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.1 t -47.71 -49.96 54.07 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.504 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.83 -9.2 25.52 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.187 1.925 . . . . 0.0 114.209 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.84 -48.8 7.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.04 1.336 . . . . 0.0 108.793 172.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -65.19 -48.79 72.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.96 1.304 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -63.69 -39.2 93.73 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.051 -1.031 . . . . 0.0 111.943 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.82 -48.86 72.62 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 124.071 0.843 . . . . 0.0 112.258 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -64.15 -46.74 92.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 118.068 0.934 . . . . 0.0 110.658 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.12 -35.3 78.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -109.62 -23.5 11.43 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.4 m -113.95 2.11 14.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.9 mt -122.91 -139.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.635 1.574 . . . . 0.0 108.104 169.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.52 -21.0 0.54 Allowed Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.157 -0.964 . . . . 0.0 114.501 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -159.66 126.72 4.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.053 0.926 . . . . 0.0 113.03 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -152.82 61.19 3.66 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 126.262 1.825 . . . . 0.0 112.034 -177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.68 -26.46 80.07 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.003 3.135 . . . . 0.0 115.249 -169.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -82.57 -10.35 59.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.334 1.454 . . . . 0.0 114.678 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.7 140.22 40.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.964 0.802 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -130.94 142.92 50.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.675 1.99 . . . . 0.0 110.847 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -159.47 -171.44 3.31 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -169.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.47 165.98 33.6 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.39 2.424 . . . . 0.0 111.201 172.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.14 137.53 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 118.074 0.937 . . . . 0.0 112.189 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.441 HD11 ' CE3' ' A' ' 140' ' ' TRP . 41.4 mt -127.88 98.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.59 153.02 25.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.208 0.527 . . . . 0.0 110.261 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -140.71 138.41 34.2 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.106 0.962 . . . . 0.0 110.58 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.2 4.87 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 122.041 -0.412 . . . . 0.0 112.55 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -150.74 135.57 17.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -5.17 10.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.988 2.115 . . . . 0.0 115.259 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -66.46 1.71 1.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -138.68 156.68 47.21 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.215 1.806 . . . . 0.0 111.627 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.68 -33.8 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -96.18 48.56 1.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.843 0.857 . . . . 0.0 111.718 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -49.92 114.77 1.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.341 -1.475 . . . . 0.0 112.701 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m 51.03 24.84 2.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -59.31 -29.63 67.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.829 -1.17 . . . . 0.0 113.259 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.37 -35.19 91.65 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 113.388 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.92 -40.45 10.56 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.526 -0.985 . . . . 0.0 112.896 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.11 -39.28 78.25 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.197 0.999 . . . . 0.0 113.291 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.7 -35.98 75.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.171 0.588 . . . . 0.0 112.57 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -74.81 -36.01 62.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.338 -0.851 . . . . 0.0 112.502 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.56 -42.87 99.47 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 119.81 -1.806 . . . . 0.0 111.303 169.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.49 88.42 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -52.93 -44.75 67.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.819 1.247 . . . . 0.0 111.142 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.09 -33.55 67.97 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -33.12 74.33 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.033 -1.042 . . . . 0.0 111.875 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.55 -17.96 64.41 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.081 -1.012 . . . . 0.0 112.77 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -99.59 6.09 45.82 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.529 1.532 . . . . 0.0 112.35 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m 58.58 19.99 7.2 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.082 1.753 . . . . 0.0 114.913 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.99 154.02 27.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.394 0.678 . . . . 0.0 111.691 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -117.15 99.9 7.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.087 1.355 . . . . 0.0 111.005 -169.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -67.8 133.89 50.01 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.055 -1.028 . . . . 0.0 111.289 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.81 33.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.92 -163.12 36.2 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.982 1.277 . . . . 0.0 112.432 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -125.86 152.47 45.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.092 1.357 . . . . 0.0 112.382 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.7 ttp -69.03 123.95 22.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.48 1.512 . . . . 0.0 111.963 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.3 tm? -80.97 140.72 35.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.914 0.885 . . . . 0.0 109.397 172.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' N ' HD13 ' A' ' 123' ' ' LEU . 59.4 mt -123.24 92.75 3.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.614 1.566 . . . . 0.0 111.167 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.98 137.74 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.355 1.062 . . . . 0.0 111.157 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.87 118.48 32.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.94 1.296 . . . . 0.0 111.402 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.7 92.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.9 m -63.41 -41.08 98.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.61 -32.65 68.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.992 0.917 . . . . 0.0 112.43 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -145.4 99.48 4.51 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.163 0.985 . . . . 0.0 112.705 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.9 2.07 7.94 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.898 3.066 . . . . 0.0 114.29 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -122.42 71.84 37.41 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.292 1.837 . . . . 0.0 109.37 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -58.78 -20.62 52.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.646 3.564 . . . . 0.0 116.149 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.84 -39.27 77.27 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.126 -0.984 . . . . 0.0 112.776 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.9 p -68.78 -6.32 25.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.291 1.036 . . . . 0.0 113.526 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.52 -2.33 17.69 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.461 1.505 . . . . 0.0 112.161 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.6 p -139.67 -28.1 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -51.95 -54.0 45.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.8 -28.13 30.53 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.666 1.577 . . . . 0.0 112.951 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.441 ' CE3' HD11 ' A' ' 90' ' ' ILE . 75.5 t90 -63.22 -47.79 81.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.381 0.672 . . . . 0.0 111.524 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.01 -40.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.587 0.631 . . . . 0.0 110.358 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -58.78 -44.76 90.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.672 0.669 . . . . 0.0 111.719 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -61.72 -56.09 23.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.984 0.914 . . . . 0.0 112.357 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -53.34 -48.62 68.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.599 1.16 . . . . 0.0 111.209 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.03 -21.81 32.82 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.586 1.565 . . . . 0.0 116.144 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -68.88 -19.41 64.23 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.507 2.154 . . . . 0.0 113.517 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -99.31 -14.88 19.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.0 113.109 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.53 147.75 48.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.185 1.394 . . . . 0.0 111.722 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.119 -172.586 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.407 HM73 ' O ' ' A' ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.22 178.41 6.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.974 1.71 . . . . 0.0 112.098 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -135.35 116.5 14.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.204 1.402 . . . . 0.0 109.31 -173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -118.72 125.39 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.95 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.53 125.05 7.52 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -114.1 91.17 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.294 1.047 . . . . 0.0 108.256 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -94.02 136.58 34.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.689 0.796 . . . . 0.0 110.872 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.87 142.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.879 0.847 . . . . 0.0 111.086 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.75 79.47 0.32 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -128.04 172.51 10.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.133 0.973 . . . . 0.0 112.974 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.5 tpt -129.67 -34.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.684 1.993 . . . . 0.0 111.627 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -132.17 1.16 3.83 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.35 -1.43 58.84 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -66.19 -42.5 88.77 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.916 1.358 . . . . 0.0 112.164 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -37.32 77.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.337 1.455 . . . . 0.0 112.639 170.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.47 -36.93 76.94 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.725 -1.234 . . . . 0.0 113.513 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -51.85 -45.19 63.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.937 0.79 . . . . 0.0 111.792 172.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.49 -36.54 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.045 -0.41 . . . . 0.0 111.7 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.09 99.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.098 0.863 . . . . 0.0 112.672 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.61 -41.96 98.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.216 0.607 . . . . 0.0 112.347 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.22 -42.19 96.69 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.363 -0.836 . . . . 0.0 112.692 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.9 91.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.494 0.717 . . . . 0.0 112.291 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.55 -47.04 80.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.406 0.682 . . . . 0.0 111.369 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.47 86.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.463 0.705 . . . . 0.0 112.649 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.72 -46.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.046 1.338 . . . . 0.0 112.362 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.46 -39.99 70.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -175.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -57.48 -46.4 83.74 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.552 1.141 . . . . 0.0 111.931 170.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.34 77.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.0 -11.7 60.66 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.33 40.0 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.579 1.561 . . . . 0.0 114.705 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -75.26 153.17 38.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.436 1.118 . . . . 0.0 111.526 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -80.62 135.69 36.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.35 154.55 43.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.13 0.572 . . . . 0.0 111.942 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 m -153.31 122.7 6.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.906 0.883 . . . . 0.0 111.184 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 140.58 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.332 1.053 . . . . 0.0 110.96 171.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -129.0 112.06 13.64 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.82 1.248 . . . . 0.0 110.333 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.49 -11.51 31.86 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.16 53.76 2.14 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.868 1.267 . . . . 0.0 111.794 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.6 162.39 42.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.64 2.893 . . . . 0.0 114.827 -172.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -131.24 169.61 15.71 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.471 2.308 . . . . 0.0 109.295 169.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.34 62.8 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.267 -1.521 . . . . 0.0 112.376 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -61.82 -12.58 18.02 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -92.93 -32.47 14.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.823 1.249 . . . . 0.0 112.216 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -70.75 -42.44 70.49 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.907 0.883 . . . . 0.0 111.926 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.6 tp -47.84 -47.27 63.11 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 127.872 2.469 . . . . 0.0 115.787 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 -9.01 25.17 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.704 2.269 . . . . 0.0 114.881 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -119.53 -15.73 8.98 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -61.77 -27.41 68.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.196 1.362 . . . . 0.0 113.081 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.72 5.97 14.19 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.921 1.288 . . . . 0.0 113.968 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -128.59 -118.95 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.999 2.52 . . . . 0.0 108.245 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -135.56 157.88 45.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.155 1.782 . . . . 0.0 108.833 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 166.39 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.231 1.012 . . . . 0.0 110.613 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.95 144.92 17.97 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.413 -0.804 . . . . 0.0 110.296 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -113.97 133.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.654 1.582 . . . . 0.0 110.467 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 t -134.33 92.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 m -135.4 154.79 51.35 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 p -133.95 -171.56 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.511 1.524 . . . . 0.0 112.469 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -122.06 153.37 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.439 1.096 . . . . 0.0 111.068 -170.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -155.14 -167.69 2.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.574 1.95 . . . . 0.0 109.31 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.23 44.98 10.37 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.715 1.626 . . . . 0.0 116.582 169.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.655 ' H ' HM73 ' A' ' 201' ' ' FMN . 79.8 mt-30 64.13 14.93 8.95 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.653 1.981 . . . . 0.0 115.11 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.38 21.07 0.23 Allowed Glycine 0 CA--C 1.537 1.43 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -129.76 173.32 10.76 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.618 1.709 . . . . 0.0 113.803 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.7 mt -64.76 147.3 98.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.306 1.442 . . . . 0.0 112.967 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -82.1 154.63 16.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.785 2.99 . . . . 0.0 111.87 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -58.78 -23.34 60.05 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.8 m -54.95 -19.1 5.97 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.992 1.717 . . . . 0.0 115.04 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.54 -5.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -45.87 -44.45 33.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 117.183 -1.389 . . . . 0.0 113.442 170.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.04 -27.51 57.66 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 122.375 1.884 . . . . 0.0 114.666 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mt -73.8 -48.54 30.74 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.06 1.3 . . . . 0.0 110.807 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.52 -38.87 82.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.835 1.254 . . . . 0.0 112.909 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -75.08 -48.31 24.52 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.178 -0.952 . . . . 0.0 112.037 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.39 82.34 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 123.795 0.712 . . . . 0.0 113.991 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.89 -44.35 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.262 1.031 . . . . 0.0 110.357 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.28 -48.37 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.196 0.998 . . . . 0.0 112.137 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.01 -41.31 59.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.235 1.414 . . . . 0.0 114.382 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.0 m -123.74 -14.64 7.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -168.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.77 -50.25 7.3 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.662 1.574 . . . . 0.0 109.599 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 -40.45 0.47 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 126.536 2.017 . . . . 0.0 117.598 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -157.68 138.53 13.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.165 1.483 . . . . 0.0 111.492 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -159.49 100.48 1.53 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.886 1.275 . . . . 0.0 111.2 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.58 -16.27 8.07 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.627 2.885 . . . . 0.0 115.067 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -110.5 -9.3 14.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.349 1.46 . . . . 0.0 113.889 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.5 tp -55.62 124.69 18.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.4 1.88 . . . . 0.0 111.113 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -128.21 140.87 51.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.725 1.61 . . . . 0.0 109.856 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -161.56 -169.29 2.22 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.68 160.7 30.48 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 127.205 2.336 . . . . 0.0 109.862 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.2 t -140.46 133.76 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.835 0.818 . . . . 0.0 111.399 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.417 HD11 ' CE3' ' A' ' 140' ' ' TRP . 42.1 mt -122.32 100.43 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.78 153.36 25.28 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 0.0 109.736 169.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.16 142.24 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.0 0.92 . . . . 0.0 110.602 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.43 -144.22 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.549 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -146.43 120.2 9.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.43 0.692 . . . . 0.0 111.328 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -59.87 -8.49 2.23 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.687 1.595 . . . . 0.0 113.855 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.5 m -60.73 -7.85 2.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.221 1.409 . . . . 0.0 114.567 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -130.38 159.25 37.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.736 1.614 . . . . 0.0 112.729 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.36 -0.91 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 -169.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.53 48.67 1.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.752 1.221 . . . . 0.0 110.528 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -51.07 114.97 1.33 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.002 -1.686 . . . . 0.0 113.148 -170.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m 52.95 24.89 3.63 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -61.38 -24.05 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.564 -1.335 . . . . 0.0 113.877 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.26 -59.33 8.55 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.562 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.59 96.69 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.317 -1.107 . . . . 0.0 114.008 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -40.46 88.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.171 0.985 . . . . 0.0 113.655 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.52 -36.15 79.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.327 0.512 . . . . 0.0 112.221 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.41 -29.34 63.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.83 -45.42 71.21 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.256 -1.527 . . . . 0.0 110.559 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.35 67.93 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.7 tp -50.39 -30.2 11.84 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.88 1.672 . . . . 0.0 113.151 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.52 -36.64 7.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.568 1.147 . . . . 0.0 111.743 -171.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -65.67 -30.26 70.93 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.343 -0.848 . . . . 0.0 112.777 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.04 -17.24 63.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.048 0.939 . . . . 0.0 112.622 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -113.7 -7.19 13.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 t 100.37 13.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.188 2.595 . . . . 0.0 113.153 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.08 162.68 4.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.365 0.666 . . . . 0.0 111.992 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -133.36 95.66 3.56 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.205 1.002 . . . . 0.0 109.935 -172.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.9 ttm105 -66.18 136.16 55.53 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.482 -0.761 . . . . 0.0 110.659 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -89.59 34.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.294 1.438 . . . . 0.0 111.503 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.64 41.37 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.979 1.276 . . . . 0.0 113.107 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -95.81 144.08 26.48 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.562 1.145 . . . . 0.0 111.02 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -63.82 123.57 19.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.832 0.853 . . . . 0.0 111.056 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.5 tm? -81.75 140.0 34.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.714 0.806 . . . . 0.0 109.293 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.505 ' N ' HD13 ' A' ' 123' ' ' LEU . 48.0 mt -122.81 92.84 3.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.272 1.429 . . . . 0.0 110.811 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.9 mt -71.77 136.9 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.797 0.839 . . . . 0.0 110.326 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -130.26 106.8 8.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.158 0.983 . . . . 0.0 113.154 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.31 -17.22 41.29 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -68.53 -14.02 62.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.753 1.161 . . . . 0.0 113.704 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.64 -10.88 1.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -139.93 110.37 7.22 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.905 1.23 . . . . 0.0 112.598 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.48 0.61 9.64 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.442 3.428 . . . . 0.0 114.794 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.01 76.17 77.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.625 1.57 . . . . 0.0 111.592 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -44.35 -34.33 7.17 Favored 'Trans proline' 0 C--N 1.354 0.831 1 C-N-CA 126.077 4.518 . . . . 0.0 117.853 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.49 -37.68 70.7 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 113.39 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -69.64 -5.97 28.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.56 1.144 . . . . 0.0 113.343 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -113.54 -2.18 13.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.595 1.558 . . . . 0.0 111.84 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 p -139.96 -28.43 0.74 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -169.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -55.88 -51.6 79.12 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.0 -28.95 41.21 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.742 1.628 . . . . 0.0 112.619 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CE3' HD11 ' A' ' 90' ' ' ILE . 70.9 t90 -63.37 -48.34 78.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.767 0.827 . . . . 0.0 111.748 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.74 -39.84 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.834 0.743 . . . . 0.0 110.409 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -57.55 -43.98 84.84 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.117 0.417 . . . . 0.0 111.342 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -63.62 -57.49 9.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.701 0.8 . . . . 0.0 112.534 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -51.49 -48.78 62.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.712 1.205 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -28.5 17.19 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.78 1.657 . . . . 0.0 116.122 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.1 p -69.75 -18.9 63.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.566 1.683 . . . . 0.0 114.025 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.96 -14.61 27.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 113.056 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.36 164.21 11.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.458 1.903 . . . . 0.0 112.468 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.767 1.227 . . . . 0.0 113.58 171.528 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.655 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.72 177.25 7.77 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.793 1.637 . . . . 0.0 112.599 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.31 115.27 16.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.918 1.687 . . . . 0.0 109.291 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -111.55 126.7 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.821 0.848 . . . . 0.0 112.76 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.93 125.87 7.53 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.1 mt -117.29 91.35 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 108.938 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -90.34 132.74 35.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.94 0.896 . . . . 0.0 110.732 -170.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.55 144.78 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.29 0.636 . . . . 0.0 111.52 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.86 104.46 0.55 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -149.22 161.37 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.028 1.331 . . . . 0.0 111.434 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 79.4 mmm -106.3 -11.79 15.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.073 0.949 . . . . 0.0 113.291 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -146.7 -26.46 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.46 -5.49 4.89 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -44.5 94.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.585 1.693 . . . . 0.0 113.228 -169.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -81.23 -31.04 34.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.372 0.669 . . . . 0.0 112.581 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.57 -38.91 75.61 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.737 -1.227 . . . . 0.0 113.239 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -52.76 -42.06 64.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.075 0.852 . . . . 0.0 111.801 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.9 t -69.47 -34.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.109 0.563 . . . . 0.0 112.008 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.56 92.07 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.44 1.018 . . . . 0.0 112.412 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.91 -41.75 96.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.567 0.747 . . . . 0.0 112.034 173.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -61.3 -46.52 89.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.281 0.632 . . . . 0.0 112.227 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.52 88.64 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 112.793 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.19 -45.89 79.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.724 0.809 . . . . 0.0 112.012 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.92 -45.89 80.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.779 0.832 . . . . 0.0 112.672 176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.56 -31.73 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.058 1.343 . . . . 0.0 112.996 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 mt -75.55 -41.38 55.03 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.807 -1.183 . . . . 0.0 110.175 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.3 m -56.6 -44.65 81.3 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.166 0.986 . . . . 0.0 111.807 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.66 76.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.74 1.216 . . . . 0.0 113.601 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.64 -5.41 47.75 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.405 1.082 . . . . 0.0 113.621 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.83 0.33 55.17 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.294 1.426 . . . . 0.0 114.502 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -81.83 -177.16 6.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.957 1.303 . . . . 0.0 111.919 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -122.51 150.76 42.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.933 1.693 . . . . 0.0 109.145 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.87 167.15 27.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -152.38 119.35 5.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 110.811 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -74.37 145.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.391 1.076 . . . . 0.0 111.02 171.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.0 109.21 9.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.426 1.49 . . . . 0.0 109.193 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.91 -28.59 35.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -144.25 56.43 4.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.878 1.671 . . . . 0.0 110.981 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.04 165.16 32.71 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.684 2.923 . . . . 0.0 115.566 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -133.98 171.68 13.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.728 2.011 . . . . 0.0 109.712 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.91 -39.61 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.989 -1.07 . . . . 0.0 113.038 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 m -58.62 -20.39 47.04 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -85.06 -33.06 22.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.211 0.914 . . . . 0.0 112.498 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.538 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 28.4 t-105 -78.34 -40.75 35.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.639 1.175 . . . . 0.0 112.578 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.3 tp -41.44 -46.97 8.67 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.752 2.821 . . . . 0.0 115.577 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.86 -28.89 67.52 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.754 2.969 . . . . 0.0 116.316 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -80.06 2.5 23.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -169.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -60.32 -23.44 64.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.71 -1.244 . . . . 0.0 114.212 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -87.32 3.5 46.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.827 1.251 . . . . 0.0 113.072 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -137.32 -137.63 0.14 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.709 2.003 . . . . 0.0 110.97 -168.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -140.83 164.29 30.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.21 1.804 . . . . 0.0 110.626 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 28.7 m -144.05 174.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.252 1.421 . . . . 0.0 111.741 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tt -152.19 146.44 25.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.669 1.988 . . . . 0.0 108.49 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.28 133.04 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.357 1.063 . . . . 0.0 109.687 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.91 90.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.933 1.293 . . . . 0.0 108.786 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.5 m -135.76 141.62 44.84 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -94.95 -165.21 1.27 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.257 1.823 . . . . 0.0 113.155 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.7 m -132.43 150.35 52.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.337 -1.477 . . . . 0.0 111.715 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -148.08 -164.91 2.13 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.28 2.232 . . . . 0.0 109.63 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 30.82 50.09 0.2 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.886 2.66 . . . . 0.0 118.642 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.469 ' H ' HM73 ' A' ' 201' ' ' FMN . 71.5 mt-30 54.19 35.05 21.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.611 1.564 . . . . 0.0 113.84 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.32 0.58 9.47 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.884 1.707 . . . . 0.0 115.071 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.26 168.41 20.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.349 1.86 . . . . 0.0 113.601 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.15 145.66 65.45 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.804 1.241 . . . . 0.0 109.759 169.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.69 140.65 57.03 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.316 2.678 . . . . 0.0 110.412 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.37 -28.82 65.49 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -59.29 -12.05 5.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.66 -3.7 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.577 1.08 . . . . 0.0 113.338 173.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.2 t -56.79 -46.2 99.87 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 120.343 -1.473 . . . . 0.0 112.34 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.93 -12.97 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.921 3.081 . . . . 0.0 116.305 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 tp -99.89 -44.49 6.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.545 1.138 . . . . 0.0 110.577 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.32 -42.9 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.644 1.178 . . . . 0.0 112.238 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.88 -26.86 67.09 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.111 -0.993 . . . . 0.0 113.446 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.97 -41.73 4.56 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.078 -171.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.25 -41.06 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.447 1.623 . . . . 0.0 111.054 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.32 -48.01 83.24 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 112.32 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -36.05 19.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.831 0.853 . . . . 0.0 113.226 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -82.49 -37.08 25.81 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.75 -46.41 15.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.18 0.9 . . . . 0.0 112.393 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.97 -39.1 0.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 126.239 1.876 . . . . 0.0 115.415 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -161.94 142.27 10.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.748 2.019 . . . . 0.0 110.187 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -150.9 102.34 3.03 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.705 1.202 . . . . 0.0 111.407 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.68 -16.31 10.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.693 2.262 . . . . 0.0 114.456 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 -5.36 9.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.4 117.39 6.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.663 1.185 . . . . 0.0 109.934 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -127.93 134.55 49.33 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.716 1.606 . . . . 0.0 110.622 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CB ' HG23 ' A' ' 52' ' ' VAL . 1.3 p90 -155.97 -171.13 3.63 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -171.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.24 160.39 28.26 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.864 1.697 . . . . 0.0 110.487 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.39 135.62 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.007 0.908 . . . . 0.0 113.328 -169.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.0 119.44 57.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.85 147.32 47.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.468 1.107 . . . . 0.0 109.84 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.0 tt -138.55 148.25 44.01 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.046 0.927 . . . . 0.0 112.158 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.65 -141.17 6.08 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.795 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -141.95 118.6 11.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 111.197 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -74.06 -0.02 15.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 t -73.21 4.49 4.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.56 1.073 . . . . 0.0 113.668 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.02 157.64 46.41 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.306 1.843 . . . . 0.0 111.673 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 m -74.45 -1.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -169.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -122.97 44.51 2.64 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.808 1.243 . . . . 0.0 110.73 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.29 116.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.302 -1.499 . . . . 0.0 113.1 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.17 24.46 2.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.693 2.397 . . . . 0.0 116.685 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -60.61 -27.8 68.04 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.371 -1.455 . . . . 0.0 113.416 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.64 73.02 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.272 -0.892 . . . . 0.0 113.447 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.64 -40.27 6.84 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.079 0.939 . . . . 0.0 113.13 170.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -58.74 -38.76 79.11 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 118.702 1.251 . . . . 0.0 113.659 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -56.34 -32.06 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -75.8 -25.63 56.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.033 0.833 . . . . 0.0 113.182 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.74 -43.16 48.14 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.31 -1.494 . . . . 0.0 110.288 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.12 -42.62 69.66 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 170.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -49.99 -43.86 50.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.88 1.672 . . . . 0.0 112.319 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.17 -37.62 14.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.046 0.939 . . . . 0.0 112.464 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.67 -30.28 71.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.461 -0.774 . . . . 0.0 112.21 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.81 -24.42 67.75 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -91.91 -2.21 56.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.748 0.703 . . . . 0.0 112.456 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m 75.09 23.95 1.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.056 2.143 . . . . 0.0 114.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 177.03 0.14 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.64 1.176 . . . . 0.0 112.681 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -135.59 164.35 28.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 O-C-N 120.565 -1.334 . . . . 0.0 110.305 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 mtm105 -130.58 142.26 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 t -96.16 25.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.004 1.722 . . . . 0.0 111.637 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.01 -171.42 44.43 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.018 1.294 . . . . 0.0 114.461 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.05 155.56 39.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.277 1.431 . . . . 0.0 111.641 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.7 ttm -68.41 121.19 15.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.488 1.115 . . . . 0.0 112.231 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -76.82 136.17 38.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.67 84.94 2.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.743 1.217 . . . . 0.0 110.866 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.2 mt -74.97 132.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.742 1.617 . . . . 0.0 110.634 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -124.35 104.2 8.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -14.86 7.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.5 m -64.58 -23.09 67.15 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.885 1.221 . . . . 0.0 113.598 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.35 -8.31 0.99 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -135.92 107.58 9.74 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.316 0.962 . . . . 0.0 113.064 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.76 -2.06 11.62 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.139 3.226 . . . . 0.0 114.346 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -125.16 78.82 66.53 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.934 1.694 . . . . 0.0 110.514 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.39 -23.24 76.49 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.448 3.432 . . . . 0.0 114.328 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.28 -43.68 67.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.557 1.543 . . . . 0.0 112.417 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -104.25 -7.66 19.9 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.632 1.173 . . . . 0.0 112.877 175.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 m -123.92 -26.16 4.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.32 -50.5 85.55 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 120.575 -1.328 . . . . 0.0 111.754 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.04 -34.46 87.21 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.012 2.475 . . . . 0.0 114.79 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -61.49 -49.32 77.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.985 0.514 . . . . 0.0 111.495 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.2 t -71.19 -33.41 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.351 -0.843 . . . . 0.0 111.223 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -66.12 -14.92 62.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.232 -0.918 . . . . 0.0 113.173 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -95.98 -57.16 2.43 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.745 1.218 . . . . 0.0 111.634 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.85 -49.02 66.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.875 1.27 . . . . 0.0 111.815 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.76 -24.97 27.98 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.835 1.207 . . . . 0.0 115.685 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.4 p -69.2 -16.54 63.64 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 120.117 1.959 . . . . 0.0 113.659 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.3 mt -99.79 -15.13 18.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.482 1.513 . . . . 0.0 112.995 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.59 143.97 53.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 111.671 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.946 1.698 . . . . 0.0 114.128 -174.586 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.469 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.567 ' N ' ' HG ' ' A' ' 149' ' ' SER . . . . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -132.62 133.82 44.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.068 1.747 . . . . 0.0 108.461 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.457 HD11 ' CD1' ' A' ' 148' ' ' LEU . 4.5 mm -125.95 117.36 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.537 0.735 . . . . 0.0 111.804 -169.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.09 126.81 7.57 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 168.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -118.32 91.21 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.673 1.189 . . . . 0.0 107.857 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -90.5 137.62 32.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.356 1.063 . . . . 0.0 110.478 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -121.26 144.77 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.523 0.678 . . . . 0.0 112.242 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.16 104.56 0.49 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.247 0.927 . . . . 0.0 111.207 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 t -151.13 163.77 38.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.462 1.105 . . . . 0.0 113.076 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.1 mtp -129.82 2.0 4.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 112.204 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -140.18 -11.87 1.08 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.8 -0.8 67.67 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 171.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -74.42 -42.94 58.34 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.739 1.769 . . . . 0.0 111.732 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -33.45 74.77 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.564 -0.71 . . . . 0.0 112.156 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.08 -40.97 97.63 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.997 -1.065 . . . . 0.0 112.562 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 tt -56.15 -44.97 79.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.142 0.883 . . . . 0.0 111.623 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.22 -38.84 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.836 0.454 . . . . 0.0 111.795 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.5 90.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.22 -42.55 99.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.868 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -61.68 -42.44 98.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.501 -0.749 . . . . 0.0 112.385 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.85 95.03 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.771 0.714 . . . . 0.0 112.457 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.08 -48.75 79.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.325 0.65 . . . . 0.0 111.539 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.22 91.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.785 0.834 . . . . 0.0 112.746 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.13 -47.75 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.411 1.085 . . . . 0.0 112.363 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.29 -39.71 78.15 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.734 -0.604 . . . . 0.0 109.892 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -58.32 -44.72 88.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.927 1.291 . . . . 0.0 112.072 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -38.24 86.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.26 1.024 . . . . 0.0 112.561 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.44 -25.01 64.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.938 0.895 . . . . 0.0 112.892 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.16 -7.03 8.7 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.922 1.725 . . . . 0.0 114.759 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -76.34 139.25 40.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.828 1.251 . . . . 0.0 110.93 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -76.93 76.94 3.5 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.784 0.834 . . . . 0.0 110.909 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.34 157.8 32.08 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 111.624 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.3 m -151.99 117.73 5.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.103 -0.998 . . . . 0.0 109.784 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.13 144.97 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.708 0.803 . . . . 0.0 112.262 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.34 97.95 4.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.409 1.484 . . . . 0.0 110.822 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.99 -18.02 60.92 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -141.67 66.04 21.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.893 1.677 . . . . 0.0 109.764 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.67 168.75 24.1 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.14 3.227 . . . . 0.0 115.237 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -149.34 159.96 43.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.973 2.109 . . . . 0.0 109.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.02 -38.05 48.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.954 -1.091 . . . . 0.0 111.468 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -56.03 -24.8 41.66 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.41 1.484 . . . . 0.0 114.826 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -99.6 -23.72 14.97 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.567 1.547 . . . . 0.0 112.908 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -71.59 -39.6 70.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.803 0.841 . . . . 0.0 112.727 170.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.98 -47.66 86.47 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.778 2.031 . . . . 0.0 115.594 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.88 -5.14 1.76 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.101 3.2 . . . . 0.0 117.731 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -119.56 2.84 11.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -28.26 69.52 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.227 -1.546 . . . . 0.0 113.187 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.91 4.91 23.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.705 1.202 . . . . 0.0 113.094 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -135.71 -132.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.867 2.067 . . . . 0.0 110.1 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -139.09 159.47 42.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.943 1.697 . . . . 0.0 111.005 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.37 168.51 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.034 1.733 . . . . 0.0 110.391 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 151.15 23.36 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.849 -1.157 . . . . 0.0 110.433 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.81 136.64 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.829 1.252 . . . . 0.0 110.405 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -135.1 95.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.937 1.295 . . . . 0.0 107.719 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 m -133.56 169.12 17.45 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -167.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -137.71 -158.95 0.91 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.122 1.369 . . . . 0.0 112.578 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.1 m -135.82 151.75 50.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.757 1.623 . . . . 0.0 110.872 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.127 1.371 . . . . 0.0 111.696 -179.797 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.498 0.666 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.47 143.96 93.78 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.219 -0.926 . . . . 0.0 111.054 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.93 137.37 43.82 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.088 3.859 . . . . 0.0 112.349 170.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.85 -24.35 66.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -61.45 -17.95 56.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.718 1.607 . . . . 0.0 114.802 171.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -124.54 -10.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.543 1.137 . . . . 0.0 113.845 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.8 t -46.98 -48.98 51.93 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.965 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.44 -17.21 43.94 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.379 1.885 . . . . 0.0 114.385 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.2 -43.71 17.31 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.962 0.801 . . . . 0.0 109.572 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.57 -49.65 72.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.096 1.359 . . . . 0.0 111.386 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -62.12 -41.7 98.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.846 -1.159 . . . . 0.0 112.262 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.99 -50.23 67.55 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.647 0.641 . . . . 0.0 112.828 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.3 -39.41 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 O-C-N 121.382 -1.069 . . . . 0.0 110.897 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -65.88 -36.7 84.14 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -112.71 -20.36 11.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.2 m -125.61 10.86 7.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.876 1.271 . . . . 0.0 113.782 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.13 -51.59 1.11 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.615 1.566 . . . . 0.0 110.302 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.31 -28.98 0.33 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 119.552 2.581 . . . . 0.0 119.552 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -153.3 136.45 15.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.499 2.15 . . . . 0.0 111.99 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -150.64 56.11 2.0 Allowed Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.219 1.408 . . . . 0.0 113.296 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.43 -18.67 65.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.036 3.158 . . . . 0.0 115.323 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.97 0.17 14.98 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.596 1.959 . . . . 0.0 113.504 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.71 124.07 22.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 109.186 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -121.31 138.89 54.04 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.201 1.4 . . . . 0.0 109.263 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -160.92 -167.48 1.84 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -168.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 160.86 31.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.625 2.536 . . . . 0.0 109.714 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.82 135.46 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 117.897 0.849 . . . . 0.0 112.212 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.2 mt -119.57 130.61 73.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.04 146.85 48.29 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.044 0.938 . . . . 0.0 110.171 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tt -141.53 133.87 28.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.553 0.741 . . . . 0.0 110.852 -169.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.58 -166.15 33.8 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 121.951 0.751 . . . . 0.0 113.733 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -98.07 118.4 34.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.877 1.271 . . . . 0.0 110.962 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.4 p -64.26 -9.94 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.974 1.71 . . . . 0.0 115.207 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -70.56 -8.26 50.1 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -138.13 159.55 41.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.67 1.188 . . . . 0.0 113.387 -169.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.16 -34.5 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.127 1.371 . . . . 0.0 113.176 -171.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -76.2 34.85 0.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.592 1.157 . . . . 0.0 113.215 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.62 113.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.915 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.3 m 52.85 25.36 3.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.329 2.251 . . . . 0.0 116.287 -171.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -60.28 -30.22 69.32 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.661 -1.275 . . . . 0.0 113.692 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.55 -38.8 61.62 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.897 -1.127 . . . . 0.0 112.695 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.67 -40.33 66.06 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.524 -0.986 . . . . 0.0 112.791 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -58.79 -40.74 84.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.881 0.872 . . . . 0.0 112.911 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.86 -38.21 84.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.27 -31.3 68.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.39 0.995 . . . . 0.0 113.413 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.57 -43.73 79.92 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 119.763 -1.835 . . . . 0.0 110.826 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.39 71.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.57 -29.64 11.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.586 1.554 . . . . 0.0 112.936 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.32 -39.1 6.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.517 1.127 . . . . 0.0 111.362 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -67.36 -34.13 76.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.306 -0.871 . . . . 0.0 113.338 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.79 -14.09 49.81 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.427 -0.796 . . . . 0.0 112.414 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -111.57 10.15 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.851 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 72.31 18.93 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.596 1.558 . . . . 0.0 114.516 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.8 165.35 1.76 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.506 0.722 . . . . 0.0 111.92 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -135.6 88.4 2.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 120.76 -1.213 . . . . 0.0 110.344 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -62.42 142.83 57.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.354 0.662 . . . . 0.0 111.346 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.56 34.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.579 1.552 . . . . 0.0 110.757 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.92 -167.89 40.91 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.841 -1.162 . . . . 0.0 113.562 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -120.17 143.14 48.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.515 1.526 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.1 ttp -67.53 124.82 24.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.265 1.026 . . . . 0.0 112.018 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -83.86 133.66 34.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.218 1.007 . . . . 0.0 109.968 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -122.41 98.13 5.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 111.575 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.1 mt -89.47 134.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.617 1.567 . . . . 0.0 111.772 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -113.38 66.97 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.624 3.17 . . . . 0.0 111.35 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -46.1 -38.94 8.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.455 1.902 . . . . 0.0 116.132 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.1 m -62.38 -16.12 52.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -134.46 12.49 3.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.065 1.746 . . . . 0.0 111.964 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -144.5 68.46 15.0 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.242 1.817 . . . . 0.0 110.704 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.85 6.92 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.841 3.694 . . . . 0.0 114.701 -171.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.5 58.91 41.66 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.275 1.83 . . . . 0.0 110.987 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -61.47 -22.06 73.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.608 3.539 . . . . 0.0 114.24 -169.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.56 -44.26 56.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.999 1.32 . . . . 0.0 111.051 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.6 p -68.57 -18.32 64.31 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -95.11 -11.93 27.38 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.283 1.433 . . . . 0.0 112.428 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 26.0 p -128.3 -31.63 2.29 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.71 -53.1 69.13 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.923 1.238 . . . . 0.0 113.877 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.61 -29.42 52.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.418 1.542 . . . . 0.0 112.678 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -61.63 -48.94 78.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.709 0.803 . . . . 0.0 111.715 171.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.31 -40.75 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.694 0.679 . . . . 0.0 110.535 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.57 -44.1 89.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.701 0.682 . . . . 0.0 111.249 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.77 -55.86 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 112.606 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.29 -37.51 67.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.881 0.873 . . . . 0.0 112.195 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.36 -20.45 65.44 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.407 1.003 . . . . 0.0 115.158 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.4 p -74.58 -17.94 60.65 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.654 1.727 . . . . 0.0 113.165 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.62 -5.8 53.29 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.856 1.262 . . . . 0.0 112.73 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 4' ' ' ILE . 80.8 mt -70.76 -173.6 0.79 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.085 1.754 . . . . 0.0 111.361 169.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 2' ' ' ALA . 92.1 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.371 1.869 . . . . 0.0 114.505 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.969 0 CA-C-O 120.793 0.33 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.44 134.66 47.95 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.174 1.389 . . . . 0.0 109.699 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.489 HD12 HD13 ' A' ' 26' ' ' LEU . 1.4 mt -137.03 124.76 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.26 130.63 10.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 168.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -117.65 90.86 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.01 1.324 . . . . 0.0 108.331 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.71 146.58 24.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.852 0.861 . . . . 0.0 112.978 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.44 129.41 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.255 1.026 . . . . 0.0 111.833 -169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.93 71.71 0.46 Allowed Glycine 0 N--CA 1.468 0.798 0 C-N-CA 126.615 2.055 . . . . 0.0 109.568 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 t -129.76 177.73 7.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.631 1.172 . . . . 0.0 113.787 -169.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.3 tpt -135.58 -36.88 0.77 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.153 0.981 . . . . 0.0 113.417 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -129.28 -22.68 3.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.568 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.65 -2.55 7.0 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.7 1.143 . . . . 0.0 115.16 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -36.8 85.08 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.447 1.624 . . . . 0.0 113.084 -169.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 -31.69 37.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.593 1.157 . . . . 0.0 113.505 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.4 tp -59.06 -35.34 73.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.953 -1.092 . . . . 0.0 113.218 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 tp -48.32 -42.04 30.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.555 0.742 . . . . 0.0 111.707 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.26 -36.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.976 -0.535 . . . . 0.0 112.137 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.04 94.37 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.703 1.138 . . . . 0.0 112.415 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.38 -42.57 99.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.032 0.533 . . . . 0.0 112.102 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -60.83 -46.95 88.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.412 0.685 . . . . 0.0 112.38 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.64 84.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.179 0.592 . . . . 0.0 111.907 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.8 -45.82 70.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.136 0.575 . . . . 0.0 111.89 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.75 74.44 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.464 0.706 . . . . 0.0 112.812 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.25 -45.88 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.831 1.252 . . . . 0.0 111.973 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.489 HD13 HD12 ' A' ' 4' ' ' ILE . 52.2 mt -73.52 -40.1 64.29 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.037 0.935 . . . . 0.0 109.846 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.4 m -56.92 -46.6 81.89 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.35 1.06 . . . . 0.0 111.573 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.88 82.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.042 0.937 . . . . 0.0 113.325 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -73.44 -9.25 58.49 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 171.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.95 -6.01 34.74 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.574 1.559 . . . . 0.0 114.982 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -76.84 153.73 34.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.54 1.17 . . . . 0.0 112.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -80.76 130.84 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.66 150.78 46.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.336 0.654 . . . . 0.0 111.457 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -155.75 121.48 4.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.966 0.906 . . . . 0.0 109.925 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.87 150.3 7.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.194 0.521 . . . . 0.0 111.383 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -133.53 102.55 5.55 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.708 1.203 . . . . 0.0 107.985 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.88 -27.12 60.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.57 1.148 . . . . 0.0 113.855 -170.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.65 58.89 4.76 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 126.297 1.839 . . . . 0.0 110.508 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.05 163.94 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.212 3.275 . . . . 0.0 116.114 -169.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.69 170.18 15.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.449 2.3 . . . . 0.0 109.178 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -53.28 -38.85 63.44 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.809 -1.182 . . . . 0.0 113.312 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.84 -13.93 28.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -89.69 -29.41 18.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.719 1.145 . . . . 0.0 112.52 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.512 ' CH2' HG21 ' A' ' 52' ' ' VAL . 38.1 t-105 -81.82 -42.85 19.1 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 0.0 112.665 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.4 tp -47.59 -44.65 55.92 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 126.803 2.041 . . . . 0.0 114.54 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.01 -9.28 0.66 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.271 3.981 . . . . 0.0 118.129 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.22 5.21 7.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 113.173 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -57.02 -36.45 70.46 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.227 -0.921 . . . . 0.0 112.605 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.03 13.06 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.561 1.944 . . . . 0.0 114.479 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -134.43 -130.43 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.591 1.556 . . . . 0.0 111.482 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.33 158.61 44.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.895 2.078 . . . . 0.0 109.691 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.512 HG21 ' CH2' ' A' ' 44' ' ' TRP . 30.3 m -147.36 172.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 110.467 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -154.86 149.58 26.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.683 1.593 . . . . 0.0 108.86 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.6 139.76 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.402 -0.811 . . . . 0.0 111.143 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 m -124.53 125.95 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.073 1.349 . . . . 0.0 108.257 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.7 m -150.87 158.28 43.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.041 -1.662 . . . . 0.0 113.38 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -136.14 178.61 6.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.505 1.522 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 m -121.51 135.37 55.03 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.01 1.324 . . . . 0.0 110.803 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 126.613 1.965 . . . . 0.0 109.28 -173.297 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.6 t0 . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.07 152.59 96.69 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.279 -0.888 . . . . 0.0 111.339 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -85.21 164.69 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.684 2.923 . . . . 0.0 112.566 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.0 -19.16 64.08 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -61.48 -19.76 62.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 tt -127.01 -8.33 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -48.42 -51.56 50.27 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-O 117.418 -1.277 . . . . 0.0 112.449 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.92 -5.18 16.56 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.362 2.041 . . . . 0.0 114.326 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -92.39 -43.43 9.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.227 0.921 . . . . 0.0 109.399 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.46 -50.03 74.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.806 1.243 . . . . 0.0 111.387 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -62.22 -40.0 94.68 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.981 -1.074 . . . . 0.0 112.485 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.89 -44.65 55.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.169 0.89 . . . . 0.0 113.505 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.43 -47.45 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.098 1.449 . . . . 0.0 110.047 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -59.92 -48.61 81.0 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.581 1.153 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.85 -41.82 22.57 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -88.52 -28.34 20.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -97.13 -42.65 7.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.85 -38.12 0.5 Allowed Glycine 0 CA--C 1.542 1.777 0 C-N-CA 125.84 1.686 . . . . 0.0 115.757 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -145.01 151.58 38.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.26 2.224 . . . . 0.0 110.82 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.24 43.12 0.23 Allowed Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -57.6 -29.48 85.3 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.141 2.561 . . . . 0.0 114.649 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -68.32 -15.26 63.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.924 2.09 . . . . 0.0 115.145 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.27 122.63 28.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.54 136.83 54.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 108.766 169.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -156.43 -172.29 4.02 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.2 161.37 27.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.127 1.346 . . . . 0.0 109.86 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.95 142.18 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.666 0.746 . . . . 0.0 111.749 -169.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mt -127.71 129.48 70.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.51 151.63 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.697 0.76 . . . . 0.0 110.853 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 tt -143.68 131.56 21.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.249 1.02 . . . . 0.0 109.976 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.78 -147.85 5.17 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 174.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -143.78 125.04 14.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.786 1.234 . . . . 0.0 110.385 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -60.16 -7.16 1.72 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -63.9 -7.87 9.49 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 171.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -126.49 136.08 52.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.42 1.488 . . . . 0.0 111.154 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.75 -36.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.513 1.125 . . . . 0.0 113.488 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.92 -17.11 59.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 23.1 t80 34.69 -118.23 0.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.443 1.897 . . . . 0.0 112.867 -169.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.19 24.69 0.52 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -46.36 -43.28 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.095 1.316 . . . . 0.0 113.883 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.55 -36.84 86.92 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 118.49 0.586 . . . . 0.0 113.142 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.53 -45.06 48.23 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.928 0.775 . . . . 0.0 113.463 170.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -58.24 -38.1 76.2 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.357 1.078 . . . . 0.0 113.374 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -55.89 -41.22 74.14 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.351 0.661 . . . . 0.0 112.29 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -71.4 -26.03 62.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.63 -41.45 45.88 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.697 -1.252 . . . . 0.0 111.462 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.93 -40.12 72.67 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.1 tp -50.68 -34.3 26.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.289 1.835 . . . . 0.0 112.92 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -103.71 -36.59 7.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -67.84 -32.39 72.89 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.9 -1.125 . . . . 0.0 113.022 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.03 -16.8 62.48 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 119.17 0.895 . . . . 0.0 111.87 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -107.04 10.14 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.06 1.744 . . . . 0.0 112.672 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m 65.71 23.95 11.55 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 114.713 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.3 177.96 0.23 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 0.0 112.618 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -136.72 163.57 30.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.498 -1.377 . . . . 0.0 109.673 -173.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -133.21 147.09 52.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.11 22.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.926 1.691 . . . . 0.0 112.14 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.2 176.56 41.1 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.405 1.479 . . . . 0.0 114.556 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.84 162.13 16.34 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.801 1.24 . . . . 0.0 112.398 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttp -71.32 123.17 21.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.615 -0.678 . . . . 0.0 111.352 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.25 138.81 47.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.035 0.934 . . . . 0.0 110.206 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.7 mt -124.73 91.3 3.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.84 1.256 . . . . 0.0 112.129 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.78 137.65 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.403 1.481 . . . . 0.0 110.34 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -133.07 102.81 5.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.278 1.037 . . . . 0.0 112.553 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.03 14.31 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 83.1 p -72.25 -14.68 61.84 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.57 1.077 . . . . 0.0 113.825 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.54 -7.54 1.3 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -136.91 112.14 9.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.538 1.135 . . . . 0.0 112.017 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.42 -3.62 12.63 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.68 2.92 . . . . 0.0 114.171 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -134.74 84.02 39.97 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.265 1.426 . . . . 0.0 111.78 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -46.24 -33.76 12.59 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 126.103 4.535 . . . . 0.0 116.229 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.08 -40.79 59.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.139 1.376 . . . . 0.0 112.605 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.5 p -67.26 -9.95 45.73 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -115.25 -3.45 12.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.587 1.155 . . . . 0.0 112.445 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.0 p -133.12 -27.45 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.66 -53.39 60.88 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 120.011 1.278 . . . . 0.0 112.752 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.18 -29.77 32.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.592 1.528 . . . . 0.0 112.694 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -60.76 -50.1 74.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.354 0.662 . . . . 0.0 111.463 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.41 -39.38 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 118.287 0.494 . . . . 0.0 110.571 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.48 -34.88 73.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.022 0.828 . . . . 0.0 112.403 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.51 -63.06 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.319 0.963 . . . . 0.0 111.945 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -57.38 -35.8 70.43 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.788 1.235 . . . . 0.0 113.045 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.58 -33.87 68.08 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.864 0.745 . . . . 0.0 113.905 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.8 p -69.99 -17.62 63.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.426 1.613 . . . . 0.0 113.884 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.99 -18.08 44.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.35 -32.72 73.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.255 1.386 0 C-N-CA 124.844 1.258 . . . . 0.0 112.364 -175.207 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.551 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 121.224 0.535 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.03 110.54 7.03 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 108.647 -173.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mm -110.89 137.41 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -169.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.01 126.61 8.85 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mt -119.62 101.12 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.493 1.117 . . . . 0.0 108.149 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.16 120.41 39.47 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.696 0.799 . . . . 0.0 112.481 -168.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.28 143.31 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.904 1.282 . . . . 0.0 110.768 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.84 76.43 0.31 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.064 1.316 . . . . 0.0 110.278 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 t -121.47 154.51 36.5 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.854 0.827 . . . . 0.0 112.447 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 tpt -90.45 -28.72 18.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.527 0.731 . . . . 0.0 112.548 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -146.3 -16.14 0.44 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.57 -14.56 4.74 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -62.96 -42.98 99.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.399 2.1 . . . . 0.0 113.093 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -77.84 -26.01 49.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.48 -44.31 89.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.886 -1.133 . . . . 0.0 112.177 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.8 -45.33 70.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.687 0.676 . . . . 0.0 111.589 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.48 -38.69 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.005 0.522 . . . . 0.0 111.892 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.66 92.44 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.964 0.802 . . . . 0.0 112.885 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.82 -43.7 98.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.696 -0.628 . . . . 0.0 112.081 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.32 -42.34 99.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.543 -0.723 . . . . 0.0 112.311 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.12 90.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.61 -0.681 . . . . 0.0 112.034 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -55.11 -47.8 74.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.425 0.69 . . . . 0.0 111.445 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.42 84.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.736 0.814 . . . . 0.0 112.849 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.13 -45.25 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.481 1.112 . . . . 0.0 112.305 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.34 -41.8 72.74 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.547 -0.721 . . . . 0.0 109.787 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -56.64 -42.92 79.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.919 1.288 . . . . 0.0 112.467 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 -42.33 65.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.31 1.044 . . . . 0.0 113.442 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -71.07 -37.04 72.48 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.4 21.86 0.03 OUTLIER Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.551 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 85.3 m-70 -133.66 -175.68 3.91 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.458 1.503 . . . . 0.0 111.155 -171.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.47 144.37 48.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.389 1.476 . . . . 0.0 108.379 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.74 153.1 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.825 -0.547 . . . . 0.0 112.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.5 m -137.6 113.46 9.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 109.442 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.02 147.34 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.336 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -134.79 105.07 6.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.97 -30.0 58.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.982 1.313 . . . . 0.0 114.041 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -148.68 65.1 8.2 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.489 1.916 . . . . 0.0 109.601 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.45 171.71 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.685 2.923 . . . . 0.0 114.188 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.85 169.18 16.1 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.77 2.028 . . . . 0.0 108.913 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.35 -35.31 65.07 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.671 -1.268 . . . . 0.0 112.344 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -57.53 -22.71 46.09 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -83.75 -36.74 23.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.121 0.873 . . . . 0.0 112.478 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 47.5 t-105 -70.57 -39.94 73.61 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.727 0.694 . . . . 0.0 112.034 174.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -43.25 -58.07 4.61 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 127.241 2.217 . . . . 0.0 115.273 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.17 -26.62 10.48 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.702 2.268 . . . . 0.0 114.731 -171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -74.18 -7.12 51.52 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -62.11 -30.57 71.11 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.667 -1.27 . . . . 0.0 112.694 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.71 2.64 7.79 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.309 1.444 . . . . 0.0 113.99 171.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -133.14 -120.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.082 2.153 . . . . 0.0 109.566 -169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -143.55 158.1 43.92 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 109.373 171.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 20.9 m -140.9 163.16 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.315 1.446 . . . . 0.0 110.718 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.19 141.87 20.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.225 1.012 . . . . 0.0 111.48 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.81 133.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.563 1.545 . . . . 0.0 109.606 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.97 106.49 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.4 m -149.16 155.16 40.24 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.297 -1.502 . . . . 0.0 114.913 -168.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -113.29 -174.22 2.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.37 1.468 . . . . 0.0 112.852 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.2 m -129.23 139.86 51.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.673 1.189 . . . . 0.0 110.666 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 108.352 -174.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -65.76 146.03 99.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.659 1.584 . . . . 0.0 112.987 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.01 155.27 19.8 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.706 2.937 . . . . 0.0 111.602 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.7 -23.86 63.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.8 m -56.85 -16.99 7.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.692 1.597 . . . . 0.0 115.153 174.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.0 tt -132.96 -4.98 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.3 t -48.88 -43.13 64.71 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.364 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 -13.95 41.02 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 CA-C-N 122.433 1.905 . . . . 0.0 114.928 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.83 -48.92 6.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.073 0.949 . . . . 0.0 109.017 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -59.85 -46.85 87.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.536 1.534 . . . . 0.0 113.612 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.6 -24.22 58.84 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.042 -1.037 . . . . 0.0 113.098 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.09 -52.21 4.14 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.218 0.913 . . . . 0.0 112.996 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.54 -38.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.591 1.195 . . . . 0.0 111.515 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -62.24 -35.43 78.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 113.297 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -115.7 -32.48 5.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -82.05 -19.14 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.3 mt -127.67 -48.87 1.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.689 1.196 . . . . 0.0 112.068 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.64 -22.84 0.23 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.932 1.933 . . . . 0.0 117.932 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.68 130.44 10.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.51 1.655 . . . . 0.0 111.704 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -163.29 66.97 1.64 Allowed Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.881 1.272 . . . . 0.0 112.895 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.3 -23.18 66.04 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.937 2.425 . . . . 0.0 114.649 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -72.53 -5.48 37.29 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -76.52 133.79 39.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.199 1.0 . . . . 0.0 111.778 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.56 145.01 51.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.732 1.613 . . . . 0.0 110.617 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -162.35 -170.9 2.6 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 165.02 33.61 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.869 2.176 . . . . 0.0 110.727 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 t -142.07 136.94 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.125 0.963 . . . . 0.0 112.259 -170.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -123.15 116.66 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.05 149.32 32.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.339 1.056 . . . . 0.0 110.571 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -138.36 149.77 45.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.267 1.027 . . . . 0.0 111.672 -170.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.03 -143.57 7.75 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.083 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -141.3 126.08 18.05 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.209 1.404 . . . . 0.0 110.262 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -66.02 -12.88 58.29 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -68.61 0.01 4.66 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -125.25 12.73 8.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.46 1.504 . . . . 0.0 114.479 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.37 -44.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 127.9 2.48 . . . . 0.0 115.205 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -76.24 48.33 0.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.027 1.285 . . . . 0.0 111.764 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.18 116.84 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.302 -1.499 . . . . 0.0 112.303 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.1 m 51.05 24.35 1.86 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.851 2.06 . . . . 0.0 116.498 -172.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.33 -15.49 48.53 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.693 -1.254 . . . . 0.0 113.559 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.18 -67.93 1.81 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.7 -36.09 77.22 Favored Glycine 0 CA--C 1.536 1.401 0 O-C-N 121.557 -0.966 . . . . 0.0 114.258 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.27 -38.32 76.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.295 1.047 . . . . 0.0 113.652 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.92 -34.68 78.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.63 0.65 . . . . 0.0 112.189 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.67 -29.88 62.58 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.124 0.874 . . . . 0.0 112.78 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.3 -46.02 74.8 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.098 -1.626 . . . . 0.0 110.395 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -35.8 72.42 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -49.15 -44.16 42.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.936 1.294 . . . . 0.0 111.445 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 mt -80.52 -31.92 36.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.254 0.622 . . . . 0.0 111.69 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -65.77 -32.75 74.47 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.854 -1.154 . . . . 0.0 112.01 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -61.75 -26.18 67.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.885 0.766 . . . . 0.0 112.175 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -82.17 -27.1 32.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.598 -0.689 . . . . 0.0 112.471 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.9 m 101.61 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 130.161 3.384 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 156.97 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.54 1.136 . . . . 0.0 113.625 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -123.93 88.07 2.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.902 1.681 . . . . 0.0 110.318 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -63.04 140.3 58.86 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.32 -0.863 . . . . 0.0 111.401 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.43 33.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.303 1.441 . . . . 0.0 111.702 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.96 -160.64 34.16 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.895 -1.128 . . . . 0.0 113.607 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -125.06 148.27 48.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.617 1.567 . . . . 0.0 111.179 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.3 ttp -69.67 124.56 24.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 112.189 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.45 140.72 39.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.072 0.949 . . . . 0.0 110.188 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.41 89.74 3.01 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.091 1.356 . . . . 0.0 111.534 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -76.87 133.96 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.611 1.564 . . . . 0.0 110.857 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -127.12 98.64 5.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.219 1.009 . . . . 0.0 113.219 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -15.31 9.79 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.0 p -73.45 -13.91 61.15 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.904 1.229 . . . . 0.0 113.822 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.02 -8.26 1.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -135.34 110.58 10.62 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.225 1.01 . . . . 0.0 112.185 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.92 -2.45 12.43 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.017 3.144 . . . . 0.0 114.481 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -129.9 80.59 70.98 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.671 1.588 . . . . 0.0 111.877 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.83 -36.49 7.92 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.654 4.236 . . . . 0.0 116.057 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.36 -45.87 36.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.426 1.89 . . . . 0.0 112.954 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.0 p -68.76 -18.09 64.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.14 -9.31 20.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.944 0.897 . . . . 0.0 112.506 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 m -116.02 -33.02 5.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -58.15 -51.53 81.08 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.396 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.99 -28.7 57.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.625 1.55 . . . . 0.0 112.723 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -61.74 -49.8 74.96 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.616 0.644 . . . . 0.0 111.68 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 t -68.27 -40.78 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.868 0.758 . . . . 0.0 110.367 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.6 -30.09 70.46 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -76.44 -57.94 3.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.274 1.03 . . . . 0.0 112.222 170.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -51.82 -47.44 64.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.831 1.252 . . . . 0.0 111.427 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.48 11.66 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.659 1.6 . . . . 0.0 115.905 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.0 p -70.52 -15.58 62.8 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.888 1.844 . . . . 0.0 113.961 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.94 -15.85 18.98 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.395 1.478 . . . . 0.0 113.192 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.7 157.63 14.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.269 2.227 . . . . 0.0 111.757 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.885 1.274 . . . . 0.0 113.536 174.076 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.593 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 121.281 0.562 . . . . 0.0 112.416 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -118.36 122.65 43.37 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.509 1.524 . . . . 0.0 108.732 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 mm -120.41 122.91 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.144 0.978 . . . . 0.0 112.367 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.59 128.77 9.17 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 168.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.46 91.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.276 1.038 . . . . 0.0 108.937 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -93.02 148.21 22.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.549 1.139 . . . . 0.0 112.448 -169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.11 143.87 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.55 0.74 . . . . 0.0 111.006 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.47 108.37 0.64 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 172.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -150.51 165.92 31.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.256 1.022 . . . . 0.0 112.08 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -110.15 -19.58 12.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.512 1.125 . . . . 0.0 113.174 171.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -143.78 -13.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.69 11.02 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.02 -44.71 97.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.35 2.075 . . . . 0.0 112.986 -174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 p -75.95 -30.25 58.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.644 0.778 . . . . 0.0 112.803 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.14 -39.25 85.67 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.907 -1.121 . . . . 0.0 113.408 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.89 -45.43 71.09 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.659 0.663 . . . . 0.0 110.899 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.66 -34.46 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 112.104 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.37 94.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.351 0.978 . . . . 0.0 112.831 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.0 -41.69 98.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.584 0.754 . . . . 0.0 111.611 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.0 -48.07 83.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.294 0.638 . . . . 0.0 111.799 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.91 91.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 112.844 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -57.67 -46.86 83.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.748 0.419 . . . . 0.0 111.512 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.98 81.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.369 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -58.1 -45.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.745 1.218 . . . . 0.0 112.201 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 mt -73.08 -40.1 65.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.556 0.616 . . . . 0.0 110.25 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.5 m -56.71 -46.78 81.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.662 1.185 . . . . 0.0 111.808 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.63 80.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.135 0.974 . . . . 0.0 113.009 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.74 -34.38 77.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.121 0.968 . . . . 0.0 111.756 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.86 5.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.213 1.387 . . . . 0.0 114.652 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.593 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 92.9 m-70 -75.36 150.62 38.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.636 1.174 . . . . 0.0 111.73 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -76.49 130.25 37.68 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.62 142.48 31.06 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.428 0.558 . . . . 0.0 111.913 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.0 m -141.0 115.63 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.971 0.908 . . . . 0.0 109.809 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.53 146.76 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.75 0.82 . . . . 0.0 111.895 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -135.18 96.13 3.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.781 . . . . 0.0 108.485 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -72.43 -27.48 62.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.309 1.444 . . . . 0.0 114.61 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -144.74 64.62 11.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.849 2.059 . . . . 0.0 108.524 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.44 162.02 43.65 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.363 3.376 . . . . 0.0 116.248 -168.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.93 163.7 29.67 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.058 2.543 . . . . 0.0 108.274 169.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.89 -45.01 15.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.955 -1.091 . . . . 0.0 112.568 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m -56.68 -20.1 19.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.18 -34.62 32.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.378 0.99 . . . . 0.0 112.313 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.5 ' CH2' HG21 ' A' ' 52' ' ' VAL . 14.3 t-105 -79.41 -32.29 42.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.596 1.558 . . . . 0.0 112.771 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 tp -39.87 -45.85 4.59 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 128.793 2.837 . . . . 0.0 116.167 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -77.58 -18.41 13.68 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.583 2.188 . . . . 0.0 115.354 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.88 -6.09 57.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -57.32 -23.8 51.0 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -102.47 13.81 33.59 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.132 1.373 . . . . 0.0 112.938 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -138.51 -131.55 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.652 1.981 . . . . 0.0 109.651 -169.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -135.31 151.51 50.61 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.237 1.015 . . . . 0.0 111.166 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.5 HG21 ' CH2' ' A' ' 44' ' ' TRP . 27.6 m -147.85 165.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.723 1.209 . . . . 0.0 111.012 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.65 149.72 24.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 109.563 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.14 143.23 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.205 0.602 . . . . 0.0 110.842 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.29 109.45 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.585 0.707 . . . . 0.0 110.298 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.4 m -138.17 144.53 40.77 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 m -95.96 -168.82 1.82 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.677 1.591 . . . . 0.0 112.587 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -128.5 149.71 50.48 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.88 1.272 . . . . 0.0 110.62 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 127.798 2.439 . . . . 0.0 108.561 179.006 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.3 t0 . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.724 0.773 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.47 139.86 55.57 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 127.185 2.194 . . . . 0.0 111.808 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.72 141.38 49.52 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.135 2.556 . . . . 0.0 110.014 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.17 -30.18 64.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -169.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -61.49 -13.35 20.17 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -121.75 -7.65 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.145 1.338 . . . . 0.0 113.896 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -50.7 -48.47 82.85 Favored Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.62 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.5 5.27 2.46 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.11 2.54 . . . . 0.0 114.749 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.4 tp -107.55 -47.34 3.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.663 1.185 . . . . 0.0 109.795 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.43 -53.71 55.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.352 1.061 . . . . 0.0 112.016 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -63.91 -37.06 86.02 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.682 -0.636 . . . . 0.0 111.844 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.81 -46.23 76.66 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.712 0.672 . . . . 0.0 113.281 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.57 -42.01 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.666 1.233 . . . . 0.0 110.57 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.81 -51.28 65.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.683 0.793 . . . . 0.0 112.987 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.93 -25.17 24.52 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.5 m -125.15 -0.37 7.78 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -119.09 -52.52 2.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.521 1.055 . . . . 0.0 110.256 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.23 -23.8 0.2 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 118.135 2.014 . . . . 0.0 118.135 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -151.98 139.76 19.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.041 1.736 . . . . 0.0 110.064 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 50.79 0.54 Allowed Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -66.03 -18.9 57.62 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.249 2.633 . . . . 0.0 114.592 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.53 -17.21 58.15 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -76.8 138.16 39.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.42 1.088 . . . . 0.0 112.663 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -129.15 145.9 51.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.932 1.693 . . . . 0.0 110.792 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -159.3 -174.9 4.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -169.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.77 154.97 25.87 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 127.357 2.408 . . . . 0.0 110.299 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.77 128.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.771 1.286 . . . . 0.0 111.169 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -105.6 143.56 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.93 48.72 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.036 -1.04 . . . . 0.0 110.343 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.3 tt -139.57 153.37 47.4 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.19 0.995 . . . . 0.0 111.339 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.69 -140.82 6.04 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.206 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -143.38 129.28 19.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.257 1.023 . . . . 0.0 111.196 -173.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.8 m -62.59 -7.0 3.96 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 m -67.2 0.34 2.82 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.05 156.09 48.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.535 1.534 . . . . 0.0 112.421 -170.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.46 -39.52 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.032 0.933 . . . . 0.0 111.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -78.08 44.85 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.209 1.404 . . . . 0.0 112.785 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -52.36 116.56 2.31 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.313 -1.492 . . . . 0.0 112.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.1 m 51.18 24.67 2.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.72 2.408 . . . . 0.0 117.219 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.45 -28.5 69.32 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.536 -1.353 . . . . 0.0 113.794 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.55 -35.81 91.66 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 118.912 0.778 . . . . 0.0 113.39 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.08 -34.17 27.45 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.276 -1.132 . . . . 0.0 113.297 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.64 -37.74 82.51 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.581 1.191 . . . . 0.0 112.636 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -57.36 -45.6 84.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.319 0.648 . . . . 0.0 111.407 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.0 -34.74 77.1 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.265 0.939 . . . . 0.0 112.952 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.94 -44.21 97.25 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 111.778 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.91 69.39 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.5 tp -53.92 -20.71 6.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.374 1.469 . . . . 0.0 113.233 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 mt -107.08 -37.7 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.788 1.235 . . . . 0.0 111.22 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -30.5 71.16 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.189 0.904 . . . . 0.0 111.26 169.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -51.83 -30.79 24.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.617 1.567 . . . . 0.0 112.131 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -116.97 17.72 14.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.395 1.478 . . . . 0.0 113.014 -169.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.3 t 65.58 16.0 10.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.602 1.961 . . . . 0.0 115.292 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.06 49.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.239 -0.913 . . . . 0.0 111.982 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -109.96 110.39 21.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.008 0.923 . . . . 0.0 111.23 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -73.1 126.23 29.53 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.054 -1.029 . . . . 0.0 110.853 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -84.44 34.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.176 1.39 . . . . 0.0 111.906 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.3 -171.47 43.1 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.682 1.611 . . . . 0.0 112.468 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -114.66 158.93 21.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.636 1.575 . . . . 0.0 111.375 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.3 mtp -61.85 159.12 14.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -127.85 127.47 43.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.413 1.085 . . . . 0.0 108.632 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.12 94.44 4.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.247 1.019 . . . . 0.0 111.669 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.5 mt -81.01 141.24 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.058 1.743 . . . . 0.0 112.154 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -124.92 103.9 8.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.877 1.271 . . . . 0.0 113.062 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -18.96 47.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.195 1.398 . . . . 0.0 114.403 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.3 p -80.6 -5.63 57.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.581 1.082 . . . . 0.0 113.56 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.13 -24.89 2.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.131 1.372 . . . . 0.0 112.848 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.48 110.44 7.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.876 0.871 . . . . 0.0 113.27 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.65 -1.92 10.76 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.061 3.174 . . . . 0.0 114.159 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -131.41 70.1 81.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.204 1.802 . . . . 0.0 109.291 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.06 -16.5 39.76 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.841 3.694 . . . . 0.0 117.262 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -57.55 -32.34 67.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.988 -1.07 . . . . 0.0 113.217 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -66.18 -6.28 13.0 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -118.91 -0.52 11.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.52 -26.05 1.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.29 -54.31 46.39 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.485 1.039 . . . . 0.0 113.067 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.26 -31.77 34.8 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 121.256 1.484 . . . . 0.0 112.852 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -60.52 -49.51 77.28 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.397 0.679 . . . . 0.0 111.669 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.19 -36.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.715 -0.616 . . . . 0.0 110.451 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.71 -44.31 96.73 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.236 0.926 . . . . 0.0 112.753 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.46 -36.09 58.08 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.995 1.27 . . . . 0.0 113.361 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -57.35 -43.79 83.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.74 1.155 . . . . 0.0 110.437 170.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.76 -13.53 25.55 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.864 -1.52 . . . . 0.0 116.131 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.7 p -107.05 -11.98 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.612 2.206 . . . . 0.0 113.183 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.12 -30.75 31.0 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.22 1.008 . . . . 0.0 111.378 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.23 152.57 20.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.362 1.465 . . . . 0.0 112.566 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.167 2.187 . . . . 0.0 114.006 -179.552 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.571 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.546 0.802 0 CA-C-O 121.29 0.566 . . . . 0.0 112.084 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -135.28 119.05 17.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.976 1.311 . . . . 0.0 109.754 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mm -118.34 124.96 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.744 0.818 . . . . 0.0 112.825 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.18 126.4 7.82 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 168.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.7 mt -117.54 90.97 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.438 1.095 . . . . 0.0 108.411 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -91.3 144.19 25.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.004 -169.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.4 141.54 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.054 0.942 . . . . 0.0 110.54 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.94 91.22 0.21 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -142.88 164.16 30.85 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.559 1.144 . . . . 0.0 113.155 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.6 mmm -125.77 0.83 7.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.531 1.532 . . . . 0.0 112.888 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -140.25 -37.3 0.47 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.32 -5.52 10.16 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.975 1.15 . . . . 0.0 115.975 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -63.15 -42.83 99.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.528 1.164 . . . . 0.0 111.481 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -39.53 86.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.061 . . . . 0.0 112.515 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 tp -59.72 -39.23 83.97 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.8 tp -49.34 -41.69 39.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.991 0.917 . . . . 0.0 112.177 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.6 -39.93 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 123.249 0.619 . . . . 0.0 112.045 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -41.07 96.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.075 0.852 . . . . 0.0 112.434 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.92 -42.06 97.37 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.35 0.66 . . . . 0.0 112.273 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.49 -43.25 85.89 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.467 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.24 92.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.702 0.801 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.64 -47.84 78.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.368 0.667 . . . . 0.0 111.529 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.77 92.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.71 0.804 . . . . 0.0 112.62 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.58 -47.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.28 . . . . 0.0 112.187 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 mt -70.32 -41.34 73.39 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.242 0.617 . . . . 0.0 109.884 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -56.73 -46.02 81.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.1 1.36 . . . . 0.0 112.24 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.79 90.14 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.169 0.987 . . . . 0.0 112.87 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.59 -32.24 71.99 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.48 4.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.26 1.41 . . . . 0.0 114.983 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.571 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 84.3 m-70 -77.95 146.72 35.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.149 1.379 . . . . 0.0 111.899 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -72.94 138.58 46.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.6 35.25 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.74 -0.6 . . . . 0.0 112.455 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.7 m -144.51 116.25 8.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.238 1.015 . . . . 0.0 110.656 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.47 140.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.106 0.562 . . . . 0.0 110.173 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.76 96.91 4.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.384 1.474 . . . . 0.0 107.899 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.4 -29.81 65.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.768 1.627 . . . . 0.0 114.265 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -146.31 64.53 9.79 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 126.862 2.065 . . . . 0.0 108.734 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.91 163.75 37.84 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.007 3.138 . . . . 0.0 115.727 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 160.67 36.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.339 2.256 . . . . 0.0 108.798 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -32.73 -54.04 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.765 2.026 . . . . 0.0 113.691 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -63.04 -21.63 66.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.493 1.517 . . . . 0.0 114.411 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.68 -36.14 62.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.222 0.919 . . . . 0.0 111.625 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.443 ' CH2' HG21 ' A' ' 52' ' ' VAL . 20.1 t-105 -79.46 -38.52 34.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 112.904 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.1 tp -38.39 -45.84 2.66 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 128.112 2.565 . . . . 0.0 116.784 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.64 -26.04 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 CA-C-N 122.543 1.944 . . . . 0.0 115.133 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -71.91 -8.8 56.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -56.49 -26.29 53.89 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.959 -1.088 . . . . 0.0 113.791 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.73 -8.05 57.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.324 1.449 . . . . 0.0 113.749 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -133.25 -128.61 0.17 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.958 2.103 . . . . 0.0 110.02 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -136.88 160.55 38.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.983 1.713 . . . . 0.0 111.277 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' CH2' ' A' ' 44' ' ' TRP . 33.6 m -144.08 170.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.878 1.271 . . . . 0.0 111.052 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -159.16 148.35 18.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.446 1.898 . . . . 0.0 108.174 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.34 142.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.684 -0.635 . . . . 0.0 112.048 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.6 116.2 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.097 0.959 . . . . 0.0 111.529 169.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.9 m -141.88 153.39 44.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 0.0 111.929 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 p -138.7 145.8 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -70.64 146.11 50.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.477 1.911 . . . . 0.0 114.654 -174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 127.469 2.308 . . . . 0.0 111.375 -173.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t0 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.59 139.74 96.15 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.734 2.013 . . . . 0.0 110.255 169.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.64 144.59 35.8 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.689 2.926 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.92 -22.39 64.31 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.5 p -63.3 -16.58 60.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.1 tt -124.89 -8.94 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.69 -48.12 77.44 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.8 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.12 5.89 1.65 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.24 2.626 . . . . 0.0 114.817 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.48 -44.98 3.44 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 110.324 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.73 -51.36 70.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.143 0.977 . . . . 0.0 111.679 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -62.87 -41.14 99.28 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 111.859 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -42.89 93.71 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.756 0.693 . . . . 0.0 113.772 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.31 -46.08 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -62.75 -40.77 98.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.54 -25.25 16.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -125.56 -31.47 2.98 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.84 -43.77 62.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.255 1.389 . . . . 0.0 109.391 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.49 -42.18 0.67 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 126.641 2.067 . . . . 0.0 116.679 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -155.14 143.26 20.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.116 1.767 . . . . 0.0 109.703 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -146.22 47.62 0.64 Allowed Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -60.86 -29.88 89.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.139 2.559 . . . . 0.0 113.799 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -65.87 -22.76 66.55 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.407 1.883 . . . . 0.0 114.615 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.8 tp -73.43 138.68 45.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.933 0.788 . . . . 0.0 111.574 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -134.8 132.74 39.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.493 1.917 . . . . 0.0 108.682 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -154.59 -171.56 3.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.59 164.18 30.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.974 1.75 . . . . 0.0 109.513 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 146.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.497 1.142 . . . . 0.0 113.533 -169.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.4 mt -129.83 141.66 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.82 1.648 . . . . 0.0 106.56 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.44 156.36 48.7 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -144.38 149.18 35.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 110.858 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.69 -151.0 9.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 123.654 0.645 . . . . 0.0 111.644 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -137.99 117.35 12.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.999 1.32 . . . . 0.0 109.876 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -59.62 -7.8 1.68 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.995 1.318 . . . . 0.0 114.505 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.0 m -61.32 -10.27 6.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.151 1.38 . . . . 0.0 114.157 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -127.21 137.02 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 111.426 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.57 -26.17 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -81.4 -18.49 45.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.316 0.962 . . . . 0.0 113.285 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.9 t80 38.93 -131.78 0.19 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.748 1.619 . . . . 0.0 112.451 -169.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.4 m -73.58 23.56 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -53.61 -30.42 42.5 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.142 -1.598 . . . . 0.0 114.495 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.1 -35.89 92.56 Favored Glycine 0 CA--C 1.533 1.156 0 O-C-N 121.125 -0.984 . . . . 0.0 113.111 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.32 -40.54 11.13 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.825 -0.809 . . . . 0.0 113.316 173.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.67 -31.9 69.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.67 1.235 . . . . 0.0 113.781 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -58.47 -39.53 80.21 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.16 -27.35 63.48 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.303 0.956 . . . . 0.0 113.33 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.64 -49.66 65.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.766 -1.209 . . . . 0.0 110.053 169.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.31 -40.45 71.15 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -49.89 -27.7 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.82 1.648 . . . . 0.0 113.644 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.6 mt -112.1 -36.67 5.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.609 1.163 . . . . 0.0 111.808 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.76 -31.24 71.75 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.169 -0.957 . . . . 0.0 113.209 170.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -66.25 -14.64 62.27 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 119.419 1.009 . . . . 0.0 112.528 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -111.81 16.84 20.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.641 1.976 . . . . 0.0 111.849 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t 61.97 20.41 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.332 1.853 . . . . 0.0 115.263 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.48 161.07 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.842 0.746 . . . . 0.0 112.972 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -112.09 162.71 15.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.769 1.628 . . . . 0.0 108.645 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mtm105 -133.88 149.05 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.85 21.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.986 172.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.85 -172.35 45.2 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.529 1.538 . . . . 0.0 113.598 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.68 156.26 44.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.282 1.433 . . . . 0.0 111.411 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.85 120.91 14.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.85 0.86 . . . . 0.0 112.098 -170.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.07 135.94 35.88 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.527 1.131 . . . . 0.0 110.074 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.58 96.03 4.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.704 1.202 . . . . 0.0 111.915 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.01 141.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.236 1.415 . . . . 0.0 111.137 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -129.49 116.73 19.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.907 1.283 . . . . 0.0 111.751 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.78 -26.87 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.618 1.167 . . . . 0.0 113.87 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.9 m -81.62 4.78 20.35 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.51 -30.18 2.36 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.371 1.468 . . . . 0.0 112.449 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -143.1 118.48 6.45 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 124.619 1.168 . . . . 0.0 112.278 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.32 -6.2 13.72 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.86 3.04 . . . . 0.0 114.498 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.98 80.58 64.58 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.529 1.532 . . . . 0.0 111.198 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.97 -35.04 9.65 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.712 4.275 . . . . 0.0 116.711 -175.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.67 -38.47 64.2 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.6 p -69.46 -6.14 28.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -116.38 -3.55 11.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.001 1.321 . . . . 0.0 112.554 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 p -132.95 -27.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -170.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -55.44 -54.09 54.92 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.254 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.5 -29.37 53.13 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.598 1.532 . . . . 0.0 112.756 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -62.49 -49.15 76.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.387 0.675 . . . . 0.0 111.442 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.89 -41.04 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.816 0.735 . . . . 0.0 110.506 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -59.03 -45.21 91.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.462 0.573 . . . . 0.0 111.541 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -61.96 -56.05 23.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.087 0.955 . . . . 0.0 112.138 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.38 -49.04 65.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.76 1.224 . . . . 0.0 111.172 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.96 -21.83 32.39 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.582 1.563 . . . . 0.0 116.165 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -70.53 -17.42 62.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.491 2.146 . . . . 0.0 113.737 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.47 -14.43 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.251 1.42 . . . . 0.0 113.578 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.2 157.67 18.79 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.412 1.885 . . . . 0.0 112.367 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.899 1.28 . . . . 0.0 113.651 177.437 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.465 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 121.444 0.64 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -135.14 119.37 17.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.618 1.567 . . . . 0.0 109.13 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.08 125.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.871 0.868 . . . . 0.0 113.267 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.6 128.6 8.97 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 mt -118.31 91.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.541 1.136 . . . . 0.0 108.519 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -90.93 139.1 31.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.274 1.029 . . . . 0.0 111.698 -169.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -125.47 144.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.713 0.768 . . . . 0.0 111.502 -169.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 105.88 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 t -155.9 161.45 40.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.385 1.474 . . . . 0.0 113.153 -173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.5 mmm -122.96 -9.28 8.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.438 1.495 . . . . 0.0 112.397 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -138.99 0.18 1.93 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.5 -4.39 83.95 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.117 1.607 . . . . 0.0 117.117 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -64.62 -42.87 95.21 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.475 1.637 . . . . 0.0 113.097 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 p -75.46 -33.9 60.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.085 0.954 . . . . 0.0 112.385 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 tp -58.43 -38.76 78.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.995 -1.065 . . . . 0.0 112.771 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -53.88 -45.68 71.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.759 0.709 . . . . 0.0 111.71 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.21 -36.9 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 111.545 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.41 92.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.261 0.937 . . . . 0.0 112.968 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.45 -41.76 97.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.356 0.662 . . . . 0.0 112.184 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.06 -41.72 97.25 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.648 -0.657 . . . . 0.0 112.562 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.528 -0.732 . . . . 0.0 112.061 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.81 -46.83 77.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.677 0.791 . . . . 0.0 111.825 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.48 95.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.742 0.817 . . . . 0.0 112.77 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.95 -43.19 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.547 1.139 . . . . 0.0 112.262 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.27 -38.71 75.15 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.21 -0.932 . . . . 0.0 109.614 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -57.64 -45.47 85.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.251 1.021 . . . . 0.0 111.516 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.14 83.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.991 0.916 . . . . 0.0 113.296 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -69.8 -10.48 58.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.29 41.43 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.574 1.559 . . . . 0.0 114.729 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.465 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 70.8 m-70 -73.03 175.36 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.289 1.435 . . . . 0.0 111.894 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -111.62 145.51 39.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.812 1.245 . . . . 0.0 109.622 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 162.67 38.81 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.2 m -153.31 120.36 5.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.111 0.964 . . . . 0.0 110.948 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.3 141.16 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.906 0.882 . . . . 0.0 110.924 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -126.67 111.12 13.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.221 1.408 . . . . 0.0 109.789 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 -16.46 23.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.461 1.504 . . . . 0.0 114.945 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -142.43 55.9 4.82 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.22 1.408 . . . . 0.0 111.068 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.37 163.15 39.81 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.977 3.118 . . . . 0.0 113.517 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -143.34 -44.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.84 -44.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.273 1.029 . . . . 0.0 113.105 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 m -58.76 -28.79 66.24 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.923 0.868 . . . . 0.0 112.257 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -54.83 40.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.948 2.899 . . . . 0.0 112.461 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -68.62 -40.89 80.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.572 1.549 . . . . 0.0 113.748 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -37.97 -56.45 1.94 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.672 2.389 . . . . 0.0 115.28 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.54 -18.72 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.594 2.196 . . . . 0.0 114.867 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.58 -5.95 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -54.88 -30.58 58.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.343 0.974 . . . . 0.0 113.158 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -86.23 4.21 39.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.378 1.471 . . . . 0.0 113.492 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -136.33 -136.27 0.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.438 1.895 . . . . 0.0 110.997 -169.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -130.1 160.47 33.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 110.642 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.89 169.55 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.303 1.441 . . . . 0.0 110.367 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.55 147.46 18.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 109.932 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.38 131.14 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.197 1.399 . . . . 0.0 109.561 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.07 86.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.5 m -126.52 164.17 21.77 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -167.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -129.34 -172.33 2.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.748 1.219 . . . . 0.0 113.216 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 m -136.61 132.08 34.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.652 1.181 . . . . 0.0 110.519 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 125.396 1.478 . . . . 0.0 110.33 -169.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t0 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.5 mt -53.46 125.71 44.93 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 126.783 2.033 . . . . 0.0 112.681 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.51 142.72 98.3 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.681 3.587 . . . . 0.0 112.136 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.12 -20.14 65.76 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 p -66.07 -11.55 49.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.76 1.624 . . . . 0.0 114.959 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.3 tt -131.58 -13.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -44.81 -49.33 28.05 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.449 -1.263 . . . . 0.0 112.995 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.37 -24.96 42.54 Favored 'Trans proline' 0 C--N 1.353 0.769 0 CA-C-N 122.155 1.805 . . . . 0.0 113.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.3 tp -75.86 -43.03 47.68 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.835 0.743 . . . . 0.0 110.062 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.86 -46.48 90.42 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.294 1.038 . . . . 0.0 111.091 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -63.7 -43.27 97.12 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.712 -1.243 . . . . 0.0 112.543 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.48 -50.18 66.95 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.688 1.137 . . . . 0.0 112.74 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.02 -46.42 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.567 1.183 . . . . 0.0 110.265 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.07 -46.72 84.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.636 1.174 . . . . 0.0 112.751 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.09 -33.51 20.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -98.59 -30.97 12.18 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.94 -32.96 11.4 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.232 0.924 . . . . 0.0 113.279 -170.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.14 -51.77 1.0 Allowed Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.39 1.947 . . . . 0.0 117.007 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -159.86 140.96 12.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -156.19 104.94 2.06 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.5 1.52 . . . . 0.0 110.298 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.1 -15.45 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.307 2.671 . . . . 0.0 116.074 -169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -124.35 1.8 8.41 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.8 tp -69.49 137.56 52.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.562 0.745 . . . . 0.0 109.811 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -128.93 143.71 50.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.592 1.557 . . . . 0.0 110.748 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.33 -170.6 2.87 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -168.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.31 162.55 31.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 127.41 2.433 . . . . 0.0 109.914 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.7 t -139.87 136.82 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.061 0.934 . . . . 0.0 112.238 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.8 mt -123.18 125.08 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.2 148.98 42.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.717 1.207 . . . . 0.0 109.598 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.07 146.42 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 111.687 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.44 -137.45 3.95 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.018 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 131.99 28.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.726 0.811 . . . . 0.0 112.091 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.4 t -64.44 -10.86 27.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.921 1.689 . . . . 0.0 114.869 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -69.41 5.4 1.35 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -131.69 154.77 48.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.664 1.585 . . . . 0.0 112.833 -171.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.65 -6.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.789 1.636 . . . . 0.0 114.835 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -125.86 44.8 2.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.731 2.012 . . . . 0.0 110.945 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -49.48 115.29 1.28 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.095 -1.628 . . . . 0.0 112.17 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.9 m 53.33 23.39 3.25 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -58.23 -27.24 63.77 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.82 63.59 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.62 -1.3 . . . . 0.0 111.912 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.66 70.7 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.43 -1.041 . . . . 0.0 113.127 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.38 -41.96 90.56 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 117.821 0.81 . . . . 0.0 112.858 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.04 -41.39 92.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.184 0.447 . . . . 0.0 112.147 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -69.5 -28.49 66.1 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.67 -46.06 66.95 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 119.807 -1.808 . . . . 0.0 110.807 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.88 68.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.7 tp -49.66 -31.07 10.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.019 1.728 . . . . 0.0 113.124 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.1 -36.97 8.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.561 1.144 . . . . 0.0 111.399 -171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -66.27 -31.16 71.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.53 -0.731 . . . . 0.0 112.826 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.65 -15.97 63.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.374 1.07 . . . . 0.0 112.942 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -113.26 -9.67 13.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.9 t 98.75 15.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.229 2.611 . . . . 0.0 113.922 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.83 161.17 8.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.222 0.465 . . . . 0.0 110.716 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.61 100.14 5.42 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.838 -1.164 . . . . 0.0 110.566 -171.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttm105 -66.93 135.7 54.23 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.407 -0.808 . . . . 0.0 110.83 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.08 34.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 111.318 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.51 -166.61 39.83 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.776 -1.202 . . . . 0.0 113.75 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.19 145.61 42.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.448 1.499 . . . . 0.0 111.974 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.16 118.08 10.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.149 0.979 . . . . 0.0 111.705 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.79 136.06 38.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.939 0.896 . . . . 0.0 109.881 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.6 mt -120.65 95.85 4.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.774 1.229 . . . . 0.0 111.775 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mt -81.4 134.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.242 1.417 . . . . 0.0 111.226 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -123.94 112.29 17.05 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.389 1.475 . . . . 0.0 111.477 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.94 -23.7 54.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.0 m -82.83 2.11 35.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.446 1.098 . . . . 0.0 113.893 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.11 -27.29 3.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.417 1.487 . . . . 0.0 112.664 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.94 115.28 6.59 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.582 1.153 . . . . 0.0 112.097 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.81 -5.29 14.59 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.682 2.921 . . . . 0.0 114.413 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -131.51 80.64 66.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.611 1.564 . . . . 0.0 111.283 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -43.68 -37.58 8.5 Favored 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 125.668 4.246 . . . . 0.0 116.056 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -45.97 -44.22 14.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.441 1.896 . . . . 0.0 113.214 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.6 p -71.25 -10.01 59.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -116.45 4.34 13.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.001 1.32 . . . . 0.0 112.423 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 p -132.31 -27.51 1.77 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -61.37 -53.68 60.08 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 119.766 1.166 . . . . 0.0 112.9 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.1 -35.6 95.15 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.565 2.177 . . . . 0.0 114.032 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -60.72 -48.03 83.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.647 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.37 -40.08 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.959 0.8 . . . . 0.0 110.774 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.36 -43.56 88.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.662 0.665 . . . . 0.0 111.311 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.24 -55.73 16.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.773 1.229 . . . . 0.0 112.393 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -53.31 -46.9 69.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.034 0.934 . . . . 0.0 111.348 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.81 -27.18 6.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.406 1.955 . . . . 0.0 116.361 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -71.94 -19.32 61.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.995 1.897 . . . . 0.0 113.824 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 -14.7 26.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.436 1.494 . . . . 0.0 113.255 -171.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.05 160.85 17.18 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.897 2.079 . . . . 0.0 112.354 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.251 1.02 . . . . 0.0 112.895 169.867 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -135.31 117.46 15.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.005 1.722 . . . . 0.0 108.527 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mm -118.9 121.4 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.007 0.821 . . . . 0.0 113.143 -172.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.87 127.41 8.27 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.18 91.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.471 1.135 . . . . 0.0 108.512 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -93.81 136.03 34.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.084 0.954 . . . . 0.0 110.948 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.73 145.26 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.611 0.764 . . . . 0.0 111.52 -169.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.6 90.24 0.22 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 125.034 1.302 . . . . 0.0 110.645 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -140.96 178.37 7.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -169.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -147.98 -21.71 0.35 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.812 2.045 . . . . 0.0 112.754 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.52 -2.49 7.94 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.91 1.21 73.55 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -64.07 -44.95 90.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.849 1.324 . . . . 0.0 112.376 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -73.64 -33.23 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.241 1.416 . . . . 0.0 112.561 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.92 -38.91 80.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.879 -1.138 . . . . 0.0 112.977 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.6 -45.08 73.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.83 0.741 . . . . 0.0 111.734 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -63.82 -36.91 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 111.594 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.73 -43.11 97.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.121 0.873 . . . . 0.0 112.623 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.26 -42.89 99.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.495 0.718 . . . . 0.0 112.578 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -62.72 -40.88 98.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.554 -0.716 . . . . 0.0 112.672 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.19 82.49 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.735 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.57 -46.02 73.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.405 0.682 . . . . 0.0 111.483 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.83 83.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.552 0.741 . . . . 0.0 112.785 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -59.33 -45.14 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.702 1.201 . . . . 0.0 112.068 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.0 mt -70.7 -41.57 71.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.636 -0.665 . . . . 0.0 109.664 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -56.93 -44.19 82.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.25 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -37.67 82.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.011 0.924 . . . . 0.0 113.016 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.522 0.729 . . . . 0.0 112.501 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.16 -9.72 7.86 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.013 1.768 . . . . 0.0 114.445 169.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -72.7 147.54 45.57 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.371 1.069 . . . . 0.0 111.734 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -72.13 140.44 48.85 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.75 159.71 42.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.282 0.633 . . . . 0.0 112.16 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.3 m -153.49 118.43 5.07 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.249 -0.907 . . . . 0.0 111.425 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -74.12 141.31 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.923 0.889 . . . . 0.0 111.014 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -128.88 109.21 11.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.835 1.254 . . . . 0.0 109.635 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.26 -19.36 34.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.614 1.565 . . . . 0.0 114.823 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.2 58.99 5.58 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.922 1.689 . . . . 0.0 109.835 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.1 159.54 53.47 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.115 3.21 . . . . 0.0 115.474 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -138.1 167.33 22.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.193 2.197 . . . . 0.0 109.411 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.41 -45.54 18.05 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.714 1.206 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -59.27 -18.51 38.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -80.27 -34.4 37.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.608 1.095 . . . . 0.0 112.334 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CH2' HG21 ' A' ' 52' ' ' VAL . 33.9 t-105 -77.22 -35.98 55.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 112.781 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -41.45 -45.85 7.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 128.609 2.764 . . . . 0.0 115.944 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.68 -26.44 5.71 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.668 2.246 . . . . 0.0 114.527 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -82.76 -13.79 55.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -59.17 -26.35 64.71 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.41 7.2 26.72 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -134.08 -117.31 0.19 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.213 1.805 . . . . 0.0 110.682 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.89 154.7 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.41 1.084 . . . . 0.0 111.151 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 44' ' ' TRP . 23.2 m -149.23 169.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 110.988 -173.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.33 146.95 17.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.097 0.959 . . . . 0.0 110.358 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.11 133.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.17 1.388 . . . . 0.0 110.139 -169.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.38 89.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 107.717 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.2 m -131.48 164.83 24.89 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -167.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -136.68 -173.09 3.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.616 1.566 . . . . 0.0 112.793 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.5 m -129.71 146.44 51.48 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.136 0.974 . . . . 0.0 111.201 -171.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 128.183 2.593 . . . . 0.0 108.765 -179.82 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.95 150.63 87.6 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.275 -0.891 . . . . 0.0 112.935 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 162.61 19.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.87 3.047 . . . . 0.0 112.592 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.16 -17.85 64.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -171.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.5 p -60.3 -18.72 51.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.0 -9.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -45.65 -48.35 37.89 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.489 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.11 -23.3 33.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 122.199 1.821 . . . . 0.0 113.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 tp -76.03 -48.67 20.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 110.097 173.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.35 -49.58 76.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.825 1.65 . . . . 0.0 111.942 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -64.56 -45.13 88.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.235 -0.916 . . . . 0.0 111.851 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.89 -43.53 97.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.254 0.931 . . . . 0.0 114.278 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.72 -46.96 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.413 1.107 . . . . 0.0 110.402 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.69 -48.02 82.68 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.856 -0.527 . . . . 0.0 111.807 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.13 -41.26 61.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.084 1.353 . . . . 0.0 114.378 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -122.29 5.06 9.71 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -168.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -122.34 -49.65 2.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.54 1.064 . . . . 0.0 110.137 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -31.35 0.29 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.696 2.093 . . . . 0.0 117.984 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -154.71 138.77 16.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.197 1.499 . . . . 0.0 112.36 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -158.18 118.24 1.88 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.225 1.41 . . . . 0.0 110.926 169.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -87.45 -30.74 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.181 2.587 . . . . 0.0 115.806 -171.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -100.39 1.58 41.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.01 135.9 41.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.387 1.075 . . . . 0.0 111.388 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -123.64 143.38 50.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.009 1.723 . . . . 0.0 111.04 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.17 -173.84 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 162.48 32.04 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.151 2.31 . . . . 0.0 110.676 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.87 130.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.916 0.865 . . . . 0.0 111.701 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 mt -119.07 125.58 74.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 169.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.29 149.95 40.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.79 0.836 . . . . 0.0 109.728 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -140.36 138.81 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.645 0.778 . . . . 0.0 110.933 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.31 -131.12 1.63 Allowed Glycine 0 CA--C 1.521 0.463 0 O-C-N 122.253 -0.279 . . . . 0.0 113.533 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -141.07 119.48 12.25 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 111.149 -172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -64.16 -6.08 6.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.0 m -65.31 0.08 1.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -134.93 154.58 51.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.722 1.609 . . . . 0.0 112.33 -173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.803 0.841 . . . . 0.0 111.948 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.75 40.7 0.53 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.773 1.229 . . . . 0.0 112.557 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -51.16 115.06 1.38 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.393 -1.442 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m 50.85 26.07 2.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.02 -30.3 69.07 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.497 -1.377 . . . . 0.0 113.117 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -37.62 94.34 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.678 0.672 . . . . 0.0 113.527 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.82 56.29 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.136 -1.214 . . . . 0.0 112.642 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.83 -36.79 82.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.051 0.94 . . . . 0.0 113.032 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.67 -38.16 74.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.141 0.976 . . . . 0.0 112.373 170.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -78.37 -35.54 47.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.677 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.19 -41.06 96.14 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 119.676 -1.89 . . . . 0.0 111.822 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.45 79.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.07 -46.46 68.59 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.454 1.024 . . . . 0.0 111.34 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.4 mt -76.31 -37.23 57.73 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.124 0.969 . . . . 0.0 112.331 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.7 -32.48 74.06 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.471 -0.768 . . . . 0.0 112.333 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.84 -25.48 65.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.701 0.682 . . . . 0.0 111.8 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -76.49 -32.26 58.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.458 1.026 . . . . 0.0 111.477 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m 99.64 15.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.305 3.042 . . . . 0.0 112.198 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.71 162.54 6.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.229 0.612 . . . . 0.0 111.267 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -131.61 104.8 7.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.175 0.99 . . . . 0.0 110.602 -169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -69.63 134.67 49.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.279 -0.888 . . . . 0.0 111.439 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.48 31.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.615 1.566 . . . . 0.0 112.104 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.25 -165.32 38.7 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.954 -1.091 . . . . 0.0 114.37 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.63 151.6 38.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.785 1.634 . . . . 0.0 110.991 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 29.8 ttm -69.3 132.5 46.54 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.64 0.776 . . . . 0.0 112.01 -170.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.9 tm? -87.97 134.11 33.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.356 0.662 . . . . 0.0 109.474 171.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.463 ' N ' HD13 ' A' ' 123' ' ' LEU . 70.1 mt -121.36 93.47 4.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.921 1.288 . . . . 0.0 111.675 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 51.0 mt -75.55 136.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.383 1.473 . . . . 0.0 110.524 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -129.18 110.23 11.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.32 1.048 . . . . 0.0 112.458 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.2 -25.16 58.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.6 m -82.95 4.95 23.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 113.689 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -133.39 -29.98 1.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.132 1.373 . . . . 0.0 113.014 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -142.94 116.84 6.24 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.537 1.135 . . . . 0.0 112.393 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.68 -3.71 11.94 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.103 3.202 . . . . 0.0 114.75 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.34 86.1 58.8 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.528 1.531 . . . . 0.0 110.49 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.28 -26.85 71.78 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.952 2.434 . . . . 0.0 114.383 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.2 -39.14 93.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -12.42 56.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.265 -0.897 . . . . 0.0 112.718 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.06 -0.68 14.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.267 1.827 . . . . 0.0 111.751 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 p -135.2 -24.24 1.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.52 1.128 . . . . 0.0 113.955 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -62.66 -52.82 62.05 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -57.85 -34.58 98.48 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.652 2.234 . . . . 0.0 113.932 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -59.94 -48.6 81.06 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.157 0.583 . . . . 0.0 111.261 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.08 -39.33 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.096 0.862 . . . . 0.0 110.891 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.64 -46.37 90.58 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.661 1.119 . . . . 0.0 111.923 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -63.28 -51.06 67.66 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.024 0.93 . . . . 0.0 112.352 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -58.23 -54.79 42.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.869 0.867 . . . . 0.0 110.623 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.26 -29.66 53.22 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.254 1.883 . . . . 0.0 114.767 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 94.2 m -59.2 -23.18 62.06 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.292 1.037 . . . . 0.0 113.238 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.92 -15.67 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.346 1.458 . . . . 0.0 114.689 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -30.78 70.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.545 1.138 . . . . 0.0 114.044 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.773 2.029 . . . . 0.0 111.685 175.8 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.421 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.356 0.598 . . . . 0.0 112.292 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.13 121.0 33.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.402 1.481 . . . . 0.0 109.383 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mm -113.05 121.51 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.106 0.962 . . . . 0.0 112.036 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 126.38 7.48 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.4 mt -118.56 108.72 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 108.876 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.07 109.71 21.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.751 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -87.48 147.34 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.774 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.93 114.55 1.21 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -160.9 175.76 12.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.596 1.558 . . . . 0.0 111.309 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ptp -132.61 4.17 3.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -146.71 -54.13 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.656 1.182 . . . . 0.0 112.887 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.35 7.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 118.097 1.999 . . . . 0.0 118.097 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -63.85 -40.02 95.6 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.515 2.158 . . . . 0.0 112.743 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 91.7 p -79.69 -33.97 40.6 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.881 0.872 . . . . 0.0 112.502 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 tp -56.49 -38.49 71.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.054 -1.029 . . . . 0.0 112.719 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.61 -42.91 75.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.698 0.799 . . . . 0.0 111.682 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.41 -37.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 111.651 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -57.86 -44.25 86.46 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.935 0.789 . . . . 0.0 112.493 173.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.74 -43.36 99.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.073 0.949 . . . . 0.0 112.168 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.41 -48.2 81.46 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.598 -0.688 . . . . 0.0 112.395 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.48 89.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.627 0.771 . . . . 0.0 112.334 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.6 -44.97 85.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.525 0.73 . . . . 0.0 111.792 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -44.99 88.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.716 0.806 . . . . 0.0 112.674 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.5 mt -61.07 -45.61 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.841 1.256 . . . . 0.0 112.216 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.28 -43.23 82.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.374 0.67 . . . . 0.0 109.377 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.7 m -55.24 -47.52 75.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.631 1.173 . . . . 0.0 112.055 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.67 85.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.086 0.955 . . . . 0.0 113.451 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -72.92 -11.14 60.47 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -4.41 42.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.343 1.449 . . . . 0.0 114.524 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.421 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 83.9 m-70 -72.86 178.35 4.29 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.16 1.384 . . . . 0.0 111.862 172.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -118.19 145.26 45.09 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.957 1.703 . . . . 0.0 109.519 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.55 155.03 41.45 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.444 -0.785 . . . . 0.0 112.623 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.3 m -143.42 100.65 3.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.019 0.927 . . . . 0.0 111.042 -172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.48 137.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.154 0.982 . . . . 0.0 111.21 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -126.0 111.1 14.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.853 1.661 . . . . 0.0 109.271 170.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.28 -20.91 43.34 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -146.45 60.07 5.81 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 126.249 1.82 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.48 160.34 49.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.274 2.649 . . . . 0.0 114.651 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -135.89 164.07 28.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.341 2.256 . . . . 0.0 108.899 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -39.08 -48.01 1.61 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.497 1.519 . . . . 0.0 113.572 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 p -58.82 -18.12 29.63 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.07 -31.8 25.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.331 1.052 . . . . 0.0 112.541 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.518 ' CH2' HG21 ' A' ' 52' ' ' VAL . 23.6 t-105 -81.51 -36.87 28.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.349 1.06 . . . . 0.0 112.641 174.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -36.63 -52.28 1.89 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.456 2.302 . . . . 0.0 114.638 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.98 6.07 5.53 Favored 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 123.09 2.527 . . . . 0.0 116.029 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -107.31 2.81 24.8 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.246 1.384 . . . . 0.0 114.64 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -58.59 -25.88 63.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -99.19 9.42 43.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.681 1.592 . . . . 0.0 113.621 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -135.33 -160.68 1.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.694 2.398 . . . . 0.0 110.326 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -111.54 159.01 18.52 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.21 1.005 . . . . 0.0 111.85 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.518 HG21 ' CH2' ' A' ' 44' ' ' TRP . 28.4 m -148.51 173.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.409 1.484 . . . . 0.0 111.537 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.51 142.44 15.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.591 1.156 . . . . 0.0 111.379 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.42 130.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.191 1.797 . . . . 0.0 109.609 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 19' ' ' ALA . 11.4 p -140.34 89.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 122.091 0.948 . . . . 0.0 109.504 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.7 m -133.83 133.71 41.94 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -167.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 m -78.84 -166.97 0.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.935 1.694 . . . . 0.0 112.722 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -131.39 152.91 50.21 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.688 -1.257 . . . . 0.0 111.286 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 p . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 127.593 2.357 . . . . 0.0 109.198 -177.457 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 mt -60.72 126.29 84.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.707 2.403 . . . . 0.0 112.008 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.16 142.65 97.27 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.502 2.801 . . . . 0.0 111.335 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.62 -29.26 69.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 m -67.21 -9.55 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -118.18 -7.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.768 1.167 . . . . 0.0 113.243 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.9 t -54.63 -45.82 99.43 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.144 -1.407 . . . . 0.0 112.342 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -55.88 -11.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.216 3.277 . . . . 0.0 116.549 169.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 tp -105.3 -44.22 4.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.405 1.082 . . . . 0.0 110.403 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -58.3 -49.22 77.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 111.47 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -62.4 -42.69 99.62 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.539 -0.726 . . . . 0.0 112.332 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.27 -40.27 70.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.248 0.928 . . . . 0.0 113.585 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.63 -45.61 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.463 1.131 . . . . 0.0 110.063 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.27 -47.21 86.23 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.487 0.715 . . . . 0.0 112.376 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -79.02 -38.2 37.2 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 m -126.06 -10.06 6.53 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -168.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 -33.28 16.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.15 1.795 . . . . 0.0 112.279 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 -55.32 1.53 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.288 1.899 . . . . 0.0 116.802 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -151.76 149.55 29.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.03 1.732 . . . . 0.0 111.383 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -148.76 38.53 0.19 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.82 -33.52 14.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.815 2.344 . . . . 0.0 115.656 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -68.67 -0.37 5.16 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.545 2.338 . . . . 0.0 116.284 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.19 142.75 49.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.961 1.304 . . . . 0.0 112.251 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.7 145.26 51.54 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.054 2.142 . . . . 0.0 110.451 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.48 -169.09 2.33 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.75 167.36 31.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.015 2.245 . . . . 0.0 110.116 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.19 126.69 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 118.391 1.095 . . . . 0.0 112.978 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -114.0 109.86 30.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 168.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.39 142.51 32.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.416 0.686 . . . . 0.0 109.27 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.1 154.6 47.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.112 0.958 . . . . 0.0 110.716 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.7 -129.12 1.86 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.922 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.44 128.13 14.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.547 1.139 . . . . 0.0 111.165 -173.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.5 p -72.5 -1.6 16.49 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 m -67.74 4.13 1.22 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.42 156.26 47.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.147 1.779 . . . . 0.0 111.557 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.49 -37.33 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.732 0.813 . . . . 0.0 111.843 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.63 44.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 112.966 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -53.1 113.63 1.18 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.673 -1.267 . . . . 0.0 111.846 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.7 m 50.21 27.7 2.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.122 2.569 . . . . 0.0 116.312 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -58.85 -28.62 66.25 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.896 -1.128 . . . . 0.0 113.498 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.16 -33.49 64.91 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.771 0.7 . . . . 0.0 113.803 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.1 -36.78 9.67 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 117.908 0.854 . . . . 0.0 113.47 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -59.21 -36.79 76.03 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.828 1.314 . . . . 0.0 113.113 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -54.84 -45.74 74.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.927 0.891 . . . . 0.0 111.424 170.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.63 -27.56 62.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.461 -0.775 . . . . 0.0 112.949 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.5 -44.0 75.65 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.674 -1.891 . . . . 0.0 110.781 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.94 77.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.728 0.811 . . . . 0.0 112.979 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.3 tp -51.12 -32.43 22.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 112.847 171.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -97.95 -39.08 9.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.898 1.279 . . . . 0.0 111.857 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -69.17 -33.47 73.44 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.2 -0.938 . . . . 0.0 113.162 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.95 -12.99 56.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.769 0.828 . . . . 0.0 112.296 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.48 10.86 18.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.015 1.726 . . . . 0.0 112.459 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m 69.51 17.86 7.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 171.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.99 165.82 3.08 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.441 -0.787 . . . . 0.0 110.853 169.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -128.03 94.51 3.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.665 -1.272 . . . . 0.0 112.419 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -66.52 132.75 48.92 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.926 -1.109 . . . . 0.0 111.133 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.93 36.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.749 1.62 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.67 40.79 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.676 -1.265 . . . . 0.0 114.331 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.89 153.12 27.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.792 1.637 . . . . 0.0 111.366 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 30.3 ttm -71.07 138.08 49.47 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -94.95 135.44 36.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.92 0.888 . . . . 0.0 109.027 172.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.453 ' N ' HD13 ' A' ' 123' ' ' LEU . 55.8 mt -120.75 93.85 4.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.522 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.14 136.58 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.933 0.893 . . . . 0.0 111.199 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -125.3 100.32 6.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 112.488 -171.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.56 -17.32 13.43 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 114.451 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 p -72.17 -15.0 61.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.542 1.064 . . . . 0.0 113.769 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.61 -10.15 1.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -134.7 103.29 11.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.483 1.038 . . . . 0.0 112.418 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.38 1.47 9.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.046 3.164 . . . . 0.0 114.474 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -131.19 74.86 78.81 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.801 1.64 . . . . 0.0 111.022 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.56 -29.01 13.1 Favored 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 125.442 4.094 . . . . 0.0 117.148 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.4 -39.36 67.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.8 p -68.42 -5.88 21.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.698 1.199 . . . . 0.0 113.443 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -113.94 -7.73 13.14 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.691 1.597 . . . . 0.0 112.077 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.5 p -134.66 -25.43 1.46 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.14 -53.44 58.71 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 119.708 1.14 . . . . 0.0 113.723 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.09 -27.96 29.04 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.538 1.492 . . . . 0.0 112.865 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -63.13 -48.8 76.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.493 0.717 . . . . 0.0 111.608 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.49 -39.52 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.43 0.559 . . . . 0.0 110.198 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -59.21 -44.49 92.27 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.603 0.638 . . . . 0.0 111.644 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.61 -57.01 12.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -53.51 -46.38 70.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.054 0.942 . . . . 0.0 111.238 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.84 -24.81 14.39 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.361 1.934 . . . . 0.0 116.447 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.0 p -70.87 -19.72 62.6 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.118 1.959 . . . . 0.0 113.938 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.4 mt -93.08 -15.27 26.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.482 1.513 . . . . 0.0 113.066 -171.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 162.85 14.83 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.526 1.93 . . . . 0.0 112.458 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.665 1.186 . . . . 0.0 113.387 173.252 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.582 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -136.52 116.18 12.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.513 1.525 . . . . 0.0 109.26 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.21 128.75 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.526 1.131 . . . . 0.0 113.11 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.15 130.21 10.22 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -120.8 101.57 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.541 1.17 . . . . 0.0 108.323 -170.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -100.77 118.01 36.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.946 0.899 . . . . 0.0 112.667 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.1 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.864 1.266 . . . . 0.0 110.985 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.35 98.95 0.27 Allowed Glycine 0 N--CA 1.47 0.927 0 C-N-CA 124.355 0.978 . . . . 0.0 110.929 171.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -154.31 166.89 31.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.18 0.992 . . . . 0.0 113.551 -171.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.0 mmm -123.81 -3.28 8.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 113.043 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.29 -58.99 0.54 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.36 -4.79 0.23 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -61.72 -44.44 96.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.285 1.542 . . . . 0.0 113.251 -173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.9 p -77.62 -31.9 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.652 0.781 . . . . 0.0 112.369 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -57.58 -41.87 82.02 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.903 -1.123 . . . . 0.0 112.414 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.91 -43.56 77.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.722 0.692 . . . . 0.0 111.679 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -39.08 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.116 0.566 . . . . 0.0 111.823 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.36 -45.13 95.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.831 0.852 . . . . 0.0 111.963 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.38 -44.2 95.87 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.627 0.771 . . . . 0.0 112.58 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.36 89.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.527 0.731 . . . . 0.0 112.11 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -56.35 -46.78 79.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.938 0.495 . . . . 0.0 111.199 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.09 85.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.839 0.856 . . . . 0.0 113.029 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.73 -46.16 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.418 1.087 . . . . 0.0 111.789 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 mt -70.07 -41.01 74.69 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.82 -0.55 . . . . 0.0 109.996 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.8 m -56.2 -46.12 79.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 112.21 169.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.38 83.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.203 1.001 . . . . 0.0 112.929 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.4 -9.75 58.92 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.307 1.043 . . . . 0.0 113.311 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -11.06 48.87 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.792 1.663 . . . . 0.0 114.587 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.582 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 81.0 m-70 -70.26 140.29 52.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.015 0.926 . . . . 0.0 110.655 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -67.94 134.35 50.63 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.01 141.61 30.23 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.208 0.458 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -139.42 115.88 10.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.035 0.934 . . . . 0.0 110.026 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.59 147.27 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.699 0.8 . . . . 0.0 111.921 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.07 103.53 5.83 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.359 1.863 . . . . 0.0 107.651 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.58 -27.9 60.69 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -144.95 64.21 10.97 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.379 1.872 . . . . 0.0 109.009 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.8 160.72 40.36 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.67 2.913 . . . . 0.0 115.188 -168.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 173.51 11.6 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.302 1.841 . . . . 0.0 109.76 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -40.82 -50.74 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.098 1.359 . . . . 0.0 113.182 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 m -62.01 -18.01 59.12 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -81.64 -35.51 29.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.377 0.99 . . . . 0.0 112.122 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.45 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 17.4 t-105 -77.73 -35.42 51.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -40.95 -44.76 5.58 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 127.64 2.376 . . . . 0.0 115.938 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.95 -31.87 23.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.177 2.585 . . . . 0.0 115.471 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -82.08 -4.92 57.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.96 -23.51 46.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -97.27 8.48 44.47 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.646 1.578 . . . . 0.0 112.84 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -132.15 -135.09 0.19 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.741 2.416 . . . . 0.0 109.123 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -133.93 161.35 35.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.605 1.562 . . . . 0.0 109.775 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 18.8 m -148.36 167.31 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.574 1.15 . . . . 0.0 111.204 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.29 139.19 14.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.318 1.056 . . . . 0.0 110.991 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -105.27 132.22 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.0 1.72 . . . . 0.0 109.685 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 19' ' ' ALA . 3.1 p -139.83 88.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 122.753 1.264 . . . . 0.0 108.062 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.6 m -129.95 163.88 25.44 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.712 1.205 . . . . 0.0 113.027 -167.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.2 p -128.07 -173.23 2.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.335 1.454 . . . . 0.0 112.782 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -134.77 132.55 38.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.674 1.189 . . . . 0.0 110.081 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 125.183 1.393 . . . . 0.0 110.098 -169.523 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t0 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.71 130.89 78.06 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.301 1.84 . . . . 0.0 113.012 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -60.8 140.41 90.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.249 3.299 . . . . 0.0 111.118 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.21 -26.88 66.72 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.406 -0.809 . . . . 0.0 113.144 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -64.41 -8.95 15.17 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 tt -125.99 -9.26 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.22 -46.9 83.23 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 117.146 -1.407 . . . . 0.0 112.751 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.83 3.91 2.98 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.148 2.566 . . . . 0.0 114.557 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -109.03 -43.08 4.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.863 1.265 . . . . 0.0 110.656 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -59.92 -48.66 80.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.782 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -63.52 -38.16 90.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.287 -0.883 . . . . 0.0 112.622 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.45 -43.32 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.462 1.03 . . . . 0.0 113.093 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.0 mt -62.28 -46.42 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 118.543 1.171 . . . . 0.0 110.106 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -50.2 74.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.699 1.2 . . . . 0.0 112.6 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -77.76 -40.26 41.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -87.62 -45.8 10.1 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.58 -44.53 18.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.074 0.852 . . . . 0.0 113.149 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.18 -43.68 0.54 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 126.172 1.844 . . . . 0.0 116.632 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -156.88 133.12 9.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.902 1.681 . . . . 0.0 110.275 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -153.23 54.55 1.2 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.26 -24.1 78.27 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.589 2.859 . . . . 0.0 114.819 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -81.68 -13.49 57.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.744 . . . . 0.0 114.943 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.76 142.63 32.45 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.165 0.893 . . . . 0.0 111.428 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -131.1 144.35 51.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.145 1.778 . . . . 0.0 111.83 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -158.44 -172.14 3.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.86 162.43 31.67 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.18 2.324 . . . . 0.0 110.55 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.57 131.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 117.927 0.864 . . . . 0.0 112.625 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.2 126.35 74.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.29 147.75 45.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.256 1.022 . . . . 0.0 110.035 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.2 147.43 36.54 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.597 0.759 . . . . 0.0 111.54 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.75 -139.33 4.8 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.257 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -138.55 130.07 27.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 111.655 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.8 p -66.7 -5.3 11.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -69.22 2.2 3.08 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.54 153.21 48.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.423 1.489 . . . . 0.0 112.83 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.47 -7.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.778 1.631 . . . . 0.0 114.831 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -120.66 44.16 2.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.578 1.951 . . . . 0.0 110.761 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -50.38 115.38 1.43 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.211 -1.556 . . . . 0.0 112.344 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.46 25.0 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -55.9 -36.75 68.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.682 -1.261 . . . . 0.0 113.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.78 -41.26 99.88 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.794 0.724 . . . . 0.0 112.583 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.16 -40.49 82.34 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.277 -1.131 . . . . 0.0 112.936 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.76 -37.78 85.54 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.918 0.859 . . . . 0.0 113.311 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -59.77 -46.35 89.46 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.769 0.713 . . . . 0.0 111.01 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.26 -25.36 64.23 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.92 -48.93 56.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.017 -1.677 . . . . 0.0 110.077 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.8 -38.19 72.2 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.2 tp -49.21 -31.94 9.52 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.949 1.7 . . . . 0.0 112.966 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.01 -37.78 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.054 1.342 . . . . 0.0 110.975 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -35.95 82.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -22.24 66.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 112.644 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.79 9.97 41.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.2 m 66.56 15.11 10.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.685 1.994 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.56 141.57 54.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.973 0.806 . . . . 0.0 109.752 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -102.62 107.51 18.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.554 1.141 . . . . 0.0 111.449 -169.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.5 ttm105 -74.02 123.45 24.37 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.838 -1.164 . . . . 0.0 110.465 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.16 35.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.846 1.658 . . . . 0.0 111.925 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -162.12 35.81 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.526 -1.359 . . . . 0.0 114.34 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -125.57 154.38 42.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.254 1.821 . . . . 0.0 111.118 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.0 ttm -69.77 131.6 44.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.896 0.879 . . . . 0.0 112.059 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -85.91 135.37 33.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.41 0.684 . . . . 0.0 109.661 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.38 93.7 3.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.775 1.23 . . . . 0.0 111.599 -171.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mt -86.59 134.34 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.202 1.401 . . . . 0.0 110.773 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -127.17 111.89 14.51 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.085 1.354 . . . . 0.0 111.436 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.07 -23.16 53.54 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -85.48 4.61 34.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.725 1.21 . . . . 0.0 113.695 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -129.91 -30.25 2.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.861 1.264 . . . . 0.0 112.734 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -146.28 118.46 4.98 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.089 0.956 . . . . 0.0 111.789 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.94 -0.76 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.741 2.96 . . . . 0.0 114.708 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.64 77.44 77.44 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.57 1.548 . . . . 0.0 112.331 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.18 -31.33 5.9 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 125.831 4.354 . . . . 0.0 116.351 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -48.08 -44.42 31.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.133 1.773 . . . . 0.0 113.269 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.8 p -71.77 -29.0 64.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.594 1.158 . . . . 0.0 113.314 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.5 -26.46 38.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.317 0.647 . . . . 0.0 112.217 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.5 p -105.33 -28.37 10.94 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.43 -59.8 6.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.2 -28.57 33.85 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.909 1.739 . . . . 0.0 112.226 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -63.05 -50.31 71.14 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.701 0.682 . . . . 0.0 111.691 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.04 -41.12 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.739 0.7 . . . . 0.0 110.318 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.61 -44.44 93.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.349 0.522 . . . . 0.0 111.624 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.92 -55.47 25.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.196 0.998 . . . . 0.0 112.554 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.59 -49.67 64.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.36 1.064 . . . . 0.0 110.907 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.36 -19.57 26.11 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.579 1.562 . . . . 0.0 116.44 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.8 p -69.78 -20.24 63.48 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.884 2.342 . . . . 0.0 113.62 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -97.49 -15.48 20.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.178 1.391 . . . . 0.0 113.151 -171.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 149.9 49.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.303 1.441 . . . . 0.0 112.183 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.023 1.729 . . . . 0.0 114.234 -172.222 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -126.64 123.66 38.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.714 1.606 . . . . 0.0 109.434 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 mm -118.03 123.75 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.496 1.118 . . . . 0.0 112.259 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.42 126.58 7.69 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 168.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -116.97 111.4 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.719 1.259 . . . . 0.0 109.075 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.32 133.09 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.613 0.765 . . . . 0.0 110.79 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.94 144.26 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.903 -169.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.72 115.17 1.64 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -157.58 162.46 38.76 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.508 -0.996 . . . . 0.0 111.424 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -120.7 -19.39 7.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.598 1.159 . . . . 0.0 112.336 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.29 -7.12 2.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.15 -2.34 47.4 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.1 -47.75 78.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.314 1.557 . . . . 0.0 112.515 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -67.83 -30.11 69.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 112.751 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 tp -64.14 -44.36 92.41 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.7 -1.25 . . . . 0.0 113.039 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.09 -42.87 77.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.021 0.828 . . . . 0.0 111.262 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.31 -38.0 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.54 0.736 . . . . 0.0 112.236 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.31 94.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.85 -39.19 93.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.51 -44.63 96.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.483 -0.761 . . . . 0.0 112.216 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.34 88.67 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.922 0.783 . . . . 0.0 112.598 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.44 -46.4 80.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.775 0.83 . . . . 0.0 111.991 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.7 84.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 112.493 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.37 -42.64 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.407 1.083 . . . . 0.0 112.563 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.55 -44.21 78.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.807 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -56.93 -46.23 82.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 112.045 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -39.59 89.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.187 0.995 . . . . 0.0 113.242 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -67.75 -28.87 68.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.657 0.783 . . . . 0.0 112.67 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.76 -5.98 6.16 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.282 1.42 . . . . 0.0 114.502 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -73.58 178.84 4.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.355 1.462 . . . . 0.0 111.482 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -117.64 144.11 45.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.354 1.462 . . . . 0.0 109.392 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.89 163.3 37.23 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.638 -0.664 . . . . 0.0 112.576 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -153.12 116.55 4.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.097 0.959 . . . . 0.0 110.999 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.87 140.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.872 1.269 . . . . 0.0 111.201 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -125.42 107.74 10.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.252 1.821 . . . . 0.0 108.959 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.48 -20.68 46.74 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -171.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.45 61.02 7.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.857 1.663 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.77 161.6 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.077 3.185 . . . . 0.0 115.023 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.2 171.34 14.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.115 2.166 . . . . 0.0 109.405 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -46.54 -48.57 19.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.354 1.062 . . . . 0.0 112.948 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 m -59.4 -19.22 45.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -79.02 -35.64 42.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.503 1.047 . . . . 0.0 111.85 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.441 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 23.0 t-105 -78.97 -37.36 39.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.239 1.415 . . . . 0.0 112.56 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.6 tp -38.68 -50.17 3.8 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 128.466 2.706 . . . . 0.0 116.318 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -15.67 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.714 2.276 . . . . 0.0 115.258 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -84.84 -1.8 56.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.12 -33.41 69.1 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.221 -0.925 . . . . 0.0 113.295 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.52 -5.7 50.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.266 1.026 . . . . 0.0 113.519 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -133.08 -134.51 0.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.927 2.491 . . . . 0.0 109.478 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.08 158.8 43.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.115 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.441 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 34.3 m -145.57 170.53 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.058 1.343 . . . . 0.0 111.896 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -157.91 148.64 20.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.334 1.453 . . . . 0.0 110.413 174.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' H ' HD22 ' A' ' 53' ' ' LEU . 39.0 t -117.09 135.59 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.57 1.548 . . . . 0.0 109.829 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.44 96.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.313 1.045 . . . . 0.0 109.681 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.0 m -138.82 152.99 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.3 p -108.33 -159.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.869 1.267 . . . . 0.0 113.514 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.1 m -122.92 151.19 42.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.082 1.753 . . . . 0.0 109.115 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 125.441 1.496 . . . . 0.0 108.73 -169.824 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pp -119.87 163.0 30.21 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.747 1.619 . . . . 0.0 113.603 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.71 142.9 78.78 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.59 3.527 . . . . 0.0 113.305 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.03 -28.15 67.51 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.617 -0.677 . . . . 0.0 112.816 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -62.02 -10.21 9.32 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.3 tt -128.1 -6.81 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.463 1.029 . . . . 0.0 113.243 175.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -47.9 -50.65 52.18 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 117.392 -1.289 . . . . 0.0 112.647 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 -2.03 10.75 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.239 1.959 . . . . 0.0 114.238 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.0 tp -98.06 -43.98 6.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.99 0.916 . . . . 0.0 110.122 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -61.57 -47.05 87.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -63.91 -44.53 92.66 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.34 -0.85 . . . . 0.0 111.876 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.61 -45.84 93.65 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.981 0.8 . . . . 0.0 113.373 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.02 -43.49 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.31 1.055 . . . . 0.0 110.596 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -62.65 -45.04 94.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.355 1.062 . . . . 0.0 112.617 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -83.67 -39.41 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.115 1.366 . . . . 0.0 114.512 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -121.8 4.92 9.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.65 -48.51 2.93 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.754 1.161 . . . . 0.0 110.823 168.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.49 -26.68 0.22 Allowed Glycine 0 CA--C 1.542 1.725 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -155.22 136.67 14.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 110.211 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -148.68 58.58 3.7 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.195 1.398 . . . . 0.0 112.471 -169.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.45 -2.53 8.45 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.603 3.535 . . . . 0.0 115.21 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -118.67 -6.12 10.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.664 2.385 . . . . 0.0 113.305 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.25 121.18 20.87 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.155 0.982 . . . . 0.0 110.155 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -123.4 140.77 52.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.87 1.668 . . . . 0.0 109.897 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -163.48 -167.57 1.46 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -168.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.54 170.46 34.05 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 127.596 2.522 . . . . 0.0 110.116 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.2 t -142.0 132.65 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.631 1.216 . . . . 0.0 112.247 -174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.72 130.4 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.59 152.5 43.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.017 0.927 . . . . 0.0 110.482 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -142.92 138.5 30.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.368 0.667 . . . . 0.0 111.803 -169.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.03 -138.86 3.36 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -144.09 122.51 12.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.501 1.12 . . . . 0.0 110.782 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -60.63 -9.42 3.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.823 1.249 . . . . 0.0 114.094 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.8 m -59.29 -13.42 7.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.419 1.488 . . . . 0.0 114.809 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -127.56 138.35 52.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.759 1.223 . . . . 0.0 111.834 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.69 -27.47 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -168.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -90.46 -14.08 33.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.761 1.164 . . . . 0.0 113.327 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 36.0 -125.33 0.14 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.409 1.484 . . . . 0.0 112.573 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.3 m -77.32 20.42 0.29 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -54.16 -33.98 59.34 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.095 -1.628 . . . . 0.0 114.71 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.27 85.38 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.481 1.037 . . . . 0.0 113.393 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.22 -41.75 52.42 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.256 -1.144 . . . . 0.0 112.429 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.88 -36.4 79.11 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -56.55 -48.48 77.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.69 0.677 . . . . 0.0 111.418 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -70.01 -29.53 66.62 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.49 -46.33 76.65 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.226 -1.546 . . . . 0.0 111.291 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.09 70.68 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -48.96 -28.55 3.95 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.924 1.689 . . . . 0.0 113.36 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -101.77 -35.26 9.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.645 1.178 . . . . 0.0 111.432 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.59 -32.84 74.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.72 1.145 . . . . 0.0 111.682 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.2 -15.31 14.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.809 1.243 . . . . 0.0 113.002 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -124.16 16.65 9.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.845 1.658 . . . . 0.0 113.201 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m 64.02 25.11 13.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.002 1.721 . . . . 0.0 115.425 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 159.79 12.27 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.243 -0.911 . . . . 0.0 112.332 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -129.13 86.33 2.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.111 1.364 . . . . 0.0 110.394 -170.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -62.51 138.96 58.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.03 31.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.552 1.541 . . . . 0.0 111.544 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.18 -165.46 38.92 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 121.015 -1.053 . . . . 0.0 113.999 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.26 158.48 28.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.066 1.747 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.0 ttm -72.32 133.96 45.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.68 -0.637 . . . . 0.0 112.149 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.27 134.13 33.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.825 0.85 . . . . 0.0 109.469 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.25 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.241 1.016 . . . . 0.0 111.196 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.58 135.07 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.074 1.35 . . . . 0.0 110.609 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -131.63 113.24 13.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.004 1.322 . . . . 0.0 111.09 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.8 30.44 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 m -77.26 -2.78 36.44 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -139.43 -18.5 0.98 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.631 1.573 . . . . 0.0 113.437 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.84 80.64 70.57 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.993 2.117 . . . . 0.0 110.772 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -16.25 42.57 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.947 2.432 . . . . 0.0 113.313 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.92 91.15 48.86 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 107.736 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.35 -27.04 84.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.461 2.774 . . . . 0.0 115.524 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.31 -29.1 60.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 p -68.92 -6.55 28.11 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -111.8 -31.83 6.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.327 1.051 . . . . 0.0 111.335 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.1 p -78.0 -32.88 51.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.88 -60.74 4.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -66.29 -29.78 46.09 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.118 1.879 . . . . 0.0 112.278 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -61.94 -51.15 69.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.532 0.605 . . . . 0.0 111.582 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.02 -40.65 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.525 0.602 . . . . 0.0 110.485 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.71 -38.01 83.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -71.41 -59.08 2.96 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.125 0.97 . . . . 0.0 112.717 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -52.17 -47.54 65.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.926 -174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.03 -34.69 12.26 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.001 1.286 . . . . 0.0 115.268 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.7 p -66.72 -15.88 63.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.023 1.411 . . . . 0.0 114.052 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -96.99 -15.92 20.85 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.249 1.419 . . . . 0.0 113.4 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.17 -36.86 80.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.561 1.544 . . . . 0.0 113.592 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.764 1.626 . . . . 0.0 112.226 -175.416 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.448 0.166 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.18 124.25 24.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.125 1.37 . . . . 0.0 109.181 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mt -136.9 125.05 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.71 132.88 11.39 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -120.02 90.79 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.984 1.314 . . . . 0.0 108.411 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.829 0.852 . . . . 0.0 110.752 -169.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.12 144.9 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.489 0.661 . . . . 0.0 111.567 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.49 101.68 0.48 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -146.92 164.1 33.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.784 1.234 . . . . 0.0 111.022 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 80.2 mmm -111.5 -11.39 14.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.944 0.898 . . . . 0.0 113.359 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -146.51 -19.62 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.89 -10.02 5.44 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 170.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.93 -44.38 91.32 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.176 1.988 . . . . 0.0 113.315 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.6 p -82.59 -28.97 30.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.6 0.76 . . . . 0.0 112.512 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.93 -40.42 84.56 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.729 -1.232 . . . . 0.0 112.912 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 tt -54.57 -41.05 69.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 111.815 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 90' ' ' ILE . 98.8 t -69.88 -35.72 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.242 0.617 . . . . 0.0 111.991 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.12 97.87 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.393 0.997 . . . . 0.0 112.506 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.47 -40.86 96.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.534 0.733 . . . . 0.0 112.269 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -60.45 -47.86 84.29 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.772 -0.58 . . . . 0.0 111.552 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.13 87.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.556 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.35 -46.24 80.06 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.727 0.811 . . . . 0.0 112.071 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.88 -47.18 81.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.367 0.667 . . . . 0.0 112.31 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.43 -32.7 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.358 . . . . 0.0 112.964 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 mt -80.14 -38.31 31.73 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.686 -1.259 . . . . 0.0 110.12 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.2 m -57.03 -45.32 83.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.669 0.788 . . . . 0.0 111.17 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.86 78.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.558 1.143 . . . . 0.0 113.487 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.05 -7.06 52.64 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.37 24.32 12.71 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.606 1.098 . . . . 0.0 114.346 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -114.87 147.89 39.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.376 1.088 . . . . 0.0 112.153 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -75.22 134.35 41.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.232 1.013 . . . . 0.0 109.034 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 155.03 45.59 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.168 0.987 . . . . 0.0 111.189 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -154.13 116.49 4.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.08 -1.013 . . . . 0.0 110.665 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.82 138.74 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.121 0.968 . . . . 0.0 110.71 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.68 101.08 6.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.308 . . . . 0.0 109.808 172.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.64 -22.79 56.47 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -144.31 64.12 11.93 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.202 1.801 . . . . 0.0 109.586 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.8 160.7 48.58 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.117 3.211 . . . . 0.0 114.703 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.37 162.04 31.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.164 2.186 . . . . 0.0 109.212 169.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -53.99 -36.62 63.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.713 -1.242 . . . . 0.0 113.346 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -58.07 -18.79 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -83.4 -35.13 25.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.406 1.003 . . . . 0.0 112.344 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.604 ' CH2' HG21 ' A' ' 52' ' ' VAL . 27.5 t-105 -75.2 -37.19 61.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.926 0.89 . . . . 0.0 112.193 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.3 tp -41.42 -46.74 8.42 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 128.34 2.656 . . . . 0.0 116.411 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.67 -30.32 4.98 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.211 1.941 . . . . 0.0 114.391 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -81.26 -9.74 59.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -55.44 -28.5 54.72 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.13 -4.98 52.99 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.471 1.508 . . . . 0.0 113.848 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.11 -115.52 0.23 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.761 1.624 . . . . 0.0 111.154 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.02 160.93 39.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.618 1.567 . . . . 0.0 110.694 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG21 ' CH2' ' A' ' 44' ' ' TRP . 31.4 m -152.4 172.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.118 1.367 . . . . 0.0 111.314 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 149.31 18.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.938 1.295 . . . . 0.0 109.771 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.07 136.98 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.84 1.256 . . . . 0.0 109.983 -170.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.11 94.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.984 1.314 . . . . 0.0 109.024 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.1 m -135.76 139.82 43.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -168.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -178.1 5.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.868 1.667 . . . . 0.0 112.381 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 m -127.75 139.11 52.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.718 -1.239 . . . . 0.0 110.899 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 120.556 1.526 . . . . 0.0 110.75 -170.644 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 CA--C 1.548 0.869 0 CA-C-O 121.583 0.706 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -53.52 136.97 52.22 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.364 1.866 . . . . 0.0 111.834 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.72 141.99 28.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.354 2.703 . . . . 0.0 110.679 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.46 -25.42 62.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 m -61.67 -17.2 54.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.42 -12.87 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 119.76 1.164 . . . . 0.0 114.138 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.68 -42.88 24.67 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.38 1.472 . . . . 0.0 114.08 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.17 -25.4 10.13 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.97 1.78 . . . . 0.0 114.075 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.49 -45.82 61.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.312 0.96 . . . . 0.0 109.616 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.19 -58.36 6.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.75 1.62 . . . . 0.0 111.381 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -66.96 -33.81 76.4 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.486 -1.384 . . . . 0.0 113.958 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.47 -48.23 87.0 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 119.097 0.862 . . . . 0.0 112.495 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.22 -41.03 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.197 -1.178 . . . . 0.0 110.557 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -61.48 -37.33 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.76 -23.07 10.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -169.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -113.21 0.45 14.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.5 mt -129.32 -49.63 1.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.739 1.216 . . . . 0.0 111.418 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.94 -22.52 0.33 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 118.447 2.139 . . . . 0.0 118.447 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -153.57 139.71 18.38 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.577 1.689 . . . . 0.0 110.677 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.59 45.85 0.28 Allowed Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -59.59 -21.57 62.94 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.555 3.504 . . . . 0.0 116.865 -169.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -106.56 -0.74 23.64 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.308 1.443 . . . . 0.0 113.849 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 52' ' ' VAL . 2.9 tm? -75.52 136.95 40.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.88 0.872 . . . . 0.0 110.258 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -130.7 133.5 46.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.681 1.992 . . . . 0.0 109.525 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -151.93 -170.87 3.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -170.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.46 164.92 30.78 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.823 1.678 . . . . 0.0 110.027 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.78 134.78 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 122.178 0.989 . . . . 0.0 112.253 -169.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 18' ' ' VAL . 87.4 mt -121.4 129.9 75.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.78 50.35 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.277 0.631 . . . . 0.0 111.591 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.1 169.69 20.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.494 1.14 . . . . 0.0 113.962 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.02 -126.03 1.28 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.643 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -142.21 128.56 19.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.3 1.04 . . . . 0.0 112.32 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -66.94 -12.13 58.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.714 1.606 . . . . 0.0 114.91 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 -15.77 63.2 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.13 148.84 22.28 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.867 1.267 . . . . 0.0 112.299 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.15 -38.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.71 0.804 . . . . 0.0 111.572 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -76.13 41.32 0.23 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.523 1.529 . . . . 0.0 112.834 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.5 117.15 2.66 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.911 -1.743 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 61.1 m 51.7 24.55 2.45 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -56.32 -33.55 65.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.622 -1.299 . . . . 0.0 113.32 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.9 -34.12 70.7 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.979 0.799 . . . . 0.0 113.522 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.89 -40.43 10.62 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.412 -1.052 . . . . 0.0 112.936 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.27 -35.75 74.28 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.293 1.047 . . . . 0.0 113.257 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -59.9 -41.88 92.6 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.231 1.013 . . . . 0.0 112.223 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -75.86 -29.04 58.41 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.443 -0.786 . . . . 0.0 112.684 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.27 -43.79 80.94 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.076 -1.64 . . . . 0.0 111.289 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.18 84.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.111 0.964 . . . . 0.0 113.199 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.5 tp -49.04 -29.39 4.95 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 112.964 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.0 mt -102.69 -42.91 5.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.567 1.147 . . . . 0.0 111.642 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.18 -31.44 72.63 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.756 1.162 . . . . 0.0 112.76 169.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.88 -18.64 63.25 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.094 -1.004 . . . . 0.0 112.86 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -107.03 15.3 25.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.865 1.666 . . . . 0.0 112.39 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.2 m 62.43 14.92 7.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.944 2.097 . . . . 0.0 115.276 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.02 156.64 17.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.915 0.78 . . . . 0.0 112.008 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -116.53 164.8 14.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 -169.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 -129.61 146.13 51.44 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.46 21.01 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 113.368 -1.742 . . . . 0.0 112.368 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.6 -176.71 46.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.104 1.811 . . . . 0.0 113.464 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.21 159.3 22.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 112.112 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.38 127.08 31.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.433 0.693 . . . . 0.0 112.388 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.81 133.56 35.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.33 94.26 3.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.864 1.266 . . . . 0.0 111.356 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.17 138.57 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.443 0.697 . . . . 0.0 111.817 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.98 114.93 23.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.535 1.534 . . . . 0.0 111.429 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.19 -25.32 58.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m -79.86 1.36 27.34 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -132.47 -27.75 1.72 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.833 1.253 . . . . 0.0 113.453 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -142.47 108.33 5.64 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 112.104 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.87 -0.99 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.112 3.208 . . . . 0.0 114.571 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.18 74.71 79.27 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.465 1.906 . . . . 0.0 109.842 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -57.94 -22.0 52.49 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.445 3.43 . . . . 0.0 116.551 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.04 -37.81 72.32 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.932 -1.105 . . . . 0.0 113.122 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.8 p -68.56 -6.35 24.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.317 1.047 . . . . 0.0 113.476 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -110.47 -12.99 14.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.211 1.404 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -129.17 -24.54 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -51.48 -52.73 57.11 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.251 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.11 -27.58 41.78 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.78 1.654 . . . . 0.0 113.419 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -62.51 -49.91 73.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.66 -33.64 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.558 -0.714 . . . . 0.0 111.113 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.52 -16.65 63.88 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -95.98 -59.26 1.89 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.826 1.251 . . . . 0.0 111.759 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -54.63 -46.04 73.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.775 1.23 . . . . 0.0 112.473 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.91 -19.6 22.83 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.2 p -76.86 -11.99 59.9 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.893 . . . . 0.0 113.715 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.08 -9.32 17.89 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 126.1 45.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.609 1.164 . . . . 0.0 113.698 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.885 2.474 . . . . 0.0 110.563 170.798 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.572 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.323 0.583 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -127.99 125.2 38.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 0.0 108.679 174.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 mm -123.07 124.25 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.398 1.079 . . . . 0.0 112.569 -171.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.62 128.52 9.24 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.5 mt -119.25 91.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -91.22 135.41 33.81 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 111.565 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.2 142.56 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.011 -170.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.16 104.72 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -147.7 169.49 19.59 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.911 1.284 . . . . 0.0 110.807 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.7 mtp -116.65 -7.2 11.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.283 1.033 . . . . 0.0 113.029 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -148.37 -32.0 0.26 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.39 -1.58 2.71 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.88 -42.18 97.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.144 1.972 . . . . 0.0 113.199 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -78.37 -31.87 48.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 172.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.3 tp -57.71 -40.09 78.74 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.037 -1.039 . . . . 0.0 113.08 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.87 -45.1 70.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.312 0.645 . . . . 0.0 111.464 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.72 -39.38 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.834 0.454 . . . . 0.0 111.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.42 87.45 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.19 0.905 . . . . 0.0 113.159 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.12 -44.24 96.17 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.564 -0.71 . . . . 0.0 111.886 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.31 -40.74 97.3 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.665 -0.647 . . . . 0.0 112.068 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -46.31 90.65 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.854 0.752 . . . . 0.0 111.799 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.44 -47.0 80.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.013 0.525 . . . . 0.0 111.493 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.67 -47.36 85.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.789 0.836 . . . . 0.0 112.911 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.32 -46.35 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.556 1.142 . . . . 0.0 112.225 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.78 -40.79 75.81 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.942 -0.474 . . . . 0.0 109.751 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -56.24 -46.54 79.55 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.859 1.264 . . . . 0.0 112.215 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.54 89.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 112.955 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -68.71 -30.77 69.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.393 0.677 . . . . 0.0 112.671 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.57 -6.69 4.56 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.875 1.226 . . . . 0.0 115.556 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.572 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 80.6 m-70 -79.07 144.1 34.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 111.04 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.82 134.9 49.04 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.76 142.68 31.03 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.8 0.727 . . . . 0.0 112.293 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.6 m -141.45 114.83 8.83 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.086 0.954 . . . . 0.0 110.137 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.6 p -80.53 149.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.919 0.888 . . . . 0.0 111.974 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -137.94 104.9 5.39 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.711 1.605 . . . . 0.0 109.321 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.82 -33.04 70.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.555 1.542 . . . . 0.0 114.522 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -145.81 62.88 8.83 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.418 1.887 . . . . 0.0 109.437 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.67 160.1 49.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.911 3.074 . . . . 0.0 115.658 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.94 170.59 15.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.423 2.289 . . . . 0.0 109.026 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -57.71 -34.99 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.7 -1.25 . . . . 0.0 113.443 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.2 p -61.21 -15.49 34.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.38 -33.38 20.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.568 1.076 . . . . 0.0 112.503 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CH2' HG21 ' A' ' 52' ' ' VAL . 39.6 t-105 -75.52 -37.15 60.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.302 1.041 . . . . 0.0 112.501 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.9 tp -43.92 -50.53 19.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 127.789 2.436 . . . . 0.0 115.216 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.61 -1.59 6.93 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.072 2.515 . . . . 0.0 115.708 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.18 0.46 10.68 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.181 1.392 . . . . 0.0 114.02 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -60.84 -14.82 24.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -121.19 18.74 11.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.619 2.368 . . . . 0.0 112.267 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -124.43 -138.05 0.29 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.697 2.399 . . . . 0.0 108.649 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -123.32 157.86 32.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.532 1.533 . . . . 0.0 109.303 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG21 ' CH2' ' A' ' 44' ' ' TRP . 18.9 m -146.33 166.79 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.111 1.364 . . . . 0.0 110.08 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.18 144.88 20.19 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.239 -0.913 . . . . 0.0 110.654 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -113.44 132.86 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.382 1.473 . . . . 0.0 110.334 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.78 91.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.52 1.128 . . . . 0.0 108.757 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 m -135.8 138.13 42.28 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -85.15 -167.76 1.96 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.767 2.027 . . . . 0.0 113.034 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -135.81 141.95 44.79 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.537 -1.352 . . . . 0.0 111.157 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.197 1.799 . . . . 0.0 109.539 -179.193 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mt -49.47 127.4 17.58 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 127.511 2.324 . . . . 0.0 113.133 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.27 141.78 94.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.296 3.331 . . . . 0.0 111.351 169.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.37 -25.99 67.54 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -171.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.3 m -63.21 -12.16 26.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.3 tt -125.19 -10.39 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.93 -47.65 63.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.263 -1.351 . . . . 0.0 113.33 170.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.15 -19.2 34.55 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 122.46 1.914 . . . . 0.0 113.987 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -78.02 -42.72 31.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.179 0.9 . . . . 0.0 109.606 171.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -62.04 -45.92 91.42 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.518 1.127 . . . . 0.0 111.386 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -62.77 -40.93 98.81 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.659 -1.276 . . . . 0.0 112.676 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -45.46 69.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.568 1.08 . . . . 0.0 112.967 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.5 mt -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 119.427 1.613 . . . . 0.0 109.98 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.79 -46.12 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.654 1.181 . . . . 0.0 112.265 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.24 -35.17 36.48 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -90.82 -33.95 15.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.22 -53.55 4.19 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.625 1.102 . . . . 0.0 111.689 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -37.59 0.29 Allowed Glycine 0 CA--C 1.544 1.862 0 C-N-CA 126.164 1.84 . . . . 0.0 115.803 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -161.87 124.7 3.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 110.557 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -149.58 53.75 1.4 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 126.035 1.734 . . . . 0.0 113.085 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.78 -27.63 78.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.942 3.095 . . . . 0.0 115.13 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.81 -26.46 67.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.889 1.276 . . . . 0.0 114.247 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.6 tp -77.78 142.1 38.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.678 0.791 . . . . 0.0 112.527 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -138.08 145.61 41.93 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.038 2.135 . . . . 0.0 110.054 -172.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 118' ' ' ARG . 29.2 p90 -161.0 -171.15 2.96 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -169.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.91 165.26 33.08 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.933 2.206 . . . . 0.0 110.525 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -139.65 134.78 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.076 0.938 . . . . 0.0 112.618 -169.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.8 mt -118.3 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.16 148.25 40.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.173 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.07 151.41 45.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.175 0.988 . . . . 0.0 112.075 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.78 -133.57 2.76 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.164 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -142.65 133.1 24.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.421 1.088 . . . . 0.0 111.967 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.7 p -68.32 -6.12 22.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 m -68.64 3.18 1.98 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -136.64 154.59 50.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.788 1.635 . . . . 0.0 111.749 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.85 -36.23 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.632 0.773 . . . . 0.0 112.897 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.43 44.78 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.769 0.827 . . . . 0.0 111.944 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -53.77 116.61 2.61 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.553 -1.342 . . . . 0.0 112.003 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 56.7 m 50.83 23.93 1.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.964 2.506 . . . . 0.0 116.957 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.07 -26.28 67.53 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.661 -1.274 . . . . 0.0 114.09 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -30.09 73.46 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.733 0.697 . . . . 0.0 113.404 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.0 -38.71 9.04 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.08 0.94 . . . . 0.0 113.179 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.18 -35.16 74.75 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.509 1.155 . . . . 0.0 113.52 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -59.38 -37.84 78.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.494 0.718 . . . . 0.0 112.423 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.04 -33.2 61.71 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.322 -0.861 . . . . 0.0 112.477 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.95 -1.719 . . . . 0.0 110.911 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.7 89.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.3 tp -46.31 -44.04 16.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.495 1.518 . . . . 0.0 111.998 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.23 -28.63 57.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.114 1.366 . . . . 0.0 112.449 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.16 -29.74 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.106 -0.996 . . . . 0.0 111.587 169.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -66.01 -23.86 66.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.638 1.108 . . . . 0.0 111.607 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -88.05 1.89 53.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.646 1.178 . . . . 0.0 111.967 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m 53.38 22.73 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.995 1.718 . . . . 0.0 114.83 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 156.1 24.34 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 111.433 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -119.48 87.63 2.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.502 1.521 . . . . 0.0 111.539 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 30.2 ttp85 -59.47 137.86 57.87 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.487 -0.758 . . . . 0.0 112.041 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.67 51.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 126.341 1.856 . . . . 0.0 109.967 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.85 -174.86 44.7 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.326 -0.859 . . . . 0.0 114.083 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.08 147.16 44.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.25 1.42 . . . . 0.0 110.717 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.06 130.66 42.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.452 0.701 . . . . 0.0 111.86 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.34 134.65 35.26 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 92.29 3.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.681 1.192 . . . . 0.0 111.246 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.5 mt -85.1 134.3 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.468 1.507 . . . . 0.0 111.631 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -121.56 109.16 14.46 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.623 1.169 . . . . 0.0 112.809 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.42 -23.39 49.23 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 174.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 m -83.5 0.82 44.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.416 1.087 . . . . 0.0 113.867 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -129.21 -26.54 2.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 113.417 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -146.59 119.29 4.97 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.007 0.822 . . . . 0.0 112.835 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.0 -5.11 12.12 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.895 3.063 . . . . 0.0 114.216 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.43 73.94 80.11 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.54 1.536 . . . . 0.0 111.175 -172.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.06 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.311 3.34 . . . . 0.0 115.055 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -48.15 -44.21 32.14 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.146 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.5 p -67.78 -18.41 64.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.51 -17.74 16.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.209 1.004 . . . . 0.0 112.425 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -113.42 -28.43 7.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -59.9 -52.12 75.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.717 -1.135 . . . . 0.0 113.204 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.49 -28.93 61.95 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.349 1.518 . . . . 0.0 112.773 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -60.95 -50.29 73.98 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.609 0.641 . . . . 0.0 111.658 171.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 -41.43 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.684 0.675 . . . . 0.0 110.461 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.91 -39.45 85.45 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.453 0.57 . . . . 0.0 111.966 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -67.19 -56.32 10.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.883 0.873 . . . . 0.0 112.51 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -53.35 -46.23 69.46 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.414 1.086 . . . . 0.0 111.4 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.5 -23.61 6.59 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.393 1.949 . . . . 0.0 116.507 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -72.69 -18.52 61.54 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.068 1.934 . . . . 0.0 114.072 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.65 -15.47 25.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.487 1.515 . . . . 0.0 113.109 -171.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.49 157.67 22.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.521 2.328 . . . . 0.0 113.154 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.256 1.397 0 C-N-CA 128.156 2.582 . . . . 0.0 114.649 -173.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.454 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.326 0.584 . . . . 0.0 111.999 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -131.88 129.49 40.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.633 1.173 . . . . 0.0 110.094 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 mm -122.0 125.17 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.894 0.878 . . . . 0.0 112.937 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.84 124.87 7.05 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mt -116.41 91.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.448 1.099 . . . . 0.0 108.26 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.68 136.09 35.38 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.021 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.31 145.21 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.215 0.606 . . . . 0.0 111.669 -169.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 80.92 0.3 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.188 1.375 . . . . 0.0 110.741 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.03 168.58 18.54 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.0 tpt -130.58 -4.18 4.2 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.938 2.095 . . . . 0.0 112.203 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -142.82 -54.74 0.41 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.114 . . . . 0.0 113.229 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.08 -2.98 1.04 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 117.097 1.599 . . . . 0.0 117.097 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -62.79 -44.14 96.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.881 1.341 . . . . 0.0 112.289 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -71.59 -35.76 70.63 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.286 1.434 . . . . 0.0 112.309 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.51 -40.78 92.65 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.718 -1.239 . . . . 0.0 112.457 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.49 -41.17 76.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.879 0.763 . . . . 0.0 111.82 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.52 -37.92 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.847 -0.533 . . . . 0.0 112.023 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.1 97.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.35 0.977 . . . . 0.0 112.844 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.48 -40.33 94.16 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.575 0.75 . . . . 0.0 112.413 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.51 -45.64 93.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.386 -0.821 . . . . 0.0 112.102 169.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.19 88.29 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.726 -0.609 . . . . 0.0 112.198 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.19 -47.73 77.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.648 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.84 92.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.564 0.745 . . . . 0.0 112.676 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.1 -47.25 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.749 1.219 . . . . 0.0 112.355 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.09 -39.35 79.08 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.253 0.621 . . . . 0.0 109.805 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -57.01 -48.71 77.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.988 1.315 . . . . 0.0 111.975 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -34.97 79.16 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.025 0.93 . . . . 0.0 113.399 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.26 -8.31 56.29 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.43 36.95 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.974 1.273 . . . . 0.0 115.009 171.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.454 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 81.5 m-70 -77.24 172.17 13.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.764 1.226 . . . . 0.0 111.557 173.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -104.97 145.29 30.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.276 1.03 . . . . 0.0 108.543 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.78 164.17 32.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.47 -0.769 . . . . 0.0 112.788 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.6 m -152.79 120.97 6.22 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 110.565 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.16 138.63 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.053 0.941 . . . . 0.0 110.651 169.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -125.9 107.4 10.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.88 1.272 . . . . 0.0 109.606 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -84.65 -14.43 48.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -143.2 56.67 4.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 126.074 1.75 . . . . 0.0 110.199 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.15 165.4 31.55 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.095 3.197 . . . . 0.0 115.524 -169.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.15 166.38 26.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.181 2.193 . . . . 0.0 109.037 172.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -40.15 25.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.577 1.151 . . . . 0.0 112.404 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.02 -20.12 15.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -97.12 -29.09 13.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.934 1.293 . . . . 0.0 112.181 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -70.66 -42.01 71.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.511 . . . . 0.0 112.771 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.08 -52.79 49.92 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.222 2.209 . . . . 0.0 114.687 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -65.77 -3.65 8.48 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.002 2.468 . . . . 0.0 115.956 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -110.72 1.11 17.67 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.888 1.275 . . . . 0.0 114.07 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -66.24 -30.29 70.7 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.484 -1.385 . . . . 0.0 113.418 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.97 3.93 13.43 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.923 1.289 . . . . 0.0 113.365 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -132.45 -123.77 0.19 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.286 1.835 . . . . 0.0 110.14 -169.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.51 160.0 40.97 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.909 1.684 . . . . 0.0 110.768 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.44 168.47 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 110.65 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.57 146.26 19.47 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.386 -0.821 . . . . 0.0 110.466 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -117.91 137.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.062 1.345 . . . . 0.0 110.595 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.2 94.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.873 1.269 . . . . 0.0 108.091 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.1 m -133.8 167.06 21.24 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.4 p -141.22 173.93 11.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 112.047 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.7 m -99.14 150.97 21.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.748 1.219 . . . . 0.0 112.447 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.476 0.855 0 C-N-CA 128.17 2.588 . . . . 0.0 108.739 170.22 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.962 0.411 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.03 147.15 34.01 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.411 1.885 . . . . 0.0 110.396 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.86 154.38 63.41 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.614 2.876 . . . . 0.0 111.36 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.48 -14.22 56.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.9 p -59.18 -27.51 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.633 1.173 . . . . 0.0 113.538 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.64 -9.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.563 1.145 . . . . 0.0 113.965 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -49.94 -46.03 81.12 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 120.369 -1.457 . . . . 0.0 112.716 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.19 -15.49 23.67 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.02 3.146 . . . . 0.0 116.119 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 tp -98.31 -45.7 6.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.88 1.272 . . . . 0.0 109.806 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -63.42 -45.36 91.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.032 1.333 . . . . 0.0 112.251 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -68.81 -38.5 79.94 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.57 -47.04 64.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.143 0.878 . . . . 0.0 112.936 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.33 -44.33 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.224 1.012 . . . . 0.0 110.652 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.85 -47.45 83.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.997 0.919 . . . . 0.0 112.524 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.22 -26.96 24.78 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -125.9 6.1 7.33 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 -169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.7 mt -123.03 -50.81 1.91 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.517 1.053 . . . . 0.0 111.48 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 -27.06 0.26 Allowed Glycine 0 CA--C 1.543 1.806 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -158.8 131.79 7.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.45 1.625 . . . . 0.0 110.845 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -159.12 52.84 0.52 Allowed Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.14 -32.28 39.26 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.463 2.775 . . . . 0.0 116.582 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -73.14 -13.19 61.13 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 tp -73.94 140.15 45.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.978 0.808 . . . . 0.0 111.845 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -135.45 144.14 46.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.102 1.761 . . . . 0.0 109.505 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -162.8 -169.43 2.06 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.29 163.05 31.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.798 2.142 . . . . 0.0 110.384 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.13 138.05 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 122.233 1.016 . . . . 0.0 112.62 -172.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.3 mt -122.1 131.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.323 1.849 . . . . 0.0 106.052 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.46 147.14 49.85 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.492 0.717 . . . . 0.0 110.36 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.8 tt -139.13 142.82 38.04 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.069 0.947 . . . . 0.0 111.601 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.58 -147.86 7.79 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.362 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -144.15 121.6 11.7 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.273 1.429 . . . . 0.0 110.029 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.5 p -62.41 -5.26 2.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.4 m -60.66 -13.2 13.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.433 1.493 . . . . 0.0 114.453 169.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -123.21 157.45 33.01 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 0.0 113.638 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 m -50.69 -23.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -168.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.99 1.84 4.3 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -173.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 14.5 t80 36.54 -128.83 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.832 1.253 . . . . 0.0 112.784 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.4 m -80.99 21.38 0.7 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.86 -33.27 48.98 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.34 95.52 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.758 1.163 . . . . 0.0 113.327 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.2 -40.25 71.27 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 121.613 -0.934 . . . . 0.0 112.95 171.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.01 -38.45 88.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.383 1.091 . . . . 0.0 113.132 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -59.05 -43.59 91.7 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.506 0.594 . . . . 0.0 111.776 170.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.66 -36.61 78.78 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.45 -43.09 98.38 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.811 -1.806 . . . . 0.0 111.711 170.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.17 69.87 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 tp -49.75 -28.36 6.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 112.956 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 mt -102.35 -37.69 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 -169.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.1 -31.9 73.04 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.938 1.244 . . . . 0.0 111.533 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.02 -17.33 24.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 113.024 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -119.81 16.53 12.68 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.122 1.769 . . . . 0.0 112.463 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m 67.74 18.64 9.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.91 2.084 . . . . 0.0 115.515 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.7 152.75 18.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.425 -0.797 . . . . 0.0 112.386 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -122.43 86.91 2.66 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.906 1.682 . . . . 0.0 110.904 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 ttm105 -61.83 141.58 57.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.675 -0.64 . . . . 0.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.83 33.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.484 1.514 . . . . 0.0 111.204 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.8 -163.29 37.02 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.07 -1.019 . . . . 0.0 113.222 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.25 156.48 43.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.71 1.604 . . . . 0.0 111.293 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.8 ttm -65.19 127.08 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.302 1.041 . . . . 0.0 111.776 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -82.3 134.42 35.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.57 93.76 4.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.01 1.324 . . . . 0.0 111.522 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.9 mt -82.5 132.03 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 0.0 110.479 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -131.75 107.71 8.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 112.352 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -19.06 31.67 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 m -69.28 -14.11 62.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.915 1.234 . . . . 0.0 114.212 171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.38 -12.53 1.59 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -142.91 102.56 5.29 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.29 0.95 . . . . 0.0 112.514 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.72 1.7 9.0 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.87 3.046 . . . . 0.0 114.267 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -121.53 77.0 36.06 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.342 1.857 . . . . 0.0 109.729 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.09 -24.81 78.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.21 3.273 . . . . 0.0 114.861 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.15 -44.58 71.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 111.969 170.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.2 p -66.06 -20.63 66.24 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.98 -15.76 27.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 112.675 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.8 p -123.26 -28.8 3.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -54.2 -52.89 64.71 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 119.503 1.047 . . . . 0.0 113.68 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.35 -29.0 32.46 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.777 1.652 . . . . 0.0 112.673 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.13 -48.73 78.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.787 0.721 . . . . 0.0 111.62 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 t -67.79 -40.37 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 118.425 0.557 . . . . 0.0 110.331 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.39 -40.16 85.7 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.595 0.634 . . . . 0.0 111.911 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -65.03 -58.43 6.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -53.24 -46.78 69.31 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.086 0.954 . . . . 0.0 111.701 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.98 -24.17 13.55 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.123 1.821 . . . . 0.0 116.382 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.7 p -71.43 -19.81 62.19 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.933 1.866 . . . . 0.0 114.072 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.93 -16.25 25.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.243 1.417 . . . . 0.0 112.977 -170.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.37 155.23 21.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.529 2.332 . . . . 0.0 111.599 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 124.772 1.229 . . . . 0.0 113.585 174.112 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.468 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -129.23 118.03 21.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.724 2.01 . . . . 0.0 108.032 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.99 126.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.05 131.72 10.68 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mt -120.9 91.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.271 1.428 . . . . 0.0 107.439 -171.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -92.58 141.55 28.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.989 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.8 148.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.569 0.748 . . . . 0.0 112.071 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.31 97.54 0.21 Allowed Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.165 1.364 . . . . 0.0 110.406 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -144.34 168.38 20.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.23 -24.37 6.45 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.312 1.845 . . . . 0.0 112.558 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -134.7 -4.65 2.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 2.09 64.57 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -64.94 -45.41 85.9 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 1.591 . . . . 0.0 112.123 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -69.43 -36.22 76.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.093 1.357 . . . . 0.0 112.408 172.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.4 tp -59.39 -42.13 91.01 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.956 -1.09 . . . . 0.0 112.715 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.9 -41.88 78.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.653 0.661 . . . . 0.0 111.575 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.53 -35.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.662 -0.649 . . . . 0.0 112.271 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.74 97.09 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.179 -0.951 . . . . 0.0 112.504 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.76 -41.04 99.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.668 . . . . 0.0 112.398 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.04 -46.46 88.15 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.504 -0.748 . . . . 0.0 111.652 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.52 85.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.389 0.676 . . . . 0.0 112.217 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.64 -47.65 76.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.777 0.831 . . . . 0.0 111.882 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.19 -47.4 86.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.538 0.735 . . . . 0.0 112.843 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.94 -45.56 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.591 1.156 . . . . 0.0 111.887 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.5 mt -69.59 -41.41 75.81 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.734 -0.604 . . . . 0.0 109.791 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -56.64 -45.65 81.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.872 1.269 . . . . 0.0 111.998 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.8 -38.0 85.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.986 0.914 . . . . 0.0 113.1 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -70.76 -23.07 62.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.3 -8.27 7.94 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.323 1.44 . . . . 0.0 114.981 170.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.468 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 86.7 m-70 -72.13 167.52 20.09 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.654 1.182 . . . . 0.0 112.111 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -100.89 137.87 38.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.323 1.449 . . . . 0.0 109.474 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.28 159.16 43.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.269 0.628 . . . . 0.0 112.432 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -153.77 119.84 5.39 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.974 0.91 . . . . 0.0 111.133 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.7 t -74.26 141.79 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.222 1.009 . . . . 0.0 110.801 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.4 104.28 7.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.856 1.262 . . . . 0.0 110.586 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.65 -17.34 38.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -142.35 60.87 10.91 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.563 1.545 . . . . 0.0 110.582 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.91 166.31 29.98 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.374 3.383 . . . . 0.0 115.694 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.35 162.74 37.53 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.637 2.375 . . . . 0.0 109.181 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.92 -38.49 56.51 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.691 -1.255 . . . . 0.0 113.655 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -62.23 -13.96 33.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -92.06 -25.48 18.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.669 1.122 . . . . 0.0 112.807 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -80.98 -40.76 23.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.557 1.543 . . . . 0.0 112.617 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 tp -50.08 -41.01 61.53 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -55.38 -9.63 2.61 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 125.108 3.872 . . . . 0.0 118.349 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -118.17 4.54 11.97 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -70.06 -9.86 56.79 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -110.65 17.72 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.423 1.489 . . . . 0.0 112.613 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.52 -135.62 0.16 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.572 1.949 . . . . 0.0 110.209 -169.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.63 159.82 38.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.702 1.601 . . . . 0.0 111.145 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.78 178.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.102 1.361 . . . . 0.0 111.581 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -155.7 149.31 25.07 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.538 1.935 . . . . 0.0 108.232 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.429 ' H ' HD23 ' A' ' 53' ' ' LEU . 89.4 t -130.33 133.44 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.577 1.151 . . . . 0.0 108.867 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.27 90.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.032 1.333 . . . . 0.0 109.47 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 m -134.39 157.34 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 t -130.76 -164.66 1.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.487 1.515 . . . . 0.0 112.747 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 m -130.69 150.14 52.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.519 1.928 . . . . 0.0 111.318 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.473 0.688 0 C-N-CA 127.315 2.246 . . . . 0.0 108.908 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.2 t0 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.11 151.59 95.98 Favored Pre-proline 0 CA--C 1.553 1.089 0 O-C-N 121.682 -0.637 . . . . 0.0 111.739 170.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.91 158.33 20.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.391 2.728 . . . . 0.0 112.332 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.2 -21.39 63.79 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -57.27 -17.42 11.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.741 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -132.88 -9.49 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.83 -49.32 38.38 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.599 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.27 -24.72 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.967 1.738 . . . . 0.0 113.7 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.94 -47.49 45.11 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.367 -0.833 . . . . 0.0 110.118 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -58.68 -50.88 72.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.746 1.619 . . . . 0.0 112.151 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -62.88 -41.36 99.37 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.203 -0.935 . . . . 0.0 112.349 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.89 -47.67 80.25 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.451 1.024 . . . . 0.0 113.141 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.59 -39.4 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 118.979 1.39 . . . . 0.0 111.316 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.15 -47.88 75.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.087 0.555 . . . . 0.0 111.751 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.31 -36.29 24.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.9 m -84.15 -30.81 25.57 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -173.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.3 mt -100.13 -49.5 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.876 0.762 . . . . 0.0 112.622 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.67 -34.3 0.28 Allowed Glycine 0 CA--C 1.544 1.877 0 C-N-CA 126.21 1.862 . . . . 0.0 116.143 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -158.17 135.75 10.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.833 2.053 . . . . 0.0 110.349 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -156.87 97.77 2.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.939 0.895 . . . . 0.0 112.862 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.85 -20.72 10.18 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.473 2.782 . . . . 0.0 114.418 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -80.66 -17.21 51.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -174.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.9 tp -70.72 138.68 50.75 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 111.779 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -137.49 138.66 39.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 108.966 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -163.5 -173.37 3.29 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.48 162.87 28.49 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.393 1.949 . . . . 0.0 109.038 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.79 132.09 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.015 0.907 . . . . 0.0 112.971 -169.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.19 128.07 74.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.54 155.02 44.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.297 1.046 . . . . 0.0 110.293 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -139.53 151.85 46.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.342 1.057 . . . . 0.0 108.705 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.39 -144.26 7.86 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 112.078 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -137.77 121.27 17.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.916 0.887 . . . . 0.0 110.559 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.1 p -71.99 -2.17 17.22 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -69.92 4.2 2.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -136.87 159.39 41.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.21 1.804 . . . . 0.0 112.425 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.19 -32.42 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.83 1.252 . . . . 0.0 113.412 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -103.94 44.11 1.04 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.812 1.245 . . . . 0.0 112.409 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -49.38 111.37 0.48 Allowed 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.677 -1.264 . . . . 0.0 112.289 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.7 m 52.78 28.15 6.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.22 2.208 . . . . 0.0 116.955 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -53.22 -40.99 64.93 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.445 1.02 . . . . 0.0 112.225 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -36.89 92.84 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 122.132 -0.355 . . . . 0.0 113.134 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.19 46.58 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.557 -0.967 . . . . 0.0 113.052 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.91 -34.49 76.15 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.649 1.179 . . . . 0.0 113.057 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -60.43 -42.76 96.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.47 0.577 . . . . 0.0 111.626 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -71.47 -28.77 64.17 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -64.77 -50.91 64.97 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.624 -1.297 . . . . 0.0 110.241 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 -40.13 72.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.498 0.719 . . . . 0.0 112.901 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.5 tp -49.61 -27.32 4.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 114.111 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.0 -38.42 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 111.782 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -69.71 -16.16 63.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.895 0.878 . . . . 0.0 112.73 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -109.06 -15.3 14.37 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -170.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 m 112.73 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 129.731 3.212 . . . . 0.0 114.013 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.92 147.42 23.76 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 118.886 0.766 . . . . 0.0 111.898 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -121.72 84.02 2.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 109.855 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mtm105 -60.84 152.41 27.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.58 27.89 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.936 1.695 . . . . 0.0 110.869 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.2 175.06 46.93 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.372 1.939 . . . . 0.0 112.184 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -123.27 157.88 32.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.373 1.469 . . . . 0.0 111.88 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.9 ttm -63.92 117.02 6.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.369 1.068 . . . . 0.0 112.171 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.01 141.34 37.55 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.0 81.68 2.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 111.64 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.34 136.74 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 110.139 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -131.26 98.5 4.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.513 1.149 . . . . 0.0 113.679 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.13 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.323 1.449 . . . . 0.0 114.695 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.4 p -67.6 -19.42 65.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.567 1.076 . . . . 0.0 113.099 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.32 -8.94 1.13 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -134.63 108.64 10.98 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.018 0.927 . . . . 0.0 112.943 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.82 -0.63 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.336 3.358 . . . . 0.0 114.427 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.62 78.49 68.6 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.225 1.81 . . . . 0.0 109.713 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -60.58 -19.77 61.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.086 3.19 . . . . 0.0 115.368 -169.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -66.93 -29.69 69.62 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.962 -1.087 . . . . 0.0 113.893 172.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.7 p -68.24 -5.23 17.24 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -117.0 -8.76 11.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.131 1.372 . . . . 0.0 112.67 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -127.14 -27.1 3.01 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.11 -52.56 67.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.286 169.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.24 -30.24 37.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.643 1.562 . . . . 0.0 113.325 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -58.74 -50.03 75.44 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.891 0.769 . . . . 0.0 111.136 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t -67.85 -41.53 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.676 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -59.63 -39.62 84.91 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.782 0.719 . . . . 0.0 112.117 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -67.93 -58.86 3.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 111.891 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -54.43 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.713 1.205 . . . . 0.0 112.318 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.87 -23.77 16.71 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.914 1.721 . . . . 0.0 115.905 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.4 p -71.82 -17.65 62.14 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.735 1.767 . . . . 0.0 113.954 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.7 mt -93.95 -16.85 23.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.369 1.468 . . . . 0.0 112.996 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.44 150.49 35.34 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.224 2.21 . . . . 0.0 111.747 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.648 1.579 . . . . 0.0 113.624 177.819 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.485 0.659 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -139.96 119.81 13.45 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.07 1.748 . . . . 0.0 108.647 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.93 127.44 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.06 130.88 10.16 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 168.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -116.23 88.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.337 1.455 . . . . 0.0 107.176 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -88.46 126.73 35.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.857 -169.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.66 143.6 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.734 0.813 . . . . 0.0 110.691 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.35 96.64 0.27 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -143.87 170.34 16.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.546 1.138 . . . . 0.0 111.897 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.4 -0.63 5.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.756 1.223 . . . . 0.0 113.553 169.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -146.41 -24.05 0.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.36 -9.47 5.6 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 118.575 2.19 . . . . 0.0 118.575 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.08 -41.64 92.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.645 2.222 . . . . 0.0 113.432 -173.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -78.19 -34.64 49.36 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.763 -0.586 . . . . 0.0 111.993 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.2 tp -55.99 -39.76 72.31 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.066 -1.022 . . . . 0.0 113.069 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.15 -40.7 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 111.713 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -71.02 -41.26 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.907 0.483 . . . . 0.0 111.937 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.08 88.15 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.015 0.825 . . . . 0.0 112.499 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -60.56 -43.38 97.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.108 0.963 . . . . 0.0 112.676 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.48 -41.52 88.85 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.508 -0.745 . . . . 0.0 112.886 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.55 92.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.544 0.738 . . . . 0.0 111.809 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.5 -47.07 80.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.869 0.468 . . . . 0.0 111.869 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.91 88.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 112.694 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.7 -45.66 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.524 1.13 . . . . 0.0 111.892 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.9 mt -72.62 -38.16 67.85 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.4 m -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.454 1.101 . . . . 0.0 111.819 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.8 82.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.097 0.959 . . . . 0.0 113.157 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -73.07 -8.82 57.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 172.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.55 -2.46 32.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.428 1.49 . . . . 0.0 115.067 170.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -80.22 165.56 22.26 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.734 1.214 . . . . 0.0 112.631 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.5 134.18 35.22 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.08 142.32 31.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.193 0.597 . . . . 0.0 112.108 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.3 m -144.72 109.36 4.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.247 1.019 . . . . 0.0 111.025 -172.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -73.98 144.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -131.72 108.94 9.82 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.525 1.53 . . . . 0.0 108.442 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.8 -28.48 40.25 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -144.83 58.03 5.02 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.428 1.891 . . . . 0.0 110.1 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.73 159.65 52.81 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.768 2.979 . . . . 0.0 113.829 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.28 163.85 26.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.0 2.12 . . . . 0.0 108.926 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tt -42.47 -44.62 4.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.347 1.459 . . . . 0.0 112.881 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -54.78 -26.46 34.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.928 1.691 . . . . 0.0 114.849 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -81.16 -35.98 30.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.413 1.085 . . . . 0.0 112.333 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.436 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 26.2 t-105 -75.68 -39.01 58.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.883 0.873 . . . . 0.0 112.419 175.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -36.31 -56.02 1.31 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.098 2.559 . . . . 0.0 115.422 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.42 -18.71 22.75 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.38 2.054 . . . . 0.0 114.748 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -78.54 -0.89 31.4 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -58.72 -25.97 63.46 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.745 -1.222 . . . . 0.0 113.795 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -97.1 12.49 32.48 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.355 1.462 . . . . 0.0 112.632 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -134.25 -145.62 0.24 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.004 2.522 . . . . 0.0 109.3 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.21 162.97 29.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.232 1.813 . . . . 0.0 109.408 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 34.5 m -148.34 171.79 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.356 1.062 . . . . 0.0 111.662 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.18 144.43 17.32 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.365 -0.835 . . . . 0.0 110.894 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.77 130.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.937 1.695 . . . . 0.0 110.565 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.46 89.07 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -134.66 136.11 42.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -168.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -87.85 -170.08 2.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.943 2.097 . . . . 0.0 113.069 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 83.0 m -136.67 138.53 41.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.401 1.081 . . . . 0.0 111.32 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 119.813 1.188 . . . . 0.0 111.62 -172.145 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.78 142.25 98.52 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.53 1.132 . . . . 0.0 112.118 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.17 153.17 24.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.644 2.896 . . . . 0.0 111.973 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.32 -26.71 66.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -62.7 -11.15 15.52 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 tt -126.2 -3.42 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -53.53 -43.89 96.6 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 117.148 -1.406 . . . . 0.0 112.356 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.04 -5.37 2.73 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.373 3.382 . . . . 0.0 116.659 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mt -105.88 -48.48 3.62 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.461 1.105 . . . . 0.0 110.308 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.41 -41.34 96.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.666 0.787 . . . . 0.0 112.685 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -67.35 -44.44 79.05 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.451 -0.781 . . . . 0.0 112.214 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.98 -41.91 39.0 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.907 0.765 . . . . 0.0 113.938 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.16 -42.94 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.024 0.912 . . . . 0.0 110.053 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -66.16 -50.19 64.78 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.593 0.757 . . . . 0.0 112.234 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.44 -31.02 42.47 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.1 t -116.01 -43.36 2.99 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -169.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.48 -44.34 58.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.459 1.027 . . . . 0.0 111.709 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.15 -28.95 0.2 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 126.679 2.085 . . . . 0.0 118.142 169.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -155.62 138.31 15.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.836 1.654 . . . . 0.0 110.102 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.6 39.59 0.19 Allowed Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -169.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.8 -34.08 15.22 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.476 2.784 . . . . 0.0 118.054 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -72.34 -20.24 61.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.14 118.46 13.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.271 1.428 . . . . 0.0 110.16 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -117.91 139.92 50.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.382 1.473 . . . . 0.0 110.127 174.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.67 -169.05 1.97 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -168.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.3 32.62 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.231 2.348 . . . . 0.0 110.318 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.36 128.81 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.695 0.76 . . . . 0.0 111.644 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -118.13 95.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.15 153.52 24.76 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.05 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -142.64 152.99 43.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.108 0.956 . . . . 0.0 111.502 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.57 -130.1 1.66 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.862 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.77 136.34 21.72 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.252 1.421 . . . . 0.0 111.533 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.5 p -68.83 -4.19 15.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -68.4 3.69 1.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -135.08 151.64 50.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.371 1.468 . . . . 0.0 112.277 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.42 -37.14 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.883 0.873 . . . . 0.0 111.483 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -75.26 39.13 0.14 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.817 1.647 . . . . 0.0 112.907 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -52.21 116.06 2.04 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 119.653 -1.904 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 82.8 m 50.74 23.59 1.44 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.735 2.414 . . . . 0.0 117.174 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.3 -14.1 59.99 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.589 -1.319 . . . . 0.0 114.247 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.45 -28.54 63.43 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.134 -0.979 . . . . 0.0 113.414 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.21 -37.97 6.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.323 1.062 . . . . 0.0 113.313 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -56.66 -39.73 74.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.42 1.11 . . . . 0.0 113.658 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -60.11 -32.79 71.32 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -74.63 -22.2 59.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.56 -44.47 34.58 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.028 -1.67 . . . . 0.0 110.068 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.63 66.92 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 tp -50.67 -28.41 8.89 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.259 1.824 . . . . 0.0 113.322 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.01 -37.13 6.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.953 1.301 . . . . 0.0 111.997 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -68.8 -31.82 71.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.176 -0.952 . . . . 0.0 113.076 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.5 -10.66 36.53 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.123 0.874 . . . . 0.0 111.96 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -115.16 12.08 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.13 1.772 . . . . 0.0 112.816 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m 65.57 20.34 11.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.49 1.516 . . . . 0.0 114.86 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.45 169.5 0.89 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.667 0.787 . . . . 0.0 111.589 169.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -133.57 90.85 2.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.493 -1.379 . . . . 0.0 111.548 -169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -63.89 134.37 55.02 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.439 -0.788 . . . . 0.0 110.924 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.39 29.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.651 1.58 . . . . 0.0 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.61 -168.43 41.49 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.633 1.111 . . . . 0.0 113.852 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.29 152.26 26.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.65 1.58 . . . . 0.0 111.259 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.1 ttm -71.92 138.1 47.88 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.075 0.95 . . . . 0.0 111.957 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -94.07 137.22 33.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.545 0.738 . . . . 0.0 109.042 169.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 123' ' ' LEU . 47.6 mt -119.76 93.45 4.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.686 1.594 . . . . 0.0 110.884 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.4 mt -79.26 135.76 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.537 0.735 . . . . 0.0 111.357 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -124.5 113.05 17.6 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.374 1.47 . . . . 0.0 112.047 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.19 62.95 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.7 m -80.9 1.06 32.53 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.53 1.132 . . . . 0.0 113.553 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -126.52 -27.94 3.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.07 1.348 . . . . 0.0 112.855 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -143.82 117.53 5.93 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.83 0.852 . . . . 0.0 112.85 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.92 -5.72 13.91 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.925 3.084 . . . . 0.0 114.548 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -130.58 76.2 77.79 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.827 1.651 . . . . 0.0 110.662 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -41.69 -34.89 2.44 Favored 'Trans proline' 0 C--N 1.354 0.857 1 C-N-CA 126.001 4.468 . . . . 0.0 118.016 -169.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -51.64 -39.06 57.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.1 p -69.75 -4.89 21.83 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.037 -1.039 . . . . 0.0 113.598 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -121.76 6.03 9.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.43 1.492 . . . . 0.0 112.416 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.1 p -141.26 -26.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -55.05 -51.75 76.87 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.921 1.237 . . . . 0.0 113.433 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.48 -28.62 53.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.673 1.582 . . . . 0.0 113.052 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -60.91 -50.51 73.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.384 0.538 . . . . 0.0 111.297 170.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.51 -42.74 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.007 0.821 . . . . 0.0 110.488 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.59 -34.75 74.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.87 -64.27 0.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.074 0.852 . . . . 0.0 111.313 169.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -51.06 -49.16 61.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.57 1.548 . . . . 0.0 112.144 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.74 -26.3 24.72 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.368 1.461 . . . . 0.0 115.546 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -75.95 -15.5 60.16 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.232 1.516 . . . . 0.0 114.159 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.75 -15.94 33.44 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.181 0.992 . . . . 0.0 113.074 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.6 -18.16 65.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.337 1.455 . . . . 0.0 114.113 -175.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.948 1.699 . . . . 0.0 113.936 -171.177 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.507 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -126.99 130.13 49.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 109.503 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.41 126.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -171.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.03 130.72 10.07 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.7 mt -118.26 86.71 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.021 1.329 . . . . 0.0 107.594 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.284 -170.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.38 140.26 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.112 0.482 . . . . 0.0 111.416 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.4 112.46 1.35 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -153.77 152.04 30.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.832 0.853 . . . . 0.0 112.715 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.8 mmm -95.66 -25.18 16.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.166 0.987 . . . . 0.0 112.732 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.93 -12.37 0.65 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.39 -9.06 8.86 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 116.601 1.401 . . . . 0.0 116.601 170.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -61.23 -41.42 96.85 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.691 1.745 . . . . 0.0 113.078 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -76.59 -34.44 58.41 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.188 0.995 . . . . 0.0 112.059 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.39 -39.41 83.28 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.682 -1.261 . . . . 0.0 113.208 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.2 tp -52.96 -47.47 68.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.382 0.992 . . . . 0.0 111.558 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.58 -35.14 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.81 0.444 . . . . 0.0 111.586 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -68.28 -37.05 80.3 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.55 -42.5 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.547 -0.72 . . . . 0.0 111.593 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.87 -46.21 85.19 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.264 0.626 . . . . 0.0 111.981 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.89 87.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.359 0.527 . . . . 0.0 112.136 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.86 -48.36 75.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.985 0.514 . . . . 0.0 111.512 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.76 84.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.659 0.784 . . . . 0.0 112.754 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.9 mt -58.61 -46.3 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.653 1.181 . . . . 0.0 111.83 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.48 -40.01 67.25 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.876 -0.515 . . . . 0.0 109.869 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.0 m -56.98 -44.8 83.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.495 1.118 . . . . 0.0 112.159 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.79 83.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.067 0.947 . . . . 0.0 112.961 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.69 -23.9 63.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.38 -13.1 6.63 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.53 1.538 . . . . 0.0 114.832 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.507 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 70.5 m-70 -71.44 143.4 50.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.255 1.028 . . . . 0.0 111.535 -178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -71.95 133.79 45.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 157.78 45.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.51 0.724 . . . . 0.0 111.977 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -151.63 110.53 3.86 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' HB1' ' A' ' 19' ' ' ALA . 7.5 p -79.65 150.71 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.721 0.808 . . . . 0.0 111.269 169.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -127.59 171.76 11.35 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.23 1.412 . . . . 0.0 111.592 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -128.7 -36.16 1.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -142.43 55.57 4.52 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 126.379 1.872 . . . . 0.0 111.511 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.01 155.58 54.64 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.063 3.175 . . . . 0.0 113.945 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.23 174.21 10.46 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.427 1.891 . . . . 0.0 110.165 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.16 -34.73 58.14 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.635 -1.291 . . . . 0.0 112.175 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.5 m -54.76 -21.8 12.16 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -96.34 -25.68 15.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.004 1.721 . . . . 0.0 112.614 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.455 ' CH2' HG21 ' A' ' 52' ' ' VAL . 60.7 t-105 -74.18 -39.6 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.228 1.011 . . . . 0.0 112.809 171.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -49.11 31.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.647 1.979 . . . . 0.0 113.349 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.25 -7.82 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.288 2.658 . . . . 0.0 115.942 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -127.82 0.36 6.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.867 1.667 . . . . 0.0 114.106 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.19 -23.12 63.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.401 1.455 . . . . 0.0 113.953 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -98.59 13.38 32.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.371 2.268 . . . . 0.0 113.302 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -139.45 -172.06 3.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.585 1.954 . . . . 0.0 111.648 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -76.62 154.52 34.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.064 0.935 . . . . 0.0 111.835 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.455 HG21 ' CH2' ' A' ' 44' ' ' TRP . 27.7 m -149.27 170.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.483 1.913 . . . . 0.0 110.264 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.93 153.24 22.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.57 0.748 . . . . 0.0 110.656 176.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.95 140.29 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.16 0.984 . . . . 0.0 111.764 -169.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 t -136.15 103.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.384 1.074 . . . . 0.0 110.249 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.6 m -140.43 143.09 35.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -93.67 -170.42 2.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.8 1.64 . . . . 0.0 113.497 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.3 m -135.95 137.22 41.08 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 111.626 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 127.819 2.448 . . . . 0.0 107.214 -171.834 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 121.005 0.431 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -80.24 155.25 74.6 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.128 -0.983 . . . . 0.0 113.571 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.73 152.01 82.49 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.01 3.14 . . . . 0.0 113.446 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.16 -20.4 65.36 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.8 p -64.71 -13.1 53.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.334 1.454 . . . . 0.0 114.683 171.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.79 -7.4 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.706 1.202 . . . . 0.0 113.919 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -47.19 -50.73 45.9 Favored Pre-proline 0 N--CA 1.481 1.09 0 O-C-N 120.307 -1.496 . . . . 0.0 113.035 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.07 -4.91 16.06 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.135 1.89 . . . . 0.0 114.253 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.36 -47.15 7.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.907 0.883 . . . . 0.0 109.134 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.37 -50.71 68.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.998 1.319 . . . . 0.0 112.107 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -62.75 -39.02 92.83 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.196 -0.94 . . . . 0.0 112.829 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.69 -41.93 48.59 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.445 1.022 . . . . 0.0 112.514 -174.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.98 -45.19 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.426 1.113 . . . . 0.0 109.482 174.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.09 -50.0 74.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.261 1.024 . . . . 0.0 112.301 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.21 -34.68 56.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.098 0.959 . . . . 0.0 113.542 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -96.72 -35.89 10.85 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -169.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 mp -89.44 -44.01 10.46 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.375 0.988 . . . . 0.0 113.365 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.44 -39.87 0.36 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 126.371 1.938 . . . . 0.0 117.118 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -157.71 134.21 9.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.511 1.524 . . . . 0.0 110.954 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -158.54 52.92 0.56 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.02 -21.38 73.1 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.96 2.44 . . . . 0.0 115.052 -173.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -72.0 -21.61 61.54 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.935 1.294 . . . . 0.0 113.876 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.97 138.64 38.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 111.114 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -133.38 143.64 49.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.691 1.996 . . . . 0.0 109.929 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.35 -170.86 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.63 28.82 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 127.676 2.56 . . . . 0.0 109.345 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.43 136.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 117.942 0.871 . . . . 0.0 110.516 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.71 104.81 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.23 25.42 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.571 -0.706 . . . . 0.0 109.871 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -139.26 153.17 47.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.227 1.011 . . . . 0.0 111.106 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.31 -147.66 11.3 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.065 0.84 . . . . 0.0 111.46 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.12 121.32 16.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.57 1.948 . . . . 0.0 109.235 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.6 p -67.12 -2.89 6.23 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -64.01 -25.6 68.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.064 0.946 . . . . 0.0 113.16 170.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -86.49 145.74 26.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.114 0.965 . . . . 0.0 112.14 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.05 -36.33 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.504 1.121 . . . . 0.0 112.422 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -87.14 -1.1 57.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.5 t80 26.72 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.569 2.747 . . . . 0.0 115.699 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 27.9 p -121.94 17.16 10.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.138 1.775 . . . . 0.0 113.853 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.03 -31.04 39.06 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.82 1.248 . . . . 0.0 113.959 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.62 -35.28 80.18 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 123.636 0.636 . . . . 0.0 113.558 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.81 -41.86 14.17 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 120.94 -1.33 . . . . 0.0 113.022 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -57.08 -36.29 70.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.139 0.976 . . . . 0.0 113.248 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -58.12 -40.03 80.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.466 0.706 . . . . 0.0 112.689 172.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.37 -30.72 62.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.45 1.023 . . . . 0.0 112.618 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.36 -45.21 92.21 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.201 -1.562 . . . . 0.0 110.55 169.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.7 -37.56 76.36 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.3 tp -52.79 -33.82 50.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.841 1.257 . . . . 0.0 112.342 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.44 -37.67 10.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.713 1.205 . . . . 0.0 111.771 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.19 -32.82 74.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.091 -1.006 . . . . 0.0 113.429 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.47 -13.26 38.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.444 1.098 . . . . 0.0 112.588 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.32 8.07 14.12 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.556 1.542 . . . . 0.0 112.114 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 m 71.65 17.66 5.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.855 2.062 . . . . 0.0 114.454 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 168.94 1.34 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.94 0.896 . . . . 0.0 111.691 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -131.13 101.67 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.734 -1.229 . . . . 0.0 112.088 -169.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 ttm105 -67.35 134.12 50.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.923 -1.11 . . . . 0.0 111.182 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.53 31.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.726 1.61 . . . . 0.0 111.781 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.05 -178.47 45.02 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.473 -1.392 . . . . 0.0 114.027 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.31 136.56 33.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.449 1.099 . . . . 0.0 110.589 170.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.0 ttp -63.4 127.58 31.93 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.874 0.87 . . . . 0.0 111.216 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.471 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -84.81 139.46 31.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 109.644 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.471 ' N ' HD13 ' A' ' 123' ' ' LEU . 37.3 mt -123.95 90.42 3.26 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.858 1.263 . . . . 0.0 111.058 -176.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -72.13 136.56 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.182 0.993 . . . . 0.0 110.673 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -129.7 105.65 8.18 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.047 1.339 . . . . 0.0 111.471 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.32 27.44 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -82.92 -6.55 59.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.445 1.02 . . . . 0.0 113.721 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.64 -26.34 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.571 . . . . 0.0 112.52 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -143.01 113.07 5.76 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.811 1.245 . . . . 0.0 111.239 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.69 -1.38 11.55 Favored 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.646 2.897 . . . . 0.0 114.497 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.43 79.12 74.55 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.485 1.514 . . . . 0.0 111.6 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.43 -34.31 7.38 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.782 4.321 . . . . 0.0 116.781 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -52.31 -45.76 65.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 112.233 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -17.0 64.42 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -95.89 -5.65 41.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.211 1.405 . . . . 0.0 112.705 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.31 -30.04 0.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -51.64 -53.83 46.2 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 119.533 1.061 . . . . 0.0 113.451 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.62 -29.52 29.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.556 1.504 . . . . 0.0 113.013 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.2 -48.06 81.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.439 0.695 . . . . 0.0 111.404 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.7 t -67.67 -41.19 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.565 0.62 . . . . 0.0 110.614 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -58.89 -41.74 87.9 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.741 0.701 . . . . 0.0 111.896 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -65.43 -57.78 7.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.874 0.87 . . . . 0.0 112.162 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -53.98 -44.32 70.7 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 111.9 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.34 -19.99 35.0 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.502 1.525 . . . . 0.0 115.995 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p -72.07 -19.0 61.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.982 1.891 . . . . 0.0 113.974 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.9 mt -93.23 -16.41 24.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.107 1.363 . . . . 0.0 113.061 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.22 150.19 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.505 2.322 . . . . 0.0 111.624 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.389 1.475 . . . . 0.0 113.689 179.721 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.478 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 120.634 0.254 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -140.51 123.96 16.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.555 1.142 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 mm -124.27 136.67 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.93 127.41 9.22 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.3 mt -117.6 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.466 1.106 . . . . 0.0 108.591 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -91.56 138.28 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.037 0.935 . . . . 0.0 111.492 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.63 143.37 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.684 0.754 . . . . 0.0 111.457 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.48 90.39 0.21 Allowed Glycine 0 N--CA 1.463 0.495 0 C-N-CA 125.347 1.451 . . . . 0.0 109.653 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -134.66 165.73 24.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.173 0.989 . . . . 0.0 113.235 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -121.63 -32.14 3.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.179 1.792 . . . . 0.0 110.996 -175.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -134.5 -5.3 2.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.611 1.564 . . . . 0.0 113.861 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -0.56 52.92 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.362 1.081 . . . . 0.0 112.776 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -76.19 -32.71 59.15 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.546 1.138 . . . . 0.0 112.872 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.87 -39.03 80.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.641 -1.287 . . . . 0.0 112.796 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.55 -41.17 72.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.572 0.623 . . . . 0.0 111.751 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.9 -35.19 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 121.753 -0.592 . . . . 0.0 112.205 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.59 95.33 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.201 -0.937 . . . . 0.0 112.662 172.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.99 -41.06 97.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.356 0.662 . . . . 0.0 112.337 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.61 -46.79 87.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.535 -0.728 . . . . 0.0 111.902 169.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.5 88.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.224 0.61 . . . . 0.0 112.317 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.15 -47.02 79.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 111.993 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -45.66 92.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.419 0.688 . . . . 0.0 112.643 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.68 -47.38 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.569 1.148 . . . . 0.0 112.094 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -68.39 -39.77 81.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 109.744 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.8 m -55.77 -50.48 70.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.7 1.2 . . . . 0.0 111.855 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.3 77.65 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -77.31 -5.52 49.82 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.84 24.32 10.0 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.918 0.781 . . . . 0.0 114.648 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 61.5 m-70 -115.93 145.69 42.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.742 1.217 . . . . 0.0 111.389 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -74.27 138.25 43.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.13 43.27 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.606 -0.684 . . . . 0.0 111.994 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -154.7 120.13 5.06 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.76 176.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.0 140.26 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.18 0.992 . . . . 0.0 110.958 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.09 110.65 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.002 1.321 . . . . 0.0 109.701 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.99 -17.66 28.97 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -144.93 56.65 3.87 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.635 1.574 . . . . 0.0 110.612 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.34 162.21 40.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.941 3.094 . . . . 0.0 115.185 -169.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.67 175.07 9.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.213 2.205 . . . . 0.0 109.668 169.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -50.73 -40.85 55.56 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.902 -1.124 . . . . 0.0 112.414 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -58.43 -14.77 8.49 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -96.81 -27.33 14.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -82.46 -39.61 22.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.452 1.501 . . . . 0.0 112.221 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -49.16 -45.3 75.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.849 1.66 . . . . 0.0 114.495 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -57.29 -10.6 6.64 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.225 2.617 . . . . 0.0 116.899 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -114.65 4.27 15.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.74 -23.32 67.32 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.263 1.392 . . . . 0.0 114.273 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -92.32 4.2 53.84 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.948 1.299 . . . . 0.0 113.525 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -130.89 -141.06 0.22 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.46 2.304 . . . . 0.0 109.771 -169.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.16 158.7 34.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.672 1.189 . . . . 0.0 111.361 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.96 168.77 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.274 1.429 . . . . 0.0 110.936 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.97 149.63 19.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.98 0.912 . . . . 0.0 110.387 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.87 135.26 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.052 1.341 . . . . 0.0 110.302 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.3 90.73 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.153 1.381 . . . . 0.0 107.581 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.8 m -133.57 168.36 18.79 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -141.51 -174.33 4.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.106 1.363 . . . . 0.0 113.432 -171.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.8 m -131.62 135.61 47.08 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.609 1.164 . . . . 0.0 110.824 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 126.393 1.877 . . . . 0.0 109.929 -173.485 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.37 136.54 60.74 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.146 1.378 . . . . 0.0 113.283 171.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.27 150.19 89.26 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.55 2.833 . . . . 0.0 111.523 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -60.65 -17.4 47.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -57.34 -17.5 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.292 1.837 . . . . 0.0 114.585 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.27 -10.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.3 t -47.1 -45.58 53.1 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 116.867 -1.539 . . . . 0.0 113.664 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.16 -27.65 35.13 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 122.676 1.991 . . . . 0.0 113.82 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.29 -47.17 65.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.023 0.829 . . . . 0.0 110.778 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.25 -47.58 84.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.126 1.37 . . . . 0.0 112.382 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -60.16 -48.95 79.57 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.295 -0.878 . . . . 0.0 112.101 171.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.64 95.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.194 0.902 . . . . 0.0 113.506 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.01 -45.87 97.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.479 1.139 . . . . 0.0 110.486 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.12 -47.04 86.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.978 0.511 . . . . 0.0 112.18 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.95 -37.25 29.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.395 1.478 . . . . 0.0 114.327 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 m -121.39 10.5 10.54 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -168.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.14 -47.18 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.713 1.142 . . . . 0.0 112.474 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.44 -34.86 0.45 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -157.23 137.55 12.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.475 1.637 . . . . 0.0 111.515 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -158.94 63.74 2.46 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.533 1.133 . . . . 0.0 113.34 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.48 -15.02 42.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.416 3.411 . . . . 0.0 116.77 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -120.9 -0.47 10.08 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.555 1.542 . . . . 0.0 114.384 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.02 141.78 47.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.973 0.909 . . . . 0.0 109.578 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -131.07 138.92 49.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 111.338 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -154.67 -171.17 3.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -170.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.71 161.8 31.64 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 127.595 2.521 . . . . 0.0 109.911 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.07 135.46 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.91 0.855 . . . . 0.0 111.879 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.5 mt -119.3 128.8 75.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.4 145.23 48.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.652 1.181 . . . . 0.0 110.231 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.75 139.49 31.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.85 0.86 . . . . 0.0 110.419 -171.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.37 -147.0 6.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -138.74 124.41 19.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.998 0.919 . . . . 0.0 110.649 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.9 p -70.05 -3.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -68.37 -0.92 5.41 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.029 1.331 . . . . 0.0 114.313 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.74 155.88 44.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.071 1.749 . . . . 0.0 112.045 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.1 m -77.21 1.26 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.61 44.74 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.255 1.422 . . . . 0.0 110.315 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -52.05 115.93 1.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.022 -1.674 . . . . 0.0 112.745 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 94.5 m 51.01 26.99 2.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -58.99 -31.79 69.09 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.045 -1.034 . . . . 0.0 113.498 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.43 87.84 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.134 0.879 . . . . 0.0 112.625 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.62 99.54 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.845 -1.385 . . . . 0.0 112.639 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.06 -40.86 97.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.908 0.883 . . . . 0.0 113.001 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -58.95 -42.13 89.08 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.075 0.95 . . . . 0.0 111.637 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.09 -30.54 63.74 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.52 -45.04 76.9 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.007 -1.683 . . . . 0.0 110.963 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.31 74.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.835 0.854 . . . . 0.0 113.212 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -50.53 -31.84 16.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.461 1.504 . . . . 0.0 112.994 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.35 -36.74 8.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.619 1.168 . . . . 0.0 111.766 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -65.49 -31.46 72.54 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.368 -0.833 . . . . 0.0 113.161 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.36 -15.32 57.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.021 . . . . 0.0 112.752 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -113.52 3.53 15.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.081 1.353 . . . . 0.0 112.652 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m 74.68 15.85 3.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.619 1.968 . . . . 0.0 113.955 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.11 164.49 6.72 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -121.93 150.79 41.5 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.869 -1.144 . . . . 0.0 110.585 -170.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -132.01 108.04 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 121.32 -0.863 . . . . 0.0 111.198 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.69 45.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.405 1.482 . . . . 0.0 112.329 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.54 -168.88 42.01 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.402 1.953 . . . . 0.0 111.995 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.42 147.78 50.67 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.223 -1.163 . . . . 0.0 112.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -66.26 123.54 20.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.781 1.232 . . . . 0.0 112.028 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -81.61 138.1 35.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.071 0.948 . . . . 0.0 110.238 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.1 mt -125.49 93.38 3.84 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.722 1.209 . . . . 0.0 111.661 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.8 mt -84.48 138.9 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.586 1.554 . . . . 0.0 111.234 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -125.72 105.17 8.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.001 1.32 . . . . 0.0 112.323 -177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.75 -21.86 43.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.14 1.376 . . . . 0.0 114.267 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -77.86 -7.88 57.29 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -126.36 -26.4 3.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.363 1.465 . . . . 0.0 112.415 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -143.86 114.77 5.52 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.897 0.879 . . . . 0.0 112.313 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.01 -0.68 10.12 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.309 3.339 . . . . 0.0 114.526 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.89 76.51 71.05 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.009 1.724 . . . . 0.0 109.942 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -61.16 -20.13 66.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.236 3.29 . . . . 0.0 115.796 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.45 -35.01 71.47 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.773 -1.204 . . . . 0.0 113.653 169.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 p -66.9 -9.56 39.31 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -109.77 -12.14 14.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.605 1.162 . . . . 0.0 112.103 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 p -126.29 -27.74 3.17 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.23 -52.76 65.99 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 119.64 1.109 . . . . 0.0 113.26 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.77 -30.13 27.83 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.726 1.617 . . . . 0.0 112.826 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -61.32 -48.74 79.98 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.671 -0.643 . . . . 0.0 111.719 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.25 -40.2 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.339 0.518 . . . . 0.0 110.474 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -59.7 -36.34 76.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.893 0.77 . . . . 0.0 112.56 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.41 -59.69 2.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.935 0.789 . . . . 0.0 111.986 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -53.08 -46.24 68.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.462 1.105 . . . . 0.0 112.09 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -24.68 5.52 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.218 1.866 . . . . 0.0 116.172 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.3 p -73.99 -21.38 60.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.723 1.762 . . . . 0.0 114.184 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.21 -23.25 47.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.314 1.046 . . . . 0.0 112.952 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.5 -28.95 69.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.6 1.56 . . . . 0.0 114.823 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.386 1.475 . . . . 0.0 111.935 173.535 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.512 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.186 0.517 . . . . 0.0 112.119 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.99 121.17 20.08 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.882 1.273 . . . . 0.0 110.399 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.6 125.39 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.911 0.885 . . . . 0.0 113.228 -169.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.98 124.74 7.0 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -117.01 99.07 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.763 1.282 . . . . 0.0 108.995 -170.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -99.66 136.61 39.33 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.06 0.944 . . . . 0.0 110.681 -169.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.83 145.69 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.432 0.634 . . . . 0.0 111.54 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.31 100.51 0.38 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.8 t -151.46 163.97 37.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.285 1.034 . . . . 0.0 113.131 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -122.9 -0.98 8.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.651 1.58 . . . . 0.0 112.54 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -141.08 -58.78 0.5 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.88 0.872 . . . . 0.0 113.053 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.27 -2.5 0.42 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -61.04 -44.99 96.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.6 1.2 . . . . 0.0 112.862 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.1 p -75.96 -32.76 59.66 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.182 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.8 tp -60.03 -40.4 89.2 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.753 -1.217 . . . . 0.0 112.794 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.9 tp -54.97 -42.85 72.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.732 0.697 . . . . 0.0 111.86 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.41 -36.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 121.805 -0.559 . . . . 0.0 111.895 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.27 97.72 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.25 -0.906 . . . . 0.0 112.941 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.88 -41.02 97.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 112.257 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -59.77 -47.54 85.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.581 0.752 . . . . 0.0 111.984 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.02 86.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.372 0.669 . . . . 0.0 112.308 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.79 -46.64 77.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 112.001 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.75 91.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.661 0.784 . . . . 0.0 112.809 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.66 -45.69 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.741 1.216 . . . . 0.0 112.04 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.6 mt -68.09 -42.25 80.61 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.596 -0.69 . . . . 0.0 109.594 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -55.24 -47.97 74.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.757 1.223 . . . . 0.0 112.214 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.35 80.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.117 0.967 . . . . 0.0 113.29 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.14 -8.58 56.67 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.54 -3.61 56.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.198 1.38 . . . . 0.0 114.583 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.512 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 86.5 m-70 -73.27 177.05 5.4 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -115.96 147.36 41.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.152 1.381 . . . . 0.0 109.548 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.25 164.32 35.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.463 -0.773 . . . . 0.0 112.642 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 m -152.93 121.01 6.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.811 0.845 . . . . 0.0 110.991 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.2 141.37 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.795 1.238 . . . . 0.0 111.428 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -130.32 109.73 10.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.412 1.485 . . . . 0.0 110.253 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.25 -16.27 40.74 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -147.94 54.77 1.96 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.886 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.17 163.48 34.89 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.6 2.867 . . . . 0.0 113.949 -170.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.0 173.65 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.821 2.048 . . . . 0.0 109.482 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.59 -40.1 62.31 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.435 -1.416 . . . . 0.0 112.499 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.1 m -62.69 -13.84 37.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -92.73 -33.61 14.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.549 1.139 . . . . 0.0 112.187 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -68.21 -48.14 65.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 112.229 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.5 tp -45.95 -49.25 39.83 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.524 2.329 . . . . 0.0 114.522 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.59 -17.4 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.898 3.732 . . . . 0.0 117.92 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.49 -0.4 15.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.21 -20.2 65.66 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.12 -1.93 54.14 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.793 1.237 . . . . 0.0 113.264 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -132.48 -130.87 0.18 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.41 2.284 . . . . 0.0 109.595 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -135.26 157.8 45.99 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.035 1.334 . . . . 0.0 110.093 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.85 168.45 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.008 0.923 . . . . 0.0 111.732 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tp -159.85 145.15 15.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.104 0.962 . . . . 0.0 110.569 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.66 132.43 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.522 1.529 . . . . 0.0 110.921 -169.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.57 87.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.1 m -131.16 159.09 38.72 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -167.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -129.87 -171.62 2.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.621 1.568 . . . . 0.0 113.187 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.0 m -123.86 153.32 41.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.895 1.278 . . . . 0.0 111.734 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 C-N-CA 125.646 1.578 . . . . 0.0 111.836 -168.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.12 145.34 97.58 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 121.563 -0.711 . . . . 0.0 111.134 170.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.39 150.17 32.06 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.679 2.919 . . . . 0.0 111.003 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.84 -25.31 64.9 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -172.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 m -59.81 -13.98 12.87 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 172.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 tt -133.3 -7.15 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.1 t -47.71 -49.96 54.07 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.504 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.83 -9.2 25.52 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.187 1.925 . . . . 0.0 114.209 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.84 -48.8 7.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.04 1.336 . . . . 0.0 108.793 172.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -65.19 -48.79 72.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.96 1.304 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -63.69 -39.2 93.73 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.051 -1.031 . . . . 0.0 111.943 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.82 -48.86 72.62 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 124.071 0.843 . . . . 0.0 112.258 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -64.15 -46.74 92.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 118.068 0.934 . . . . 0.0 110.658 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.12 -35.3 78.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -109.62 -23.5 11.43 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.4 m -113.95 2.11 14.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.9 mt -122.91 -139.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.635 1.574 . . . . 0.0 108.104 169.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.52 -21.0 0.54 Allowed Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.157 -0.964 . . . . 0.0 114.501 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -159.66 126.72 4.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.053 0.926 . . . . 0.0 113.03 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -152.82 61.19 3.66 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 126.262 1.825 . . . . 0.0 112.034 -177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.68 -26.46 80.07 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.003 3.135 . . . . 0.0 115.249 -169.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -82.57 -10.35 59.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.334 1.454 . . . . 0.0 114.678 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.7 140.22 40.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.964 0.802 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -130.94 142.92 50.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.675 1.99 . . . . 0.0 110.847 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -159.47 -171.44 3.31 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -169.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.47 165.98 33.6 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.39 2.424 . . . . 0.0 111.201 172.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.14 137.53 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 118.074 0.937 . . . . 0.0 112.189 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.441 HD11 ' CE3' ' A' ' 140' ' ' TRP . 41.4 mt -127.88 98.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.59 153.02 25.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.208 0.527 . . . . 0.0 110.261 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -140.71 138.41 34.2 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.106 0.962 . . . . 0.0 110.58 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.2 4.87 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 122.041 -0.412 . . . . 0.0 112.55 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -150.74 135.57 17.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -5.17 10.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.988 2.115 . . . . 0.0 115.259 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -66.46 1.71 1.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -138.68 156.68 47.21 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.215 1.806 . . . . 0.0 111.627 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.68 -33.8 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -96.18 48.56 1.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.843 0.857 . . . . 0.0 111.718 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -49.92 114.77 1.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.341 -1.475 . . . . 0.0 112.701 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m 51.03 24.84 2.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -59.31 -29.63 67.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.829 -1.17 . . . . 0.0 113.259 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.37 -35.19 91.65 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 113.388 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.92 -40.45 10.56 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.526 -0.985 . . . . 0.0 112.896 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.11 -39.28 78.25 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.197 0.999 . . . . 0.0 113.291 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.7 -35.98 75.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.171 0.588 . . . . 0.0 112.57 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -74.81 -36.01 62.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.338 -0.851 . . . . 0.0 112.502 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.56 -42.87 99.47 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 119.81 -1.806 . . . . 0.0 111.303 169.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.49 88.42 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -52.93 -44.75 67.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.819 1.247 . . . . 0.0 111.142 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.09 -33.55 67.97 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -33.12 74.33 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.033 -1.042 . . . . 0.0 111.875 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.55 -17.96 64.41 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.081 -1.012 . . . . 0.0 112.77 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -99.59 6.09 45.82 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.529 1.532 . . . . 0.0 112.35 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m 58.58 19.99 7.2 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.082 1.753 . . . . 0.0 114.913 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.99 154.02 27.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.394 0.678 . . . . 0.0 111.691 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -117.15 99.9 7.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.087 1.355 . . . . 0.0 111.005 -169.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -67.8 133.89 50.01 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.055 -1.028 . . . . 0.0 111.289 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.81 33.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.92 -163.12 36.2 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.982 1.277 . . . . 0.0 112.432 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -125.86 152.47 45.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.092 1.357 . . . . 0.0 112.382 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.7 ttp -69.03 123.95 22.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.48 1.512 . . . . 0.0 111.963 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.3 tm? -80.97 140.72 35.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.914 0.885 . . . . 0.0 109.397 172.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' N ' HD13 ' A' ' 123' ' ' LEU . 59.4 mt -123.24 92.75 3.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.614 1.566 . . . . 0.0 111.167 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.98 137.74 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.355 1.062 . . . . 0.0 111.157 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.87 118.48 32.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.94 1.296 . . . . 0.0 111.402 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.7 92.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.9 m -63.41 -41.08 98.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.61 -32.65 68.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.992 0.917 . . . . 0.0 112.43 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -145.4 99.48 4.51 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.163 0.985 . . . . 0.0 112.705 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.9 2.07 7.94 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.898 3.066 . . . . 0.0 114.29 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -122.42 71.84 37.41 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.292 1.837 . . . . 0.0 109.37 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -58.78 -20.62 52.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.646 3.564 . . . . 0.0 116.149 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.84 -39.27 77.27 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.126 -0.984 . . . . 0.0 112.776 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.9 p -68.78 -6.32 25.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.291 1.036 . . . . 0.0 113.526 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.52 -2.33 17.69 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.461 1.505 . . . . 0.0 112.161 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.6 p -139.67 -28.1 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -51.95 -54.0 45.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.8 -28.13 30.53 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.666 1.577 . . . . 0.0 112.951 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.441 ' CE3' HD11 ' A' ' 90' ' ' ILE . 75.5 t90 -63.22 -47.79 81.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.381 0.672 . . . . 0.0 111.524 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.01 -40.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.587 0.631 . . . . 0.0 110.358 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -58.78 -44.76 90.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.672 0.669 . . . . 0.0 111.719 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -61.72 -56.09 23.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.984 0.914 . . . . 0.0 112.357 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -53.34 -48.62 68.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.599 1.16 . . . . 0.0 111.209 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.03 -21.81 32.82 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.586 1.565 . . . . 0.0 116.144 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -68.88 -19.41 64.23 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.507 2.154 . . . . 0.0 113.517 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -99.31 -14.88 19.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.0 113.109 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.53 147.75 48.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.185 1.394 . . . . 0.0 111.722 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.119 -172.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.484 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.395 0.617 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -135.35 116.5 14.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.204 1.402 . . . . 0.0 109.31 -173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -118.72 125.39 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.95 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.53 125.05 7.52 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -114.1 91.17 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.294 1.047 . . . . 0.0 108.256 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -94.02 136.58 34.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.689 0.796 . . . . 0.0 110.872 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.87 142.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.879 0.847 . . . . 0.0 111.086 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.75 79.47 0.32 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -128.04 172.51 10.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.133 0.973 . . . . 0.0 112.974 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.5 tpt -129.67 -34.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.684 1.993 . . . . 0.0 111.627 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -132.17 1.16 3.83 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.35 -1.43 58.84 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -66.19 -42.5 88.77 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.916 1.358 . . . . 0.0 112.164 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -37.32 77.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.337 1.455 . . . . 0.0 112.639 170.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.47 -36.93 76.94 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.725 -1.234 . . . . 0.0 113.513 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -51.85 -45.19 63.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.937 0.79 . . . . 0.0 111.792 172.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.49 -36.54 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.045 -0.41 . . . . 0.0 111.7 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.09 99.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.098 0.863 . . . . 0.0 112.672 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.61 -41.96 98.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.216 0.607 . . . . 0.0 112.347 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.22 -42.19 96.69 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.363 -0.836 . . . . 0.0 112.692 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.9 91.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.494 0.717 . . . . 0.0 112.291 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.55 -47.04 80.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.406 0.682 . . . . 0.0 111.369 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.47 86.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.463 0.705 . . . . 0.0 112.649 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.72 -46.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.046 1.338 . . . . 0.0 112.362 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.46 -39.99 70.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -175.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -57.48 -46.4 83.74 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.552 1.141 . . . . 0.0 111.931 170.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.34 77.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.0 -11.7 60.66 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.33 40.0 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.579 1.561 . . . . 0.0 114.705 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.484 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 74.8 m-70 -75.26 153.17 38.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.436 1.118 . . . . 0.0 111.526 176.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -80.62 135.69 36.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.35 154.55 43.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.13 0.572 . . . . 0.0 111.942 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 m -153.31 122.7 6.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.906 0.883 . . . . 0.0 111.184 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 140.58 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.332 1.053 . . . . 0.0 110.96 171.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -129.0 112.06 13.64 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.82 1.248 . . . . 0.0 110.333 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.49 -11.51 31.86 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.16 53.76 2.14 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.868 1.267 . . . . 0.0 111.794 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.6 162.39 42.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.64 2.893 . . . . 0.0 114.827 -172.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -131.24 169.61 15.71 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.471 2.308 . . . . 0.0 109.295 169.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.34 62.8 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.267 -1.521 . . . . 0.0 112.376 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -61.82 -12.58 18.02 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -92.93 -32.47 14.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.823 1.249 . . . . 0.0 112.216 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -70.75 -42.44 70.49 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.907 0.883 . . . . 0.0 111.926 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.6 tp -47.84 -47.27 63.11 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 127.872 2.469 . . . . 0.0 115.787 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 -9.01 25.17 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.704 2.269 . . . . 0.0 114.881 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -119.53 -15.73 8.98 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -61.77 -27.41 68.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.196 1.362 . . . . 0.0 113.081 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.72 5.97 14.19 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.921 1.288 . . . . 0.0 113.968 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -128.59 -118.95 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.999 2.52 . . . . 0.0 108.245 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -135.56 157.88 45.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.155 1.782 . . . . 0.0 108.833 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 166.39 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.231 1.012 . . . . 0.0 110.613 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.95 144.92 17.97 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.413 -0.804 . . . . 0.0 110.296 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -113.97 133.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.654 1.582 . . . . 0.0 110.467 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 t -134.33 92.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 m -135.4 154.79 51.35 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 p -133.95 -171.56 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.511 1.524 . . . . 0.0 112.469 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -122.06 153.37 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.439 1.096 . . . . 0.0 111.068 -170.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 126.574 1.95 . . . . 0.0 109.31 179.03 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.7 mt -64.76 147.3 98.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.306 1.442 . . . . 0.0 112.967 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -82.1 154.63 16.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.785 2.99 . . . . 0.0 111.87 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -58.78 -23.34 60.05 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.8 m -54.95 -19.1 5.97 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.992 1.717 . . . . 0.0 115.04 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.54 -5.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -45.87 -44.45 33.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 117.183 -1.389 . . . . 0.0 113.442 170.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.04 -27.51 57.66 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 122.375 1.884 . . . . 0.0 114.666 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mt -73.8 -48.54 30.74 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.06 1.3 . . . . 0.0 110.807 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.52 -38.87 82.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.835 1.254 . . . . 0.0 112.909 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -75.08 -48.31 24.52 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.178 -0.952 . . . . 0.0 112.037 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.39 82.34 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 123.795 0.712 . . . . 0.0 113.991 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.89 -44.35 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.262 1.031 . . . . 0.0 110.357 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.28 -48.37 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.196 0.998 . . . . 0.0 112.137 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.01 -41.31 59.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.235 1.414 . . . . 0.0 114.382 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.0 m -123.74 -14.64 7.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -168.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.77 -50.25 7.3 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.662 1.574 . . . . 0.0 109.599 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 -40.45 0.47 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 126.536 2.017 . . . . 0.0 117.598 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -157.68 138.53 13.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.165 1.483 . . . . 0.0 111.492 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -159.49 100.48 1.53 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.886 1.275 . . . . 0.0 111.2 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.58 -16.27 8.07 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.627 2.885 . . . . 0.0 115.067 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -110.5 -9.3 14.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.349 1.46 . . . . 0.0 113.889 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.5 tp -55.62 124.69 18.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.4 1.88 . . . . 0.0 111.113 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -128.21 140.87 51.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.725 1.61 . . . . 0.0 109.856 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -161.56 -169.29 2.22 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.68 160.7 30.48 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 127.205 2.336 . . . . 0.0 109.862 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.2 t -140.46 133.76 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.835 0.818 . . . . 0.0 111.399 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.417 HD11 ' CE3' ' A' ' 140' ' ' TRP . 42.1 mt -122.32 100.43 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.78 153.36 25.28 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 0.0 109.736 169.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.16 142.24 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.0 0.92 . . . . 0.0 110.602 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.43 -144.22 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.549 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -146.43 120.2 9.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.43 0.692 . . . . 0.0 111.328 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -59.87 -8.49 2.23 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.687 1.595 . . . . 0.0 113.855 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.5 m -60.73 -7.85 2.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.221 1.409 . . . . 0.0 114.567 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -130.38 159.25 37.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.736 1.614 . . . . 0.0 112.729 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.36 -0.91 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 -169.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.53 48.67 1.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.752 1.221 . . . . 0.0 110.528 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -51.07 114.97 1.33 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.002 -1.686 . . . . 0.0 113.148 -170.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m 52.95 24.89 3.63 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -61.38 -24.05 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.564 -1.335 . . . . 0.0 113.877 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.26 -59.33 8.55 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.562 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.59 96.69 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.317 -1.107 . . . . 0.0 114.008 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -40.46 88.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.171 0.985 . . . . 0.0 113.655 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.52 -36.15 79.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.327 0.512 . . . . 0.0 112.221 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.41 -29.34 63.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.83 -45.42 71.21 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.256 -1.527 . . . . 0.0 110.559 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.35 67.93 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.7 tp -50.39 -30.2 11.84 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.88 1.672 . . . . 0.0 113.151 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.52 -36.64 7.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.568 1.147 . . . . 0.0 111.743 -171.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -65.67 -30.26 70.93 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.343 -0.848 . . . . 0.0 112.777 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.04 -17.24 63.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.048 0.939 . . . . 0.0 112.622 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -113.7 -7.19 13.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 t 100.37 13.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.188 2.595 . . . . 0.0 113.153 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.08 162.68 4.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.365 0.666 . . . . 0.0 111.992 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -133.36 95.66 3.56 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.205 1.002 . . . . 0.0 109.935 -172.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.9 ttm105 -66.18 136.16 55.53 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.482 -0.761 . . . . 0.0 110.659 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -89.59 34.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.294 1.438 . . . . 0.0 111.503 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.64 41.37 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.979 1.276 . . . . 0.0 113.107 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -95.81 144.08 26.48 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.562 1.145 . . . . 0.0 111.02 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -63.82 123.57 19.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.832 0.853 . . . . 0.0 111.056 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.5 tm? -81.75 140.0 34.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.714 0.806 . . . . 0.0 109.293 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.505 ' N ' HD13 ' A' ' 123' ' ' LEU . 48.0 mt -122.81 92.84 3.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.272 1.429 . . . . 0.0 110.811 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.9 mt -71.77 136.9 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.797 0.839 . . . . 0.0 110.326 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -130.26 106.8 8.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.158 0.983 . . . . 0.0 113.154 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.31 -17.22 41.29 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -68.53 -14.02 62.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.753 1.161 . . . . 0.0 113.704 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.64 -10.88 1.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -139.93 110.37 7.22 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.905 1.23 . . . . 0.0 112.598 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.48 0.61 9.64 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.442 3.428 . . . . 0.0 114.794 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.01 76.17 77.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.625 1.57 . . . . 0.0 111.592 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -44.35 -34.33 7.17 Favored 'Trans proline' 0 C--N 1.354 0.831 1 C-N-CA 126.077 4.518 . . . . 0.0 117.853 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.49 -37.68 70.7 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 113.39 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -69.64 -5.97 28.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.56 1.144 . . . . 0.0 113.343 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -113.54 -2.18 13.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.595 1.558 . . . . 0.0 111.84 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 p -139.96 -28.43 0.74 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -169.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -55.88 -51.6 79.12 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.0 -28.95 41.21 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.742 1.628 . . . . 0.0 112.619 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CE3' HD11 ' A' ' 90' ' ' ILE . 70.9 t90 -63.37 -48.34 78.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.767 0.827 . . . . 0.0 111.748 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.74 -39.84 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.834 0.743 . . . . 0.0 110.409 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -57.55 -43.98 84.84 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.117 0.417 . . . . 0.0 111.342 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -63.62 -57.49 9.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.701 0.8 . . . . 0.0 112.534 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -51.49 -48.78 62.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.712 1.205 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -28.5 17.19 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.78 1.657 . . . . 0.0 116.122 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.1 p -69.75 -18.9 63.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.566 1.683 . . . . 0.0 114.025 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.96 -14.61 27.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 113.056 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.36 164.21 11.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.458 1.903 . . . . 0.0 112.468 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.767 1.227 . . . . 0.0 113.58 171.528 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.536 ' N ' ' HD1' ' A' ' 31' ' ' HIS . . . . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.31 115.27 16.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.918 1.687 . . . . 0.0 109.291 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -111.55 126.7 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.821 0.848 . . . . 0.0 112.76 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.93 125.87 7.53 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.1 mt -117.29 91.35 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 108.938 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -90.34 132.74 35.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.94 0.896 . . . . 0.0 110.732 -170.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.55 144.78 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.29 0.636 . . . . 0.0 111.52 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.86 104.46 0.55 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -149.22 161.37 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.028 1.331 . . . . 0.0 111.434 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 79.4 mmm -106.3 -11.79 15.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.073 0.949 . . . . 0.0 113.291 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -146.7 -26.46 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.46 -5.49 4.89 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -44.5 94.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.585 1.693 . . . . 0.0 113.228 -169.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -81.23 -31.04 34.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.372 0.669 . . . . 0.0 112.581 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.57 -38.91 75.61 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.737 -1.227 . . . . 0.0 113.239 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -52.76 -42.06 64.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.075 0.852 . . . . 0.0 111.801 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.9 t -69.47 -34.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.109 0.563 . . . . 0.0 112.008 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.56 92.07 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.44 1.018 . . . . 0.0 112.412 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.91 -41.75 96.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.567 0.747 . . . . 0.0 112.034 173.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -61.3 -46.52 89.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.281 0.632 . . . . 0.0 112.227 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.52 88.64 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 112.793 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.19 -45.89 79.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.724 0.809 . . . . 0.0 112.012 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.92 -45.89 80.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.779 0.832 . . . . 0.0 112.672 176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.56 -31.73 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.058 1.343 . . . . 0.0 112.996 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 mt -75.55 -41.38 55.03 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.807 -1.183 . . . . 0.0 110.175 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.3 m -56.6 -44.65 81.3 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.166 0.986 . . . . 0.0 111.807 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.66 76.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.74 1.216 . . . . 0.0 113.601 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.64 -5.41 47.75 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.405 1.082 . . . . 0.0 113.621 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.83 0.33 55.17 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.294 1.426 . . . . 0.0 114.502 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HD1' ' N ' ' A' ' 2' ' ' ALA . 87.0 m-70 -81.83 -177.16 6.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.957 1.303 . . . . 0.0 111.919 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -122.51 150.76 42.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.933 1.693 . . . . 0.0 109.145 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.87 167.15 27.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -152.38 119.35 5.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 110.811 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -74.37 145.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.391 1.076 . . . . 0.0 111.02 171.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.0 109.21 9.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.426 1.49 . . . . 0.0 109.193 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.91 -28.59 35.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -144.25 56.43 4.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.878 1.671 . . . . 0.0 110.981 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.04 165.16 32.71 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.684 2.923 . . . . 0.0 115.566 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -133.98 171.68 13.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.728 2.011 . . . . 0.0 109.712 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.91 -39.61 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.989 -1.07 . . . . 0.0 113.038 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 m -58.62 -20.39 47.04 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -85.06 -33.06 22.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.211 0.914 . . . . 0.0 112.498 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.538 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 28.4 t-105 -78.34 -40.75 35.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.639 1.175 . . . . 0.0 112.578 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.3 tp -41.44 -46.97 8.67 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.752 2.821 . . . . 0.0 115.577 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.86 -28.89 67.52 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.754 2.969 . . . . 0.0 116.316 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -80.06 2.5 23.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -169.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -60.32 -23.44 64.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.71 -1.244 . . . . 0.0 114.212 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -87.32 3.5 46.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.827 1.251 . . . . 0.0 113.072 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -137.32 -137.63 0.14 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.709 2.003 . . . . 0.0 110.97 -168.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -140.83 164.29 30.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.21 1.804 . . . . 0.0 110.626 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.538 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 28.7 m -144.05 174.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.252 1.421 . . . . 0.0 111.741 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tt -152.19 146.44 25.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.669 1.988 . . . . 0.0 108.49 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.28 133.04 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.357 1.063 . . . . 0.0 109.687 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.91 90.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.933 1.293 . . . . 0.0 108.786 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.5 m -135.76 141.62 44.84 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -94.95 -165.21 1.27 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.257 1.823 . . . . 0.0 113.155 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.7 m -132.43 150.35 52.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.337 -1.477 . . . . 0.0 111.715 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 127.28 2.232 . . . . 0.0 109.63 -175.84 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t0 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.15 145.66 65.45 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.804 1.241 . . . . 0.0 109.759 169.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.69 140.65 57.03 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.316 2.678 . . . . 0.0 110.412 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.37 -28.82 65.49 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -59.29 -12.05 5.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.66 -3.7 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.577 1.08 . . . . 0.0 113.338 173.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.2 t -56.79 -46.2 99.87 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 120.343 -1.473 . . . . 0.0 112.34 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.93 -12.97 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.921 3.081 . . . . 0.0 116.305 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 tp -99.89 -44.49 6.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.545 1.138 . . . . 0.0 110.577 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.32 -42.9 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.644 1.178 . . . . 0.0 112.238 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.88 -26.86 67.09 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.111 -0.993 . . . . 0.0 113.446 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.97 -41.73 4.56 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.078 -171.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.25 -41.06 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.447 1.623 . . . . 0.0 111.054 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.32 -48.01 83.24 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 112.32 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -36.05 19.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.831 0.853 . . . . 0.0 113.226 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -82.49 -37.08 25.81 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.75 -46.41 15.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.18 0.9 . . . . 0.0 112.393 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.97 -39.1 0.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 126.239 1.876 . . . . 0.0 115.415 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -161.94 142.27 10.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.748 2.019 . . . . 0.0 110.187 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -150.9 102.34 3.03 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.705 1.202 . . . . 0.0 111.407 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.68 -16.31 10.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.693 2.262 . . . . 0.0 114.456 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 -5.36 9.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.4 117.39 6.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.663 1.185 . . . . 0.0 109.934 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -127.93 134.55 49.33 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.716 1.606 . . . . 0.0 110.622 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CB ' HG23 ' A' ' 52' ' ' VAL . 1.3 p90 -155.97 -171.13 3.63 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -171.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.24 160.39 28.26 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.864 1.697 . . . . 0.0 110.487 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.39 135.62 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.007 0.908 . . . . 0.0 113.328 -169.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.0 119.44 57.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.85 147.32 47.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.468 1.107 . . . . 0.0 109.84 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.0 tt -138.55 148.25 44.01 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.046 0.927 . . . . 0.0 112.158 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.65 -141.17 6.08 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.795 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -141.95 118.6 11.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 111.197 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -74.06 -0.02 15.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 t -73.21 4.49 4.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.56 1.073 . . . . 0.0 113.668 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.02 157.64 46.41 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.306 1.843 . . . . 0.0 111.673 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 m -74.45 -1.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -169.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -122.97 44.51 2.64 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.808 1.243 . . . . 0.0 110.73 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.29 116.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.302 -1.499 . . . . 0.0 113.1 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.17 24.46 2.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.693 2.397 . . . . 0.0 116.685 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -60.61 -27.8 68.04 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.371 -1.455 . . . . 0.0 113.416 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.64 73.02 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.272 -0.892 . . . . 0.0 113.447 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.64 -40.27 6.84 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.079 0.939 . . . . 0.0 113.13 170.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -58.74 -38.76 79.11 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 118.702 1.251 . . . . 0.0 113.659 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -56.34 -32.06 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -75.8 -25.63 56.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.033 0.833 . . . . 0.0 113.182 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.74 -43.16 48.14 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.31 -1.494 . . . . 0.0 110.288 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.12 -42.62 69.66 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 170.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -49.99 -43.86 50.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.88 1.672 . . . . 0.0 112.319 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.17 -37.62 14.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.046 0.939 . . . . 0.0 112.464 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.67 -30.28 71.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.461 -0.774 . . . . 0.0 112.21 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.81 -24.42 67.75 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -91.91 -2.21 56.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.748 0.703 . . . . 0.0 112.456 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m 75.09 23.95 1.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.056 2.143 . . . . 0.0 114.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 177.03 0.14 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.64 1.176 . . . . 0.0 112.681 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -135.59 164.35 28.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 O-C-N 120.565 -1.334 . . . . 0.0 110.305 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 mtm105 -130.58 142.26 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 t -96.16 25.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.004 1.722 . . . . 0.0 111.637 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.01 -171.42 44.43 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.018 1.294 . . . . 0.0 114.461 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.05 155.56 39.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.277 1.431 . . . . 0.0 111.641 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.7 ttm -68.41 121.19 15.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.488 1.115 . . . . 0.0 112.231 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -76.82 136.17 38.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.67 84.94 2.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.743 1.217 . . . . 0.0 110.866 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.2 mt -74.97 132.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.742 1.617 . . . . 0.0 110.634 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -124.35 104.2 8.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -14.86 7.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.5 m -64.58 -23.09 67.15 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.885 1.221 . . . . 0.0 113.598 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.35 -8.31 0.99 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -135.92 107.58 9.74 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.316 0.962 . . . . 0.0 113.064 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.76 -2.06 11.62 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.139 3.226 . . . . 0.0 114.346 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -125.16 78.82 66.53 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.934 1.694 . . . . 0.0 110.514 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.39 -23.24 76.49 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.448 3.432 . . . . 0.0 114.328 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.28 -43.68 67.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.557 1.543 . . . . 0.0 112.417 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -104.25 -7.66 19.9 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.632 1.173 . . . . 0.0 112.877 175.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 m -123.92 -26.16 4.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.32 -50.5 85.55 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 120.575 -1.328 . . . . 0.0 111.754 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.04 -34.46 87.21 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.012 2.475 . . . . 0.0 114.79 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -61.49 -49.32 77.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.985 0.514 . . . . 0.0 111.495 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.2 t -71.19 -33.41 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.351 -0.843 . . . . 0.0 111.223 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -66.12 -14.92 62.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.232 -0.918 . . . . 0.0 113.173 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -95.98 -57.16 2.43 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.745 1.218 . . . . 0.0 111.634 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.85 -49.02 66.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.875 1.27 . . . . 0.0 111.815 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.76 -24.97 27.98 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.835 1.207 . . . . 0.0 115.685 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.4 p -69.2 -16.54 63.64 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 120.117 1.959 . . . . 0.0 113.659 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.3 mt -99.79 -15.13 18.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.482 1.513 . . . . 0.0 112.995 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.59 143.97 53.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 111.671 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.946 1.698 . . . . 0.0 114.128 -174.586 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.94 166.88 8.5 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -132.62 133.82 44.11 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.068 1.747 . . . . 0.0 108.461 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.457 HD11 ' CD1' ' A' ' 148' ' ' LEU . 4.5 mm -125.95 117.36 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.537 0.735 . . . . 0.0 111.804 -169.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.09 126.81 7.57 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 168.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -118.32 91.21 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.673 1.189 . . . . 0.0 107.857 -172.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -90.5 137.62 32.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.356 1.063 . . . . 0.0 110.478 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -121.26 144.77 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.523 0.678 . . . . 0.0 112.242 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.16 104.56 0.49 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.247 0.927 . . . . 0.0 111.207 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 t -151.13 163.77 38.05 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.462 1.105 . . . . 0.0 113.076 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.1 mtp -129.82 2.0 4.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 112.204 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -140.18 -11.87 1.08 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.8 -0.8 67.67 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 171.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -74.42 -42.94 58.34 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.739 1.769 . . . . 0.0 111.732 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -33.45 74.77 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.564 -0.71 . . . . 0.0 112.156 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.1 tp -62.08 -40.97 97.63 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.997 -1.065 . . . . 0.0 112.562 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 tt -56.15 -44.97 79.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.142 0.883 . . . . 0.0 111.623 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.22 -38.84 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.836 0.454 . . . . 0.0 111.795 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.5 90.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.22 -42.55 99.29 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.334 -0.854 . . . . 0.0 111.868 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -61.68 -42.44 98.93 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.501 -0.749 . . . . 0.0 112.385 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.85 95.03 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.771 0.714 . . . . 0.0 112.457 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.08 -48.75 79.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.325 0.65 . . . . 0.0 111.539 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.22 91.97 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.785 0.834 . . . . 0.0 112.746 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.13 -47.75 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.411 1.085 . . . . 0.0 112.363 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.29 -39.71 78.15 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.734 -0.604 . . . . 0.0 109.892 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.5 m -58.32 -44.72 88.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.927 1.291 . . . . 0.0 112.072 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -38.24 86.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.26 1.024 . . . . 0.0 112.561 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -68.44 -25.01 64.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.938 0.895 . . . . 0.0 112.892 172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.16 -7.03 8.7 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.922 1.725 . . . . 0.0 114.759 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -76.34 139.25 40.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.828 1.251 . . . . 0.0 110.93 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -76.93 76.94 3.5 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.784 0.834 . . . . 0.0 110.909 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.34 157.8 32.08 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.271 -0.893 . . . . 0.0 111.624 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.3 m -151.99 117.73 5.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.103 -0.998 . . . . 0.0 109.784 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.13 144.97 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.708 0.803 . . . . 0.0 112.262 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.34 97.95 4.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.409 1.484 . . . . 0.0 110.822 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.99 -18.02 60.92 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -141.67 66.04 21.66 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.893 1.677 . . . . 0.0 109.764 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.67 168.75 24.1 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.14 3.227 . . . . 0.0 115.237 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -149.34 159.96 43.83 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.973 2.109 . . . . 0.0 109.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.02 -38.05 48.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.954 -1.091 . . . . 0.0 111.468 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -56.03 -24.8 41.66 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.41 1.484 . . . . 0.0 114.826 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -99.6 -23.72 14.97 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.567 1.547 . . . . 0.0 112.908 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -71.59 -39.6 70.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.803 0.841 . . . . 0.0 112.727 170.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.98 -47.66 86.47 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.778 2.031 . . . . 0.0 115.594 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.88 -5.14 1.76 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.101 3.2 . . . . 0.0 117.731 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -119.56 2.84 11.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -28.26 69.52 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.227 -1.546 . . . . 0.0 113.187 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.91 4.91 23.72 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.705 1.202 . . . . 0.0 113.094 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -135.71 -132.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.867 2.067 . . . . 0.0 110.1 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -139.09 159.47 42.08 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.943 1.697 . . . . 0.0 111.005 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.37 168.51 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.034 1.733 . . . . 0.0 110.391 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.85 151.15 23.36 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.849 -1.157 . . . . 0.0 110.433 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.81 136.64 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.829 1.252 . . . . 0.0 110.405 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.6 t -135.1 95.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.937 1.295 . . . . 0.0 107.719 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 m -133.56 169.12 17.45 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -167.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -137.71 -158.95 0.91 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.122 1.369 . . . . 0.0 112.578 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.1 m -135.82 151.75 50.38 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.757 1.623 . . . . 0.0 110.872 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 t -150.17 -176.07 5.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.127 1.371 . . . . 0.0 111.696 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.46 -132.18 9.07 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.697 1.617 . . . . 0.0 114.377 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -81.74 19.67 1.04 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 113.069 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.65 15.73 10.83 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.763 1.173 . . . . 0.0 114.924 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -80.37 170.07 16.88 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.424 1.89 . . . . 0.0 112.388 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mp -69.47 143.96 93.78 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.219 -0.926 . . . . 0.0 111.054 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.93 137.37 43.82 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.088 3.859 . . . . 0.0 112.349 170.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.85 -24.35 66.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -61.45 -17.95 56.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.718 1.607 . . . . 0.0 114.802 171.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.7 tt -124.54 -10.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.543 1.137 . . . . 0.0 113.845 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.8 t -46.98 -48.98 51.93 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 117.211 -1.376 . . . . 0.0 112.965 169.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.44 -17.21 43.94 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.379 1.885 . . . . 0.0 114.385 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.2 -43.71 17.31 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.962 0.801 . . . . 0.0 109.572 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.57 -49.65 72.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.096 1.359 . . . . 0.0 111.386 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -62.12 -41.7 98.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.846 -1.159 . . . . 0.0 112.262 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.99 -50.23 67.55 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.647 0.641 . . . . 0.0 112.828 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.3 -39.41 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 O-C-N 121.382 -1.069 . . . . 0.0 110.897 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -65.88 -36.7 84.14 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -112.71 -20.36 11.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.2 m -125.61 10.86 7.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.876 1.271 . . . . 0.0 113.782 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -130.13 -51.59 1.11 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.615 1.566 . . . . 0.0 110.302 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.31 -28.98 0.33 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 119.552 2.581 . . . . 0.0 119.552 168.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -153.3 136.45 15.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.499 2.15 . . . . 0.0 111.99 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -150.64 56.11 2.0 Allowed Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.219 1.408 . . . . 0.0 113.296 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.43 -18.67 65.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.036 3.158 . . . . 0.0 115.323 -172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.97 0.17 14.98 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.596 1.959 . . . . 0.0 113.504 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.71 124.07 22.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.613 1.165 . . . . 0.0 109.186 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -121.31 138.89 54.04 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.201 1.4 . . . . 0.0 109.263 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -160.92 -167.48 1.84 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -168.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 160.86 31.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.625 2.536 . . . . 0.0 109.714 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.82 135.46 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 117.897 0.849 . . . . 0.0 112.212 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.2 mt -119.57 130.61 73.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.04 146.85 48.29 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.044 0.938 . . . . 0.0 110.171 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tt -141.53 133.87 28.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.553 0.741 . . . . 0.0 110.852 -169.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.58 -166.15 33.8 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 121.951 0.751 . . . . 0.0 113.733 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -98.07 118.4 34.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.877 1.271 . . . . 0.0 110.962 -176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.4 p -64.26 -9.94 20.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.974 1.71 . . . . 0.0 115.207 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -70.56 -8.26 50.1 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -138.13 159.55 41.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.67 1.188 . . . . 0.0 113.387 -169.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.6 t -63.16 -34.5 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.127 1.371 . . . . 0.0 113.176 -171.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -76.2 34.85 0.13 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.592 1.157 . . . . 0.0 113.215 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.62 113.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.915 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.3 m 52.85 25.36 3.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.329 2.251 . . . . 0.0 116.287 -171.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -60.28 -30.22 69.32 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.661 -1.275 . . . . 0.0 113.692 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.55 -38.8 61.62 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.897 -1.127 . . . . 0.0 112.695 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.67 -40.33 66.06 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.524 -0.986 . . . . 0.0 112.791 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -58.79 -40.74 84.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.881 0.872 . . . . 0.0 112.911 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.86 -38.21 84.81 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 171.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.27 -31.3 68.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.39 0.995 . . . . 0.0 113.413 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.57 -43.73 79.92 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 119.763 -1.835 . . . . 0.0 110.826 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.39 71.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -50.57 -29.64 11.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.586 1.554 . . . . 0.0 112.936 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.32 -39.1 6.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.517 1.127 . . . . 0.0 111.362 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -67.36 -34.13 76.66 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.306 -0.871 . . . . 0.0 113.338 172.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.79 -14.09 49.81 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.427 -0.796 . . . . 0.0 112.414 169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -111.57 10.15 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.851 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.6 t 72.31 18.93 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.596 1.558 . . . . 0.0 114.516 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.8 165.35 1.76 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.506 0.722 . . . . 0.0 111.92 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -135.6 88.4 2.4 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 120.76 -1.213 . . . . 0.0 110.344 -170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -62.42 142.83 57.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.354 0.662 . . . . 0.0 111.346 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.56 34.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.579 1.552 . . . . 0.0 110.757 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.92 -167.89 40.91 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.841 -1.162 . . . . 0.0 113.562 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -120.17 143.14 48.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.515 1.526 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.1 ttp -67.53 124.82 24.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.265 1.026 . . . . 0.0 112.018 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -83.86 133.66 34.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.218 1.007 . . . . 0.0 109.968 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -122.41 98.13 5.78 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.515 1.126 . . . . 0.0 111.575 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.1 mt -89.47 134.24 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.617 1.567 . . . . 0.0 111.772 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -113.38 66.97 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.624 3.17 . . . . 0.0 111.35 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -46.1 -38.94 8.68 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.455 1.902 . . . . 0.0 116.132 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.1 m -62.38 -16.12 52.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -134.46 12.49 3.8 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.065 1.746 . . . . 0.0 111.964 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -144.5 68.46 15.0 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.242 1.817 . . . . 0.0 110.704 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.85 6.92 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.841 3.694 . . . . 0.0 114.701 -171.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.5 58.91 41.66 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.275 1.83 . . . . 0.0 110.987 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -61.47 -22.06 73.52 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.608 3.539 . . . . 0.0 114.24 -169.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.56 -44.26 56.59 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.999 1.32 . . . . 0.0 111.051 169.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.6 p -68.57 -18.32 64.31 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -95.11 -11.93 27.38 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.283 1.433 . . . . 0.0 112.428 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 26.0 p -128.3 -31.63 2.29 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -169.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -57.71 -53.1 69.13 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.923 1.238 . . . . 0.0 113.877 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.61 -29.42 52.18 Favored 'Trans proline' 0 C--N 1.354 0.843 0 CA-C-N 121.418 1.542 . . . . 0.0 112.678 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -61.63 -48.94 78.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.709 0.803 . . . . 0.0 111.715 171.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -68.31 -40.75 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.694 0.679 . . . . 0.0 110.535 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.57 -44.1 89.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.701 0.682 . . . . 0.0 111.249 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.77 -55.86 22.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 112.606 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -55.29 -37.51 67.43 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.881 0.873 . . . . 0.0 112.195 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.36 -20.45 65.44 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.407 1.003 . . . . 0.0 115.158 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.4 p -74.58 -17.94 60.65 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.654 1.727 . . . . 0.0 113.165 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.62 -5.8 53.29 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.856 1.262 . . . . 0.0 112.73 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 4' ' ' ILE . 80.8 mt -70.76 -173.6 0.79 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.085 1.754 . . . . 0.0 111.361 169.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.371 1.869 . . . . 0.0 114.505 178.389 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.294 0.092 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.97 179.81 6.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.391 1.876 . . . . 0.0 111.361 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.44 134.66 47.95 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.174 1.389 . . . . 0.0 109.699 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.489 HD12 HD13 ' A' ' 26' ' ' LEU . 1.4 mt -137.03 124.76 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.26 130.63 10.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 168.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 mt -117.65 90.86 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.01 1.324 . . . . 0.0 108.331 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -89.71 146.58 24.41 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.852 0.861 . . . . 0.0 112.978 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -122.44 129.41 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.255 1.026 . . . . 0.0 111.833 -169.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -125.93 71.71 0.46 Allowed Glycine 0 N--CA 1.468 0.798 0 C-N-CA 126.615 2.055 . . . . 0.0 109.568 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 t -129.76 177.73 7.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.631 1.172 . . . . 0.0 113.787 -169.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.3 tpt -135.58 -36.88 0.77 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.153 0.981 . . . . 0.0 113.417 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -129.28 -22.68 3.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.747 1.619 . . . . 0.0 112.568 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.65 -2.55 7.0 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.7 1.143 . . . . 0.0 115.16 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -36.8 85.08 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.447 1.624 . . . . 0.0 113.084 -169.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 -31.69 37.44 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.593 1.157 . . . . 0.0 113.505 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.4 tp -59.06 -35.34 73.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.953 -1.092 . . . . 0.0 113.218 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 tp -48.32 -42.04 30.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.555 0.742 . . . . 0.0 111.707 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.26 -36.45 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.976 -0.535 . . . . 0.0 112.137 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.04 94.37 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.703 1.138 . . . . 0.0 112.415 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.38 -42.57 99.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.032 0.533 . . . . 0.0 112.102 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -60.83 -46.95 88.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.412 0.685 . . . . 0.0 112.38 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.64 84.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.179 0.592 . . . . 0.0 111.907 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.8 -45.82 70.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.136 0.575 . . . . 0.0 111.89 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.75 74.44 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.464 0.706 . . . . 0.0 112.812 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.25 -45.88 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.831 1.252 . . . . 0.0 111.973 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.489 HD13 HD12 ' A' ' 4' ' ' ILE . 52.2 mt -73.52 -40.1 64.29 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.037 0.935 . . . . 0.0 109.846 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.4 m -56.92 -46.6 81.89 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.35 1.06 . . . . 0.0 111.573 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.88 82.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.042 0.937 . . . . 0.0 113.325 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -73.44 -9.25 58.49 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 171.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.95 -6.01 34.74 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.574 1.559 . . . . 0.0 114.982 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -76.84 153.73 34.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.54 1.17 . . . . 0.0 112.184 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -80.76 130.84 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.66 150.78 46.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.336 0.654 . . . . 0.0 111.457 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.8 m -155.75 121.48 4.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.966 0.906 . . . . 0.0 109.925 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.87 150.3 7.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.194 0.521 . . . . 0.0 111.383 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -133.53 102.55 5.55 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.708 1.203 . . . . 0.0 107.985 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.88 -27.12 60.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.57 1.148 . . . . 0.0 113.855 -170.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.65 58.89 4.76 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 126.297 1.839 . . . . 0.0 110.508 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.05 163.94 37.47 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.212 3.275 . . . . 0.0 116.114 -169.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.69 170.18 15.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.449 2.3 . . . . 0.0 109.178 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -53.28 -38.85 63.44 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.809 -1.182 . . . . 0.0 113.312 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.84 -13.93 28.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -89.69 -29.41 18.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.719 1.145 . . . . 0.0 112.52 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.512 ' CH2' HG21 ' A' ' 52' ' ' VAL . 38.1 t-105 -81.82 -42.85 19.1 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 0.0 112.665 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.4 tp -47.59 -44.65 55.92 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 126.803 2.041 . . . . 0.0 114.54 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.01 -9.28 0.66 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.271 3.981 . . . . 0.0 118.129 170.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -125.22 5.21 7.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 113.173 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -57.02 -36.45 70.46 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.227 -0.921 . . . . 0.0 112.605 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.03 13.06 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.561 1.944 . . . . 0.0 114.479 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -134.43 -130.43 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.591 1.556 . . . . 0.0 111.482 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.33 158.61 44.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.895 2.078 . . . . 0.0 109.691 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.512 HG21 ' CH2' ' A' ' 44' ' ' TRP . 30.3 m -147.36 172.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 110.467 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -154.86 149.58 26.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.683 1.593 . . . . 0.0 108.86 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -137.6 139.76 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.402 -0.811 . . . . 0.0 111.143 -170.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 m -124.53 125.95 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.073 1.349 . . . . 0.0 108.257 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.7 m -150.87 158.28 43.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.041 -1.662 . . . . 0.0 113.38 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -136.14 178.61 6.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.505 1.522 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 m -121.51 135.37 55.03 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.01 1.324 . . . . 0.0 110.803 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 t -163.29 -160.08 0.58 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.613 1.965 . . . . 0.0 109.28 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.68 -69.59 0.56 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.822 2.153 . . . . 0.0 115.542 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -154.63 29.64 0.43 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.345 1.858 . . . . 0.0 110.637 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.36 40.88 6.73 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.16 -0.963 . . . . 0.0 111.682 -169.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -137.15 168.21 20.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.051 1.74 . . . . 0.0 112.41 -169.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.07 152.59 96.69 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.279 -0.888 . . . . 0.0 111.339 169.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -85.21 164.69 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.684 2.923 . . . . 0.0 112.566 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.0 -19.16 64.08 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -61.48 -19.76 62.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 tt -127.01 -8.33 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -48.42 -51.56 50.27 Favored Pre-proline 0 N--CA 1.479 1.007 0 CA-C-O 117.418 -1.277 . . . . 0.0 112.449 169.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.92 -5.18 16.56 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.362 2.041 . . . . 0.0 114.326 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 tp -92.39 -43.43 9.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.227 0.921 . . . . 0.0 109.399 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -61.46 -50.03 74.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.806 1.243 . . . . 0.0 111.387 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -62.22 -40.0 94.68 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.981 -1.074 . . . . 0.0 112.485 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.89 -44.65 55.27 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.169 0.89 . . . . 0.0 113.505 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.43 -47.45 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.098 1.449 . . . . 0.0 110.047 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -59.92 -48.61 81.0 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.581 1.153 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.85 -41.82 22.57 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.6 p -88.52 -28.34 20.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -97.13 -42.65 7.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.85 -38.12 0.5 Allowed Glycine 0 CA--C 1.542 1.777 0 C-N-CA 125.84 1.686 . . . . 0.0 115.757 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -145.01 151.58 38.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.26 2.224 . . . . 0.0 110.82 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.24 43.12 0.23 Allowed Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -57.6 -29.48 85.3 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.141 2.561 . . . . 0.0 114.649 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -68.32 -15.26 63.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.924 2.09 . . . . 0.0 115.145 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -82.27 122.63 28.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.225 1.01 . . . . 0.0 110.543 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.54 136.83 54.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 108.766 169.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -156.43 -172.29 4.02 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.2 161.37 27.62 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.127 1.346 . . . . 0.0 109.86 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.95 142.18 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.666 0.746 . . . . 0.0 111.749 -169.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mt -127.71 129.48 70.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.51 151.63 47.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.697 0.76 . . . . 0.0 110.853 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 tt -143.68 131.56 21.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.249 1.02 . . . . 0.0 109.976 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.78 -147.85 5.17 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 174.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -143.78 125.04 14.59 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.786 1.234 . . . . 0.0 110.385 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -60.16 -7.16 1.72 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -63.9 -7.87 9.49 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 171.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -126.49 136.08 52.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.42 1.488 . . . . 0.0 111.154 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.75 -36.03 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.513 1.125 . . . . 0.0 113.488 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.92 -17.11 59.88 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 23.1 t80 34.69 -118.23 0.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.443 1.897 . . . . 0.0 112.867 -169.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.19 24.69 0.52 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -46.36 -43.28 15.96 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.095 1.316 . . . . 0.0 113.883 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.55 -36.84 86.92 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-N 118.49 0.586 . . . . 0.0 113.142 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.53 -45.06 48.23 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 123.928 0.775 . . . . 0.0 113.463 170.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -58.24 -38.1 76.2 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 118.357 1.078 . . . . 0.0 113.374 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -55.89 -41.22 74.14 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.351 0.661 . . . . 0.0 112.29 172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -71.4 -26.03 62.59 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.63 -41.45 45.88 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.697 -1.252 . . . . 0.0 111.462 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.93 -40.12 72.67 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.1 tp -50.68 -34.3 26.03 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.289 1.835 . . . . 0.0 112.92 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.7 mt -103.71 -36.59 7.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.868 1.267 . . . . 0.0 111.784 -172.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -67.84 -32.39 72.89 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.9 -1.125 . . . . 0.0 113.022 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.03 -16.8 62.48 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 119.17 0.895 . . . . 0.0 111.87 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -107.04 10.14 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.06 1.744 . . . . 0.0 112.672 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m 65.71 23.95 11.55 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.308 1.443 . . . . 0.0 114.713 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.3 177.96 0.23 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 0.0 112.618 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -136.72 163.57 30.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.498 -1.377 . . . . 0.0 109.673 -173.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.0 mtm105 -133.21 147.09 52.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.11 22.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.926 1.691 . . . . 0.0 112.14 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.2 176.56 41.1 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.405 1.479 . . . . 0.0 114.556 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -88.84 162.13 16.34 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.801 1.24 . . . . 0.0 112.398 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttp -71.32 123.17 21.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.615 -0.678 . . . . 0.0 111.352 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.25 138.81 47.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.035 0.934 . . . . 0.0 110.206 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.7 mt -124.73 91.3 3.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.84 1.256 . . . . 0.0 112.129 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 38.3 mt -80.78 137.65 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.403 1.481 . . . . 0.0 110.34 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -133.07 102.81 5.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.278 1.037 . . . . 0.0 112.553 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.03 14.31 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 83.1 p -72.25 -14.68 61.84 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.57 1.077 . . . . 0.0 113.825 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.54 -7.54 1.3 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -136.91 112.14 9.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.538 1.135 . . . . 0.0 112.017 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.42 -3.62 12.63 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.68 2.92 . . . . 0.0 114.171 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -134.74 84.02 39.97 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.265 1.426 . . . . 0.0 111.78 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -46.24 -33.76 12.59 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 126.103 4.535 . . . . 0.0 116.229 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -51.08 -40.79 59.17 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.139 1.376 . . . . 0.0 112.605 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.5 p -67.26 -9.95 45.73 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -115.25 -3.45 12.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.587 1.155 . . . . 0.0 112.445 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.0 p -133.12 -27.45 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -169.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.66 -53.39 60.88 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-N 120.011 1.278 . . . . 0.0 112.752 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -68.18 -29.77 32.29 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.592 1.528 . . . . 0.0 112.694 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -60.76 -50.1 74.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.354 0.662 . . . . 0.0 111.463 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.41 -39.38 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 118.287 0.494 . . . . 0.0 110.571 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.48 -34.88 73.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.022 0.828 . . . . 0.0 112.403 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -72.51 -63.06 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.319 0.963 . . . . 0.0 111.945 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -57.38 -35.8 70.43 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.788 1.235 . . . . 0.0 113.045 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.58 -33.87 68.08 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.864 0.745 . . . . 0.0 113.905 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.8 p -69.99 -17.62 63.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.426 1.613 . . . . 0.0 113.884 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.99 -18.08 44.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.35 -32.72 73.02 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.255 1.386 0 C-N-CA 124.844 1.258 . . . . 0.0 112.364 -175.207 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.34 178.07 7.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.223 1.809 . . . . 0.0 111.862 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.03 110.54 7.03 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 108.647 -173.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mm -110.89 137.41 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -169.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.01 126.61 8.85 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.5 mt -119.62 101.12 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.493 1.117 . . . . 0.0 108.149 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -99.16 120.41 39.47 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.696 0.799 . . . . 0.0 112.481 -168.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.28 143.31 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.904 1.282 . . . . 0.0 110.768 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.84 76.43 0.31 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.064 1.316 . . . . 0.0 110.278 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 t -121.47 154.51 36.5 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.854 0.827 . . . . 0.0 112.447 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 tpt -90.45 -28.72 18.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.527 0.731 . . . . 0.0 112.548 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -146.3 -16.14 0.44 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.57 -14.56 4.74 Favored Glycine 0 CA--C 1.542 1.72 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -62.96 -42.98 99.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 120.399 2.1 . . . . 0.0 113.093 -173.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -77.84 -26.01 49.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.1 tp -58.48 -44.31 89.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.886 -1.133 . . . . 0.0 112.177 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.8 -45.33 70.74 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.687 0.676 . . . . 0.0 111.589 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.48 -38.69 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.005 0.522 . . . . 0.0 111.892 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.66 92.44 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.964 0.802 . . . . 0.0 112.885 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.82 -43.7 98.12 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.696 -0.628 . . . . 0.0 112.081 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.32 -42.34 99.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.543 -0.723 . . . . 0.0 112.311 172.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.12 90.06 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.61 -0.681 . . . . 0.0 112.034 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -55.11 -47.8 74.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.425 0.69 . . . . 0.0 111.445 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.42 84.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.736 0.814 . . . . 0.0 112.849 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.13 -45.25 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.481 1.112 . . . . 0.0 112.305 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.34 -41.8 72.74 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.547 -0.721 . . . . 0.0 109.787 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -56.64 -42.92 79.73 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.919 1.288 . . . . 0.0 112.467 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.4 -42.33 65.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.31 1.044 . . . . 0.0 113.442 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -71.07 -37.04 72.48 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.4 21.86 0.03 OUTLIER Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -133.66 -175.68 3.91 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.458 1.503 . . . . 0.0 111.155 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -120.47 144.37 48.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.389 1.476 . . . . 0.0 108.379 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.74 153.1 41.34 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.825 -0.547 . . . . 0.0 112.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.5 m -137.6 113.46 9.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.834 1.254 . . . . 0.0 109.442 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.02 147.34 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.336 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -134.79 105.07 6.27 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -75.97 -30.0 58.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.982 1.313 . . . . 0.0 114.041 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -148.68 65.1 8.2 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.489 1.916 . . . . 0.0 109.601 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.45 171.71 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.685 2.923 . . . . 0.0 114.188 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.85 169.18 16.1 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.77 2.028 . . . . 0.0 108.913 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.35 -35.31 65.07 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.671 -1.268 . . . . 0.0 112.344 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -57.53 -22.71 46.09 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -83.75 -36.74 23.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.121 0.873 . . . . 0.0 112.478 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 47.5 t-105 -70.57 -39.94 73.61 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.727 0.694 . . . . 0.0 112.034 174.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -43.25 -58.07 4.61 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 127.241 2.217 . . . . 0.0 115.273 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.17 -26.62 10.48 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.702 2.268 . . . . 0.0 114.731 -171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -74.18 -7.12 51.52 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -62.11 -30.57 71.11 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.667 -1.27 . . . . 0.0 112.694 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.71 2.64 7.79 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.309 1.444 . . . . 0.0 113.99 171.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -133.14 -120.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 127.082 2.153 . . . . 0.0 109.566 -169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -143.55 158.1 43.92 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 109.373 171.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 20.9 m -140.9 163.16 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.315 1.446 . . . . 0.0 110.718 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.19 141.87 20.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 122.225 1.012 . . . . 0.0 111.48 175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.9 t -107.81 133.22 53.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 125.563 1.545 . . . . 0.0 109.606 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.97 106.49 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.4 m -149.16 155.16 40.24 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.297 -1.502 . . . . 0.0 114.913 -168.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -113.29 -174.22 2.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.37 1.468 . . . . 0.0 112.852 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.2 m -129.23 139.86 51.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.673 1.189 . . . . 0.0 110.666 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -146.23 -166.1 2.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.106 2.162 . . . . 0.0 108.352 -174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 44.37 44.87 8.12 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 125.876 1.703 . . . . 0.0 116.36 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.438 ' H ' HM73 ' A' ' 201' ' ' FMN . 82.8 mt-30 65.02 8.23 4.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.359 2.264 . . . . 0.0 115.507 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.47 31.89 0.1 OUTLIER Glycine 0 N--CA 1.475 1.295 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -138.46 172.44 12.88 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.88 1.84 . . . . 0.0 113.194 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.1 mt -65.76 146.03 99.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.659 1.584 . . . . 0.0 112.987 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.01 155.27 19.8 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.706 2.937 . . . . 0.0 111.602 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.7 -23.86 63.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.8 m -56.85 -16.99 7.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.692 1.597 . . . . 0.0 115.153 174.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.0 tt -132.96 -4.98 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.3 t -48.88 -43.13 64.71 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.364 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 -13.95 41.02 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 CA-C-N 122.433 1.905 . . . . 0.0 114.928 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.83 -48.92 6.93 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.073 0.949 . . . . 0.0 109.017 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -59.85 -46.85 87.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.536 1.534 . . . . 0.0 113.612 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.6 -24.22 58.84 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.042 -1.037 . . . . 0.0 113.098 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.09 -52.21 4.14 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.218 0.913 . . . . 0.0 112.996 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.54 -38.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.591 1.195 . . . . 0.0 111.515 -176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -62.24 -35.43 78.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.021 1.328 . . . . 0.0 113.297 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -115.7 -32.48 5.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -82.05 -19.14 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.3 mt -127.67 -48.87 1.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.689 1.196 . . . . 0.0 112.068 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.64 -22.84 0.23 Allowed Glycine 0 CA--C 1.544 1.851 0 N-CA-C 117.932 1.933 . . . . 0.0 117.932 170.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.68 130.44 10.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.51 1.655 . . . . 0.0 111.704 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -163.29 66.97 1.64 Allowed Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.881 1.272 . . . . 0.0 112.895 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.3 -23.18 66.04 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.937 2.425 . . . . 0.0 114.649 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -72.53 -5.48 37.29 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -76.52 133.79 39.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.199 1.0 . . . . 0.0 111.778 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.56 145.01 51.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.732 1.613 . . . . 0.0 110.617 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -162.35 -170.9 2.6 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.11 165.02 33.61 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.869 2.176 . . . . 0.0 110.727 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 t -142.07 136.94 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.125 0.963 . . . . 0.0 112.259 -170.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -123.15 116.66 49.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -112.05 149.32 32.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.339 1.056 . . . . 0.0 110.571 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -138.36 149.77 45.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.267 1.027 . . . . 0.0 111.672 -170.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.03 -143.57 7.75 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.083 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -141.3 126.08 18.05 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.209 1.404 . . . . 0.0 110.262 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -66.02 -12.88 58.29 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -68.61 0.01 4.66 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -125.25 12.73 8.24 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.46 1.504 . . . . 0.0 114.479 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t 70.37 -44.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 127.9 2.48 . . . . 0.0 115.205 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -76.24 48.33 0.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.027 1.285 . . . . 0.0 111.764 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -56.18 116.84 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.302 -1.499 . . . . 0.0 112.303 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.1 m 51.05 24.35 1.86 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.851 2.06 . . . . 0.0 116.498 -172.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -62.33 -15.49 48.53 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.693 -1.254 . . . . 0.0 113.559 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.18 -67.93 1.81 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.7 -36.09 77.22 Favored Glycine 0 CA--C 1.536 1.401 0 O-C-N 121.557 -0.966 . . . . 0.0 114.258 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.27 -38.32 76.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.295 1.047 . . . . 0.0 113.652 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.92 -34.68 78.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.63 0.65 . . . . 0.0 112.189 173.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -73.67 -29.88 62.58 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.124 0.874 . . . . 0.0 112.78 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.3 -46.02 74.8 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.098 -1.626 . . . . 0.0 110.395 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -35.8 72.42 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -49.15 -44.16 42.42 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.936 1.294 . . . . 0.0 111.445 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.1 mt -80.52 -31.92 36.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.254 0.622 . . . . 0.0 111.69 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -65.77 -32.75 74.47 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.854 -1.154 . . . . 0.0 112.01 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -61.75 -26.18 67.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 118.885 0.766 . . . . 0.0 112.175 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -82.17 -27.1 32.87 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.598 -0.689 . . . . 0.0 112.471 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.9 m 101.61 16.56 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 130.161 3.384 . . . . 0.0 112.635 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 156.97 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.54 1.136 . . . . 0.0 113.625 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -123.93 88.07 2.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.902 1.681 . . . . 0.0 110.318 -169.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 -63.04 140.3 58.86 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.32 -0.863 . . . . 0.0 111.401 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.43 33.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.303 1.441 . . . . 0.0 111.702 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.96 -160.64 34.16 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.895 -1.128 . . . . 0.0 113.607 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -125.06 148.27 48.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.617 1.567 . . . . 0.0 111.179 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.3 ttp -69.67 124.56 24.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 112.189 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.45 140.72 39.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.072 0.949 . . . . 0.0 110.188 175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.41 89.74 3.01 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.091 1.356 . . . . 0.0 111.534 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -76.87 133.96 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.611 1.564 . . . . 0.0 110.857 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -127.12 98.64 5.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.219 1.009 . . . . 0.0 113.219 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -15.31 9.79 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.0 p -73.45 -13.91 61.15 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.904 1.229 . . . . 0.0 113.822 174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.02 -8.26 1.19 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -135.34 110.58 10.62 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.225 1.01 . . . . 0.0 112.185 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.92 -2.45 12.43 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.017 3.144 . . . . 0.0 114.481 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -129.9 80.59 70.98 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.671 1.588 . . . . 0.0 111.877 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -43.83 -36.49 7.92 Favored 'Trans proline' 0 C--N 1.354 0.866 1 C-N-CA 125.654 4.236 . . . . 0.0 116.057 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.36 -45.87 36.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.426 1.89 . . . . 0.0 112.954 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 62.0 p -68.76 -18.09 64.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.14 -9.31 20.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.944 0.897 . . . . 0.0 112.506 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.4 m -116.02 -33.02 5.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -58.15 -51.53 81.08 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.396 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.99 -28.7 57.66 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.625 1.55 . . . . 0.0 112.723 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -61.74 -49.8 74.96 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.616 0.644 . . . . 0.0 111.68 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 t -68.27 -40.78 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.868 0.758 . . . . 0.0 110.367 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.6 -30.09 70.46 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -76.44 -57.94 3.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.274 1.03 . . . . 0.0 112.222 170.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -51.82 -47.44 64.32 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.831 1.252 . . . . 0.0 111.427 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.36 -27.48 11.66 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.659 1.6 . . . . 0.0 115.905 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.0 p -70.52 -15.58 62.8 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.888 1.844 . . . . 0.0 113.961 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.7 mt -98.94 -15.85 18.98 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.395 1.478 . . . . 0.0 113.192 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.7 157.63 14.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.269 2.227 . . . . 0.0 111.757 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.885 1.274 . . . . 0.0 113.536 174.076 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.438 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.396 0.141 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.24 -177.53 4.56 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.14 1.776 . . . . 0.0 112.416 -170.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -118.36 122.65 43.37 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.509 1.524 . . . . 0.0 108.732 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 mm -120.41 122.91 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.144 0.978 . . . . 0.0 112.367 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.59 128.77 9.17 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 168.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.46 91.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.276 1.038 . . . . 0.0 108.937 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -93.02 148.21 22.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.549 1.139 . . . . 0.0 112.448 -169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.11 143.87 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.55 0.74 . . . . 0.0 111.006 -170.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.47 108.37 0.64 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 172.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -150.51 165.92 31.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.256 1.022 . . . . 0.0 112.08 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -110.15 -19.58 12.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.512 1.125 . . . . 0.0 113.174 171.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -143.78 -13.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -173.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.69 11.02 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.02 -44.71 97.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.35 2.075 . . . . 0.0 112.986 -174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 p -75.95 -30.25 58.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.644 0.778 . . . . 0.0 112.803 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.14 -39.25 85.67 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.907 -1.121 . . . . 0.0 113.408 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.89 -45.43 71.09 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.659 0.663 . . . . 0.0 110.899 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.66 -34.46 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.26 0.624 . . . . 0.0 112.104 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.37 94.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.351 0.978 . . . . 0.0 112.831 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.0 -41.69 98.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.584 0.754 . . . . 0.0 111.611 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.0 -48.07 83.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.294 0.638 . . . . 0.0 111.799 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.91 91.09 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.454 0.702 . . . . 0.0 112.844 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -57.67 -46.86 83.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.748 0.419 . . . . 0.0 111.512 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.98 81.8 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.763 0.825 . . . . 0.0 112.369 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -58.1 -45.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.745 1.218 . . . . 0.0 112.201 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 mt -73.08 -40.1 65.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.556 0.616 . . . . 0.0 110.25 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 95.5 m -56.71 -46.78 81.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.662 1.185 . . . . 0.0 111.808 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.63 80.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.135 0.974 . . . . 0.0 113.009 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -63.74 -34.38 77.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.121 0.968 . . . . 0.0 111.756 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.14 -6.86 5.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.213 1.387 . . . . 0.0 114.652 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.36 150.62 38.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.636 1.174 . . . . 0.0 111.73 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -76.49 130.25 37.68 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.62 142.48 31.06 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.428 0.558 . . . . 0.0 111.913 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.0 m -141.0 115.63 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.971 0.908 . . . . 0.0 109.809 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.53 146.76 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.75 0.82 . . . . 0.0 111.895 173.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -135.18 96.13 3.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.151 1.781 . . . . 0.0 108.485 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -72.43 -27.48 62.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.309 1.444 . . . . 0.0 114.61 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -144.74 64.62 11.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.849 2.059 . . . . 0.0 108.524 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.44 162.02 43.65 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.363 3.376 . . . . 0.0 116.248 -168.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.93 163.7 29.67 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.058 2.543 . . . . 0.0 108.274 169.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.89 -45.01 15.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.955 -1.091 . . . . 0.0 112.568 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m -56.68 -20.1 19.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -81.18 -34.62 32.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.378 0.99 . . . . 0.0 112.313 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.5 ' CH2' HG21 ' A' ' 52' ' ' VAL . 14.3 t-105 -79.41 -32.29 42.9 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.596 1.558 . . . . 0.0 112.771 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.3 tp -39.87 -45.85 4.59 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 128.793 2.837 . . . . 0.0 116.167 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -77.58 -18.41 13.68 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.583 2.188 . . . . 0.0 115.354 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.88 -6.09 57.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -57.32 -23.8 51.0 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -102.47 13.81 33.59 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.132 1.373 . . . . 0.0 112.938 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -138.51 -131.55 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.652 1.981 . . . . 0.0 109.651 -169.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -135.31 151.51 50.61 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.237 1.015 . . . . 0.0 111.166 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.5 HG21 ' CH2' ' A' ' 44' ' ' TRP . 27.6 m -147.85 165.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.723 1.209 . . . . 0.0 111.012 -174.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.65 149.72 24.05 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.88 0.872 . . . . 0.0 109.563 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.14 143.23 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.205 0.602 . . . . 0.0 110.842 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.29 109.45 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.585 0.707 . . . . 0.0 110.298 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.4 m -138.17 144.53 40.77 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -168.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 m -95.96 -168.82 1.82 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.677 1.591 . . . . 0.0 112.587 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.9 m -128.5 149.71 50.48 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.88 1.272 . . . . 0.0 110.62 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.0 p -141.92 -171.59 3.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.798 2.439 . . . . 0.0 108.561 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.36 25.92 1.38 Allowed Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.229 1.871 . . . . 0.0 117.466 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 55.11 18.06 2.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.772 2.029 . . . . 0.0 114.295 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 158.52 36.2 0.02 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.633 1.111 . . . . 0.0 115.302 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -137.52 169.51 17.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.321 1.448 . . . . 0.0 112.971 -169.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.47 139.86 55.57 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 127.185 2.194 . . . . 0.0 111.808 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.72 141.38 49.52 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.135 2.556 . . . . 0.0 110.014 170.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -57.17 -30.18 64.28 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -169.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -61.49 -13.35 20.17 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -121.75 -7.65 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.145 1.338 . . . . 0.0 113.896 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.6 t -50.7 -48.47 82.85 Favored Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.62 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.5 5.27 2.46 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.11 2.54 . . . . 0.0 114.749 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.4 tp -107.55 -47.34 3.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.663 1.185 . . . . 0.0 109.795 170.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.43 -53.71 55.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.352 1.061 . . . . 0.0 112.016 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -63.91 -37.06 86.02 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.682 -0.636 . . . . 0.0 111.844 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.81 -46.23 76.66 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.712 0.672 . . . . 0.0 113.281 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.57 -42.01 94.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.666 1.233 . . . . 0.0 110.57 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -63.81 -51.28 65.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.683 0.793 . . . . 0.0 112.987 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.93 -25.17 24.52 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.5 m -125.15 -0.37 7.78 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -119.09 -52.52 2.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.521 1.055 . . . . 0.0 110.256 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.23 -23.8 0.2 Allowed Glycine 0 CA--C 1.542 1.769 0 N-CA-C 118.135 2.014 . . . . 0.0 118.135 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -151.98 139.76 19.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.041 1.736 . . . . 0.0 110.064 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.03 50.79 0.54 Allowed Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -66.03 -18.9 57.62 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.249 2.633 . . . . 0.0 114.592 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -77.53 -17.21 58.15 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -76.8 138.16 39.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.42 1.088 . . . . 0.0 112.663 -169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -129.15 145.9 51.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.932 1.693 . . . . 0.0 110.792 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -159.3 -174.9 4.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -169.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.77 154.97 25.87 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 127.357 2.408 . . . . 0.0 110.299 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.77 128.85 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.771 1.286 . . . . 0.0 111.169 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -105.6 143.56 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.93 48.72 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.036 -1.04 . . . . 0.0 110.343 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.3 tt -139.57 153.37 47.4 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.19 0.995 . . . . 0.0 111.339 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.69 -140.82 6.04 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.206 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -143.38 129.28 19.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.257 1.023 . . . . 0.0 111.196 -173.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.8 m -62.59 -7.0 3.96 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 m -67.2 0.34 2.82 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.05 156.09 48.85 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.535 1.534 . . . . 0.0 112.421 -170.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.46 -39.52 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.032 0.933 . . . . 0.0 111.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -78.08 44.85 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.209 1.404 . . . . 0.0 112.785 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -52.36 116.56 2.31 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.313 -1.492 . . . . 0.0 112.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 86.1 m 51.18 24.67 2.08 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.72 2.408 . . . . 0.0 117.219 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.45 -28.5 69.32 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.536 -1.353 . . . . 0.0 113.794 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.55 -35.81 91.66 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 118.912 0.778 . . . . 0.0 113.39 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.08 -34.17 27.45 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.276 -1.132 . . . . 0.0 113.297 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -60.64 -37.74 82.51 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.581 1.191 . . . . 0.0 112.636 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -57.36 -45.6 84.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.319 0.648 . . . . 0.0 111.407 169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -68.0 -34.74 77.1 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.265 0.939 . . . . 0.0 112.952 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.94 -44.21 97.25 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 111.778 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.91 69.39 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.5 tp -53.92 -20.71 6.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.374 1.469 . . . . 0.0 113.233 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 mt -107.08 -37.7 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.788 1.235 . . . . 0.0 111.22 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.78 -30.5 71.16 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.189 0.904 . . . . 0.0 111.26 169.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -51.83 -30.79 24.91 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.617 1.567 . . . . 0.0 112.131 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -116.97 17.72 14.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.395 1.478 . . . . 0.0 113.014 -169.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.3 t 65.58 16.0 10.3 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.602 1.961 . . . . 0.0 115.292 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.8 150.06 49.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.239 -0.913 . . . . 0.0 111.982 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -109.96 110.39 21.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.008 0.923 . . . . 0.0 111.23 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.7 ttm105 -73.1 126.23 29.53 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.054 -1.029 . . . . 0.0 110.853 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -84.44 34.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.176 1.39 . . . . 0.0 111.906 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.3 -171.47 43.1 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.682 1.611 . . . . 0.0 112.468 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -114.66 158.93 21.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.636 1.575 . . . . 0.0 111.375 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.3 mtp -61.85 159.12 14.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -127.85 127.47 43.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.413 1.085 . . . . 0.0 108.632 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.12 94.44 4.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.247 1.019 . . . . 0.0 111.669 -169.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.5 mt -81.01 141.24 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.058 1.743 . . . . 0.0 112.154 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -124.92 103.9 8.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.877 1.271 . . . . 0.0 113.062 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -18.96 47.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.195 1.398 . . . . 0.0 114.403 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.3 p -80.6 -5.63 57.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.581 1.082 . . . . 0.0 113.56 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -129.13 -24.89 2.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.131 1.372 . . . . 0.0 112.848 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.48 110.44 7.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.876 0.871 . . . . 0.0 113.27 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.65 -1.92 10.76 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 124.061 3.174 . . . . 0.0 114.159 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -131.41 70.1 81.81 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 126.204 1.802 . . . . 0.0 109.291 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.06 -16.5 39.76 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.841 3.694 . . . . 0.0 117.262 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -57.55 -32.34 67.01 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.988 -1.07 . . . . 0.0 113.217 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 67.8 p -66.18 -6.28 13.0 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -118.91 -0.52 11.17 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.718 1.207 . . . . 0.0 112.741 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.52 -26.05 1.12 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.29 -54.31 46.39 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.485 1.039 . . . . 0.0 113.067 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.26 -31.77 34.8 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 121.256 1.484 . . . . 0.0 112.852 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -60.52 -49.51 77.28 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.397 0.679 . . . . 0.0 111.669 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.19 -36.51 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.715 -0.616 . . . . 0.0 110.451 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.71 -44.31 96.73 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.236 0.926 . . . . 0.0 112.753 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.46 -36.09 58.08 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.995 1.27 . . . . 0.0 113.361 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -57.35 -43.79 83.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.74 1.155 . . . . 0.0 110.437 170.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.76 -13.53 25.55 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.864 -1.52 . . . . 0.0 116.131 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.7 p -107.05 -11.98 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.612 2.206 . . . . 0.0 113.183 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.12 -30.75 31.0 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.22 1.008 . . . . 0.0 111.378 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.23 152.57 20.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.362 1.465 . . . . 0.0 112.566 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.167 2.187 . . . . 0.0 114.006 -179.552 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.11 -175.61 3.22 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.948 1.699 . . . . 0.0 112.084 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -135.28 119.05 17.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.976 1.311 . . . . 0.0 109.754 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 mm -118.34 124.96 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.744 0.818 . . . . 0.0 112.825 -171.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.18 126.4 7.82 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 107.466 -2.253 . . . . 0.0 107.466 168.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.7 mt -117.54 90.97 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.438 1.095 . . . . 0.0 108.411 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -91.3 144.19 25.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.004 -169.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.4 141.54 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 C-N-CA 124.054 0.942 . . . . 0.0 110.54 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.94 91.22 0.21 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.5 t -142.88 164.16 30.85 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.559 1.144 . . . . 0.0 113.155 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.6 mmm -125.77 0.83 7.43 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.531 1.532 . . . . 0.0 112.888 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -140.25 -37.3 0.47 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.32 -5.52 10.16 Favored Glycine 0 N--CA 1.479 1.52 0 N-CA-C 115.975 1.15 . . . . 0.0 115.975 170.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -63.15 -42.83 99.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.528 1.164 . . . . 0.0 111.481 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -39.53 86.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.061 . . . . 0.0 112.515 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 tp -59.72 -39.23 83.97 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.8 tp -49.34 -41.69 39.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.991 0.917 . . . . 0.0 112.177 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.6 -39.93 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 123.249 0.619 . . . . 0.0 112.045 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -41.07 96.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.075 0.852 . . . . 0.0 112.434 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.92 -42.06 97.37 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.35 0.66 . . . . 0.0 112.273 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.49 -43.25 85.89 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.467 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.24 92.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.702 0.801 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.64 -47.84 78.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.368 0.667 . . . . 0.0 111.529 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.77 92.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.71 0.804 . . . . 0.0 112.62 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.58 -47.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.28 . . . . 0.0 112.187 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 mt -70.32 -41.34 73.39 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.242 0.617 . . . . 0.0 109.884 -175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -56.73 -46.02 81.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.1 1.36 . . . . 0.0 112.24 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.79 90.14 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.169 0.987 . . . . 0.0 112.87 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.59 -32.24 71.99 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.48 4.82 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.26 1.41 . . . . 0.0 114.983 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.95 146.72 35.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.149 1.379 . . . . 0.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -72.94 138.58 46.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.18 149.6 35.25 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.74 -0.6 . . . . 0.0 112.455 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 36.7 m -144.51 116.25 8.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.238 1.015 . . . . 0.0 110.656 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.47 140.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.106 0.562 . . . . 0.0 110.173 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.76 96.91 4.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.384 1.474 . . . . 0.0 107.899 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.4 -29.81 65.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.768 1.627 . . . . 0.0 114.265 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -146.31 64.53 9.79 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 126.862 2.065 . . . . 0.0 108.734 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.91 163.75 37.84 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.007 3.138 . . . . 0.0 115.727 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.97 160.67 36.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.339 2.256 . . . . 0.0 108.798 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -32.73 -54.04 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.765 2.026 . . . . 0.0 113.691 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -63.04 -21.63 66.3 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.493 1.517 . . . . 0.0 114.411 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -74.68 -36.14 62.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.222 0.919 . . . . 0.0 111.625 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.443 ' CH2' HG21 ' A' ' 52' ' ' VAL . 20.1 t-105 -79.46 -38.52 34.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 112.904 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.1 tp -38.39 -45.84 2.66 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 128.112 2.565 . . . . 0.0 116.784 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.64 -26.04 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 CA-C-N 122.543 1.944 . . . . 0.0 115.133 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -71.91 -8.8 56.51 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -56.49 -26.29 53.89 Favored 'General case' 0 CA--C 1.55 0.964 0 O-C-N 120.959 -1.088 . . . . 0.0 113.791 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.73 -8.05 57.4 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.324 1.449 . . . . 0.0 113.749 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -133.25 -128.61 0.17 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.958 2.103 . . . . 0.0 110.02 -168.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -136.88 160.55 38.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.983 1.713 . . . . 0.0 111.277 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' CH2' ' A' ' 44' ' ' TRP . 33.6 m -144.08 170.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.878 1.271 . . . . 0.0 111.052 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -159.16 148.35 18.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.446 1.898 . . . . 0.0 108.174 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.34 142.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.684 -0.635 . . . . 0.0 112.048 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.6 116.2 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.097 0.959 . . . . 0.0 111.529 169.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.9 m -141.88 153.39 44.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 0.0 111.929 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 p -138.7 145.8 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -70.64 146.11 50.21 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.477 1.911 . . . . 0.0 114.654 -174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 p -146.13 -165.27 2.17 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.469 2.308 . . . . 0.0 111.375 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 42.76 -99.68 0.01 OUTLIER Glycine 0 CA--C 1.541 1.705 0 C-N-CA 127.545 2.498 . . . . 0.0 116.599 176.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -129.46 36.22 4.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.965 1.306 . . . . 0.0 110.111 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.24 20.96 7.94 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 124.066 0.841 . . . . 0.0 113.712 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -96.06 164.89 12.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.342 1.857 . . . . 0.0 115.169 -169.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.59 139.74 96.15 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.734 2.013 . . . . 0.0 110.255 169.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.64 144.59 35.8 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.689 2.926 . . . . 0.0 110.939 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.92 -22.39 64.31 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.5 p -63.3 -16.58 60.77 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.1 tt -124.89 -8.94 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.3 t -49.69 -48.12 77.44 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.8 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.12 5.89 1.65 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.24 2.626 . . . . 0.0 114.817 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 tp -111.48 -44.98 3.44 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.02 1.328 . . . . 0.0 110.324 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.73 -51.36 70.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.143 0.977 . . . . 0.0 111.679 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -62.87 -41.14 99.28 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 111.859 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.36 -42.89 93.71 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.756 0.693 . . . . 0.0 113.772 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.31 -46.08 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -62.75 -40.77 98.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.54 -25.25 16.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.7 m -125.56 -31.47 2.98 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.84 -43.77 62.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.255 1.389 . . . . 0.0 109.391 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.49 -42.18 0.67 Allowed Glycine 0 CA--C 1.54 1.608 0 C-N-CA 126.641 2.067 . . . . 0.0 116.679 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -155.14 143.26 20.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.116 1.767 . . . . 0.0 109.703 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -146.22 47.62 0.64 Allowed Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -60.86 -29.88 89.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.139 2.559 . . . . 0.0 113.799 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -65.87 -22.76 66.55 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.407 1.883 . . . . 0.0 114.615 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.8 tp -73.43 138.68 45.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.933 0.788 . . . . 0.0 111.574 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -134.8 132.74 39.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.493 1.917 . . . . 0.0 108.682 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -154.59 -171.56 3.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -172.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.59 164.18 30.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.974 1.75 . . . . 0.0 109.513 169.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 146.69 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 122.497 1.142 . . . . 0.0 113.533 -169.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.4 mt -129.83 141.66 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 125.82 1.648 . . . . 0.0 106.56 169.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.44 156.36 48.7 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -144.38 149.18 35.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 110.858 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.69 -151.0 9.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 123.654 0.645 . . . . 0.0 111.644 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -137.99 117.35 12.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.999 1.32 . . . . 0.0 109.876 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -59.62 -7.8 1.68 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.995 1.318 . . . . 0.0 114.505 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.0 m -61.32 -10.27 6.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.151 1.38 . . . . 0.0 114.157 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -127.21 137.02 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.481 1.512 . . . . 0.0 111.426 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.57 -26.17 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -169.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -81.4 -18.49 45.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.316 0.962 . . . . 0.0 113.285 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.9 t80 38.93 -131.78 0.19 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.748 1.619 . . . . 0.0 112.451 -169.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.4 m -73.58 23.56 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -53.61 -30.42 42.5 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.142 -1.598 . . . . 0.0 114.495 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.1 -35.89 92.56 Favored Glycine 0 CA--C 1.533 1.156 0 O-C-N 121.125 -0.984 . . . . 0.0 113.111 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.32 -40.54 11.13 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.825 -0.809 . . . . 0.0 113.316 173.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -59.67 -31.9 69.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 118.67 1.235 . . . . 0.0 113.781 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -58.47 -39.53 80.21 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.16 -27.35 63.48 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.303 0.956 . . . . 0.0 113.33 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.64 -49.66 65.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.766 -1.209 . . . . 0.0 110.053 169.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.31 -40.45 71.15 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.8 tp -49.89 -27.7 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.82 1.648 . . . . 0.0 113.644 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.6 mt -112.1 -36.67 5.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.609 1.163 . . . . 0.0 111.808 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.76 -31.24 71.75 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.169 -0.957 . . . . 0.0 113.209 170.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -66.25 -14.64 62.27 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 119.419 1.009 . . . . 0.0 112.528 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -111.81 16.84 20.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.641 1.976 . . . . 0.0 111.849 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.2 t 61.97 20.41 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.332 1.853 . . . . 0.0 115.263 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.48 161.07 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.842 0.746 . . . . 0.0 112.972 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -112.09 162.71 15.12 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.769 1.628 . . . . 0.0 108.645 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 mtm105 -133.88 149.05 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.85 21.96 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.304 -1.771 . . . . 0.0 111.986 172.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.85 -172.35 45.2 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.529 1.538 . . . . 0.0 113.598 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.68 156.26 44.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.282 1.433 . . . . 0.0 111.411 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.85 120.91 14.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.85 0.86 . . . . 0.0 112.098 -170.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.07 135.94 35.88 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.527 1.131 . . . . 0.0 110.074 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.58 96.03 4.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.704 1.202 . . . . 0.0 111.915 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.2 mt -82.01 141.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.236 1.415 . . . . 0.0 111.137 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -129.49 116.73 19.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.907 1.283 . . . . 0.0 111.751 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.78 -26.87 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.618 1.167 . . . . 0.0 113.87 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.9 m -81.62 4.78 20.35 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -128.51 -30.18 2.36 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.371 1.468 . . . . 0.0 112.449 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -143.1 118.48 6.45 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 124.619 1.168 . . . . 0.0 112.278 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.32 -6.2 13.72 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.86 3.04 . . . . 0.0 114.498 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.98 80.58 64.58 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.529 1.532 . . . . 0.0 111.198 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.97 -35.04 9.65 Favored 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.712 4.275 . . . . 0.0 116.711 -175.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.67 -38.47 64.2 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.6 p -69.46 -6.14 28.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -116.38 -3.55 11.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.001 1.321 . . . . 0.0 112.554 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 p -132.95 -27.82 1.61 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -170.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -55.44 -54.09 54.92 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.254 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.5 -29.37 53.13 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.598 1.532 . . . . 0.0 112.756 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -62.49 -49.15 76.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.387 0.675 . . . . 0.0 111.442 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.89 -41.04 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.816 0.735 . . . . 0.0 110.506 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -59.03 -45.21 91.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.462 0.573 . . . . 0.0 111.541 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -61.96 -56.05 23.1 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.087 0.955 . . . . 0.0 112.138 173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.38 -49.04 65.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.76 1.224 . . . . 0.0 111.172 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.96 -21.83 32.39 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.582 1.563 . . . . 0.0 116.165 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -70.53 -17.42 62.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.491 2.146 . . . . 0.0 113.737 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.47 -14.43 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.251 1.42 . . . . 0.0 113.578 -170.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.2 157.67 18.79 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.412 1.885 . . . . 0.0 112.367 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.899 1.28 . . . . 0.0 113.651 177.437 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.0 -177.83 4.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.843 1.657 . . . . 0.0 112.277 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -135.14 119.37 17.72 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.618 1.567 . . . . 0.0 109.13 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mm -119.08 125.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.871 0.868 . . . . 0.0 113.267 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.6 128.6 8.97 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 mt -118.31 91.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.541 1.136 . . . . 0.0 108.519 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -90.93 139.1 31.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.274 1.029 . . . . 0.0 111.698 -169.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -125.47 144.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.713 0.768 . . . . 0.0 111.502 -169.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 105.88 0.54 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 t -155.9 161.45 40.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.385 1.474 . . . . 0.0 113.153 -173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 76.5 mmm -122.96 -9.28 8.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.438 1.495 . . . . 0.0 112.397 170.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -138.99 0.18 1.93 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.5 -4.39 83.95 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.117 1.607 . . . . 0.0 117.117 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -64.62 -42.87 95.21 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.475 1.637 . . . . 0.0 113.097 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 p -75.46 -33.9 60.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.085 0.954 . . . . 0.0 112.385 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 tp -58.43 -38.76 78.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.995 -1.065 . . . . 0.0 112.771 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.7 tp -53.88 -45.68 71.13 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.759 0.709 . . . . 0.0 111.71 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.21 -36.9 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 122.77 0.428 . . . . 0.0 111.545 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.41 -42.41 92.57 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.261 0.937 . . . . 0.0 112.968 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.45 -41.76 97.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.356 0.662 . . . . 0.0 112.184 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -64.06 -41.72 97.25 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.648 -0.657 . . . . 0.0 112.562 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.8 94.98 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.528 -0.732 . . . . 0.0 112.061 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.81 -46.83 77.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.677 0.791 . . . . 0.0 111.825 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.48 95.53 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.742 0.817 . . . . 0.0 112.77 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.95 -43.19 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.547 1.139 . . . . 0.0 112.262 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.7 mt -70.27 -38.71 75.15 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.21 -0.932 . . . . 0.0 109.614 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -57.64 -45.47 85.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.251 1.021 . . . . 0.0 111.516 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.14 83.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.991 0.916 . . . . 0.0 113.296 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -69.8 -10.48 58.58 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.29 41.43 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.574 1.559 . . . . 0.0 114.729 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -73.03 175.36 6.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.289 1.435 . . . . 0.0 111.894 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -111.62 145.51 39.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.812 1.245 . . . . 0.0 109.622 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.88 162.67 38.81 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.2 m -153.31 120.36 5.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.111 0.964 . . . . 0.0 110.948 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.3 141.16 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.906 0.882 . . . . 0.0 110.924 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -126.67 111.12 13.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.221 1.408 . . . . 0.0 109.789 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 -16.46 23.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.461 1.504 . . . . 0.0 114.945 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -142.43 55.9 4.82 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.22 1.408 . . . . 0.0 111.068 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.37 163.15 39.81 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.977 3.118 . . . . 0.0 113.517 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -143.34 -44.13 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.84 -44.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.273 1.029 . . . . 0.0 113.105 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.1 m -58.76 -28.79 66.24 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.923 0.868 . . . . 0.0 112.257 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -54.83 40.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.948 2.899 . . . . 0.0 112.461 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -68.62 -40.89 80.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.572 1.549 . . . . 0.0 113.748 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -37.97 -56.45 1.94 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.672 2.389 . . . . 0.0 115.28 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.54 -18.72 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.594 2.196 . . . . 0.0 114.867 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.58 -5.95 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -54.88 -30.58 58.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.343 0.974 . . . . 0.0 113.158 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -86.23 4.21 39.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.378 1.471 . . . . 0.0 113.492 175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -136.33 -136.27 0.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.438 1.895 . . . . 0.0 110.997 -169.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -130.1 160.47 33.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 110.642 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.89 169.55 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.303 1.441 . . . . 0.0 110.367 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.55 147.46 18.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 109.932 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.8 t -116.38 131.14 69.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.197 1.399 . . . . 0.0 109.561 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.07 86.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.5 m -126.52 164.17 21.77 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -167.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -129.34 -172.33 2.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.748 1.219 . . . . 0.0 113.216 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.3 m -136.61 132.08 34.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.652 1.181 . . . . 0.0 110.519 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.5 t -158.71 -166.58 1.92 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.396 1.478 . . . . 0.0 110.33 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.01 -65.4 0.2 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.825 2.631 . . . . 0.0 116.474 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -147.42 22.22 1.17 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.034 2.134 . . . . 0.0 111.523 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.21 44.36 6.66 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 -169.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -139.53 -179.52 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.283 1.433 . . . . 0.0 114.475 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.5 mt -53.46 125.71 44.93 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 126.783 2.033 . . . . 0.0 112.681 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.51 142.72 98.3 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.681 3.587 . . . . 0.0 112.136 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.12 -20.14 65.76 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.6 p -66.07 -11.55 49.31 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.76 1.624 . . . . 0.0 114.959 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.3 tt -131.58 -13.85 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -44.81 -49.33 28.05 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 117.449 -1.263 . . . . 0.0 112.995 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.37 -24.96 42.54 Favored 'Trans proline' 0 C--N 1.353 0.769 0 CA-C-N 122.155 1.805 . . . . 0.0 113.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.3 tp -75.86 -43.03 47.68 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.835 0.743 . . . . 0.0 110.062 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.86 -46.48 90.42 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.294 1.038 . . . . 0.0 111.091 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -63.7 -43.27 97.12 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.712 -1.243 . . . . 0.0 112.543 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.48 -50.18 66.95 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 124.688 1.137 . . . . 0.0 112.74 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.02 -46.42 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.567 1.183 . . . . 0.0 110.265 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.07 -46.72 84.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.636 1.174 . . . . 0.0 112.751 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.09 -33.51 20.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -98.59 -30.97 12.18 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.94 -32.96 11.4 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.232 0.924 . . . . 0.0 113.279 -170.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.14 -51.77 1.0 Allowed Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.39 1.947 . . . . 0.0 117.007 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -159.86 140.96 12.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 -173.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -156.19 104.94 2.06 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.5 1.52 . . . . 0.0 110.298 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.1 -15.45 9.14 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.307 2.671 . . . . 0.0 116.074 -169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -124.35 1.8 8.41 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.8 tp -69.49 137.56 52.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.562 0.745 . . . . 0.0 109.811 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -128.93 143.71 50.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.592 1.557 . . . . 0.0 110.748 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.33 -170.6 2.87 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -168.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.31 162.55 31.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 127.41 2.433 . . . . 0.0 109.914 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.7 t -139.87 136.82 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.061 0.934 . . . . 0.0 112.238 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.8 mt -123.18 125.08 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.2 148.98 42.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.717 1.207 . . . . 0.0 109.598 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.07 146.42 35.44 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.598 0.759 . . . . 0.0 111.687 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.44 -137.45 3.95 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.018 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 131.99 28.17 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.726 0.811 . . . . 0.0 112.091 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.4 t -64.44 -10.86 27.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.921 1.689 . . . . 0.0 114.869 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -69.41 5.4 1.35 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -131.69 154.77 48.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.664 1.585 . . . . 0.0 112.833 -171.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.65 -6.84 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.789 1.636 . . . . 0.0 114.835 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -125.86 44.8 2.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.731 2.012 . . . . 0.0 110.945 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -49.48 115.29 1.28 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.095 -1.628 . . . . 0.0 112.17 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 77.9 m 53.33 23.39 3.25 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -172.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -58.23 -27.24 63.77 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.31 -44.82 63.59 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 120.62 -1.3 . . . . 0.0 111.912 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.66 70.7 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.43 -1.041 . . . . 0.0 113.127 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.38 -41.96 90.56 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 117.821 0.81 . . . . 0.0 112.858 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -60.04 -41.39 92.18 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.184 0.447 . . . . 0.0 112.147 171.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -69.5 -28.49 66.1 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.67 -46.06 66.95 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 119.807 -1.808 . . . . 0.0 110.807 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.88 68.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.7 tp -49.66 -31.07 10.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.019 1.728 . . . . 0.0 113.124 173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.6 mt -102.1 -36.97 8.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.561 1.144 . . . . 0.0 111.399 -171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -66.27 -31.16 71.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.53 -0.731 . . . . 0.0 112.826 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -65.65 -15.97 63.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.374 1.07 . . . . 0.0 112.942 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -113.26 -9.67 13.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.9 t 98.75 15.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.229 2.611 . . . . 0.0 113.922 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.83 161.17 8.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.222 0.465 . . . . 0.0 110.716 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.61 100.14 5.42 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 120.838 -1.164 . . . . 0.0 110.566 -171.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 ttm105 -66.93 135.7 54.23 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.407 -0.808 . . . . 0.0 110.83 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.08 34.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 111.318 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.51 -166.61 39.83 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 120.776 -1.202 . . . . 0.0 113.75 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.19 145.61 42.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.448 1.499 . . . . 0.0 111.974 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.16 118.08 10.82 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.149 0.979 . . . . 0.0 111.705 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.79 136.06 38.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.939 0.896 . . . . 0.0 109.881 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.6 mt -120.65 95.85 4.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.774 1.229 . . . . 0.0 111.775 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.7 mt -81.4 134.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.242 1.417 . . . . 0.0 111.226 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -123.94 112.29 17.05 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.389 1.475 . . . . 0.0 111.477 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.94 -23.7 54.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.0 m -82.83 2.11 35.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.446 1.098 . . . . 0.0 113.893 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -127.11 -27.29 3.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.417 1.487 . . . . 0.0 112.664 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.94 115.28 6.59 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.582 1.153 . . . . 0.0 112.097 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.81 -5.29 14.59 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.682 2.921 . . . . 0.0 114.413 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -131.51 80.64 66.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.611 1.564 . . . . 0.0 111.283 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -43.68 -37.58 8.5 Favored 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 125.668 4.246 . . . . 0.0 116.056 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -45.97 -44.22 14.76 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.441 1.896 . . . . 0.0 113.214 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.6 p -71.25 -10.01 59.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -116.45 4.34 13.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.001 1.32 . . . . 0.0 112.423 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.0 p -132.31 -27.51 1.77 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -61.37 -53.68 60.08 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 119.766 1.166 . . . . 0.0 112.9 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.1 -35.6 95.15 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.565 2.177 . . . . 0.0 114.032 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -60.72 -48.03 83.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.763 0.825 . . . . 0.0 111.647 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.37 -40.08 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.959 0.8 . . . . 0.0 110.774 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.36 -43.56 88.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.662 0.665 . . . . 0.0 111.311 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.24 -55.73 16.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.773 1.229 . . . . 0.0 112.393 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -53.31 -46.9 69.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.034 0.934 . . . . 0.0 111.348 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.81 -27.18 6.16 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.406 1.955 . . . . 0.0 116.361 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.2 p -71.94 -19.32 61.93 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 119.995 1.897 . . . . 0.0 113.824 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 -14.7 26.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.436 1.494 . . . . 0.0 113.255 -171.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.05 160.85 17.18 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.897 2.079 . . . . 0.0 112.354 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.251 1.02 . . . . 0.0 112.895 169.867 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.69 171.32 14.54 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -135.31 117.46 15.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.005 1.722 . . . . 0.0 108.527 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 mm -118.9 121.4 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.007 0.821 . . . . 0.0 113.143 -172.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.87 127.41 8.27 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.8 mt -119.18 91.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.471 1.135 . . . . 0.0 108.512 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -93.81 136.03 34.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.084 0.954 . . . . 0.0 110.948 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.73 145.26 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.611 0.764 . . . . 0.0 111.52 -169.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.6 90.24 0.22 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 125.034 1.302 . . . . 0.0 110.645 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -140.96 178.37 7.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -169.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -147.98 -21.71 0.35 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.812 2.045 . . . . 0.0 112.754 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.52 -2.49 7.94 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.91 1.21 73.55 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -64.07 -44.95 90.85 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.849 1.324 . . . . 0.0 112.376 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -73.64 -33.23 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.241 1.416 . . . . 0.0 112.561 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.92 -38.91 80.03 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.879 -1.138 . . . . 0.0 112.977 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.6 -45.08 73.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.83 0.741 . . . . 0.0 111.734 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.7 t -63.82 -36.91 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 111.594 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.73 -43.11 97.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.121 0.873 . . . . 0.0 112.623 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.26 -42.89 99.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.495 0.718 . . . . 0.0 112.578 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -62.72 -40.88 98.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.554 -0.716 . . . . 0.0 112.672 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.3 -48.19 82.49 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.556 -0.715 . . . . 0.0 111.735 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.57 -46.02 73.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.405 0.682 . . . . 0.0 111.483 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.83 83.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.552 0.741 . . . . 0.0 112.785 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.1 mt -59.33 -45.14 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.702 1.201 . . . . 0.0 112.068 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.0 mt -70.7 -41.57 71.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.636 -0.665 . . . . 0.0 109.664 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -56.93 -44.19 82.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.25 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.7 -37.67 82.6 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.011 0.924 . . . . 0.0 113.016 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.522 0.729 . . . . 0.0 112.501 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.16 -9.72 7.86 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.013 1.768 . . . . 0.0 114.445 169.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -72.7 147.54 45.57 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.371 1.069 . . . . 0.0 111.734 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -72.13 140.44 48.85 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.75 159.71 42.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.282 0.633 . . . . 0.0 112.16 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.3 m -153.49 118.43 5.07 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.249 -0.907 . . . . 0.0 111.425 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -74.12 141.31 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.923 0.889 . . . . 0.0 111.014 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -128.88 109.21 11.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.835 1.254 . . . . 0.0 109.635 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.26 -19.36 34.01 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.614 1.565 . . . . 0.0 114.823 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.2 58.99 5.58 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.922 1.689 . . . . 0.0 109.835 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.1 159.54 53.47 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.115 3.21 . . . . 0.0 115.474 -169.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -138.1 167.33 22.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.193 2.197 . . . . 0.0 109.411 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.41 -45.54 18.05 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.714 1.206 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -59.27 -18.51 38.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -80.27 -34.4 37.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.608 1.095 . . . . 0.0 112.334 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.471 ' CH2' HG21 ' A' ' 52' ' ' VAL . 33.9 t-105 -77.22 -35.98 55.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 112.781 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -41.45 -45.85 7.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 128.609 2.764 . . . . 0.0 115.944 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.68 -26.44 5.71 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.668 2.246 . . . . 0.0 114.527 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -82.76 -13.79 55.66 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -59.17 -26.35 64.71 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.41 7.2 26.72 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -134.08 -117.31 0.19 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.213 1.805 . . . . 0.0 110.682 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.89 154.7 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.41 1.084 . . . . 0.0 111.151 -177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 44' ' ' TRP . 23.2 m -149.23 169.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 110.988 -173.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.33 146.95 17.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.097 0.959 . . . . 0.0 110.358 176.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.11 133.58 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.17 1.388 . . . . 0.0 110.139 -169.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.38 89.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 107.717 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.2 m -131.48 164.83 24.89 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -167.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -136.68 -173.09 3.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.616 1.566 . . . . 0.0 112.793 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.5 m -129.71 146.44 51.48 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.136 0.974 . . . . 0.0 111.201 -171.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.6 t -149.96 -169.62 3.43 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.183 2.593 . . . . 0.0 108.765 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.02 35.37 13.22 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 125.784 1.659 . . . . 0.0 116.141 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.442 ' H ' HM73 ' A' ' 201' ' ' FMN . 18.2 tp60 67.89 6.77 5.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.072 2.149 . . . . 0.0 114.911 -176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 158.07 18.21 0.03 OUTLIER Glycine 0 CA--C 1.534 1.235 0 N-CA-C 119.368 2.507 . . . . 0.0 119.368 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 159.31 34.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.579 2.19 . . . . 0.0 112.443 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.95 150.63 87.6 Favored Pre-proline 0 CA--C 1.555 1.149 0 O-C-N 121.275 -0.891 . . . . 0.0 112.935 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 162.61 19.17 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.87 3.047 . . . . 0.0 112.592 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.16 -17.85 64.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -171.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.5 p -60.3 -18.72 51.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.0 -9.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -45.65 -48.35 37.89 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.489 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.11 -23.3 33.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 CA-C-N 122.199 1.821 . . . . 0.0 113.597 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 tp -76.03 -48.67 20.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.937 0.79 . . . . 0.0 110.097 173.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.35 -49.58 76.69 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.825 1.65 . . . . 0.0 111.942 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -64.56 -45.13 88.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.235 -0.916 . . . . 0.0 111.851 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.89 -43.53 97.41 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.254 0.931 . . . . 0.0 114.278 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.0 mt -63.72 -46.96 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.413 1.107 . . . . 0.0 110.402 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -61.69 -48.02 82.68 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.856 -0.527 . . . . 0.0 111.807 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.13 -41.26 61.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.084 1.353 . . . . 0.0 114.378 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -122.29 5.06 9.71 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -168.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -122.34 -49.65 2.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.54 1.064 . . . . 0.0 110.137 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -31.35 0.29 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.696 2.093 . . . . 0.0 117.984 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -154.71 138.77 16.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.197 1.499 . . . . 0.0 112.36 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -158.18 118.24 1.88 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.225 1.41 . . . . 0.0 110.926 169.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -87.45 -30.74 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.181 2.587 . . . . 0.0 115.806 -171.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -100.39 1.58 41.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.01 135.9 41.27 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.387 1.075 . . . . 0.0 111.388 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -123.64 143.38 50.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.009 1.723 . . . . 0.0 111.04 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.17 -173.84 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -169.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.61 162.48 32.04 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.151 2.31 . . . . 0.0 110.676 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.87 130.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.916 0.865 . . . . 0.0 111.701 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 mt -119.07 125.58 74.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 169.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.29 149.95 40.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.79 0.836 . . . . 0.0 109.728 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -140.36 138.81 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.645 0.778 . . . . 0.0 110.933 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.31 -131.12 1.63 Allowed Glycine 0 CA--C 1.521 0.463 0 O-C-N 122.253 -0.279 . . . . 0.0 113.533 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -141.07 119.48 12.25 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 111.149 -172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -64.16 -6.08 6.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.0 m -65.31 0.08 1.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -134.93 154.58 51.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.722 1.609 . . . . 0.0 112.33 -173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.803 0.841 . . . . 0.0 111.948 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.75 40.7 0.53 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.773 1.229 . . . . 0.0 112.557 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -51.16 115.06 1.38 Allowed 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.393 -1.442 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m 50.85 26.07 2.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.02 -30.3 69.07 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.497 -1.377 . . . . 0.0 113.117 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.31 -37.62 94.34 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.678 0.672 . . . . 0.0 113.527 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.82 56.29 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.136 -1.214 . . . . 0.0 112.642 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.83 -36.79 82.2 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.051 0.94 . . . . 0.0 113.032 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -57.67 -38.16 74.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.141 0.976 . . . . 0.0 112.373 170.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -78.37 -35.54 47.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.677 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.19 -41.06 96.14 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 119.676 -1.89 . . . . 0.0 111.822 169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.45 79.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.07 -46.46 68.59 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.454 1.024 . . . . 0.0 111.34 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.4 mt -76.31 -37.23 57.73 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.124 0.969 . . . . 0.0 112.331 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -65.7 -32.48 74.06 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.471 -0.768 . . . . 0.0 112.333 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.84 -25.48 65.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.701 0.682 . . . . 0.0 111.8 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -76.49 -32.26 58.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.458 1.026 . . . . 0.0 111.477 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 m 99.64 15.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.305 3.042 . . . . 0.0 112.198 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.71 162.54 6.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.229 0.612 . . . . 0.0 111.267 171.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -131.61 104.8 7.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.175 0.99 . . . . 0.0 110.602 -169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -69.63 134.67 49.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.279 -0.888 . . . . 0.0 111.439 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.48 31.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.615 1.566 . . . . 0.0 112.104 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.25 -165.32 38.7 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.954 -1.091 . . . . 0.0 114.37 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.63 151.6 38.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.785 1.634 . . . . 0.0 110.991 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 29.8 ttm -69.3 132.5 46.54 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.64 0.776 . . . . 0.0 112.01 -170.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.9 tm? -87.97 134.11 33.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.356 0.662 . . . . 0.0 109.474 171.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' N ' HD13 ' A' ' 123' ' ' LEU . 70.1 mt -121.36 93.47 4.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.921 1.288 . . . . 0.0 111.675 -176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 51.0 mt -75.55 136.99 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.383 1.473 . . . . 0.0 110.524 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -129.18 110.23 11.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.32 1.048 . . . . 0.0 112.458 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.2 -25.16 58.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.6 m -82.95 4.95 23.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.578 1.151 . . . . 0.0 113.689 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -133.39 -29.98 1.34 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.132 1.373 . . . . 0.0 113.014 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -142.94 116.84 6.24 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.537 1.135 . . . . 0.0 112.393 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.68 -3.71 11.94 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.103 3.202 . . . . 0.0 114.75 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.34 86.1 58.8 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.528 1.531 . . . . 0.0 110.49 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.28 -26.85 71.78 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.952 2.434 . . . . 0.0 114.383 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.2 -39.14 93.79 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.3 -12.42 56.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.265 -0.897 . . . . 0.0 112.718 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -113.06 -0.68 14.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.267 1.827 . . . . 0.0 111.751 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 p -135.2 -24.24 1.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.52 1.128 . . . . 0.0 113.955 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -62.66 -52.82 62.05 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 119.826 1.194 . . . . 0.0 113.254 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -57.85 -34.58 98.48 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.652 2.234 . . . . 0.0 113.932 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -59.94 -48.6 81.06 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.157 0.583 . . . . 0.0 111.261 173.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.08 -39.33 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.096 0.862 . . . . 0.0 110.891 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.64 -46.37 90.58 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.661 1.119 . . . . 0.0 111.923 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -63.28 -51.06 67.66 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.024 0.93 . . . . 0.0 112.352 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -58.23 -54.79 42.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.869 0.867 . . . . 0.0 110.623 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.26 -29.66 53.22 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.254 1.883 . . . . 0.0 114.767 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 94.2 m -59.2 -23.18 62.06 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.292 1.037 . . . . 0.0 113.238 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.92 -15.67 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.346 1.458 . . . . 0.0 114.689 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -30.78 70.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.545 1.138 . . . . 0.0 114.044 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.773 2.029 . . . . 0.0 111.685 175.8 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.442 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tmm? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.86 169.37 15.84 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.558 1.543 . . . . 0.0 112.292 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.13 121.0 33.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.402 1.481 . . . . 0.0 109.383 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mm -113.05 121.51 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.106 0.962 . . . . 0.0 112.036 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 126.38 7.48 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.4 mt -118.56 108.72 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 108.876 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.07 109.71 21.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.768 0.827 . . . . 0.0 110.751 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -87.48 147.34 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.774 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.93 114.55 1.21 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 169.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -160.9 175.76 12.18 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.596 1.558 . . . . 0.0 111.309 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ptp -132.61 4.17 3.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.917 1.687 . . . . 0.0 112.034 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -146.71 -54.13 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.656 1.182 . . . . 0.0 112.887 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.35 7.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 118.097 1.999 . . . . 0.0 118.097 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -63.85 -40.02 95.6 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.515 2.158 . . . . 0.0 112.743 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 91.7 p -79.69 -33.97 40.6 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.881 0.872 . . . . 0.0 112.502 173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.3 tp -56.49 -38.49 71.82 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.054 -1.029 . . . . 0.0 112.719 172.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.61 -42.91 75.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.698 0.799 . . . . 0.0 111.682 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.41 -37.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 111.651 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -57.86 -44.25 86.46 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.935 0.789 . . . . 0.0 112.493 173.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.74 -43.36 99.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.073 0.949 . . . . 0.0 112.168 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -58.41 -48.2 81.46 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.598 -0.688 . . . . 0.0 112.395 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.48 89.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.627 0.771 . . . . 0.0 112.334 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.6 -44.97 85.83 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.525 0.73 . . . . 0.0 111.792 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -44.99 88.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.716 0.806 . . . . 0.0 112.674 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.5 mt -61.07 -45.61 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.841 1.256 . . . . 0.0 112.216 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.28 -43.23 82.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.374 0.67 . . . . 0.0 109.377 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.7 m -55.24 -47.52 75.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.631 1.173 . . . . 0.0 112.055 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.67 85.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.086 0.955 . . . . 0.0 113.451 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -72.92 -11.14 60.47 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.8 -4.41 42.43 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.343 1.449 . . . . 0.0 114.524 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -72.86 178.35 4.29 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.16 1.384 . . . . 0.0 111.862 172.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -118.19 145.26 45.09 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.957 1.703 . . . . 0.0 109.519 171.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.55 155.03 41.45 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.444 -0.785 . . . . 0.0 112.623 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.3 m -143.42 100.65 3.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.019 0.927 . . . . 0.0 111.042 -172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.48 137.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.154 0.982 . . . . 0.0 111.21 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -126.0 111.1 14.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.853 1.661 . . . . 0.0 109.271 170.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.28 -20.91 43.34 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -173.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -146.45 60.07 5.81 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 126.249 1.82 . . . . 0.0 109.551 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.48 160.34 49.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.274 2.649 . . . . 0.0 114.651 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -135.89 164.07 28.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.341 2.256 . . . . 0.0 108.899 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -39.08 -48.01 1.61 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.497 1.519 . . . . 0.0 113.572 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 p -58.82 -18.12 29.63 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -84.07 -31.8 25.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.331 1.052 . . . . 0.0 112.541 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.518 ' CH2' HG21 ' A' ' 52' ' ' VAL . 23.6 t-105 -81.51 -36.87 28.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.349 1.06 . . . . 0.0 112.641 174.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -36.63 -52.28 1.89 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 127.456 2.302 . . . . 0.0 114.638 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.98 6.07 5.53 Favored 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 123.09 2.527 . . . . 0.0 116.029 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -107.31 2.81 24.8 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.246 1.384 . . . . 0.0 114.64 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -58.59 -25.88 63.07 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -99.19 9.42 43.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.681 1.592 . . . . 0.0 113.621 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -135.33 -160.68 1.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.694 2.398 . . . . 0.0 110.326 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -111.54 159.01 18.52 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.21 1.005 . . . . 0.0 111.85 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.518 HG21 ' CH2' ' A' ' 44' ' ' TRP . 28.4 m -148.51 173.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.409 1.484 . . . . 0.0 111.537 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.51 142.44 15.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.591 1.156 . . . . 0.0 111.379 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.42 130.87 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.191 1.797 . . . . 0.0 109.609 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 19' ' ' ALA . 11.4 p -140.34 89.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 122.091 0.948 . . . . 0.0 109.504 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.7 m -133.83 133.71 41.94 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -167.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 m -78.84 -166.97 0.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.935 1.694 . . . . 0.0 112.722 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.3 m -131.39 152.91 50.21 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.688 -1.257 . . . . 0.0 111.286 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 p -142.96 -167.07 2.44 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.593 2.357 . . . . 0.0 109.198 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 37.89 40.25 0.75 Allowed Glycine 0 CA--C 1.542 1.746 0 C-N-CA 127.05 2.262 . . . . 0.0 118.466 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 58.16 20.18 6.8 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 114.519 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.13 36.13 0.09 OUTLIER Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -126.51 169.72 12.76 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.509 1.654 . . . . 0.0 114.691 -169.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.2 mt -60.72 126.29 84.86 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 127.707 2.403 . . . . 0.0 112.008 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.16 142.65 97.27 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.502 2.801 . . . . 0.0 111.335 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.62 -29.26 69.12 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 m -67.21 -9.55 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 tt -118.18 -7.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.768 1.167 . . . . 0.0 113.243 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.9 t -54.63 -45.82 99.43 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.144 -1.407 . . . . 0.0 112.342 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -55.88 -11.47 5.42 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 124.216 3.277 . . . . 0.0 116.549 169.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 tp -105.3 -44.22 4.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.405 1.082 . . . . 0.0 110.403 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -58.3 -49.22 77.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 111.47 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -62.4 -42.69 99.62 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.539 -0.726 . . . . 0.0 112.332 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.27 -40.27 70.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.248 0.928 . . . . 0.0 113.585 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.63 -45.61 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.463 1.131 . . . . 0.0 110.063 173.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.27 -47.21 86.23 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.487 0.715 . . . . 0.0 112.376 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -79.02 -38.2 37.2 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 m -126.06 -10.06 6.53 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 118.192 2.664 . . . . 0.0 118.192 -168.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 -33.28 16.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.15 1.795 . . . . 0.0 112.279 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 -55.32 1.53 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.288 1.899 . . . . 0.0 116.802 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -151.76 149.55 29.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.03 1.732 . . . . 0.0 111.383 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -148.76 38.53 0.19 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -46.82 -33.52 14.23 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.815 2.344 . . . . 0.0 115.656 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -68.67 -0.37 5.16 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.545 2.338 . . . . 0.0 116.284 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.19 142.75 49.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.961 1.304 . . . . 0.0 112.251 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.7 145.26 51.54 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.054 2.142 . . . . 0.0 110.451 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.48 -169.09 2.33 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.75 167.36 31.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.015 2.245 . . . . 0.0 110.116 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.19 126.69 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 118.391 1.095 . . . . 0.0 112.978 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.3 mt -114.0 109.86 30.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 168.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -101.39 142.51 32.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.416 0.686 . . . . 0.0 109.27 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.1 154.6 47.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.112 0.958 . . . . 0.0 110.716 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.7 -129.12 1.86 Allowed Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.922 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.44 128.13 14.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.547 1.139 . . . . 0.0 111.165 -173.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.5 p -72.5 -1.6 16.49 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 m -67.74 4.13 1.22 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.42 156.26 47.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.147 1.779 . . . . 0.0 111.557 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.49 -37.33 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.732 0.813 . . . . 0.0 111.843 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -79.63 44.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 112.966 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -53.1 113.63 1.18 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.673 -1.267 . . . . 0.0 111.846 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.7 m 50.21 27.7 2.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.122 2.569 . . . . 0.0 116.312 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -58.85 -28.62 66.25 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.896 -1.128 . . . . 0.0 113.498 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.16 -33.49 64.91 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.771 0.7 . . . . 0.0 113.803 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.1 -36.78 9.67 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 117.908 0.854 . . . . 0.0 113.47 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -59.21 -36.79 76.03 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.828 1.314 . . . . 0.0 113.113 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -54.84 -45.74 74.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.927 0.891 . . . . 0.0 111.424 170.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -72.63 -27.56 62.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.461 -0.775 . . . . 0.0 112.949 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.5 -44.0 75.65 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.674 -1.891 . . . . 0.0 110.781 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.89 -37.94 77.73 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.728 0.811 . . . . 0.0 112.979 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.3 tp -51.12 -32.43 22.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 112.847 171.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -97.95 -39.08 9.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.898 1.279 . . . . 0.0 111.857 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -69.17 -33.47 73.44 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.2 -0.938 . . . . 0.0 113.162 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.95 -12.99 56.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.769 0.828 . . . . 0.0 112.296 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.48 10.86 18.28 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.015 1.726 . . . . 0.0 112.459 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.0 m 69.51 17.86 7.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 171.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.99 165.82 3.08 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.441 -0.787 . . . . 0.0 110.853 169.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -128.03 94.51 3.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.665 -1.272 . . . . 0.0 112.419 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -66.52 132.75 48.92 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.926 -1.109 . . . . 0.0 111.133 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.93 36.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.749 1.62 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.67 40.79 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.676 -1.265 . . . . 0.0 114.331 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.89 153.12 27.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.792 1.637 . . . . 0.0 111.366 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 30.3 ttm -71.07 138.08 49.47 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -94.95 135.44 36.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.92 0.888 . . . . 0.0 109.027 172.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.453 ' N ' HD13 ' A' ' 123' ' ' LEU . 55.8 mt -120.75 93.85 4.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.522 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.14 136.58 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.933 0.893 . . . . 0.0 111.199 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -125.3 100.32 6.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 112.488 -171.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.56 -17.32 13.43 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 114.451 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 p -72.17 -15.0 61.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.542 1.064 . . . . 0.0 113.769 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.61 -10.15 1.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -134.7 103.29 11.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.483 1.038 . . . . 0.0 112.418 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.38 1.47 9.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.046 3.164 . . . . 0.0 114.474 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -131.19 74.86 78.81 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.801 1.64 . . . . 0.0 111.022 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.56 -29.01 13.1 Favored 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 125.442 4.094 . . . . 0.0 117.148 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.4 -39.36 67.19 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 50.8 p -68.42 -5.88 21.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.698 1.199 . . . . 0.0 113.443 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -113.94 -7.73 13.14 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.691 1.597 . . . . 0.0 112.077 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 30.5 p -134.66 -25.43 1.46 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.14 -53.44 58.71 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 119.708 1.14 . . . . 0.0 113.723 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.09 -27.96 29.04 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.538 1.492 . . . . 0.0 112.865 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -63.13 -48.8 76.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.493 0.717 . . . . 0.0 111.608 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.49 -39.52 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.43 0.559 . . . . 0.0 110.198 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -59.21 -44.49 92.27 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.603 0.638 . . . . 0.0 111.644 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.61 -57.01 12.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.192 0.997 . . . . 0.0 112.302 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -53.51 -46.38 70.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.054 0.942 . . . . 0.0 111.238 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.84 -24.81 14.39 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.361 1.934 . . . . 0.0 116.447 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.0 p -70.87 -19.72 62.6 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 120.118 1.959 . . . . 0.0 113.938 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.4 mt -93.08 -15.27 26.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.482 1.513 . . . . 0.0 113.066 -171.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 162.85 14.83 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.526 1.93 . . . . 0.0 112.458 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.665 1.186 . . . . 0.0 113.387 173.252 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.27 -176.63 3.41 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.119 1.767 . . . . 0.0 112.906 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -136.52 116.18 12.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.513 1.525 . . . . 0.0 109.26 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.21 128.75 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.526 1.131 . . . . 0.0 113.11 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -93.15 130.21 10.22 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -120.8 101.57 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.541 1.17 . . . . 0.0 108.323 -170.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -100.77 118.01 36.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.946 0.899 . . . . 0.0 112.667 -168.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.0 t -85.1 144.71 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.864 1.266 . . . . 0.0 110.985 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.35 98.95 0.27 Allowed Glycine 0 N--CA 1.47 0.927 0 C-N-CA 124.355 0.978 . . . . 0.0 110.929 171.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -154.31 166.89 31.76 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.18 0.992 . . . . 0.0 113.551 -171.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.0 mmm -123.81 -3.28 8.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 113.043 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.29 -58.99 0.54 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.36 -4.79 0.23 Allowed Glycine 0 N--CA 1.479 1.549 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -61.72 -44.44 96.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.285 1.542 . . . . 0.0 113.251 -173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.9 p -77.62 -31.9 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.652 0.781 . . . . 0.0 112.369 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 tp -57.58 -41.87 82.02 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.903 -1.123 . . . . 0.0 112.414 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.91 -43.56 77.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.722 0.692 . . . . 0.0 111.679 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -39.08 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.116 0.566 . . . . 0.0 111.823 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 55' ' ' VAL . . . -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.36 -45.13 95.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.831 0.852 . . . . 0.0 111.963 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.38 -44.2 95.87 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.627 0.771 . . . . 0.0 112.58 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.9 -46.36 89.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.527 0.731 . . . . 0.0 112.11 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -56.35 -46.78 79.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.938 0.495 . . . . 0.0 111.199 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.09 85.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.839 0.856 . . . . 0.0 113.029 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.73 -46.16 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.418 1.087 . . . . 0.0 111.789 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 mt -70.07 -41.01 74.69 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.82 -0.55 . . . . 0.0 109.996 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.8 m -56.2 -46.12 79.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.827 1.251 . . . . 0.0 112.21 169.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.38 83.61 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.203 1.001 . . . . 0.0 112.929 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -72.4 -9.75 58.92 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.307 1.043 . . . . 0.0 113.311 171.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -11.06 48.87 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.792 1.663 . . . . 0.0 114.587 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -70.26 140.29 52.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.015 0.926 . . . . 0.0 110.655 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -67.94 134.35 50.63 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.01 141.61 30.23 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.208 0.458 . . . . 0.0 111.32 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -139.42 115.88 10.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.035 0.934 . . . . 0.0 110.026 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.59 147.27 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.699 0.8 . . . . 0.0 111.921 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -134.07 103.53 5.83 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.359 1.863 . . . . 0.0 107.651 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.58 -27.9 60.69 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -144.95 64.21 10.97 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 126.379 1.872 . . . . 0.0 109.009 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.8 160.72 40.36 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.67 2.913 . . . . 0.0 115.188 -168.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.28 173.51 11.6 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.302 1.841 . . . . 0.0 109.76 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -40.82 -50.74 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.098 1.359 . . . . 0.0 113.182 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 m -62.01 -18.01 59.12 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -81.64 -35.51 29.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.377 0.99 . . . . 0.0 112.122 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.45 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 17.4 t-105 -77.73 -35.42 51.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.417 1.087 . . . . 0.0 112.613 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -40.95 -44.76 5.58 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 127.64 2.376 . . . . 0.0 115.938 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.95 -31.87 23.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.177 2.585 . . . . 0.0 115.471 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -82.08 -4.92 57.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -56.96 -23.51 46.16 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -97.27 8.48 44.47 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.646 1.578 . . . . 0.0 112.84 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -132.15 -135.09 0.19 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.741 2.416 . . . . 0.0 109.123 -170.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -133.93 161.35 35.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.605 1.562 . . . . 0.0 109.775 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 18.8 m -148.36 167.31 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.574 1.15 . . . . 0.0 111.204 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.29 139.19 14.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 122.318 1.056 . . . . 0.0 110.991 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.0 t -105.27 132.22 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 126.0 1.72 . . . . 0.0 109.685 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 19' ' ' ALA . 3.1 p -139.83 88.53 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 122.753 1.264 . . . . 0.0 108.062 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.6 m -129.95 163.88 25.44 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.712 1.205 . . . . 0.0 113.027 -167.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.2 p -128.07 -173.23 2.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.335 1.454 . . . . 0.0 112.782 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -134.77 132.55 38.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.674 1.189 . . . . 0.0 110.081 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.4 t -158.86 -166.99 1.99 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.183 1.393 . . . . 0.0 110.098 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.59 -64.77 0.11 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.104 2.764 . . . . 0.0 116.378 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -148.6 21.67 1.03 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.073 2.149 . . . . 0.0 111.842 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.83 43.91 6.6 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -168.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -138.88 -178.79 5.48 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.937 1.695 . . . . 0.0 114.029 -168.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.71 130.89 78.06 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.301 1.84 . . . . 0.0 113.012 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -60.8 140.41 90.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.249 3.299 . . . . 0.0 111.118 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.21 -26.88 66.72 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.406 -0.809 . . . . 0.0 113.144 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -64.41 -8.95 15.17 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.9 tt -125.99 -9.26 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -50.22 -46.9 83.23 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 117.146 -1.407 . . . . 0.0 112.751 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.83 3.91 2.98 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.148 2.566 . . . . 0.0 114.557 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -109.03 -43.08 4.27 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.863 1.265 . . . . 0.0 110.656 170.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -59.92 -48.66 80.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.06 0.944 . . . . 0.0 111.782 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -63.52 -38.16 90.07 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.287 -0.883 . . . . 0.0 112.622 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.45 -43.32 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.462 1.03 . . . . 0.0 113.093 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.0 mt -62.28 -46.42 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 118.543 1.171 . . . . 0.0 110.106 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -50.2 74.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.699 1.2 . . . . 0.0 112.6 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -77.76 -40.26 41.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -87.62 -45.8 10.1 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.58 -44.53 18.83 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.074 0.852 . . . . 0.0 113.149 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.18 -43.68 0.54 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 126.172 1.844 . . . . 0.0 116.632 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -156.88 133.12 9.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.902 1.681 . . . . 0.0 110.275 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -153.23 54.55 1.2 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.26 -24.1 78.27 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.589 2.859 . . . . 0.0 114.819 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -81.68 -13.49 57.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.061 1.744 . . . . 0.0 114.943 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 tp -81.76 142.63 32.45 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.165 0.893 . . . . 0.0 111.428 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -131.1 144.35 51.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.145 1.778 . . . . 0.0 111.83 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -158.44 -172.14 3.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.86 162.43 31.67 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 127.18 2.324 . . . . 0.0 110.55 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.57 131.15 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 117.927 0.864 . . . . 0.0 112.625 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.2 126.35 74.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.29 147.75 45.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.256 1.022 . . . . 0.0 110.035 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.2 147.43 36.54 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.597 0.759 . . . . 0.0 111.54 -169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.75 -139.33 4.8 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.257 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -138.55 130.07 27.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 111.655 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.8 p -66.7 -5.3 11.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.54 1.682 . . . . 0.0 115.54 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -69.22 2.2 3.08 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.54 153.21 48.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.423 1.489 . . . . 0.0 112.83 -171.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.47 -7.85 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.778 1.631 . . . . 0.0 114.831 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -120.66 44.16 2.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.578 1.951 . . . . 0.0 110.761 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -50.38 115.38 1.43 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.211 -1.556 . . . . 0.0 112.344 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 72.3 m 52.46 25.0 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -55.9 -36.75 68.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.682 -1.261 . . . . 0.0 113.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.78 -41.26 99.88 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 118.794 0.724 . . . . 0.0 112.583 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.16 -40.49 82.34 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 121.277 -1.131 . . . . 0.0 112.936 171.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.76 -37.78 85.54 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 117.918 0.859 . . . . 0.0 113.311 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -59.77 -46.35 89.46 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.769 0.713 . . . . 0.0 111.01 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -69.26 -25.36 64.23 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.92 -48.93 56.6 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 120.017 -1.677 . . . . 0.0 110.077 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.8 -38.19 72.2 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.2 tp -49.21 -31.94 9.52 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.949 1.7 . . . . 0.0 112.966 173.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.01 -37.78 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.054 1.342 . . . . 0.0 110.975 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -35.95 82.8 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -22.24 66.78 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 112.644 172.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.79 9.97 41.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.133 1.373 . . . . 0.0 112.139 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.2 m 66.56 15.11 10.02 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.685 1.994 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.56 141.57 54.58 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.973 0.806 . . . . 0.0 109.752 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -102.62 107.51 18.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.554 1.141 . . . . 0.0 111.449 -169.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.5 ttm105 -74.02 123.45 24.37 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.838 -1.164 . . . . 0.0 110.465 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.16 35.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.846 1.658 . . . . 0.0 111.925 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -162.12 35.81 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.526 -1.359 . . . . 0.0 114.34 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -125.57 154.38 42.29 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.254 1.821 . . . . 0.0 111.118 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 31.0 ttm -69.77 131.6 44.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.896 0.879 . . . . 0.0 112.059 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -85.91 135.37 33.71 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.41 0.684 . . . . 0.0 109.661 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.38 93.7 3.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.775 1.23 . . . . 0.0 111.599 -171.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.7 mt -86.59 134.34 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.202 1.401 . . . . 0.0 110.773 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -127.17 111.89 14.51 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.085 1.354 . . . . 0.0 111.436 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.07 -23.16 53.54 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -85.48 4.61 34.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.725 1.21 . . . . 0.0 113.695 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -129.91 -30.25 2.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.861 1.264 . . . . 0.0 112.734 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -146.28 118.46 4.98 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.089 0.956 . . . . 0.0 111.789 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.94 -0.76 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.741 2.96 . . . . 0.0 114.708 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.64 77.44 77.44 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.57 1.548 . . . . 0.0 112.331 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.18 -31.33 5.9 Favored 'Trans proline' 0 C--N 1.355 0.913 1 C-N-CA 125.831 4.354 . . . . 0.0 116.351 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -48.08 -44.42 31.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.133 1.773 . . . . 0.0 113.269 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.8 p -71.77 -29.0 64.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.594 1.158 . . . . 0.0 113.314 -175.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -80.5 -26.46 38.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.317 0.647 . . . . 0.0 112.217 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.5 p -105.33 -28.37 10.94 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -169.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.43 -59.8 6.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.2 -28.57 33.85 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.909 1.739 . . . . 0.0 112.226 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.7 t90 -63.05 -50.31 71.14 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.701 0.682 . . . . 0.0 111.691 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.04 -41.12 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 118.739 0.7 . . . . 0.0 110.318 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.61 -44.44 93.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.349 0.522 . . . . 0.0 111.624 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.92 -55.47 25.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.196 0.998 . . . . 0.0 112.554 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.59 -49.67 64.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.36 1.064 . . . . 0.0 110.907 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.36 -19.57 26.11 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.579 1.562 . . . . 0.0 116.44 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.8 p -69.78 -20.24 63.48 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.884 2.342 . . . . 0.0 113.62 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -97.49 -15.48 20.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.178 1.391 . . . . 0.0 113.151 -171.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.89 149.9 49.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.303 1.441 . . . . 0.0 112.183 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.023 1.729 . . . . 0.0 114.234 -172.222 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 110.885 -0.043 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.36 177.94 7.2 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.324 1.45 . . . . 0.0 113.474 -170.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -126.64 123.66 38.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.714 1.606 . . . . 0.0 109.434 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 mm -118.03 123.75 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.496 1.118 . . . . 0.0 112.259 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.42 126.58 7.69 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 168.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -116.97 111.4 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.719 1.259 . . . . 0.0 109.075 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.32 133.09 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.613 0.765 . . . . 0.0 110.79 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.94 144.26 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.903 -169.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.72 115.17 1.64 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -157.58 162.46 38.76 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.508 -0.996 . . . . 0.0 111.424 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.2 mmm -120.7 -19.39 7.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.598 1.159 . . . . 0.0 112.336 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -134.29 -7.12 2.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.15 -2.34 47.4 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 116.267 1.267 . . . . 0.0 116.267 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.1 -47.75 78.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.314 1.557 . . . . 0.0 112.515 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -67.83 -30.11 69.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.039 0.935 . . . . 0.0 112.751 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 tp -64.14 -44.36 92.41 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.7 -1.25 . . . . 0.0 113.039 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tt -56.09 -42.87 77.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.021 0.828 . . . . 0.0 111.262 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.31 -38.0 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.54 0.736 . . . . 0.0 112.236 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.85 -40.31 94.95 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.85 -39.19 93.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -61.51 -44.63 96.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.483 -0.761 . . . . 0.0 112.216 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.34 88.67 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.922 0.783 . . . . 0.0 112.598 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.44 -46.4 80.31 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.775 0.83 . . . . 0.0 111.991 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.7 84.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.65 0.78 . . . . 0.0 112.493 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.37 -42.64 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.407 1.083 . . . . 0.0 112.563 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.55 -44.21 78.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.807 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.2 m -56.93 -46.23 82.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 112.045 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -39.59 89.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.187 0.995 . . . . 0.0 113.242 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -67.75 -28.87 68.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.657 0.783 . . . . 0.0 112.67 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.76 -5.98 6.16 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.282 1.42 . . . . 0.0 114.502 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -73.58 178.84 4.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.355 1.462 . . . . 0.0 111.482 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -117.64 144.11 45.51 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.354 1.462 . . . . 0.0 109.392 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.89 163.3 37.23 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.638 -0.664 . . . . 0.0 112.576 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.0 m -153.12 116.55 4.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.097 0.959 . . . . 0.0 110.999 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.87 140.1 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.872 1.269 . . . . 0.0 111.201 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -125.42 107.74 10.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.252 1.821 . . . . 0.0 108.959 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.48 -20.68 46.74 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -171.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.45 61.02 7.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.857 1.663 . . . . 0.0 110.226 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.77 161.6 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.077 3.185 . . . . 0.0 115.023 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.2 171.34 14.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.115 2.166 . . . . 0.0 109.405 169.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tt -46.54 -48.57 19.38 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.354 1.062 . . . . 0.0 112.948 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 m -59.4 -19.22 45.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -79.02 -35.64 42.41 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.503 1.047 . . . . 0.0 111.85 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.441 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 23.0 t-105 -78.97 -37.36 39.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.239 1.415 . . . . 0.0 112.56 176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.6 tp -38.68 -50.17 3.8 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 128.466 2.706 . . . . 0.0 116.318 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -15.67 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.714 2.276 . . . . 0.0 115.258 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -84.84 -1.8 56.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.12 -33.41 69.1 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.221 -0.925 . . . . 0.0 113.295 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.52 -5.7 50.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.266 1.026 . . . . 0.0 113.519 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -133.08 -134.51 0.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.927 2.491 . . . . 0.0 109.478 -169.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -140.08 158.8 43.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.115 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.441 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 34.3 m -145.57 170.53 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.058 1.343 . . . . 0.0 111.896 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -157.91 148.64 20.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.334 1.453 . . . . 0.0 110.413 174.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' H ' HD22 ' A' ' 53' ' ' LEU . 39.0 t -117.09 135.59 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.57 1.548 . . . . 0.0 109.829 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.44 96.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.313 1.045 . . . . 0.0 109.681 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.0 m -138.82 152.99 48.32 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.3 p -108.33 -159.81 0.7 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.869 1.267 . . . . 0.0 113.514 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.1 m -122.92 151.19 42.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.082 1.753 . . . . 0.0 109.115 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -158.27 -177.27 6.43 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.441 1.496 . . . . 0.0 108.73 -169.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 42.57 44.58 5.33 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.61 ' H ' HM73 ' A' ' 201' ' ' FMN . 7.6 tt0 60.81 21.54 11.64 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.408 1.883 . . . . 0.0 114.801 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.3 -6.87 2.81 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.316 1.436 . . . . 0.0 115.502 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.07 -158.42 0.2 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 126.245 1.818 . . . . 0.0 113.027 175.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 pp -119.87 163.0 30.21 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.747 1.619 . . . . 0.0 113.603 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -64.71 142.9 78.78 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.59 3.527 . . . . 0.0 113.305 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.03 -28.15 67.51 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.617 -0.677 . . . . 0.0 112.816 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.0 m -62.02 -10.21 9.32 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.3 tt -128.1 -6.81 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 119.463 1.029 . . . . 0.0 113.243 175.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -47.9 -50.65 52.18 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 117.392 -1.289 . . . . 0.0 112.647 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 -2.03 10.75 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.239 1.959 . . . . 0.0 114.238 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.0 tp -98.06 -43.98 6.82 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.99 0.916 . . . . 0.0 110.122 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -61.57 -47.05 87.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.122 0.969 . . . . 0.0 111.554 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -63.91 -44.53 92.66 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.34 -0.85 . . . . 0.0 111.876 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.61 -45.84 93.65 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.981 0.8 . . . . 0.0 113.373 -175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.8 mt -64.02 -43.49 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.31 1.055 . . . . 0.0 110.596 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -62.65 -45.04 94.68 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.355 1.062 . . . . 0.0 112.617 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -83.67 -39.41 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.115 1.366 . . . . 0.0 114.512 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -121.8 4.92 9.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -113.65 -48.51 2.93 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.754 1.161 . . . . 0.0 110.823 168.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.49 -26.68 0.22 Allowed Glycine 0 CA--C 1.542 1.725 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -155.22 136.67 14.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 110.211 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -148.68 58.58 3.7 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 125.195 1.398 . . . . 0.0 112.471 -169.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -67.45 -2.53 8.45 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.603 3.535 . . . . 0.0 115.21 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -118.67 -6.12 10.66 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.664 2.385 . . . . 0.0 113.305 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -74.25 121.18 20.87 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.155 0.982 . . . . 0.0 110.155 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -123.4 140.77 52.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.87 1.668 . . . . 0.0 109.897 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -163.48 -167.57 1.46 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -168.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.54 170.46 34.05 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 127.596 2.522 . . . . 0.0 110.116 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.2 t -142.0 132.65 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.631 1.216 . . . . 0.0 112.247 -174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.72 130.4 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.59 152.5 43.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.017 0.927 . . . . 0.0 110.482 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tt -142.92 138.5 30.23 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.368 0.667 . . . . 0.0 111.803 -169.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.03 -138.86 3.36 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -144.09 122.51 12.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.501 1.12 . . . . 0.0 110.782 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.8 p -60.63 -9.42 3.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.823 1.249 . . . . 0.0 114.094 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.8 m -59.29 -13.42 7.89 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.419 1.488 . . . . 0.0 114.809 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -127.56 138.35 52.86 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.759 1.223 . . . . 0.0 111.834 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.69 -27.47 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -168.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -90.46 -14.08 33.52 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.761 1.164 . . . . 0.0 113.327 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 36.0 -125.33 0.14 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.409 1.484 . . . . 0.0 112.573 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.3 m -77.32 20.42 0.29 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -54.16 -33.98 59.34 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.095 -1.628 . . . . 0.0 114.71 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.19 -33.27 85.38 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.481 1.037 . . . . 0.0 113.393 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.22 -41.75 52.42 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.256 -1.144 . . . . 0.0 112.429 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.88 -36.4 79.11 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -56.55 -48.48 77.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.69 0.677 . . . . 0.0 111.418 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -70.01 -29.53 66.62 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -66.49 -46.33 76.65 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.226 -1.546 . . . . 0.0 111.291 169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.09 70.68 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -48.96 -28.55 3.95 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.924 1.689 . . . . 0.0 113.36 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.7 mt -101.77 -35.26 9.12 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.645 1.178 . . . . 0.0 111.432 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.59 -32.84 74.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.72 1.145 . . . . 0.0 111.682 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.2 -15.31 14.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.809 1.243 . . . . 0.0 113.002 170.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -124.16 16.65 9.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.845 1.658 . . . . 0.0 113.201 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.6 m 64.02 25.11 13.75 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.002 1.721 . . . . 0.0 115.425 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 159.79 12.27 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.243 -0.911 . . . . 0.0 112.332 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -129.13 86.33 2.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.111 1.364 . . . . 0.0 110.394 -170.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ttm105 -62.51 138.96 58.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.03 31.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.552 1.541 . . . . 0.0 111.544 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.18 -165.46 38.92 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 121.015 -1.053 . . . . 0.0 113.999 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.26 158.48 28.02 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.066 1.747 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.0 ttm -72.32 133.96 45.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.68 -0.637 . . . . 0.0 112.149 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.27 134.13 33.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.825 0.85 . . . . 0.0 109.469 170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.25 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.241 1.016 . . . . 0.0 111.196 -170.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.58 135.07 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.074 1.35 . . . . 0.0 110.609 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -131.63 113.24 13.37 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.004 1.322 . . . . 0.0 111.09 -173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.8 30.44 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.4 m -77.26 -2.78 36.44 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -139.43 -18.5 0.98 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.631 1.573 . . . . 0.0 113.437 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.84 80.64 70.57 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 126.993 2.117 . . . . 0.0 110.772 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -16.25 42.57 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.947 2.432 . . . . 0.0 113.313 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -125.92 91.15 48.86 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.672 1.989 . . . . 0.0 107.736 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.35 -27.04 84.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.461 2.774 . . . . 0.0 115.524 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.31 -29.1 60.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 172.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.5 p -68.92 -6.55 28.11 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -111.8 -31.83 6.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.327 1.051 . . . . 0.0 111.335 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 84.1 p -78.0 -32.88 51.44 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -50.88 -60.74 4.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -66.29 -29.78 46.09 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.118 1.879 . . . . 0.0 112.278 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -61.94 -51.15 69.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.532 0.605 . . . . 0.0 111.582 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.02 -40.65 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.525 0.602 . . . . 0.0 110.485 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.71 -38.01 83.63 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -71.41 -59.08 2.96 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.125 0.97 . . . . 0.0 112.717 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -52.17 -47.54 65.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.926 -174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.03 -34.69 12.26 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.001 1.286 . . . . 0.0 115.268 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.7 p -66.72 -15.88 63.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.023 1.411 . . . . 0.0 114.052 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -96.99 -15.92 20.85 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.249 1.419 . . . . 0.0 113.4 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.17 -36.86 80.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.561 1.544 . . . . 0.0 113.592 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.764 1.626 . . . . 0.0 112.226 -175.416 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.61 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.54 176.13 8.0 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.763 2.025 . . . . 0.0 110.78 170.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.18 124.25 24.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.125 1.37 . . . . 0.0 109.181 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 mt -136.9 125.05 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.71 132.88 11.39 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -120.02 90.79 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.984 1.314 . . . . 0.0 108.411 -171.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -91.69 138.26 31.7 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.829 0.852 . . . . 0.0 110.752 -169.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.12 144.9 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.489 0.661 . . . . 0.0 111.567 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.49 101.68 0.48 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -146.92 164.1 33.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.784 1.234 . . . . 0.0 111.022 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 80.2 mmm -111.5 -11.39 14.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.944 0.898 . . . . 0.0 113.359 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -146.51 -19.62 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.89 -10.02 5.44 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 170.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.93 -44.38 91.32 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.176 1.988 . . . . 0.0 113.315 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.6 p -82.59 -28.97 30.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.6 0.76 . . . . 0.0 112.512 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.93 -40.42 84.56 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.729 -1.232 . . . . 0.0 112.912 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 tt -54.57 -41.05 69.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 111.815 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 90' ' ' ILE . 98.8 t -69.88 -35.72 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.242 0.617 . . . . 0.0 111.991 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.12 97.87 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.393 0.997 . . . . 0.0 112.506 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.47 -40.86 96.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.534 0.733 . . . . 0.0 112.269 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -60.45 -47.86 84.29 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.772 -0.58 . . . . 0.0 111.552 169.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.13 87.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.56 0.744 . . . . 0.0 112.556 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.35 -46.24 80.06 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.727 0.811 . . . . 0.0 112.071 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.88 -47.18 81.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.367 0.667 . . . . 0.0 112.31 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.43 -32.7 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.096 1.358 . . . . 0.0 112.964 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.9 mt -80.14 -38.31 31.73 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.686 -1.259 . . . . 0.0 110.12 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.2 m -57.03 -45.32 83.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.669 0.788 . . . . 0.0 111.17 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.06 -34.86 78.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.558 1.143 . . . . 0.0 113.487 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.05 -7.06 52.64 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.37 24.32 12.71 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.606 1.098 . . . . 0.0 114.346 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -114.87 147.89 39.31 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.376 1.088 . . . . 0.0 112.153 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -75.22 134.35 41.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.232 1.013 . . . . 0.0 109.034 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -141.81 155.03 45.59 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.168 0.987 . . . . 0.0 111.189 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.1 m -154.13 116.49 4.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.08 -1.013 . . . . 0.0 110.665 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.82 138.74 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.121 0.968 . . . . 0.0 110.71 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.68 101.08 6.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.969 1.308 . . . . 0.0 109.808 172.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.64 -22.79 56.47 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -144.31 64.12 11.93 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.202 1.801 . . . . 0.0 109.586 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.8 160.7 48.58 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.117 3.211 . . . . 0.0 114.703 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.37 162.04 31.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.164 2.186 . . . . 0.0 109.212 169.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -53.99 -36.62 63.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.713 -1.242 . . . . 0.0 113.346 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -58.07 -18.79 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -83.4 -35.13 25.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.406 1.003 . . . . 0.0 112.344 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.604 ' CH2' HG21 ' A' ' 52' ' ' VAL . 27.5 t-105 -75.2 -37.19 61.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.926 0.89 . . . . 0.0 112.193 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.3 tp -41.42 -46.74 8.42 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 128.34 2.656 . . . . 0.0 116.411 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.67 -30.32 4.98 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.211 1.941 . . . . 0.0 114.391 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -81.26 -9.74 59.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -55.44 -28.5 54.72 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.13 -4.98 52.99 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.471 1.508 . . . . 0.0 113.848 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.11 -115.52 0.23 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.761 1.624 . . . . 0.0 111.154 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.02 160.93 39.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.618 1.567 . . . . 0.0 110.694 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG21 ' CH2' ' A' ' 44' ' ' TRP . 31.4 m -152.4 172.4 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.118 1.367 . . . . 0.0 111.314 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.3 149.31 18.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.938 1.295 . . . . 0.0 109.771 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.07 136.98 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.84 1.256 . . . . 0.0 109.983 -170.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.11 94.63 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.984 1.314 . . . . 0.0 109.024 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.1 m -135.76 139.82 43.85 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -168.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -178.1 5.32 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.868 1.667 . . . . 0.0 112.381 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 m -127.75 139.11 52.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.718 -1.239 . . . . 0.0 110.899 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.1 t -158.4 -168.73 2.53 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.556 1.526 . . . . 0.0 110.75 -170.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.64 -66.88 0.17 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 127.807 2.622 . . . . 0.0 116.045 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -153.45 32.02 0.46 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.599 1.96 . . . . 0.0 110.812 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.31 40.48 13.34 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.238 -0.913 . . . . 0.0 111.623 -169.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -129.35 175.22 8.93 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.635 1.974 . . . . 0.0 112.881 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -53.52 136.97 52.22 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.364 1.866 . . . . 0.0 111.834 169.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.72 141.99 28.22 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.354 2.703 . . . . 0.0 110.679 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -58.46 -25.42 62.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 m -61.67 -17.2 54.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.42 -12.87 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 119.76 1.164 . . . . 0.0 114.138 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.68 -42.88 24.67 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 125.38 1.472 . . . . 0.0 114.08 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.17 -25.4 10.13 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.97 1.78 . . . . 0.0 114.075 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.49 -45.82 61.47 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.312 0.96 . . . . 0.0 109.616 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -51.19 -58.36 6.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.75 1.62 . . . . 0.0 111.381 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -66.96 -33.81 76.4 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.486 -1.384 . . . . 0.0 113.958 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.47 -48.23 87.0 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 119.097 0.862 . . . . 0.0 112.495 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.22 -41.03 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.197 -1.178 . . . . 0.0 110.557 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -61.48 -37.33 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.76 -23.07 10.37 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -169.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -113.21 0.45 14.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.5 mt -129.32 -49.63 1.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.739 1.216 . . . . 0.0 111.418 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.94 -22.52 0.33 Allowed Glycine 0 CA--C 1.543 1.782 0 N-CA-C 118.447 2.139 . . . . 0.0 118.447 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -153.57 139.71 18.38 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.577 1.689 . . . . 0.0 110.677 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.59 45.85 0.28 Allowed Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -169.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -59.59 -21.57 62.94 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.555 3.504 . . . . 0.0 116.865 -169.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -106.56 -0.74 23.64 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.308 1.443 . . . . 0.0 113.849 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 52' ' ' VAL . 2.9 tm? -75.52 136.95 40.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.88 0.872 . . . . 0.0 110.258 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -130.7 133.5 46.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.681 1.992 . . . . 0.0 109.525 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -151.93 -170.87 3.77 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -170.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.46 164.92 30.78 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.823 1.678 . . . . 0.0 110.027 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.78 134.78 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 122.178 0.989 . . . . 0.0 112.253 -169.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 18' ' ' VAL . 87.4 mt -121.4 129.9 75.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.94 154.78 50.35 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.277 0.631 . . . . 0.0 111.591 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.9 pp -149.1 169.69 20.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.494 1.14 . . . . 0.0 113.962 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.02 -126.03 1.28 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.643 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -142.21 128.56 19.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.3 1.04 . . . . 0.0 112.32 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 t -66.94 -12.13 58.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.714 1.606 . . . . 0.0 114.91 -174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 -15.77 63.2 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.13 148.84 22.28 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.867 1.267 . . . . 0.0 112.299 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.15 -38.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.71 0.804 . . . . 0.0 111.572 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -76.13 41.32 0.23 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.523 1.529 . . . . 0.0 112.834 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -52.5 117.15 2.66 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.911 -1.743 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 61.1 m 51.7 24.55 2.45 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -56.32 -33.55 65.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.622 -1.299 . . . . 0.0 113.32 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -57.9 -34.12 70.7 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.979 0.799 . . . . 0.0 113.522 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.89 -40.43 10.62 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.412 -1.052 . . . . 0.0 112.936 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -59.27 -35.75 74.28 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.293 1.047 . . . . 0.0 113.257 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -59.9 -41.88 92.6 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.231 1.013 . . . . 0.0 112.223 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -75.86 -29.04 58.41 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.443 -0.786 . . . . 0.0 112.684 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.27 -43.79 80.94 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.076 -1.64 . . . . 0.0 111.289 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.18 84.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.111 0.964 . . . . 0.0 113.199 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.5 tp -49.04 -29.39 4.95 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 112.964 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.0 mt -102.69 -42.91 5.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.567 1.147 . . . . 0.0 111.642 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.18 -31.44 72.63 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.756 1.162 . . . . 0.0 112.76 169.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.88 -18.64 63.25 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.094 -1.004 . . . . 0.0 112.86 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -107.03 15.3 25.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.865 1.666 . . . . 0.0 112.39 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 48.2 m 62.43 14.92 7.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.944 2.097 . . . . 0.0 115.276 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.02 156.64 17.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.915 0.78 . . . . 0.0 112.008 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -116.53 164.8 14.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.852 1.661 . . . . 0.0 109.897 -169.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.2 mtm105 -129.61 146.13 51.44 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.46 21.01 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 113.368 -1.742 . . . . 0.0 112.368 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.6 -176.71 46.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.104 1.811 . . . . 0.0 113.464 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.21 159.3 22.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 112.112 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 49.5 ttm -68.38 127.08 31.66 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.433 0.693 . . . . 0.0 112.388 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.81 133.56 35.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 169.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.33 94.26 3.75 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.864 1.266 . . . . 0.0 111.356 -169.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.17 138.57 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.443 0.697 . . . . 0.0 111.817 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.98 114.93 23.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.535 1.534 . . . . 0.0 111.429 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.19 -25.32 58.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m -79.86 1.36 27.34 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -132.47 -27.75 1.72 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.833 1.253 . . . . 0.0 113.453 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -142.47 108.33 5.64 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 112.104 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.87 -0.99 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.112 3.208 . . . . 0.0 114.571 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -128.18 74.71 79.27 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.465 1.906 . . . . 0.0 109.842 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -57.94 -22.0 52.49 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.445 3.43 . . . . 0.0 116.551 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.04 -37.81 72.32 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.932 -1.105 . . . . 0.0 113.122 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.8 p -68.56 -6.35 24.97 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.317 1.047 . . . . 0.0 113.476 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -110.47 -12.99 14.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.211 1.404 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -129.17 -24.54 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -51.48 -52.73 57.11 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 117.703 -1.141 . . . . 0.0 113.251 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.11 -27.58 41.78 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.78 1.654 . . . . 0.0 113.419 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 60.9 t90 -62.51 -49.91 73.5 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.459 0.704 . . . . 0.0 111.083 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.4 t -70.66 -33.64 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 121.558 -0.714 . . . . 0.0 111.113 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.52 -16.65 63.88 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 172.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -95.98 -59.26 1.89 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.826 1.251 . . . . 0.0 111.759 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -54.63 -46.04 73.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.775 1.23 . . . . 0.0 112.473 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.91 -19.6 22.83 Favored Glycine 0 CA--C 1.541 1.703 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 33.2 p -76.86 -11.99 59.9 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.986 1.893 . . . . 0.0 113.715 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.08 -9.32 17.89 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 126.1 45.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.609 1.164 . . . . 0.0 113.698 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 97.0 p . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.885 2.474 . . . . 0.0 110.563 170.798 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 120.326 0.108 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.02 -177.95 3.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.726 1.61 . . . . 0.0 112.525 -172.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -127.99 125.2 38.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 0.0 108.679 174.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 mm -123.07 124.25 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.398 1.079 . . . . 0.0 112.569 -171.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.62 128.52 9.24 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.5 mt -119.25 91.0 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -170.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -91.22 135.41 33.81 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.173 0.989 . . . . 0.0 111.565 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.2 142.56 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.011 -170.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.16 104.72 0.55 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -147.7 169.49 19.59 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.911 1.284 . . . . 0.0 110.807 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.7 mtp -116.65 -7.2 11.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.283 1.033 . . . . 0.0 113.029 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -148.37 -32.0 0.26 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.39 -1.58 2.71 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.88 -42.18 97.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.144 1.972 . . . . 0.0 113.199 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -78.37 -31.87 48.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 172.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.3 tp -57.71 -40.09 78.74 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.037 -1.039 . . . . 0.0 113.08 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.87 -45.1 70.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.312 0.645 . . . . 0.0 111.464 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -65.72 -39.38 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.834 0.454 . . . . 0.0 111.834 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.42 87.45 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.19 0.905 . . . . 0.0 113.159 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.12 -44.24 96.17 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.564 -0.71 . . . . 0.0 111.886 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.31 -40.74 97.3 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.665 -0.647 . . . . 0.0 112.068 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -46.31 90.65 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.854 0.752 . . . . 0.0 111.799 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.44 -47.0 80.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.013 0.525 . . . . 0.0 111.493 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.67 -47.36 85.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.789 0.836 . . . . 0.0 112.911 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.32 -46.35 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.556 1.142 . . . . 0.0 112.225 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.5 mt -69.78 -40.79 75.81 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.942 -0.474 . . . . 0.0 109.751 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.5 m -56.24 -46.54 79.55 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.859 1.264 . . . . 0.0 112.215 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.54 89.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.367 1.067 . . . . 0.0 112.955 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -68.71 -30.77 69.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.393 0.677 . . . . 0.0 112.671 175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.57 -6.69 4.56 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.875 1.226 . . . . 0.0 115.556 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -79.07 144.1 34.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 111.04 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -69.82 134.9 49.04 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.76 142.68 31.03 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.8 0.727 . . . . 0.0 112.293 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.6 m -141.45 114.83 8.83 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.086 0.954 . . . . 0.0 110.137 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.6 p -80.53 149.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.919 0.888 . . . . 0.0 111.974 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -137.94 104.9 5.39 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.711 1.605 . . . . 0.0 109.321 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.82 -33.04 70.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.555 1.542 . . . . 0.0 114.522 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -145.81 62.88 8.83 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.418 1.887 . . . . 0.0 109.437 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.67 160.1 49.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.911 3.074 . . . . 0.0 115.658 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.94 170.59 15.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.423 2.289 . . . . 0.0 109.026 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -57.71 -34.99 70.04 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.7 -1.25 . . . . 0.0 113.443 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.2 p -61.21 -15.49 34.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -86.38 -33.38 20.52 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.568 1.076 . . . . 0.0 112.503 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.46 ' CH2' HG21 ' A' ' 52' ' ' VAL . 39.6 t-105 -75.52 -37.15 60.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.302 1.041 . . . . 0.0 112.501 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.9 tp -43.92 -50.53 19.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 127.789 2.436 . . . . 0.0 115.216 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.61 -1.59 6.93 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.072 2.515 . . . . 0.0 115.708 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -120.18 0.46 10.68 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.181 1.392 . . . . 0.0 114.02 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -60.84 -14.82 24.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -121.19 18.74 11.55 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.619 2.368 . . . . 0.0 112.267 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -124.43 -138.05 0.29 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.697 2.399 . . . . 0.0 108.649 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -123.32 157.86 32.3 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.532 1.533 . . . . 0.0 109.303 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG21 ' CH2' ' A' ' 44' ' ' TRP . 18.9 m -146.33 166.79 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.111 1.364 . . . . 0.0 110.08 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.18 144.88 20.19 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.239 -0.913 . . . . 0.0 110.654 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.8 t -113.44 132.86 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.382 1.473 . . . . 0.0 110.334 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.78 91.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.52 1.128 . . . . 0.0 108.757 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 m -135.8 138.13 42.28 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -85.15 -167.76 1.96 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.767 2.027 . . . . 0.0 113.034 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -135.81 141.95 44.79 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.537 -1.352 . . . . 0.0 111.157 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.9 t -142.12 -169.26 2.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.197 1.799 . . . . 0.0 109.539 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 46.24 37.32 7.97 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 126.08 1.8 . . . . 0.0 116.881 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 67.96 10.7 7.97 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.734 2.014 . . . . 0.0 114.518 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.61 28.38 0.07 OUTLIER Glycine 0 N--CA 1.474 1.185 0 N-CA-C 117.876 1.91 . . . . 0.0 117.876 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.22 168.21 18.44 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 120.094 1.947 . . . . 0.0 114.269 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mt -49.47 127.4 17.58 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 127.511 2.324 . . . . 0.0 113.133 174.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.27 141.78 94.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.296 3.331 . . . . 0.0 111.351 169.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.37 -25.99 67.54 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -171.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.3 m -63.21 -12.16 26.37 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.3 tt -125.19 -10.39 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.93 -47.65 63.43 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.263 -1.351 . . . . 0.0 113.33 170.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.15 -19.2 34.55 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 CA-C-N 122.46 1.914 . . . . 0.0 113.987 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 tp -78.02 -42.72 31.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.179 0.9 . . . . 0.0 109.606 171.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -62.04 -45.92 91.42 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.518 1.127 . . . . 0.0 111.386 177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -62.77 -40.93 98.81 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.659 -1.276 . . . . 0.0 112.676 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -45.46 69.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.568 1.08 . . . . 0.0 112.967 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.5 mt -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 119.427 1.613 . . . . 0.0 109.98 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.79 -46.12 78.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.654 1.181 . . . . 0.0 112.265 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.24 -35.17 36.48 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -90.82 -33.95 15.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.22 -53.55 4.19 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.625 1.102 . . . . 0.0 111.689 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.83 -37.59 0.29 Allowed Glycine 0 CA--C 1.544 1.862 0 C-N-CA 126.164 1.84 . . . . 0.0 115.803 -176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -161.87 124.7 3.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.363 1.865 . . . . 0.0 110.557 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -149.58 53.75 1.4 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 126.035 1.734 . . . . 0.0 113.085 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -57.78 -27.63 78.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.942 3.095 . . . . 0.0 115.13 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.81 -26.46 67.69 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.889 1.276 . . . . 0.0 114.247 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.6 tp -77.78 142.1 38.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.678 0.791 . . . . 0.0 112.527 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -138.08 145.61 41.93 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.038 2.135 . . . . 0.0 110.054 -172.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 118' ' ' ARG . 29.2 p90 -161.0 -171.15 2.96 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -169.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.91 165.26 33.08 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.933 2.206 . . . . 0.0 110.525 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.4 t -139.65 134.78 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.076 0.938 . . . . 0.0 112.618 -169.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.8 mt -118.3 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.16 148.25 40.55 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.173 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.07 151.41 45.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.175 0.988 . . . . 0.0 112.075 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.78 -133.57 2.76 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.164 169.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -142.65 133.1 24.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.421 1.088 . . . . 0.0 111.967 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.7 p -68.32 -6.12 22.43 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 m -68.64 3.18 1.98 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -136.64 154.59 50.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.788 1.635 . . . . 0.0 111.749 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.85 -36.23 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.632 0.773 . . . . 0.0 112.897 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.43 44.78 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.769 0.827 . . . . 0.0 111.944 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -53.77 116.61 2.61 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.553 -1.342 . . . . 0.0 112.003 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 56.7 m 50.83 23.93 1.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.964 2.506 . . . . 0.0 116.957 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.07 -26.28 67.53 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.661 -1.274 . . . . 0.0 114.09 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.47 -30.09 73.46 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.733 0.697 . . . . 0.0 113.404 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.0 -38.71 9.04 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.08 0.94 . . . . 0.0 113.179 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.18 -35.16 74.75 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.509 1.155 . . . . 0.0 113.52 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -59.38 -37.84 78.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.494 0.718 . . . . 0.0 112.423 170.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.04 -33.2 61.71 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.322 -0.861 . . . . 0.0 112.477 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.87 -43.7 98.31 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.95 -1.719 . . . . 0.0 110.911 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.7 89.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.3 tp -46.31 -44.04 16.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.495 1.518 . . . . 0.0 111.998 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.23 -28.63 57.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.114 1.366 . . . . 0.0 112.449 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.16 -29.74 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.106 -0.996 . . . . 0.0 111.587 169.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -66.01 -23.86 66.65 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 119.638 1.108 . . . . 0.0 111.607 169.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -88.05 1.89 53.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.646 1.178 . . . . 0.0 111.967 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m 53.38 22.73 2.94 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.995 1.718 . . . . 0.0 114.83 -172.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 156.1 24.34 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.697 0.799 . . . . 0.0 111.433 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -119.48 87.63 2.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.502 1.521 . . . . 0.0 111.539 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 30.2 ttp85 -59.47 137.86 57.87 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.487 -0.758 . . . . 0.0 112.041 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.67 51.13 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 126.341 1.856 . . . . 0.0 109.967 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.85 -174.86 44.7 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.326 -0.859 . . . . 0.0 114.083 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.08 147.16 44.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.25 1.42 . . . . 0.0 110.717 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.06 130.66 42.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.452 0.701 . . . . 0.0 111.86 -169.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.34 134.65 35.26 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 92.29 3.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.681 1.192 . . . . 0.0 111.246 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.5 mt -85.1 134.3 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.468 1.507 . . . . 0.0 111.631 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -121.56 109.16 14.46 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.623 1.169 . . . . 0.0 112.809 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.42 -23.39 49.23 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 174.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 m -83.5 0.82 44.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.416 1.087 . . . . 0.0 113.867 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -129.21 -26.54 2.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.398 1.079 . . . . 0.0 113.417 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -146.59 119.29 4.97 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.007 0.822 . . . . 0.0 112.835 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.0 -5.11 12.12 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.895 3.063 . . . . 0.0 114.216 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.43 73.94 80.11 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.54 1.536 . . . . 0.0 111.175 -172.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.06 -17.08 58.41 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.311 3.34 . . . . 0.0 115.055 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -48.15 -44.21 32.14 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.146 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.5 p -67.78 -18.41 64.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.51 -17.74 16.27 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.209 1.004 . . . . 0.0 112.425 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -113.42 -28.43 7.56 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -59.9 -52.12 75.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.717 -1.135 . . . . 0.0 113.204 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.49 -28.93 61.95 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.349 1.518 . . . . 0.0 112.773 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -60.95 -50.29 73.98 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.609 0.641 . . . . 0.0 111.658 171.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.45 -41.43 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.684 0.675 . . . . 0.0 110.461 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.91 -39.45 85.45 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.453 0.57 . . . . 0.0 111.966 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -67.19 -56.32 10.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.883 0.873 . . . . 0.0 112.51 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -53.35 -46.23 69.46 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.414 1.086 . . . . 0.0 111.4 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.5 -23.61 6.59 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.393 1.949 . . . . 0.0 116.507 174.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.9 p -72.69 -18.52 61.54 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.068 1.934 . . . . 0.0 114.072 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.65 -15.47 25.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.487 1.515 . . . . 0.0 113.109 -171.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.49 157.67 22.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.521 2.328 . . . . 0.0 113.154 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.256 1.397 0 C-N-CA 128.156 2.582 . . . . 0.0 114.649 -173.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.94 177.16 7.94 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.79 1.636 . . . . 0.0 111.999 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -131.88 129.49 40.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.633 1.173 . . . . 0.0 110.094 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 mm -122.0 125.17 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.894 0.878 . . . . 0.0 112.937 -170.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.84 124.87 7.05 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.8 mt -116.41 91.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.448 1.099 . . . . 0.0 108.26 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -94.68 136.09 35.38 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.021 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.31 145.21 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.215 0.606 . . . . 0.0 111.669 -169.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.73 80.92 0.3 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 125.188 1.375 . . . . 0.0 110.741 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -134.03 168.58 18.54 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.0 tpt -130.58 -4.18 4.2 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.938 2.095 . . . . 0.0 112.203 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -142.82 -54.74 0.41 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.114 . . . . 0.0 113.229 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.08 -2.98 1.04 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 117.097 1.599 . . . . 0.0 117.097 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -62.79 -44.14 96.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.881 1.341 . . . . 0.0 112.289 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 p -71.59 -35.76 70.63 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.286 1.434 . . . . 0.0 112.309 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 tp -60.51 -40.78 92.65 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.718 -1.239 . . . . 0.0 112.457 174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.49 -41.17 76.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.879 0.763 . . . . 0.0 111.82 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.52 -37.92 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.847 -0.533 . . . . 0.0 112.023 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.1 97.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.35 0.977 . . . . 0.0 112.844 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.48 -40.33 94.16 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.575 0.75 . . . . 0.0 112.413 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.51 -45.64 93.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.386 -0.821 . . . . 0.0 112.102 169.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.19 88.29 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.726 -0.609 . . . . 0.0 112.198 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.19 -47.73 77.76 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.512 0.725 . . . . 0.0 111.648 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.84 92.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.564 0.745 . . . . 0.0 112.676 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.1 -47.25 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.749 1.219 . . . . 0.0 112.355 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.09 -39.35 79.08 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.253 0.621 . . . . 0.0 109.805 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.1 m -57.01 -48.71 77.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.988 1.315 . . . . 0.0 111.975 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -34.97 79.16 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.025 0.93 . . . . 0.0 113.399 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.26 -8.31 56.29 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.43 36.95 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.974 1.273 . . . . 0.0 115.009 171.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -77.24 172.17 13.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.764 1.226 . . . . 0.0 111.557 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -104.97 145.29 30.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.276 1.03 . . . . 0.0 108.543 169.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -145.78 164.17 32.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.47 -0.769 . . . . 0.0 112.788 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.6 m -152.79 120.97 6.22 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 110.565 173.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.16 138.63 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.053 0.941 . . . . 0.0 110.651 169.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -125.9 107.4 10.44 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.88 1.272 . . . . 0.0 109.606 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -84.65 -14.43 48.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -143.2 56.67 4.9 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 126.074 1.75 . . . . 0.0 110.199 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.15 165.4 31.55 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.095 3.197 . . . . 0.0 115.524 -169.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.15 166.38 26.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.181 2.193 . . . . 0.0 109.037 172.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -40.15 25.56 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.577 1.151 . . . . 0.0 112.404 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.02 -20.12 15.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -97.12 -29.09 13.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.934 1.293 . . . . 0.0 112.181 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -70.66 -42.01 71.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.511 . . . . 0.0 112.771 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.08 -52.79 49.92 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.222 2.209 . . . . 0.0 114.687 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -65.77 -3.65 8.48 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.002 2.468 . . . . 0.0 115.956 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -110.72 1.11 17.67 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.888 1.275 . . . . 0.0 114.07 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -66.24 -30.29 70.7 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.484 -1.385 . . . . 0.0 113.418 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.97 3.93 13.43 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.923 1.289 . . . . 0.0 113.365 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -132.45 -123.77 0.19 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.286 1.835 . . . . 0.0 110.14 -169.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -140.51 160.0 40.97 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.909 1.684 . . . . 0.0 110.768 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.44 168.47 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 110.65 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.57 146.26 19.47 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.386 -0.821 . . . . 0.0 110.466 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -117.91 137.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.062 1.345 . . . . 0.0 110.595 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.2 94.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.873 1.269 . . . . 0.0 108.091 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.1 m -133.8 167.06 21.24 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.4 p -141.22 173.93 11.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.71 2.004 . . . . 0.0 112.047 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.7 m -99.14 150.97 21.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.748 1.219 . . . . 0.0 112.447 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 p -144.16 -169.89 3.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 128.17 2.588 . . . . 0.0 108.739 170.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 47.07 26.28 2.96 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 126.233 1.873 . . . . 0.0 117.296 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 56.05 13.27 1.12 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.121 2.168 . . . . 0.0 114.231 -169.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.69 38.0 0.02 OUTLIER Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.385 0.993 . . . . 0.0 114.4 -174.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.71 177.52 8.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.914 1.686 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.03 147.15 34.01 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.411 1.885 . . . . 0.0 110.396 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.86 154.38 63.41 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.614 2.876 . . . . 0.0 111.36 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.48 -14.22 56.02 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.9 p -59.18 -27.51 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.633 1.173 . . . . 0.0 113.538 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.64 -9.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.563 1.145 . . . . 0.0 113.965 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.4 t -49.94 -46.03 81.12 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 120.369 -1.457 . . . . 0.0 112.716 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.19 -15.49 23.67 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.02 3.146 . . . . 0.0 116.119 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.1 tp -98.31 -45.7 6.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.88 1.272 . . . . 0.0 109.806 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -63.42 -45.36 91.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.032 1.333 . . . . 0.0 112.251 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -68.81 -38.5 79.94 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.57 -47.04 64.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.143 0.878 . . . . 0.0 112.936 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.33 -44.33 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 118.224 1.012 . . . . 0.0 110.652 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -62.85 -47.45 83.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.997 0.919 . . . . 0.0 112.524 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.22 -26.96 24.78 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -125.9 6.1 7.33 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.177 1.918 . . . . 0.0 116.177 -169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.7 mt -123.03 -50.81 1.91 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.517 1.053 . . . . 0.0 111.48 169.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.32 -27.06 0.26 Allowed Glycine 0 CA--C 1.543 1.806 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -158.8 131.79 7.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.45 1.625 . . . . 0.0 110.845 -175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -159.12 52.84 0.52 Allowed Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.14 -32.28 39.26 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.463 2.775 . . . . 0.0 116.582 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -73.14 -13.19 61.13 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 tp -73.94 140.15 45.39 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.978 0.808 . . . . 0.0 111.845 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -135.45 144.14 46.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.102 1.761 . . . . 0.0 109.505 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -162.8 -169.43 2.06 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.29 163.05 31.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.798 2.142 . . . . 0.0 110.384 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.13 138.05 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 122.233 1.016 . . . . 0.0 112.62 -172.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.3 mt -122.1 131.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.323 1.849 . . . . 0.0 106.052 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.46 147.14 49.85 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.492 0.717 . . . . 0.0 110.36 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.8 tt -139.13 142.82 38.04 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.069 0.947 . . . . 0.0 111.601 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.58 -147.86 7.79 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.362 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -144.15 121.6 11.7 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.273 1.429 . . . . 0.0 110.029 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.5 p -62.41 -5.26 2.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.4 m -60.66 -13.2 13.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.433 1.493 . . . . 0.0 114.453 169.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -123.21 157.45 33.01 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.72 1.208 . . . . 0.0 113.638 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.7 m -50.69 -23.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -168.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.99 1.84 4.3 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -173.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 14.5 t80 36.54 -128.83 0.14 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.832 1.253 . . . . 0.0 112.784 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.4 m -80.99 21.38 0.7 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.86 -33.27 48.98 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.34 95.52 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.758 1.163 . . . . 0.0 113.327 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.2 -40.25 71.27 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 121.613 -0.934 . . . . 0.0 112.95 171.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.01 -38.45 88.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.383 1.091 . . . . 0.0 113.132 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -59.05 -43.59 91.7 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.506 0.594 . . . . 0.0 111.776 170.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.66 -36.61 78.78 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.45 -43.09 98.38 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 119.811 -1.806 . . . . 0.0 111.711 170.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 -32.17 69.87 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 tp -49.75 -28.36 6.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 112.956 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 mt -102.35 -37.69 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 -169.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.1 -31.9 73.04 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.938 1.244 . . . . 0.0 111.533 169.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.02 -17.33 24.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 113.024 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -119.81 16.53 12.68 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.122 1.769 . . . . 0.0 112.463 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m 67.74 18.64 9.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.91 2.084 . . . . 0.0 115.515 173.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.7 152.75 18.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.425 -0.797 . . . . 0.0 112.386 172.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -122.43 86.91 2.66 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.906 1.682 . . . . 0.0 110.904 -169.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 ttm105 -61.83 141.58 57.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.675 -0.64 . . . . 0.0 111.481 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.83 33.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.484 1.514 . . . . 0.0 111.204 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.8 -163.29 37.02 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.07 -1.019 . . . . 0.0 113.222 -173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.25 156.48 43.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.71 1.604 . . . . 0.0 111.293 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.8 ttm -65.19 127.08 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.302 1.041 . . . . 0.0 111.776 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -82.3 134.42 35.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.57 93.76 4.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.01 1.324 . . . . 0.0 111.522 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 25.9 mt -82.5 132.03 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.63 1.172 . . . . 0.0 110.479 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -131.75 107.71 8.96 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 112.352 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.3 -19.06 31.67 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 m -69.28 -14.11 62.76 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.915 1.234 . . . . 0.0 114.212 171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.38 -12.53 1.59 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -142.91 102.56 5.29 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.29 0.95 . . . . 0.0 112.514 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.72 1.7 9.0 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.87 3.046 . . . . 0.0 114.267 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -121.53 77.0 36.06 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.342 1.857 . . . . 0.0 109.729 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -60.09 -24.81 78.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.21 3.273 . . . . 0.0 114.861 -169.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.15 -44.58 71.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 111.969 170.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.2 p -66.06 -20.63 66.24 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.98 -15.76 27.5 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 112.675 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.8 p -123.26 -28.8 3.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -54.2 -52.89 64.71 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 119.503 1.047 . . . . 0.0 113.68 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.35 -29.0 32.46 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.777 1.652 . . . . 0.0 112.673 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.13 -48.73 78.85 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.787 0.721 . . . . 0.0 111.62 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.7 t -67.79 -40.37 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 118.425 0.557 . . . . 0.0 110.331 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.39 -40.16 85.7 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.595 0.634 . . . . 0.0 111.911 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -65.03 -58.43 6.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.911 0.884 . . . . 0.0 112.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -53.24 -46.78 69.31 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.086 0.954 . . . . 0.0 111.701 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -51.98 -24.17 13.55 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.123 1.821 . . . . 0.0 116.382 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.7 p -71.43 -19.81 62.19 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.933 1.866 . . . . 0.0 114.072 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.93 -16.25 25.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.243 1.417 . . . . 0.0 112.977 -170.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.37 155.23 21.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.529 2.332 . . . . 0.0 111.599 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 124.772 1.229 . . . . 0.0 113.585 174.112 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.35 178.97 4.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.727 1.611 . . . . 0.0 112.901 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -129.23 118.03 21.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.724 2.01 . . . . 0.0 108.032 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.99 126.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.05 131.72 10.68 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mt -120.9 91.08 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.271 1.428 . . . . 0.0 107.439 -171.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -92.58 141.55 28.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.989 -169.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.8 148.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.569 0.748 . . . . 0.0 112.071 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.31 97.54 0.21 Allowed Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.165 1.364 . . . . 0.0 110.406 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -144.34 168.38 20.23 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.23 -24.37 6.45 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.312 1.845 . . . . 0.0 112.558 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -134.7 -4.65 2.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 2.09 64.57 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -64.94 -45.41 85.9 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 1.591 . . . . 0.0 112.123 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -69.43 -36.22 76.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.093 1.357 . . . . 0.0 112.408 172.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.4 tp -59.39 -42.13 91.01 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.956 -1.09 . . . . 0.0 112.715 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.9 -41.88 78.91 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.653 0.661 . . . . 0.0 111.575 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.53 -35.42 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.662 -0.649 . . . . 0.0 112.271 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.74 97.09 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.179 -0.951 . . . . 0.0 112.504 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.76 -41.04 99.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.371 0.668 . . . . 0.0 112.398 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.04 -46.46 88.15 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.504 -0.748 . . . . 0.0 111.652 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.52 85.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.389 0.676 . . . . 0.0 112.217 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.64 -47.65 76.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.777 0.831 . . . . 0.0 111.882 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.19 -47.4 86.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.538 0.735 . . . . 0.0 112.843 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.94 -45.56 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.591 1.156 . . . . 0.0 111.887 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.5 mt -69.59 -41.41 75.81 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.734 -0.604 . . . . 0.0 109.791 -176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.5 m -56.64 -45.65 81.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.872 1.269 . . . . 0.0 111.998 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.8 -38.0 85.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.986 0.914 . . . . 0.0 113.1 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -70.76 -23.07 62.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.3 -8.27 7.94 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.323 1.44 . . . . 0.0 114.981 170.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.13 167.52 20.09 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.654 1.182 . . . . 0.0 112.111 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -100.89 137.87 38.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.323 1.449 . . . . 0.0 109.474 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.28 159.16 43.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.269 0.628 . . . . 0.0 112.432 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -153.77 119.84 5.39 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.974 0.91 . . . . 0.0 111.133 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.7 t -74.26 141.79 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.222 1.009 . . . . 0.0 110.801 170.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.4 104.28 7.83 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.856 1.262 . . . . 0.0 110.586 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.65 -17.34 38.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -142.35 60.87 10.91 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 125.563 1.545 . . . . 0.0 110.582 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.91 166.31 29.98 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.374 3.383 . . . . 0.0 115.694 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.35 162.74 37.53 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.637 2.375 . . . . 0.0 109.181 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.92 -38.49 56.51 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.691 -1.255 . . . . 0.0 113.655 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -62.23 -13.96 33.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -92.06 -25.48 18.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.669 1.122 . . . . 0.0 112.807 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -80.98 -40.76 23.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.557 1.543 . . . . 0.0 112.617 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.0 tp -50.08 -41.01 61.53 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -55.38 -9.63 2.61 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 125.108 3.872 . . . . 0.0 118.349 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -118.17 4.54 11.97 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -70.06 -9.86 56.79 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -110.65 17.72 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.423 1.489 . . . . 0.0 112.613 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -134.52 -135.62 0.16 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.572 1.949 . . . . 0.0 110.209 -169.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.63 159.82 38.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.702 1.601 . . . . 0.0 111.145 173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.78 178.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.102 1.361 . . . . 0.0 111.581 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -155.7 149.31 25.07 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.538 1.935 . . . . 0.0 108.232 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.429 ' H ' HD23 ' A' ' 53' ' ' LEU . 89.4 t -130.33 133.44 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.577 1.151 . . . . 0.0 108.867 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.27 90.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.032 1.333 . . . . 0.0 109.47 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 m -134.39 157.34 46.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -168.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 t -130.76 -164.66 1.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.487 1.515 . . . . 0.0 112.747 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.8 m -130.69 150.14 52.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.519 1.928 . . . . 0.0 111.318 -169.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.8 t -148.48 -171.18 3.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.315 2.246 . . . . 0.0 108.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 49.03 35.13 17.88 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.549 1.547 . . . . 0.0 116.122 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.555 ' H ' HM73 ' A' ' 201' ' ' FMN . 86.6 mt-30 63.57 4.0 1.67 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 127.461 2.304 . . . . 0.0 115.361 -174.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.01 39.79 0.02 OUTLIER Glycine 0 N--CA 1.472 1.034 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -143.09 162.2 36.15 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.282 1.541 . . . . 0.0 112.334 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.11 151.59 95.98 Favored Pre-proline 0 CA--C 1.553 1.089 0 O-C-N 121.682 -0.637 . . . . 0.0 111.739 170.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.91 158.33 20.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.391 2.728 . . . . 0.0 112.332 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.2 -21.39 63.79 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.5 m -57.27 -17.42 11.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.543 1.537 . . . . 0.0 114.741 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.0 tt -132.88 -9.49 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.2 t -45.83 -49.32 38.38 Favored Pre-proline 0 N--CA 1.481 1.094 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.599 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.27 -24.72 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.967 1.738 . . . . 0.0 113.7 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.94 -47.49 45.11 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.367 -0.833 . . . . 0.0 110.118 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -58.68 -50.88 72.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.746 1.619 . . . . 0.0 112.151 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -62.88 -41.36 99.37 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.203 -0.935 . . . . 0.0 112.349 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.89 -47.67 80.25 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.451 1.024 . . . . 0.0 113.141 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.59 -39.4 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 118.979 1.39 . . . . 0.0 111.316 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -65.15 -47.88 75.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.087 0.555 . . . . 0.0 111.751 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.31 -36.29 24.57 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.9 m -84.15 -30.81 25.57 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -173.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.3 mt -100.13 -49.5 4.27 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.876 0.762 . . . . 0.0 112.622 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.67 -34.3 0.28 Allowed Glycine 0 CA--C 1.544 1.877 0 C-N-CA 126.21 1.862 . . . . 0.0 116.143 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -158.17 135.75 10.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.833 2.053 . . . . 0.0 110.349 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -156.87 97.77 2.09 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.939 0.895 . . . . 0.0 112.862 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.85 -20.72 10.18 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.473 2.782 . . . . 0.0 114.418 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -80.66 -17.21 51.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -174.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.9 tp -70.72 138.68 50.75 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.771 -0.58 . . . . 0.0 111.779 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -137.49 138.66 39.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.726 2.01 . . . . 0.0 108.966 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -163.5 -173.37 3.29 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.48 162.87 28.49 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.393 1.949 . . . . 0.0 109.038 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.79 132.09 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 118.015 0.907 . . . . 0.0 112.971 -169.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.19 128.07 74.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.54 155.02 44.45 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 122.297 1.046 . . . . 0.0 110.293 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 tt -139.53 151.85 46.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.342 1.057 . . . . 0.0 108.705 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.39 -144.26 7.86 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 112.078 169.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -137.77 121.27 17.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.916 0.887 . . . . 0.0 110.559 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.1 p -71.99 -2.17 17.22 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -69.92 4.2 2.19 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -136.87 159.39 41.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.21 1.804 . . . . 0.0 112.425 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.19 -32.42 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.83 1.252 . . . . 0.0 113.412 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -103.94 44.11 1.04 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.812 1.245 . . . . 0.0 112.409 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -49.38 111.37 0.48 Allowed 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.677 -1.264 . . . . 0.0 112.289 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 85.7 m 52.78 28.15 6.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.22 2.208 . . . . 0.0 116.955 -173.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -53.22 -40.99 64.93 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.445 1.02 . . . . 0.0 112.225 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.89 -36.89 92.84 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 122.132 -0.355 . . . . 0.0 113.134 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.19 46.58 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.557 -0.967 . . . . 0.0 113.052 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.91 -34.49 76.15 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.649 1.179 . . . . 0.0 113.057 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -60.43 -42.76 96.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.47 0.577 . . . . 0.0 111.626 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -71.47 -28.77 64.17 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -64.77 -50.91 64.97 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.624 -1.297 . . . . 0.0 110.241 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.84 -40.13 72.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.498 0.719 . . . . 0.0 112.901 176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.5 tp -49.61 -27.32 4.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 114.111 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.0 -38.42 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 111.782 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -69.71 -16.16 63.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.895 0.878 . . . . 0.0 112.73 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -109.06 -15.3 14.37 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 -170.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.0 m 112.73 13.42 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 129.731 3.212 . . . . 0.0 114.013 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.92 147.42 23.76 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 118.886 0.766 . . . . 0.0 111.898 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -121.72 84.02 2.18 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 109.855 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.8 mtm105 -60.84 152.41 27.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.58 27.89 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.936 1.695 . . . . 0.0 110.869 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -179.2 175.06 46.93 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.372 1.939 . . . . 0.0 112.184 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -123.27 157.88 32.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.373 1.469 . . . . 0.0 111.88 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 45.9 ttm -63.92 117.02 6.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.369 1.068 . . . . 0.0 112.171 -171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.01 141.34 37.55 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.0 81.68 2.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 111.64 -173.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.34 136.74 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 110.139 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -131.26 98.5 4.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.513 1.149 . . . . 0.0 113.679 -169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.13 7.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.323 1.449 . . . . 0.0 114.695 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.4 p -67.6 -19.42 65.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.567 1.076 . . . . 0.0 113.099 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -140.32 -8.94 1.13 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -134.63 108.64 10.98 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.018 0.927 . . . . 0.0 112.943 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.82 -0.63 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.336 3.358 . . . . 0.0 114.427 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.62 78.49 68.6 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.225 1.81 . . . . 0.0 109.713 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -60.58 -19.77 61.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.086 3.19 . . . . 0.0 115.368 -169.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -66.93 -29.69 69.62 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.962 -1.087 . . . . 0.0 113.893 172.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 80.7 p -68.24 -5.23 17.24 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -117.0 -8.76 11.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.131 1.372 . . . . 0.0 112.67 176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 p -127.14 -27.1 3.01 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.11 -52.56 67.45 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.286 169.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.24 -30.24 37.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.643 1.562 . . . . 0.0 113.325 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 64.6 t90 -58.74 -50.03 75.44 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.891 0.769 . . . . 0.0 111.136 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t -67.85 -41.53 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 118.825 -0.607 . . . . 0.0 110.676 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -59.63 -39.62 84.91 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.782 0.719 . . . . 0.0 112.117 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -67.93 -58.86 3.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 111.891 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -54.43 -44.6 72.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.713 1.205 . . . . 0.0 112.318 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.87 -23.77 16.71 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.914 1.721 . . . . 0.0 115.905 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.4 p -71.82 -17.65 62.14 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.735 1.767 . . . . 0.0 113.954 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.7 mt -93.95 -16.85 23.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.369 1.468 . . . . 0.0 112.996 -172.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.44 150.49 35.34 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.224 2.21 . . . . 0.0 111.747 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.0 m . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.648 1.579 . . . . 0.0 113.624 177.819 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.555 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.34 171.01 8.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.114 1.366 . . . . 0.0 112.07 174.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -139.96 119.81 13.45 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.07 1.748 . . . . 0.0 108.647 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.93 127.44 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.06 130.88 10.16 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 168.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -116.23 88.68 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.337 1.455 . . . . 0.0 107.176 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -88.46 126.73 35.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.857 -169.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.66 143.6 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.734 0.813 . . . . 0.0 110.691 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.35 96.64 0.27 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -143.87 170.34 16.09 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.546 1.138 . . . . 0.0 111.897 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.4 -0.63 5.65 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.756 1.223 . . . . 0.0 113.553 169.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -146.41 -24.05 0.43 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.36 -9.47 5.6 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 118.575 2.19 . . . . 0.0 118.575 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.08 -41.64 92.89 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.645 2.222 . . . . 0.0 113.432 -173.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -78.19 -34.64 49.36 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.763 -0.586 . . . . 0.0 111.993 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.2 tp -55.99 -39.76 72.31 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.066 -1.022 . . . . 0.0 113.069 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -54.15 -40.7 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 111.713 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -71.02 -41.26 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 122.907 0.483 . . . . 0.0 111.937 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.3 -41.08 88.15 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.015 0.825 . . . . 0.0 112.499 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -60.56 -43.38 97.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.108 0.963 . . . . 0.0 112.676 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.48 -41.52 88.85 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.508 -0.745 . . . . 0.0 112.886 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.55 92.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.544 0.738 . . . . 0.0 111.809 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -56.5 -47.07 80.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.869 0.468 . . . . 0.0 111.869 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.91 88.48 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.776 0.83 . . . . 0.0 112.694 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.7 -45.66 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.524 1.13 . . . . 0.0 111.892 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.9 mt -72.62 -38.16 67.85 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 92.4 m -57.56 -47.25 82.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.454 1.101 . . . . 0.0 111.819 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.8 82.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.097 0.959 . . . . 0.0 113.157 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -73.07 -8.82 57.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 172.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.55 -2.46 32.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.428 1.49 . . . . 0.0 115.067 170.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -80.22 165.56 22.26 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.734 1.214 . . . . 0.0 112.631 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -92.5 134.18 35.22 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 169.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -143.08 142.32 31.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.193 0.597 . . . . 0.0 112.108 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.3 m -144.72 109.36 4.94 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.247 1.019 . . . . 0.0 111.025 -172.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -73.98 144.94 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -131.72 108.94 9.82 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.525 1.53 . . . . 0.0 108.442 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.8 -28.48 40.25 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -144.83 58.03 5.02 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.428 1.891 . . . . 0.0 110.1 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.73 159.65 52.81 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.768 2.979 . . . . 0.0 113.829 -169.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.28 163.85 26.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.0 2.12 . . . . 0.0 108.926 171.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tt -42.47 -44.62 4.13 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.347 1.459 . . . . 0.0 112.881 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -54.78 -26.46 34.68 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.928 1.691 . . . . 0.0 114.849 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -81.16 -35.98 30.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.413 1.085 . . . . 0.0 112.333 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.436 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 26.2 t-105 -75.68 -39.01 58.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.883 0.873 . . . . 0.0 112.419 175.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -36.31 -56.02 1.31 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 128.098 2.559 . . . . 0.0 115.422 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.42 -18.71 22.75 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.38 2.054 . . . . 0.0 114.748 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -78.54 -0.89 31.4 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -58.72 -25.97 63.46 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.745 -1.222 . . . . 0.0 113.795 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -97.1 12.49 32.48 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.355 1.462 . . . . 0.0 112.632 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -134.25 -145.62 0.24 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.004 2.522 . . . . 0.0 109.3 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.21 162.97 29.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.232 1.813 . . . . 0.0 109.408 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 34.5 m -148.34 171.79 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.356 1.062 . . . . 0.0 111.662 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.18 144.43 17.32 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.365 -0.835 . . . . 0.0 110.894 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.77 130.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.937 1.695 . . . . 0.0 110.565 -169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.46 89.07 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -134.66 136.11 42.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -168.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -87.85 -170.08 2.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.943 2.097 . . . . 0.0 113.069 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 83.0 m -136.67 138.53 41.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.401 1.081 . . . . 0.0 111.32 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -155.49 -171.01 3.63 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.813 1.188 . . . . 0.0 111.62 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.8 -74.13 0.05 OUTLIER Glycine 0 CA--C 1.54 1.625 0 C-N-CA 128.207 2.813 . . . . 0.0 115.784 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -140.69 11.62 2.27 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.03 2.132 . . . . 0.0 111.835 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.25 38.48 1.65 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.269 0.938 . . . . 0.0 112.902 -169.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -135.65 179.51 6.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.945 1.698 . . . . 0.0 112.658 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.78 142.25 98.52 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.53 1.132 . . . . 0.0 112.118 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.17 153.17 24.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.644 2.896 . . . . 0.0 111.973 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -60.32 -26.71 66.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -62.7 -11.15 15.52 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 tt -126.2 -3.42 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -53.53 -43.89 96.6 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 117.148 -1.406 . . . . 0.0 112.356 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.04 -5.37 2.73 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.373 3.382 . . . . 0.0 116.659 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mt -105.88 -48.48 3.62 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.461 1.105 . . . . 0.0 110.308 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.41 -41.34 96.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.666 0.787 . . . . 0.0 112.685 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -67.35 -44.44 79.05 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.451 -0.781 . . . . 0.0 112.214 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.98 -41.91 39.0 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.907 0.765 . . . . 0.0 113.938 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.16 -42.94 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.024 0.912 . . . . 0.0 110.053 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -66.16 -50.19 64.78 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.593 0.757 . . . . 0.0 112.234 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.44 -31.02 42.47 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.1 t -116.01 -43.36 2.99 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -169.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.5 mt -73.48 -44.34 58.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.459 1.027 . . . . 0.0 111.709 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.15 -28.95 0.2 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 126.679 2.085 . . . . 0.0 118.142 169.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -155.62 138.31 15.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.836 1.654 . . . . 0.0 110.102 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.6 39.59 0.19 Allowed Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -169.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.8 -34.08 15.22 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.476 2.784 . . . . 0.0 118.054 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -72.34 -20.24 61.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.14 118.46 13.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.271 1.428 . . . . 0.0 110.16 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -117.91 139.92 50.45 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.382 1.473 . . . . 0.0 110.127 174.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.67 -169.05 1.97 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 -168.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.3 32.62 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.231 2.348 . . . . 0.0 110.318 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.36 128.81 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.695 0.76 . . . . 0.0 111.644 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.2 mt -118.13 95.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.15 153.52 24.76 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.05 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tt -142.64 152.99 43.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.108 0.956 . . . . 0.0 111.502 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.57 -130.1 1.66 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.862 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -147.77 136.34 21.72 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.252 1.421 . . . . 0.0 111.533 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.5 p -68.83 -4.19 15.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.7 m -68.4 3.69 1.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -135.08 151.64 50.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.371 1.468 . . . . 0.0 112.277 -171.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.42 -37.14 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.883 0.873 . . . . 0.0 111.483 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -75.26 39.13 0.14 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.817 1.647 . . . . 0.0 112.907 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -52.21 116.06 2.04 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 119.653 -1.904 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 82.8 m 50.74 23.59 1.44 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.735 2.414 . . . . 0.0 117.174 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.3 -14.1 59.99 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.589 -1.319 . . . . 0.0 114.247 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.45 -28.54 63.43 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.134 -0.979 . . . . 0.0 113.414 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.21 -37.97 6.51 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.323 1.062 . . . . 0.0 113.313 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -56.66 -39.73 74.24 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.42 1.11 . . . . 0.0 113.658 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -60.11 -32.79 71.32 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -74.63 -22.2 59.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -76.56 -44.47 34.58 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.028 -1.67 . . . . 0.0 110.068 168.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.03 -37.63 66.92 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 tp -50.67 -28.41 8.89 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.259 1.824 . . . . 0.0 113.322 172.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.01 -37.13 6.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.953 1.301 . . . . 0.0 111.997 -173.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -68.8 -31.82 71.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.176 -0.952 . . . . 0.0 113.076 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.5 -10.66 36.53 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.123 0.874 . . . . 0.0 111.96 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -115.16 12.08 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.13 1.772 . . . . 0.0 112.816 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m 65.57 20.34 11.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.49 1.516 . . . . 0.0 114.86 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.45 169.5 0.89 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.667 0.787 . . . . 0.0 111.589 169.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -133.57 90.85 2.77 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.493 -1.379 . . . . 0.0 111.548 -169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ttm105 -63.89 134.37 55.02 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.439 -0.788 . . . . 0.0 110.924 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.39 29.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.651 1.58 . . . . 0.0 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.61 -168.43 41.49 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.633 1.111 . . . . 0.0 113.852 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.29 152.26 26.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.65 1.58 . . . . 0.0 111.259 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.1 ttm -71.92 138.1 47.88 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.075 0.95 . . . . 0.0 111.957 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -94.07 137.22 33.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.545 0.738 . . . . 0.0 109.042 169.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 123' ' ' LEU . 47.6 mt -119.76 93.45 4.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.686 1.594 . . . . 0.0 110.884 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 29.4 mt -79.26 135.76 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.537 0.735 . . . . 0.0 111.357 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -124.5 113.05 17.6 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.374 1.47 . . . . 0.0 112.047 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.19 62.95 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.7 m -80.9 1.06 32.53 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.53 1.132 . . . . 0.0 113.553 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -126.52 -27.94 3.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.07 1.348 . . . . 0.0 112.855 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -143.82 117.53 5.93 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.83 0.852 . . . . 0.0 112.85 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.92 -5.72 13.91 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.925 3.084 . . . . 0.0 114.548 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -130.58 76.2 77.79 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.827 1.651 . . . . 0.0 110.662 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -41.69 -34.89 2.44 Favored 'Trans proline' 0 C--N 1.354 0.857 1 C-N-CA 126.001 4.468 . . . . 0.0 118.016 -169.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -51.64 -39.06 57.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.1 p -69.75 -4.89 21.83 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.037 -1.039 . . . . 0.0 113.598 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -121.76 6.03 9.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.43 1.492 . . . . 0.0 112.416 176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.1 p -141.26 -26.66 0.7 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -55.05 -51.75 76.87 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 119.921 1.237 . . . . 0.0 113.433 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.48 -28.62 53.7 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.673 1.582 . . . . 0.0 113.052 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -60.91 -50.51 73.1 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.384 0.538 . . . . 0.0 111.297 170.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.51 -42.74 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.007 0.821 . . . . 0.0 110.488 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.59 -34.75 74.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.87 -64.27 0.97 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.074 0.852 . . . . 0.0 111.313 169.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -51.06 -49.16 61.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.57 1.548 . . . . 0.0 112.144 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.74 -26.3 24.72 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.368 1.461 . . . . 0.0 115.546 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -75.95 -15.5 60.16 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.232 1.516 . . . . 0.0 114.159 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.75 -15.94 33.44 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.181 0.992 . . . . 0.0 113.074 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.6 -18.16 65.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.337 1.455 . . . . 0.0 114.113 -175.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.948 1.699 . . . . 0.0 113.936 -171.177 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.5 -178.24 3.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.397 1.479 . . . . 0.0 112.826 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -126.99 130.13 49.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 109.503 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.41 126.45 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -171.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.03 130.72 10.07 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.7 mt -118.26 86.71 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.021 1.329 . . . . 0.0 107.594 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.284 -170.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.38 140.26 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.112 0.482 . . . . 0.0 111.416 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -129.4 112.46 1.35 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -153.77 152.04 30.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.832 0.853 . . . . 0.0 112.715 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 99.8 mmm -95.66 -25.18 16.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.166 0.987 . . . . 0.0 112.732 169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.93 -12.37 0.65 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -169.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.39 -9.06 8.86 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 116.601 1.401 . . . . 0.0 116.601 170.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -61.23 -41.42 96.85 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.691 1.745 . . . . 0.0 113.078 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 p -76.59 -34.44 58.41 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.188 0.995 . . . . 0.0 112.059 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.39 -39.41 83.28 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.682 -1.261 . . . . 0.0 113.208 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.2 tp -52.96 -47.47 68.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.382 0.992 . . . . 0.0 111.558 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.58 -35.14 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.81 0.444 . . . . 0.0 111.586 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -68.28 -37.05 80.3 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.55 -42.5 95.67 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.547 -0.72 . . . . 0.0 111.593 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -57.87 -46.21 85.19 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.264 0.626 . . . . 0.0 111.981 169.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.89 87.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.359 0.527 . . . . 0.0 112.136 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.86 -48.36 75.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.985 0.514 . . . . 0.0 111.512 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.76 84.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.659 0.784 . . . . 0.0 112.754 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.9 mt -58.61 -46.3 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.653 1.181 . . . . 0.0 111.83 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.48 -40.01 67.25 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.876 -0.515 . . . . 0.0 109.869 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.0 m -56.98 -44.8 83.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.495 1.118 . . . . 0.0 112.159 170.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.79 83.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.067 0.947 . . . . 0.0 112.961 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.69 -23.9 63.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.38 -13.1 6.63 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.53 1.538 . . . . 0.0 114.832 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -71.44 143.4 50.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.255 1.028 . . . . 0.0 111.535 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -71.95 133.79 45.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.95 157.78 45.68 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.51 0.724 . . . . 0.0 111.977 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -151.63 110.53 3.86 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 172.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' HB1' ' A' ' 19' ' ' ALA . 7.5 p -79.65 150.71 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.721 0.808 . . . . 0.0 111.269 169.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -127.59 171.76 11.35 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.23 1.412 . . . . 0.0 111.592 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -128.7 -36.16 1.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -142.43 55.57 4.52 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 126.379 1.872 . . . . 0.0 111.511 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.01 155.58 54.64 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 124.063 3.175 . . . . 0.0 113.945 -170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.23 174.21 10.46 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.427 1.891 . . . . 0.0 110.165 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.16 -34.73 58.14 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.635 -1.291 . . . . 0.0 112.175 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.5 m -54.76 -21.8 12.16 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -96.34 -25.68 15.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.004 1.721 . . . . 0.0 112.614 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.455 ' CH2' HG21 ' A' ' 52' ' ' VAL . 60.7 t-105 -74.18 -39.6 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.228 1.011 . . . . 0.0 112.809 171.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.14 -49.11 31.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.647 1.979 . . . . 0.0 113.349 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.25 -7.82 11.03 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.288 2.658 . . . . 0.0 115.942 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -127.82 0.36 6.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.867 1.667 . . . . 0.0 114.106 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -60.19 -23.12 63.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.401 1.455 . . . . 0.0 113.953 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -98.59 13.38 32.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.371 2.268 . . . . 0.0 113.302 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -139.45 -172.06 3.27 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.585 1.954 . . . . 0.0 111.648 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -76.62 154.52 34.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.064 0.935 . . . . 0.0 111.835 169.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.455 HG21 ' CH2' ' A' ' 44' ' ' TRP . 27.7 m -149.27 170.2 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.483 1.913 . . . . 0.0 110.264 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.93 153.24 22.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.57 0.748 . . . . 0.0 110.656 176.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.95 140.29 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.16 0.984 . . . . 0.0 111.764 -169.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 t -136.15 103.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.384 1.074 . . . . 0.0 110.249 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.6 m -140.43 143.09 35.41 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.4 p -93.67 -170.42 2.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.8 1.64 . . . . 0.0 113.497 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.3 m -135.95 137.22 41.08 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 111.626 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -161.43 -148.27 0.15 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.819 2.448 . . . . 0.0 107.214 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 41.94 44.87 4.73 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 126.227 1.87 . . . . 0.0 117.171 169.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.66 ' H ' HM73 ' A' ' 201' ' ' FMN . 8.9 tt0 63.92 26.04 14.11 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 113.997 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.11 26.43 3.51 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.198 1.38 . . . . 0.0 114.302 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -132.26 178.24 6.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.052 1.741 . . . . 0.0 111.628 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -80.24 155.25 74.6 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.128 -0.983 . . . . 0.0 113.571 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -63.73 152.01 82.49 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.01 3.14 . . . . 0.0 113.446 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.16 -20.4 65.36 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.8 p -64.71 -13.1 53.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.334 1.454 . . . . 0.0 114.683 171.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.79 -7.4 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.706 1.202 . . . . 0.0 113.919 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -47.19 -50.73 45.9 Favored Pre-proline 0 N--CA 1.481 1.09 0 O-C-N 120.307 -1.496 . . . . 0.0 113.035 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.07 -4.91 16.06 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.135 1.89 . . . . 0.0 114.253 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.36 -47.15 7.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.907 0.883 . . . . 0.0 109.134 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.37 -50.71 68.85 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.998 1.319 . . . . 0.0 112.107 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -62.75 -39.02 92.83 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.196 -0.94 . . . . 0.0 112.829 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.69 -41.93 48.59 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.445 1.022 . . . . 0.0 112.514 -174.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -64.98 -45.19 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.426 1.113 . . . . 0.0 109.482 174.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.09 -50.0 74.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.261 1.024 . . . . 0.0 112.301 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.21 -34.68 56.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.098 0.959 . . . . 0.0 113.542 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -96.72 -35.89 10.85 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -169.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 mp -89.44 -44.01 10.46 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.375 0.988 . . . . 0.0 113.365 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.44 -39.87 0.36 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 126.371 1.938 . . . . 0.0 117.118 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -157.71 134.21 9.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.511 1.524 . . . . 0.0 110.954 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -158.54 52.92 0.56 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.02 -21.38 73.1 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.96 2.44 . . . . 0.0 115.052 -173.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -72.0 -21.61 61.54 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.935 1.294 . . . . 0.0 113.876 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.97 138.64 38.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 111.114 -174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -133.38 143.64 49.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.691 1.996 . . . . 0.0 109.929 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -160.35 -170.86 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.63 28.82 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 127.676 2.56 . . . . 0.0 109.345 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.0 t -139.43 136.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 117.942 0.871 . . . . 0.0 110.516 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.71 104.81 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.09 152.23 25.42 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.571 -0.706 . . . . 0.0 109.871 169.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -139.26 153.17 47.77 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.227 1.011 . . . . 0.0 111.106 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.31 -147.66 11.3 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.065 0.84 . . . . 0.0 111.46 170.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -138.12 121.32 16.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.57 1.948 . . . . 0.0 109.235 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 91.6 p -67.12 -2.89 6.23 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -64.01 -25.6 68.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.064 0.946 . . . . 0.0 113.16 170.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -86.49 145.74 26.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.114 0.965 . . . . 0.0 112.14 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.05 -36.33 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.504 1.121 . . . . 0.0 112.422 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -87.14 -1.1 57.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.5 t80 26.72 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.569 2.747 . . . . 0.0 115.699 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 27.9 p -121.94 17.16 10.93 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.138 1.775 . . . . 0.0 113.853 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.03 -31.04 39.06 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.82 1.248 . . . . 0.0 113.959 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.62 -35.28 80.18 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 123.636 0.636 . . . . 0.0 113.558 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.81 -41.86 14.17 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 120.94 -1.33 . . . . 0.0 113.022 172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -57.08 -36.29 70.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.139 0.976 . . . . 0.0 113.248 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -58.12 -40.03 80.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.466 0.706 . . . . 0.0 112.689 172.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.37 -30.72 62.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.45 1.023 . . . . 0.0 112.618 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.36 -45.21 92.21 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.201 -1.562 . . . . 0.0 110.55 169.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.7 -37.56 76.36 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.3 tp -52.79 -33.82 50.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.841 1.257 . . . . 0.0 112.342 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.44 -37.67 10.82 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.713 1.205 . . . . 0.0 111.771 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -66.19 -32.82 74.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.091 -1.006 . . . . 0.0 113.429 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.47 -13.26 38.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.444 1.098 . . . . 0.0 112.588 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -116.32 8.07 14.12 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.556 1.542 . . . . 0.0 112.114 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.8 m 71.65 17.66 5.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.855 2.062 . . . . 0.0 114.454 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 168.94 1.34 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.94 0.896 . . . . 0.0 111.691 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -131.13 101.67 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.734 -1.229 . . . . 0.0 112.088 -169.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 ttm105 -67.35 134.12 50.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.923 -1.11 . . . . 0.0 111.182 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.53 31.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.726 1.61 . . . . 0.0 111.781 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.05 -178.47 45.02 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 120.473 -1.392 . . . . 0.0 114.027 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.31 136.56 33.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.449 1.099 . . . . 0.0 110.589 170.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.0 ttp -63.4 127.58 31.93 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.874 0.87 . . . . 0.0 111.216 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.471 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -84.81 139.46 31.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 109.644 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.471 ' N ' HD13 ' A' ' 123' ' ' LEU . 37.3 mt -123.95 90.42 3.26 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.858 1.263 . . . . 0.0 111.058 -176.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -72.13 136.56 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.182 0.993 . . . . 0.0 110.673 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -129.7 105.65 8.18 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.047 1.339 . . . . 0.0 111.471 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.29 -20.32 27.44 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -82.92 -6.55 59.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.445 1.02 . . . . 0.0 113.721 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.64 -26.34 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.571 . . . . 0.0 112.52 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -143.01 113.07 5.76 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.811 1.245 . . . . 0.0 111.239 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.69 -1.38 11.55 Favored 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.646 2.897 . . . . 0.0 114.497 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -129.43 79.12 74.55 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.485 1.514 . . . . 0.0 111.6 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.43 -34.31 7.38 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.782 4.321 . . . . 0.0 116.781 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -52.31 -45.76 65.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.767 1.227 . . . . 0.0 112.233 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -17.0 64.42 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -95.89 -5.65 41.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.211 1.405 . . . . 0.0 112.705 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 p -136.31 -30.04 0.95 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -51.64 -53.83 46.2 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 119.533 1.061 . . . . 0.0 113.451 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.62 -29.52 29.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.556 1.504 . . . . 0.0 113.013 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -62.2 -48.06 81.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.439 0.695 . . . . 0.0 111.404 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.7 t -67.67 -41.19 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.565 0.62 . . . . 0.0 110.614 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -58.89 -41.74 87.9 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.741 0.701 . . . . 0.0 111.896 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -65.43 -57.78 7.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.874 0.87 . . . . 0.0 112.162 173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -53.98 -44.32 70.7 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 111.9 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.34 -19.99 35.0 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.502 1.525 . . . . 0.0 115.995 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p -72.07 -19.0 61.89 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 119.982 1.891 . . . . 0.0 113.974 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 59.9 mt -93.23 -16.41 24.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.107 1.363 . . . . 0.0 113.061 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.22 150.19 26.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.505 2.322 . . . . 0.0 111.624 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.389 1.475 . . . . 0.0 113.689 179.721 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.66 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 ttp . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.487 0.184 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.14 -176.88 4.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.591 1.956 . . . . 0.0 110.914 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -140.51 123.96 16.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.555 1.142 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 mm -124.27 136.67 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.93 127.41 9.22 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.3 mt -117.6 91.15 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.466 1.106 . . . . 0.0 108.591 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -91.56 138.28 31.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.037 0.935 . . . . 0.0 111.492 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.63 143.37 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.684 0.754 . . . . 0.0 111.457 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.48 90.39 0.21 Allowed Glycine 0 N--CA 1.463 0.495 0 C-N-CA 125.347 1.451 . . . . 0.0 109.653 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 t -134.66 165.73 24.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.173 0.989 . . . . 0.0 113.235 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -121.63 -32.14 3.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.179 1.792 . . . . 0.0 110.996 -175.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -134.5 -5.3 2.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.611 1.564 . . . . 0.0 113.861 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.59 -0.56 52.92 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.362 1.081 . . . . 0.0 112.776 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -76.19 -32.71 59.15 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.546 1.138 . . . . 0.0 112.872 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.87 -39.03 80.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.641 -1.287 . . . . 0.0 112.796 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.55 -41.17 72.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.572 0.623 . . . . 0.0 111.751 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.9 -35.19 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 121.753 -0.592 . . . . 0.0 112.205 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.59 95.33 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.201 -0.937 . . . . 0.0 112.662 172.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.99 -41.06 97.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.356 0.662 . . . . 0.0 112.337 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -59.61 -46.79 87.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.535 -0.728 . . . . 0.0 111.902 169.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.5 88.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.224 0.61 . . . . 0.0 112.317 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.15 -47.02 79.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.397 0.679 . . . . 0.0 111.993 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.97 -45.66 92.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.419 0.688 . . . . 0.0 112.643 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.68 -47.38 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.569 1.148 . . . . 0.0 112.094 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -68.39 -39.77 81.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 109.744 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.8 m -55.77 -50.48 70.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.7 1.2 . . . . 0.0 111.855 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.3 77.65 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -77.31 -5.52 49.82 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.84 24.32 10.0 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.918 0.781 . . . . 0.0 114.648 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -115.93 145.69 42.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.742 1.217 . . . . 0.0 111.389 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -74.27 138.25 43.49 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.49 159.13 43.27 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.606 -0.684 . . . . 0.0 111.994 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -154.7 120.13 5.06 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.76 176.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.0 140.26 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.18 0.992 . . . . 0.0 110.958 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.09 110.65 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.002 1.321 . . . . 0.0 109.701 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.99 -17.66 28.97 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -170.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -144.93 56.65 3.87 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.635 1.574 . . . . 0.0 110.612 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.34 162.21 40.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.941 3.094 . . . . 0.0 115.185 -169.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -136.67 175.07 9.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.213 2.205 . . . . 0.0 109.668 169.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -50.73 -40.85 55.56 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.902 -1.124 . . . . 0.0 112.414 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -58.43 -14.77 8.49 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -96.81 -27.33 14.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -82.46 -39.61 22.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.452 1.501 . . . . 0.0 112.221 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -49.16 -45.3 75.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.849 1.66 . . . . 0.0 114.495 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -57.29 -10.6 6.64 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.225 2.617 . . . . 0.0 116.899 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -114.65 4.27 15.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.74 -23.32 67.32 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.263 1.392 . . . . 0.0 114.273 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -92.32 4.2 53.84 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.948 1.299 . . . . 0.0 113.525 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -130.89 -141.06 0.22 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.46 2.304 . . . . 0.0 109.771 -169.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -126.16 158.7 34.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.672 1.189 . . . . 0.0 111.361 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.96 168.77 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.274 1.429 . . . . 0.0 110.936 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.97 149.63 19.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.98 0.912 . . . . 0.0 110.387 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.0 t -118.87 135.26 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.052 1.341 . . . . 0.0 110.302 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.3 90.73 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.153 1.381 . . . . 0.0 107.581 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.8 m -133.57 168.36 18.79 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -141.51 -174.33 4.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.106 1.363 . . . . 0.0 113.432 -171.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.8 m -131.62 135.61 47.08 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.609 1.164 . . . . 0.0 110.824 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 t -153.71 -167.37 2.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.393 1.877 . . . . 0.0 109.929 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' HM73 ' A' ' 201' ' ' FMN . . . 45.52 -129.87 9.16 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 126.039 1.781 . . . . 0.0 114.078 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -65.79 -4.23 6.29 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.51 39.52 1.0 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.985 1.279 . . . . 0.0 112.574 -170.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -135.13 176.41 8.69 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.602 1.961 . . . . 0.0 113.85 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.37 136.54 60.74 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.146 1.378 . . . . 0.0 113.283 171.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.27 150.19 89.26 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.55 2.833 . . . . 0.0 111.523 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -60.65 -17.4 47.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -57.34 -17.5 12.72 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.292 1.837 . . . . 0.0 114.585 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.27 -10.34 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.3 t -47.1 -45.58 53.1 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 116.867 -1.539 . . . . 0.0 113.664 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.16 -27.65 35.13 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 122.676 1.991 . . . . 0.0 113.82 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 tp -69.29 -47.17 65.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.023 0.829 . . . . 0.0 110.778 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.25 -47.58 84.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.126 1.37 . . . . 0.0 112.382 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -60.16 -48.95 79.57 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.295 -0.878 . . . . 0.0 112.101 171.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.64 95.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.194 0.902 . . . . 0.0 113.506 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.0 mt -62.01 -45.87 97.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.479 1.139 . . . . 0.0 110.486 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.12 -47.04 86.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.978 0.511 . . . . 0.0 112.18 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.95 -37.25 29.74 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.395 1.478 . . . . 0.0 114.327 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.8 m -121.39 10.5 10.54 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -168.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.14 -47.18 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.713 1.142 . . . . 0.0 112.474 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.44 -34.86 0.45 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 169.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -157.23 137.55 12.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.475 1.637 . . . . 0.0 111.515 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -158.94 63.74 2.46 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.533 1.133 . . . . 0.0 113.34 -173.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.48 -15.02 42.86 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.416 3.411 . . . . 0.0 116.77 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -120.9 -0.47 10.08 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.555 1.542 . . . . 0.0 114.384 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.02 141.78 47.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.973 0.909 . . . . 0.0 109.578 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -131.07 138.92 49.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 111.338 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -154.67 -171.17 3.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -170.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.71 161.8 31.64 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 127.595 2.521 . . . . 0.0 109.911 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.07 135.46 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.91 0.855 . . . . 0.0 111.879 -172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.5 mt -119.3 128.8 75.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 169.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.4 145.23 48.47 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.652 1.181 . . . . 0.0 110.231 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.75 139.49 31.07 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.85 0.86 . . . . 0.0 110.419 -171.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.37 -147.0 6.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -138.74 124.41 19.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.998 0.919 . . . . 0.0 110.649 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.9 p -70.05 -3.37 16.13 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -68.37 -0.92 5.41 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.029 1.331 . . . . 0.0 114.313 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.74 155.88 44.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.071 1.749 . . . . 0.0 112.045 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.1 m -77.21 1.26 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.61 44.74 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.255 1.422 . . . . 0.0 110.315 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -52.05 115.93 1.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.022 -1.674 . . . . 0.0 112.745 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 94.5 m 51.01 26.99 2.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -58.99 -31.79 69.09 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.045 -1.034 . . . . 0.0 113.498 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.43 87.84 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.134 0.879 . . . . 0.0 112.625 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.62 99.54 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.845 -1.385 . . . . 0.0 112.639 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.06 -40.86 97.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.908 0.883 . . . . 0.0 113.001 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -58.95 -42.13 89.08 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.075 0.95 . . . . 0.0 111.637 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.09 -30.54 63.74 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.52 -45.04 76.9 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.007 -1.683 . . . . 0.0 110.963 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -38.31 74.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.835 0.854 . . . . 0.0 113.212 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -50.53 -31.84 16.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.461 1.504 . . . . 0.0 112.994 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.35 -36.74 8.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.619 1.168 . . . . 0.0 111.766 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -65.49 -31.46 72.54 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.368 -0.833 . . . . 0.0 113.161 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.36 -15.32 57.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.254 1.021 . . . . 0.0 112.752 170.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -113.52 3.53 15.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.081 1.353 . . . . 0.0 112.652 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m 74.68 15.85 3.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.619 1.968 . . . . 0.0 113.955 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.11 164.49 6.72 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -121.93 150.79 41.5 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.869 -1.144 . . . . 0.0 110.585 -170.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.2 ttp85 -132.01 108.04 9.07 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 121.32 -0.863 . . . . 0.0 111.198 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.69 45.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.405 1.482 . . . . 0.0 112.329 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.54 -168.88 42.01 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.402 1.953 . . . . 0.0 111.995 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.42 147.78 50.67 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.223 -1.163 . . . . 0.0 112.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -66.26 123.54 20.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.781 1.232 . . . . 0.0 112.028 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -81.61 138.1 35.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.071 0.948 . . . . 0.0 110.238 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.1 mt -125.49 93.38 3.84 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.722 1.209 . . . . 0.0 111.661 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.8 mt -84.48 138.9 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.586 1.554 . . . . 0.0 111.234 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -125.72 105.17 8.78 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.001 1.32 . . . . 0.0 112.323 -177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.75 -21.86 43.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.14 1.376 . . . . 0.0 114.267 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.5 p -77.86 -7.88 57.29 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 174.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -126.36 -26.4 3.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.363 1.465 . . . . 0.0 112.415 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -143.86 114.77 5.52 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.897 0.879 . . . . 0.0 112.313 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.01 -0.68 10.12 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 124.309 3.339 . . . . 0.0 114.526 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.89 76.51 71.05 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.009 1.724 . . . . 0.0 109.942 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -61.16 -20.13 66.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.236 3.29 . . . . 0.0 115.796 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.45 -35.01 71.47 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.773 -1.204 . . . . 0.0 113.653 169.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 p -66.9 -9.56 39.31 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -109.77 -12.14 14.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.605 1.162 . . . . 0.0 112.103 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 p -126.29 -27.74 3.17 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -54.23 -52.76 65.99 Favored Pre-proline 0 CA--C 1.552 1.055 0 CA-C-N 119.64 1.109 . . . . 0.0 113.26 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.77 -30.13 27.83 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.726 1.617 . . . . 0.0 112.826 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.2 t90 -61.32 -48.74 79.98 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.671 -0.643 . . . . 0.0 111.719 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.2 t -68.25 -40.2 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.339 0.518 . . . . 0.0 110.474 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -59.7 -36.34 76.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.893 0.77 . . . . 0.0 112.56 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -68.41 -59.69 2.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.935 0.789 . . . . 0.0 111.986 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -53.08 -46.24 68.51 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.462 1.105 . . . . 0.0 112.09 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -49.42 -24.68 5.52 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 126.218 1.866 . . . . 0.0 116.172 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.3 p -73.99 -21.38 60.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.723 1.762 . . . . 0.0 114.184 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.21 -23.25 47.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.314 1.046 . . . . 0.0 112.952 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.5 -28.95 69.56 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.6 1.56 . . . . 0.0 114.823 -169.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.253 1.285 0 C-N-CA 125.386 1.475 . . . . 0.0 111.935 173.535 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.405 HM73 ' O ' ' A' ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.53 175.57 8.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.944 1.698 . . . . 0.0 112.119 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.99 121.17 20.08 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.882 1.273 . . . . 0.0 110.399 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mm -115.6 125.39 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.911 0.885 . . . . 0.0 113.228 -169.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.98 124.74 7.0 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -117.01 99.07 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.763 1.282 . . . . 0.0 108.995 -170.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -99.66 136.61 39.33 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.06 0.944 . . . . 0.0 110.681 -169.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.83 145.69 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.432 0.634 . . . . 0.0 111.54 -169.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.31 100.51 0.38 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.8 t -151.46 163.97 37.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.285 1.034 . . . . 0.0 113.131 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 95.1 mmm -122.9 -0.98 8.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.651 1.58 . . . . 0.0 112.54 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -141.08 -58.78 0.5 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.88 0.872 . . . . 0.0 113.053 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.27 -2.5 0.42 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -61.04 -44.99 96.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.6 1.2 . . . . 0.0 112.862 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.1 p -75.96 -32.76 59.66 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.182 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.8 tp -60.03 -40.4 89.2 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.753 -1.217 . . . . 0.0 112.794 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.9 tp -54.97 -42.85 72.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.732 0.697 . . . . 0.0 111.86 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.41 -36.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 121.805 -0.559 . . . . 0.0 111.895 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.27 97.72 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.25 -0.906 . . . . 0.0 112.941 171.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.88 -41.02 97.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 112.257 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -59.77 -47.54 85.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.581 0.752 . . . . 0.0 111.984 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.02 86.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.372 0.669 . . . . 0.0 112.308 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.79 -46.64 77.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 112.001 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.38 -45.75 91.76 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.661 0.784 . . . . 0.0 112.809 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.4 mt -60.66 -45.69 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.741 1.216 . . . . 0.0 112.04 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.6 mt -68.09 -42.25 80.61 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.596 -0.69 . . . . 0.0 109.594 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -55.24 -47.97 74.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.757 1.223 . . . . 0.0 112.214 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -35.35 80.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.117 0.967 . . . . 0.0 113.29 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.14 -8.58 56.67 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.54 -3.61 56.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.198 1.38 . . . . 0.0 114.583 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -73.27 177.05 5.4 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -115.96 147.36 41.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.152 1.381 . . . . 0.0 109.548 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.25 164.32 35.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.463 -0.773 . . . . 0.0 112.642 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 m -152.93 121.01 6.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.811 0.845 . . . . 0.0 110.991 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -76.2 141.37 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.795 1.238 . . . . 0.0 111.428 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -130.32 109.73 10.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.412 1.485 . . . . 0.0 110.253 172.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.25 -16.27 40.74 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -147.94 54.77 1.96 Allowed Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.886 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.17 163.48 34.89 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.6 2.867 . . . . 0.0 113.949 -170.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.0 173.65 10.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.821 2.048 . . . . 0.0 109.482 169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.59 -40.1 62.31 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.435 -1.416 . . . . 0.0 112.499 -174.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.1 m -62.69 -13.84 37.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -92.73 -33.61 14.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.549 1.139 . . . . 0.0 112.187 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -68.21 -48.14 65.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.723 0.809 . . . . 0.0 112.229 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.5 tp -45.95 -49.25 39.83 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 127.524 2.329 . . . . 0.0 114.522 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.59 -17.4 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.898 3.732 . . . . 0.0 117.92 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.49 -0.4 15.27 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.21 -20.2 65.66 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.12 -1.93 54.14 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.793 1.237 . . . . 0.0 113.264 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -132.48 -130.87 0.18 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.41 2.284 . . . . 0.0 109.595 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -135.26 157.8 45.99 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.035 1.334 . . . . 0.0 110.093 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.85 168.45 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.008 0.923 . . . . 0.0 111.732 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tp -159.85 145.15 15.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.104 0.962 . . . . 0.0 110.569 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.66 132.43 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.522 1.529 . . . . 0.0 110.921 -169.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.57 87.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.1 m -131.16 159.09 38.72 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -167.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -129.87 -171.62 2.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.621 1.568 . . . . 0.0 113.187 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.0 m -123.86 153.32 41.25 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.895 1.278 . . . . 0.0 111.734 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.34 -177.68 6.35 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.646 1.578 . . . . 0.0 111.836 -168.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.407 ' O ' HM73 ' A' ' 201' ' ' FMN . . . 53.28 -84.21 0.01 OUTLIER Glycine 0 CA--C 1.545 1.935 0 C-N-CA 127.358 2.409 . . . . 0.0 117.108 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -142.43 18.26 2.05 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.636 1.574 . . . . 0.0 111.014 170.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.01 14.46 1.83 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 114.657 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -94.81 160.37 14.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.116 2.167 . . . . 0.0 113.446 -169.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.12 145.34 97.58 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 121.563 -0.711 . . . . 0.0 111.134 170.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.39 150.17 32.06 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.679 2.919 . . . . 0.0 111.003 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.84 -25.31 64.9 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -172.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.4 m -59.81 -13.98 12.87 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 172.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 tt -133.3 -7.15 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.1 t -47.71 -49.96 54.07 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.504 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.83 -9.2 25.52 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 122.187 1.925 . . . . 0.0 114.209 179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.84 -48.8 7.89 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.04 1.336 . . . . 0.0 108.793 172.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -65.19 -48.79 72.17 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.96 1.304 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -63.69 -39.2 93.73 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.051 -1.031 . . . . 0.0 111.943 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.82 -48.86 72.62 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 124.071 0.843 . . . . 0.0 112.258 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.2 mt -64.15 -46.74 92.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 118.068 0.934 . . . . 0.0 110.658 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.12 -35.3 78.33 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -109.62 -23.5 11.43 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.4 m -113.95 2.11 14.93 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.9 mt -122.91 -139.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.635 1.574 . . . . 0.0 108.104 169.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.52 -21.0 0.54 Allowed Glycine 0 CA--C 1.534 1.241 0 O-C-N 121.157 -0.964 . . . . 0.0 114.501 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -159.66 126.72 4.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.053 0.926 . . . . 0.0 113.03 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -152.82 61.19 3.66 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 126.262 1.825 . . . . 0.0 112.034 -177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.68 -26.46 80.07 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.003 3.135 . . . . 0.0 115.249 -169.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -82.57 -10.35 59.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.334 1.454 . . . . 0.0 114.678 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -76.7 140.22 40.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.964 0.802 . . . . 0.0 111.651 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -130.94 142.92 50.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.675 1.99 . . . . 0.0 110.847 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -159.47 -171.44 3.31 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -169.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.47 165.98 33.6 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.39 2.424 . . . . 0.0 111.201 172.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.14 137.53 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 118.074 0.937 . . . . 0.0 112.189 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.441 HD11 ' CE3' ' A' ' 140' ' ' TRP . 41.4 mt -127.88 98.51 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.59 153.02 25.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.208 0.527 . . . . 0.0 110.261 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -140.71 138.41 34.2 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.106 0.962 . . . . 0.0 110.58 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.2 4.87 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 122.041 -0.412 . . . . 0.0 112.55 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -150.74 135.57 17.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -5.17 10.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.988 2.115 . . . . 0.0 115.259 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 m -66.46 1.71 1.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -138.68 156.68 47.21 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.215 1.806 . . . . 0.0 111.627 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.68 -33.8 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -96.18 48.56 1.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.843 0.857 . . . . 0.0 111.718 -171.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -49.92 114.77 1.16 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.341 -1.475 . . . . 0.0 112.701 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m 51.03 24.84 2.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -59.31 -29.63 67.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.829 -1.17 . . . . 0.0 113.259 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.37 -35.19 91.65 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 113.388 176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.92 -40.45 10.56 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.526 -0.985 . . . . 0.0 112.896 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -58.11 -39.28 78.25 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.197 0.999 . . . . 0.0 113.291 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -59.7 -35.98 75.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.171 0.588 . . . . 0.0 112.57 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -74.81 -36.01 62.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.338 -0.851 . . . . 0.0 112.502 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.56 -42.87 99.47 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 119.81 -1.806 . . . . 0.0 111.303 169.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.49 88.42 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -52.93 -44.75 67.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.819 1.247 . . . . 0.0 111.142 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.09 -33.55 67.97 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -33.12 74.33 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.033 -1.042 . . . . 0.0 111.875 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.55 -17.96 64.41 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.081 -1.012 . . . . 0.0 112.77 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -99.59 6.09 45.82 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.529 1.532 . . . . 0.0 112.35 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 m 58.58 19.99 7.2 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.082 1.753 . . . . 0.0 114.913 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.99 154.02 27.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.394 0.678 . . . . 0.0 111.691 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -117.15 99.9 7.35 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.087 1.355 . . . . 0.0 111.005 -169.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.0 ttm105 -67.8 133.89 50.01 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.055 -1.028 . . . . 0.0 111.289 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.81 33.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.92 -163.12 36.2 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.982 1.277 . . . . 0.0 112.432 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -125.86 152.47 45.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.092 1.357 . . . . 0.0 112.382 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.7 ttp -69.03 123.95 22.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.48 1.512 . . . . 0.0 111.963 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.3 tm? -80.97 140.72 35.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.914 0.885 . . . . 0.0 109.397 172.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' N ' HD13 ' A' ' 123' ' ' LEU . 59.4 mt -123.24 92.75 3.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.614 1.566 . . . . 0.0 111.167 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.98 137.74 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.355 1.062 . . . . 0.0 111.157 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.87 118.48 32.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.94 1.296 . . . . 0.0 111.402 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.7 92.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.9 m -63.41 -41.08 98.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.61 -32.65 68.23 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.992 0.917 . . . . 0.0 112.43 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -145.4 99.48 4.51 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.163 0.985 . . . . 0.0 112.705 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.9 2.07 7.94 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.898 3.066 . . . . 0.0 114.29 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -122.42 71.84 37.41 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.292 1.837 . . . . 0.0 109.37 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -58.78 -20.62 52.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.646 3.564 . . . . 0.0 116.149 -168.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.84 -39.27 77.27 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.126 -0.984 . . . . 0.0 112.776 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 41.9 p -68.78 -6.32 25.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.291 1.036 . . . . 0.0 113.526 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.52 -2.33 17.69 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.461 1.505 . . . . 0.0 112.161 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.6 p -139.67 -28.1 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -51.95 -54.0 45.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.8 -28.13 30.53 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.666 1.577 . . . . 0.0 112.951 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.441 ' CE3' HD11 ' A' ' 90' ' ' ILE . 75.5 t90 -63.22 -47.79 81.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.381 0.672 . . . . 0.0 111.524 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.01 -40.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 118.587 0.631 . . . . 0.0 110.358 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -58.78 -44.76 90.75 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.672 0.669 . . . . 0.0 111.719 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -61.72 -56.09 23.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.984 0.914 . . . . 0.0 112.357 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -53.34 -48.62 68.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.599 1.16 . . . . 0.0 111.209 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.03 -21.81 32.82 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.586 1.565 . . . . 0.0 116.144 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.3 p -68.88 -19.41 64.23 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 120.507 2.154 . . . . 0.0 113.517 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.5 mt -99.31 -14.88 19.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.0 113.109 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.53 147.75 48.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.185 1.394 . . . . 0.0 111.722 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.119 -172.586 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.407 HM73 ' O ' ' A' ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.22 178.41 6.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.974 1.71 . . . . 0.0 112.098 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -135.35 116.5 14.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.204 1.402 . . . . 0.0 109.31 -173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -118.72 125.39 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.95 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.53 125.05 7.52 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -114.1 91.17 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 118.294 1.047 . . . . 0.0 108.256 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -94.02 136.58 34.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.689 0.796 . . . . 0.0 110.872 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.87 142.64 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.879 0.847 . . . . 0.0 111.086 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.75 79.47 0.32 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -128.04 172.51 10.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.133 0.973 . . . . 0.0 112.974 -170.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.5 tpt -129.67 -34.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.684 1.993 . . . . 0.0 111.627 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -132.17 1.16 3.83 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.35 -1.43 58.84 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -66.19 -42.5 88.77 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.916 1.358 . . . . 0.0 112.164 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -37.32 77.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.337 1.455 . . . . 0.0 112.639 170.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.47 -36.93 76.94 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.725 -1.234 . . . . 0.0 113.513 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -51.85 -45.19 63.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.937 0.79 . . . . 0.0 111.792 172.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.49 -36.54 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.045 -0.41 . . . . 0.0 111.7 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.09 99.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.098 0.863 . . . . 0.0 112.672 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.61 -41.96 98.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.216 0.607 . . . . 0.0 112.347 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.22 -42.19 96.69 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.363 -0.836 . . . . 0.0 112.692 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.9 91.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.494 0.717 . . . . 0.0 112.291 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.55 -47.04 80.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.406 0.682 . . . . 0.0 111.369 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.47 86.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.463 0.705 . . . . 0.0 112.649 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.72 -46.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.046 1.338 . . . . 0.0 112.362 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.0 mt -71.46 -39.99 70.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.534 -0.729 . . . . 0.0 110.104 -175.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -57.48 -46.4 83.74 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.552 1.141 . . . . 0.0 111.931 170.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.34 77.77 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.0 -11.7 60.66 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.33 40.0 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.579 1.561 . . . . 0.0 114.705 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -75.26 153.17 38.13 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.436 1.118 . . . . 0.0 111.526 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -80.62 135.69 36.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.35 154.55 43.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.13 0.572 . . . . 0.0 111.942 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.4 m -153.31 122.7 6.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.906 0.883 . . . . 0.0 111.184 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.33 140.58 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.332 1.053 . . . . 0.0 110.96 171.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -129.0 112.06 13.64 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.82 1.248 . . . . 0.0 110.333 171.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.49 -11.51 31.86 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -145.16 53.76 2.14 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.868 1.267 . . . . 0.0 111.794 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.6 162.39 42.18 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.64 2.893 . . . . 0.0 114.827 -172.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -131.24 169.61 15.71 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.471 2.308 . . . . 0.0 109.295 169.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -38.34 62.8 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.267 -1.521 . . . . 0.0 112.376 -174.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.5 p -61.82 -12.58 18.02 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -92.93 -32.47 14.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.823 1.249 . . . . 0.0 112.216 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -70.75 -42.44 70.49 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.907 0.883 . . . . 0.0 111.926 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.6 tp -47.84 -47.27 63.11 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 127.872 2.469 . . . . 0.0 115.787 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 -9.01 25.17 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.704 2.269 . . . . 0.0 114.881 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -119.53 -15.73 8.98 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -61.77 -27.41 68.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.196 1.362 . . . . 0.0 113.081 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.72 5.97 14.19 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.921 1.288 . . . . 0.0 113.968 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -128.59 -118.95 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.999 2.52 . . . . 0.0 108.245 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -135.56 157.88 45.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.155 1.782 . . . . 0.0 108.833 169.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.01 166.39 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.231 1.012 . . . . 0.0 110.613 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.95 144.92 17.97 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.413 -0.804 . . . . 0.0 110.296 176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -113.97 133.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.654 1.582 . . . . 0.0 110.467 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 t -134.33 92.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 m -135.4 154.79 51.35 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -168.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 p -133.95 -171.56 2.76 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.511 1.524 . . . . 0.0 112.469 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.0 m -122.06 153.37 38.73 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.439 1.096 . . . . 0.0 111.068 -170.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -155.14 -167.69 2.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.574 1.95 . . . . 0.0 109.31 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 45.23 44.98 10.37 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.715 1.626 . . . . 0.0 116.582 169.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.655 ' H ' HM73 ' A' ' 201' ' ' FMN . 79.8 mt-30 64.13 14.93 8.95 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.653 1.981 . . . . 0.0 115.11 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.38 21.07 0.23 Allowed Glycine 0 CA--C 1.537 1.43 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -129.76 173.32 10.76 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.618 1.709 . . . . 0.0 113.803 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.7 mt -64.76 147.3 98.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.306 1.442 . . . . 0.0 112.967 173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -82.1 154.63 16.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.785 2.99 . . . . 0.0 111.87 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -58.78 -23.34 60.05 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.8 m -54.95 -19.1 5.97 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.992 1.717 . . . . 0.0 115.04 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.54 -5.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -45.87 -44.45 33.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 117.183 -1.389 . . . . 0.0 113.442 170.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.04 -27.51 57.66 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 122.375 1.884 . . . . 0.0 114.666 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mt -73.8 -48.54 30.74 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.06 1.3 . . . . 0.0 110.807 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -59.52 -38.87 82.13 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.835 1.254 . . . . 0.0 112.909 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -75.08 -48.31 24.52 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.178 -0.952 . . . . 0.0 112.037 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.39 82.34 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 123.795 0.712 . . . . 0.0 113.991 -170.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.89 -44.35 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.262 1.031 . . . . 0.0 110.357 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.28 -48.37 81.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.196 0.998 . . . . 0.0 112.137 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.01 -41.31 59.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.235 1.414 . . . . 0.0 114.382 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.0 m -123.74 -14.64 7.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -168.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.77 -50.25 7.3 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.662 1.574 . . . . 0.0 109.599 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.31 -40.45 0.47 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 126.536 2.017 . . . . 0.0 117.598 169.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -157.68 138.53 13.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.165 1.483 . . . . 0.0 111.492 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -159.49 100.48 1.53 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.886 1.275 . . . . 0.0 111.2 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.58 -16.27 8.07 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.627 2.885 . . . . 0.0 115.067 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -110.5 -9.3 14.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.349 1.46 . . . . 0.0 113.889 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.5 tp -55.62 124.69 18.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.4 1.88 . . . . 0.0 111.113 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -128.21 140.87 51.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.725 1.61 . . . . 0.0 109.856 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -161.56 -169.29 2.22 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -168.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.68 160.7 30.48 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 127.205 2.336 . . . . 0.0 109.862 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.2 t -140.46 133.76 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.835 0.818 . . . . 0.0 111.399 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.417 HD11 ' CE3' ' A' ' 140' ' ' TRP . 42.1 mt -122.32 100.43 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.78 153.36 25.28 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.317 0.58 . . . . 0.0 109.736 169.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.16 142.24 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.0 0.92 . . . . 0.0 110.602 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.43 -144.22 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.549 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -146.43 120.2 9.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.43 0.692 . . . . 0.0 111.328 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -59.87 -8.49 2.23 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.687 1.595 . . . . 0.0 113.855 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.5 m -60.73 -7.85 2.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.221 1.409 . . . . 0.0 114.567 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -130.38 159.25 37.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.736 1.614 . . . . 0.0 112.729 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.36 -0.91 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 116.102 1.889 . . . . 0.0 116.102 -169.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.53 48.67 1.92 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.752 1.221 . . . . 0.0 110.528 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -51.07 114.97 1.33 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.002 -1.686 . . . . 0.0 113.148 -170.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m 52.95 24.89 3.63 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -61.38 -24.05 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.564 -1.335 . . . . 0.0 113.877 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.26 -59.33 8.55 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 121.249 -0.907 . . . . 0.0 111.562 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.68 -38.59 96.69 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.317 -1.107 . . . . 0.0 114.008 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -40.46 88.54 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.171 0.985 . . . . 0.0 113.655 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.52 -36.15 79.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.327 0.512 . . . . 0.0 112.221 173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.41 -29.34 63.63 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.83 -45.42 71.21 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.256 -1.527 . . . . 0.0 110.559 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.35 67.93 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.7 tp -50.39 -30.2 11.84 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.88 1.672 . . . . 0.0 113.151 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.52 -36.64 7.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.568 1.147 . . . . 0.0 111.743 -171.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -65.67 -30.26 70.93 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.343 -0.848 . . . . 0.0 112.777 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.04 -17.24 63.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.048 0.939 . . . . 0.0 112.622 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -113.7 -7.19 13.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 t 100.37 13.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.188 2.595 . . . . 0.0 113.153 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.08 162.68 4.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.365 0.666 . . . . 0.0 111.992 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -133.36 95.66 3.56 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.205 1.002 . . . . 0.0 109.935 -172.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.9 ttm105 -66.18 136.16 55.53 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.482 -0.761 . . . . 0.0 110.659 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -89.59 34.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.294 1.438 . . . . 0.0 111.503 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.64 41.37 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.979 1.276 . . . . 0.0 113.107 -176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -95.81 144.08 26.48 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.562 1.145 . . . . 0.0 111.02 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttp -63.82 123.57 19.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.832 0.853 . . . . 0.0 111.056 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.5 tm? -81.75 140.0 34.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.714 0.806 . . . . 0.0 109.293 175.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.505 ' N ' HD13 ' A' ' 123' ' ' LEU . 48.0 mt -122.81 92.84 3.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.272 1.429 . . . . 0.0 110.811 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.9 mt -71.77 136.9 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.797 0.839 . . . . 0.0 110.326 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -130.26 106.8 8.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.158 0.983 . . . . 0.0 113.154 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.31 -17.22 41.29 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -68.53 -14.02 62.72 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.753 1.161 . . . . 0.0 113.704 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -139.64 -10.88 1.19 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -139.93 110.37 7.22 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 119.905 1.23 . . . . 0.0 112.598 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.48 0.61 9.64 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.442 3.428 . . . . 0.0 114.794 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.01 76.17 77.36 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.625 1.57 . . . . 0.0 111.592 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -44.35 -34.33 7.17 Favored 'Trans proline' 0 C--N 1.354 0.831 1 C-N-CA 126.077 4.518 . . . . 0.0 117.853 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.49 -37.68 70.7 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.244 -0.91 . . . . 0.0 113.39 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -69.64 -5.97 28.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.56 1.144 . . . . 0.0 113.343 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -113.54 -2.18 13.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.595 1.558 . . . . 0.0 111.84 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 p -139.96 -28.43 0.74 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -169.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -55.88 -51.6 79.12 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.0 -28.95 41.21 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.742 1.628 . . . . 0.0 112.619 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CE3' HD11 ' A' ' 90' ' ' ILE . 70.9 t90 -63.37 -48.34 78.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.767 0.827 . . . . 0.0 111.748 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.74 -39.84 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 118.834 0.743 . . . . 0.0 110.409 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -57.55 -43.98 84.84 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.117 0.417 . . . . 0.0 111.342 175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -63.62 -57.49 9.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.701 0.8 . . . . 0.0 112.534 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -51.49 -48.78 62.76 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.712 1.205 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -50.93 -28.5 17.19 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.78 1.657 . . . . 0.0 116.122 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.1 p -69.75 -18.9 63.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.566 1.683 . . . . 0.0 114.025 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.96 -14.61 27.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 113.056 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.36 164.21 11.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.458 1.903 . . . . 0.0 112.468 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.767 1.227 . . . . 0.0 113.58 171.528 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.655 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.72 177.25 7.77 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.793 1.637 . . . . 0.0 112.599 -173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -131.31 115.27 16.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.918 1.687 . . . . 0.0 109.291 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mm -111.55 126.7 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.821 0.848 . . . . 0.0 112.76 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.93 125.87 7.53 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.1 mt -117.29 91.35 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 108.938 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -90.34 132.74 35.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.94 0.896 . . . . 0.0 110.732 -170.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.55 144.78 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.29 0.636 . . . . 0.0 111.52 -169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.86 104.46 0.55 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -149.22 161.37 42.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.028 1.331 . . . . 0.0 111.434 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 79.4 mmm -106.3 -11.79 15.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.073 0.949 . . . . 0.0 113.291 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -146.7 -26.46 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.46 -5.49 4.89 Favored Glycine 0 CA--C 1.537 1.425 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.95 -44.5 94.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.585 1.693 . . . . 0.0 113.228 -169.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -81.23 -31.04 34.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.372 0.669 . . . . 0.0 112.581 173.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.57 -38.91 75.61 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.737 -1.227 . . . . 0.0 113.239 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -52.76 -42.06 64.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.075 0.852 . . . . 0.0 111.801 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.9 t -69.47 -34.67 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.109 0.563 . . . . 0.0 112.008 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.56 92.07 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.44 1.018 . . . . 0.0 112.412 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.91 -41.75 96.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.567 0.747 . . . . 0.0 112.034 173.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -61.3 -46.52 89.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.281 0.632 . . . . 0.0 112.227 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.52 88.64 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.501 -0.749 . . . . 0.0 112.793 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.19 -45.89 79.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.724 0.809 . . . . 0.0 112.012 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.92 -45.89 80.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.779 0.832 . . . . 0.0 112.672 176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.56 -31.73 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.058 1.343 . . . . 0.0 112.996 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.1 mt -75.55 -41.38 55.03 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.807 -1.183 . . . . 0.0 110.175 174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.3 m -56.6 -44.65 81.3 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.166 0.986 . . . . 0.0 111.807 171.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.66 76.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.74 1.216 . . . . 0.0 113.601 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.64 -5.41 47.75 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.405 1.082 . . . . 0.0 113.621 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.83 0.33 55.17 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.294 1.426 . . . . 0.0 114.502 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -81.83 -177.16 6.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.957 1.303 . . . . 0.0 111.919 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -122.51 150.76 42.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.933 1.693 . . . . 0.0 109.145 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -149.87 167.15 27.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -152.38 119.35 5.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 110.811 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -74.37 145.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.391 1.076 . . . . 0.0 111.02 171.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.0 109.21 9.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.426 1.49 . . . . 0.0 109.193 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.91 -28.59 35.79 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -144.25 56.43 4.11 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.878 1.671 . . . . 0.0 110.981 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.04 165.16 32.71 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.684 2.923 . . . . 0.0 115.566 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -133.98 171.68 13.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.728 2.011 . . . . 0.0 109.712 169.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -50.91 -39.61 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.989 -1.07 . . . . 0.0 113.038 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 m -58.62 -20.39 47.04 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -85.06 -33.06 22.55 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.211 0.914 . . . . 0.0 112.498 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.538 ' CZ2' HG21 ' A' ' 52' ' ' VAL . 28.4 t-105 -78.34 -40.75 35.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.639 1.175 . . . . 0.0 112.578 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.3 tp -41.44 -46.97 8.67 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.752 2.821 . . . . 0.0 115.577 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.86 -28.89 67.52 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.754 2.969 . . . . 0.0 116.316 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -80.06 2.5 23.63 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -169.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -60.32 -23.44 64.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.71 -1.244 . . . . 0.0 114.212 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -87.32 3.5 46.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.827 1.251 . . . . 0.0 113.072 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -137.32 -137.63 0.14 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.709 2.003 . . . . 0.0 110.97 -168.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -140.83 164.29 30.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.21 1.804 . . . . 0.0 110.626 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG21 ' CZ2' ' A' ' 44' ' ' TRP . 28.7 m -144.05 174.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.252 1.421 . . . . 0.0 111.741 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tt -152.19 146.44 25.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.669 1.988 . . . . 0.0 108.49 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.28 133.04 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.357 1.063 . . . . 0.0 109.687 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.91 90.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.933 1.293 . . . . 0.0 108.786 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.5 m -135.76 141.62 44.84 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -94.95 -165.21 1.27 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.257 1.823 . . . . 0.0 113.155 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.7 m -132.43 150.35 52.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.337 -1.477 . . . . 0.0 111.715 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -148.08 -164.91 2.13 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.28 2.232 . . . . 0.0 109.63 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 30.82 50.09 0.2 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.886 2.66 . . . . 0.0 118.642 169.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.469 ' H ' HM73 ' A' ' 201' ' ' FMN . 71.5 mt-30 54.19 35.05 21.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.611 1.564 . . . . 0.0 113.84 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.32 0.58 9.47 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.884 1.707 . . . . 0.0 115.071 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -75.26 168.41 20.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.349 1.86 . . . . 0.0 113.601 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.15 145.66 65.45 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.804 1.241 . . . . 0.0 109.759 169.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.69 140.65 57.03 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.316 2.678 . . . . 0.0 110.412 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.37 -28.82 65.49 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -59.29 -12.05 5.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -122.66 -3.7 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.577 1.08 . . . . 0.0 113.338 173.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.2 t -56.79 -46.2 99.87 Favored Pre-proline 0 N--CA 1.475 0.808 0 O-C-N 120.343 -1.473 . . . . 0.0 112.34 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.93 -12.97 7.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.921 3.081 . . . . 0.0 116.305 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 tp -99.89 -44.49 6.04 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.545 1.138 . . . . 0.0 110.577 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.32 -42.9 99.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.644 1.178 . . . . 0.0 112.238 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -66.88 -26.86 67.09 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.111 -0.993 . . . . 0.0 113.446 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.97 -41.73 4.56 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.078 -171.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.25 -41.06 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 119.447 1.623 . . . . 0.0 111.054 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.32 -48.01 83.24 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.701 1.2 . . . . 0.0 112.32 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -36.05 19.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.831 0.853 . . . . 0.0 113.226 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 m -82.49 -37.08 25.81 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.75 -46.41 15.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.18 0.9 . . . . 0.0 112.393 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.97 -39.1 0.42 Allowed Glycine 0 CA--C 1.542 1.762 0 C-N-CA 126.239 1.876 . . . . 0.0 115.415 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -161.94 142.27 10.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.748 2.019 . . . . 0.0 110.187 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -150.9 102.34 3.03 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.705 1.202 . . . . 0.0 111.407 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.68 -16.31 10.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.693 2.262 . . . . 0.0 114.456 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.95 -5.36 9.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.4 117.39 6.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.663 1.185 . . . . 0.0 109.934 172.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -127.93 134.55 49.33 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.716 1.606 . . . . 0.0 110.622 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CB ' HG23 ' A' ' 52' ' ' VAL . 1.3 p90 -155.97 -171.13 3.63 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -171.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.24 160.39 28.26 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.864 1.697 . . . . 0.0 110.487 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.39 135.62 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 122.007 0.908 . . . . 0.0 113.328 -169.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.6 mt -123.0 119.44 57.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.85 147.32 47.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.468 1.107 . . . . 0.0 109.84 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.0 tt -138.55 148.25 44.01 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.046 0.927 . . . . 0.0 112.158 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.65 -141.17 6.08 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.795 169.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -141.95 118.6 11.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.472 1.109 . . . . 0.0 111.197 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.6 t -74.06 -0.02 15.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 t -73.21 4.49 4.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.56 1.073 . . . . 0.0 113.668 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -135.02 157.64 46.41 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.306 1.843 . . . . 0.0 111.673 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 m -74.45 -1.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -169.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -122.97 44.51 2.64 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.808 1.243 . . . . 0.0 110.73 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.29 116.05 1.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.302 -1.499 . . . . 0.0 113.1 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 69.1 m 52.17 24.46 2.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.693 2.397 . . . . 0.0 116.685 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -60.61 -27.8 68.04 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.371 -1.455 . . . . 0.0 113.416 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.64 73.02 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.272 -0.892 . . . . 0.0 113.447 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.64 -40.27 6.84 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.079 0.939 . . . . 0.0 113.13 170.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -58.74 -38.76 79.11 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 118.702 1.251 . . . . 0.0 113.659 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -56.34 -32.06 64.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -75.8 -25.63 56.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.033 0.833 . . . . 0.0 113.182 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.74 -43.16 48.14 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.31 -1.494 . . . . 0.0 110.288 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.12 -42.62 69.66 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 170.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 tp -49.99 -43.86 50.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.88 1.672 . . . . 0.0 112.319 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.17 -37.62 14.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.046 0.939 . . . . 0.0 112.464 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.67 -30.28 71.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.461 -0.774 . . . . 0.0 112.21 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.81 -24.42 67.75 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -91.91 -2.21 56.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.748 0.703 . . . . 0.0 112.456 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.8 m 75.09 23.95 1.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.056 2.143 . . . . 0.0 114.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 177.03 0.14 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.64 1.176 . . . . 0.0 112.681 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -135.59 164.35 28.03 Favored 'General case' 0 CA--C 1.52 -0.184 0 O-C-N 120.565 -1.334 . . . . 0.0 110.305 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.0 mtm105 -130.58 142.26 50.46 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 t -96.16 25.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.004 1.722 . . . . 0.0 111.637 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.01 -171.42 44.43 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.018 1.294 . . . . 0.0 114.461 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.05 155.56 39.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.277 1.431 . . . . 0.0 111.641 -176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 28.7 ttm -68.41 121.19 15.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.488 1.115 . . . . 0.0 112.231 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -76.82 136.17 38.93 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -125.67 84.94 2.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.743 1.217 . . . . 0.0 110.866 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.2 mt -74.97 132.87 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.742 1.617 . . . . 0.0 110.634 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -124.35 104.2 8.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -14.86 7.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 172.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.5 m -64.58 -23.09 67.15 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.885 1.221 . . . . 0.0 113.598 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.35 -8.31 0.99 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -135.92 107.58 9.74 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 119.316 0.962 . . . . 0.0 113.064 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.76 -2.06 11.62 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.139 3.226 . . . . 0.0 114.346 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -125.16 78.82 66.53 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.934 1.694 . . . . 0.0 110.514 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -61.39 -23.24 76.49 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.448 3.432 . . . . 0.0 114.328 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.28 -43.68 67.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.557 1.543 . . . . 0.0 112.417 169.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -171.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -104.25 -7.66 19.9 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.632 1.173 . . . . 0.0 112.877 175.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.8 m -123.92 -26.16 4.12 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -60.32 -50.5 85.55 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 120.575 -1.328 . . . . 0.0 111.754 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.04 -34.46 87.21 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.012 2.475 . . . . 0.0 114.79 169.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -61.49 -49.32 77.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.985 0.514 . . . . 0.0 111.495 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.2 t -71.19 -33.41 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.351 -0.843 . . . . 0.0 111.223 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -66.12 -14.92 62.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.232 -0.918 . . . . 0.0 113.173 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -95.98 -57.16 2.43 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.745 1.218 . . . . 0.0 111.634 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.85 -49.02 66.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.875 1.27 . . . . 0.0 111.815 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.76 -24.97 27.98 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.835 1.207 . . . . 0.0 115.685 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.4 p -69.2 -16.54 63.64 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 120.117 1.959 . . . . 0.0 113.659 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.3 mt -99.79 -15.13 18.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.482 1.513 . . . . 0.0 112.995 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.59 143.97 53.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.112 1.365 . . . . 0.0 111.671 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.946 1.698 . . . . 0.0 114.128 -174.586 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.469 HM73 ' H ' ' A' ' 61' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_